<SEC-DOCUMENT>0001213900-20-002773.txt : 20200206
<SEC-HEADER>0001213900-20-002773.hdr.sgml : 20200206
<ACCEPTANCE-DATETIME>20200206153019
ACCESSION NUMBER:		0001213900-20-002773
CONFORMED SUBMISSION TYPE:	F-1/A
PUBLIC DOCUMENT COUNT:		17
FILED AS OF DATE:		20200206
DATE AS OF CHANGE:		20200206

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Zhongchao Inc.
		CENTRAL INDEX KEY:			0001785566
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-EDUCATIONAL SERVICES [8200]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		F-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-234807
		FILM NUMBER:		20582505

	BUSINESS ADDRESS:	
		STREET 1:		841 YAN AN MIDDLE ROAD, JING AN DISTRICT
		STREET 2:		NANXI CREATIVE CENTER, SUITE 218
		CITY:			SHANGHAI
		STATE:			F4
		ZIP:			200040
		BUSINESS PHONE:		021-32205987

	MAIL ADDRESS:	
		STREET 1:		841 YAN AN MIDDLE ROAD, JING AN DISTRICT
		STREET 2:		NANXI CREATIVE CENTER, SUITE 218
		CITY:			SHANGHAI
		STATE:			F4
		ZIP:			200040
</SEC-HEADER>
<DOCUMENT>
<TYPE>F-1/A
<SEQUENCE>1
<FILENAME>ff12019a4_zhongchaoinc.htm
<DESCRIPTION>AMENDMENT NO. 4 TO FORM F-1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>As filed with the Securities and
Exchange Commission on February 6, 2020</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No.&nbsp;333-234807</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNITED STATES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> AMENDMENT No. 4 to </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM F-1</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OF 1933</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ZHONGCHAO INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified
in its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Cayman Islands</FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">8200</FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Not applicable</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;(State or Other Jurisdiction of</FONT><BR>
    <FONT STYLE="font-size: 10pt">Incorporation or Organization)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Primary Standard Industrial</FONT><BR>
    <FONT STYLE="font-size: 10pt">Classification Code Number)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(I.R.S. Employer </FONT><BR>
    <FONT STYLE="font-size: 10pt">Identification Number)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Nanxi Creative Center, Suite 218</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">841 Yan&rsquo;An Middle Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Jing&rsquo;An District, Shanghai, China
200040</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: 021-32205987</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address, including zip code, and telephone
number,&nbsp;including area code, of principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Copies to:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Arila Zhou,
                           Esq.</P>
                           <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Hunter Taubman Fischer &amp; Li LLC</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">1450 Broadway, 26<SUP>th</SUP>
        Floor</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">New York, NY 10018</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: 212-530-2232</P></TD>
    <TD STYLE="width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Fang Liu, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">VCL Law LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">8300 Boone Boulevard, Suite 500</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Vienna, VA 22182</P>

<P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Tel: 703-919-7285</P>



</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Approximate date of commencement of proposed
sale to the public: As soon as practicable after this Registration Statement becomes effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any of the securities being registered
on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the
following box.&nbsp;&nbsp;&#9746;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is filed to register additional
securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment
filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment
filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company &#9746;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company that prepares
its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards&dagger; provided pursuant to Section 7(a)(2)(B)
of the Securities Act &nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&dagger; The term &ldquo;new or revised
financial accounting standard&rdquo; refers to any update issued by the Financial Accounting Standards Board to its Accounting
Standards Codification after April 5, 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="17" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> CALCULATION
    OF REGISTRATION FEE </TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"> Title of Class of Securities to
    be Registered </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Amount
    to Be Registered&nbsp;(1) </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Proposed
    Maximum Offering Price <BR> per Share&nbsp;(2) </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Proposed<BR>
    Maximum<BR> Aggregate<BR> Offering<BR> Price&nbsp;(2)(3) </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Amount
    of&nbsp;<BR> Registration Fee </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"> Class
    A Ordinary Shares, par value $0.0001 per share sold by the Registrant </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,025,000 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 4.5 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 18,112,500 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,351 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> Underwriter&rsquo;s compensation warrants (4) </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> - </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"> Class A Ordinary Shares underlying underwriter&rsquo;s warrants </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 362,250 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 5.625 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,037,656 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 264.5 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> Total </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 4,387,250 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font-size: 10pt; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 4pt double; font-size: 10pt; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 4pt; font-size: 10pt; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 20,150,156 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> 2,615.5 </TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 525,000 Class A Ordinary Shares, par value $0.0001
per share (each, a &ldquo;Share&rdquo;, collectively, &ldquo;Shares&rdquo;) subject to the underwriters&rsquo; option to purchase
additional shares.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated solely
    for the purpose of calculating the registration fee pursuant to Rule 457(a) under the Securities Act of 1933, as amended.
    </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes the offering price of any additional Shares that the
underwriters have the option to purchase.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have agreed
    to issue upon the closing of this Offering, compensation warrants to Network 1 Financial Securities Inc. (&ldquo;Network 1&rdquo;),
    as the lead underwriter, entitling it to purchase up to 9.0% of the aggregate Shares being sold in this Offering. The exercise
    price of the compensation warrants is equal to 125% of the offering price of the Shares offered hereby. Assuming an exercise
    price of $5.625 per Share, we would receive, in the aggregate, $2,037,656 upon exercise of the compensation warrants, of which
    there can be no guarantee.&nbsp;The compensation warrants are exercisable commencing six (6) months after the closing date
    of the offering&nbsp;and will terminate three years after the date of effectiveness. An underwriting discount or spread equal
    to 7.0% of the aggregate offering price will also be provided to the underwriters. The Registration Statement of which this
    prospectus is a part also covers the Shares issuable upon the exercise thereof. For additional information regarding our arrangement
    with the underwriters, please see &ldquo;Underwriting&rdquo; beginning on page 164.</FONT> </TD></TR>
</TABLE>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The registrant hereby amends this registration
statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment
which specifically states that this registration statement shall thereafter become effective in accordance with Section&nbsp;8(a)
of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the Commission,
acting pursuant to such Section&nbsp;8(a), may determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXPLANATORY NOTE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> This Amendment No.
4 to the Registration Statement on Form F-1 (File No. 333-234807) of Zhongchao Inc. (the &ldquo;Registration Statement&rdquo;)
is being filed to (i) include exhibit No. 23.1; (ii) update the Summary Compensation Table under the Executive Compensation section
of Part I, the form of prospectus, with the annual compensation paid by the Company for the year ended 2019. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="color: Red">The information
in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement is filed
with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not
soliciting an offer to buy these securities in any state or other jurisdiction where the offer or sale is not permitted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <B>SUBJECT TO COMPLETION, DATED FEBRUARY
6, 2020</B> </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: Red"><B>&nbsp;</B></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_01.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ZHONGCHAO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>3,500,000 Class
A Ordinary Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>or </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>4,025,000 Class A Ordinary Shares
if the underwriters exercise their over-allotment option in full</B> </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> This is the initial
public offering (the &ldquo;Offering&rdquo;) of ZHONGCHAO INC., a Cayman Islands exempted company with limited liability whose
principal place of business is in Shanghai, China. We are offering 3,500,000 Class A ordinary shares (or 4,025,000 Class A Ordinary
Shares if the underwriters exercise their over-allotment option in full), par value $0.0001 per share (each, a &ldquo;Class A
Ordinary Share&rdquo;, collectively, &ldquo;Class A Ordinary Shares&rdquo;) on a firm commitment basis. We expect that the initial
public offering price will be between $4.0 and $4.5 per share. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As the date hereof,
our authorized share capital is 500,000,000 ordinary shares consisting of 450,000,000 Class A Ordinary Shares and 50,000,000 Class
B ordinary shares, par value $0.0001 per share (each, a &ldquo;Class B Ordinary Share&rdquo;; collectively, &ldquo;Class B Ordinary
Shares&rdquo;). As of the date hereof, we have 16,102,420 Class A Ordinary Shares (including 1,350,068 Class A Ordinary Shares
to be issued upon exercise of the HF Warrant the Company issued to HF Capital. For more details of the HF Warrant, see &ldquo;Prospectus
Summary- Our Corporate History and Structure&rdquo; on page 11) and 5,497,715 Class B Ordinary Shares, issued and outstanding,
respectively.&nbsp;Holders of Class A Ordinary Shares and Class B Class A Ordinary Shares have the same rights except for voting
and conversion rights. In respect of matters requiring a shareholder vote, each Class A Ordinary Share will be entitled to 1 vote
and each Class B Ordinary Share will be entitled to 15 votes. The Class A Ordinary Shares are not convertible into shares of any
other class. The Class B Ordinary Shares are convertible into Class A Ordinary Shares at any time after issuance at the option
of the holder on a one to one basis. The Class B Ordinary Shares are not being converted as part of this Offering.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No public market currently
exists for our Class A Ordinary Shares or Class B Ordinary Shares. We have applied for approval for quotation on the NASDAQ Capital
Market under the symbol &ldquo;ZCMD&rdquo; for the Class A Ordinary Shares we are offering. We believe that upon the completion
of the offering contemplated by this prospectus, we will meet the standards for listing on the NASDAQ Capital Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">We are an &ldquo;emerging
growth company&rdquo; as defined in the Jumpstart Our Business Act of 2012, as amended, and, as such, will be subject to reduced
public company reporting requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> We anticipate that
following the completion of this Offering, our Chief Executive Officer and Chairman of the Board of the Directors, Weiguang Yang,
will beneficially own aggregate 84.48% voting power of the Company given the effect of 1 vote power of each Class A Ordinary Shares
and 15 votes of each Class B Ordinary Share and assuming the full exercise of the over-allotment option by the underwriters and
the exercise of the HF Warrant. While under NASDAQ Marketplace Rules 5615(c), we may be deemed a &ldquo;controlled company,&rdquo;
we do not intend to avail ourselves of the corporate governance exemptions afforded to a &ldquo;controlled company&rdquo; under
the NASDAQ Marketplace Rules. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>An investment in
our securities is highly speculative, involves a high degree of risk and should be considered only by persons who can afford the
loss of their entire investment. See &ldquo;Risk Factors&rdquo; beginning on page 24 of this prospectus. &nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Neither the SEC
nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful
or complete. Any representation to the contrary is a criminal offense.&nbsp;</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus does
not constitute, and there will not be, an offering of securities to the public in the Cayman Islands.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per<BR>
    Ordinary Share</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom; width: 76%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumed
    initial public offering price</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: top; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#9679;]</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: top; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#9679;]</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
    discount and commissions</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumed proceeds
    to us, before expenses (1)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0"> &nbsp; </TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"> <FONT STYLE="font-size: 10pt">(1)</FONT> </TD>
    <TD STYLE="font-size: 10pt; text-align: justify"> <FONT STYLE="font-size: 10pt">Represents underwriting discount and commissions
    equal to 7.0% of the Offering Price for the Class A Ordinary Shares and a non-accountable fee equal to 1.5% of the gross proceeds
    of the Offering. We have also agreed to grant to the underwriter warrants equal to 9% of the aggregate number of Class A
    Ordinary Shares sold in the offering. See &ldquo;Underwriting&rdquo; in this prospectus for more information regarding our
    arrangements with the underwriter.</FONT> </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         total estimated expenses related to this offering are set forth in the section entitled
                                         &ldquo;Underwriting - Discounts, Commissions and Expenses.&rdquo;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> The underwriters
are selling 3,500,000 Class A Ordinary Shares (or 4,025,000 Class A Ordinary Shares if the underwriters exercise their over-allotment
option in full) in this Offering on a firm commitment basis. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> In addition to
the underwriting discounts listed above and the expense allowance described in the footnote, we have agreed to issue upon the
closing of this Offering, compensation warrants to Network 1 Financial Securities Inc. (&ldquo;Network 1&rdquo;), as the lead
underwriter, &nbsp;entitling it to purchase up to 9.0% of the total number of Class A Ordinary Shares being sold in this Offering.
The exercise price of the compensation warrants is equal to 125% of the Offering Price of the Class A Ordinary Shares offered
hereby. The compensation warrants are exercisable commencing 6 months after the closing date of the offering and will terminate
3 years after the date of effectiveness. An underwriting discount or spread equal to 7.0% of the Offering Price will also be provided
to underwriters. The Registration Statement of which this prospectus is a part also covers the Class A Ordinary Shares issuable
upon the exercise thereof. For additional information regarding our arrangement with the underwriters, please see &ldquo;Underwriting&rdquo;
beginning on page 164. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"> We have granted
the underwriters an option, exercisable for 45 days from the date of this prospectus, to purchase up to an additional 15% of the
Class A Ordinary shares on the same terms as the other shares being purchased by the underwriters from us. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"> The underwriters
expect to deliver the Class A Ordinary Shares to purchasers in the Offering on or about [&#9679;], 2019.&nbsp; </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THESE SECURITIES HAVE NOT BEEN APPROVED
OR DISAPPROVED BY THE SECURITIES AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION NOR HAS THE SECURITIES AND EXCHANGE
COMMISSION OR ANY STATE SECURITIES COMMISSION PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE
CONTRARY IS A CRIMINAL OFFENSE.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 34%; font-size: 10pt; text-align: center"> <FONT STYLE="font-size: 10pt">Network 1 Financial Securities
    Inc.</FONT> </TD>
    <TD STYLE="width: 33%; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
</TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_02.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <FONT STYLE="font-size: 9pt">Tiger Brokers (NZ) Limited</FONT> </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> The date of this
prospectus is February 6, 2020 </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_003"><FONT STYLE="font-size: 10pt">Forward-Looking Statements</FONT></A></TD>
    <TD STYLE="text-align: center">iii</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="width: 90%"><A HREF="#a_001"><FONT STYLE="font-size: 10pt">Prospectus Summary</FONT></A></TD>
    <TD STYLE="width: 10%; text-align: center">1</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_002"><FONT STYLE="font-size: 10pt">Risk Factors </FONT></A></TD>
    <TD STYLE="text-align: center">24</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_004"><FONT STYLE="font-size: 10pt">Use of Proceeds</FONT></A></TD>
    <TD STYLE="text-align: center">60</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_005"><FONT STYLE="font-size: 10pt">Dividend Policy</FONT></A></TD>
    <TD STYLE="text-align: center">62</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_006"><FONT STYLE="font-size: 10pt">Exchange Rate Information</FONT></A></TD>
    <TD STYLE="text-align: center">63</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_009"><FONT STYLE="font-size: 10pt">Selected Historical Financial and Operating Data</FONT></A></TD>
    <TD STYLE="text-align: center">63</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_007"><FONT STYLE="font-size: 10pt">Capitalization</FONT></A></TD>
    <TD STYLE="text-align: center">65</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_008"><FONT STYLE="font-size: 10pt">Dilution</FONT></A></TD>
    <TD STYLE="text-align: center">66</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_010"><FONT STYLE="font-size: 10pt">Post-Offering Ownership </FONT></A></TD>
    <TD STYLE="text-align: center">66</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_011"><FONT STYLE="font-size: 10pt">Management&rsquo;s Discussion and Analysis of Financial Condition and Results
    of Operations</FONT></A></TD>
    <TD STYLE="text-align: center">67</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_012"><FONT STYLE="font-size: 10pt">Our Business</FONT></A></TD>
    <TD STYLE="text-align: center">82</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><P STYLE="margin: 0pt 0"><A HREF="#a_013">Management</A></P>


</TD>
    <TD STYLE="text-align: center">127</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_014"><FONT STYLE="font-size: 10pt">Related Party Transactions</FONT></A></TD>
    <TD STYLE="text-align: center">138</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_015">Principal Shareholders</A></TD>
    <TD STYLE="text-align: center">139</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_016"><FONT STYLE="font-size: 10pt">Description of Share Capital</FONT></A></TD>
    <TD STYLE="text-align: center">142</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_017"><FONT STYLE="font-size: 10pt">Shares Eligible for Future Sale</FONT></A></TD>
    <TD STYLE="text-align: center">152</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><P STYLE="margin: 0pt 0"><A HREF="#a_018">Taxation</A></P>


</TD>
    <TD STYLE="text-align: center">155</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_019"><FONT STYLE="font-size: 10pt">Enforceability of Civil Liabilities</FONT></A></TD>
    <TD STYLE="text-align: center">163</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_020"><FONT STYLE="font-size: 10pt">Underwriting</FONT></A></TD>
    <TD STYLE="text-align: center">164</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_021"><FONT STYLE="font-size: 10pt">Legal Matters</FONT></A></TD>
    <TD STYLE="text-align: center">174</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_022"><FONT STYLE="font-size: 10pt">Experts</FONT></A></TD>
    <TD STYLE="text-align: center">174</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_023"><FONT STYLE="font-size: 10pt">Where You Can Find More Information</FONT></A></TD>
    <TD STYLE="text-align: center">174</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_024"><FONT STYLE="font-size: 10pt">Financial Statements</FONT></A></TD>
    <TD STYLE="text-align: center">F-1</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> You should rely
only on the information contained in this prospectus or in any free writing prospectus we may authorize to be delivered or made
available to you. Neither we, nor the underwriters have authorized anyone to provide you with different information. The information
in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus,
or any free writing prospectus, as the case may be, or any sale of shares in the Company. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> For investors outside
the United States: Neither we, nor the underwriters have done anything that would permit this offering or possession or distribution
of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside
the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating
to, the offering of the Class A Ordinary Shares and the distribution of this prospectus outside the United States. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt">This prospectus
includes statistical and other industry and market data that we obtained from industry publications and research, surveys and
studies conducted by third parties. Industry publications and third-party research, surveys and studies generally indicate that
their information has been obtained from sources believed to be reliable, although they do not guarantee the accuracy or completeness
of such information. While we believe these industry publications and third-party research, surveys and studies are reliable,
you are cautioned not to give undue weight to this information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2pt; text-align: justify; text-indent: 34pt">All references
in this prospectus to &ldquo;$,&rdquo; &ldquo;U.S.$,&rdquo; &ldquo;U.S. dollars,&rdquo; &ldquo;dollars&rdquo; and &ldquo;USD&rdquo;
mean U.S. dollars and all references to &ldquo;RMB&rdquo; mean Renminbi, unless otherwise noted. All references to &ldquo;PRC&rdquo;
or &ldquo;China&rdquo; in this prospectus refer to the People&rsquo;s Republic of China.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMONLY USED DEFINED TERMS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    references to &ldquo;RMB,&rdquo; &ldquo;yuan&rdquo; and &ldquo;Renminbi&rdquo; are to the legal currency of China, all references
    to &ldquo;HKD&rdquo; is to the legal currency of Hong Kong, and all references to &ldquo;USD,&rdquo; and &ldquo;U.S. dollars&rdquo;
    are to the legal currency of the United States.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;China&rdquo;
    and &ldquo;PRC&rdquo; refer to the People&rsquo;s Republic of China, excluding, for the purposes of this prospectus only,
    Macau, Taiwan and Hong Kong; </FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">&ldquo;Class
                                         A Ordinary Shares&rdquo; refers to our Class A ordinary shares, $0.0001 par value per
                                         share;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">&ldquo;Class
                                         B Ordinary Shares&rdquo; refers to our Class B ordinary shares, $0.0001 par value per
                                         share;</TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.25pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Controlling
    Shareholder&rdquo; refers to Mr. Weiguang Yang, the CEO of the Company;</FONT></TD></TR>
</TABLE>
<P STYLE="margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Depending
                                         on the context, the terms &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our company,&rdquo;
                                         &ldquo;our&rdquo;, &ldquo;Zhongchao&rdquo; and &ldquo;Zhongchao Cayman&rdquo; refer to
                                         Zhongchao Inc., a Cayman Islands company, and its subsidiaries and affiliated companies;</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&ldquo;Horgos Zhongchao Medical&rdquo; refers to Horgos Zhongchao Medical
    Technology Co., Ltd., a PRC company.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Horgos
                                         Zhongchao Zhongxing&rdquo; refers to Horgos Zhongchao Zhongxing Medical Technology Co.,
                                         Ltd., a PRC company.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;mobile
    MAUs&rdquo; are the number of unique IP address that various mobile devices having access to our MDMOOC mobile app or Sunshine
    Health Forums from mobile end at least once during a month. The numbers of our mobile MAUs are calculated using internal company
    data that has not been independently verified, and we treat each distinguishable device IP address as a separate user for
    purposes of calculating mobile MAUs, although inaccuracy may result from the possibility that one mobile device may have more
    than one IP addresses;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;monthly
    UVs&rdquo; of MDMOOC website, MDMOOC.org, or the website of our Sunshine Health Forums, ygjkclass.com, are to the number of
    unique IP address that various internet browsers apply to access our websites, from either PC end or mobile end, at least
    once during a month. The numbers of our monthly UVs of our websites&nbsp;are calculated using internal company data that has
    not been independently verified, and we treat each distinguishable IP address as a separate user for purposes of calculating
    monthly UVs, although inaccuracy may result from the possibility that some individuals may have more than one IP address and/or
    share the same IP address with other individuals to access our platform.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;SAIC&rdquo;
    refers to State Administration for Industry and Commerce in China and currently known as State Administration for Market Regulation;</FONT></TD></TR>
</TABLE>
<P STYLE="margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Shanghai
    Huijing&rdquo; refers to Shanghai Huijing Information Technology Co., Ltd., a PRC company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Shanghai
    Jingyi&rdquo; refers to Shanghai Jingyi Medical Technology Co., Ltd., a PRC company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Shanghai
    Maidemu&rdquo; refers to Shanghai Maidemu Cultural Communication Corp., a PRC company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Shanghai
    Xingzhong&rdquo; refers to Shanghai Xingzhong Investment Management LP, a PRC company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Shanghai
    Zhongxun&rdquo; refers to Shanghai Zhongxun Medical Technology Co., Ltd., a PRC company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Zhongchao
    BVI&rdquo; refers to Zhongchao Group Inc., a British Virgin Island company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Zhongchao
    HK&rdquo; refers to Zhongchao Group Limited, a Hong Kong company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Zhongchao
    Shanghai&rdquo; refers to Zhongchao Medical Technology (Shanghai) Co., Ltd., a PRC company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Zhongchao
                                         WFOE&rdquo; refers to Beijing Zhongchao Zhongxing Technology Limited, a PRC company.</FONT></TD>
</TR></TABLE>
<P STYLE="margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_003"></A>FORWARD-LOOKING
STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have made statements
in this prospectus, including under &ldquo;Prospectus Summary,&rdquo; &ldquo;Risk Factors,&rdquo; &ldquo;Management&rsquo;s Discussion
and Analysis of Financial Condition and Results of Operations,&rdquo; &ldquo;Our Business&rdquo; and elsewhere that constitute
forward-looking statements. Forward-looking statements involve risks and uncertainties, such as statements about our plans, objectives,
expectations, assumptions or future events. In some cases, you can identify forward-looking statements by terminology such as
&ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo; &ldquo;plan,&rdquo; &ldquo;project,&rdquo; &ldquo;continuing,&rdquo; &ldquo;ongoing,&rdquo;
&ldquo;expect,&rdquo; &ldquo;we believe,&rdquo; &ldquo;we intend,&rdquo; &ldquo;may,&rdquo; &ldquo;should,&rdquo; &ldquo;will,&rdquo;
&ldquo;could&rdquo; and similar expressions denoting uncertainty or an action that may, will or is expected to occur in the future.
These statements involve estimates, assumptions, known and unknown risks, uncertainties and other factors that could cause actual
results to differ materially from any future results, performances or achievements expressed or implied by the forward-looking
statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Examples of forward-looking
statements include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the
                                         timing of the development of future services;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">projections
                                         of revenue, earnings, capital structure and other financial items;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the
                                         development of future company-owned branches;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">statements
                                         regarding the capabilities of our business operations;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">statements
                                         of expected future economic performance;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">statements
                                         regarding competition in our market; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">assumptions
                                         underlying statements regarding us or our business.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The ultimate correctness
of these forward-looking statements depends upon a number of known and unknown risks and events. We discuss our known material
risks under the heading &ldquo;Risk Factors&rdquo; above. Many factors could cause our actual results to differ materially from
those expressed or implied in our forward-looking statements. Consequently, you should not place undue reliance on these forward-looking
statements. The forward-looking statements speak only as of the date on which they are made, and, except as required by law, we
undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the
statement is made or to reflect the occurrence of unanticipated events. In addition, we cannot assess the impact of each factor
on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from
those contained in any forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B><A NAME="a_001"></A>PROSPECTUS SUMMARY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>This summary highlights
information that we present more fully in the rest of this prospectus. This summary does not contain all of the information you
should consider before buying Class A Ordinary Shares in this offering. This summary contains forward-looking statements that
involve risks and uncertainties, such as statements about our plans, objectives, expectations, assumptions or future events. In
some cases, you can identify forward-looking statements by terminology such as &ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;plan,&rdquo; &ldquo;project,&rdquo; &ldquo;continuing,&rdquo; &ldquo;ongoing,&rdquo; &ldquo;expect,&rdquo; &ldquo;we believe,&rdquo;
&ldquo;we intend,&rdquo; &ldquo;may,&rdquo; &ldquo;should,&rdquo; &ldquo;will,&rdquo; &ldquo;could,&rdquo; and similar expressions
denoting uncertainty or an action that may, will or is expected to occur in the future. These statements involve estimates, assumptions,
known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from any future
results, performances or achievements expressed or implied by the forward-looking statements. You should read the entire prospectus
carefully, including the &ldquo;Risk Factors&rdquo; section and the financial statements and the notes to those statements. Unless
otherwise stated, all references to &ldquo;us,&rdquo; &ldquo;our,&rdquo; &ldquo;Zhongchao,&rdquo; &ldquo;we,&rdquo; the &ldquo;company&rdquo;
and similar designations refer to Zhongchao Inc., a Cayman Islands Company, and its consolidated subsidiaries. See Note 1 to our
consolidated financial statements&nbsp;as of and for the years ended December 31, 2018 and 2017 included elsewhere in this prospectus.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 5.25pt; margin-bottom: 0pt; text-align: left"><B><I>Our
Company </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a provider
of healthcare information, education, and training services to healthcare professionals and the public in China. We offer a wide
range of online and onsite health information services, healthcare education programs, and healthcare training products, consisting
primarily of clinical practice training, open classes of popular medical topics, interactive case studies, academic conference
and workshops, continuing education courses, and articles and short videos with educational healthcare content to healthcare professionals
as well as the public. The services, programs, and products that we provide:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">make
                                         it easier for healthcare professionals to access healthcare reference sources, stay abreast
                                         of the latest medical information, learn about new treatment options, earn continuing
                                         medical education credits and communicate with peers; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">enable
                                         the public to obtain health information on a particular disease or condition, offer content
                                         on topics of individual interest, improve public health consciousness, and promote people&rsquo;s
                                         lifestyle.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">We provide our healthcare
information, education, and training services to the healthcare professionals under our &ldquo;MDMOOC&rdquo; brand, which we believe
is one of the leading consumer brands in China&rsquo;s healthcare training and education sector, as evidenced by the 2017 Research
Report on Chinese National Equities Exchange and Quotations (NEEQ) by Beijing Wutong Ideal Capital Management Co., Ltd., a Chinese
NEEQ research company, where we are considered as one of the main and typical medical teaching video provider with doctor interactive
and online training platform. We provide our healthcare educational content to the public via our &ldquo;Sunshine Health Forums&rdquo;,
which, based on the amount of the registered users and daily review volume, we believe is one of the largest platform in China,
for general healthcare knowledge and information to the public. Please see &ldquo;Our Business - Competition&rdquo; beginning
on page 94.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We commenced our operation,
through Zhongchao Shanghai, in August 2012 with a vision to offer a wide range of accessible and immediate healthcare information
and continuous learning and training opportunities for Chinese healthcare professionals. Since our inception, we have focused
on developing our information, education, and training programs to address the needs in the healthcare industry in China; and
developing online platforms and onsite activities to deliver our information services, education programs and training products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B><I>MDMOOC-Healthcare
                                         Information, Education and Training for Professionals</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Online Platforms</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">We launched our first
online platform in a form of website, www.mdmooc.org, under our &ldquo;MDMOOC&rdquo; brand in 2013 to provide information, education,
and training services to physicians and allied healthcare professionals, such as pharmacists and nurses primarily located in China,
via Internet-Plus solutions. Internet Plus refers to the applications of the internet and other information technology in conventional
industries, such as manufacturing, education and healthcare. It is an incomplete equation where various internet (mobile, cloud
computing, big data or Internet of Things) can be added to other traditional fields. We further launched our MDMOOC Wechat subscription
account and MDMOOC mobile App in 2015 and 2016, respectively (together with the website, the &ldquo;MDMOOC online platform&rdquo;).
Healthcare professionals in China can apply for registration with their healthcare qualification to get access to our MDMOOC online
platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">The programs available
on our MDMOOC online platform enable our users to timely obtain extension knowledge of precedents, treatments, and first-hand
experiences of various disease and other healthcare related matters. In addition, our MDMOOC online platform offers these professional
users what we believe is one of the largest online libraries of continuing medical education programs in China that are produced
in association with entities accredited by the National Health Commission of the PRC, such as Chinese Medical Association and
Chinese Journal of Continuing Medical Education. From the convenience of their home or office computer and mobile App, our professional
users can access a variety of accredited editorial resources and programs including online journal articles, medical conferences,
and open classes and obtain continuing medical education credits which are required for the healthcare qualification of doctors,
nurses, and pharmacists.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe MDMOOC
online platform helps healthcare professionals improve their clinical knowledge and practice of medicine. Since launching in 2013,
we have been continuously developing our MDMOOC online platform with new forms of Internet-based education solutions. There are
currently approximately 1,429 education and training programs available on our MDMOOC online platform and free to our registered
users. About 95% of all our programs are self-developed by our research and development team. The original content of these programs,
including daily medical thesis, commentary, conference coverage, expert columns, and activities are written by our research and
development team and authors from widely respected academic institutions, and edited and managed by our in-house editorial staff.
The remaining 5% of programs are created under the purchase orders of our corporate or institution customers, where we develop
customized programs with designated healthcare topics. Such 5% of programs are only available to certain registered users with
program passcodes provided by our corporate or institution customers. Our revenues are mainly sourced from these 5% of programs.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">We currently provide
our proprietary interactive programs via Practice Improvement (PI), a problem-based and case-based form of healthcare course,
which integrates state-of-the-art treatment information and clinical cases for particular diseases into interactive practice modules;
Community of Practice Share (COPS), an online and live clinical experience sharing platform that creates the most effective discussion
in a particular healthcare domain or medical area due to the common interests of the users; Continuing Professional Development
(CPD), a section of our platform that provides discussions and articles focusing on the future development and the differences
between Continuing Medical Education (CME) and Continuing Professional Development (CPD), and other general information of physician
competency framework and Meta-analysis. Our original, exclusive and proprietary content includes innovative features such as after-class
quiz, key point summary and highlight during the courses, and peer-review and comments. For additional information regarding our
online platforms, please see &ldquo;Our Business - Our Business Model - Our Online Platform&rdquo; beginning on page 98.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">We believe that our
ability to create, source, edit and organize online healthcare-related content, interactive education services, and training programs
has made MDMOOC online platform one of the leading health destinations and most recognized information platform in healthcare
sector in China. As of the date of this prospectus, our MDMOOC online platform has more than 390,000 registered users and a database
of more than 2 million healthcare experts including over 700,000 physicians, and 1,300,000 allied healthcare professionals in
medical academics, associations, and leading hospitals who constantly collaborate with us to develop training programs on needed
basis.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Onsite
                                         Education Activities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">In addition to healthcare
information, education, and training via Internet-Plus, we organize onsite healthcare and medical training sessions and academic
conferences from time to time under our &ldquo;MDMOOC&rdquo; brand. For instance, in January 2019, we launched EWMA-certified
(defined as below) wound-management collaboration training programs, covering the topics including but not limited to basic concepts
of acute and chronic wounds, management of different levels of surgical and non-surgical wounds, the construction of different
levels of wound centers, and medical staff collaboration in the process of wound management. Please see &ldquo;Our Business -
Onsite Education Activities&rdquo; beginning on page 83 for more information about our onsite program and our collaboration with
EWMA.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">We believe the combination
of online and onsite services would provide our end-users the greatest convenience. With more choices of the forms of healthcare
education, we enrich the learning experience of our end-users.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Sunshine Health Forums-Healthcare
Information and Education for the Public</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Our goal is not only
provide continuing education and training to healthcare professionals but to promote healthy lifestyle and provide healthcare
knowledge to the public. In order to achieve that, we develop and operate the Sunshine Health Forums, online education-for-all
platforms that disseminate articles and features related to healthcare and wellness education, medical behavior intervention,
and newly developed health technology and application. We launched our Sunshine Health Forums in a form of website, www.ygjkclass.com,
in May 2016 followed by WeChat subscription account in August 2016, and mobile App in 2017. We establish one forum for each category
of diseases for the convenience of the public. We cooperate with certain well-known we-media platforms in China, including but
not limited Toutiao.com, Yidianzixun.com, Douyin.com, CN-Healthcare.com, iQiyi, Youku, and Huoshan.com to streamline our articles
co-produced by healthcare professionals and us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Recent Developments</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Commencing from the fourth
quarter of 2018, in addition to providing trainings and education through our platforms, we have been engaged by certain customers
on project basis to establish individual websites to provide training and knowledge of certain drug treatment, most of which are
cancer-related treatment, to healthcare professionals and patients. Such websites are established to facilitate qualified patients
to obtain free drug treatment from NFPs till the free drugs are completely delivered and distributed as planned. For each website,
we also plug in features to manage the project including reviewing patients&rsquo; applications, tracking their usage of drugs
and collecting related information. Those customers are and existing customers of us. They provide those drugs sponsored by pharmaceutical
companies without charge to qualified patients and we charge those customers on our services in connection with the website and
related training and management.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our Customers and End Users</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><B>MDMOOC&rsquo;s Customers
and End Users</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">MDMOOC&rsquo;s customers
are enterprises, NFPs, and medical journals, primarily located in China. MDMOOC&rsquo;s end users are healthcare professionals,
nurses, doctors and other healthcare workers.</P>

</Div>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Our enterprise customers
are pharmaceutical enterprises, healthcare enterprises engaged in researches and develops pharmaceuticals, vaccines, and consumer
healthcare products, pharmaceutical enterprises that engages in drug innovation, manufacturing, and marketing, and medical journals.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Our NFP customers,
most of whom are sponsored by pharmaceutical enterprises to produce training courses for specific healthcare topics, are charity
organizations, national public foundations, and nonprofit non-governmental association, that are governed by provincial and regional
government agencies and commissions. Government agencies include the National Health and Family Planning Commission (NHFPC) and
Ministry of Civil Affairs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">We maintain good relationship
with our customers and some of them have long term relationship with us. We generate our revenue on a case-by-case or project-by-project
basis and by providing our customers with healthcare information, education, and training services, including the production of
online medical training materials, the arrangement of onsite training programs or academic conferences, and the development of
medical education software to their targeted end users.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
the fiscal year ended December 31, 2017, we generated revenue from a total of 70 customers, of which 14 customers were NFP and
56 customers were pharmaceutical enterprises. For the fiscal year ended December 31, 2018, we generated revenue from a total of
71 customers, of which 15 were NFP and 56 were pharmaceutical enterprises. For the six months ended June 30, 2019, we generated
revenue from a total of 50 customers, of which 16 customers were NFP and 34 customers were pharmaceutical enterprises.</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We generate our revenues
from a relatively small number of customers. For the fiscal years ended December 31, 2018 and 2017, our pharmaceutical enterprise
customers accounted for 60.1% and 80.7% of our total revenues, respectively. For the fiscal years ended December 31, 2018 and
2017, our NFP customers accounted for 39.9% and 19.3% of our total revenues, respectively. For the six months ended June 30, 2019
and 2018, our pharmaceutical enterprise customers accounted for 33.6% and 78.2% of our total revenues, respectively. For the six
months ended June 30, 2019 and 2018, our NFP customers accounted for 66.4% and 21.8% of our total revenues, respectively. The
sharp decrease of revenues generated by pharmaceutical enterprises customers as a percentage of total revenue was mainly because
the pharmaceutical enterprises placed more orders through NFP to attract more medical experts and professionals in the name of
NFP.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Sunshine Health Forums&rsquo; Users</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unlike MDMOOC online
platform where we require our users to register with their healthcare qualification and some of our programs are limited to certain
registered users of the platform, our Sunshine Health Forums is accessible to the public without limitation. As of the date of
this prospectus, we have established nearly 150 forums, with more than an aggregate of 4.95 million subscriptions and an aggregate
of 1.25 billion click-through.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Source of Revenues</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">We currently derive
our revenues from 2 sources: (1) revenue generated from the information, education, and training programs, services, and products
under our &ldquo;MDMOOC&rdquo; brand, including but not limited to (a) revenue from designing and producing healthcare training
products as requested by our customers; (b) revenue from our onsite education, including organizing medical training sessions
and academic conferences; and (c) revenue from the healthcare consulting services we provide to our customers; and (2) revenue
generated from disseminating general healthcare knowledge and information and the book selling via our Sunshine Health Forums.
We do not charge user fees for access to our MDMOOC online platform or attend some of our onsite conferences. The MDMOOC online
platform and onsite education activities enable customers to reach, educate and inform target audiences of healthcare professionals.
We work closely with our customers to develop programs to reach specific groups of healthcare professionals and give them placement
on the most relevant areas on our MDMOOC online platform.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

</div>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the fiscal years
ended December 31, 2018 and 2017, our revenues were US$12,865,870 and US$9,816,312, respectively, and our net income were US$3,001,489
and US$1,494,928, respectively. For the six months ended June 30, 2019 and 2018, our revenues were US$6,987,623 and US$5,232,210,
respectively, and our net income were US$1,708,888 and US$551,205, respectively. We currently generate most of our revenues from
MDMOOC. The revenue from Sunshine Health Forums was immaterial for the fiscal years ended December 31, 2018 and 2017 and for the
six months ended June 30, 2019 and 2018. We plan to focus our development on Sunshine Health Forums and expand more information
sharing services in this platform.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Research and Development</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Research and Development
(&ldquo;R&amp;D&rdquo;) is an integral part of our continued growth. Our R&amp;D consists of product development and technology
support. As of the date of this prospectus, we have 25 researchers in our product development team and 13 developers in our technology
support team. Most of our R&amp;D members have no less than 5 years of working experience and 30% R&amp;D staff have master or
doctor degree.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Our product development
team is focused on market research and product development. We develop and update our products and services based on market conditions
and government policies. Our product development team closely monitors the market to adjust and upgrade our existing educational
products, and designs new products based on customers&rsquo; requests. We analysis the information about concepts and forms of
medical education by searching medical articles from medical journals, and attending medical conferences such as Global Alliance
for Medical Education, or GAME, annual meeting, and integrate the information into our programs. Also, we work with healthcare
professionals to develop our programs. When starting to create any programs, we make face to face or telephone surveys and get
the learning needs from healthcare professionals, such as medical knowledge, clinical skills, case sharing, and the desire to
communicate with peers. We incorporate such needs into our program design. When developing our course module, the healthcare professionals,
after review and test, may give us advice on the module to match the learning and thinking habits of physicians and allied healthcare
professionals. After we complete the course production, we invite these professionals to do final review on the content to assure
its correctness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Our technology team
are experienced in the development, design, operation and maintenance of platform products, servers and mobile apps. They are
responsible for monitoring the performance of our online platform, updating and exploring new and advanced technologies and integrating
them into our existing and new services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">During fiscal years
2018 and 2017, our R&amp;D expenses were approximately $1,447,949 and $943,253, respectively, representing 11.3% and 9.6% of our
total revenues for fiscal years 2018 and 2017, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Intellectual Property</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">We regard our trademarks,
copyrights, patents, domain names,&nbsp;know-how,&nbsp;proprietary technologies, and similar intellectual property as critical
to our success, and we rely on copyright, trademark and patent law in the PRC, as well as confidentiality procedures and contractual
provisions with our employees, contractors and others to protect our proprietary rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of December 31, 2018, we own 11 registered trademarks, copyrights to 37 software programs developed by us relating to various
aspects of our operations, and 33 registered domain names. As of the date of this prospectus, we own 16 registered trademarks,
copyrights to 37 software programs developed by us relating to various aspects of our operations, and 31 registered domain names,
including&nbsp;<I>mdmooc.com.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Our intellectual property
is subject to risks of theft and other unauthorized use, and our ability to protect our intellectual property from unauthorized
use is limited. In addition, we may be subject to claims that we have infringed the intellectual property rights of others. See
&ldquo;Risk Factors&mdash;Risks Relating to Our Business&mdash; We may not be able to prevent others from unauthorized use of
our intellectual property, which could cause a loss of customers, reduce our revenues and harm our competitive position.&rdquo;</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

</div>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Market
                                         Opportunities and Competition</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">China has the largest
group of healthcare professionals in the whole world, providing a solid foundation for the development of the healthcare education
market. According to the 2018 Statistical Bulletin on the Development of China&rsquo;s Health and Wellness Industry, China currently
has more than 12 million healthcare professionals, including more than 3.6 million doctors, reflecting a huge demand on knowledge
learning and professional training.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While we see the need
for the long-term stability of the traditional form of onsite training, with long working hours and heavy workloads, more and
more healthcare professionals in China turn to use online platforms for academic conferences or training sessions. Continuing
changes in the healthcare industry, including the increasing adoption of managed care plans and the need to keep informed about
rapidly emerging medical and pharmaceutical therapies are also placing increasing pressures on healthcare professionals&rsquo;
time. Healthcare professionals must keep abreast of the latest developments within their medical specialty to provide their patients
with the best possible care and to meet continuing medical education requirements. There is a vast flow of information from many
sources, including traditional medical journals, medical textbooks, academic conferences and other training literature. The sheer
volume of medical information and the time constraints that physicians face make it extremely difficult for them to stay current
and to quickly and efficiently access the information most relevant to their practice. We believe online healthcare professionals
education services will provide them another option to find and manage the information they are seeking.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Internet plus training
model emerged with the growth of technologies, internet and the needs for convenient and reliable source of information. Specifically,
Internet plus will optimize the traditional mode of education and training for healthcare professionals with real-time services
anytime, anywhere, based on users&rsquo; demands. Through the Internet, the latest medical information and online training courses
can be obtained from the mobile terminal and healthcare professionals can make full use of their spare time to get the information
most related to them. Gradually, the Internet plus education model has been accepted by healthcare professionals. A Chinese Internet
Doctors Insights Report (DIR) released by United States Medical Scientific in November 2018 provides that more than 90% of doctors
in China obtained medical information through professional online platform, 46.7% of doctors in China obtained medical information
through offline meetings, and 58.5% of doctors in China obtained information of pharmaceutical enterprises and drugs through professional
websites.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2019, Internet
plus healthcare education has become the education model guided and supported by the Chinese government. The Opinion Concerning
the Promotion of the Development of Internet Plus Medical and Health promulgated and implemented on April 25, 2018 by the General
Office of the State Council (the &ldquo;Opinion&rdquo;), states its plan to enhance the Internet plus medical education model.
The Opinion encourages the establishment of healthcare education training cloud platform that provides a diverse range of medical
online courses and healthcare information. The Opinion also encourages the establishment of a networked, digital, personalized,
and lifelong medical education and training system for the healthcare professionals to carry out researches and discussions on
incurable diseases and major diseases, and eventually improve their healthcare quality. The Opinion further includes the implementation
plan of the &ldquo;Continuous Medical Education + Appropriate Technology Promotion&rdquo; policy, focusing on the needs of healthcare
and poverty reduction, targeting the grass-root levels and deprived areas of the country, to popularize practical and appropriate
healthcare technologies via distance education. The Opinions further indicates to establish an Internet-based science platform
to provide accurate and up-to-date information on healthcare science knowledge and healthy lifestyles. The Opinion aims to improve
residents&rsquo; health management ability and health literacy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">Healthcare
education is a large sector of the Chinese market with outstanding development prospects. According to the report released on
December 24, 2018 by TrendForce (&ldquo;TrendForce Report&rdquo;), a global provider of market intelligence on the technology
industries, driven by the large amount of new drugs joining the market and the continuous increase in the use of new drug products,
the 2018 market size of global pharmaceutical is approximately USD 1.2 trillion, with a 3.8% annual growth rate. TrendForce Report
indicates that the expected global drug market will reach USD1.55 trillion in 2023 with a compound annual growth rate of 5.1%
from 2018 to 2023. According to a 2018 report by The Economic Observer, sales expenses in Chinese pharmaceutical industry account
for more than 40% of the total revenue and the costs of market promotion is a key part of sales expenses. We believe the need
for Internet-based healthcare education will continue to grow, driven by the increasing demand for healthcare services by Chinese
people, the implementation of China&rsquo;s grading diagnosis and treatment policy, and the establishment of doctors&rsquo; multi-point
practice system.</FONT></P>

</div>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We
                                         face competition from providers of traditional healthcare education programs and training
                                         services as well as the increasing competition from existing competitors and new market
                                         entrants in the&nbsp;online healthcare education&nbsp;market including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Chinese
                                         online education companies and institutions that also offer continuing healthcare education
                                         and other online courses and training programs. Examples of our competitors include 91huayi,
                                         a Chinese medical education website dedicated to improving medical service providers
                                         professional skills and public&rsquo;s healthcare knowledge; bbs.iivi.com, a Chinese
                                         medical bulletin board system allowing medical professionals in different specialties
                                         to share their views regarding their medical practice, career development and medical
                                         examinations; and www.ccmtv.cn, a Chinese website providing surgery education videos
                                         to medical professionals in different specialties.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Healthcare
                                         education companies or institutions organizing onsite healthcare workshop, academic conference,
                                         and other healthcare communication activities. This segment is the most significant competitor
                                         to our onsite education programs. Examples of&nbsp;our competition&nbsp;in this segment
                                         include Medcon, MEDLINK, and Beijing Medical Group 3 AD Ltd., all of which are Chinese
                                         company dedicated to promoting medical information and health knowledge via onsite activities.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">China-based
                                         digital service provider in the healthcare industry that also offer information sharing
                                         services and data accumulation and management in China. Examples of our competitors include
                                         DXY (<FONT STYLE="font-family: Times New Roman, Times, Serif">&#19969;&#39321;&#22253;</FONT>),
                                         a Chinese medical knowledge sharing website, which is built as an academic article retrieving
                                         database. DXY has developed more functions to enrich the services it provides to healthcare
                                         professionals and the public, including but not limited to establishing online forum
                                         for physicians, launching a series of mobile applications such as Drug Assistant and
                                         Dingxiang Doctor, and opening its wholly-owned offline Family Clinics.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Education
                                         companies that targets the public and patients. This segment is the most significant
                                         competitor to our Sunshine Healthcare Forum. Examples of our competitors include CN-Healthcare,
                                         an internet-based healthcare education platform targeting patients. CN- Healthcare organizes
                                         content-partners, including healthcare professionals and medical associations to generate
                                         health-related news and information. CN-Healthcare currently has 1773 individual content-partners,
                                         751 association partners, and 1.3 million subscribers.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our Competitive Strengths and Strategies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that the
principal competitive factors in our markets are industry expertise, breadth and depth of service offerings, quality of the services
offered, reputation and track record, marketing, scalability of infrastructure and price. The combination of our large user base,
professional database and high quality education content position us to be a leading provider of healthcare information, education,
and training services to meet the needs of healthcare organizations and professionals and will continue to contribute to our growth
and success.</P>

</div>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Acknowledged
    by leading pharmaceutical enterprises: </I>our customers include leading pharmaceutical enterprises who position our MDMOOC
    as preeminent branded sources of consumer-oriented health and wellness information on the Internet. Almost all leading pharmaceutical
    enterprises have their own vendor lists regarding different types of service they request. It is an industry norm that it
    usually takes three to four years for a service provider to be accepted by the leading pharmaceutical enterprises to be included
    in the vendor list. We are one of the prominent service providers in the category of course production services on the vendor
    lists of a few well-known pharmaceutical enterprises. Pursuant to the consultant agreements we entered into with the pharmaceutical
    enterprises regarding the course production services, we will create online training courses of specific medical topics and
    then post them on our MDMOOC platforms. The users need to obtain the passwords from the pharmaceutical enterprises or from
    us to get free access to the series of online courses. We also entered into framework agreements with certain pharmaceutical
    enterprises. The terms of the agreements are usually one (1) years. Pursuant to the framework agreements, when our customers
    have a need for medical course production, they will reach out to us by sending over formal purchase orders.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Reliable
    Professional Content Production</I>. We use reliable, highly relevant, interactive and multi-media content to satisfy the
    requirements of our customers, including the NPO and pharmaceutical enterprises, and our end-users. We maintain good long-term
    working relationship with many well-known healthcare professionals. With our self-generated resource library of healthcare
    professionals, we can easily reach out to the healthcare experts in certain medical fields when we receive purchase orders
    from our customers to generate relevant medical courses. We also have one of the most comprehensive online content library
    in China for different type of diseases and medical information which makes it easier for us to customize the content under
    different needs of our customers for online medical education. We also have a large pool of experienced in-house editors who
    incubate original medical information and present them in visually appealing formats. They also collaborate with healthcare
    professionals throughout the content generating process. Our content is interactive and largely in the form of videos, articles,
    and photographs, covering a full spectrum of the latest medical information.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><I>High-Quality,
                                         Timely and Original Medical Information: </I>We provide high-quality, timely and original
                                         content on important healthcare trends and disease topics. Using the real-time publishing
                                         capabilities of the Internet, we can deliver this content to our audience faster and
                                         more cost effectively than traditional print media and on-site training session, which
                                         is limited by publication schedules and physical distribution. Many of our articles are
                                         written by industry-leading medical experts and are peer-reviewed by other physicians
                                         to insure they meet the high standards of medical integrity. Our experienced editorial
                                         staff has strong medical background, most of whom graduated from well-known medical universities
                                         and have more than ten-year work experience in relevant areas. Our medical specialty
                                         areas are carefully designed and their features are regularly updated by our editorial
                                         and quality control staff.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><I>Well
                                         Organized and Easy-To-Use Websites and Apps</I>: We design our websites and mobile Apps
                                         to meet the needs of our users in a personalized and easy-to-use manner. We organize
                                         our training products on MDMOOC online platform by healthcare specialty areas. We also
                                         provide functions of Practice Improvement (PI), Community of Practice Share (COPS), and
                                         Continuing Professional Development (CPD) to satisfy different needs of the healthcare
                                         professionals. We create different Sunshine Health Forums for different categories of
                                         diseases and healthcare matters. Currently, we have more than 150 forums, covering healthcare
                                         topics such as the kidney disease, the liver disease, and diabetes. In addition to high-quality
                                         medical content, our consumer sites provide community features and interactive programs
                                         to encourage academic discussion and communication as well as information and experience
                                         sharing.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cost-Effective
    Access to Our Audience</I>: Our users registration profiles give us the ability to segment our audience based on their medical
    specialty or healthcare interest. In addition, our proprietary users&rsquo; profile and traffic database enables us to provide
    advertising and sponsored content. MDMOOC online platform also offers online programs that complement many of the pharmaceutical
    enterprises&rsquo; offline promotional and educational efforts. For example, we expand the audience of sponsored medical conferences
    by making next-day summaries of the proceedings available to users who were unable to attend. In addition, we believe Sunshine
    Health Forums create an attractive e-commerce environment for health-related products, i.e., educational healthcare books,
    due to the size of the audience and the focus on relevant healthcare topics.</FONT></TD></TR>
</TABLE>

</div>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify"><TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><I>High-Level
                                         and Small-Class Teaching Onsite Training Courses. </I>Along with online training courses
                                         and education programs, we also organize onsite education and training sessions. To ensure
                                         the quality and results of the onsite training programs, we usually limit the size of
                                         our training session to a relatively small one and build up certain criteria for the
                                         applicants. Also, the good long-term working relationship with well-known healthcare
                                         professionals enable us to generate outstanding training content and create high-quality
                                         education experience. For Example, in the EWMA-certified wound-management collaboration
                                         training program, we work with healthcare experts and institutions to do the lecturing.
                                         Our lecturers include Dr. Yixin Zhang, professor and doctoral supervisor of Shanghai
                                         Jiaotong University and vice president of Asian Pacific Federation of Societies for Reconstructive
                                         Microsurgery, Guozhong Lv, Dr. Yan Liu, vice president of Burn Injury Department of Chinese
                                         Medical Association, and Dr. Chunmeng Shi, professor and doctoral supervisor of Army
                                         Medical University. We plan to hold an aggregate of six (6) training programs. Each one
                                         of them will accept no more than twenty (20) applicants who shall hold academic credential
                                         above undergraduate. We also require all applicants to have more than six-year working
                                         experience in the field of wound repair.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our objective is to
become the premier healthcare destination platforms in China where physicians, allied healthcare professionals and the public
visitors can find reliable and comprehensive information that enables them to make better and more informed medical and health
decisions. We intend to achieve this objective by pursuing the following strategies:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><I>Strengthening
                                         Our Brands</I>. We intend to build up MDMOOC as the leading single brand for healthcare
                                         information, education, and training for professionals and Sunshine Health Forums as
                                         the leading brand for online healthcare information forums. We believe that strengthening
                                         our brand awareness is critical to attracting and retaining users, advertisers, sponsors
                                         and strategic partners. We plan to pursue a brand development strategy through online
                                         and offline advertising, promotions, media coverage and word-of-mouth support. We believe
                                         our brand visibility will significantly benefit from promotion on leading we-media and
                                         medical associations, such as China Association of Health Promotion and Education, Beijing
                                         Medical and Health Foundation, and China Primary Health Care Foundation.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><I>Improving
                                         and Enhancing Our Products</I>. We intend to expand the content on both our healthcare
                                         programs for professionals and the public by adding new medical specialty areas, enlarging
                                         our editorial staff and utilizing our extensive relationships with leading medical experts.
                                         We intend to enhance the users&rsquo; experience by adding general health and wellness
                                         information, community features and interactive programs that take advantage of our credibility
                                         with medical professionals and our existing professional medical specialty content.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><I>Growing
                                         User Community</I>. Except for the online training programs, we also share the latest
                                         news and healthcare information in the medical industry on MDMOOC online platform. We
                                         intend to build our medical professional community via Practice Improvement (PI), a problem-based
                                         and case-based form of healthcare course, which integrates state-of-the-art treatment
                                         information and clinical cases for particular diseases into interactive practice modules,
                                         and Community of Practice Share (COPS), an online and live clinical experience sharing
                                         platform that creates the most effective discussion in a particular healthcare domain
                                         or medical area due to the common interests of the users, and increase the frequency
                                         and length of their visits to our site. By continuing to offer compelling content, providing
                                         interactive programs and services, and building relationships with relevant healthcare
                                         organizations to increase user loyalty, repeat usage and time spent on our site, we believe
                                         MDMOOC online platform will become an integral part of the medical professional&rsquo;s
                                         daily work flow.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Developing
    Multiple Revenue Sources</I>. We believe our attractive audience demographics and high-quality content offerings provide us
    with significant opportunities to develop multiple sources of revenue. In addition to advertising and sponsorships, we plan
    to generate e-commerce revenues by building Sunshine Health Forums as a full-service online healthcare platform with functions
    of book-selling and drug-selling. We also plan develop other research products that we expect will complement pharmaceutical
    enterprises&rsquo; product detailing efforts. In addition, we plan to introduce products and services that appeal directly
    to our international and allied healthcare users.</FONT></TD></TR>
</TABLE>

</div>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Risks
                                         and Challenges</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">Our
prospects should be considered in light of the risks, uncertainties, expenses and difficulties frequently encountered by similar
companies. Our ability to realize our business objectives and execute our strategies is subject to risks and uncertainties, including,
among others, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">our inability to effectively manage our rapid growth, which
    could place significant strain on our management personnel, systems and resources;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">adverse changes in the economic environment either in China
    or globally;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">intense competition from onshore and offshore healthcare information,
    education, and training services companies;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    reliance on a relatively small number of major customers, including a customer accounted for 38% and 55% of our total revenue
    for fiscal years 2018 and 2017, respectively;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">our ability to anticipate and develop new services and enhance
    existing services to keep pace with rapid changes in technology;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to attract new customers for our services and/or growing revenues from existing customers;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">risks associated with having a long selling and implementation
    cycle for our services that require us to make significant resource commitments prior to realizing revenues for those services;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">increases in wages for professionals in China;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the international nature of our business;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">risks related to unauthorized disclosure of sensitive and confidential
    information;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">risks related to intellectual property infringement claims;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">risks related to material weakness in our internal control over
    financial reporting such that if we fail to develop and maintain an effective system of internal control over financial reporting,
    we may be unable to accurately report our financial results or prevent fraud;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">business interruptions resulting from occurrence of natural disasters, health epidemics
    and other outbreaks or events;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">fluctuation in the value of the Renminbi and other currencies;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">disruptions in disruptive technologies or significant failure in our technology platform
    that could harm our service; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">vulnerabilities to security risks that could disrupt our services and adversely affect our
    operations; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">possibilities to expose us to malpractice liability and other liability inherent in healthcare
    delivery.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-indent: 0.5in; text-align: justify">In addition, we face other risks and uncertainties
that may materially affect our business prospect, financial condition, and operations. You should consider the risks discussed
in &ldquo;Risk Factors&rdquo; and elsewhere in this prospectus before investing in our Class A Ordinary Shares.</P>
</div>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><B><I>Our
                                         Securities</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our authorized share
capital is divided into Class A Ordinary Shares and Class B Ordinary Shares prior to the completion of this Offering. Holders
of Class A Ordinary Shares and Class B Ordinary Shares have the same rights except for voting and conversion rights. In respect
of matters requiring a shareholder vote, each Class A Ordinary Share will be entitled to 1 vote and each Class B Ordinary Share
will be entitled to 15 votes. Due to the Class B Ordinary Share&rsquo;s voting power, the holders of Class B Ordinary Shares currently
and may continue to have a concentration of voting power, which limits the holders of Class A Ordinary Shares&rsquo; ability to
influence corporate matters.&nbsp;(See &ldquo;Risk Factors -&nbsp;<B><I>Our Class B Ordinary Shares have stronger voting power
than our Class A Ordinary Shares and certain existing shareholders have substantial influence over our Company and their interests
may not be aligned with the interests of our other shareholders.&rdquo;)&nbsp;</I></B>Each Class B Ordinary Share is convertible
into one Class A Ordinary Share at any time by the holder thereof. Class A Ordinary Shares are not convertible into Class B Ordinary
Shares under any circumstances. (See &ldquo;Description of Share Capital&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"> Unless the context
requires otherwise, all references to the number of shares of Class A and Class B Ordinary Shares to be outstanding after our
initial public offering is based on 16,102,420 Class A Ordinary Shares (including 1,350,068 Class A Ordinary Shares to be issued
upon exercise of the HF Warrant the Company issued to HF Capital. For more details of the HF Warrant, see &ldquo;Prospectus Summary-
Our Corporate History and Structure&rdquo; on page 11) and 5,497,715 Class B Ordinary Shares outstanding as of date of this prospectus,
and excludes 980,121 Class A Ordinary Shares (or up to 1,006,371 Class A Ordinary Shares if the underwriters fully exercise the
over-allotment option) reserved for issuance under our 2019 Equity Incentive Plan (the &ldquo;Plan&rdquo;), which will be adopted
upon the completion of this Offering. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">Unless otherwise indicated,
all information in this prospectus assumes a price to the public in this Offering of $4.5 per share.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">&nbsp;<B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B><I>Corporate Information</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our principal executive
office is located at Nanxi Creative Center, Suite 218, 841 Yan&rsquo;An Middle Road, Jing&rsquo;An District, Shanghai, China 200040.
Our telephone number is 021-32205987. Our website is as follows http://www.mdmooc.org/. The information on our website is not
part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B><I>Our Corporate History and Structure </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a holding company
incorporated on April 16, 2019, under the laws of the Cayman Islands, or Zhongchao Cayman. We have no substantive operations other
than holding all of the issued and outstanding shares of Zhongchao Group Inc., or Zhongchao BVI, established under the laws of
the British Virgin Islands on April 23, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Zhongchao BVI is also
a holding company holding all of the outstanding equity of Zhongchao Group Limited, or Zhongchao HK, which was established in
Hong Kong on May 14, 2019. Zhongchao HK is also a holding company holding all of the outstanding equity of Beijing Zhongchao Zhongxing
Technology Limited, or Zhongchao WFOE, which was established on May 29, 2019 under the laws of the PRC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We conduct our business
through our variable interest entity, or VIE, Zhongchao Medical Technology (Shanghai) Corp., or Zhongchao Shanghai, a PRC company,
and through its wholly owned subsidiaries, including Shanghai Maidemu Cultural Communication Corp., or Shanghai Maidemu, Horgos
Zhongchao Medical Technology Co., Ltd., or Horgos Zhongchao Medical, and Shanghai Zhongxun Medical Technology Co., Ltd., or Shanghai
Zhongxun, Horgos Zhongchao Zhongxing Medical Technology Co., Ltd., or Horgos Zhongchao Zhongxing, each a PRC company. We commenced
our operations under the name Zhongchao Medical Consulting (Shanghai) Limited, or Shanghai Zhongchao Limited, a limited liability
company established under the laws of the PRC, to provide medical online and offline training services. Zhongchao Shanghai was
incorporated on August 17, 2012 by Juru Guo and Baorong Xue, who held 60% and 40% equity interests in Zhongchao Shanghai respectively.
On May 25, 2015, the two shareholders transferred all equity interests to Weiguang Yang who held 100% equity interests in Zhongchao
Shanghai after the transfer. On January 15, 2016, the name was changed to Zhongchao Medical Technology (Shanghai) Co., Ltd. On
February 5, 2016, the management completed its registration with the State Administration for Industry and Commerce, or SAIC,
to convert Shanghai Zhongchao Limited into a company limited by shares, or Zhongchao Shanghai. Through direct ownership, Zhongchao
Shanghai has established subsidiaries and branch offices in various cities in PRC, including Beijing, Shanghai, and Horgos.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On June 27, 2016, Zhongchao
Shanghai was listed on the National Equities Exchange and Quotations Co., Ltd., or the NEEQ. At the time of listing, Weiguang
Yang directly held 54.60% equity interests in Zhongchao Shanghai and Shanghai Xingzhong Investment Management LP. Ltd., a limited
partnership incorporated under the PRC laws (&ldquo;Shanghai Xingzhong&rdquo;), directly held 17.90% equity interests in Zhongchao
Shanghai. Shanghai Xingzhong was incorporated on September 22, 2015 by management of Zhongchao Shanghai as a platform for certain
officers and employees holding founder shares. Pursuant to its partner agreement, Weiguan Yang is the general partner of Shanghai
Xingzhong; and manages and operates Shanghai Xingzhong. He has the right, among others, to possess, manage, maintain and dispose
the assets of Shanghai Xingzhong including its equity interest in Zhongchao Shanghai. As a result, Weiguang Yang controlled 72.50%
equity interests in Zhongchao Shanghai upon listing on NEEQ.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

</div>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">To facilitate our initial
public offering in the United States, Zhongchao Shanghai was delisted from NEEQ in February 2019. At the time of delisting, Weiguang
Yang controlled 57.29% equity interests in Zhongchao Shanghai (43.41% of which was directly held and 13.88% of which was controlled
through Shanghai Xingzhong). After the delisting, a minority shareholder of Zhongchao Shanghai transferred his shares to Mr. Yang.
At the time of our restructure in August 2019, Mr. Yang controlled 58.78% equity interests in Zhongchao Shanghai (44.90% of which
was directly held and 13.88% of which was controlled through Shanghai Xingzhong). To conclude, Zhongchao Shanghai has been under
the control of Weiguan Yang since its initial listing on NEEQ in June 2016.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June 24, 2019,
Zhongchao Shanghai changed its name to Zhongchao Medical Technology (Shanghai) Limited. Zhongchao Shanghai engages in technology
development, technology transfer, and technical services in the field of medical technology, technical consulting in the field
of network technology, and medical information consulting.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 12, 2015,
Zhongchao Shanghai established its wholly owned subsidiary, Shanghai Maidemu. Shanghai Maidemu engages in planning for cultural
and artistic exchanges, designing, producing, acting for and publishing various kinds of advertisements, and medical consultation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 27, 2017, Zhongchao
Shanghai established its wholly owned subsidiary, Shanghai Zhongxun. Shanghai Zhongxun engages in technology development, transfer,
service and consulting in the fields of medical technology and computer technology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 12, 2017,
Zhongchao Shanghai established its wholly owned subsidiary, Horgos Zhongchao Medical Technology Limited Company (&ldquo;Horgos
Zhongchao Medical&rdquo;). Horgos Zhongchao Medical engages in technology development, transfer, service and consulting in the
fields of medical technology and computer technology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 28, 2016,
Shanghai Maidemu formed a joint venture with Ms. Hongxia Zhang and Ms. Shuhua Gao, contributing a 55% equity interest in Shanghai
Huijing Information Technology Co., Ltd., or Shanghai Huijing, a PRC company. On January 21, 2019, Shanghai Huijing was 100% owned
by Shanghai Maidemu. Shanghai Huijing engages in technology development, transfer, service and consulting in the fields of computer
technology, graphic designing, website page designing, planning cultural and artistic exchanges.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 16, 2019,
Zhongchao Cayman was incorporated in the Cayman Islands and issued 5,497,715 Class B Ordinary Shares at 0.0001 par value as founder
shares to More Healthy Holding Limited, representing 83.66% of total voting power of the Company, on converted basis, given that
each Class B Ordinary Share is entitled to 15 votes and each Class A Ordinary Share is entitled to 1 vote and assuming the exercise
of the HF Warrant. More Healthy Holding Limited is a BVI company 100% owned by Weiguang Yang (&ldquo;More Healthy&rdquo;).</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 29, 2019,
Zhongchao Shanghai established its wholly owned subsidiary, Horgos Zhongchao Zhongxing. Horgos Zhongchao Zhongxing engages in
technology development, transfer, service and consulting in the fields of medical technology and computer technology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 14, 2019,
Zhongchao Cayman completed a reorganization of entities under common control of Weiguang Yang, who owned a majority of the voting
power of Zhongchao Cayman prior to the reorganization. Zhongchao Cayman, Zhongchao BVI, and Zhongchao HK were established as the
holding companies of Zhongchao WFOE. Zhongchao WFOE is the primary beneficiary of Zhongchao Shanghai and its subsidiaries, and
all of these entities included in Zhongchao Cayman are under common control which results in the consolidation of Zhongchao Shanghai
and subsidiaries which have been accounted for as a reorganization of entities under common control at carrying value. The consolidated
financial statements are prepared on the basis as if the reorganization became effective as of the beginning of the first period
presented in the consolidated financial statements.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As part of the Company&rsquo;s
organization for the purpose of this Offering and listing on Nasdaq, on August 1, 2019, the Company and HF Capital Management
Delta, Inc., a company incorporated under the laws of the Cayman Islands (&ldquo;HF Capital&rdquo;) entered into a certain warrant
agreement to purchase Class A Ordinary Shares of the Company (the &ldquo;HF Warrant&rdquo;). At the issuance of the HF Warrant,
Yantai Hanfujingfei Investment Centre (LP), a limited partnership incorporated under PRC laws (&ldquo;Yantai HF&rdquo;, whose
managing partner, Hanfor Capital Management Co., Ltd., is the sole member of HF Capital, and together with &ldquo;HF Capital&rdquo;
hereinafter collectively referred to as &ldquo;HF&rdquo;) was a 6.25 % shareholder of Zhongchao Shanghai (which represented 1,350,068
shares in Zhongchao Shanghai, among which 675,068 shares were issued by Zhongchao Shanghai and the remaining 675,000 shares were
purchased from two pre-existing shareholders) and planned to withdraw its capital contribution in Zhongchao Shanghai but to contribute
the same amount of capital to Zhongchao Cayman directly via HF Capital. As HF Capital needs to complete necessary administrative
registration required under Chinese regulations of outbound direct investments (ODI) to hold equity interest in Zhongchao Cayman,
the HF Warrant entitles HF Capital to purchase 1,350,068 Class A Ordinary Shares, or 6.25% economic beneficial interest, or 1.37%
of the voting ownership interest of the Company, from the Company, if the following conditions are met:</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 7.7%">&nbsp;</TD>
    <TD STYLE="width: 3.84%; font-size: 10pt"><FONT STYLE="font-size: 10pt">1)</FONT></TD>
    <TD STYLE="width: 88.46%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">All PRC governmental consent
    and approval required for HF Capital to exercise the warrant and payment of the capital contribution have been obtained, including
    without limitation, any approval or filing with respect to HF Capital&rsquo;s investment into the Company, and payment by
    HF Capital of the capital contribution to the Company, and reasonable evidence thereof shall have been provided to the Company;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 7.7%">&nbsp;</TD>
    <TD STYLE="width: 3.84%; font-size: 10pt"><FONT STYLE="font-size: 10pt">2)</FONT></TD>
    <TD STYLE="width: 88.46%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">HF Capital has fully paid the
    capital contribution to Zhongchao Cayman; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 7.7%">&nbsp;</TD>
    <TD STYLE="width: 3.84%; font-size: 10pt"><FONT STYLE="font-size: 10pt">3)</FONT></TD>
    <TD STYLE="width: 88.46%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">The Company released the paid-in
    capital of Yantai HF from Zhongchao Shanghai.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>



</div>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The
                                         HF Warrant was issued in connection with a framework agreement among Zhongchao Shanghai,
                                         Mr. Weigang Yang, and Yantai HF dated August 1, 2019 (the &ldquo;Framework Agreement&rdquo;),
                                         pursuant to which Zhongchao Shanghai has agreed to complete Yantai HF&rsquo;s withdrawal
                                         of capital contribution in Zhongchao Shanghai no later than one month following the completion
                                         of HF Capital&rsquo;s ODI and HF has agreed to invest the same amount of fund in U.S.
                                         dollars in Zhongchao Cayman upon the completion of its ODI registration. In addition,
                                         the parties have agreed to, once the ODI registration of HF Capital is completed, deposit
                                         Yantai HF&rsquo;s capital contribution into a bank account mutually controlled by Zhongchao
                                         Shanghai and Yantai HF, to be used as HF Capital&rsquo;s capital contribution in Zhongchao
                                         Cayman. The foregoing is a brief description of the material terms and conditions of
                                         the Framework Agreement, a copy of which is attached as Exhibit 10.18 to this prospectus
                                         and incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of
this prospectus, the registration of Yantai HF&rsquo;s withdrawal of its capital contribution in Zhongchao Shanghai has been completed
with local State Administration for Industry and Commerce. The paid-in capital of Yantai HF in an amount of RMB20 million (approximately
US$2.9 million) is currently being held in the corporate bank account of Zhongchao Shanghai and is to be deposited in a designated
bank account mutually controlled by Zhongchao Shanghai and Yantai HF after the completion of HF Capital&rsquo;s ODI procedures
and to be released as HF Capital&rsquo;s capital contribution in Zhongchao Cayman as provided in the Framework Agreement. According
to the Administrative Measures for the Outbound Investment by Enterprises promulgated by the NDRC on December 26, 2017 which became
effective on March 1, 2018, the Administrative Measures on Outbound Investments promulgated by the MOFCOM on September 6, 2014
which became effective on October 6, 2014, and the Notice of the SAFE on Further Simplifying and Improving the Foreign Exchange
Management Policies for Direct Investment promulgated by the SAFE on 13 February 2015 which became effective on June 1, 2015,
the procedures of ODI include obtaining the Filing Notice of Outbound Direct Investment Projects issued by the competent branch
of the NDRC, the Certificate of Outbound Direct Investment of Enterprises issued by the competent branch of the MOFCOM, and completing
the foreign exchange registration of outbound direct investments. HF Capital is currently in the process of completing its ODI
procedures. HF has further committed that in any event if it cannot complete its ODI procedures, HF shall make such capital contribution
to Zhongchao Shanghai in an amount of RMB20 million (approximately US$2.9 million) or to Zhongchao Cayman in the same amount of
fund in U.S. dollars, subject to certain condition.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> The following charts
summarize our corporate legal structure and identify our subsidiaries, our VIE and its subsidiaries upon completion of this Offering
based on a proposed maximum number of 4,025,000 Class A Ordinary Shares being offered assuming the full exercise of the over-allotment
option by the underwriters and the exercise of the HF Warrant, as compared to the structure immediately prior to the Closing of
the Offering. For more details on our corporate history, please refer to &ldquo;<I>Business &mdash; Our Corporate History and
Structure</I>&rdquo;. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><IMG SRC="image_03.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notes: All percentages reflect the voting
ownership interests instead of the equity interests held by each one of the shareholder of the Company given that each Class B
Ordinary Share will be entitled to 15 votes as compared to Class A Ordinary Share, each one of which will be entitled to 1 vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">Represents 5,497,715 Class
                                         B Ordinary Shares held by Mr. Weiguang Yang, the 100% owner of More Healthy Holding Limited,
                                         as of the date of this prospectus.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                         an aggregate of 16,102,420 Class A Ordinary Shares including 14,752,352 Class A Ordinary
                                         Shares held by 12 shareholders of Company, each one of which holds less than 5% voting
                                         ownership interests of the Company, as of the date of this prospectus and 1,350,068 Class
                                         A Ordinary Shares to be issued upon exercise of the HF Warrant. See footnote 3 below.</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P></DIV>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid"><P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD></TD><TD> (3) </TD><TD STYLE="text-align: justify"> In order to directly hold equity interest in the Company, HF Capital Management
                     Delta, Inc. (&ldquo;HF Capital&rdquo;) has to complete certain registration and obtain approval with local
                     governmental authority in PRC. As a part of reorganization and due to the aforementioned factor, HF Capital
                     was granted a warrant to purchase 1,350,068 Class A Ordinary Shares of the Company at a price $0.0001 per
                     share or such other amount agreed by the Company and HF Capital at a grant price of RMB 20,000,000 (approximately
                     USD$2.9 million) conditioned upon (i) HF Capital completes necessary registration and obtains approval with
                     local governmental authority in PRC for its direct investment in the Company and (ii) Zhongchao Shanghai
                     shall have paid HF Capital RMB 20,000,000 as returned capital contribution in Zhongchao Shanghai. The above
                     chart assumes that HF Capital has not exercised such warrant. </TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(4)</TD><TD STYLE="text-align: justify">Represents RMB 2.74 million
                                         (approximately USD$0.4 million) subscribed capital contribution to Zhongchao Shanghai,
                                         as of the date of this prospectus.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(5)</TD><TD STYLE="text-align: justify">Represents RMB 9.70 million
                                         (approximately USD$1.4 million) subscribed capital contribution to Zhongchao Shanghai,
                                         as of the date of this prospectus.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(6)</TD><TD STYLE="text-align: justify">Represents RMB 1.35 million
                                         (approximately USD$0.2 million) subscribed capital contribution to Zhongchao Shanghai,
                                         as of the date of this prospectus.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(7)</TD><TD STYLE="text-align: justify">Represents RMB 3.00 million
                                         (approximately USD$0.4 million) subscribed capital contribution to Zhongchao Shanghai,
                                         as of the date of this prospectus. Shanghai Xingzhong Investment Management LP. Ltd.,
                                         a limited partnership incorporated under the PRC laws (&ldquo;Shanghai Xingzhong&rdquo;),
                                         the general partner of which is Weiguang Yang. As the general partner of Shanghai Xingzhong,
                                         Weiguang Yang exercises the voting rights with respect to the shares held by Shanghai
                                         Xingzhong.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(8)</TD><TD STYLE="text-align: justify">Represents RMB 1.35 million
                                         (approximately USD$0.2 million) subscribed capital contribution to Zhongchao Shanghai,
                                         as of the date of this prospectus.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; text-align: justify; text-indent: 0.5in">For details of each shareholder&rsquo;s ownership, please refer
to the beneficial ownership table in the section captioned &ldquo;Principle Shareholders.&rdquo;</P>

<P STYLE="margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; width: 20%; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 53%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Background</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 25%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ownership</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zhongchao BVI</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        BVI company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on April 23, 2019</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        holding company</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% owned by Zhongchao
    Cayman </FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zhongchao HK</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        Hong Kong company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on May 14, 2019</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        holding company</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% owned by Zhongchao
    BVI</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zhongchao WFOE</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        PRC company and deemed a wholly foreign owned enterprise</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on May 29, 2019</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of $10 million</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        holding company</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% owned by Zhongchao
    HK</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zhongchao Shanghai</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        PRC limited liability company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on August 17, 2012</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of RMB 20,250,067 (approximately $3,064,272) with registered capital fully paid-up </FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Engaged
        in technology development, technology transfer, and technical services in the field of medical technology, technical consulting
        in the field of network technology, and medical information consulting</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIE of Beijing Zhongchao
    Zhongxing Technology Limited</FONT></TD></TR>
</TABLE>





<P STYLE="margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

</div>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; width: 20%; border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%; text-align: justify; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 53%; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Background</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%; text-align: justify; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 25%; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Ownership</B></FONT></TD></TR>
    <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 20%"><FONT STYLE="font-size: 10pt">Shanghai Maidemu</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 53%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.05pt; text-align: justify; text-indent: -14.05pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
                           PRC limited liability company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.05pt; text-align: justify; text-indent: -14.05pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on March 12, 2015</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19pt; text-align: justify; text-indent: -19pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of $1,597,087 (RMB 10 million) with registered capital fully paid-up</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19pt; text-align: justify; text-indent: -19pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Planning
        for cultural and artistic exchanges, designing, producing, acting for and publishing various kinds of advertisements,
        and medical consultation (no medical diagnosis and treatment activities allowed).</P></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 25%; text-align: justify"><FONT STYLE="font-size: 10pt">100% owned by Zhongchao Shanghai</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">Shanghai Zhongxun</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.05pt; text-align: justify; text-indent: -14.05pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        PRC limited liability company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.05pt; text-align: justify; text-indent: -14.05pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on May 27, 2017</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19pt; text-align: justify; text-indent: -19pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of $1,021,525 (RMB 7 million) with registered capital fully paid-up</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19pt; text-align: justify; text-indent: -19pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Engaged
        in technology development, transfer, service and consulting in the fields of medical technology and computer technology
        (no medical diagnosis and treatment activities allowed).</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">100% owned by Zhongchao Shanghai</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Horgos Zhongchao Medical&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.05pt; text-align: justify; text-indent: -14.05pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        PRC limited liability company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.05pt; text-align: justify; text-indent: -14.05pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on September 12, 2017</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19pt; text-align: justify; text-indent: -19pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of $153,060 (RMB 1 million) with registered capital of $153,060 to be funded</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19pt; text-align: justify; text-indent: -19pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Engaged
        in technology development, transfer, service and consulting in the fields of medical technology and computer technology.</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">100% owned by Zhongchao Shanghai</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">Horgos Zhongchao Zhongxing </FONT></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.05pt; text-align: justify; text-indent: -14.05pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        PRC limited liability company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.05pt; text-align: justify; text-indent: -14.05pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on July 29, 2019</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19pt; text-align: justify; text-indent: -19pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of $145,081 (RMB 1 million) with registered capital of $145,081 to be funded</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.1pt; text-align: justify; text-indent: -18.1pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Engaged
        in technology development, transfer, service and consulting in the fields of medical technology and computer technology.</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">100% owned by Zhongchao Shanghai</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shanghai Jingyi</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.05pt; text-align: justify; text-indent: -14.05pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        PRC limited liability company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.05pt; text-align: justify; text-indent: -14.05pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on October 10, 2018</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19pt; text-align: justify; text-indent: -19pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of $144,459 (RMB 1 million) with registered capital of $107,622 to be funded</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19pt; text-align: justify; text-indent: -19pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Engaged
        in technology development, transfer, service and consulting in the fields of medical technology and computer technology,
        market information consulting and investigating.</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">51% owned by Zhongchao Shanghai</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shanghai Huijing</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.05pt; text-align: justify; text-indent: -14.05pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        PRC limited liability company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.05pt; text-align: justify; text-indent: -14.05pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on September 28, 2016</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19pt; text-align: justify; text-indent: -19pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of $149,948 (RMB 1 million) with registered capital of $74,974 to be funded</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.1pt; text-align: justify; text-indent: -18.1pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Engaged
        in technology development, transfer, service and consulting in the fields of computer technology, graphic designing, website
        page designing, planning cultural and artistic exchanges.</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">100% owned by Shanghai Maidemu</FONT></TD></TR>
</TABLE>
</div>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>VIE
                                         Arrangements</I></B></FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Due to the restrictions
imposed by PRC laws and regulations on foreign ownership of companies engaged in value-added telecommunication services and certain
other businesses, we operate our businesses in which foreign investment is restricted or prohibited in the PRC through certain
PRC domestic companies. As such, Zhongchao Shanghai is controlled through VIE Arrangements in lieu of direct equity ownership
by us or any of our subsidiaries. Such VIE Arrangements consist of a series of six agreements&nbsp;(collectively,&nbsp;the &ldquo;VIE
Arrangements&rdquo;), which were signed on August 14, 2019. For more details and risks related to our variable interest entity
structure, please see &ldquo;Our Corporate History and Structure&mdash;VIE Arrangements&rdquo; and &ldquo;Risk Factors&mdash;Risks
Related to Our Corporate Structure&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">The significant terms
of the VIE Arrangements by and among our wholly-owned subsidiary, Zhongchao WFOE, our consolidated variable interest entity, Zhongchao
Shanghai, and the shareholders of Zhongchao Shanghai are as follows:</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Agreements that Provide Us Effective
Control over Zhongchao Shanghai</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our PRC Wholly Foreign
Owned Entity, Zhongchao WFOE, has entered into the following agreements with Zhongchao Shanghai and its shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Equity Interest
Pledge Agreement.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Pursuant to the equity
interest pledge agreement dated August 14, 2019, each shareholder of Zhongchao Shanghai has pledged all of its equity interest
in Zhongchao Shanghai to guarantee the shareholder&rsquo;s and Zhongchao Shanghai&rsquo;s performance of their obligations under
the master exclusive service agreement, business cooperation agreement, exclusive option agreement and proxy agreement and power
of attorney. If Zhongchao Shanghai or any of its shareholders breaches their contractual obligations under these agreements, Zhongchao
WFOE, as pledgee, will be entitled to dispose the pledged equity interest entirely or partially. Each of the shareholders of Zhongchao
Shanghai agrees that, during the term of the equity interest pledge agreement, it will not dispose of the pledged equity interests
or create or allow any encumbrance on the pledged equity interests without the prior written consent of Zhongchao WFOE. In addition,
Zhongchao WFOE has the right to collect dividends generated by the pledged equity interest during the term of the pledge. The
term of the initial equity interest pledge agreement is 20 years. After the expiration of the term of initial pledge registration,
Zhongchao WFOE may at its sole discretion require the Shareholders to extend the term of the equity interest registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Proxy Agreement
and Power of Attorney.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Pursuant to the proxy
agreement and power of attorney dated August 14, 2019, each shareholder of Zhongchao Shanghai has irrevocably appointed Zhongchao
WFOE to act as such shareholder&rsquo;s exclusive attorney-in-fact to exercise all shareholder rights, including, but not limited
to, voting on all matters of Zhongchao Shanghai requiring shareholder approval, disposing of all or part of the shareholder&rsquo;s
equity interest in Zhongchao Shanghai, oversee and review Zhongchao Shanghai&rsquo;s operation and financial information. Zhongchao
WFOE is entitled to designate any person to act as such shareholder&rsquo;s exclusive attorney-in-fact without notifying or the
approval of such shareholder, and if required by PRC law, Zhongchao WFOE shall designate a PRC citizen to exercise such right.
Each proxy agreement power of attorney will remain in force for so long as the Zhongchao Shanghai exists. The shareholders of
Zhongchao Shanghai do not have the right to terminate this agreement or revoke the appointment of the Attorney-in-Fact without
the prior written consent of Zhongchao WFOE.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Spouse Consent&nbsp;Letters.&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Pursuant to the&nbsp;Spouse
Consent&nbsp;Letters dated August 14, 2019, the spouse of each married shareholder of Zhongchao Shanghai, unconditionally and
irrevocably agreed not to assert any rights over the equity interest in Zhongchao Shanghai held by and registered in the name
of their spouse. In addition, each of them agreed to be bound by the VIE Arrangements described here if the spouse obtains any
equity interest in Zhongchao Shanghai for any reason.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

</div>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Agreement
                                         that allows us to Receive Economic Benefits from Zhongchao Shanghai</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Master Exclusive
Service Agreement.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Under the master exclusive
service agreement between Zhongchao WFOE and Zhongchao Shanghai dated August 14, 2019, Zhongchao WFOE has the exclusive right
to provide Zhongchao Shanghai with technical support, consulting services and other services. Zhongchao WFOE has the right to
designate and appoint, at its sole discretion, any entities affiliated with the Zhongchao WFOE to provide any and all services.
The service fees are calculated and paid on a yearly basis and at the amount that equals to 100% of the consolidated net profits
of Zhongchao Shanghai. Zhongchao WFOE may adjust the service fee at its discretion after taking into account multiple factors,
such as the difficulty of the services provided, the time consumed, the content and commercial value of services provided and
the market price of comparable services. Zhongchao WFOE owns the intellectual property rights arising out of the performance of
this agreements. Zhongchao Shanghai shall seek approval from Zhongchao WFOE prior to entering into any contracts obtaining the
same or similar services as provided under the Master Exclusive Service Agreement. This agreement will remain effective as long
as Zhongchao Shanghai exists, unless Zhongchao WFOE advance written notice to Zhongchao Shanghai and its shareholders or upon
the transfer of all the equity interest held by Zhongchao Shanghai&rsquo;s shareholders to Zhongchao WFOE and/or a third party
designated by Zhongchao WFOE.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Business Cooperation
Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Under the business
cooperation agreement dated August 14, 2019, without Zhongchao WFOE&rsquo;s prior written consent, Zhongchao Shanghai agrees not
to engage in any transaction which may materially affect its asset, obligation, right or operation, including but not limited
to: any activities not within its normal business scope, merger and acquisition, offering any loan to any third party and incurring
any debt from any third party. Zhongchao Shanghai shall seek approval from Zhongchao WFOE prior to entering into any material
contract, except the contracts executed in the ordinary course of business. Zhongchao Shanghai shall cause the persons designated
by Zhongchao WFOE to be the directors and executive officers of Zhongchao Shanghai. This agreement will remain effective as long
as Zhongchao Shanghai exists, unless Zhongchao WFOE advance written notice to Zhongchao Shanghai and its shareholders or upon
the transfer of all the equity interest held by Zhongchao Shanghai&rsquo;s shareholders to Zhongchao WFOE and/or a third party
designated by Zhongchao WFOE.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Agreements that Provide Us with
the Option to Purchase the Equity Interest in Zhongchao Shanghai</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Exclusive Option
Agreement.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Pursuant to the exclusive
option agreement dated August 14, 2019, each shareholder of Zhongchao Shanghai has irrevocably granted Zhongchao WFOE an exclusive
option to purchase, or have its designated person or persons to purchase, at its discretion, to the extent permitted under PRC
law, all or part of the shareholder&rsquo;s equity interests in Zhongchao Shanghai. The purchase price is equal to the lowest
price allowable under PRC laws and regulations at the time of the transfer. Zhongchao Shanghai has agreed that without Zhongchao
WFOE&rsquo;s prior written consent, Zhongchao Shanghai shall cause the persons designated by Zhongchao WFOE to be the directors
and executive officers of Zhongchao Shanghai, not amend its articles of association, increase or decrease the registered capital,
sell or otherwise dispose of its assets or beneficial interest, create or allow any encumbrance on its assets or other beneficial
interests, provide any loans to any third parties, enter into any material contract, except the contracts executed in the ordinary
course of business, merge with or acquire any other persons or make any investments, or distribute dividends to the shareholders.
The shareholders of Zhongchao Shanghai have agreed that, without Zhongchao WFOE&rsquo;s prior written consent, they will not dispose
of their equity interests in Zhongchao Shanghai or create or allow any encumbrance on their equity interests. Moreover, without
Zhongchao WFOE&rsquo;s prior written consent, no dividend will be distributed to Zhongchao Shanghai&rsquo;s shareholders, and
if any of the shareholders receives any profit, interest, dividend or proceeds of share transfer or liquidation, the shareholder
must give such profit, interest, dividend and proceeds to Zhongchao WFOE. These agreements will remain effective as long as Zhongchao
Shanghai exists unless Zhongchao WFOE advance written notice to Zhongchao Shanghai and the shareholders or upon the transfer of
all the equity interest held by the shareholders to Zhongchao WFOE and/or its designee.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

</div>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Controlled
                                         Company</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Upon the completion
of this offering, our outstanding shares will consist of Class A Ordinary Shares and Class B Ordinary Shares, and we will be a
&ldquo;controlled company&rdquo; as defined under the Nasdaq Stock Market Rules because Mr. Weiguang Yang, our founder, chairman
of the board of directors and chief executive officer, will beneficially own all of our then issued Class B ordinary shares and
will be able to exercise 84.48% of the total voting power of our issued and outstanding shares, assuming the full exercise of
the over-allotment option by the underwriters and the exercise of the HF Warrant. Holders of Class A Ordinary Shares and Class
B Ordinary Shares have the same rights except for voting and conversion rights. Each Class A Ordinary Share is entitled to one
vote, and each Class B Ordinary Share is entitled to fifteen votes and is convertible into one Class A Ordinary Share at any time
by the holders thereof. Class A Ordinary Shares are not convertible into Class B Ordinary Shares under any circumstances. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Upon the completion
of this offering, our directors, executive officers and principal shareholders will continue to have substantial control over
our company. Our affiliates will be able to exercise 86.34% of the total voting power of our issued and outstanding shares, assuming
the full exercise of the over-allotment option by the underwriters and the exercise of the HF Warrant. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As long as our officers
and directors, either individually or in the aggregate, own at least 50% of the voting power of our Company, we are a &ldquo;controlled
company&rdquo; as defined under NASDAQ Marketplace Rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For so as we are a
controlled company under that definition, we are permitted to elect to rely, and may rely, on certain exemptions from corporate
governance rules, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">an
                                         exemption from the rule that a majority of our board of directors must be independent
                                         directors;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">an
                                         exemption from the rule that the compensation of our chief executive officer must be
                                         determined or recommended solely by independent directors; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">an
                                         exemption from the rule that our director nominees must be selected or recommended solely
                                         by independent directors.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result, you will
not have the same protection afforded to shareholders of companies that are subject to these corporate governance requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we do not
intend to rely on the &ldquo;controlled company&rdquo; exemption under the NASDAQ listing rules, we could elect to rely on this
exemption in the future. If we elect to rely on the &ldquo;controlled company&rdquo; exemption, a majority of the members of our
board of directors might not be independent directors and our nominating and corporate governance and compensation committees
might not consist entirely of independent directors. (See &ndash; Risk Factor &ldquo;As a &ldquo;controlled company&rdquo; under
the rules of the NASDAQ Capital Market, we may choose to exempt our company from certain corporate governance requirements that
could have an adverse effect on our public shareholders.&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Compliance with Foreign Investment</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All limited liability
companies formed and operating in the PRC are governed by the Company Law of the People&rsquo;s Republic of China, or the Company
Law, which was amended and promulgated by the Standing Committee of the National People&rsquo;s Congress on October 26, 2018 and
came into effect on the same day. Foreign invested enterprises must also comply with the Company Law, with exceptions as specified
in the relevant foreign investment laws. Under our corporate structure as of the date of this prospectus, 100% of the equity interests
of Zhongchao Shanghai are entirely and indirectly held by our company through Beijing Zhongchao Zhongxing Technology Limited.
Therefore, Beijing Zhongchao Zhongxing Technology Limited, a wholly foreign-owned enterprise (&ldquo;Zhongchao WFOE&rdquo;) of
Zhongchao BVI which is a wholly-owned subsidiary of Zhongchao Cayman, should be regarded as a foreign-invested enterprise and
comply with both the Company Law and other applicable foreign investment laws.</P>

</div>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With
                                         respect to the establishment and operation of Zhongchao WFOE, the Ministry of Commerce
                                         of the People&rsquo;s Republic of China (the &ldquo;MOFCOM&rdquo;), and the National
                                         Development and Reform Commission (the &ldquo;NDRC&rdquo;) promulgated the Catalogue
                                         of Industries for Guiding Foreign Investment, or the Catalogue (2017 Version), as amended
                                         on June 28, 2017, which came into effect on August 28, 2017. The Catalogue divides industries
                                         for foreign investment into three categories: encouraged, restricted and prohibited.
                                         Those industries not set out in the Catalogue shall be classified as industries permitted
                                         for foreign investment. The Catalogue serves as the main basis for management and guidance
                                         for the MOFCOM to manage and supervise foreign investments to PRC. In addition, in June
                                         30, 2019, MOFCOM and NDRC promulgated the Special Management Measures (Negative List)
                                         for the Access of Foreign Investment, or the Negative List, effective July 30<FONT STYLE="font-family: Times New Roman, Times, Serif">,
                                         </FONT>2019. The Negative List expands the scope of permitted industries by foreign investment
                                         by reducing the number of industries that fall within the Negative List where restrictions
                                         on the shareholding percentage or requirements on the composition of board or senior
                                         management still exists. According to the Catalogue and the Negative List, the permitted
                                         foreign investment in value-added telecommunications service providers may not be more
                                         than 50%, except for electronic commerce, domestic multi-party communication, storage
                                         and forwarding and call centers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 5.25pt; margin-bottom: 0pt; text-align: left"><B><I>Emerging
Growth Company Status </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a company with
less than $1.07 billion in revenue during our last fiscal year, we qualify as an &ldquo;emerging growth company&rdquo; as defined
in the Jumpstart Our Business Startups Act, or JOBS Act, enacted in April 2012, and may take advantage of reduced reporting requirements
that are otherwise applicable to public companies. These provisions include, but are not limited to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">being
                                         permitted to present only two years of audited financial statements and only two years
                                         of related Management&rsquo;s Discussion and Analysis of Financial Condition and Results
                                         of Operations in our SEC filings;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">not
                                         being required to comply with the auditor attestation requirements of Section 404 of
                                         the Sarbanes-Oxley Act;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">reduced
                                         disclosure obligations regarding executive compensation in periodic reports, proxy statements
                                         and registration statements; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><P STYLE="margin: 0pt 0">exemptions
                                         from the requirements of holding a nonbinding advisory vote on executive compensation
                                         and shareholder approval of any golden parachute payments not previously approved.</P>


</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may take advantage
of these provisions until the last day of our fiscal year following the fifth anniversary of the date of the first sale of our
common equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended. However,
if certain events occur before the end of such five-year period, including if we become a &ldquo;large accelerated filer,&rdquo;
our annual gross revenues exceed $1.07 billion or we issue more than $1.00 billion of non-convertible debt in any three-year period,
we will cease to be an emerging growth company before the end of such five-year period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, Section
107 of the JOBS Act provides that an &ldquo;emerging growth company&rdquo; can take advantage of the extended transition period
provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. We have elected to
take advantage of the extended transition period for complying with new or revised accounting standards and acknowledge such election
is irrevocable pursuant to Section 107 of the JOBS Act.&nbsp;</P>

</div>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 5.25pt; margin-bottom: 0pt; text-align: left"><B><I>Foreign
                                         Private Issuer Status </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are incorporated
in the Cayman Islands, and more than 50 percent of our outstanding voting securities are not directly or indirectly held by residents
of the United States. Therefore, we are a &ldquo;foreign private issuer,&rdquo; as defined in Rule 405 under the Securities Act
and Rule 3b-4(c) under the Exchange Act. As a result, we are not subject to the same requirements as U.S. domestic issuers. Under
the Exchange Act, we will be subject to reporting obligations that, to some extent, are more lenient and less frequent than those
of U.S. domestic reporting companies. For example, we will not be required to issue quarterly reports or proxy statements. We
will not be required to disclose detailed individual executive compensation information. Furthermore, our directors and executive
officers will not be required to report equity holdings under Section 16 of the Exchange Act and will not be subject to the insider
short-swing profit disclosure and recovery regime.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B><I>Notes on Prospectus Presentation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Numerical figures included
in this prospectus have been subject to rounding adjustments. Accordingly, numerical figures shown as totals in various tables
may not be arithmetic aggregations of the figures that precede them. Certain market data and other statistical information contained
in this prospectus are based on information from independent industry organizations, publications, surveys and forecasts. Some
market data and statistical information contained in this prospectus are also based on management&rsquo;s estimates and calculations,
which are derived from our review and interpretation of the independent sources listed above, our internal research and our knowledge
of the PRC information technology industry. While we believe such information is reliable, we have not independently verified
any third-party information and our internal data has not been verified by any independent source.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">For the sake of clarity,
this prospectus follows the English naming convention of first name followed by last name, regardless of whether an individual&rsquo;s
name is Chinese or English.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Unless otherwise noted,
all currency figures in this filing are in U.S. dollars. Any discrepancies in any table between the amounts identified as total
amounts and the sum of the amounts listed therein are due to rounding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our reporting currency
is U.S.&nbsp;dollar and our functional currency is Renminbi. This prospectus contains translations of certain foreign currency
amounts into U.S.&nbsp;dollars for the convenience of the reader. Other than in accordance with relevant accounting rules and
as otherwise stated, all translations of Renminbi into U.S.&nbsp;dollars in this prospectus were made at the rate of RMB6.8755
to USD1.00, the buying rate on December 31, 2018, as set forth in the H.10&nbsp;statistical release of the U.S.&nbsp;Federal Reserve
Board. Where we make period-on-period comparisons of operational metrics, such calculations are based on the Renminbi amount and
not the translated U.S.&nbsp;dollar equivalent. We make no representation that the Renminbi or U.S.&nbsp;dollar amounts referred
to in this prospectus could have been or could be converted into U.S.&nbsp;dollars or Renminbi, as the case may be, at any particular
rate or at all.</P>

</div>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>The
                                         Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuer: </FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 69%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zhongchao Inc.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities being Offered:</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,500,000 Class A Ordinary Shares (or 4,025,000 Class A Ordinary
Shares if the underwriters exercise their over-allotment option in full), par value $0.0001 per share, on a firm commitment basis.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over-Allotment:</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have granted to the underwriters the option, exercisable
for 45 days from the date of this prospectus, to purchase up to 525,000 additional Class A Ordinary Shares.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price per Share:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purchase price will be between $4.0 and
    $4.5.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class A Ordinary Shares Outstanding before the
    Offering </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">16,102,420 (including 1,350,068 Class A Ordinary Shares to be issued upon exercise of the HF Warrant the Company issued
    to HF Capital. For more details of the HF Warrant, see &ldquo;Prospectus Summary- Our Corporate History and Structure&rdquo;
    on page 11)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class A Ordinary Shares&nbsp;&nbsp;Outstanding
    following the consummation of the Offering:</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,602,420 Class A Ordinary Shares (or 20,127,420 Class A Ordinary
Shares if the underwriters exercise their over-allotment option in full) assuming exercise of the HF Warrant.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Symbol:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We plan to apply
    to list our Class A Ordinary Shares on the NASDAQ Capital Market under the symbol &ldquo;ZCMD&rdquo; </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer Agent:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transhare Corporation</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

</div>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid">

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 30%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of Proceeds</FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 69%; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    estimate that we will receive net proceeds from this Offering of $12.6 million (or up to $14.6 million if the underwriters
    exercise the over-allotment option), based on an assumed price to the public in this Offering of $4.25, the midpoint of the
    price range set forth on the cover page of this prospectus, after deducting underwriting discounts and commissions and estimated
    offering expenses and assuming no exercise of the overallotment. We currently intend to allocate the net proceeds as follows:
    30% for development of the online course content; 20% for platform technology upgrade and system integration; and 50% for
    business expansion, i.e., to expand our existing locations to develop new customers by hiring more qualified personnel, and
    marketing effort. See &ldquo;Use of Proceeds&rdquo; for additional information.</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk Factors</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing in our Class A Ordinary Shares involves a high degree of risk and purchasers of our Class A Ordinary Shares may lose part or all of their investment. See &ldquo;Risk Factors&rdquo; for a discussion of factors you should carefully consider before deciding to invest in our beginning on page 24. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lock-Up</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We, our directors,
    executive officers, and substantially all of our existing shareholders are expected to enter into a lock-up agreement with
    the underwriters not to sell, transfer or dispose of any Class A Ordinary Shares for a period of 180 days after the date of
    this prospectus. See &ldquo;Shares Eligible for Future Sales&rdquo; and &ldquo;Underwriting.&rdquo;</FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend Policy:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have no present plans to declare dividends
        and plan to retain our earnings to continue to grow our business.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting Rights</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Shares of Class A Ordinary
        Share are entitled to 1 vote per share. </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Shares of Class&nbsp;B Ordinary
        Share are entitled to 15 votes per share. </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Holders of our Class&nbsp;A
        Ordinary Share and Class&nbsp;B Ordinary Share will generally vote together as a single class, unless otherwise required
        by law. Mr.&nbsp;Weiguang Yang, who after our initial public offering will control more than 84.48% of the voting power
        of our outstanding ordinary share assuming the full exercise of the over-allotment option by the underwriters and the
        exercise of the HF Warrant, will have the ability to control the outcome of matters submitted to our shareholders for
        approval, including the election of our directors. See &ldquo;Description of Share Capital.&rdquo; </P></TD></TR>
</TABLE>
</DIV>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 6pt; border: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><B>Summary
                                         Financial Data</B></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following summary
consolidated statements of income for the years ended December 31, 2018 and 2017 and six months ended June 30, 2019 and 2018 and
the summary consolidated balance sheet data as of December 31, 2018 and 2017 and June 30, 2019 have been derived from our consolidated
financial statements included elsewhere in this prospectus.</P>





<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Our management believes
that the assumptions underlying our financial statements and the above allocations are reasonable. Our financial statements, however,
may not necessarily reflect our results of operations, financial position and cash flows as if we had operated as a separate,
stand-alone company during the periods presented. You should not view our historical results as an indicator of our future performance.</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
presents our summary consolidated statements of income and comprehensive income for the fiscal years ended December 31, 2018 and
2017 and for the six months ended June 30, 2019 and 2018.</P>



<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Selected Consolidated Statement of Income
and Comprehensive Income</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(In U.S. dollars, except number of shares)</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">For the years ended <BR> December 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">For the Six Months Ended<BR> June 30,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2017</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%">Revenues</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">12,865,870</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">9,816,312</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">6,987,623</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">5,232,210</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">Cost of revenues</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(4,456,353</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,970,068</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,237,277</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,736,783</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Gross profit</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">8,409,517</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">5,846,244</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,750,346</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,495,427</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Operating expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Selling and marketing expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,261,258</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,715,201</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,303,740</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,456,105</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt">General and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,425,663</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,139,165</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,633,056</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(886,932</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Research and development expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,447,949</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(943,253</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(553,282</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(624,343</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total operating expenses</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(5,134,870</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(4,797,619</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(3,490,078</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(2,967,380</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Income from operations</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,274,647</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,048,625</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,260,268</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">528,047</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Interest income, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">191,609</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,331</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">118,943</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">81,380</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other income, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37,364</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">275,019</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">535,587</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,966</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Income before income tax</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,503,620</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,340,975</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,914,798</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">635,393</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Income tax (expenses) benefits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(502,131</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">153,953</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(205,910</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(84,188</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net income</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,001,489</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,494,928</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,708,888</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">551,205</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Net loss (income) attributable to non-controlling interests</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,352</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,641</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,681</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net Income Attributable to Zhongchao Inc.&rsquo;s shareholders</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,019,323</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,529,280</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1,730,529</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">543,524</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other comprehensive (loss) income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Foreign currency translation adjustment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(379,520</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">228,786</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(2,947</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(110,037</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -5pt; padding-left: 5pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -5pt; padding-left: 5pt">Other comprehensive (loss) income</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(379,520</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">228,786</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(2,947</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(110,037</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Comprehensive income attributable to</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Zhongchao Inc.&rsquo;s shareholders</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,639,803</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,758,066</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,727,582</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">433,487</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Non-controlling interests</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">17,834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">34,352</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,641</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(7,681</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Basic and diluted earnings per ordinary share*</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.15</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.08</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.08</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.03</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Weighted average number of ordinary share outstanding &ndash; basic and diluted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,764,245</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,562,121</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,600,135</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,250,135</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>






<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: justify">The
                                         number of shares are presented on a retroactive basis to reflect the reorganization and
                                         the stock dividend announce<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d
                                         on November 21, 2017.</FONT></TD>
</TR></TABLE>





<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following table presents our summary consolidated balance sheet data as of December 31, 2018 and 2017 and June 30, 2019.</FONT></P>





<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; white-space: nowrap">As of<BR>
    December&nbsp;31,<BR>
    2018</TD><TD STYLE="padding-bottom: 1.5pt; white-space: nowrap">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; white-space: nowrap">As of<BR>
    December 31,<BR>
    2017</TD><TD STYLE="padding-bottom: 1.5pt; white-space: nowrap">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; white-space: nowrap">As of<BR> June 30,<BR>
    2019,</TD><TD STYLE="padding-bottom: 1.5pt; white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">7,918,675</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">2,978,515</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">6,558,332</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">12,561,357</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">6,409,472</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">13,367,362</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Total assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">14,046,124</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">6,976,003</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">15,675,558</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Total liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,660,758</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,778,383</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,541,340</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Total Zhongchao Inc.&rsquo;s shareholders&rsquo; equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">11,413,202</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,207,622</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">13,156,305</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Non-controlling Interests</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(27,836</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(10,002</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(22,087</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Total shareholders&rsquo; equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">11,385,366</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,197,620</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">13,134,218</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Total liabilities and shareholders&rsquo; equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">14,046,124</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">6,976,003</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">15,675,558</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</div>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_002"></A><B>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Investment in our
securities involves a high degree of risk.&nbsp;You should carefully consider the risks described below together with all of the
other information included in this prospectus before making an investment decision.&nbsp;The risks and uncertainties described
below represent our known material risks to our business.&nbsp;If any of the following risks actually occurs, our business, financial
condition or results of operations could suffer.&nbsp;In that case, you may lose all or part of your investment.&nbsp;You should
not invest in this offering unless you can afford to lose your entire investment.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RISKS RELATED TO OUR BUSINESS AND INDUSTRY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may be unable to effectively
manage our rapid growth, which could place significant strain on our management personnel, systems and resources. We may not be
able to achieve anticipated growth, which could materially and adversely affect our business and prospects.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We have significantly
grown and expanded our business recently. Our revenues grew from $9,816,312 in fiscal 2017 to $12,865,870 in fiscal 2018. As of
the date of this prospectus, we maintain 3 subsidiaries and 2 branches, of which are located in China (Beijing and Shanghai) to
serve different customers in various geographic locations. The number of our total employees grew from 57 in fiscal 2017 to 58
in fiscal 2018. As of the date of this prospectus, we have 90 full-time employees. We are actively looking for additional locations
to establish new offices and expand our current offices and sales and delivery centers. We intend to continue our expansion in
the foreseeable future to pursue existing and potential market opportunities. Our growth has placed and will continue to place
significant demands on our management and our administrative, operational and financial infrastructure. Continued expansion increases
the challenges we face in:</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">recruiting,
                                         training, developing and retaining sufficient IT talents and management personnel;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">creating and capitalizing upon economies of scale;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">managing a larger number
    of customers in a greater number locations;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">maintaining effective oversight of personnel and offices;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">coordinating work among offices and project teams and maintaining
    high resource utilization rates;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">integrating new management personnel and expanded operations
    while preserving our culture and core values;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">developing and improving our internal administrative infrastructure,
    particularly our financial, operational, human resources, communications and other internal systems, procedures and controls;
    and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">adhering to and further improving our high quality and process
    execution standards and maintaining high levels of client satisfaction.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Moreover, as we introduce
new services or enter into new markets, we may face new market, technological and operational risks and challenges with which
we are unfamiliar, and it may require substantial management efforts and skills to mitigate these risks and challenges. As a result
of any of these problems associated with expansion, our business, results of operations and financial condition could be materially
and adversely affected. Furthermore, we may not be able to achieve anticipated growth, which could materially and adversely affect
our business and prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We depend on the healthcare industry
for a significant portion of our revenues.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Our revenues could
seriously decrease if there were adverse developments in the healthcare industry. Our near-term and long-term prospects depend
upon selling our services to the healthcare industry. In 2018, 60.1% of our revenues were derived from services provided to pharmaceutical
enterprises. Accordingly, our success is highly dependent on the sales and marketing expenditures of pharmaceutical enterprises
and our ability to attract these expenditures. Some of the adverse developments in the healthcare industry that could affect our
revenues would be:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">- a reduction in sales
and marketing expenditures of pharmaceutical enterprises;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">- public or private
market initiatives or reforms designed to regulate the manner in which pharmaceutical enterprises promote their products;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">- regulatory or legislative
developments that discourage or prohibit pharmaceutical enterprises&rsquo; promotional activities;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">- a decrease in the
number of new drugs being developed; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">- the adoption of
current legislative and regulatory proposals to control drug costs for patients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We face intense competition from
onshore and offshore healthcare information, education, and training services companies, and, if we are unable to compete effectively,
we may lose customers and our revenues may decline.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">The market for healthcare
information, education, and training services is highly competitive and we expect competition to persist and intensify. We believe
that the principal competitive factors in our markets are industry expertise, breadth and depth of service offerings, quality
of the services offered, reputation and track record, marketing and selling skills, scalability of infrastructure and price. In
addition, the trend towards offshore outsourcing, international expansion by foreign and domestic competitors and continuing technological
changes will result in new and different competitors entering our markets. Our ability to compete also depends in part on a number
of factors beyond our control, including the ability of our competitors to recruit, train, develop and retain highly skilled professionals,
the price at which our competitors offer comparable services and our competitors&rsquo; responsiveness to client needs. Therefore,
we cannot assure you that we will be able to retain our customers while competing against such competitors. Increased competition,
our inability to compete successfully against competitors, pricing pressures or loss of market share could harm our business,
financial condition and results of operations.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our success depends substantially
on the continuing efforts of our senior executives and other key personnel, and our business may be severely disrupted if we lose
their services.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Our future success
heavily depends upon the continued services of our senior executives and other key employees. If one or more of our senior executives
or key employees are unable or unwilling to continue in their present positions, it could disrupt our business operations, and
we may not be able to replace them easily or at all. In addition, competition for senior executives and key personnel in our industry
is intense, and we may be unable to retain our senior executives and key personnel or attract and retain new senior executive
and key personnel in the future, in which case our business may be severely disrupted, and our financial condition and results
of operations may be materially and adversely affected. If any of our senior executives or key personnel joins a competitor or
forms a competing company, we may lose customers, suppliers, know-how and key professionals and staff members to them. Also, if
any of our business development managers, who generally keep a close relationship with our customers, joins a competitor or forms
a competing company, we may lose customers, and our revenues may be materially and adversely affected. Additionally, there could
be unauthorized disclosure or use of our technical knowledge, practices or procedures by such personnel. Most of our executives
and key personnel have entered into employment agreements with us that contain non-competition provisions, non-solicitation and
nondisclosure covenants. However, if any dispute arises between our executive officers and key personnel and us, such non-competition,
non-solicitation and non-disclosure provisions might not provide effective protection to us, especially in China, where most of
these executive officers and key employees reside, in light of the uncertainties with China&rsquo;s legal system.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may be unable to maintain our
existing relationships with our content providers or to build new relationships with other content providers.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our success depends
significantly on our ability to maintain our existing relationships with the third parties who provide healthcare information,
education, and training content for our library and courses and our ability to build new relationships with other content partners.
Most of our agreements with content providers are on a case-by-case basis. We generate our resource library of content providers,
most of whom are healthcare experts working in leading Chinese hospital or well-known universities. Every time we have a need
for content production, we will search in our resource library and reach out to the relevant experts for content production. Upon
the completion of the content production, we will send over a standard form of service order to the experts evidencing such completion
and ask for their best ways for the service payment. Our content partners usually receive their service payment within one week
days after we receive the signed copies of the service orders. If a significant number of our content providers refuse to cooperate
with us, it could result in a reduction in the number of courses we are able to produce and decreased revenues. Most of our agreements
with our content partners are also non-exclusive, and our competitors offer, or could offer, healthcare information, education,
and training content that is similar to or the same as ours. If our current content partners offer information to users or our
competitors on more favorable terms than those offered to us or increase our service fees, our competitive position and our profit
margins and prospects could be harmed. In addition, the failure by our content partners to deliver high-quality content and to
continuously upgrade their content in response to user demand and evolving healthcare advances and trends could result in user
dissatisfaction and inhibit our ability to attract users.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If we fail to provide high-quality
and reliable content in a cost-effective manner, we may not be able to attract and retain users to remain competitive.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our success depends
on our ability to maintain and grow user engagement on our platform. To attract and retain users and compete against our competitors,
we must continue to offer high-quality and reliable content to provide our users with a superior healthcare information, education,
and training service experience. To this end, we must continue to produce original content and source new professional and user-generated
content in a cost effective manner. Given that we operate in a rapidly evolving industry, we need to anticipate industry changes
and respond to such changes timely and effectively. If we fail to continue to offer high-quality and reliable content to our users,
we may suffer from reduced user traffic and engagement, and our business, financial condition and results of operations may be
materially and adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to content
generated by our users and content partners, we rely on our&nbsp;in-house&nbsp;team to create original content and to edit, manage,
and supervise the original content origination and production process, and we intend to continue to invest resources in content
production. We face competition for qualified personnel in a limited pool of high-quality creative talent. If we are not able
to compete effectively for talents or attract and retain top talents at reasonable costs, our original content production capabilities
would be negatively impacted. Any deterioration in our&nbsp;in-house&nbsp;content production capability, inability to attract
creative talents at reasonable costs or losses in personnel may materially and adversely affect our business and operating results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We generate a significant portion
of our revenues from a relatively small number of major customers and loss of business from these customers could reduce our revenues
and significantly harm our business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
believe that in the foreseeable future we will continue to derive a significant portion of our revenues from a small number of
major customers.</FONT>&nbsp;&nbsp; <FONT STYLE="font-family: Times New Roman, Times, Serif">For the years ended December 31,
2018 and 2017, a customer accounted for 38% and 55% of the Company&rsquo;s total revenues, respectively. Our ability to maintain
close relationships with these and other major customers is essential to the growth and profitability of our business. However,
the volume of work performed for a specific client is likely to vary from year to year, especially when we are not our customers&rsquo;
exclusive healthcare information, education, and training services provider and we do not have long-term commitments from any
of our customers to purchase our services. A major client in one year may not provide the same level of revenues for us in any
subsequent year. The healthcare information, education, and training services we provide to our customers, and the revenues and
income from those services, may decline or vary as the type and quantity of healthcare information, education, and training services
we provide changes over time. In addition, our reliance on any individual client for a significant portion of our revenues may
give that client a certain degree of pricing leverage against us when negotiating contracts and terms of service. In addition,
a number of factors other than our performance could cause the loss of or reduction in business or revenues from a client, and
these factors are not predictable. These factors may include corporate restructuring, pricing pressure, changes to its outsourcing
strategy, switching to another services provider or returning work in-house. In the future, a small number of customers may continue
to represent a significant portion of our total revenues in any given period. The loss of any of our major customers could adversely
affect our financial condition and results of operations.</FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We expect competition to increase
significantly in the future which could reduce our revenues, potential profits and overall market share.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The market for traditional
and online healthcare information, education, and training services is competitive. Barriers to entry on the Internet are relatively
low, and we expect competition to increase significantly in the future. We face competitive pressures from certain actual and
potential competitors, both online and onsite, many of which have longer operating histories, greater brand name recognition,
larger user bases and significantly greater financial, technical and marketing resources than we do. We cannot assure you that
healthcare information, education, and training education services maintained by our existing and potential competitors will not
be perceived by the healthcare community as being superior to ours.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may be unable to adequately develop
our systems, processes and support in a manner that will enable us to meet the demand for our services.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have initiated
our online operations in the recent 7 years and are developing our ability to provide our courses and education systems on a transactional
basis over the Internet. Our future success will depend on our ability to develop the infrastructure effectively, including additional
hardware and software, and implement the services, including customer support, necessary to meet the demand for our services.
In the event we are not successful in developing the necessary systems and implementing the necessary services on a timely basis,
our revenues could be adversely affected, which would have a material adverse effect on our financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may lose business if we are unable
to keep up with rapid technological or other changes.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we are unable to
keep up with changing technology and other factors related to our market, we may be unable to attract and retain users and advertisers,
which would reduce our revenues. The markets in which we compete are characterized by rapidly changing technology, evolving technological
standards in the industry, frequent new service and product announcements and changing consumer demands. Our future success will
depend on our ability to adapt to these changes and to continuously improve the performance, features and reliability of our service
in response to competitive services and product offerings and the evolving demands of the marketplace. In addition, the widespread
adoption of new Internet, networking or telecommunications technologies or other technological changes could require us to incur
substantial expenditures to modify or adapt our services or infrastructure, which might impact our ability to become or remain
profitable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If we are unable to collect our
receivables from our customers, our results of operations and cash flows could be adversely affected.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Our business depends
on our ability to successfully obtain payment from our customers of the amounts they owe us for work performed. As of December
31, 2018 and 2017, our accounts receivable balance amounted to approximately $1,993,237 and $1,301,810, respectively. As of December
31, 2018 and 2017, we had no doubtful allowance on accounts receivable. Since we generally do not require collateral or other
security from our customers, we establish an allowance for doubtful accounts based upon estimates, historical experience and other
factors surrounding the credit risk of specific customers. However, actual losses on client receivables balance could differ from
those that we anticipate and as a result we might need to adjust our allowance. There is no guarantee that we will accurately
assess the creditworthiness of our customers. Macroeconomic conditions, including related turmoil in the global financial system,
could also result in financial difficulties for our customers, including limited access to the credit markets, insolvency or bankruptcy,
and as a result could cause customers to delay payments to us, request modifications to their payment arrangements that could
increase our receivables balance, or default on their payment obligations to us. As a result, an extended delay or default in
payment relating to a significant account will have a material and adverse effect on the aging schedule and turnover days of our
accounts receivable. If we are unable to collect our receivables from our customers in accordance with the contracts with our
customers, our results of operations and cash flows could be adversely affected.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The growth and success of our business
depends on our ability to anticipate and develop new services and enhance existing services in order to keep pace with rapid changes
in technology and in the industries we focus on</I></B><I>.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">The market for our
services is characterized by rapid technological change, evolving industry standards, changing client preferences and new product
and service introductions. Our future growth and success depend significantly on our ability to anticipate developments in healthcare
information, education, and training services, and develop and offer new product and service lines to meet our customers&rsquo;
and end-users&rsquo; evolving needs. We may not be successful in anticipating or responding to these developments in a timely
manner, or if we do respond, the services or technologies we develop may not be successful in the marketplace. The development
of some of the services and technologies may involve significant upfront investments and the failure of these services and technologies
may result in our being unable to recover these investments, in part or in full. Further, services or technologies that are developed
by our competitors may render our services uncompetitive or obsolete. In addition, new technologies may be developed that allow
our customers to more cost-effectively perform the services that we provide, thereby reducing demand for our services. Should
we fail to adapt to the rapidly changing healthcare information, education, and training services market or if we fail to develop
suitable services to meet the evolving and increasingly sophisticated requirements of our customers in a timely manner, our business
and results of operations could be materially and adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If we do not succeed in attracting
new customers for our services or growing revenues from existing customers, we may not achieve our revenue growth goals.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">We plan to significantly
expand the number of customers we serve to diversify our client base and grow our revenues. Revenues from a new client often rise
quickly over the first several years following our initial engagement as we expand the services that we provide to that client.
Therefore, obtaining new customers is important for us to achieve rapid revenue growth. We also plan to grow revenues from our
existing customers by identifying and selling additional services to them. Our ability to attract new customers, as well as our
ability to grow revenues from existing customers, depends on a number of factors, including our ability to offer high quality
services at competitive prices, the strength of our competitors and the capabilities of our sales and marketing teams. If we are
not able to continue to attract new customers or to grow revenues from our existing customers in the future, we may not be able
to grow our revenues as quickly as we anticipate or at all.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>As a result of our significant recent
growth, evaluating our business and prospects may be difficult and our past results may not be indicative of our future performance.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our future success
depends on our ability to significantly increase revenue and maintain profitability from our operations. Our business has grown
and evolved significantly in recent years. Our growth in recent years makes it difficult to evaluate our historical performance
and make a period-to-period comparison of our historical operating results less meaningful. We may not be able to achieve a similar
growth rate or maintain profitability in future periods. Therefore, you should not rely on our past results or our historic rate
of growth as an indication of our future performance. You should consider our future prospects in light of the risks and challenges
encountered by a company seeking to grow and expand in a competitive industry that is characterized by rapid technological change,
evolving industry standards, changing client preferences and new product and service introductions. These risks and challenges
include, among others:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the
                                         uncertainties associated with our ability to continue our growth and maintain profitability;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">preserving our competitive position in the healthcare information,
    education, and training services industry in China;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">offering consistent and high-quality services to retain and
    attract customers;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">implementing our strategy and modifying it from time to time
    to respond effectively to competition and changes in client preferences;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">managing our expanding operations and successfully expanding
    our solution and service offerings;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">responding in a timely manner to technological or other changes
    in the healthcare information, education, and training services industry;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">managing risks associated with intellectual property; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">recruiting, training, developing and retaining qualified managerial
    and other personnel.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">If we are unsuccessful
in addressing any of these risks or challenges, our business may be materially and adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our profitability will suffer if
we are not able to maintain our resource utilization levels or continue to improve our productivity levels.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Our gross margin and
profitability are significantly impacted by our utilization of human resources as well as other resources, such as computers,
IT infrastructure and office space, and our ability to increase our productivity levels. We have expanded our operations significantly
in recent years through organic growth, which has resulted in a significant increase in our headcount and fixed overhead costs.
We may face difficulties maintaining high levels of utilization, especially for our newly established businesses and resources.
The framework agreements with some of our customers typically do not impose a minimum or maximum purchase amount and allow our
customers to place service orders from time to time at their discretion. Customers demand is varied and it may fall to zero or
surge to a level that we cannot cost-effectively satisfy. Although we try to use all commercially reasonable efforts to accurately
estimate service orders and resource requirements from our customers, we may overestimate or underestimate, which may result in
unexpected cost and strain or redundancy of our human capital and adversely effects on our utilization ability. Our ability to
continually increase our productivity levels depends significantly on our ability to recruit, train, develop and retain high-performing
professionals, staff projects appropriately and optimize our mix of services and delivery methods. If we experience a slowdown
or stoppage of work for any client or on any project for which we have dedicated professionals or facilities, we may not be able
to efficiently reallocate these professionals and facilities to other customers and projects to keep their high utilization and
productivity levels. If we are not able to maintain high resource utilization levels without corresponding cost reductions or
price increases, our profitability will suffer.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Increases in wages for professionals
in China could prevent us from sustaining our competitive advantage and could reduce our profit margins.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Part of our most significant
costs are the salaries and other compensation expenses for our medical professionals and other employees. Wage costs for professionals
in China are lower than those in more developed countries and India. However, because of rapid economic growth, increased productivity
levels, and increased competition for skilled employees and consultants in China, wages for highly skilled employees in China,
in particular middle- and senior-level managers, are increasing at a faster rate than in the past. We may need to increase the
levels of employee and consultant compensation more rapidly than in the past to remain competitive in retaining the quality and
attracting number of employees that our business requires. Increases in the wages and other compensation we pay our employees
and consultants in China could reduce our competitive advantage unless we are able to increase the efficiency and productivity
of our professionals as well as the prices we can charge for our services. In addition, any appreciation in the value of the Renminbi
relative to U.S. dollar and other foreign currencies will cause an increase in the relative wage levels in China, which could
further reduce our competitive advantage and adversely impact our profit margin.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We must continue to upgrade our
technology infrastructure, or we will be unable to effectively meet demand for our services.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We must continue to
add hardware and enhance software to accommodate the increasing content in our library and increasing use of our websites, mobile
apps, and Wechat accounts. In order to make timely decisions about hardware and software enhancements, we must be able to accurately
forecast the growth in demand for our services. This growth in demand for our services could be difficult to forecast and the
potential audience of our services is large. If we are unable to increase the data storage and processing capacity of our systems
at least as fast as the growth in demand, our systems may become unstable and may fail to operate for unknown periods of time.
Unscheduled downtime could harm our business and also could discourage current and potential end users and reduce future revenues.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our data and web server systems
may stop working or work improperly due to natural disasters, failure of third-party services and other unexpected problems.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An unexpected event
like a power or telecommunications outage, fire, flood or earthquake at our on-site data facility or at our Internet service providers&rsquo;
facilities could cause the loss of critical data and prevent us from offering our services. Currently we don&rsquo;t have any
business interruption insurance to compensate us for losses that may occur. In addition, we rely on third parties to securely
store our archived data, house our Web server and network systems and connect us to the Internet. The failure by any of these
third parties to provide these services satisfactorily and our inability to find suitable replacements would impair our ability
to access archives and operate our systems.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our computer networks may be vulnerable
to security risks that could disrupt our services and adversely affect our results of operations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Our computer networks
may be vulnerable to unauthorized access, computer hackers, computer viruses and other security problems caused by unauthorized
access to, or improper use of, systems by third parties or employees. A hacker who circumvents security measures could misappropriate
proprietary information or cause interruptions or malfunctions in our operations. Although we intend to continue to implement
security measures, computer attacks or disruptions may jeopardize the security of information stored in and transmitted through
our computer systems. Actual or perceived concerns that our systems may be vulnerable to such attacks or disruptions may deter
our customers from using our platforms or services. As a result, we may be required to expend significant resources to protect
against the threat of these security breaches or to alleviate problems caused by these breaches.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Data networks are also
vulnerable to attacks, unauthorized access and disruptions. For example, in a number of public networks, hackers have bypassed
firewalls and misappropriated confidential information. It is possible that, despite existing safeguards, an employee could misappropriate
our customers&rsquo; proprietary information or data, exposing us to a risk of loss or litigation and possible liability. Losses
or liabilities that are incurred as a result of any of the foregoing could have a material adverse effect on our business.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may lose users and lose revenues
if our cyber security measures fail.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the security measures
that we use to protect personal information are ineffective, we may lose users of our services, which could reduce our revenues.
We rely on security and authentication technology licensed from third parties. We cannot predict whether these security measures
could be circumvented by new technological developments. In addition, our software, databases and servers may be vulnerable to
computer viruses, physical or electronic break-ins and similar disruptions. We may need to spend significant resources to protect
against security breaches or to alleviate problems caused by any breaches. We cannot assure you that we can prevent all cyber
security breaches.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We depend significantly on the strength
of our brand and reputation. Any failure to maintain and enhance, or any damage to, our brand image or reputation could materially
and adversely affect our business, results of operations, financial condition and prospects.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our reputation and
brand recognition, which depend on cultivating awareness, trust and confidence among our current or potential users, is critical
to the success of our business. We believe a well-recognized brand is crucial to increasing our user base and, in turn, facilitating
our effort to monetize our services and enhancing our attractiveness to our users and service providers. Our reputation and brand
are vulnerable to many threats that can be difficult or impossible to control, and costly or impossible to remediate. Regulatory
inquiries or investigations, lawsuits and other claims in the ordinary course of our business, perceptions of conflicts of interest
and rumors, including complaints made by our competitors, among other things, could substantially damage our reputation, even
if they are baseless or satisfactorily addressed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, any perception
that the quality of our healthcare information, education, and training services may not be the same as or better than that of
other healthcare information, education, and training service platforms can damage our reputation. Any negative media publicity
about any of the services available on our platform or product or service quality problems at other healthcare training service
platforms, including at our competitors, may also negatively impact our reputation and brand. Negative perceptions of healthcare
information, education, and training solutions and services, or the industry in general, may reduce the number of users coming
to our platform and the number of transactions conducted through our platform, which would adversely impact our revenues and liquidity
position.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>We
may not be able to prevent others from unauthorized use of our intellectual property, which could cause a loss of customers, reduce
our revenues and harm our competitive position.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">We rely on a combination
of copyright, trademark, software registration, anti-unfair competition and trade secret laws, as well as confidentiality agreements
and other methods to protect our intellectual property rights. To protect our trade secrets and other proprietary information,
employees, customers, subcontractors, consultants, advisors and collaborators are required to enter into confidentiality agreements.
These agreements might not provide effective protection for the trade secrets, know-how or other proprietary information in the
event of any unauthorized use, misappropriation or disclosure of such trade secrets, know-how or other proprietary information.
Implementation of intellectual property-related laws in China has historically been lacking, primarily because of ambiguities
in the PRC laws and difficulties in enforcement. Accordingly, intellectual property rights and confidentiality protections in
China may not be as effective as those in the United States or other developed countries, and infringement of intellectual property
rights continues to pose a serious risk of doing business in China. Policing unauthorized use of proprietary technology is difficult
and expensive. The steps we have taken may be inadequate to prevent the misappropriation of our proprietary technology. Unauthorized
copying, other misappropriation, or negligent or accidental leakage of our proprietary technologies could enable third parties
to benefit from our technologies without obtaining our consent or paying us for doing so, which could harm our business and competitive
position. Though we are not currently involved in any litigation with respect to intellectual property, we may need to enforce
our intellectual property rights through litigation. Litigation relating to our intellectual property may not prove successful
and might result in substantial costs and diversion of resources and management attention.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may face intellectual property
infringement claims that could be time-consuming and costly to defend. If we fail to defend ourselves against such claims, we
may lose significant intellectual property rights and may be unable to continue providing our existing services.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Our success largely
depends on our ability to use and develop our technology and services without infringing the intellectual property rights of third
parties, including copyrights, trade secrets and trademarks. We may be subject to risk related to potential infringement claims
of the copyrights, as the copyrights of our some medical education courses developed by us belong to our customers or share with
our customers based on agreements. For example, pursuant to the Copyright Law of the PRC, providing the public with works by wired
or wireless means, so as to make the public able to respectively obtain the works at the individually selected time and place,
without permission from the owner of the copyrights therein shall constitute infringements of copyrights. The infringer shall,
according to the circumstances of the case, undertake to cease the infringement, take remedial action, and offer an apology, pay
damages, etc. We may be subject to litigation involving claims of violation of other intellectual property rights of third parties.
We may be unaware of intellectual property registrations or applications relating to our services that may give rise to potential
infringement claims against us. There may also be technologies licensed to and relied on by us that are subject to infringement
or other corresponding allegations or claims by third parties which may damage our ability to rely on such technologies. We are
subject to additional risks as a result of our hiring of new employees who may misappropriate intellectual property from their
former employers. Parties making infringement claims may be able to obtain an injunction to prevent us from delivering our services
or using technology involving the allegedly infringing intellectual property. Intellectual property litigation is expensive and
time-consuming and could divert management&rsquo;s attention from our business. A successful infringement claim against us, whether
with or without merit, could, among others things, require us to pay substantial damages, develop non-infringing technology, or
re-brand our name or enter into royalty or license agreements that may not be available on acceptable terms, if at all, and cease
making, licensing or using products that have infringed a third party&rsquo;s intellectual property rights. Protracted litigation
could also result in existing or potential customers deferring or limiting their purchase or use of our products until resolution
of such litigation, or could require us to indemnify our customers against infringement claims in certain instances. Any intellectual
property claim or litigation in this area, whether we ultimately win or lose, could damage our reputation and have a material
adverse effect on our business, results of operations or financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Disruptions in telecommunications
or significant failure in our IT systems could harm our service model, which could result in a reduction of our revenue.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A significant element
of our business strategy is to continue to leverage and expand our branches strategically located in China. We believe that the
use of a strategically located network of branches will provide us with cost advantages, the ability to attract highly skilled
personnel in various regions of the country and the world, and the ability to serve customers on a regional and global basis.
Part of our service model is to maintain active voice and data communications, financial control, accounting, customer service
and other data processing systems between our main offices in Shanghai, our customers&rsquo; locations, and our other branches
and support facilities. Our business activities may be materially disrupted in the event of a partial or complete failure of any
of these IT or communication systems, which could be caused by, among other things, software malfunction, computer virus attacks,
conversion errors due to system upgrading, damage from fire, earthquake, power loss, telecommunications failure, unauthorized
entry or other events beyond our control. Loss of all or part of the systems for a period of time could hinder our performance
or our ability to complete client projects on time which, in turn, could lead to a reduction of our revenue or otherwise have
a material adverse effect on our business and business reputation. We may also be liable to our customers for breach of contract
for interruptions in service.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may be liable to third parties
for content that is available from our online library.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may be liable to
third parties for the content in our online library if the text, graphics, software or other content in our library violates copyright,
trademark, or other intellectual property rights, our content partners violate their contractual obligations to others by providing
content to our library or the content does not conform to accepted standards of care in the healthcare profession. We may also
be liable for anything that is accessible from our Website through links to other Websites. We attempt to minimize these types
of liabilities by requiring representations and warranties relating to our content partners&rsquo; ownership of, the rights to
distribute as well as the accuracy of their content. We also take necessary measures to review this content ourselves. Although
our agreements with our content partners contain provisions providing for indemnification by the content providers in the event
of inaccurate content, we cannot assure you that our content partners will have the financial resources to meet this obligation.
Alleged liability could harm our business by damaging our reputation, requiring us to incur legal costs in defense, exposing us
to awards of damages and costs and diverting management&rsquo;s attention away from our business. See &ldquo;Business -- Intellectual
Property Rights&rdquo; for a more complete discussion of the potential effects of this liability on our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Any reduction in the regulation
of continuing education and training in the healthcare industry may adversely affect our business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business model
is dependent in part on required training and continuing education for healthcare professionals and other healthcare workers resulting
from regulations of Chinese Health Department. Any change in these regulations which reduce the demands for continuing education
and training for the healthcare industry could harm our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may need additional capital and
any failure by us to raise additional capital on terms favorable to us, or at all, could limit our ability to grow our business
and develop or enhance our service offerings to respond to market demand or competitive challenges.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that our
current cash, cash flow from operations and the proceeds from this offering should be sufficient to meet our anticipated cash
needs for at least the next 12 months. We may, however, require additional cash resources due to changed business conditions or
other future developments, including any investments or acquisitions we may decide to pursue. If these resources are insufficient
to satisfy our cash requirements, we may seek to sell additional equity or debt securities or obtain a credit facility. The sale
of additional equity securities could result in dilution to our shareholders. The incurrence of indebtedness would result in increased
debt service obligations and could require us to agree to operating and financing covenants that would restrict our operations.
Our ability to obtain additional capital on acceptable terms is subject to a variety of uncertainties, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">investors&rsquo;
                                         perception of, and demand for, securities of technology services outsourcing companies;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">conditions of the U.S. and other capital markets in which we
    may seek to raise funds;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">our future results of operations and financial condition;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">PRC government regulation of foreign investment in China;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">economic, political and other conditions in China; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">PRC government policies relating to the borrowing and remittance
    outside China of foreign currency.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financing may not
be available in amounts or on terms acceptable to us, if at all. Any failure by us to raise additional funds on terms favorable
to us, or at all, could limit our ability to grow our business and develop or enhance our product and service offerings to respond
to market demand or competitive challenges.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may incur losses resulting from
business interruptions resulting from occurrence of natural disasters, health epidemics and other outbreaks or events.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Our operational facilities
may be damaged in natural disasters such as earthquakes, floods, heavy rains, sand storms, tsunamis and cyclones, or other events
such as fires. Such natural disasters or other events may lead to disruption of information systems and telephone service for
sustained periods. Damage or destruction that interrupts our provision of outsourcing services could damage our relationships
with our customers and may cause us to incur substantial additional expenses to repair or replace damaged equipment or facilities.
We may also be liable to our customers for disruption in service resulting from such damage or destruction. Prolonged disruption
of our services as a result of natural disasters or other events may also entitle our customers to terminate their contracts with
us. We currently do not have insurance against business interruptions.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Fluctuation in the value of the
Renminbi and other currencies may have a material adverse effect on the value of your investment.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our financial statements
are expressed in U.S. dollars. However, a majority of our revenues and expenses are denominated in Renminbi (RMB). Our exposure
to foreign exchange risk primarily relates to the limited cash denominated in currencies other than the functional currencies
of each entity. We do not believe that we currently have any significant direct foreign exchange risk and have not hedged exposures
denominated in foreign currencies or any other derivative financial instruments. However, the value of your investment in our
Class A Ordinary Shares will be affected by the foreign exchange rate between U.S. dollars and RMB because the primary value of
our business is effectively denominated in RMB, while the Class A Ordinary Shares will be traded in U.S. dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The value of the RMB
against the U.S. dollar and other currencies is affected by, among other things, changes in China&rsquo;s political and economic
conditions and China&rsquo;s foreign exchange policies. The People&rsquo;s Bank of China regularly intervenes in the foreign exchange
market to limit fluctuations in RMB exchange rate and achieve certain exchange rate targets, and through such intervention kept
the U.S. dollar-RMB exchange rate relatively stable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As we may rely on
dividends paid to us by our PRC subsidiaries and branches, any significant revaluation of the RMB may have a material adverse
effect on our revenues and financial condition, and the value of any dividends payable on our Class A Ordinary Shares in foreign
currency terms. For example, to the extent that we need to convert U.S. dollars we receive from this offering into for our operations,
appreciation of the RMB against the U.S. dollar would have an adverse effect on the RMB amount we receive from the conversion.
Conversely, if we decide to convert our RMB into U.S. dollars for the purpose of making payments for dividends on our Class A
Ordinary Share or for other business purposes, appreciation of the U.S. dollar against the RMB would have a negative effect on
the U.S. dollar amount available to us. Furthermore, appreciation or depreciation in the value of the RMB relative to the U.S.
dollar would affect our financial results reported in U.S. dollar terms without giving effect to any underlying change in our
business or results of operations. We cannot predict the impact of future exchange rate fluctuations on our results of operations
and may incur net foreign exchange losses in the future. In addition, our foreign currency exchange losses may be magnified by
PRC exchange control regulations that restrict our ability to convert into foreign currencies.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Fluctuations in exchange rates could
adversely affect our business and the value of our securities.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Changes in the value
of the RMB against the U.S. dollar, euro and other foreign currencies are affected by, among other things, changes in China political
and economic conditions. Any significant revaluation of the RMB may have a material adverse effect on our revenues and financial
condition, and the value of, and any dividends payable on our shares in the U.S. dollar terms. For example, to the extent that
we need to convert U.S. dollar we receive from our offering into RMB for our operations, appreciation of the RMB against the U.S.
dollar would have an adverse effect on the RMB amount we would receive from the conversion. Conversely, if we decide to convert
our RMB into U.S. dollar for the purpose of paying dividends on our ordinary shares or for other business purposes, appreciation
of the U.S. dollar against the RMB would have a negative effect on the U.S. dollar amount available to us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since July 2005, the
RMB is no longer pegged to the U.S. dollar, although the People&rsquo;s Bank of China regularly intervenes in the foreign exchange
market to prevent significant short-term fluctuations in the exchange rate, the RMB may appreciate or depreciate significantly
in value against the U.S. dollar in the medium to long term. Moreover, it is possible that in future, PRC authorities may lift
restrictions on fluctuations in the RMB exchange rate and lessen intervention in the foreign exchange market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Very limited hedging
transactions are available in China to reduce our exposure to exchange rate fluctuations. To date, we have not entered into any
hedging transactions. While we may enter into hedging transactions in the future, the availability and effectiveness of these
transactions may be limited, and we may not be able to successfully hedge our exposure at all. In addition our foreign currency
exchange losses may be magnified by PRC exchange control regulations that restrict our ability to convert RMB into foreign currencies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We have identified material weaknesses
in our internal control over financial reporting. If we fail to develop and maintain an effective system of internal control over
financial reporting, we may be unable to accurately report our financial results or prevent fraud.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
audits of our financial statements for the fiscal years ended December 31, 2018 and 2017, our management identified a material
weakness in the design and operation of our internal controls because:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company lacked of the key monitoring mechanisms such as internal control department to
                                         oversee and monitor Company&rsquo;s risk management, business strategies and financial
                                         reporting procedures, also we did not have adequately designed and documented management
                                         review controls to properly detect and prevent certain accounting errors and omitted
                                         disclosures in the footnotes to the consolidated financial statements;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in; padding: 0; text-indent: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="padding: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company lacked of sufficient resources and expertise with US GAAP and the SEC reporting
                                         experiences in the accounting department to provide accurate information on a timely
                                         manner.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As defined under standards
established by the Public Company Accounting Oversight Board, a material weakness is a deficiency, or a combination of deficiencies,
in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the
Company&rsquo;s annual or interim consolidated financial statements will not be prevented or detected on a timely basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, in order
to address the material weakness in internal control over financial reporting of the Company, we have: (a) hired an experienced
outside consultant with adequate experience with US GAAP and the SEC reporting and compliance requirements. (b) continued our
efforts to provide ongoing training courses in US GAAP to existing personnel, including our Chief Financial Officer; (c) continued
our efforts to set up the internal audit department, and enhance the effectiveness of the internal control system; and (d) continued
our efforts to implement necessary review and controls at related levels and all important documents and contracts will be submitted
to the office of its chief executive officer for retention.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All internal control
systems, no matter how well designed, have inherent limitations including the possibility of human error and the circumvention
or overriding of controls. Further, because of changes in conditions, the effectiveness of internal controls may vary over time.
Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because
of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. Accordingly, even
those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation
and presentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cannot be certain
that these measures will successfully remediate the material weakness or that other material weaknesses will not be discovered
in the future. If our efforts are not successful or other material weaknesses or control deficiencies occur in the future, we
may be unable to report our financial results accurately on a timely basis or help prevent fraud, which could cause our reported
financial results to be materially misstated and result in the loss of investor confidence or delisting and cause the market price
of our ordinary shares to decline. In addition, it could in turn limit our access to capital markets, harm our results of operations,
and lead to a decline in the trading price of our securities. Additionally, ineffective internal control over financial reporting
could expose us to increased risk of fraud or misuse of corporate assets and subject us to potential delisting from the stock
exchange on which we list, regulatory investigations and civil or criminal sanctions. We may also be required to restate our financial
statements from prior periods. Because of our status as an emerging growth company, you will not be able to depend on any attestation
from our independent registered public accountants as to our internal control over financial reporting for the foreseeable future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If major mobile application distribution
channels change their standard terms and conditions in a manner that is detrimental to us, or suspend or terminate their existing
relationship with us, our business, financial condition and results of operations may be materially and adversely affected.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently cooperate
with Apple&rsquo;s app store and major&nbsp;PRC-based&nbsp;Android app stores to distribute our&nbsp;MDMOOC and Sunshine Health
Forum&nbsp;mobile application to users. As such, the promotion, distribution and operation of our application are subject to such
distribution platforms&rsquo; standard terms and policies for application developers, which are subject to the interpretation
of, and frequent changes by, these distribution channels. If these third-party distribution platforms change their terms and conditions
in a manner that is detrimental to us, or refuse to distribute our application, or if any other major distribution channel with
which we would like to seek collaboration refuses to collaborate with us in the future on commercially favorable terms, our business,
financial condition and results of operations may be materially and adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Our activities may expose us to malpractice liability
and other liability inherent in healthcare delivery.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may be exposed
to malpractice or other liability against which we may not be adequately insured, resulting in a decline in our financial results.
A court or government agency may take the position that our delivery of health information directly, including through licensed
physicians, or information delivered by a third-party site that a consumer accesses through our Website, exposes us to malpractice
or other personal injury liability for wrongful delivery of healthcare services or erroneous health information. The amount of
insurance we maintain with insurance carriers may not be sufficient to cover all of the losses we might incur from these claims
and legal actions. In addition, insurance for some risks is difficult, impossible or too costly to obtain, and as a result, we
may not be able to purchase insurance for some types of risks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Healthcare reforms and the cost
of regulatory compliance could negatively affect our business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">The healthcare industry
is heavily regulated in China. Various laws, regulations and guidelines promulgated by government, industry and professional associations
affect, among other matters, the provision, licensing, labeling, marketing, promotion and reimbursement of healthcare services
and products, including pharmaceutical products. Our failure or our customers&rsquo; failure to comply with any applicable regulatory
requirements or industry guidelines could:</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">- limit or prohibit business activities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">- subject us or our customers to adverse
publicity; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">- increase the costs
of regulatory compliance or subject us or our customers to monetary fines or other penalties.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Some of PRC laws have
been applied to the marketing and promotional practices of pharmaceutical manufacturers, to payments to physicians for services
and to other benefits to physicians, and could constrain our relationships, including financial, marketing and continuing medical
education relationships, with our sponsors and advertisers and with physicians, including any physicians who perform services
for us. It is possible that additional or changed laws, regulations or guidelines could be adopted in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">In addition, implementation
of government healthcare reform may adversely affect promotional and marketing expenditures by pharmaceutical enterprises, which
could decrease the business opportunities available to us.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The Internet is subject to many
legal uncertainties and potential government regulations that may decrease demand for our services, increase our cost of doing
business or otherwise have a material adverse effect on our financial results or prospects.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any new law or regulation
pertaining to the Internet or online publication, or the application or interpretation of existing laws, could decrease demand
for our services, increase our cost of doing business or otherwise have a material adverse effect on our financial results and
prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">New laws and regulations
or the application or interpretation of existing laws and regulations pertaining to the Internet or online publication may be
adopted by PRC regulatory authorities in the future that address Internet-related issues, including online content, user privacy,
pricing and quality of products and services. For example, due to the ambiguity of the definition of &ldquo;online publishing
service,&rdquo; the online distribution of content, including our online services, the courseware or audio-visual contents uploaded
by the users in MDMOOC platforms, through our website or mobile apps, may be regarded as &ldquo;online publishing service&rdquo;
and therefore we may be required to obtain an Online Publishing License in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The United States
or foreign nations may adopt legislation aimed at protecting Internet users&rsquo; privacy. This legislation could increase our
cost of doing business and negatively affect our financial results. Moreover, it may take years to determine the extent to which
existing laws governing issues like property ownership, libel, negligence and personal privacy are applicable to the Internet.
Currently, U.S. privacy law consists of disparate state and federal statutes regulating specific industries that collect personal
data. Most of them predate and therefore do not specifically address online activities. In addition, a number of comprehensive
legislative and regulatory privacy proposals are now under consideration by federal, state and local governments in the United
States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our future growth depends on the
further acceptance of the Internet and particularly the mobile Internet as an effective platform for assessing healthcare training
services and content.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While the Internet
and the mobile Internet have gained increased popularity in China as platforms for online healthcare training and information
sharing in recent years, many users have limited experience in accessing healthcare training services or healthcare information
online. For example, users may not consider online content to be reliable sources of healthcare information. If we fail to educate
users about the value of our content, our platform and our services, our growth may be limited and our business, financial performance
and prospects may be materially and adversely affected. The further acceptance of the internet and the mobile internet as an effective
and efficient platform for healthcare information sharing and training content is also affected by factors beyond our control,
including negative publicity around online healthcare training or information sharing services and potential restrictive regulatory
measures taken by the PRC government. If online and mobile networks do not achieve adequate acceptance in the market, our growth
prospects, results of operations and financial condition could be harmed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>PRC laws that protect individual
information may limit our plans to collect, use and disclose that information.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we fail to comply
with current or future laws or regulations governing the collection, dissemination, use and confidentiality of users&rsquo; health
information, this failure could have a material adverse effect on our business, operating results and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">End users sometimes
enter private health information about themselves or their family members when using our services. Also, our systems record use
patterns when End users access our databases that may reveal health-related information or other private information about the
users. Certain PRC laws and regulations govern collection, dissemination, use and confidentiality of users&rsquo; private information.
For example, General Provisions of the Civil Law of the PRC which stipulates that the personal information of a natural person
shall be protected by laws, any organization or individual that needs to obtain the personal information of others shall obtain
such information pursuant to the law and ensure information security, and may neither illegally collect, use, transmit the personal
information of others, nor illegally trade, provide or disclose the personal information of others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The PRC government
has been considering proposed legislation that would establish a new standard for protection and use of health information. In
addition, the laws of other countries also govern the use of and disclosure of health information. Our systems for safeguarding
users&rsquo; health information from unauthorized disclosure or use may not preclude successful claims against us for violation
of applicable law. Other third-party sites that users access through our site also may not maintain systems to safeguard this
health information. In some cases, we may place our content on computers that are under the physical control of others, which
may increase the risk of an inappropriate disclosure of health information. For example, we may contract out the hosting of our
Website to a third party. In addition, future laws or changes in current laws may necessitate costly adaptations to our systems.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We intend to develop
medical information systems and market research services that we will use to collect, analyze and report aggregate medical care,
medical research, outcomes and financial data pertaining to items such as prescribing patterns and usage habits. Because this
area of the law is rapidly changing, our collection, analysis and reporting of aggregate healthcare data maintained in our database
may not at all times and in all respects comply with laws or regulations governing the ownership, collection and use of this data.
Future laws or changes in current laws governing the ownership, collection and use of aggregate healthcare data may necessitate
costly adaptations to our systems or limit our ability to use this data.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RISKS RELATED TO OUR CORPORATE STRUCTURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>We will likely not pay dividends in the foreseeable future.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Dividend policy is
subject to the discretion of our Board of Directors and will depend on, among other things, our earnings, financial condition,
capital requirements and other factors. There is no assurance that our Board of Directors will declare dividends even if we are
profitable. The payment of dividends by entities organized in China is subject to limitations as described herein. Under Cayman
Islands law, we may only pay dividends from profits of the Company, or credits standing in the Company&rsquo;s share premium account,
and we must be solvent before and after the dividend payment in the sense that we will be able to satisfy our liabilities as they
become due in the ordinary course of business; and the realizable value of assets of our Company will not be less than the sum
of our total liabilities, other than deferred taxes as shown on our books of account, and our capital. Pursuant to the Chinese
enterprise income tax law, dividends payable by a foreign investment entity to its foreign investors are subject to a withholding
tax of 10%. Similarly, dividends payable by a foreign investment entity to its Hong Kong investor who owns 25% or more of the
equity of the foreign investment entity is subject to a withholding tax of 5%. The payment of dividends by entities organized
in China is subject to limitations, procedures and formalities. Regulations in China currently permit payment of dividends only
out of accumulated profits as determined in accordance with accounting standards and regulations in China. The transfer to this
reserve must be made before distribution of any dividend to shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The dual class structure of our
ordinary shares has the effect of concentrating voting control with our CEO, directors and their affiliates.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Our Class B Ordinary
Share has 15 votes per share, and our Class&nbsp;A Ordinary Share, which is the share we are offering in our initial public offering,
has 1 vote per share. The shareholder who holds shares of Class&nbsp;B Ordinary Shares will hold approximately 80.38% of the voting
power of our outstanding ordinary shares following our initial public offering, assuming the full exercise of the over-allotment
option by the underwriters and the exercise of the HF Warrant. Because of the fifteen-to-one voting ratio between our Class&nbsp;B
and Class&nbsp;A Ordinary Shares, the holder of our Class&nbsp;B Ordinary Shares will continue to control a majority of the combined
voting power of our ordinary share and therefore be able to control all matters submitted to our shareholders for approval so
long as the shares of Class&nbsp;B Ordinary Shares represent more than 6.25%&nbsp;&nbsp;of all outstanding shares of our Class&nbsp;A
and Class&nbsp;B Ordinary Shares, assuming the full exercise of the over-allotment option by the underwriters and the exercise
of the HF Warrant. This concentrated control will limit your ability to influence corporate matters for the foreseeable future. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Future transfers by
the holder of Class&nbsp;B Ordinary Shares will generally result in those shares converting to Class&nbsp;A Ordinary Shares, subject
to limited exceptions, such as certain transfers effected for estate planning purposes. The conversion of Class&nbsp;B Ordinary
Shares to Class&nbsp;A Ordinary Shares will have the effect, over time, of increasing the relative voting power of those holders
of Class&nbsp;B Ordinary Shares who retain their shares in the long term. If, for example, Mr.&nbsp;Weiguang Yang retains a significant
portion of his holdings of Class&nbsp;B Ordinary Share for an extended period of time, he could, in the future, continue to control
a majority of the combined voting power of our Class&nbsp;A Ordinary Shares and Class&nbsp;B Ordinary Shares. For a description
of the dual class structure, see &ldquo;Description of Capital Stock&mdash;Anti-Takeover Provisions.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our CEO has control over key decision
making as a result of his control of a majority of our voting shares.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Founder, CEO,
and our Chairman of the Board, Mr. Weiguang Yang, and his affiliates which he deemed to have control and/or have substantial influence
will be able to exercise full voting rights with respect to an aggregate of 5,497,715 Class B Ordinary Shares and 4,203,385 Class
A Ordinary Shares, representing a majority of the voting power of our outstanding ordinary shares following our initial public
offering. As a result, Mr. Yang has the ability to control the outcome of matters submitted to our shareholders for approval,
including the election of directors and any merger, consolidation, or sale of all or substantially all of our assets. In addition,
Mr. Yang has the ability to control the management and affairs of our company as a result of his position as our CEO and his ability
to control the election of our directors. Additionally, in the event that Mr. Yang controls our company at the time of his death,
control may be transferred to a person or entity that he designates as his successor. As a board member and officer, Mr. Yang
owes a fiduciary duty to our shareholders and must act in good faith in a manner he reasonably believes to be in the best interests
of our shareholders. As a shareholder, even a controlling shareholder, Mr. Yang is entitled to vote his shares, and shares over
which he has voting control as a result of voting agreements, in his own interests, which may not always be in the interests of
our shareholders generally. For a description of the voting rights, see &ldquo;Description of Share Capital&mdash;Voting Rights.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>As a &ldquo;controlled company&rdquo;
under the rules of the NASDAQ Capital Market, we may choose to exempt our company from certain corporate governance requirements
that could have an adverse effect on our public shareholders.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Prior to the completion
of this Offering, our directors and officers beneficially own a majority of the voting power of our outstanding Class A Ordinary
Shares. Even if we raise the maximum offering amount, we may continue to be a &ldquo;controlled company.&rdquo; Under the Rule
4350(c) of the NASDAQ Capital Market, a company of which more than 50% of the voting power is held by an individual, group or
another company is a &ldquo;controlled company&rdquo; and may elect&nbsp;<B><I>not</I></B>&nbsp;to comply with certain corporate
governance requirements, including the requirement that a majority of our directors be independent, as defined in the NASDAQ Capital
Market Rules, and the requirement that our compensation and nominating and corporate governance committees consist entirely of
independent directors. Although we do not intend to rely on the &ldquo;controlled company&rdquo; exemption under the Nasdaq listing
rules, we could elect to rely on this exemption in the future. If we elect to rely on the &ldquo;controlled company&rdquo; exemption,
a majority of the members of our board of directors might not be independent directors and our nominating and corporate governance
and compensation committees might not consist entirely of independent directors. Accordingly, during any time while we remain
a&nbsp;controlled company&nbsp;relying on the exemption and during any transition period following a time when we are no longer
a&nbsp;controlled company, you would not have the same protections afforded to shareholders of companies that are subject to all
of the NASDAQ Capital Market corporate governance requirements. Our status as a controlled company could cause our Class&nbsp;A
Ordinary Share to look less attractive to certain investors or otherwise harm our trading price.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We depend upon the VIE Arrangements
in conducting our business in China, which may not be as effective as direct ownership.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Our affiliation with
Zhongchao Shanghai is managed through the VIE Arrangements, which agreements may not be as effective in providing us with control
over Zhongchao Shanghai as direct ownership. The VIE Arrangements are governed by and would be interpreted in accordance with
the laws of the People&rsquo;s Republic of China, or the PRC. If Zhongchao Shanghai fails to perform the obligations under the
VIE Arrangements, we may have to rely on legal remedies under the laws of the PRC, including seeking specific performance or injunctive
relief, and claiming damages. There is a risk that we may be unable to obtain any of these remedies. The legal environment in
the PRC is not as developed as in other jurisdictions. As a result, uncertainties in the PRC legal system could limit our ability
to enforce the VIE Arrangements, or could affect the validity of the VIE Arrangements.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may not be able to consolidate
the financial results of some of our affiliated companies or such consolidation could materially adversely affect our operating
results and financial condition.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of our business
is conducted through Zhongchao Shanghai, which is considered a VIE for accounting purposes, and we, through Zhongchao WFOE, are
considered the primary beneficiary, thus enabling us to consolidate our financial results in our consolidated financial statements.
In the event that in the future a company we hold as a VIE no longer meets the definition of a VIE under applicable accounting
rules, or we are deemed not to be the primary beneficiary, we would not be able to consolidate line by line that entity&rsquo;s
financial results in our consolidated financial statements for reporting purposes. Also, if in the future an affiliate company
becomes a VIE and we become the primary beneficiary, we would be required to consolidate that entity&rsquo;s financial results
in our consolidated financial statements for accounting purposes. If such entity&rsquo;s financial results were negative, this
would have a corresponding negative impact on our operating results for reporting purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Because we rely on the VIE Arrangements
for our revenue, the termination of these agreements would severely and detrimentally affect our continuing business viability
under our current corporate structure.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">We are a holding company
and all of our business operations are conducted through the VIE Arrangements. Zhongchao Shanghai may terminate the VIE Arrangements
for any or no reason at all. Because neither we, nor our subsidiaries, own equity interests of Zhongchao Shanghai, the termination
of the VIE Arrangements would sever our ability to receive payments from Zhongchao Shanghai under our current holding company
structure. While we are currently not aware of any event or reason that may cause the VIE Arrangements to terminate, we cannot
assure you that such an event or reason will not occur in the future. In the event that the VIE Arrangements are terminated, this
would have a severe and detrimental effect on our continuing business viability under our current corporate structure, which,
in turn, may affect the value of your investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>VIE Arrangements in relation to
our VIE may be subject to scrutiny by the PRC tax authorities and they may determine that we or our VIE owe additional taxes,
which could negatively affect our financial condition and the value of your investment.</I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Under applicable PRC
laws and regulations, arrangements and transactions among related parties may be subject to audit or challenge by the PRC tax
authorities within ten years after the taxable year when the transactions are conducted. We could face material and adverse tax
consequences if the PRC tax authorities determine that the VIE Arrangements were not entered into on an arm&rsquo;s-length basis
in such a way as to result in an impermissible reduction in taxes under applicable PRC laws, rules and regulations, and adjust
the income of our VIE in the form of a transfer pricing adjustment. A transfer pricing adjustment could, among other things, result
in a reduction of expense deductions recorded by our VIE for PRC tax purposes, which could in turn increase its tax liabilities
without reducing our subsidiary&rsquo;s tax expenses. In addition, the PRC tax authorities may impose late payment fees and other
penalties on our VIE for the adjusted but unpaid taxes according to the applicable regulations. Our financial position could be
materially and adversely affected if our VIE&rsquo;s tax liabilities increase or if it is required to pay late payment fees and
other penalties. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We conduct our business through
Zhongchao Shanghai by means of VIE Arrangements. If the PRC courts or administrative authorities determine that these VIE Arrangements
do not comply with applicable regulations, we could be subject to severe penalties and our business could be adversely affected.
In addition, changes in such PRC laws and regulations may materially and adversely affect our business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">There
are uncertainties regarding the interpretation and application of PRC laws, rules and regulations, including the laws, rules and
regulations governing the validity and enforcement of the VIE Arrangements between Zhongchao WFOE and Zhongchao Shanghai. We have
been advised by our PRC counsel, Zong Heng Law Firm, </FONT>&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">based
on their understanding of the current PRC laws, rules and regulations, that (i) the structure for operating our business in China
(including our corporate structure and VIE Arrangements with Zhongchao Shanghai, Zhongchao Shanghai and their shareholders) will
not result in any violation of PRC laws or regulations currently in effect; and (ii) the VIE Arrangements among Zhongchao WFOE
and Zhongchao Shanghai and their shareholders governed by PRC law are valid, binding and enforceable, and will not result in any
violation of PRC laws or regulations currently in effect. However, there are substantial uncertainties regarding the interpretation
and application of current or future PRC laws and regulations concerning foreign investment in the PRC, and their application
to and effect on the legality, binding effect and enforceability of the VIE Arrangements. In particular, we cannot rule out the
possibility that PRC regulatory authorities, courts or arbitral tribunals may in the future adopt a different or contrary interpretation
or take a view that is inconsistent with the opinion of our PRC legal counsel.</FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">If any of our PRC entities
or their ownership structure or the VIE Arrangements are determined to be in violation of any existing or future PRC laws, rules
or regulations, or any of our PRC entities fail to obtain or maintain any of the required governmental permits or approvals, the
relevant PRC regulatory authorities would have broad discretion in dealing with such violations, including:</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">revoking
                                         the business and operating licenses;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">discontinuing
                                         or restricting the operations;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">imposing
                                         conditions or requirements with which the PRC entities may not be able to comply;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">requiring
                                         us and our PRC entities to restructure the relevant ownership structure or operations;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">restricting
                                         or prohibiting our use of the proceeds from this offering to finance our business and
                                         operations in China; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">imposing
                                         fines.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The imposition of
any of these penalties would severely disrupt our ability to conduct business and have a material adverse effect on our financial
condition, results of operations and prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The shareholders of our VIE may
have actual or potential conflicts of interest with us, which may materially and adversely affect our business and financial condition.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">The shareholders of
our VIE may have actual or potential conflicts of interest with us. These shareholders may refuse to sign or breach, or cause
our VIE to breach, or refuse to renew, the existing VIE Arrangements we have with them and our VIE, which would have a material
and adverse effect on our ability to effectively control our VIE and receive economic benefits from it. For example, the shareholders
may be able to cause our agreements with our VIE to be performed in a manner adverse to us by, among other things, failing to
remit payments due under the VIE Arrangements to us on a timely basis. We cannot assure you that when conflicts of interest arise
any or all of these shareholders will act in the best interests of our company or such conflicts will be resolved in our favor.
Currently, we do not have any arrangements to address potential conflicts of interest between these shareholders and our company.
If we cannot resolve any conflict of interest or dispute between us and these shareholders, we would have to rely on legal proceedings,
which could result in disruption of our business and subject us to substantial uncertainty as to the outcome of any such legal
proceedings.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our current corporate structure
and business operations may be affected by the newly enacted Foreign Investment Law.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 18pt">On March 15, 2019,
the National People&rsquo;s Congress approved the Foreign Investment Law, which will take effect on January 1, 2020. Since it
is relatively new, uncertainties exist in relation to its interpretation and its implementation rules that are yet to be issued.
The Foreign Investment Law does not explicitly classify whether variable interest entities that are controlled through VIE Arrangements
would be deemed as foreign-invested enterprises if they are ultimately &ldquo;controlled&rdquo; by foreign investors. However,
it has a catch-all provision under definition of &ldquo;foreign investment&rdquo; that includes investments made by foreign investors
in China through other means as provided by laws, administrative regulations or the State Council. Therefore it still leaves leeway
for future laws, administrative regulations or provisions of the State Council to provide for VIE Arrangements as a form of foreign
investment. Therefore, there can be no assurance that our control over our consolidated VIE through VIE Arrangements will not
be deemed as foreign investment in the future.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

















































































<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">The Foreign Investment
Law grants national treatment to foreign-invested entities, except for those foreign-invested entities that operate in industries
specified as either &ldquo;restricted&rdquo; or &ldquo;prohibited&rdquo; from foreign investment in a &ldquo;negative list&rdquo;
that is yet to be published. It is unclear whether the &ldquo;negative list&rdquo; to be published will differ from the current
Special Administrative Measures for Market Access of Foreign Investment (Negative List). The Foreign Investment Law provides that
foreign-invested entities operating in &ldquo;restricted&rdquo; or &ldquo;prohibited&rdquo; industries will require market entry
clearance and other approvals from relevant PRC government authorities. If our control over our consolidated VIE through VIE Arrangements
are deemed as foreign investment in the future, and any business of our consolidated VIE is &ldquo;restricted&rdquo; or &ldquo;prohibited&rdquo;
from foreign investment under the &ldquo;negative list&rdquo; effective at the time, we may be deemed to be in violation of the
Foreign Investment Law, the VIE Arrangements that allow us to have control over our consolidated VIE may be deemed as invalid
and illegal, and we may be required to unwind such VIE Arrangements and/or restructure our business operations, any of which may
have a material adverse effect on our business operation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Furthermore, if future
laws, administrative regulations or provisions mandate further actions to be taken by companies with respect to existing VIE Arrangements,
we may face substantial uncertainties as to whether we can complete such actions in a timely manner, or at all. Failure to take
timely and appropriate measures to cope with any of these or similar regulatory compliance challenges could materially and adversely
affect our current corporate structure and business operations.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If any of our affiliated entities
becomes the subject of a bankruptcy or liquidation proceeding, we may lose the ability to use and enjoy assets held by such entity,
which could materially and adversely affect our business, financial condition and results of operations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">We currently conduct
our operations in China through our VIE Arrangements. As part of these arrangements, substantially all of our assets that are
significant to the operation of our business are held by our affiliated entities. If any of these entities becomes bankrupt and
all or part of their assets become subject to liens or rights of third-party creditors, we may be unable to continue some or all
of our business activities, which could materially and adversely affect our business, financial condition and results of operations.
In addition, if any of our affiliated entities undergoes a voluntary or involuntary liquidation proceeding, its equity owner or
unrelated third-party creditors may claim rights relating to some or all of these assets, which would hinder our ability to operate
our business and could materially and adversely affect our business, our ability to generate revenue and the market price of our
ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>The
approval of the China Securities Regulatory Commission may be required in connection with this offering under a regulation adopted
in August 2006, and, if required, we cannot assure you that we will be able to obtain such approval.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 8, 2006,
six Chinese regulatory agencies, including the MOFCOM, jointly issued the Regulations on Mergers and Acquisitions of Domestic
Enterprises by Foreign Investors (the &ldquo;M&amp;A Rule&rdquo;). The M&amp;A Rule contains provisions that require that an offshore
special purpose vehicle (&ldquo;SPV&rdquo;) formed for listing purposes and controlled directly or indirectly by Chinese companies
or individuals shall obtain the approval of the CSRC prior to the listing and trading of such SPV&rsquo;s securities on an overseas
stock exchange. On September 21, 2006, the CSRC published procedures specifying documents and materials required to be submitted
to it by an SPV seeking CSRC approval of overseas listings. However, the application of the M&amp;A Rule remains unclear with
no consensus currently existing among leading Chinese law firms regarding the scope and applicability of the CSRC approval requirement.
The CSRC has not issued any such definitive rule or interpretation, and we have not chosen to voluntarily request approval under
the M&amp;A Rule. If the CSRC requires that we obtain its approval prior to the completion of this offering, the offering will
be delayed until we obtain CSRC approval, which may take several months. There is also the possibility that we may not be able
to obtain such approval. If prior CSRC approval was required, we may face regulatory actions or other sanctions from the CSRC
or other Chinese regulatory authorities. These authorities may impose fines and penalties upon our operations in China, limit
our operating privileges in China, delay or restrict the repatriation of the proceeds from this offering into China, or take other
actions that could have a material adverse effect upon our business, financial condition, results of operations, reputation and
prospects, as well as the trading price of our Class A Ordinary Shares. The CSRC or other Chinese regulatory agencies may also
take actions requiring us, or making it advisable for us, to terminate this offering prior to closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If we fail to maintain continuing
compliance with the PRC state regulatory rules, policies and procedures applicable to our industry, we may risk losing certain
preferential tax and other treatments which may adversely affect the viability of our current corporate structure, corporate governance
and business operations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The State Council
has promulgated several notices since 2000 to launch favorable policies for IT services, such as preferential tax treatments and
credit support. Under rules and regulations promulgated by various Chinese government agencies, enterprises that have met specified
criteria and are recognized as software enterprises by the relevant government authorities in China are entitled to preferential
treatment, including financing support, preferential tax rates, export incentives, discretion and flexibility in determining employees&rsquo;
welfare benefits and remuneration. Software enterprise qualifications are subject to annual examination. Enterprises that fail
to meet the annual examination standards will lose the favorable enterprise income tax treatment. Enterprises exporting software
or producing software products that are registered with the relevant government authorities are also entitled to preferential
treatment including governmental financial support, preferential import, export policies and preferential tax rates. Companies
in China engaging in systems integration are required to obtain qualification certificates from the Ministry of Industry and Information
Technology. Companies planning to set up computer information systems may only retain systems integration companies with appropriate
qualification certificates. Currently the Company does not engage in information system integration business, therefore the Company
is not required to have such qualification certificates. The qualification certificate is subject to review every two years and
is renewable every four years. In 2003, the Ministry of Industry and Information Technology promulgated the Amended Appraisal
Condition for Qualification Grade of Systems Integration of Computer Information to elaborate the conditions for appraising each
of the four qualification grades of systems integration companies. Companies applying for qualification are graded depending on
the scale of the work they undertake. The grades range from Grade 1 (highest) to Grade 4 (lowest) in the scale of the work the
respective companies can undertake. Companies with Grade 3 qualification can independently undertake projects at the medium-scale
and small-scale enterprise level and undertake projects at the large-scale enterprise level in cooperation with other entities.
If and to the extent we fail to maintain compliance with such applicable rules and regulations, our operations and financial results
may be adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RISKS RELATED TO DOING BUSINESS IN CHINA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><B><I>Adverse changes in political,
economic and other policies of the Chinese government could have a material adverse effect on the overall economic growth of China,
which could materially and adversely affect the growth of our business and our competitive position.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The majority of our
business operations are conducted in China. Accordingly, our business, financial condition, results of operations and prospects
are affected significantly by economic, political and legal developments in China. Although the PRC economy has been transitioning
from a planned economy to a more market-oriented economy since the late 1970s, the PRC government continues to exercise significant
control over China&rsquo;s economic growth through direct allocation of resources, monetary and tax policies, and a host of other
government policies such as those that encourage or restrict investment in certain industries by foreign investors, control the
exchange between the Renminbi and foreign currencies, and regulate the growth of the general or specific market. While the Chinese
economy has experienced significant growth in the past 40&nbsp;years, growth has been uneven, both geographically and among various
sectors of the economy. As the PRC economy has become increasingly linked with the global economy, China is affected in various
respects by downturns and recessions of major economies around the world. The various economic and policy measures enacted by
the PRC government to forestall economic downturns or bolster China&rsquo;s economic growth could materially affect our business.
Any adverse change in the economic conditions in China, in policies of the PRC government or in laws and regulations in China
could have a material adverse effect on the overall economic growth of China and market demand for our outsourcing services. Such
developments could adversely affect our businesses, lead to reduction in demand for our services and adversely affect our competitive
position.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><B><I>Uncertainties with respect to
the PRC legal system could have a material adverse effect on us.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">The PRC legal system
is based on written statutes. Prior court decisions may be cited for reference but have limited precedential value. Since the
late 1970s, the PRC government has been building a comprehensive system of laws and regulations governing economic matters in
general. The overall effect has been to significantly enhance the protections afforded to various forms of foreign investments
in China. We conduct our business primarily through our subsidiaries established in China. These subsidiaries are generally subject
to laws and regulations applicable to foreign investment in China. However, since these laws and regulations are relatively new
and the PRC legal system continues to rapidly evolve, the interpretations of many laws, regulations and rules are not always uniform
and enforcement of these laws, regulations and rules involves uncertainties, which may limit legal protections available to us.
In addition, some regulatory requirements issued by certain PRC government authorities may not be consistently applied by other
government authorities (including local government authorities), thus making strict compliance with all regulatory requirements
impractical, or in some circumstances impossible. For example, we may have to resort to administrative and court proceedings to
enforce the legal protection that we enjoy either by law or contract. However, since PRC administrative and court authorities
have discretion in interpreting and implementing statutory and contractual terms, it may be more difficult to predict the outcome
of administrative and court proceedings and the level of legal protection we enjoy than in more developed legal systems. These
uncertainties may impede our ability to enforce the contracts we have entered into with our business partners, customers and suppliers.
In addition, such uncertainties, including any inability to enforce our contracts, together with any development or interpretation
of PRC law that is adverse to us, could materially and adversely affect our business and operations. Furthermore, intellectual
property rights and confidentiality protections in China may not be as effective as in the United States or other more developed
countries. We cannot predict the effect of future developments in the PRC legal system, including the promulgation of new laws,
changes to existing laws or the interpretation or enforcement thereof, or the preemption of local regulations by national laws.
These uncertainties could limit the legal protections available to us and other foreign investors, including you. In addition,
any litigation in China may be protracted and result in substantial costs and diversion of our resources and management attention.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><B><I>We may face risks and uncertainties
with respect to the licensing requirement for internet audio-visual programs. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December 20, 2007,
the State Administration of Press, Publication, Radio, Film and Television (&ldquo;SAPPRFT&rdquo;) and the Ministry of Industry
and Information Technology (&ldquo;MIIT&rdquo;), jointly promulgated the Administrative Provisions on Internet Audio-Visual Program
Service, or the Audio-Visual Program Provisions, which became effective on January 31, 2008 and was last amended on August 28,
2015. Among other things, the Audio-Visual Program Provisions stipulated that no entities or individuals may provide internet
audio-visual program services without a License for Online Transmission of Audio-Visual Programs issued by SAPPRFT or its local
bureaus or completing the relevant registration procedures with SAPPRFT or its local bureaus, and only state-owned or state-controlled
entities are eligible to apply for a License for Online Transmission of Audio-Visual Programs. On March 17, 2010, SAPPRFT promulgated
the Tentative Categories of Internet Audio-Visual Program Services, or the Categories, clarifying the scope of internet audio-visual
programs services, which was amended on March 10, 2017. The making and editing of certain specialized audio-visual programs concerning,
among other things, educational content, and broadcasting such content to the general public online is covered in the Categories.
However, there are still significant uncertainties relating to the interpretation and implementation of the Audio-Visual Program
Provisions, in particular, the scope of &ldquo;internet audio-visual programs.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We offer short audio
clips and the live course on our mobile apps or website for users to listen and learn, which can be repeatedly played by the users.
We believe the audio clips we offer and the live courses we transmit distinguish us from general providers of internet audio-visual
program services. However, we cannot assure you that the competent PRC government authorities will not take a view contrary to
our opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Categories describe
&ldquo;internet audio-visual program services&rdquo; in a very broad, vague manner and are unclear as to whether the contents
we offer or are available on our platforms fall into the definition of &ldquo;internet audio-visual programs.&rdquo; The PRC government
may find that our activities mentioned above or any other content offered on our mobile apps or website fall within the definition
of &ldquo;internet audio-visual programs&rdquo; and thus are subject to the licensing requirement for internet audio-visual programs.
We currently do not hold a License for Online Transmission of Audio-Visual Programs. If the PRC government determines that our
content should be considered as &ldquo;internet audio-visual programs&rdquo; for the purpose of the Audio-Visual Program Provisions,
we may be required to obtain a License for Online Transmission of Audio-Visual Programs. We are, however, not eligible to apply
for such license since we are not a state-owned or state-controlled entity. If this were to occur, we may be subject to penalties,
fines, legal sanctions or an order to suspend the provision of our relevant content.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><B><I>We face risks associated with
uncertainties surrounding the PRC laws and regulations governing the education industry in general, and the online for-profit
private training in particular. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The principal regulations
governing private education in China primarily consist of the PRC Education Law, the Law for Promoting Private Education, or Private
Education Law, the Implementation Rules for Private Education Law and the Implementation Rules on the Supervision and Administration
of For-profit Private Schools, or the Implementation Rules, as amended from time to time. These PRC laws and regulations on private
education generally apply to the establishment and operation of all private schools, including schools and other education institutions,
and provide that, among others, (i) the establishment of a for-profit private school shall be approved by the education authorities
or the authorities in charge of labor and social welfare, (ii) such for-profit private schools should be registered with the competent
branch of the State Administration for Industry and Commerce (&ldquo;SAIC&rdquo;, currently known as the State Administration
for Market Regulation), and (iii) a duly approved private school will be granted a private school operating permit. The Implementation
Rules further provide that the provisions contained therein should be applicable to &ldquo;for-profit private training institutions&rdquo;
in an analogous manner. Shanghai, has accordingly promulgated specific local regulations to clarify the requirements and procedures
for establishing and operating private schools in December 2017, however, it expressly provided that management measures and regulations
applicable to private training institutions that only provide online courses would be promulgated separately. As of the date of
this prospectus, no explicit local rules or guideline on regulation of online private training institutions have been promulgated
in Shanghai, where our operating entity of our online platform and our VIE, Zhongchao Shanghai, was incorporated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We operate online
platform that provides online training programs through the internet, and our PRC subsidiaries and our operating entity of our
online platform are registered with local counterparts of the competent PRC government authorities as for-profit enterprises.
As there lacks clear and consistent statutory interpretation regarding the implementation of the above laws and regulations, it
is unclear how these regulatory requirements shall be applied to us. During our previous consultation with relevant governmental
authorities, we were informed that we are not required to obtain a private school operating permit or other approval from education
authorities or the authorities in charge of labor and social welfare for our operation of online education platform. However,
we cannot assure you that the government authorities will not take a different view in the future. We may be required to obtain
the above-mentioned, or any other approvals, licenses, permits or filings, or otherwise comply with additional regulatory requirements
in the future, due to clarification or change in interpretation or implementation of laws and regulations in education industry,
or promulgation of new regulations or guidelines regulating online education institutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In August 2018, the
Ministry of Justice of the People&rsquo;s Republic of China published the Draft Amendment for the Implementation Rules for Private
Education Law, for public review and comments, which is still subject to discussion, potential revision and adoption by the State
Council before it becomes effective. Accordingly, the Draft Amendment for the Implementation Rules for Private Education Law clarifies
that the scope of &ldquo;private school&rdquo; includes private training education institutions engaging in non-degree education,
which could potentially include us. According to the Draft Amendment for the Implementation Rules for Private Education Law, a
for-profit private institution that provides online training education or an online platform that facilitates such training education
services, which does not engage in (i) cultural education related to school curriculums or tutoring services for kindergarten,
primary or second school examinations or entrance requirements for primary, secondary or high school, or (ii) education that leads
to a degree, would require a filing with (but not approval by) education or human resources and social security authorities. If
enacted into law in its current form, the Draft Amendment for the Implementation Rules for Private Education Law would represent
a major change to the laws and regulations relating to private schools, including, among others, (i) the required composition
of the board of directors of private schools, (ii) that related party transactions to which a private school is a party would
be required to be conducted on a fair and just basis without impediment to the interests of the state, the school, the teachers
and the students and any director who is interested in any related party transactions of such private school should abstain from
voting to approve any such transactions, and (iii) that, for a for-profit private school, 25% of its net profit per annum should
be reserved for its development. If the Draft Amendment for the Implementation Rules for Private Education Law is enacted in its
current form, we may be required to change our corporate governance practices and our compliance costs could increase. The Draft
Amendment for the Implementation Rules for Private Education Law also expressly provides that any investor controlled by a foreign
entity is prohibited from establishing, participating in the establishment of, or exercising de facto control over compulsory
education schools. As we do not provide compulsory education services, we believe such prohibition, even if enacted in its current
form, would not apply to us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we fail to comply
with any regulatory requirements, including obtaining any required licenses, approvals, permits or filings in a timely manner
or at all, our continued business operations may be disrupted and we may be subject to various penalties or be unable to continue
our operations, all of which will materially and adversely affect our business, financial condition and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our failure to obtain, maintain
or renew other licenses, approvals, permits, registrations or filings necessary to conduct our operations in China could have
a material adverse impact on our business, financial conditions and results of operations. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A number of PRC regulatory
authorities oversee different aspects of our business operations, and we are required to obtain a wide range of licenses, approvals,
permits, registrations and filings required for conducting our business in China, which we cannot assure you that we have obtained
all of them or will continue to maintain or renew all of them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may be deemed as
providing certain restricted services or conduct certain restricted activities and thus be subject to certain licenses, approvals,
permits, registrations and filings due to lack official interpretations on certain terms under internet related PRC regulations
and laws. For example, certain content posted on our website or mobile apps, including our course materials, the courseware or
audio-visual content uploaded by users in MDMOOC online platform, may be deemed as &ldquo;internet cultural products,&rdquo; and
our use of those contents may be regarded as &ldquo;internet cultural activities,&rdquo; thus we may be required to obtain an
Internet Culture Business Operating License for provision of those contents. Also, due to the ambiguity of the definition of &ldquo;online
publishing service,&rdquo; the online distribution of content, including our course materials, the courseware or audio-visual
contents uploaded by the users MDMOOC online platform may be regarded as &ldquo;online publishing service&rdquo; and therefore
we may be required to obtain an Online Publishing License. In addition, we deliver certain courses in live-streaming format on
our MDMOOC online platform which the relevant authorities may regard us as a live-streaming platform and may thus subject us to
the requirement of making necessary filings as a live-streaming platform. We currently have not obtained any of the above licenses
or have made any such filings. Under current PRC laws and regulations, an information service provider that reposts news for internet
publication shall first obtain license from Cyberspace Administration of China (&ldquo;CAC&rdquo;) or its local counterpart. Certain
learning materials we provide on our platform are partly from foreign media. Due to the ambiguity of the definition of &ldquo;news&rdquo;
under the current PRC laws and regulations, we cannot assure you that our provision of such materials will not be deemed by the
relevant PRC government authorities as reposting &ldquo;news&rdquo; without proper license, which will subject us to various penalties,
including fines and suspension of such provision. Although we do not think we are subject to any of these licenses or filing requirements,
and as of the date of this prospectus, we have not been subject to any fines or other form of regulatory or administrative penalties
or sanctions due to the lack of any the licenses, approvals, permits, registrations and filings, we cannot assure you that the
PRC government authorities will not take a different view or will not require us to obtain any additional licenses, approvals,
permits, registrations and filings in the future. If we fail to do so, we may be subject to various penalties, such as confiscation
of illegal revenues, fines and discontinuation or restriction of business operations, which may materially and adversely affect
our business, financial condition and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in ">In addition, there
can be no assurance that we will be able to maintain our existing licenses, approvals, registrations or permits necessary to provide
our current online services in China, renew any of them when their current term expires, or update existing licenses or obtain
additional licenses, approvals, permits, registrations or filings necessary for our business expansion from time to time. If we
fail to do so, our business, financial conditions and operational results may be materially and adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We must remit the offering proceeds
to China before they may be used to benefit our business in China, and we cannot assure that we can finish all necessary governmental
registration processes in a timely manner.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The proceeds of this
offering must be sent back to China, and the process for sending such proceeds back to China may take several months after the
closing of this offering. In utilizing the proceeds of this offering in the manner described in &ldquo;Use of Proceeds,&rdquo;
as an offshore holding company of our PRC subsidiary, we may make loans to our PRC subsidiary, or we may make additional capital
contributions to our PRC subsidiary. Any shareholder loan or additional capital contribution are subject to PRC regulations. For
example, loans by us or making additional capital contribution to our subsidiaries in China, which are foreign invested entities
(the &ldquo;FIEs&rdquo;), to finance their activities cannot exceed statutory limits, while the shareholder loan must be also
registered with the China&rsquo;s State Administration of Foreign Exchange (&ldquo;SAFE&rdquo;). The statutory limit for the total
amount of foreign debts of a foreign-invested company is the difference between the amount of total investment as approved by
MOFCOM or its local counterpart and the amount of registered capital of such foreign-invested company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To remit the proceeds
of the offering, we must take the steps legally required under the PRC laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In light of the various
requirements imposed by PRC regulations on loans to, and direct investment in, PRC entities by offshore holding companies, we
cannot assure you that we will be able to complete the necessary government registrations or obtain the necessary government approvals
on a timely basis, if at all, with respect to future loans by us to our PRC subsidiary or PRC consolidated VIE or with respect
to future capital contributions by us to our PRC subsidiary. If we fail to complete such registrations or obtain such approvals,
our ability to use the proceeds from this offering and to capitalize or otherwise fund our PRC operations may be negatively affected,
which could materially and adversely affect our liquidity, our ability to fund and expand our business and our ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>U.S. regulators&rsquo; ability to
conduct investigations or enforce rules in China is limited. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The majority of our
operations conducted outside of the U.S. As a result, it may not be possible for the U.S. regulators to conduct investigations
or inspections, or to effect service of process within the U.S. or elsewhere outside China on us, our subsidiaries, officers,
directors and shareholders, and others, including with respect to matters arising under U.S. federal or state securities laws.
China does not have treaties providing for reciprocal recognition and enforcement of judgments of courts with the U.S. and many
other countries. As a result, recognition and enforcement in China of these judgments in relation to any matter, including U.S.
securities laws and the laws of the Cayman Islands, may be difficult.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><B><I>We face uncertainty regarding
the PRC tax reporting obligations and consequences for certain indirect transfers of the stock of our operating company.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Notice
on Strengthening Administration of Enterprise Income Tax for Share Transfers by Non-PRC Resident Enterprises issued by the PRC
State Administration of Taxation on December&nbsp;10, 2009, or Circular 698, where a foreign investor transfers the equity interests
of a PRC resident enterprise indirectly by way of the sale of equity interests of an overseas holding company, or an Indirect
Transfer, and such overseas holding company is located in a tax jurisdiction that: (i)&nbsp;has an effective tax rate less than
12.5% or (ii)&nbsp;does not tax foreign income of its residents, the foreign investor should report such Indirect Transfer to
the competent tax authority of the PRC resident enterprise. The PRC tax authority will examine the true nature of the Indirect
Transfer, and if the tax authority considers that the foreign investor has adopted an abusive arrangement in order to avoid PRC
tax, they will disregard the existence of the overseas holding company and re-characterize the Indirect Transfer and as a result,
gains derived from such Indirect Transfer may be subject to PRC withholding tax at the rate of up to 10%. In addition, the PRC
resident enterprise is supposed to provide necessary assistance to support the enforcement of Circular 698. At present, the PRC
tax authorities will neither confirm nor deny&nbsp;that they&nbsp;would enforce Circular 698, in conjunction with other tax collection
and tax withholding rules, to make claims against our PRC subsidiary as being&nbsp;indirectly liable&nbsp;for&nbsp;unpaid taxes,
if any,&nbsp;arising from Indirect Transfers by shareholders who did not obtain their shares in the public offering of our shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><B><I>PRC regulations relating to the
establishment of offshore special purpose companies by PRC residents may subject our PRC resident shareholders to personal liability
and limit our ability to acquire PRC companies or to inject capital into our PRC subsidiary, limit our PRC subsidiary ability
to distribute profits to us, or otherwise materially and adversely affect us.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In July 2014, SAFE
has promulgated the Circular on Relevant Issues Concerning Foreign Exchange Control on Domestic Residents&rsquo; Offshore Investment
and Financing and Roundtrip Investment Through Special Purpose Vehicles, or SAFE Circular 37, to replace the Notice on Relevant
Issues Concerning Foreign Exchange Administration for Domestic Residents&rsquo; Financing and Roundtrip Investment Through Offshore
Special Purpose Vehicles, or SAFE Circular 75, which ceased to be effective upon the promulgation of SAFE Circular 37. SAFE Circular
37 requires PRC residents (including PRC individuals and PRC corporate entities) to register with local branches of SAFE in connection
with their direct or indirect offshore investment activities. SAFE Circular 37 is applicable to our shareholders who are PRC residents
and may be applicable to any offshore acquisitions that we make in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under SAFE Circular
37, PRC residents who make, or have prior to the implementation of SAFE Circular 37 made, direct or indirect investments in offshore
special purpose vehicles, or SPVs, will be required to register such investments with the SAFE or its local branches. In addition,
any PRC resident who is a direct or indirect shareholder of an SPV, is required to update its filed registration with the local
branch of SAFE with respect to that SPV, to reflect any material change. Moreover, any subsidiaries of such SPV in China is required
to urge the PRC resident shareholders to update their registration with the local branch of SAFE. If any PRC shareholder of such
SPV fails to make the required registration or to update the previously filed registration, the subsidiaries of such SPV in China
may be prohibited from distributing its profits or the proceeds from any capital reduction, share transfer or liquidation to the
SPV, and the SPV may also be prohibited from making additional capital contribution into its subsidiary in China. On February
28, 2015, the SAFE promulgated a Notice on Further Simplifying and Improving Foreign Exchange Administration Policy on Direct
Investment, or SAFE Notice 13, which became effective on June 1, 2015. Under SAFE Notice 13, applications for foreign exchange
registration of inbound foreign direct investment and outbound overseas direct investment, including those required under the
SAFE Circular 37, will be filed with qualified banks instead of the SAFE. The qualified banks will directly examine the applications
and accept registrations under the supervision of the SAFE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have requested
our shareholders that we know are PRC residents and hold direct or indirect interests in us to make the necessary applications,
filings and amendments as required under SAFE Circular 37 and other related rules. However, we cannot guarantee that all or any
of those shareholders will complete the 37 registration before the closing of this Offering. In addition, we may not at all times
be fully aware or informed of the identities of all our beneficial owners who are PRC residents, and we may not always be able
to compel our beneficial owners to comply with the SAFE Circular 37 requirements. As a result, we cannot assure you that all of
our shareholders or beneficial owners who are PRC residents will at all times comply with, or in the future make or obtain any
applicable registrations or approvals required by, SAFE Circular 37 or other related regulations. Failure by any such shareholders
or beneficial owners to comply with SAFE Circular 37 could subject us to fines or legal sanctions, restrict our overseas or cross-border
investment activities, limit our PRC subsidiary&rsquo;s ability to make distributions or pay dividends or affect our ownership
structure, which could adversely affect our business and prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, as the
interpretation and implementation of foreign exchange regulations has been constantly evolving, it is unclear how these regulations,
and any future regulation concerning offshore or cross-border transactions, will be interpreted, amended and implemented by the
relevant governmental authorities. For example, we may be subject to a more stringent review and approval process with respect
to our foreign exchange activities, such as remittance of dividends and foreign-currency-denominated borrowings, which may adversely
affect our financial condition and results of operations. In addition, if we decide to acquire a PRC domestic company, we cannot
assure you that we or the owners of such company, as the case may be, will be able to obtain the necessary approvals or complete
the necessary filings and registrations required by the foreign exchange regulations. This may restrict our ability to implement
our acquisition strategy and could adversely affect our business and prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in ">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><B><I>PRC regulation of loans and direct
investment by offshore holding companies to PRC entities may delay or prevent us from using the proceeds of this Offering to make
loans or additional capital contributions to our PRC subsidiary, which could materially and adversely affect our liquidity and
our ability to fund and expand our business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In utilizing the proceeds
from this public offering or any future offerings, as an offshore holding company of our PRC subsidiary, we may make loans to
our PRC subsidiary and controlled PRC affiliate, or we may make additional capital contributions to our PRC subsidiary. Any loans
to our PRC subsidiary or controlled PRC affiliate are subject to PRC regulations and approvals. For example, loans by us to our
PRC subsidiary in China, each of which is a foreign-invested enterprise, to finance their activities cannot exceed statutory limits
and must be registered with SAFE or its local counterpart.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may also decide
to finance our PRC subsidiary through capital contributions. These capital contributions must be approved by the MOFCOM or its
local counterpart. We cannot assure you that we will be able to obtain these government registrations or approvals on a timely
basis, if at all, with respect to future loans by us to our PRC subsidiary or controlled PRC affiliate or capital contributions
by us to our subsidiaries or any of their respective subsidiaries. If we fail to receive such registrations or approvals, our
ability to use the proceeds of this Offering and to capitalize our PRC operations may be negatively affected, which could adversely
and materially affect our liquidity and our ability to fund and expand our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2015, SAFE promulgated
Circular 19, a notice regulating the conversion by a foreign-invested enterprise of foreign currency into Renminbi by restricting
how the converted Renminbi may be used. Circular 19 requires that Renminbi converted from the foreign currency-denominated capital
of a foreign-invested enterprise may only be used for purposes within the business scope approved by the applicable governmental
authority and may not be used for equity investments within the PRC unless specifically provided for otherwise in its business
scope. In addition, SAFE strengthened its oversight of the flow and use of Renminbi funds converted from the foreign currency-denominated
capital of a foreign-invested enterprise. The use of such Renminbi may not be changed without approval from SAFE and may not be
used to repay Renminbi loans if the proceeds of such loans have not yet been used for purposes within the foreign-invested enterprise&rsquo;s
approved business scope.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cannot assure you
that we will be able to complete the necessary government registrations or obtain the necessary government approvals on a timely
basis, if at all, with respect to future loans by us to our PRC subsidiary or controlled PRC affiliate or with respect to future
capital contributions by us to our PRC subsidiary. If we fail to complete such registrations or obtain such approvals, our ability
to use the proceeds we receive from this Offering and to capitalize or otherwise fund our PRC operations may be negatively affected,
which could adversely and materially affect our liquidity and our ability to fund and expand our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><B><I>Governmental control of currency
conversion may limit our ability to use our revenues effectively and the ability of our PRC subsidiaries to obtain financing.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The PRC government
imposes control on the convertibility of the RMB into foreign currencies and, in certain cases, the remittance of currency out
of China. We receive a majority of our revenues in Renminbi, which currently is not a freely convertible currency. Restrictions
on currency conversion imposed by the PRC government may limit our ability to use revenues generated in Renminbi to fund our expenditures
denominated in foreign currencies or our business activities outside China. Under China&rsquo;s existing foreign exchange regulations,
Renminbi may be freely converted into foreign currency for payments relating to current account transactions, which include among
other things dividend payments and payments for the import of goods and services, by complying with certain procedural requirements.
Our PRC subsidiaries are able to pay dividends in foreign currencies to us without prior approval from SAFE, by complying with
certain procedural requirements. Our PRC subsidiaries may also retain foreign currency in their respective current account bank
accounts for use in payment of international current account transactions. However, we cannot assure you that the PRC government
will not take measures in the future to restrict access to foreign currencies for current account transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Conversion of Renminbi
into foreign currencies, and of foreign currencies into Renminbi, for payments relating to capital account transactions, which
principally includes investments and loans, generally requires the approval of SAFE and other relevant PRC governmental authorities.
Restrictions on the convertibility of the Renminbi for capital account transactions could affect the ability of our PRC subsidiaries
to make investments overseas or to obtain foreign currency through debt or equity financing, including by means of loans or capital
contributions from us. We cannot assure you that the registration process will not delay or prevent our conversion of Renminbi
for use outside of China.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><B><I>We may be classified as a &ldquo;resident
enterprise&rdquo; for PRC enterprise income tax purposes; such classification could result in unfavorable tax consequences to
us and our non-PRC shareholders.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Enterprise Income
Tax Law provides that enterprises established outside of China whose &ldquo;de facto management bodies&rdquo; are located in China
are considered PRC tax resident enterprises and will generally be subject to the uniform 25% PRC enterprise income tax rate on
their global income. In addition, a tax circular issued by the State Administration of Taxation on April&nbsp;22, 2009 regarding
the standards used to classify certain Chinese-invested enterprises established outside of China as resident enterprises clarified
that dividends and other income paid by such resident enterprises will be considered to be PRC source income, subject to PRC withholding
tax, currently at a rate of 10%, when recognized by non-PRC enterprise shareholders. This circular also subjects such resident
enterprises to various reporting requirements with the PRC tax authorities. Under the implementation rules to the Enterprise Income
Tax Law, a de facto management body is defined as a body that has material and overall management and control over the manufacturing
and business operations, personnel and human resources, finances and other assets of an enterprise. In addition, the tax circular
mentioned above details that certain Chinese-invested enterprises will be classified as resident enterprises if the following
are located or resident in China: senior management personnel and departments that are responsible for daily production, operation
and management; financial and personnel decision making bodies; key properties, accounting books, company seal, and minutes of
board meetings and shareholders&rsquo; meetings; and half or more of the senior management or directors having voting rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Currently, there are
no detailed rules or precedents governing the procedures and specific criteria for determining de facto management bodies which
are applicable to our company or our overseas subsidiaries. We do not believe that Zhongchao meets all of the conditions required
for PRC resident enterprise. The Company is a company incorporated outside the PRC. As a holding company, its key assets are its
ownership interests in its subsidiaries, and its key assets are located, and its records (including the resolutions of its board
of directors and the resolutions of its shareholders) are maintained, outside the PRC. For the same reasons, we believe our other
entities outside of China are not PRC resident enterprises either. However, the tax resident status of an enterprise is subject
to determination by the PRC tax authorities and uncertainties remain with respect to the interpretation of the term &ldquo;de
facto management body.&rdquo; There can be no assurance that the PRC government will ultimately take a view that is consistent
with ours.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">However, if the PRC
tax authorities determine that Zhongchao is a PRC resident enterprise for enterprise income tax purposes, we may be required to
withhold a 10% withholding tax from dividends we pay to our shareholders that are non-resident enterprises. Such 10% tax rate
could be reduced by applicable tax treaties or similar arrangements between China and the jurisdiction of our shareholders. For
example, for shareholders eligible for the benefits of the tax treaty between China and Hong Kong, the tax rate is reduced to
5% for dividends if relevant conditions are met. In addition, non-resident enterprise shareholders may be subject to a 10% PRC
tax on gains realized on the sale or other disposition of ordinary shares, if such income is treated as sourced from within the
PRC. It is unclear whether our non-PRC individual shareholders would be subject to any PRC tax on dividends or gains obtained
by such non-PRC individual shareholders in the event we are determined to be a PRC resident enterprise. If any PRC tax were to
apply to such dividends or gains, it would generally apply at a rate of 20% unless a reduced rate is available under an applicable
tax treaty. However, it is also unclear whether non-PRC shareholders of the Company would be able to claim the benefits of any
tax treaties between their country of tax residence and the PRC in the event that the Company is treated as a PRC resident enterprise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Provided that our
Cayman Islands holding company, Zhongchao, is not deemed to be a PRC resident enterprise, our shareholders who are not PRC residents
will not be subject to PRC income tax on dividends distributed by us or gains realized from the sale or other disposition of our
shares. However, under the Circular on Issues of Enterprise Income Tax on Indirect Transfers of Assets by Non-PRC Resident Enterprises,
or Circular 7, where a non-resident enterprise conducts an &ldquo;indirect transfer&rdquo; by transferring taxable assets, including,
in particular, equity interests in a PRC resident enterprise, indirectly by disposing of the equity interests of an overseas holding
company, the non-resident enterprise, being the transferor, or the transferee or the PRC entity which directly owned such taxable
assets may report to the relevant tax authority such indirect transfer. Using a &ldquo;substance over form&rdquo; principle, the
PRC tax authority may disregard the existence of the overseas holding company if it lacks a reasonable commercial purpose and
was established for the purpose of reducing, avoiding or deferring PRC tax. As a result, gains derived from such indirect transfer
may be subject to PRC enterprise income tax, and the transferee would be obligated to withhold the applicable taxes, currently
at a rate of 10% for the transfer of equity interests in a PRC resident enterprise. We and our non-PRC resident investors may
be at risk of being required to file a return and being taxed under Circular 7, and we may be required to expend valuable resources
to comply with the Circular on Issues of Enterprise Income Tax on Indirect Transfers of Assets by Non-PRC Resident Enterprises,
or Bulletin 37, or to establish that we should not be taxed under Circular 7 and Bulletin 37.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to the
uncertainty in how the new resident enterprise classification could apply, it is also possible that the rules may change in the
future, possibly with retroactive effect. If we are required under the Enterprise Income Tax law to withhold PRC income tax on
our dividends payable to our foreign shareholders, or if you are required to pay PRC income tax on the transfer of our shares
under the circumstances mentioned above, the value of your investment in our shares may be materially and adversely affected.
These rates may be reduced by an applicable tax treaty, but it is unclear whether, if we are considered a PRC resident enterprise,
holders of our shares would be able to claim the benefit of income tax treaties or agreements entered into between China and other
countries or areas. Any such tax may reduce the returns on your investment in our shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The M&amp;A Rules and certain other
PRC regulations establish complex procedures for some acquisitions of Chinese companies by foreign investors, which could make
it more difficult for us to pursue growth through acquisitions in China.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">The Regulations
on Mergers and Acquisitions of Domestic Companies by Foreign Investors, or the M&amp;A Rules, adopted by six PRC regulatory agencies
in August&nbsp;2006 and amended in 2009, requires an overseas special purpose vehicle formed for listing purposes through acquisitions
of PRC domestic companies and controlled by PRC companies or individuals to obtain the approval of the China Securities Regulatory
Commission, or the CSRC, prior to the listing and trading of such special purpose vehicle&rsquo;s securities on an overseas stock
exchange. In September&nbsp;2006, the CSRC published a notice on its official website specifying documents and materials required
to be submitted to it by a special purpose vehicle seeking CSRC approval of its overseas listings. The application of the M&amp;A
Rules remains unclear. These M&amp;A Rules and some other regulations and rules concerning mergers and acquisitions established
additional procedures and requirements that could make merger and acquisition activities by foreign investors more time consuming
and complex, including requirements in some instances that the Ministry of C<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ommerce
(&ldquo;MOC&rdquo;) be notified in advance of any change-of-control transaction in which a foreign investor takes control of a
PRC domestic enterprise. Moreover, the Anti-Monopoly Law requires that the MOC shall be notified in advance of any concentration
of undertaking if certain thresholds are triggered. In addition, the security review rules issued by the MOC that became effective
in September&nbsp;2011 specify that mergers and acquisitions by foreign investors that raise &ldquo;national defense and security&rdquo;
concerns and mergers and acquisitions through which foreign investors may acquire de facto control over domestic enterprises that
raise &ldquo;national security&rdquo; concerns are subject to strict review by the MOC, and the rules prohibit any activities
attempting to bypass a security review, including by structuring the transaction through a proxy or contractual control arrangement.
In the future, we may grow our business by acquiring complementary businesses. Complying with the requirements of the above-mentioned
regulations and other relevant rules to complete such transactions could be time consuming, and any required approval processes,
including obtaining approval from the MOC or its local counterparts may delay or inhibit our ability to complete such transactions,
which could affect our ability to expand our business or maintain our market share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Any failure to comply with PRC regulations
regarding the registration requirements for employee stock incentive plans may subject the PRC plan participants or us to fines
and other legal or administrative sanctions.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In February&nbsp;2012,
SAFE promulgated the Notices on Issues Concerning the Foreign Exchange Administration for Domestic Individuals Participating in
Stock Incentive Plans of Overseas Publicly-Listed Companies, replacing earlier rules promulgated in March&nbsp;2007. Pursuant
to these rules, PRC citizens and non-PRC citizens who reside in China for a continuous period of not less than one year who participate
in any stock incentive plan of an overseas publicly listed company, subject to a few exceptions, are required to register with
SAFE through a domestic qualified agent, which could be the PRC subsidiary of such overseas listed company, and complete certain
other procedures. In addition, an overseas entrusted institution must be retained to handle matters in connection with the exercise
or sale of stock options and the purchase or sale of shares and interests. We and our executive officers and other employees who
are PRC citizens or who have resided in the PRC for a continuous period of not less than one year and who are granted options
or other awards under the equity incentive plan will be subject to these regulations when our company becomes an overseas listed
company upon the completion of this offering. Failure to complete the SAFE registrations may subject them to fines and legal sanctions
and may also limit our ability to contribute additional capital into our PRC subsidiary and limit our PRC subsidiary&rsquo; ability
to distribute dividends to us. We also face regulatory uncertainties that could restrict our ability to adopt additional incentive
plans for our directors, executive officers and employees under PRC law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt"></P>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><B><I>Failure to make adequate contributions
to various mandatory social security plans as required by PRC regulations may subject us to penalties.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">PRC laws and regulations
require us to pay several statutory social welfare benefits for our employees, including pensions, medical insurance, work-related
injury insurance, unemployment insurance, maternity insurance and housing provident fund contributions. Local governments usually
implement localized requirements as to mandatory social security plans considering differences in economic development in different
regions. Our failure in making contributions to various mandatory social security plans and in complying with applicable PRC labor-related
laws may subject us to late payment penalties. We may be required to make up the contributions for these plans as well as to pay
late fees and fines. If we are subject to late fees or fines in relation to the underpaid employee benefits, our financial condition
and results of operations may be adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><B><I>Our current employment practices
may be restricted under the PRC Labor Contract Law and our labor costs may increase as a result.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The PRC Labor Contract
Law and its implementing rules impose requirements concerning contracts entered into between an employer and its employees and
establish time limits for probationary periods and for how long an employee can be placed in a fixed-term labor contract. Because
the Labor Contract Law and its implementing rules have not been in effect very long and because there is lack of clarity with
respect to their implementation and potential penalties and fines, it is uncertain how it will impact our current employment policies
and practices. We cannot assure you that our employment policies and practices do not, or will not, violate the Labor Contract
Law or its implementing rules and that we will not be subject to related penalties, fines or legal fees. If we are subject to
large penalties or fees related to the Labor Contract Law or its implementing rules, our business, financial condition and results
of operations may be materially and adversely affected. In addition, according to the Labor Contract Law and its implementing
rules, if we intend to enforce the non-compete provision with an employee in a labor contract or non-competition agreement, we
have to compensate the employee on a monthly basis during the term of the restriction period after the termination or ending of
the labor contract, which may cause extra expenses to us. Furthermore, the Labor Contract Law and its implementation rules require
certain terminations to be based upon seniority rather than merit, which significantly affects the cost of reducing workforce
for employers. In the event we decide to significantly change or decrease our workforce in the PRC, the Labor Contract Law could
adversely affect our ability to enact such changes in a manner that is most advantageous to our circumstances or in a timely and
cost effective manner, thus our results of operations could be adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If the chops of our PRC company
and branches are not kept safely, are stolen or are used by unauthorized persons or for unauthorized purposes, the corporate governance
of these entities could be severely and adversely compromised.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In China, a company
chop or seal serves as the legal representation of the company towards third parties even when unaccompanied by a signature. Each
legally registered company in China is required to maintain a company chop, which must be registered with the local Public Security
Bureau. In addition to this mandatory company chop, companies may have several other chops which can be used for specific purposes.
The chops of our PRC subsidiary are generally held securely by personnel designated or approved by us in accordance with our internal
control procedures. To the extent those chops are not kept safely, are stolen or are used by unauthorized persons or for unauthorized
purposes, the corporate governance of these entities could be severely and adversely compromised and those corporate entities
may be bound to abide by the terms of any documents so chopped, even if they were chopped by an individual who lacked the requisite
power and authority to do so. In addition, if the chops are misused by unauthorized persons, we could experience disruption to
our normal business operations. We may have to take corporate or legal action, which could involve significant time and resources
to resolve while distracting management from our operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in "></P>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>RISKS RELATED
TO THIS OFFERING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><B><I>There has been no public market
for our Class A Ordinary Shares prior to this offering, and you may not be able to resell our Class A Ordinary Shares at or above
the price you paid, or at all.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Prior to this initial
public offering, there has been no public market for our shares. We intend to list our Class A Ordinary Shares on the NASDAQ Capital
Market. If an active trading market for our Class A Ordinary Shares does not develop after this offering, the market price and
liquidity of our Class A Ordinary Shares will be materially and adversely affected. Negotiations with the underwriters will determine
the initial public offering price for our Class A Ordinary Shares which may bear no relationship to their market price after the
initial public offering. We cannot assure you that an active trading market for our Class A Ordinary Shares will develop or that
the market price of our Class A Ordinary Shares will not decline below the initial public offering price. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <B><I>The price of the Class A Ordinary
Shares and other terms of this Offering have been determined by us along with our underwriters.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> If you purchase
our Class A Ordinary Shares in this Offering, you will pay a price that was not established in a competitive market. Rather, you
will pay a price that was determined by us along with our underwriters. The offering price for our Class A Ordinary Shares may
bear no relationship to our assets, book value, historical results of operations or any other established criterion of value.
The trading price, if any, of the Class A Ordinary Shares that may prevail in any market that may develop in the future, for which
there can be no assurance, may be higher or lower than the price you paid for our Class A Ordinary Shares. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Shares eligible for future sale
may adversely affect the market price of our Class A Ordinary Shares if the shares are successfully listed on NASDAQ or other
stock markets, as the future sale of a substantial amount of outstanding Class A Ordinary Shares in the public marketplace could
reduce the price of our Class A Ordinary Shares.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The market price of
our Class A Ordinary Shares could decline as a result of sales of substantial amounts of our Class A Ordinary Shares in the public
market, or the perception that these sales could occur. In addition, these factors could make it more difficult for us to raise
funds through future offerings of our Class A Ordinary Shares. An aggregate of 16,102,420 Class A Ordinary Shares are outstanding
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(including 1,350,068 Class A Ordinary Shares to be issued
upon exercise of the HF Warrant) before the consummation of this Offering. All of the Class A Ordinary Shares sold in the Offering
will be freely transferable without restriction or further registration under the Securities Act. The remaining Class A Ordinary
Shares will be &ldquo;restricted securities&rdquo; as defined in Rule 144. These Class A Ordinary Shares may be sold without registration
under the Securities Act to the extent permitted by Rule 144 or other exemptions under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>A sale or perceived sale of a substantial
number of our Ordinary Shares may cause the price of our Class A Ordinary Shares to decline.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of our executive
officers and directors and almost all of our shareholders have agreed not to sell our Class A Ordinary Shares for a period of
six months following this Offering, subject to extension under specified circumstances. Class A Ordinary shares subject to these
lock-up agreements will become eligible for sale in the public market upon expiration of these lock-up agreements, subject to
limitations imposed by Rule 144 under the Securities Act of 1933, as amended. If our shareholders sell substantial amounts of
our Class A Ordinary Shares in the public market, the market price of our Class A Ordinary Shares could fall. Moreover, the perceived
risk of this potential dilution could cause shareholders to attempt to sell their shares and investors to short our Class A Ordinary
Shares. These sales also may make it more difficult for us to sell equity or equity-related securities in the future at a time
and price that we deem reasonable or appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><B><I>If we are listed on the NASDAQ
Capital Market and our financial condition deteriorates, we may not meet continued listing standards on the NASDAQ Capital Market.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">The NASDAQ Capital
Market also requires companies to fulfill specific requirements in order for their shares to continue to be listed. If our shares
are listed on the NASDAQ Capital Market but are delisted from the NASDAQ Capital Market at some later date, our shareholders could
find it difficult to sell our shares. In addition, if our Class A Ordinary Shares are delisted from the NASDAQ Capital Market
at some later date, we may apply to have our Class A Ordinary Shares quoted on the Bulletin Board or in the &ldquo;pink sheets&rdquo;
maintained by the National Quotation Bureau, Inc. The Bulletin Board and the &ldquo;pink sheets&rdquo; are generally considered
to be less efficient markets than the NASDAQ Capital Market. In addition, if our Class A Ordinary Shares are not so listed or
are delisted at some later date, our Class A Ordinary Shares may be subject to the &ldquo;penny stock&rdquo; regulations. These
rules impose additional sales practice requirements on broker-dealers that sell low-priced securities to persons other than established
customers and institutional accredited investors and require the delivery of a disclosure schedule explaining the nature and risks
of the penny stock market. As a result, the ability or willingness of broker-dealers to sell or make a market in our Class A Ordinary
Shares might decline. If our Class A Ordinary Shares are not so listed or are delisted from the NASDAQ Capital Market at some
later date or become subject to the penny stock regulations, it is likely that the price of our shares would decline and that
our shareholders would find it difficult to sell their shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><B><I>If a limited number of participants
in this offering purchase a significant percentage of the offering, the effective public float may be smaller than anticipated
and the price of our Class A Ordinary Shares may be volatile. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">As a company conducting
a relatively modest public offering, we are subject to the risk that a small number of investors will purchase a high percentage
of the offering. If this were to happen, investors could find our shares to be more volatile than they might otherwise anticipate.
Companies that experience such volatility in their stock price may be more likely to be the subject of securities litigation.
In addition, if a large portion of our public float were to be held by a few investors, smaller investors may find it more difficult
to sell their shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><B><I>The market price for our shares
may be volatile.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">The trading prices
of our Class A Ordinary Shares are likely to be volatile and could fluctuate widely due to factors beyond our control. This may
happen because of broad market and industry factors, like the performance and fluctuation in the market prices or the underperformance
or deteriorating financial results of internet or other companies based in China that have listed their securities in the United
States in recent years. The securities of some of these companies have experienced significant volatility since their initial
public offerings, including, in some cases, substantial decline in their trading prices. The trading performances of other Chinese
companies&rsquo; securities after their offerings may affect the attitudes of investors toward Chinese companies listed in the
United States, which consequently may impact the trading performance of our Class A Ordinary Shares, regardless of our actual
operating performance. In addition, any negative news or perceptions about inadequate corporate governance practices or fraudulent
accounting, corporate structure or other matters of other Chinese companies may also negatively affect the attitudes of investors
towards Chinese companies in general, including us, regardless of whether we have conducted any inappropriate activities. In addition,
securities markets may from time to time experience significant price and volume fluctuations that are not related to our operating
performance, which may have a material adverse effect on the market price of our shares. In addition to the above factors, the
price and trading volume of our Class A Ordinary Shares may be highly volatile due to multiple factors, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">regulatory
                                         developments affecting us, our users, or our industry;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">regulatory
                                         uncertainties with regard to our variable interest entity arrangements;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">announcements
                                         of studies and reports relating to our service offerings or those of our competitors;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">actual
                                         or anticipated fluctuations in our quarterly results of operations and changes or revisions
                                         of our expected results;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">changes
                                         in financial estimates by securities research analysts;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 63; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">announcements
                                         by us or our competitors of new product and service offerings, acquisitions, strategic
                                         relationships, joint ventures or capital commitments;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">additions
                                         to or departures of our senior management;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">detrimental
                                         negative publicity about us, our management or our industry;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">fluctuations
                                         of exchange rates between the RMB and the U.S. dollar;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">release
                                         or expiry of lock-up or other transfer restrictions on our outstanding Class A Ordinary
                                         Shares; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">sales
                                         or perceived potential sales of additional Class A Ordinary Shares.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our Class B Ordinary Shares have
stronger voting power than our Class A Ordinary Shares and certain existing shareholders have substantial influence over our Company
and their interests may not be aligned with the interests of our other shareholders.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have a dual-class
voting structure consisting of Class A Ordinary Shares and Class B Ordinary Shares. Under this structure, holders of Class A Ordinary
Shares are entitled to 1 vote per share, and holders of Class B Ordinary Shares are entitled to 15 votes per share, which can
cause the holders of Class B Ordinary Shares to have an unbalanced, higher concentration of voting power. Immediately prior to
the Offering, Mr. Weiguang Yang, the sole shareholder of Class B Ordinary Shares, directly own 5,497,715 Class B Ordinary Shares
and beneficially owns 4,203,385 Class A Ordinary Shares, representing over 87.93% voting power assuming the exercise of the HF
Warrant. As a result, until such time as his collective voting power is below 50%, Mr. Yang as the controlling shareholder has
substantial influence over our business, including decisions regarding mergers, consolidations and the sale of all or substantially
all of our assets, election of directors and other significant corporate actions. He may take actions that are not in the best
interests of us or our other shareholders. These corporate actions may be taken even if they are opposed by our other shareholders.&nbsp;Further,&nbsp;concentration&nbsp;of
ownership of our Class B Ordinary Shares may discourage, prevent or delay the consummation of change of control transactions that
shareholders may consider favorable, including transactions in which shareholders might otherwise receive a premium for their
shares. Future issuances of Class B Ordinary Shares may also be dilutive to the holders of Class A Ordinary Shares. As a result,
the market price of our Class A Ordinary Shares could be adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> The sole shareholder
who holds shares of Class&nbsp;B Ordinary Shares will hold approximately 80.38% of the voting power of our outstanding ordinary
shares following this Offering, assuming the full exercise of the over-allotment option by the underwriters and the exercise of
the HF Warrant. Because of the fifteen-to-one voting ratio between our Class&nbsp;B and Class&nbsp;A Ordinary Shares, the sole
holder of our Class&nbsp;B Ordinary Shares will continue to control a majority of the combined voting power of our Ordinary Shares
and therefore be able to control all matters submitted to our shareholders for approval, so long as the Class&nbsp;B Ordinary
Shares represent at least 6.25% of all outstanding shares of our Ordinary Shares, assuming the full exercise of the over-allotment
option by the underwriters and the exercise of the HF Warrant. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><B><I>We are a &ldquo;foreign private
issuer,&rdquo; and our disclosure obligations differ from those of U.S. domestic reporting companies. As a result, we may not
provide you the same information as U.S. domestic reporting companies or we may provide information at different times, which
may make it more difficult for you to evaluate our performance and prospects. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a foreign private
issuer and, as a result, we are not subject to the same requirements as U.S. domestic issuers. Under the Exchange Act, we will
be subject to reporting obligations that, to some extent, are more lenient and less frequent than those of U.S. domestic reporting
companies. For example, we will not be required to issue quarterly reports or proxy statements. We will not be required to disclose
detailed individual executive compensation information. Furthermore, our directors and executive officers will not be required
to report equity holdings under Section 16 of the Exchange Act and will not be subject to the insider short-swing profit disclosure
and recovery regime. As a foreign private issuer, we will also be exempt from the requirements of Regulation FD (Fair Disclosure)
which, generally, are meant to ensure that select groups of investors are not privy to specific information about an issuer before
other investors. However, we will still be subject to the anti-fraud and anti-manipulation rules of the SEC, such as Rule 10b-5
under the Exchange Act. Since many of the disclosure obligations imposed on us as a foreign private issuer differ from those imposed
on U.S. domestic reporting companies, you should not expect to receive the same information about us and at the same time as the
information provided by U.S. domestic reporting companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 64; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><B><I>Shares eligible for future sale
may adversely affect the market price of our Class A Ordinary Shares, as the future sale of a substantial amount of outstanding
Class A Ordinary Shares in the public marketplace could reduce the price of our Class A Ordinary Shares.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> The market price
of our shares could decline as a result of sales of substantial amounts of our shares in the public market, or the perception
that these sales could occur.&nbsp;In addition, these factors could make it more difficult for us to raise funds through future
offerings of our Class A Ordinary Shares.&nbsp;An aggregate of 16,102,420 Class A Ordinary Shares (including 1,350,068 Class A
Ordinary Shares to be issued upon exercise of the HF Warrant) is outstanding before the consummation of this offering and 19,602,420
Class A Ordinary Shares (20,127,420 Class A Ordinary Shares if the underwriters exercise their over-allotment option in full)
assuming exercise of the HF Warrant will be outstanding immediately after this offering.&nbsp;All of the Class A Ordinary Shares
sold in the Offering will be freely transferable without restriction or further registration under the Securities Act.&nbsp;The
remaining shares will be &ldquo;restricted securities&rdquo; as defined in Rule 144.&nbsp;These Class A Ordinary Shares may be
sold in the future without registration under the Securities Act to the extent permitted by Rule 144 or other exemptions under
the Securities Act. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><B><I>Investors in this Offering will
experience immediate and substantial dilution.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">The Offering Price
of our shares is expected to be substantially higher than the pro forma net tangible book value per share of our Class A Ordinary
Shares.&nbsp;Assuming the completion of the Offering and an Offering Price of $4.25 per share, the midpoint of the estimated price
range set forth on the cover page of this prospectus, if you purchase shares in this Offering, you will incur immediate dilution
of approximately $3.24 or approximately 76% in the pro forma net tangible book value per share from the price per share that you
pay for the shares. <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly, if you purchase shares
in this Offering, you will incur immediate and substantial dilution of your investment.&nbsp;See &ldquo;Dilution.&rdquo;</FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><B><I>We have not finally determined
the use of the proceeds from this offering, and we may use the proceeds in ways with which you may not agree.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While we have identified
the priorities to which we expect to put the proceeds of this offering, our management will have considerable discretion in the
application of the net proceeds received by us. Specifically, we intend to use the net proceeds from this offering for development
of our online content, platform technology upgrade and system integration, and business expansion, including expansion of our
existing locations to develop new customers by hiring more qualified personnel, and increase in our marketing efforts. We have
reserved the right to re-allocate funds currently allocated to that purpose to our general working capital. If that were to happen,
then our management would have discretion over even more of the net proceeds to be received by our company in this offering. You
will not have the opportunity, as part of your investment decision, to assess whether the proceeds are being used appropriately.
You must rely on the judgment of our management regarding the application of the net proceeds of this offering. The net proceeds
may be used for corporate purposes that do not improve our efforts to achieve profitability or increase our stock price. The net
proceeds from this offering may be placed in investments that do not produce profit or increase value. See &ldquo;Use of Proceeds.&rdquo;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We will incur increased costs as
a result of being a publicly-traded company.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a company with
publicly-traded securities, we will incur additional legal, accounting and other expenses not presently incurred. In addition,
the Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, as well as rules promulgated
by the SEC and the national securities exchange on which we list, requires us to adopt corporate governance practices applicable
to U.S. public companies. These rules and regulations will increase our legal and financial compliance costs. We estimate that
during the first year of our listing, we may incur approximately $500,000 to $800,000 additional expenses being a public company
which may vary depending on numerous factors such as the legal, accounting and marketing needs associated with the development
of the Company.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 65; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If we fail to implement and maintain
an effective system of internal control, we may be unable to accurately report our operating results, meet our reporting obligations
or prevent fraud.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prior to this Offering,
we were a company with limited accounting personnel and other resources with which to address our internal controls and procedures.
Our management has not completed an assessment of the effectiveness of our&nbsp;internal control over financial reporting, and
our independent registered public accounting firm has not conducted an audit of our&nbsp;internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon completion of
this Offering, we will become a public company in the United States subject to the Sarbanes-Oxley Act of 2002. Section 404 of
the Sarbanes-Oxley Act of 2002 will require that we include a report of management on our&nbsp;internal control over financial
reporting&nbsp;in our annual report on Form 20-F beginning with our annual report for the fiscal year ending December 31, 2019.
In addition, once we cease to be an &ldquo;emerging growth company&rdquo; as such term is defined under the JOBS Act, our independent
registered public accounting firm must attest to and report on the effectiveness of our&nbsp;internal control over financial reporting.
Our management may conclude that our&nbsp;internal control over financial reporting&nbsp;is not effective. Moreover, even if our
management concludes that our&nbsp;internal control over financial reporting&nbsp;is effective, our independent registered public
accounting firm, after conducting its own independent testing, may issue a report that is qualified if it is not satisfied with
our internal controls or the level at which our controls are documented, designed, operated or reviewed, or if it interprets the
relevant requirements differently from us. In addition, after we become a public company, our reporting obligations may place
a significant strain on our management, operational and financial resources and systems for the foreseeable future. We may be
unable to timely complete our evaluation testing and any required remediation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the course
of documenting and testing our internal control procedures, in order to satisfy the requirements of Section 404 of the Sarbanes-Oxley
Act of 2002, we may identify other weaknesses and deficiencies in our&nbsp;internal control over financial reporting. In addition,
if we fail to maintain the adequacy of our&nbsp;internal control over financial reporting, as these standards are modified, supplemented
or amended from time to time, we may not be able to conclude on an ongoing basis that we have effective&nbsp;internal control
over financial reporting&nbsp;in accordance with Section 404 of the Sarbanes-Oxley Act of 2002. Generally, if we fail to achieve
and maintain an effective internal control environment, we could suffer material misstatements in our financial statements and
fail to meet our reporting obligations, which would likely cause investors to lose confidence in our reported financial information.
This could in turn limit our access to capital markets, and harm our results of operations. Additionally, ineffective&nbsp;internal
control over financial reporting&nbsp;could expose us to increased risk of fraud or misuse of corporate assets and subject us
to potential delisting from the stock exchange on which we list, regulatory investigations and civil or criminal sanctions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>As an &ldquo;emerging growth company&rdquo;
under the Jumpstart Our Business Startups Act, or JOBS Act, we are permitted to, and intend to, rely on exemptions from certain
disclosure requirements.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As an &ldquo;emerging
growth company&rdquo; under the JOBS Act, we are permitted to, and intend to, rely on exemptions from certain disclosure requirements.
We are an emerging growth company until the earliest of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the
                                         last day of the fiscal year during which we have total annual gross revenues of $1 billion
                                         or more;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 43.9pt; text-align: justify; text-indent: -0.3in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the
                                         last day of the fiscal year following the fifth anniversary of this offering;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 43.9pt; text-align: justify; text-indent: -0.3in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the
                                         date on which we have, during the previous 3-year period, issued more than $1 billion
                                         in non-convertible debt; or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 43.9pt; text-align: justify; text-indent: -0.3in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the
                                         date on which we are deemed a &ldquo;large accelerated issuer&rdquo; as defined under
                                         the federal securities laws.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 66; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For so long as we
remain an emerging growth company, we may take advantage of certain exemptions from various reporting requirements that are applicable
to public companies that are not &ldquo;emerging growth companies&rdquo; including, but not limited to, not being required to
comply with the auditor attestation requirements of section 404 of the Sarbanes-Oxley Act for up to five fiscal years after the
date of this offering. We cannot predict if investors will find our Class A Ordinary Shares less attractive because we may rely
on these exemptions. If some investors find our Class A Ordinary Shares less attractive as a result, there may be a less active
trading market for our Class A Ordinary Shares and the trading price of our Class A Ordinary Shares may be more volatile. In addition,
our costs of operating as a public company may increase when we cease to be an emerging growth company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We are an&nbsp;emerging growth&nbsp;company
and may take advantage of certain reduced reporting requirements.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are an &ldquo;emerging
growth&nbsp;company,&rdquo; as defined in the JOBS Act, and we may take advantage of certain exemptions from various requirements
applicable to other public companies that are not&nbsp;emerging growth&nbsp;companies including, most significantly, not being
required to comply with the auditor attestation requirements of Section 404 of Sarbanes-Oxley Act of 2002 for so long as we are
an&nbsp;emerging growth&nbsp;company. As a result, if we elect not to comply with such auditor attestation requirements, our investors
may not have access to certain information they may deem important.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The JOBS Act also
provides that an&nbsp;emerging growth&nbsp;company does not need to comply with any new or revised financial accounting standards
until such date that a private company is otherwise required to comply with such new or revised accounting standards. We do not
plan to &ldquo;opt out&rdquo; of such exemptions afforded to an&nbsp;emerging growth&nbsp;company. As a result of this election,
our financial statements may not be comparable to companies that comply with public company effective data.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may be classified as a passive
foreign investment company, which could result in adverse U.S. federal income tax consequences to U.S. holders of our Class A
Ordinary Shares.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on the anticipated
market price of our Class A Ordinary Shares in this offering and expected price of our Class A Ordinary Shares following this
offering, and the composition of our income, assets and operations, we do not expect to be treated as a passive foreign investment
company (&ldquo;PFIC&rdquo;) for U.S. federal income tax purposes for the current taxable year or in the foreseeable future. However,
the application of the PFIC rules is subject to uncertainty in several respects, and we cannot assure you the U.S. Internal Revenue
Service will not take a contrary position. Furthermore, this is a factual determination that must be made annually after the close
of each taxable year. If we are a PFIC for any taxable year during which a U.S. holder holds our Class A Ordinary Shares, certain
adverse U.S. federal income tax consequences could apply to such U.S. Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If securities or industry analysts
do not publish research or publish inaccurate or unfavorable research about our business, the market price for our Class A Ordinary
Shares and trading volume could decline.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The trading market
for our Class A Ordinary Shares will depend in part on the research and reports that securities or industry analysts publish about
us or our business. If research analysts do not establish and maintain adequate research coverage or if one or more of the analysts
who cover us downgrade our Class A Ordinary Shares or publish inaccurate or unfavorable research about our business, the market
price for our Class A Ordinary Shares would likely decline. If one or more of these analysts cease coverage of our company or
fail to publish reports on us regularly, we could lose visibility in the financial markets, which, in turn, could cause the market
price or trading volume for our Class A Ordinary Shares to decline.<BR STYLE="clear: both"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_004"></A>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> We estimate that
we will receive net proceeds from the sale of the Shares of approximately $12.6 million, (or up to $14.6 million if the underwriters
exercise the over-allotment option) based upon an assumed initial public offering price of $4.25 per share, the midpoint of the
range set forth on the cover page of this prospectus, and after deducting estimated underwriting discounts and commissions and
estimated offering expenses </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each $0.25 increase
(decrease) in the assumed initial public offering price of $4.25 per share, the midpoint of the range set forth on the cover page
of this prospectus, would increase (decrease) the net proceeds to us from this offering by approximately $875,000, assuming the
number of shares offered, as set forth on the cover page of this prospectus, remains the same and after deducting estimated underwriting
discounts and commissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We intend to use the
net proceeds of this offering as follows after we complete the remittance process:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximately
    $3.78 million or 30% for development of the online course content;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximately
    $2.52 million or 20% for platform technology upgrade and system integration;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximately
    $6.30 million or 50% for business expansion, i.e., to expand our existing locations to develop new customers by hiring more
    qualified personnel, and marketing effort.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 38.7pt">The precise amounts
and percentage of proceeds we would devote to particular categories of activity will depend on prevailing market and business
conditions as well as particular opportunities that may arise from time to time. This expected use of our net proceeds from this
Offering represents our intentions based upon our current plans and business conditions, which could change in the future as our
plans and business conditions evolve. The amounts and timing of our actual expenditures may vary significantly depending on numerous
factors, including any unforeseen cash needs. Similarly, the priority of our prospective uses of proceeds will depend on business
and market conditions are they develop. Accordingly, our management will have significant flexibility and broad discretion in
applying the net proceeds of the offering. If an unforeseen event occurs or business conditions change, we may use the proceeds
of this Offering differently than as described in this prospectus.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 38.7pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 38.7pt">In utilizing the
proceeds of this Offering, we are permitted under PRC laws and regulations to provide funding to our PRC subsidiary and branches
only through loans or capital contributions.&nbsp;None of the proceeds of this Offering can be loaned or contributed to our PRC
subsidiary without additional government registration or approval. Subject to satisfaction of applicable government registration
and approval requirements, we may extend inter-company loans or make additional capital contributions to our PRC subsidiary and
branches to fund its capital expenditures or working capital.&nbsp;There is, in effect, no statutory limit on the amount of capital
contribution that we can make to our PRC subsidiary. This is because there are no statutory limits on the amount of registered
capital for our PRC subsidiary, and we are allowed to make capital contributions to our PRC subsidiary by subscribing for its
initial registered capital and increased registered capital, provided that the PRC subsidiary completes the relevant necessary
filing and registration procedures in accordance with the applicable laws and regulations. With respect to loans to the PRC subsidiary
by us, (i) if the relevant PRC subsidiary determines to adopt the traditional foreign exchange administration mechanism, or the
current foreign debt mechanism, the outstanding amount of the loans shall not exceed the difference between the total investment
and the registered capital of the PRC subsidiary and there is, in effect, no statutory limits on the amount of loans that we can
make to our PRC subsidiary under this circumstance since we can increase the registered capital of our PRC subsidiary by making
capital contributions to them, subject to the completion of relevant registrations, and the difference between the total investment
and the registered capital will increase accordingly; and (ii) if the relevant PRC subsidiary determines to adopt the foreign
exchange administration mechanism as provided in the Notice of the People&rsquo;s Bank of China (&ldquo;PBOC&rdquo;) on Full-coverage
Macro-prudent Management of Cross-border Financing (the &ldquo;PBOC Notice No.&nbsp;9&rdquo;), the risk-weighted outstanding amount
of the loans, which shall be calculated based on the formula provided in the PBOC Notice No.&nbsp;9, shall not exceed 200% of
the net asset of the relevant PRC subsidiary. According to the PBOC Notice No.&nbsp;9, after a transition period of one year since
the promulgation of the PBOC Notice No.&nbsp;9, the PBOC and SAFE will determine the cross-border financing administration mechanism
for the foreign-invested enterprises after evaluating the overall implementation of the PBOC Notice No.&nbsp;9. As of the date
hereof, neither PBOC nor SAFE has promulgated and made public any further rules, regulations, notices or circulars in this regard.
It is uncertain which mechanism will be adopted by PBOC and SAFE in the future and what statutory limits will be imposed on us
when providing loans to our PRC subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 38.7pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 38.7pt"></P>

<!-- Field: Page; Sequence: 68; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 38.7pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 38.7pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 38.7pt">According to the
relevant PRC laws and regulations, in terms of capital contributions, it typically takes about eight weeks to complete the relevant
filings and registrations. In terms of loans, the SAFE registration process typically takes about four weeks or longer to complete,
provided that all the necessary procedures could be successfully consummated by the relevant PRC subsidiary or consolidated VIE,
as case may be, and/or our company. While we currently see no material obstacles to completing the filing and registration procedures
with respect to future capital contributions to our PRC subsidiary and loans to our PRC subsidiary or to our consolidated VIE,
we cannot assure you that we will be able to obtain these government registrations or approvals on a timely basis, if at all.
See &ldquo;Risk Factors&mdash;Risks Related to Doing Business in China&mdash;We cannot assure you that we will be able to complete
the necessary government registrations or obtain the necessary government approvals on a timely basis, if at all, with respect
to future loans by us to our PRC subsidiary or controlled PRC affiliate or with respect to future capital contributions by us
to our PRC subsidiary. If we fail to complete such registrations or obtain such approvals, our ability to use the proceeds we
receive from this Offering and to capitalize or otherwise fund our PRC operations may be negatively affected, which could adversely
and materially affect our liquidity and our ability to fund and expand our business&rdquo;, and &ldquo;Risk Factors&mdash;Risks
Related to Doing Business in China&mdash;However, we cannot assure you that the PRC government will not take measures in the future
to restrict access to foreign currencies for current account transactions.&rdquo; It is likely that we will need to convert some
of our net proceeds in U.S. dollars into Renminbi in order to use as proceeds as contemplated in this section. For details of
PRC regulations governing foreign currency conversion, see &ldquo;Government Regulation&mdash;Regulation of Foreign Currency Exchange
and Dividend Distribution.&rdquo;&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 38.7pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pending remitting
the Offering proceeds to the PRC, we intend to invest our net proceeds in short-term, interest bearing, investment-grade obligations.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we may use
a portion of the proceeds for the acquisition of, or investment in, companies, technologies, products or assets that complement
our business, we have no present understandings, commitments or agreements to enter into any acquisitions or make any investments.
We cannot assure you that we will make any acquisitions or investments in the future.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 69; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="a_005"></A>DIVIDEND
POLICY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The holders of our
Class A Ordinary Shares are entitled to dividends out of funds legally available when and as declared by our board of directors.
Our board of directors has never declared a dividend and does not anticipate declaring a dividend in the foreseeable future. Should
we decide in the future to pay dividends, as a holding company, our ability to do so and meet other obligations depends upon the
receipt of dividends or other payments from our operating subsidiaries and other holdings and investments. In addition, our operating
subsidiaries may, from time to time, be subject to restrictions on their ability to make distributions to us, including as a result
of restrictive covenants in loan agreements, restrictions on the conversion of local currency into U.S. dollars or other hard
currency and other regulatory restrictions. In the event of our liquidation, dissolution or winding up, holders of our Class A
Ordinary Shares are entitled to receive, ratably, the net assets available to shareholders after payment of all creditors.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under Cayman Islands
law, dividends may be declared and paid only out of funds legally available therefor, namely out of either profit or our share
premium account, and provided further that a dividend may not be paid if this would result in our Company being unable to pay
its debts as they fall due in the ordinary course of business.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we determine to
pay dividends on any of our Class A Ordinary Shares in the future, as a holding company, we will be dependent on receipt of funds
from our subsidiaries in China for our cash requirements, including any payment of dividends to our shareholders.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Current PRC regulations
permit our indirect PRC subsidiary to pay dividends to Zhongchao WFOE only out of its accumulated profits, if any, determined
in accordance with Chinese accounting standards and regulations. In addition, our subsidiary in China is required to set aside
at least 10% of its after-tax profits each year, if any, to fund a statutory reserve funds until the accumulative amount of such
funds reaches 50% of its registered capital. Each of such entity in China is also required to further set aside a portion of its
after-tax profits to fund the employee welfare fund, although the amount to be set aside, if any, is determined at the discretion
of such entity. Although the statutory reserves can be used, among other ways, to increase the registered capital and eliminate
future losses in excess of retained earnings of the respective companies, the reserve funds are not distributable as cash dividends
except in the event of liquidation.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The PRC government
also imposes controls on the conversion of RMB into foreign currencies and the remittance of currencies out of the PRC. Therefore,
we may experience difficulties in completing the administrative procedures necessary to obtain and remit foreign currency for
the payment of dividends from our profits, if any. Furthermore, if our subsidiary and affiliates in the PRC incur debt on their
own in the future, the instruments governing the debt may restrict their ability to pay dividends or make other payments. If we
or our subsidiaries are unable to receive all of the revenues from our operations, we may be unable to pay dividends on our Class
A Ordinary Shares.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cash dividends, if
any, on our Class A Ordinary Shares will be paid in U.S. dollars. Zhongchao WFOE may be considered a non-resident enterprise for
tax purposes, so that any dividends Zhongchao Shanghai pay to Zhongchao WFOE may be regarded as China-sourced income and as a
result may be subject to PRC withholding tax at a rate of up to 10.0%.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Arrangement
between Mainland China and the Hong Kong Special Administrative Region for the Avoidance of Double Taxation and Tax Evasion on
Income, or the Double Tax Avoidance Arrangement, the 10% withholding tax rate may be lowered to 5% if a Hong Kong resident enterprise
owns no less than 25% of the PRC enterprise. However, pursuant to the Notice of the State Administration of Taxation on the Issues
concerning the Application of the Dividend Clauses of Tax Agreements, or SAT Circular 81, the 5% withholding tax rate does not
automatically apply and certain requirements must be satisfied, including without limitation that (a) the Hong Kong enterprise
must directly own the required percentage of equity interests and voting rights in the PRC resident enterprise; and (b) the Hong
Kong enterprise must have directly owned no less than 25% equity interests in the PRC resident enterprise during the 12 consecutive
months preceding its receipt of the dividends. In current practice, a Hong Kong enterprise must obtain a tax resident certificate
from the Hong Kong tax authority to apply for the 5% lower PRC withholding tax rate. As the Hong Kong tax authority will issue
such a tax resident certificate on a case-by-case basis, we cannot assure you that we will be able to obtain the tax resident
certificate from the relevant Hong Kong tax authority and enjoy the preferential withholding tax rate of 5% under the Double Taxation
Arrangement with respect to dividends to be paid by our PRC subsidiary to its immediate holding company, Zhongchao HK. As of the
date of this prospectus, we have not applied for the tax resident certificate from the relevant Hong Kong tax authority. Zhongchao
HK intends to apply for the tax resident certificate when Zhongchao Shanghai plans to declare and pay dividends to Zhongchao HK.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 70; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="a_006"></A>EXCHANGE
RATE INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business is conducted
in China and all of our revenues are denominated in RMB. Capital accounts of our financial statements are translated into U.S.
dollars from RMB at their historical exchange rates when the capital transactions occurred. RMB is not freely convertible into
foreign currency and all foreign exchange transactions must take place through authorized institutions. No representation is made
that the RMB amounts could have been, or could be, converted into U.S. dollars at the rates used in translation. The following
table sets forth information concerning exchange rates between the RMB and the U.S. dollar for the periods indicated. Assets and
liabilities are translated at the exchange rates as of the balance sheet date.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap">Balance sheet items, except for equity accounts</TD><TD STYLE="padding-bottom: 1.5pt; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; white-space: nowrap">December&nbsp;31, <BR>2018</TD><TD STYLE="padding-bottom: 1.5pt; white-space: nowrap">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; white-space: nowrap">December&nbsp;31,<BR>
    2017</TD><TD STYLE="padding-bottom: 1.5pt; white-space: nowrap">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; white-space: nowrap">December&nbsp;31,<BR>
    2016</TD><TD STYLE="padding-bottom: 1.5pt; white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%">USD:RMB</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">6.8755</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">6.5063</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">6.9430</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Items in the statements
of operations and comprehensive loss, and statements cash flows are translated at the average exchange rate of the period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="a_009"></A>SELECTED
HISTORICAL FINANCIAL AND OPERATING DATA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
presents our selected historical financial data for the periods presented and should be read in conjunction with &ldquo;Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operations&rdquo; and the financial statement and notes thereto
included elsewhere in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 71; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
presents our summary consolidated statements of income and comprehensive income for the fiscal years ended December 31, 2018 and
2017 and the six months ended June 30, 2019 and 2018.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Selected Consolidated
Statement of Income and Comprehensive Income</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(In U.S. dollars,
except number of shares)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">For
    the years ended <BR> December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">For
    the Six Months Ended<BR> June 30,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">2017</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; font: 10pt Times New Roman, Times, Serif">Revenues</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">12,865,870</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">9,816,312</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">6,987,623</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">5,232,210</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Cost of revenues</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(4,456,353</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,970,068</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,237,277</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,736,783</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Gross profit</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">8,409,517</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">5,846,244</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">4,750,346</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">3,495,427</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Operating expenses:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Selling and marketing expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,261,258</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,715,201</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,303,740</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,456,105</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">General and administrative expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,425,663</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,139,165</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,633,056</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(886,932</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in">Research and development expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,447,949</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(943,253</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(553,282</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(624,343</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Total operating expenses</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(5,134,870</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(4,797,619</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(3,490,078</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(2,967,380</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Income from operations</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">3,274,647</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">1,048,625</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">1,260,268</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">528,047</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Interest income, net</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">191,609</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">17,331</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">118,943</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">81,380</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Other income, net</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">37,364</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">275,019</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">535,587</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">25,966</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Income before income tax</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">3,503,620</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">1,340,975</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">1,914,798</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">635,393</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Income tax (expenses) benefits</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(502,131</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">153,953</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(205,910</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(84,188</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Net income</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">3,001,489</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">1,494,928</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">1,708,888</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">551,205</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Net loss (income) &nbsp;attributable to non-controlling
    interests</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">17,834</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">34,352</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">21,641</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(7,681</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Net Income Attributable to Zhongchao
    Inc.&rsquo;s shareholders</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">3,019,323</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">1,529,280</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">1,730,529</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">543,524</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Other comprehensive (loss) income</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Foreign currency translation adjustment</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(379,520</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">228,786</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,947</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(110,037</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other comprehensive (loss) income</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(379,520</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">228,786</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(2,947</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(110,037</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Comprehensive income attributable to</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Zhongchao Inc.&rsquo;s shareholders</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,639,803</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,758,066</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,727,582</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">433,487</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Non-controlling interests</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">17,834</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">34,352</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,641</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(7,681</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Basic and diluted earnings per ordinary share*</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.15</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.08</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.08</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.03</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Weighted average number of ordinary share outstanding
    &ndash; basic and diluted</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">20,764,245</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">19,562,121</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">21,600,135</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">20,250,135</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;&nbsp;<FONT STYLE="font-size: 8pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares are presented on a retroactive basis to reflect the reorganization and the stock dividend announced on November
    21, 2017.</FONT></TD></TR>
</TABLE>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The&nbsp;
following table presents our summary consolidated balance sheet data as of December 31, 2018 and 2017 and June 30, 2019.</FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">As
    of December 31, 2018</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">As
    of December 31, 2017</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">As
    of <BR>June 30, 2019</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">(unaudited)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; font: 10pt Times New Roman, Times, Serif; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">7,918,675</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">2,978,515</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">6,558,332</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total current assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">12,561,357</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">6,409,472</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">13,367,362</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total assets</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">14,046,124</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">6,976,003</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">15,675,558</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total liabilities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,660,758</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,778,383</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,541,340</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total Zhongchao Inc.&rsquo;s shareholders&rsquo; equity</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">11,413,202</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5,207,622</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">13,156,305</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Non-controlling Interests</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(27,836</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(10,002</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(22,087</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total shareholders&rsquo; equity</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">11,385,366</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5,197,620</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">13,134,218</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Total liabilities and shareholders&rsquo; equity</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">14,046,124</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">6,976,003</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">15,675,558</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT>&nbsp;</P>


<!-- Field: Page; Sequence: 72; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="a_007"></A>CAPITALIZATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table sets forth our capitalization
as of June 30, 2019:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 7%"></TD><TD STYLE="width: 3%; text-align: left">&#9679;</TD><TD STYLE="text-align: justify; width: 90%">On
                                         an actual basis; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%">&nbsp;</TD>
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="width: 90%; text-align: justify; font-size: 10pt">On a pro forma basis to give effect to the sale of 3,500,000
    Class A Ordinary Shares by us in this offering at the assumed initial public offering price of $4.25 per share, the midpoint
    of the range set forth on the cover page of this prospectus, after deducting the estimated underwriting commissions and estimated
    offering expenses.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we
currently have 5,497,715 Class B Ordinary Shares issued and outstanding. Holders of Class A Ordinary Shares and Class B Class
A Ordinary Shares have the same rights except for voting and conversion rights. In respect of matters requiring a shareholder
vote, each Class A Ordinary Share will be entitled to 1 vote and each Class B Ordinary Share will be entitled to 15 votes. The
Class A Ordinary Shares are not convertible into shares of any other class. The Class B Ordinary Shares are convertible into Class
A Ordinary Shares at any time after issuance at the option of the holder on a one to one basis. The Class B Ordinary Shares are not being converted as part of this Offering.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You should read this
table in conjunction with our financial statements and related notes appearing elsewhere in this prospectus and &ldquo;Use of
Proceeds&rdquo; and &ldquo;Description of Share Capital.&rdquo; You should read this table in conjunction with our financial statements
and related notes appearing elsewhere in this prospectus and &ldquo;Use of Proceeds&rdquo; and &ldquo;Description of Share Capital.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">As of June 30, 2019</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">As&nbsp;Reported</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Pro&nbsp;Forma<BR> Adjusted<BR> for&nbsp;IPO</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Ordinary Shares</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Class A Ordinary Shares</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">16,102,420</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">19,602,420</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Class B Ordinary Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,497,715</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,497,715</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt">Par Value Amount of Ordinary Shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,160</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,510</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Additional Paid-In Capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">11,961,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">24,557,871</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Statutory Reserves</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">20,539</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">20,539</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Retained Earnings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,346,220</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,346,220</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Accumulated Other Comprehensive
    Income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(174,114</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(174,114</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt; text-indent: -10pt; padding-left: 10pt">Total equity attributable to Zhongchao
    Inc.&rsquo;s shareholders</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">13,156,305</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><P STYLE="margin: 0pt 0; text-align: right">25,753,026</P>




</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 73; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="a_008"></A>DILUTION
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
you invest in our shares, your interest will be diluted to the extent of the difference between the initial public offering price
per Class A Ordinary Share </FONT>&nbsp;and the pro forma net tangible book value per Class A Ordinary Share&nbsp; after the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">Holders
of Class A Ordinary Shares and Class B Class A Ordinary Shares have the same rights except for voting and conversion rights.
In respect of matters requiring a shareholder vote, each Class A Ordinary Share will be entitled to 1 vote and each Class B
Ordinary Share will be entitled to 15 votes. The Class A Ordinary Share and Class B Ordinary Share are collectively known as
ordinary shares. The Class B Ordinary Shares are not being converted as part of this Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our net tangible
book value as of June 30, 2019 was $12,732,280, or $0.59 per share. Our net tangible book value per share set forth below represents
our total tangible assets less total liabilities, divided by the number of ordinary shares outstanding (including 1,350,068 Class
A Ordinary Shares underlying the HF Warrant).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Dilution results
from the fact that the per ordinary share offering price is substantially in excess of the book value per ordinary shares attributable
to the existing shareholders for our presently outstanding ordinary shares. After giving effect to our issuance and sale of 3,500,000
Class A Ordinary Shares in this offering at an assumed initial public offering price of $4.25 per share, after deducting the estimated
underwriting discounts and offering expenses payable by us, the pro forma as adjusted net tangible book value as of June 30, 2019
would have been $25,329,001, or $1.01 per share. This represents an immediate increase in net tangible book value to existing
shareholders of $0.42&nbsp;per share. The public offering price per share will significantly exceed the net tangible book value
per share. Accordingly, new investors who purchase shares in this offering will suffer an immediate dilution of their investment
of $3.24 per share. The following table illustrates this per share dilution to the new investors purchasing shares in this offering:</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Offering</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left">Assumed offering price per Class A Ordinary Share</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">4.25</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Net tangible book value as of June 30, 2019</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">12,732,280</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Net tangible book value per ordinary share as of June 30, 2019</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.59</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Pro forma net tangible book value after the offering</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">25,329,001</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Pro forma net tangible book value per ordinary share after the offering</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.01</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Increase per ordinary share attributable to this offering</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.42</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Dilution per Class A Ordinary Share &nbsp;to new investors</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3.24</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A $1.00 increase (decrease)
in the assumed public offering price of $4.25 per share would increase (decrease) the pro forma net tangible book value by $3,202,500,
the pro forma net tangible book value per share after this offering by $0.13 per share and the dilution in pro forma net tangible
book value per share to investors in this offering by $0.13 per share, assuming that the number of shares offered by us, as set
forth on the cover page of this prospectus, remains the same and after deducting the estimated underwriting discount and offering
expenses payable by us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_010"></A><B>POST-OFFERING OWNERSHIP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">The following charts
illustrate our pro forma proportionate ownership, upon completion of this offering by present shareholders and investors in this
offering, compared to the relative amounts paid by each. The charts reflect payment by present shareholders as of the date the
consideration was received and by investors in this offering at the assumed offering price without deduction of commissions or
expenses. The charts further assume no changes in net tangible book value other than those resulting from the offering<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
and the exercise of the HF Warrant.</FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Shares Purchased</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Total Consideration</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Average&nbsp;Price</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount&nbsp;(#)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Percent&nbsp;(%)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount&nbsp;($)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Percent&nbsp;(%)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Per&nbsp;Share ($)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left">Existing shareholders</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">21,600,135</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">86.06</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">9,770,529</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">39.64</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">0.45</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">New investors</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,500,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13.94</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,875,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60.36</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.25</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,100,135</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.00</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,645,529</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.00</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.98</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 74; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="a_011"></A>MANAGEMENT&rsquo;S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>The following management&rsquo;s discussion
and analysis of financial condition and results of operations contains forward-looking statements which involve risks and uncertainties.
Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors,
including those set forth under &ldquo;Risk Factors&rdquo; and elsewhere in this prospectus. We assume no obligation to update
forward-looking statements or the risk factors. You should read the following discussion in conjunction with our consolidated
financial statements and related notes included elsewhere in this prospectus</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Overview</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Our Business</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a provider
of healthcare information, education, and training services to healthcare professionals and the public in China. We offer a wide
range of online and onsite health information services, healthcare education programs, and healthcare training products, consisting
primarily of clinical practice training, open classes of popular medical topics, interactive case studies, academic conference
and workshops, continuing education courses, and articles and short videos with educational healthcare content to healthcare professionals
as well as the public.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We commenced our operation,
through Zhongchao Shanghai, in August 2012 with a vision to offer a wide range of accessible and immediate healthcare information
and continuous learning and training opportunities for Chinese healthcare professionals. Since our inception, we have focused
on developing our information, education, and training programs to address the needs in the healthcare industry in China; and
developing online platforms and onsite activities to deliver our information services, education programs and training products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0"><I>MDMOOC</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We provide our healthcare
information, education, and training services to the healthcare professionals under our &ldquo;MDMOOC&rdquo; brand, which we believe
is one of the leading consumer brands in China&rsquo;s healthcare training and education sector, as evidenced by the 2017 Research
Report on Chinese National Equities Exchange and Quotations (NEEQ) by Beijing Wutong Ideal Capital Management Co., Ltd., a Chinese
NEEQ research company, where we are considered as one of the main and typical medical teaching video provider with doctor interactive
and online training platform.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We launched our first
online platform in a form of website, www.mdmooc.org, under our &ldquo;MDMOOC&rdquo; brand in 2013 to provide information, education,
and training services to physicians and allied healthcare professionals, such as pharmacists and nurses primarily located in China,
via Internet-Plus solutions. We further launched our MDMOOC Wechat subscription account and MDMOOC mobile App in 2015 and 2016,
respectively (together with the website, the &ldquo;MDMOOC online platform&rdquo;). Healthcare professionals in China can apply
for registration with their healthcare qualification to get access to our MDMOOC online platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of
this prospectus, our MDMOOC online platform has more than 390,000 registered users and a database of more than 2 million healthcare
experts including over 700,000 physicians, and 1,300,000 allied healthcare professionals in medical academics, associations, and
leading hospitals who constantly collaborate with us to develop training programs on needed basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since launching in
2013, we have been continuously developing our MDMOOC online platform with new forms of Internet-based education solutions. There
are currently approximately 1,429 education and training programs available on our MDMOOC online platform and free to our registered
users. About 95% of all our programs are self-developed by our research and development team. The original content of these programs,
including daily medical thesis, commentary, conference coverage, expert columns, and activities are written by our research and
development team and authors from widely respected academic institutions, and edited and managed by our in-house editorial staff.
The remaining 5% of programs are created under the purchase orders of our corporate or institution customers, where we develop
customized programs with designated healthcare topics. Such 5% of programs are only available to certain registered users with
program passcodes provided by our corporate or institution customers. Our revenues are mainly sourced from these 5% of programs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our original, exclusive
and proprietary content includes innovative features such as after-class quiz, key point summary and highlight during the courses,
and peer-review and comments.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 75; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to healthcare
information, education, and training via Internet-Plus, we organize onsite healthcare and medical training sessions and academic
conferences from time to time under our &ldquo;MDMOOC&rdquo; brand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of
this prospectus, we have successfully held the first short-term training program for Essential Course for Wound Care Management
in Fujian, China from March 28, 2019 to April 4, 2019 and our first training program for Advanced Course for Surgical Wound Treatment
from June 23, 2019 to June 29, 2019 in Jiangsu, China. We further held the second and third training programs for Essential Course
for Wound Care Management in Zhejiang, China from August 25, 2019 to August 31, 2019 and our second and third training programs
for Advanced Course for Surgical Wound Treatment from December 1, 2019 to December 7, 2019 in Jilin, China. We plan to hold our
future training programs in the 1<SUP>st</SUP> quarter of 2020 in Zhengzhou, Henan Province.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Sunshine Health Forums</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We provide our healthcare
educational content to the public via our &ldquo;Sunshine Health Forums&rdquo;, which, based on the amount of the registered users
and daily review volume, we believe is one of the largest platform in China, for general healthcare knowledge and information
to the public.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to MDMOOC,
we develop and operate the Sunshine Health Forums, online education-for-all platforms that disseminate articles and features related
to healthcare and wellness education, medical behavior intervention, and newly developed health technology and application. We
launched our Sunshine Health Forums in a form of website, www.ygjkclass.com, in May 2016 followed by WeChat subscription account
in August 2016, and mobile App in 2017. We establish one forum for each category of diseases for the convenience of the public.
We cooperate with certain well-known we-media platforms in China, including but not limited Toutiao.com, Yidianzixun.com, Douyin.com,
CN-Healthcare.com, iQiyi, Youku, and Huoshan.com to streamline our articles co-produced by healthcare professionals and us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of
this prospectus, we have established nearly 150 forums, with more than an aggregate of 4.95 million subscriptions and an aggregate
of 1.25 billion click-through.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Recent Development</I></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Commencing from the fourth
quarter of 2018, in addition to providing trainings and education through our platforms, we have been engaged by certain customers
on project basis to establish individual websites to provide training and knowledge of certain drugs, most of which are cancer-related
treatment, to healthcare professionals and patients. Such websites are established to facilitate qualified patients to obtain
free drug treatment from NFPs till the free drugs are completely delivered and distributed as planned. For each website, we also
plug in features to manage the project including reviewing patients&rsquo; applications, tracking their usage of drugs and collecting
related information. Those customers are existing customers of us. They provide those drugs sponsored by pharmaceutical companies
without charge to qualified patients. We charge those customers on our services in connection with the websites and related training
and management.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of the date of this prospectus, we have assisted our customers to establish 8 websites and we expect that we continue to generate
revenue from this type of arrangements.</FONT>&nbsp;</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Our Customers and End Users</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">MDMOOC&rsquo;s customers
are enterprises, non-for-profit organizations (&ldquo;NFP&rdquo;), and medical journals, primarily located in China. MDMOOC&rsquo;s
end users are healthcare professionals, nurses, doctors and other healthcare workers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Our enterprise customers
are pharmaceutical enterprises, healthcare enterprises engaged in researches and develops pharmaceuticals, vaccines, and consumer
healthcare products, pharmaceutical enterprises that engages in drug innovation, manufacturing, and marketing, and medical journals.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Our NFP customers,
most of whom are sponsored by pharmaceutical enterprises to produce training courses for specific healthcare topics, are charity
organizations, national public foundations, and nonprofit non-governmental association, that are governed by provincial and regional
government agencies and commissions. Government agencies include the National Health and Family Planning Commission (NHFPC) and
Ministry of Civil Affairs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">We maintain good relationship
with our customers and some of them have long term relationship with us. We generate our revenue on a case-by-case or project-by-project
basis and by providing our customers with healthcare information, education, and training services, including the production of
online medical training materials, the arrangement of onsite training programs or academic conferences, and the development of
medical education software to their targeted end users.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 76; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
the fiscal year ended December 31, 2017, we generated revenue from a total of 70 customers, of which 14 customers were NFP and
56 customers were pharmaceutical enterprises. For the fiscal year ended December 31, 2018, we generated revenue from a total of
71 customers, of which 15 were NFP and 56 were pharmaceutical enterprises. For the six months ended June 30, 2019, we generated
revenue from a total of 50 customers, of which 16 customers were NFP and 34 customers were pharmaceutical enterprises.</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We generate our revenues
from a relatively small number of customers. For the fiscal years ended December 31, 2018 and 2017, our pharmaceutical enterprise
customers accounted for 60.1% and 80.7% of our total revenues, respectively. For the fiscal years ended December 31, 2018 and
2017, our NFP customers accounted for 39.9% and 19.3% of our total revenues, respectively. For the six months ended June 30, 2019
and 2018, our pharmaceutical enterprise customers accounted for 33.6% and 78.2% of our total revenues, respectively. For the six
months ended June 30, 2019 and 2018, our NFP customers accounted for 66.4% and 21.8% of our total revenues, respectively. The
sharp decrease of revenues generated by pharmaceutical enterprises customers as a percentage of total revenue was mainly because
the pharmaceutical enterprises placed more orders through NFP to attract more medical experts and professionals in the name of
NFP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Sunshine Health
Forums is accessible to the public without limitation. As of the date of this prospectus, we have established nearly 150 forums,
with more than an aggregate of 4.95 million subscriptions and an aggregate of 1.25 billion click-through.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Our Revenue Streams</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently derive
our revenues from 2 sources: (1) revenue generated from the information, education, and training programs, services, and products
under our &ldquo;MDMOOC&rdquo; brand, including but not limited to (a) revenue from designing and producing healthcare training
products as requested by our customers; (b) revenue from our onsite education, including organizing medical training sessions
and academic conferences; and (c) revenue from the healthcare consulting services we provide to our customers; and (2) revenue
generated from disseminating general healthcare knowledge and information and the book selling via our Sunshine Health Forums.
We do not charge user fees for access to our MDMOOC online platform or attend some of our onsite conferences. The MDMOOC online
platform and onsite education activities enable customers to reach, educate and inform target audiences of healthcare professionals.
We work closely with our customers to develop programs to reach specific groups of healthcare professionals and give them placement
on the most relevant areas on our MDMOOC online platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the fiscal years
ended December 31, 2018 and 2017, our revenues were US$12,865,870 and US$9,816,312, respectively, and our net income were US$3,001,489
and US$1,494,928, respectively. For the six months ended June 30, 2019 and 2018, our revenues were US$6,987,623 and US$5,232,210,
respectively, and our net income were US$1,708,888 and US$551,205, respectively. We currently generate most of our revenues from
MDMOOC. The revenue from Sunshine Health Forums was immaterial for the fiscal years ended December 31, 2018 and 2017 and for the
six months ended June 30, 2019 and 2018.&nbsp;&nbsp;We plan to focus our development on Sunshine Health Forums and expand more
information sharing services in this platform.&nbsp;</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 77; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Key Factors that Affect Operating Results</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that the
principal competitive factors in our markets are industry expertise, breadth and depth of service offerings, quality of the services
offered, reputation and track record, marketing, scalability of infrastructure and price. The combination of our large user base,
professional database and high quality education content position us to be a leading provider of healthcare information, education,
and training services to meet the needs of healthcare organizations and professionals and will continue to contribute to our growth
and success.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe the following
factors drive our success:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-align: justify"><I>Acknowledged by leading
pharmaceutical enterprises</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">We believe that in
the foreseeable future we will continue to derive a significant portion of our revenues from a small number of major customers.
Our ability to maintain close relationships with these and other major customers is essential to the growth and profitability
of our business. However, the volume of work performed for a specific client is likely to vary from year to year, especially when
we are not our customers&rsquo; exclusive healthcare information, education, and training services provider and we do not have
long-term commitments from any of our customers to purchase our services. A major client in one year may not provide the same
level of revenues for us in any subsequent year. The healthcare information, education, and training services we provide to our
customers, and the revenues and income from those services, may decline or vary as the type and quantity of healthcare information,
education, and training services we provide changes over time. In addition, our reliance on any individual client for a significant
portion of our revenues may give that client a certain degree of pricing leverage against us when negotiating contracts and terms
of service. In addition, a number of factors other than our performance could cause the loss of or reduction in business or revenues
from a client, and these factors are not predictable. These factors may include corporate restructuring, pricing pressure, changes
to its outsourcing strategy, switching to another services provider or returning work in-house. In the future, a small number
of customers may continue to represent a significant portion of our total revenues in any given period. The loss of any of our
major customers could adversely affect our financial condition and results of operations.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-align: justify"><I>Reliable Professional Content
Production</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our success depends
on our ability to maintain and grow user engagement on our platform. To attract and retain users and compete against our competitors,
we must continue to offer high-quality and reliable content to provide our users with a superior healthcare information, education,
and training service experience. To this end, we must continue to produce original content and source new professional and user-generated
content in a cost effective manner. Given that we operate in a rapidly evolving industry, we need to anticipate industry changes
and respond to such changes timely and effectively. If we fail to continue to offer high-quality and reliable content to our users,
we may suffer from reduced user traffic and engagement, and our business, financial condition and results of operations may be
materially and adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-align: justify"><I>Well Organized and Easy-To-Use
Websites and Apps</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have initiated
our online operations in the recent 7 years and are developing our ability to provide our courses and education systems on a transactional
basis over the Internet. Our future success will depend on our ability to develop the infrastructure effectively, including additional
hardware and software, and implement the services, including customer support, necessary to meet the demand for our services.
In the event we are not successful in developing the necessary systems and implementing the necessary services on a timely basis,
our revenues could be adversely affected, which would have a material adverse effect on our financial condition.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 78; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Results of Operations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>For the twelve months ended December
31, 2018 and 2017</I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
sets forth a summary of our consolidated results of operations for the fiscal years ended December 31, 2018 and 2017. This information
should be read together with our consolidated financial statements and related notes included elsewhere in this Form F-1. The
results of operations in any period are not necessarily indicative of our future trends.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For
                                         the fiscal years ended </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>December
                                         31,</B></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Changes</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; border-bottom: Black 1.5pt solid; text-align: center">Amount</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">%</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%">Revenues</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">12,865,870</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">9,816,312</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">3,049,558</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">31</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">Cost of revenues</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(4,456,353</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(3,970,068</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(486,285</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: right; padding-bottom: 1.5pt">12</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Gross Profit</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">8,409,517</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">5,846,244</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,563,273</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">44</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Operating Expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Selling and marketing expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,261,258</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,715,201</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">453,943</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-17</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">General and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,425,663</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,139,165</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(286,498</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Research and development expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(1,447,949</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(943,253</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(504,696</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: right; padding-bottom: 1.5pt">54</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Operating Expenses</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(5,134,870</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(4,797,619</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(337,251</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">7</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Income from Operations</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">3,274,647</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">1,048,625</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">2,226,022</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">212</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Interest income, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">191,609</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,331</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">174,278</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1006</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other income, net</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">37,364</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">275,019</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(237,655</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: right; padding-bottom: 1.5pt">-86</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Income Before Income Taxes</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">3,503,620</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">1,340,975</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">2,162,645</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">161</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Income tax (expenses) benefits</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(502,131</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">153,953</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(656,084</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: right; padding-bottom: 1.5pt">-426</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt">Net Income</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3,001,489</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,494,928</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,506,561</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">101</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Revenues</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We generate revenues
for pharmaceutical enterprise customers and NFP from design and production of online medical courses, organizing offline medical
training services, and other consulting and academic support services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revenues increased
by $3,049,558, or 31% from $9,816,312 for the fiscal year ended December 31, 2017 to $12,865,870 for the fiscal year ended December
31, 2018. The increase was caused by increasing orders from our existing customers with our increasing acknowledgement among the
pharmaceutical enterprises customers and NFP customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the fiscal year
ended December 31, 2018 and 2017, we earned a high gross profit margin of 65% and 60%, respectively. The high gross profit margin
was attributable to our reputation acknowledgement among leading pharmaceutical enterprises with our capability to design and
produce of high-quality professional content. The Company expected to maintain the high profit margin in the future.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 79; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Cost of revenues</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cost of revenues was
comprised of direct related costs incurred by both online and offline seminars, including expenses of travelling and accommodation,
seminar site-rental, video production and backdrop production, professional service fees charged by experts who provide offline
seminars, and salary and welfare expenses incurred by the key members of the editorial, design and production team. The travelling
and accommodation expenses, including but not limited to the air-ticket expenses and hotel accommodation expenses, represented
the costs arising from lecturers&rsquo; attendance and participation of the offline seminars. Other travelling expenses were incurred
by the Company&rsquo;s medical department for videos production, live streaming of the offline seminars, and materials collection
to create online courses. These travelling and accommodation expenses are well budgeted before any agreements entered into by
the Company and the customers. Therefore, such expenses are well covered by the customers under those agreements. The Company
is not reimbursed by the customers separately.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cost of revenues increased
by $486,285, or 12%, from $3,970,068 for the fiscal year ended December 31, 2017 to $4,456,353 for the fiscal year ended December
31, 2018. The increase was mainly attributable to an increase of $325,732 in professional service fees with an increase of charge
rates of outsourced experts, and an increase of $127,525 in travelling expenses as increased number of end users including healthcare
professionals, nurses and doctors were invited to our offline seminars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Selling and marketing expenses</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Selling and marketing
expenses decreased by $453,943, or 17%, from $2,715,201 for the fiscal year ended December 31, 2017 to $2,261,258 for the fiscal
year ended December 31, 2018. The decrease was mainly attributable to a decrease of $446,839 in advertising expenses, as the Company
decreased its expenditures in certain cities where it gained expected reputation in medical healthcare industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>General and administrative expenses</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">General and administrative
expenses increased by $286,498, or 25%, from $1,139,165 for the fiscal year ended December 31, 2017 to $1,425,663 for the fiscal
year ended December 31, 2018. The increase was mainly attributable to an increase of $186,400 in salary and welfare expenses as
a result of combining effects of an increase of around 6 headcounts in supporting functions and increase in package of employees,
an increase of $40,768 in entertainment expenses which is in line with the business expansion, and an increase in office rental
expenses of $23,539 as the Company entered into a new lease contract for its Beijing office in May 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Research and development expenses</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Research and development
expenses increased by $504,696, or 54%, from $943,253 for the fiscal year ended December 31, 2017 to $1,447,949 for the fiscal
year ended December 31, 2018. The increase was mainly attributable to an increase of $237,710 in salary and welfare expenses as
a result of combining effects of an increase of around 8 headcounts in IT department and increase in package of employees, and
an increase of $266,986 in software and related intellectual property expenses which was used to develop an extensive library
of licensed content and medical database.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Other income, net</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other income, net
was primarily consisted of government subsidies, netting off against donations made to NFPs. The other income, net decreased by
237,655, or 86%, from $275,019 for the fiscal year ended December 31, 2017 to $37,364 for the fiscal year ended December 31, 2018.
The decrease was caused by the Company&rsquo;s recognition of government grants of $221,995 as a reward for its successful IPO
listing on the National Equities Exchange and Quotations Co., Ltd. (&ldquo;NEEQ&rdquo;) upon receipt of cash during the fiscal
year ended December 31, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Income tax (expenses) benefits</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We had income tax
expenses of $502,131 for the fiscal year ended December 31, 2018, as compared to income tax benefits of $153,953 for the fiscal
year ended December 31, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Current income tax
expenses increased by $441,156 from $nil for the fiscal year ended December 31, 2017 to $441,156 for the fiscal year ended December
31, 2018. The increase was caused by increase of $137,802 in current income tax expenses incurred by Zhongchao Shanghai, who was
subject to an income tax rate of 12.5% for the fiscal year ended December 31, 2018 while 0% for the fiscal year ended December
31, 2017, and an increase of $303,354 in current income tax expenses incurred by Zhongxun Shanghai and Shanghai Maidemu, both
of which made net income for the fiscal year ended December 31, 2018 while incurred net loss for the fiscal year ended December
31, 2017.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 80; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Deferred income tax
expenses changed from deferred tax benefits of $153,953 for the fiscal year ended December 31, 2017 to deferred tax expenses of
$60,975 for the fiscal year ended December 31, 2018. The change was mainly caused by a decrease of $284,263 in deferred tax benefit
from advertising expenses, as the Company launched online medical course business in the end of the year ended December 31, 2016
and incurred significant investments in promotion of its online platform since the fiscal year ended December 31, 2017, netting
off against a decrease of $119,472 in deferred tax expenses from net operating losses, as the Company utilized more net operating
losses brought forwards in the fiscal year ended December 31, 2017 than in the fiscal year ended December 31, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Net income</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result of the
foregoing, our net income increased from $1,494,928 for the fiscal year ended December 31, 2017 to $3,001,489 for the fiscal year
ended December 31, 2018.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>For the six months ended June 30,
2019 and 2018</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
sets forth a summary of our consolidated results of operations for the six months ended June 30, 2019 and 2018. This information
should be read together with our consolidated financial statements and related notes included elsewhere in this Form F-1. The
results of operations in any period are not necessarily indicative of our future trends.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For
                                         the Six Months ended </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>June
                                         30,</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Changes</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">%</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; font: 10pt Times New Roman, Times, Serif">Revenues</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">6,987,623</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">5,232,210</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">1,755,413</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">34</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Cost of revenues</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(2,237,277</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,736,783</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(500,494</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right">29</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Gross Profit</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">4,750,346</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">3,495,427</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">1,254,919</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right">36</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Operating Expenses</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Selling and marketing expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,303,740</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,456,105</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">152,365</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-10</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">General and administrative expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,633,056</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(886,932</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(746,124</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">84</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Research and development expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(553,282</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(624,343</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">71,061</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right">-11</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Total Operating Expenses</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(3,490,078</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(2,967,380</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(522,698</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right">18</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Income from Operations</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">1,260,268</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">528,047</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">732,221</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">139</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Interest income, net</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">118,943</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">81,380</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">37,563</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">46</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other income, net</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">535,587</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">25,966</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">509,621</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right">1,963</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Income Before Income Taxes</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">1,914,798</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">635,393</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">1,279,405</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">201</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Income tax expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(205,910</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(84,188</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(121,722</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: right">145</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Net Income</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">1,708,888</TD><TD STYLE="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">551,205</TD><TD STYLE="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">1,157,683</TD><TD STYLE="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: right">210</TD><TD STYLE="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Revenues</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We generate revenues
from NFPs and pharmaceutical enterprise customers for design and production of online medical courses, organizing offline medical
training services, and other consulting and academic support services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Revenues increased
by $1,755,413, or 34% from $5,232,210 for the six months ended June 30, 2018 to $6,987,623 for the six months ended June 30, 2019.
The increase was caused by increasing orders from our existing customers with our increasing acknowledgement among the pharmaceutical
enterprises customers and NFP customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the six months
ended June 30, 2019 and 2018, we earned a high gross profit margin of 68% and 67%, respectively. The high gross profit margin
was attributable to our reputation acknowledgement among leading pharmaceutical enterprises with our capability to design and
produce of high-quality professional content. The Company expected to maintain the high profit margin in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 81; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Cost of revenues</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cost of revenues was
comprised of direct related costs incurred by both online and offline seminars, including expenses of travelling and accommodation,
seminar site-rental, video production and backdrop production, professional service fees charged by experts who provide offline
seminars, and salary and welfare expenses incurred by the key members of the editorial, design and production team. The travelling
and accommodation expenses, including but not limited to the air-ticket expenses and hotel accommodation expenses, represented
the costs arising from lecturers&rsquo; attendance and participation of the offline seminars. Other travelling expenses were incurred
by the Company&rsquo;s medical department for videos production, live streaming of the offline seminars, and materials collection
to create online courses. These travelling and accommodation expenses are well budgeted before any agreements entered into by
the Company and the customers. Therefore, such expenses are well covered by the customers under those agreements. The Company
is not reimbursed by the customers separately.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cost of revenues increased
by $500,494, or 29%, from $1,736,783 for the six months ended June 30, 2018 to $2,237,277 for the six months ended June 30, 2019.
The increase of cost of revenues was in line with the increase of revenues.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Selling and marketing expenses</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Selling and marketing
expenses decreased by $152,365, or 10%, from $1,456,105 for the six months ended June 30, 2018 to $1,303,740 for the six months
ended June 30, 2019. The decrease was mainly attributable to a decrease of $202,743 in advertising expenses, as the Company decreased
its expenditures in certain cities where it gained expected reputation in medical healthcare industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>General and administrative expenses</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">General and administrative
expenses increased by $746,124, or 84%, from $886,932 for the six months ended June 30, 2018 to $1,633,056 for the six months
ended June 30, 2019. The increase was mainly attributable to increase of $440,764 in service fees, $173,679 in audit fees for
preparation of initial public offerings, and $76,244 in office rental expenses as the Company entered into two new lease contract
for its Beijing offices in February 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Research and development expenses</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Research and development
expenses decreased by $71,061, or 11%, from $624,343 for the six months ended June 30, 2018 to $553,282 for the six months ended
June 30, 2019. The decrease was mainly attributable to the combined impact of an increase of $80,559 in salary and welfare expenses
as a result of combining effects of an increase of around 8 headcounts in IT department and increase in package of employees,
an increase of $126,765 in consulting service fees for development of medical courses, against a decrease of $282,583 in software
and related intellectual property expenses which was incurred for the six months ended June 30, 2018 to develop an extensive library
of licensed content and medical database.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Other income, net</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other income, net
was primarily consisted of government subsidies, netting off against donations made to NFPs. The other income, net increased by
$509,621 from $25,966 for the six months ended June 30, 2018 to $535,587 for the six months ended June 30, 2019. The increase
was caused by the Company&rsquo;s recognition of government grants of $515,950 in connection with the Company&rsquo;s development
of medical database and online medical lectures sharing application and cloud. The government grants were recognized as other
income upon the Company passing the quality check.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 82; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Income tax expenses </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We had income tax
expenses of $205,910 for the six months ended June 30, 2019, as compared to $84,188 for the six months ended June 30, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Current income tax
expenses increased by $85,257 from $162,943 for the six months ended June 30, 2018 to $248,200 for the six months ended June 30,
2019. The increase was caused by increase of $207,809 in current income tax expenses incurred by Zhongchao Shanghai, as a result
of increased profit before tax, netting off against a decrease of $138,846 in current income tax expenses incurred by Shanghai
Maidemu as a result of reduced profit before tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Deferred income tax
benefits decreased from $78,755 for the six months ended June 30, 2018 to $42,290 for the six months ended June 30, 2019. The
decrease was mainly caused by 1) a decrease of $80,311 in deferred tax benefit from excess advertising expenses. Pursuant to tax
laws of China, the deductible advertising expenses are limited to 15% of revenue of the year, with excess advertising expenses
deductible in future years. As compared with the six months ended June 30, 2018, the Company generated higher revenue and incurred
less advertising expenses for the six months ended June 30, 2019, leading to decreased excess advertising expenses and deferred
tax benefits; and 2) a change of $39,667 from deferred tax expense of $32,966 for the six months ended June 30, 2018 to deferred
tax benefit of $6,701 for the six months ended June 30, 2019 from net operating losses, as a result of combined impacts of a)
some of the operating entities incurred net operating losses for the six months ended June 30, 2019 and b) some of the operating
entities fully utilized net operating losses carryforwards during the six months ended June 30, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Net income</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result of the
foregoing, our net income increased from $551,205 for the six months ended June 30, 2018 to $1,708,888&nbsp;for the six months
ended June 30, 2019.&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Liquidity and Capital Resources</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In assessing our liquidity,
we monitor and analyze our cash on-hand and our operating and capital expenditure commitments. To date, we have financed our operations
primarily through cash flows from operations, bank borrowings and equity financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the fiscal
years ended December 31, 2018, we generated net income of $3,001,489, and raised funds of $756,544 and $3,580,260 from bank borrowings
and equity financing, respectively. During the fiscal year ended December 31, 2017, we generated net income of $1,494,928, and
raised funds of $2,732,081 from equity financing. During the six months ended June 30, 2019 and 2018, the Company generated net
income of $1,708,888 and $551,205, but did not raise funds from financing institutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of June 30, 2019
and December 31, 2018, we had cash and cash equivalents of $6,558,332 and $7,918,675, and working capital of $10,826,022 and $10,227,848,
respectively. We intend to continue to use these funds to grow our business primarily by:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strengthen
    our brand awareness of MDMOOC and Sunshine Health School</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expand
    and enhancement of medical course content</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grow
    medical professional user community</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recruit more experienced
    editorial staff, and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Development of multiple
    revenues streams such as online bookstore</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Although we consolidate
the results of our VIE and its subsidiaries, we only have access to cash balances or future earnings of our VIE and its subsidiaries
through our VIE Arrangements with our VIE.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Current foreign exchange
and other regulations in the PRC may restrict our PRC entities in their ability to transfer their net assets to the Company and
its subsidiaries in Cayman Islands, and Hong Kong. However, these restrictions have no impact on the ability of these PRC entities
to transfer funds to us as we have no present plans to declare dividend which we plan to retain our retained earnings to continue
to grow our business. In addition, these restrictions have no impact on the ability for us to meet our cash obligations as all
of our current cash obligations are due within the PRC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To utilize the proceeds
we expect to receive from this offering, we may make additional capital contributions to our PRC subsidiary, establish new PRC
subsidiaries and make capital contributions to these new PRC subsidiaries, or make loans to the PRC subsidiaries. However, most
of these uses are subject to PRC regulations. Foreign direct investment and loans must be approved by and/or registered in accordance
with the Foreign Exchange Administration Regulations (1996), as amended in 2008. The total amount of loans we can make to our
PRC subsidiary cannot exceed statutory limits and must be registered with the local counterpart of SAFE. The statutory limit for
the total amount of foreign debts of a foreign-invested company is the difference between the amount of total investment as approved
by the Ministry of Commerce or its local counterpart and the amount of registered capital of such foreign-invested company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 83; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are permitted under
PRC laws and regulations to provide funding to our PRC subsidiary only through loans or capital contributions, and to our consolidated
VIE only through loans, and only if we satisfy the applicable government registration and approval requirements. The relevant
filing and registration processes for capital contributions to our PRC subsidiary typically take approximately eight weeks to
complete. The filing and registration processes for loans either to our PRC subsidiary or to our consolidated VIE typically take
approximately four weeks or longer to complete. While we currently see no material obstacles to completing the filing and registration
procedures with respect to future capital contributions to our PRC subsidiary and loans to our PRC subsidiary or our consolidated
VIE, we cannot assure you that we will be able to complete these filings and registrations on a timely basis, or at all. See &ldquo;Risk
Factors&mdash;Risks Related to Doing Business in China&mdash;PRC regulation of loans and direct investment by offshore holding
enterprises to PRC entities may delay or prevent us from using the proceeds of this Offering to make loans or additional capital
contributions to our PRC subsidiary, which could materially and adversely affect our liquidity and our ability to fund and expand
our business.&rsquo;&rsquo; Additionally, while there is no statutory limit on the amount of capital contribution that we can
make to our PRC subsidiaries, loans provided to our PRC subsidiary and consolidated VIE in the PRC are subject to certain statutory
limits. With respect to our PRC subsidiaries, the maximum amount of the loans that they can acquire in aggregate from outside
China as of June 30, 2019 and December 31, 2018 is approximately RMB 156.6 million (US$22.8 million) under the net asset approach
(subject to the uncertainty whether the competent SAFE local branch would accept the net assets amount of the WFOE which is consolidated
from our VIE at the time of the use of the proceed). We are able to use all of the net proceeds from this offering for investment
in our PRC operations by funding our PRC subsidiary through capital contributions which is not subject to any statutory limit
on the amount under PRC laws and regulations. We expect the net proceeds from this offering to be used in the PRC will be in the
form of RMB and, therefore, our PRC subsidiary and consolidated VIE will need to convert any capital contributions or loans from
U.S. dollars into Renminbi in accordance with applicable PRC laws and regulations.</P>







<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Cash Flows</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table
sets forth a summary of our cash flows for the fiscal years ended December 31, 2018 and 2017, and for the six months ended June
30, 2019 and 2018.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For
                                         the fiscal years ended </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>December
                                         31,</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For
                                         the Six Months ended </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>June
                                         30,</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">2017</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; font: 10pt Times New Roman, Times, Serif; text-align: left">Net Cash Provided by (Used in) Operating
    Activities</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">1,312,647</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">(537,654</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,290,429</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">1,821,810</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Net Cash (Used in) Provided by Investing Activities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(504,048</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,835,459</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">(98,358</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">145,932</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Net Cash Provided by Financing Activities</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,336,804</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,732,081</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Effect of exchange rate changes
    on cash and cash equivalents</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(205,243</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">195,860</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">28,444</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(124,691</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Net increase (decrease) in
    cash and cash equivalents</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">4,940,160</TD><TD STYLE="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">554,828</TD><TD STYLE="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">(1,360,343</TD><TD STYLE="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">1,843,051</TD><TD STYLE="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Operating activities</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Fiscal Years Ended December 31,
2018 and 2017</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net cash provided
by operating activities was $1,312,647 for the fiscal year ended December 31, 2018, a change of $1,850,301 from net cash used
in operating activities of $537,654 for the fiscal year ended December 31, 2017. We made a net income of $3,001,489 for the fiscal
year ended December 31, 2018, an increase of $1,506,561 from the fiscal year ended December 3<FONT STYLE="font-family: Times New Roman, Times, Serif">1,
2017, during which we made a net income of $1,494,928. In addition to the change in profitability, the decrease in net cash used
in operating activities was the result of several factors, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 21pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">An
                                         increase in changes in deferred income of $345,081. The increase was mainly caused by
                                         increased government grants received in connection with the Company&rsquo;s development
                                         of medical database and online medical lectures sharing application and cloud. For the
                                         fiscal year ended December 31, 2018 and 2017, the Company received government grants
                                         of $552,277 and $207,196, respectively;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 21pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
                                         decrease in changes in prepayments to suppliers of $589,965. The decrease was mainly
                                         caused by prepayments in December 2018 of $341,353 and $158,672 to a filming production
                                         vendor and a travel agency, respectively; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 21pt">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">An
                                         increase in changes in accrued expenses and other liabilities of $684,763. The increase
                                         was mainly caused by improvements in payment process in the fiscal year ended December
                                         31, 2017.</FONT></TD></TR></TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 84; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Six Months Ended June 30, 2019 and
2018</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net cash used in operating
activities was $1,290,429 for the six months ended June 30, 2019, a change of $3,112,239 from net cash provided by operating activities
of $1,821,810 for the six months ended June 30, 2018. We made a net income of $1,708,888 for the six months ended June 30, 2019,
an increase of $1,157,683 from the six months ended June 30, 2018, during which we made a net income of $551,205. In addition
to the change in net income, the change of net cash used in operating activities from net cash provided by operating activities
was the result of several factors, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 28px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
    increase of $3,169,533 in accounts receivable for the six months ended June 30, 2019, as compared with an increase of $104,780
    for the same period ended June 30, 2018. The change was mainly caused by an increase of revenue recognized in the three months
    ended June 30, 2019 as compared with the same period ended June 30, 2018, and the Company generally provide credit term ranging
    between one and three months for customers. In addition, Zhongchao Shanghai changed its official name in June 30, 2019, which
    delayed payments from some customers who had to update vendor information in their payment system; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 28px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    decrease of $412,760 in deferred income for the six months ended June 30, 2019, as compared with an increase of $573,404 for
    the same period ended June 30, 2018. The change was mainly caused by&nbsp;&nbsp;government grants of &nbsp;$nil and $573,404
    received during the six months ended June 30, 2019 and 2018, respectively, in connection with the Company&rsquo;s development
    of medical database and online medical lectures sharing application and cloud system, and recognition of government grants
    of $515,950 and $nil over the periods, respectively; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57pt; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 28px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    decrease in changes in accrued expenses and other liabilities of $410,001. The decrease was mainly caused by more frequent
    and timely payments over the years.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Investing activities</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Fiscal Years Ended December 31,
2018 and 2017</U></I></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the fiscal year
ended December 31, 2018, we had net cash used in investing activities of $504,048 which was primarily attributable to purchase
of property and equipment of $668,067, payment for land use rights of $418,520 and net release from short-term investments of
$582,539.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the fiscal year
ended December 31, 2017, we had net cash used in investing activities of $1,835,459 which was primarily attributable to net investments
in short-term investments of $1,753,763.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Six Months Ended June 30, 2019 and
2018</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the six months
ended June 30, 2019, we had net cash used in investing activities of $98,358 which was primarily attributable to payment for construction
of the staff dormitory, purchase of property and equipment of $835,430, deducted by net release from short-term investments of
$737,072.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the six months
ended June 30, 2018, we had net cash provided investing activities of $145,932 which was primarily attributable to net release
from short-term investments of $447,726, deducted by purchase of land use rights of $298,484.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Financing activities</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Fiscal Years Ended December 31,
2018 and 2017</U></I></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the fiscal year
ended December 31, 2018, we had net cash provided by financing activities of $4,336,804 which was primarily attributable to proceeds
of $3,580,260 raised in an equity financing with one strategic investor, and proceeds from bank borrowings of $756,544.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the fiscal year
ended December 31, 2017, we had net cash provided by financing activities of $2,732,081 which was primarily attributable to proceeds
of $2,732,081 raised in equity financings with three strategic investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I><U>Six Months Ended June 30, 2019 and
2018</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the six months
ended June 30, 2019 and 2018, we generated no cash flows from financing activities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Research and Development, Patents,
and Licenses, etc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Research and development
expenses consist primarily of salary and welfare expenses for IT department employees who work for development of the Company&rsquo;s
platform and database, and software and related intellectual property expenses which was used to develop an extensive library
of licensed content and medical database.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 85; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our research and development
expenses were $1,447,949 and $943,253 for the fiscal years ended December 31, 2018 and 2017, respectively.&nbsp;&nbsp;Our research
and development expenses were $553,282 and $624,343 for the six months ended June 30, 2019 and 2018, respectively.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are continued to
commit to work on the development and maintenance in our platform and database as we intend to provide professionals and consumers
with Internet-based access to our courses and education software and enhance the consumer experience.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Trend Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other than as disclosed
elsewhere in this Form F-1, we are not aware of any trends, uncertainties, demands, commitments or events that are reasonably
likely to have a material effect on our net revenues, income from continuing operations, profitability, liquidity or capital resources,
or that would cause reported financial information not necessarily to be indicative of future operating results or financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Tabular Disclosure of Contractual Obligations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Commitments and Contingencies</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time,
the Company may be subject to certain legal proceedings, claims and disputes that arise in the ordinary course of business. Although
the outcomes of these legal proceedings cannot be predicted, the Company does not believe these actions, in the aggregate, will
have a material adverse impact on its financial position, results of operations or liquidity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Operating Lease</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December 31,
2018, the Company had two office lease agreements with two lessors. The lease term of the two lease agreements expire in January
and May 2019, respectively. In January 2019, the Company extended one of the lease agreements for one year. For the six months
ended June 30, 2019, the Company entered into two new office lease agreements with one lessor. As of June 30, 2019, the Company
had three office lease agreements with two lessors, and the lease term will expire in February 2020 through March 2021. Future
minimum lease payment under non-cancelable operating leases are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid">As of June 30, 2019</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Minimum<BR>
    lease<BR> payments</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; font: 10pt Times New Roman, Times, Serif">Six months ending December 31, 2019</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">123,665</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Twelve months ending December 31, 2020</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">233,968</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Twelve months ending December 31, 2021 and thereafter</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">37,690</TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">Total</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">395,323</TD><TD STYLE="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.05pt"><I><U>Contractual
commitment for construction of the Company&rsquo;s office campus </U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.05pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2018,
the Company obtained two pieces of land use rights, on which it commenced construction of the office campus and facilities. The
construction is expected to complete in December 2019. Future minimum capital commitment under construction contract as of June
30, 2019 are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid">As of June 30, 2019</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid">Minimum<BR>
    capital<BR> payments</TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Six months ending December 31, 2019</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">474,865</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">Total</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">474,865</TD><TD STYLE="padding-bottom: 4pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Bank borrowings</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 30, 2018
and December 21, 2018, the Company borrowed $290,888 and $436,332 from Shanghai Pudong Development Bank, with interest rates of
5.09%. The borrowings are due on August 29, 2019 and December 20, respectively. For the years ended December 31, 2018 and 2017,
the interest expenses charged for the bank borrowings were $5,840 and $nil, respectively. For the six months ended June 30, 2019
and 2018, the interest expenses charged for the short term bank borrowings was $18,967 and $nil, respectively. The following table
sets forth our contractual obligations as of June 30, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">For
                                         the <BR>
                                         six months ending December&nbsp;31,</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">2019</P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">For
                                         the <BR>
                                         twelve months ending December 31,</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">2020</P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For
                                         the <BR>
                                         twelve months<BR>
                                         ending December 31, 2021 and </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>thereafter</B></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 52%; text-align: center">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Bank borrowings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">728,332</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">728,332</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 86; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Off-Balance Sheet Arrangements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have not entered
into any derivative contracts that are indexed to our shares and classified as shareholders&rsquo; equity or that are not reflected
in our consolidated financial statements. Furthermore, we do not have any retained or contingent interest in assets transferred
to an unconsolidated entity that serves as credit, liquidity or market risk support to such entity. We do not have any variable
interest in any unconsolidated entity that provides financing, liquidity, market risk or credit support to us or that engages
in leasing, hedging or research and development services with us.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Critical Accounting Policies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We prepare our consolidated
financial statements in accordance with U.S. GAAP, which requires us to make judgments, estimates and assumptions that affect
(i) the reported amounts of assets and liabilities, (ii) disclosure of contingent assets and liabilities at the end of each reporting
period and (iii) the reported amounts of revenues and expenses during each reporting period. We continually evaluate these estimates
and assumptions based on historical experience, knowledge and assessment of current business and other conditions, expectations
regarding the future based on available information and reasonable assumptions, which together form a basis for making judgments
about matters not readily apparent from other sources. The use of estimates is an integral component of the financial reporting
process, though actual results could differ from those estimates. Some of our accounting policies require higher degrees of judgment
than others in the<FONT STYLE="font-family: Times New Roman, Times, Serif">ir application. We consider the policies discussed
below to be critical to an understanding of our financial statements as their application places the most significant demands
on the judgment of our management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Basis
                                         of presentation</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
accompanying audited consolidated financial statements have been prepared in conformity with accounting principles generally accepted
in the United States of America (&ldquo;U.S. GAAP&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Principal
                                         of consolidation</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
consolidated financial statements include the accounts of the Company, its wholly and majority owned subsidiaries, and consolidated
VIE and its subsidiaries for which the Company is the primary beneficiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">All
transactions and balances among the Company, its subsidiaries and&nbsp;consolidated VIE have been eliminated upon consolidation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Revenue
                                         recognition</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company early adopted ASC 606, Revenue from Contracts with Customers (&ldquo;ASC 606&rdquo;) on January 1, 2017, using the modified
retrospective approach. ASC 606 establishes principles for reporting information about the nature, amount, timing an</FONT>d uncertainty
of revenue and cash flows arising from the entity&rsquo;s contracts to provide goods or services to customers. The core principle
requires an entity to recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the
consideration that it expects to be entitled to receive in exchange for those goods or services recognized as performance obligations
are satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has assessed
the impact of the guidance by reviewing its existing customer contracts and current accounting policies and practices to identify
differences that will result from applying the new requirements, including the evaluation of its performance obligations, transaction
price, customer payments, transfer of control and principal versus agent considerations. Based on the assessment, the Company
concluded that there was no change to the timing and pattern of revenue recognition for its current revenue streams in scope of
ASC 605 and therefore there was no material changes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 87; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In according with
ASC 606, revenues are recognized when control of the promised services is transferred to customers, in an amount that reflects
the consideration the Company expects to be entitled to in exchange for those services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company identified
each distinct service, or each series of distinct services that are that are substantially the same and that have the same pattern
of transfer to the customer, as a performance obligation. Transaction price is allocated among different performance obligations
identified in one contract, by using expected cost plus margin approach, if the standalone selling price of each performance obligation
is not observable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Timing of revenue
recognition may differ from the timing of invoicing to customers. Accounts receivable represents amounts invoiced and revenue
recognized prior to invoicing when the Company has satisfied its performance obligation and has the unconditional right to payment.
The balance of accounts receivable was $1,993,237 and $1,301,810 as of December&nbsp;31, 2018 and 2017, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Advances from customers
consists of payments received related to unsatisfied performance obligations at the end of the period. As of December&nbsp;31,
2017, the Company&rsquo;s total advance from customers was $712,671, all of which was recognized as revenue for the year ended
December&nbsp;31, 2018. The Company&rsquo;s total advance from customers was $553,409 as of December&nbsp;31, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company applied
a practical expedient to expense costs as incurred for costs to obtain a contract with a customer when the amortization period
would have been one year or less. The Company has no material incremental costs of obtaining contracts with customers that the
Company expects the benefit of those costs to be longer than one year which need to be recognized as assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Medical training and education services</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company designs
and provides both online and offline medical training and education courses to physicians and allied healthcare professionals
(the &ldquo;training and education services&rdquo;). The Company identifies a single performance obligation from contracts for
both offline and online medical training and education services. The Company recognizes revenue at the point of provision of services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Offline medical
training and education services courses</I> &ndash; though customers can benefit from each service commitment, including design,
production and presentation of medical courses, together with other readily available resources. The promises in the contracts
with customers is integration of all of these service commitments. &nbsp;&nbsp;The Company concludes that these service commitments
are highly dependent with each other, in the context of the contract term. Thus these service commitments are not distinct from
each other, and the Company combines all service commitments performed as a single performance obligation. In cases where the
Company engages third party experts to provide presentation in medical courses, as the Company determines the contents and the
participants, it has the ability to direct these experts to provide medical training services for the Company. Therefore the Company
is primarily responsible for fulfilling the promise to provide the medial courses and has the discretion in establishing the transaction
price. The Company is a principal in the provision of services and recognizes revenues on a gross basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Online medical
training and education services courses</I> &ndash; the promises in the contracts with customers consist of provision of online
courses and presentation of the courses online for users to access for a period of time. The performance obligation of presentation
of the courses online for users for a period of time is immaterial in the context of the contract because presentation of each
course incurred no significant additional cost, nor will it occupy any significant resources of the Company, except for little
digital space on the Company&rsquo;s server, which is inconsequential. Therefore, the Company combines all service commitments
performed as a single performance obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fees are collected
either in advance to provision of services or after the services. In cases where fees are collected in advance, the fees are recorded
as &ldquo;advance from customers&rdquo; in the consolidated balance sheets. Advance from customers is recognized as revenue when
the Company delivers the courses to its customers. The fees are non-refundable. In cases where fees are collected after the sales,
revenue and accounts receivable are recognized upon delivery of medical training and education courses to the Company. The fees
are fixed and determinable at the inception of the services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Assistance in operation of patient-aid
projects</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company is engaged
by not-for-profit organizations (&ldquo;NFP&rdquo;) to assist in operation of patient aid projects with a purpose to facilitate
qualified patients to obtain free drug treatment from NFPs. The Company is responsible to provide doctors with access to training
courses or training materials in connection with the drug treatment, review the completeness of application documents from patients,
and other ad-hoc works. The arrangements are structured as fixed price contracts. The price is determined as stated in contracts
and does not include any variable consideration. The Company identifies a single performance obligation from contracts and recognizes
revenue over a period of time during which the Company provides the assistance to the NFPs till the free drugs are completely
delivered. The Company uses an input-based method to measure the progress, by reference to the cost incurred in performing the
obligation.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The fees are fixed at
the inception of the services and are collected either in advance to provision of services or after the services are provided.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Other consulting services</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company also provides
consulting services to its customers, including drafting research papers and other academic supports. The consulting services
are accounted for as a single performance obligation and was recognized as revenue when the Company delivers services to the customers.
Fees are generally collected after provision of services. For the years ended December 31, 2018 and 2017, the Company generated
minimal amount from other consulting services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 88; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><I>Income
                                         taxes</I></B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts
for income taxes in accordance with the U.S. GAAP for income taxes. Under the asset and liability method as required by this accounting
standard, the recognition of deferred income tax liabilities and assets for the expected future tax consequences of temporary
differences between the income tax basis and financial reporting basis of assets and liabilities. Provision for income taxes consists
of taxes currently due plus deferred taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The charge for taxation
is based on the results for the year as adjusted for items which are non-assessable or disallowed. It is calculated using tax
rates that have been enacted or substantively enacted by the balance sheet date.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Deferred tax is accounted
for using the balance sheet liability method in respect of temporary differences arising from differences between the carrying
amount of assets and liabilities in the financial statements and the corresponding tax basis. Deferred tax assets are recognized
to the extent that it is probable that taxable income to be utilized with prior net operating loss carried forwards. Deferred
tax is calculated using tax rates that are expected to apply to the period when the asset is realized or the liability is settled.
Deferred tax is charged or credited in the income statement, except when it is related to items credited or charged directly to
equity. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not
that some portion or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance
with the laws of the relevant taxing authorities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An uncertain tax position
is recognized as a benefit only if it is &ldquo;more likely than not&rdquo; that the tax position would be sustained in a tax
examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is
greater than 50% likely of being realized on examination. Penalties and interest incurred related to underpayment of income tax
are classified as income tax expense in the period incurred. As of June 30, 2019, income tax returns for the tax years ended December
31, 2014 through December 31, 2018 remain open for statutory examination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Quantitative and Qualitative Disclosures about Market Risks</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is also
exposed to liquidity risk which is risk that it is unable to provide sufficient capital resources and liquidity to meet its commitments
and business needs. Liquidity risk is controlled by the application of financial position analysis and monitoring procedures.
When necessary, the Company will turn to other financial institutions and the shareholders to obtain short-term funding to meet
the liquidity shortage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Inflation risk</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since our inception,
inflation in China has not materially affected our results of operations. According to the National Bureau of Statistics of China,
the year-over-year percent changes in the consumer price index for December 31, 2018 and 2017 were increases of 2.1% and 1.8%,
respectively. Although we have not been materially affected by inflation in the past, we may be affected if China experiences
higher rates of inflation in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Interest rate risk</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our exposure to interest
rate risk primarily relates to the interest rate that our deposited cash can earn, on the other hand. Interest-earning instruments
carry a degree of interest rate risk. We have not been exposed to material risks due to changes in interest rates. An increase,
however, may raise the cost of any debt we incur in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Foreign currency translation and transaction
</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Substantially all
of the Company&rsquo;s operating activities and the Company&rsquo;s assets and liabilities are denominated in RMB, which is not
freely convertible into foreign currencies. All foreign exchange transactions take place either through the Peoples&rsquo; Bank
of China (&ldquo;PBOC&rdquo;) or other authorized financial institutions at exchange rates quoted by PBOC. Approval of foreign
currency payments by the PBOC or other regulatory institutions requires submitting a payment application form together with suppliers&rsquo;
invoices and signed contracts. The value of RMB is subject to changes in central government policies and to international economic
and political developments affecting supply and demand in the China Foreign Exchange Trading System market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Recently Issued Accounting Standards
</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A list of recently
issued accounting pronouncements that are relevant to us is included in Note 2(bb) to our consolidated financial statements included
elsewhere in this prospectus.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 89; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_012"></A>OUR BUSINESS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Overview </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0"><B><I>Our Company</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a provider
of healthcare information, education, and training services to healthcare professionals and the public in China. We offer a wide
range of online and onsite health information services, healthcare education programs, and healthcare training products, consisting
primarily of clinical practice training, open classes of popular medical topics, interactive case studies, academic conference
and workshops, continuing education courses, and articles and short videos with educational healthcare content to healthcare professionals
as well as the public. The services, programs, and products that we provide:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">make
                                         it easier for healthcare professionals to access healthcare reference sources, stay abreast
                                         of the latest medical information, learn about new treatment options, earn continuing
                                         medical education credits and communicate with peers; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">enable
                                         the public to obtain health information on a particular disease or condition, offer content
                                         on topics of individual interest, improve public health consciousness, and promote people&rsquo;s
                                         lifestyle.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We provide our healthcare
information, education, and training services to the healthcare professionals under our &ldquo;MDMOOC&rdquo; brand, which we believe
is one of the leading consumer brands in China&rsquo;s healthcare training and education sector, as evidenced by the 2017 Research
Report on Chinese National Equities Exchange and Quotations (NEEQ) by Beijing Wutong Ideal Capital Management Co., Ltd., a Chinese
NEEQ research company, where we are considered as one of the main and typical medical teaching video provider with doctor interactive
and online training platform. We provide our healthcare educational content to the public via our &ldquo;Sunshine Health Forums&rdquo;,
which, based on the amount of the registered users and daily review volume, we believe is one of the largest platform in China,
for general healthcare knowledge and information to the public.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We <FONT STYLE="font-family: Times New Roman, Times, Serif">c</FONT>ommenced
our operation, through Zhongchao Shanghai, in August 2012 with a vision to offer a wide range of accessible and immediate healthcare
information and continuous learning and training opportunities for Chinese healthcare professionals. Since our inception, we have
focused on developing our information, education, and training programs to address the needs in the healthcare industry in China;
and developing online platforms and onsite activities to deliver our information services, education programs and training products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0"><B><I>MDMOOC-Healthcare Information, Education,
and Training for Professionals</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Online Platforms</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We launched our first
online platform in a form of website, www.mdmooc.org, under our &ldquo;MDMOOC&rdquo; brand in 2013 to provide information, education,
and training services to physicians and allied healthcare professionals, such as pharmacists and nurses primarily located in China,
via Internet-Plus solutions. Internet Plus refers to the applications of the internet and other information technology in conventional
industries, such as manufacturing, education and healthcare. It is an incomplete equation where various internet (mobile, cloud
computing, big data or Internet of Things) can be added to other traditional fields. We further launched our MDMOOC Wechat subscription
account and MDMOOC mobile App in 2015 and 2016, respectively (together with the website, the &ldquo;MDMOOC online platform&rdquo;).
Healthcare professionals in China can apply for registration with their healthcare qualification to get access to our MDMOOC online
platform.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 90; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The programs available
on our MDMOOC online platform enable our users to timely obtain extension knowledge of precedents, treatments, and first-hand
experiences of various disease and other healthcare related matters. In addition, our MDMOOC online platform offers these professional
users what we believe is one of the largest online libraries of continuing medical education programs in China that are produced
in association with entities accredited by the National Health Commission of the PRC, such as Chinese Medical Association and
Chinese Journal of Continuing Medical Education. From the convenience of their home or office computer and mobile App, our professional
users can access a variety of accredited editorial resources and programs including online journal articles, medical conferences,
and open classes and obtain continuing medical education credits which are required for the healthcare qualification of doctors,
nurses, and pharmacists.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe MDMOOC
online platform helps healthcare professionals improve their clinical knowledge and practice of medicine. Since launching in 2013,
we have been continuously developing our MDMOOC online platform with new forms of Internet-based education solutions. There are
currently approximately 1,429 education and training programs available on our MDMOOC online platform and free to our registered
users. About 95% of all our programs are self-developed by our research and development team. The original content of these programs,
including daily medical thesis, commentary, conference coverage, expert columns, and activities are written by our research and
development team and authors from widely respected academic institutions, and edited and managed by our in-house editorial staff.
The remaining 5% of programs are created under the purchase orders of our corporate or institution customers, where we develop
customized programs with designated healthcare topics. Such 5% of programs are only available to certain registered users with
program passcodes provided by our corporate or institution customers. Our revenues are mainly sourced from these 5% of programs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently provide
our proprietary interactive programs via Practice Improvement (PI), a problem-based and case-based form of healthcare course,
which integrates state-of-the-art treatment information and clinical cases for particular diseases into interactive practice modules;
Community of Practice Share (COPS), an online and live clinical experience sharing platform that creates the most effective discussion
in a particular healthcare domain or medical area due to the common interests of the users; Continuing Professional Development
(CPD), a section of our platform that provides discussions and articles focusing on the future development and the differences
between Continuing Medical Education (CME) and Continuing Professional Development (CPD), and other general information of physician
competency framework and Meta-analysis. Our original, exclusive and proprietary content includes innovative features such as after-class
quiz, key point summary and highlight during the courses, and peer-review and comments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that our
ability to create, source, edit and organize online healthcare-related content, interactive education services, and training programs
has made MDMOOC online platform one of the leading health destinations and most recognized information platform in healthcare
sector in China. As of the date of this prospectus, our MDMOOC online platform has more than 390,000 registered users and a database
of more than 2 million healthcare experts including over 700,000 physicians, and 1,300,000 allied healthcare professionals in
medical academics, associations, and leading hospitals who constantly collaborate with us to develop training programs on needed
basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Onsite Education
Activities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to healthcare
information, education, and training via Internet-Plus, we organize onsite healthcare and medical training sessions and academic
conferences from time to time under our &ldquo;MDMOOC&rdquo; brand. For instance, in January 2019, we launched EWMA-certified
(defined as below) wound-management collaboration training programs, covering the topics including but not limited to basic concepts
of acute and chronic wounds, management of different levels of surgical and non-surgical wounds, the construction of different
levels of wound centers, and medical staff collaboration in the process of wound management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cooperate with
Beijing Chronic Disease Prevention and Health Education Research Association and Professor Yixin Zhang from the Ninth People&rsquo;s
Hospital of Shanghai Jiao Tong University School of Medicine to create courses titled &ldquo;Essential Course for Wound Care Management&rdquo;
and &ldquo;Advanced Course for Surgical Wound Treatment&rdquo;. These courses have been certified and authorized by the European
Wound Management Association (EWMA), a European not-for-profit umbrella organization, linking national wound management organizations,
individuals and groups with interest in wound care. We plan to hold four (4) training programs for Essential Course for Wound
Care Management and two (2) training programs for Advanced Course for Surgical Wound Treatment. Each program will accept no more
than twenty (20) applicants who shall hold academic credential above undergraduate. We also require all applicants to have more
than six-year working experience in the field of wound repair. We will issue a certificate to each of the applicant upon completion
of the training as their proof of achievement and ability in the wound management and treatment</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 91; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of
this prospectus, we have successfully held the first short-term training program for Essential Course for Wound Care Management
in Fujian, China from March 28, 2019 to April 4, 2019 and our first training program for Advanced Course for Surgical Wound Treatment
from June 23, 2019 to June 29, 2019 in Jiangsu, China. We further held the second and third training programs for Essential Course
for Wound Care Management in Zhejiang, China from August 25, 2019 to August 31, 2019 and our second and third training programs
for Advanced Course for Surgical Wound Treatment from December 1, 2019 to December 7, 2019 in Jilin, China. We plan to hold our
future training programs in the 1<SUP>st</SUP> quarter of 2020 in Zhengzhou, Henan Province.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe the combination
of online and onsite services would provide our end-users the greatest convenience. With more choices of the forms of healthcare
education, we enrich the learning experience of our end-users.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Sunshine Health Forums-Healthcare
Information and Education for the Public</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our goal is not only
provide continuing education and training to healthcare professionals but to promote healthy lifestyle and provide healthcare
knowledge to the public. In order to achieve that, we develop and operate the Sunshine Health Forums, online education-for-all
platforms that disseminate articles and features related to healthcare and wellness education, medical behavior intervention,
and newly developed health technology and application. We launched our Sunshine Health Forums in a form of website, www.ygjkclass.com,
in May 2016 followed by WeChat subscription account in August 2016, and mobile App in 2017. We establish one forum for each category
of diseases for the convenience of the public. We cooperate with certain well-known we-media platforms in China, including but
not limited Toutiao.com, Yidianzixun.com, Douyin.com, CN-Healthcare.com, iQiyi, Youku, and Huoshan.com to streamline our articles
co-produced by healthcare professionals and us.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Recent Developments</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Commencing from the fourth
quarter of 2018, in addition to providing trainings and education through our platforms, we have been engaged by certain customers
on project basis to establish individual websites to provide training and knowledge of certain drug treatment, most of which are
cancer-related treatment, to healthcare professionals and patients. Such websites are established to facilitate qualified patients
to obtain free drug treatment from NFPs till the free drugs are completely delivered and distributed as planned. For each website,
we also plug in features to manage the project including reviewing patients&rsquo; applications, tracking their usage of drugs
and collecting related information. Those customers are existing customers of us. They provide those drugs sponsored by pharmaceutical
companies without charge to qualified patients and we charge those customers on our services in connection with the website and
related training and management.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our Customers and End Users</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>MDMOOC&rsquo;s
Customers and End Users</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our customers are
enterprises, non-for-profit organizations (&ldquo;NFP&rdquo;), and medical journals, primarily located in China. Our terminal
customers and end-users are healthcare professionals, nurses, doctors and other healthcare workers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Our enterprise customers
are pharmaceutical enterprises, healthcare enterprises engaged in researches and develops pharmaceuticals, vaccines, and consumer
healthcare products, pharmaceutical enterprises that engages in drug innovation, manufacturing, and marketing, and medical journals.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Our NFP customers,
most of whom are sponsored by pharmaceutical enterprises to produce training courses for specific healthcare topics, are charity
organizations, national public foundations, and nonprofit non-governmental association, that are governed by provincial and regional
government agencies and commissions. Government agencies include the National Health and Family Planning Commission (NHFPC) and
Ministry of Civil Affairs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
maintain good relationship with our customers and some of them have long term relationship with us. </FONT>&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">We
generate our revenue on a case-by-case or project-by-project basis and by providing our customers with healthcare information,
education, and training services, including the production of online medical training materials, the arrangement of onsite training
programs or academic conferences, and the development of medical education software to their targeted end users.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
the fiscal year ended December 31, 2017, we generated revenue from a total of 70 customers, of which 14 customers were NFP and
56 customers were pharmaceutical enterprises. For the fiscal year ended December 31, 2018, we generated revenue from a total of
71 customers, of which 15 were NFP and 56 were pharmaceutical enterprises. For the six months ended June 30, 2019, we generated
revenue from a total of 50 customers, of which 16 customers were NFP and 34 customers were pharmaceutical enterprises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We generate our revenues
from a relatively small number of customers. For the fiscal years ended December 31, 2018 and 2017, our pharmaceutical enterprise
customers accounted for 60.1% and 80.7% of our total revenues, respectively. For the fiscal years ended December 31, 2018 and
2017, our NFP customers accounted for 39.9% and 19.3% of our total revenues, respectively. For the six months ended June 30, 2019
and 2018, our pharmaceutical enterprise customers accounted for 33.6% and 78.2% of our total revenues, respectively. For the six
months ended June 30, 2019 and 2018, our NFP customers accounted for 66.4% and 21.8% of our total revenues, respectively. The
sharp decrease of revenues generated by pharmaceutical enterprises customers as a percentage of total revenue was mainly because
the pharmaceutical enterprises placed more orders through NFP to attract more medical experts and professionals in the name of
NFP.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Sunshine Health
Forums&rsquo; Users</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unlike MDMOOC online
platform where we require our users to register with their healthcare qualification and some of our programs are limited to certain
registered users of the platform, our Sunshine Health Forums is accessible to the public without limitation. As of the date of
this prospectus, we have established nearly 150 forums, with more than an aggregate of 4.95 million subscriptions and an aggregate
of 1.25 billion click-through.</P>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 92; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Source of Revenues</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently derive
our revenues from 2 sources: (1) revenue generated from the information, education, and training programs, services, and products
under our &ldquo;MDMOOC&rdquo; brand, including but not limited to (a) revenue from designing and producing healthcare training
products as requested by our customers; (b) revenue from our onsite education, including organizing medical training sessions
and academic conferences; and (c) revenue from the healthcare consulting services we provide to our customers; and (2) revenue
generated from disseminating general healthcare knowledge and information and the book selling via our Sunshine Health Forums.
We do not charge user fees for access to our MDMOOC online platform or attend some of our onsite conferences. The MDMOOC online
platform and onsite education activities enable customers to reach, educate and inform target audiences of healthcare professionals.
We work closely with our customers to develop programs to reach specific groups of healthcare professionals and give them placement
on the most relevant areas on our MDMOOC online platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> For the fiscal
years ended December 31, 2018 and 2017, our revenues were US$12,865,870 and US$9,816,312, respectively, and our net income were
US$3,001,489 and US$1,494,928, respectively. For the six months ended June 30, 2019 and 2018, our revenues were US$6,987,623 and
US$5,232,210, respectively, and our net income were US$1,708,888 and US$551,205, respectively. We currently generate most of our
revenues from MDMOOC. The revenue from Sunshine Health Forums was immaterial for the fiscal years ended December 31, 2018 and
2017 and for the six months ended June 30, 2019 and 2018.&nbsp;We plan to focus our development on Sunshine Health Forums and
expand more information sharing services in this platform.&nbsp; </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our Corporate History and Structure</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a holding company
incorporated on April 16, 2019, under the laws of the Cayman Islands, or Zhongchao Cayman. We have no substantive operations other
than holding all of the issued and outstanding shares of Zhongchao Group Inc., or Zhongchao BVI, established under the laws of
the British Virgin Islands on April 23, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Zhongchao BVI is also
a holding company holding all of the outstanding equity of Zhongchao Group Limited, or Zhongchao HK, which was established in
Hong Kong on May 14, 2019. Zhongchao HK is also a holding company holding all of the outstanding equity of Beijing Zhongchao Zhongxing
Technology Limited, or Zhongchao WFOE, which was established on May 29, 2019 under the laws of the PRC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We conduct our business
through our variable interest entity, or VIE, Zhongchao Medical Technology (Shanghai) Corp., or Zhongchao Shanghai, a PRC company,
and through its wholly owned subsidiaries, including Shanghai Maidemu Cultural Communication Corp., or Shanghai Maidemu, Horgos
Zhongchao Medical Technology Co., Ltd., or Horgos Zhongchao Medical, and Shanghai Zhongxun Medical Technology Co., Ltd., or Shanghai
Zhongxun, Horgos Zhongchao Zhongxing Medical Technology Co., Ltd., or Horgos Zhongchao Zhongxing, each a PRC company. We commenced
our operations under the name Zhongchao Medical Consulting (Shanghai) Limited, or Shanghai Zhongchao Limited, a limited liability
company established under the laws of the PRC, to provide medical online and offline training services. Zhongchao Shanghai was
incorporated on August 17, 2012 by Juru Guo and Baorong Xue, who held 60% and 40% equity interests in Zhongchao Shanghai respectively.
On May 25, 2015, the two shareholders transferred all equity interests to Weiguang Yang who held 100% equity interests in Zhongchao
Shanghai after the transfer. On January 15, 2016, the name was changed to Zhongchao Medical Technology (Shanghai) Co., Ltd. On
February 5, 2016, the management completed its registration with the State Administration for Industry and Commerce, or SAIC,
to convert Shanghai Zhongchao Limited into a company limited by shares, or Zhongchao Shanghai. Through direct ownership, Zhongchao
Shanghai has established subsidiaries and branch offices in various cities in PRC, including Beijing, Shanghai, and Horgos.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On June 27, 2016, Shanghai
Zhongchao was listed on the National Equities Exchange and Quotations Co., Ltd., or the NEEQ. At the time of listing, Weiguang
Yang directly held 54.60% equity interests in Zhongchao Shanghai and Shanghai Xingzhong Investment Management LP. Ltd., a limited
partnership incorporated under the PRC laws (&ldquo;Shanghai Xingzhong&rdquo;), directly held 17.90% equity interests in Zhongchao
Shanghai. Shanghai Xingzhong was incorporated on September 22, 2015 by management of Zhongchao Shanghai as a platform for certain
officers and employees holding founder shares. Pursuant to its partner agreement, Weiguan Yang is the general partner of Shanghai
Xingzhong; and manages and operates Shanghai Xingzhong. He has the right, among others, to possess, manage, maintain and dispose
the assets of Shanghai Xingzhong including its equity interest in Zhongchao Shanghai. As a result, Weiguang Yang controlled 72.50%
equity interests in Zhongchao Shanghai upon listing on NEEQ.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">To facilitate our initial
public offering in the United States, Zhongchao Shanghai was delisted from NEEQ in February 2019. At the time of delisting, Weiguang
Yang controlled 57.29% equity interests in Zhongchao Shanghai (43.41% of which was directly held and 13.88% of which was controlled
through Shanghai Xingzhong). After the delisting, a minority shareholder of Zhongchao Shanghai transferred his shares to Mr. Yang.
At the time of our restructure in August 2019, Mr. Yang controlled 58.78% equity interests in Zhongchao Shanghai (44.90% of which
was directly held and 13.88% of which was controlled through Shanghai Xingzhong). To conclude, Zhongchao Shanghai has been under
the control of Weiguan Yang since its initial listing on NEEQ in June 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June 24, 2019,
Zhongchao Shanghai changed its name to Zhongchao Medical Technology (Shanghai) Limited. Zhongchao Shanghai engages in technology
development, technology transfer, and technical services in the field of medical technology, technical consulting in the field
of network technology, and medical information consulting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 12, 2015,
Zhongchao Shanghai established its wholly owned subsidiary, Shanghai Maidemu. Shanghai Maidemu engages in planning for cultural
and artistic exchanges, designing, producing, acting for and publishing various kinds of advertisements, and medical consultation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 27, 2017, Zhongchao
Shanghai established its wholly owned subsidiary, Shanghai Zhongxun. Shanghai Zhongxun engages in technology development, transfer,
service and consulting in the fields of medical technology and computer technology.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 93; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 12, 2017,
Zhongchao Shanghai established its wholly owned subsidiary, Horgos Zhongchao Medical Technology Limited Company (&ldquo;Horgos
Zhongchao Medical&rdquo;). Horgos Zhongchao Medical engages in technology development, transfer, service and consulting in the
fields of medical technology and computer technology.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 28, 2016,
Shanghai Maidemu formed a joint venture with Ms. Hongxia Zhang and Ms. Shuhua Gao, contributing a 55% equity interest in Shanghai
Huijing Information Technology Co., Ltd., or Shanghai Huijing, a PRC company. On January 21, 2019, Shanghai Huijing was 100% owned
by Shanghai Maidemu. Shanghai Huijing engages in technology development, transfer, service and consulting in the fields of computer
technology, graphic designing, website page designing, planning cultural and artistic exchanges.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 16, 2019,
Zhongchao Cayman was incorporated in the Cayman Islands and issued 5,497,715 Class B Ordinary Shares at 0.0001 par value as founder
shares to More Healthy Holding Limited, representing 83.66% of total voting power of the Company, on converted basis, given that
each Class B Ordinary Share is entitled to 15 votes and each Class A Ordinary Share is entitled to 1 vote and assuming the exercise
of the HF Warrant. More Healthy Holding Limited is a BVI company 100% owned by Weiguang Yang (&ldquo;More Healthy&rdquo;).</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 29, 2019,
Zhongchao Shanghai established its wholly owned subsidiary, Horgos Zhongchao Zhongxing. Horgos Zhongchao Zhongxing engages in
technology development, transfer, service and consulting in the fields of medical technology and computer technology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.25pt 0 0; text-align: justify; text-indent: 0.5in">On August 14,
2019, Zhongchao Cayman completed a reorganization of entities under common control of Weiguang Yang, who owned a majority of the
voting power of Zhongchao Cayman prior to the reorganization. Zhongchao Cayman, Zhongchao BVI, and Zhongchao HK were established
as the holding companies of Zhongchao WFOE. Zhongchao WFOE is the primary beneficiary of Zhongchao Shanghai and its subsidiaries,
and all of these entities included in Zhongchao Cayman are under common control which results in the consolidation of Zhongchao
Shanghai and subsidiaries which have been accounted for as a reorganization of entities under common control at carrying value.
The consolidated financial statements are prepared on the basis as if the reorganization became effective as of the beginning
of the first period presented in the consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As part of the Company&rsquo;s
organization for the purpose of this Offering and listing on Nasdaq, on August 1, 2019, the Company and HF Capital Management
Delta, Inc., a company incorporated under the laws of the Cayman Islands (&ldquo;HF Capital&rdquo;) entered into a certain warrant
agreement to purchase Class A Ordinary Shares of the Company (the &ldquo;HF Warrant&rdquo;). At the issuance of the HF Warrant,
Yantai Hanfujingfei Investment Centre (LP), a limited partnership incorporated under PRC laws (&ldquo;Yantai HF&rdquo;, whose
managing partner, Hanfor Capital Management Co., Ltd., is the sole member of HF Capital, and together with &ldquo;HF Capital&rdquo;
hereinafter collectively referred to as &ldquo;HF&rdquo;) was a 6.25 % shareholder of Zhongchao Shanghai (which represented 1,350,068
shares in Zhongchao Shanghai, among which 675,068 shares were issued by Zhongchao Shanghai and the remaining 675,000 shares were
purchased from two pre-existing shareholders) and planned to withdraw its capital contribution in Zhongchao Shanghai but to contribute
the same amount of capital to Zhongchao Cayman directly via HF Capital. As HF Capital needs to complete necessary administrative
registration required under Chinese regulations of outbound direct investments (ODI) to hold equity interest in Zhongchao Cayman,
the HF Warrant entitles HF Capital to purchase 1,350,068 Class A Ordinary Shares, or 6.25% economic beneficial interest, or 1.37%
of the voting ownership interest of the Company, from the Company, if the following conditions are met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                         PRC governmental consent and approval required for HF Capital to exercise the warrant
                                         and payment of the capital contribution have been obtained, including without limitation,
                                         any approval or filing with respect to HF Capital&rsquo;s investment into the Company,
                                         and payment by HF Capital of the capital contribution to the Company, and reasonable
                                         evidence thereof shall have been provided to the Company;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HF
                                         Capital has fully paid the capital contribution to Zhongchao Cayman; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company released the paid-in capital of Yantai HF from Zhongchao Shanghai.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The HF Warrant was
issued in connection with a framework agreement among Zhongchao Shanghai, Mr. Weigang Yang, and Yantai HF dated August 1, 2019
(the &ldquo;Framework Agreement&rdquo;), pursuant to which Zhongchao Shanghai has agreed to complete Yantai HF&rsquo;s withdrawal
of capital contribution in Zhongchao Shanghai no later than one month following the completion of HF Capital&rsquo;s ODI and HF
has agreed to invest the same amount of fund in U.S. dollars in Zhongchao Cayman upon the completion of its ODI registration.
In addition, the parties have agreed to, once the ODI registration of HF Capital is completed, deposit Yantai HF&rsquo;s capital
contribution into a bank account mutually controlled by Zhongchao Shanghai and Yantai HF, to be used as HF Capital&rsquo;s capital
contribution in Zhongchao Cayman. The foregoing is a brief description of the material terms and conditions of the Framework Agreement,
a copy of which is attached as Exhibit 10.18 to this prospectus and incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of
this prospectus, the registration of Yantai HF&rsquo;s withdrawal of its capital contribution in Zhongchao Shanghai has been completed
with local State Administration for Industry and Commerce. The paid-in capital of Yantai HF in an amount of RMB20 million (approximately
US$2.9 million) is currently being held in the corporate bank account of Zhongchao Shanghai and is to be deposited in a designated
bank account mutually controlled by Zhongchao Shanghai and Yantai HF after the completion of HF Capital&rsquo;s ODI procedures
and to be released as HF Capital&rsquo;s capital contribution in Zhongchao Cayman as provided in the Framework Agreement. According
to the Administrative Measures for the Outbound Investment by Enterprises promulgated by the NDRC on December 26, 2017 which became
effective on March 1, 2018, the Administrative Measures on Outbound Investments promulgated by the MOFCOM on September 6, 2014
which became effective on October 6, 2014, and the Notice of the SAFE on Further Simplifying and Improving the Foreign Exchange
Management Policies for Direct Investment promulgated by the SAFE on 13 February 2015 which became effective on June 1, 2015,
the procedures of ODI include obtaining the Filing Notice of Outbound Direct Investment Projects issued by the competent branch
of the NDRC, the Certificate of Outbound Direct Investment of Enterprises issued by the competent branch of the MOFCOM, and completing
the foreign exchange registration of outbound direct investments. HF Capital is currently in the process of completing its ODI
procedures. HF has further committed that in any event if it cannot complete its ODI procedures, HF shall make such capital contribution
to Zhongchao Shanghai in an amount of RMB20 million (approximately US$2.9 million) or to Zhongchao Cayman in the same amount of
fund in U.S. dollars, subject to certain condition.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 94; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> The following diagram
summarizes our corporate identify our subsidiaries, our VIE and its subsidiaries upon completion of this Offering based on a proposed
maximum number of 4,025,000 Class A Ordinary Shares being offered assuming the full exercise of the over-allotment option by the
underwriters and the exercise of the HF Warrant, as compared to the structure immediately prior to the Closing of the Offering. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_03.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notes: All percentages reflect the voting
ownership interests instead of the equity interests held by each one of the shareholder of the Company given that each Class B
Ordinary Share will be entitled to 15 votes as compared to Class A Ordinary Share, each one of which will be entitled to 1 vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">Represents 5,497,715 Class
                                         B Ordinary Shares held by Mr. Weiguang Yang, the 100% owner of More Healthy Holding Limited,
                                         as of the date of this prospectus.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify"><P STYLE="margin: 0pt 0">Represents
                                         an aggregate of 16,102,420 Class A Ordinary Shares <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">including
                                         14,752,352 Class A Ordinary Shares held by 12 shareholders of Company, each one of which
                                         holds less than 5% voting ownership interests of the Company, and 1,350,068 Class A Ordinary
                                         Shares to be held by HF Capital upon exercise of the HF Warrant, as of the date of this
                                         prospectus. See footnote 3 below. </FONT></P>


</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"> (3) </TD><TD STYLE="text-align: justify"><P STYLE="margin: 0pt 0"> In order
                                         to directly hold equity interest in the Company, HF Capital Management Delta, Inc. (&ldquo;HF
                                         Capital&rdquo;) has to complete certain registration and obtain approval with local governmental
                                         authority in PRC. As a part of reorganization and due to the aforementioned factor, HF
                                         Capital was granted a warrant to purchase 1,350,068 Class A Ordinary Shares of the Company
                                         at a price $0.0001 per share or such other amount agreed by the Company and HF Capital
                                         at a grant price of RMB 20,000,000 (approximately $2.9 million) conditioned upon (i)
                                         HF Capital completes necessary registration and obtains approval with local governmental
                                         authority in PRC for its direct investment in the Company and (ii) Zhongchao Shanghai
                                         shall have paid HF Capital RMB 20,000,000 as returned capital contribution in Zhongchao
                                         Shanghai. The above chart assumes that HF Capital has not exercised such warrant. </P> </TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(4)</TD><TD STYLE="text-align: justify"><P STYLE="margin: 0">Represents
                                         RMB 2.74 million (approximately USD$0.4 million) subscribed capital contribution to Zhongchao
                                         Shanghai, as of the date of this prospectus.</P>


</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(5)</TD><TD STYLE="text-align: justify">Represents RMB 9.70 million
                                         (approximately USD$1.4 million) subscribed capital contribution to Zhongchao Shanghai,
                                         as of the date of this prospectus.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(6)</TD><TD STYLE="text-align: justify"><P STYLE="margin: 0">Represents
                                         RMB 1.35 million (approximately USD$0.2 million) subscribed capital contribution to Zhongchao
                                         Shanghai, as of the date of this prospectus.</P>


</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(7)</TD><TD STYLE="text-align: justify">Represents RMB 3.00 million
                                         (approximately USD$0.4 million) subscribed capital contribution to Zhongchao Shanghai,
                                         as of the date of this prospectus. Shanghai Xingzhong Investment Management LP. Ltd.,
                                         a limited partnership incorporated under the PRC laws (&ldquo;Shanghai Xingzhong&rdquo;),
                                         the general partner of which is Weiguang Yang. As the general partner of Shanghai Xingzhong,
                                         Weiguang Yang exercises the voting rights with respect to the shares held by Shanghai
                                         Xingzhong.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(8)</TD><TD STYLE="text-align: justify">Represents RMB 1.35 million
                                         (approximately USD$0.2 million) subscribed capital contribution to Zhongchao Shanghai,
                                         as of the date of this prospectus.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 95; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For details of each
shareholder&rsquo;s ownership, please refer to the beneficial ownership table in the section captioned &ldquo;Principle Shareholders.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; width: 20%; border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%; text-align: justify; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 53%; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Background</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%; text-align: justify; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 25%; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Ownership</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">Zhongchao BVI</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        BVI company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on April 23, 2019</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        holding company</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">100% owned by Zhongchao Cayman </FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">Zhongchao HK</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        Hong Kong company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on May 14, 2019</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        holding company</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">100% owned by Zhongchao BVI</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">Zhongchao WFOE</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        PRC company and deemed a wholly foreign owned enterprise</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on May 29, 2019</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of $10 million</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        holding company</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">100% owned by Zhongchao HK</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">Zhongchao Shanghai</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        PRC limited liability company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on August 17, 2012</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of RMB 20,250,067 (approximately $3,064,272) with registered capital fully paid-up</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Engaged
        in technology development, technology transfer, and technical services in the field of medical technology, technical consulting
        in the field of network technology, and medical information consulting</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">VIE of Beijing Zhongchao Zhongxing Technology Limited</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">Shanghai Maidemu</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        PRC limited liability company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on March 12, 2015</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of $1,597,087 (RMB 10 million) with registered capital fully paid-up</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Planning
        for cultural and artistic exchanges, designing, producing, acting for and publishing various kinds of advertisements,
        and medical consultation (no medical diagnosis and treatment activities allowed).</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">100% owned by Zhongchao Shanghai</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">Shanghai Zhongxun</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        PRC limited liability company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on May 27, 2017</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of $1,021,525 (RMB 7 million) with registered capital fully paid-up</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Engaged
        in technology development, transfer, service and consulting in the fields of medical technology and computer technology
        (no medical diagnosis and treatment activities allowed).</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">100% owned by Zhongchao Shanghai</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Horgos Zhongchao Medical</TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        PRC limited liability company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on September 12, 2017</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of $153,060 (RMB 1 million) with registered capital of $153,060 to be funded</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Engaged
        in technology development, transfer, service and consulting in the fields of medical technology and computer technology.</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">100% owned by Zhongchao Shanghai</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt">Horgos Zhongchao Zhongxing </FONT></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        PRC limited liability company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on July 29, 2019</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of $145,081 (RMB 1 million) with registered capital of $145,081 to be funded</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Engaged
        in technology development, transfer, service and consulting in the fields of medical technology and computer technology.</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">100% owned by Zhongchao Shanghai</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shanghai Jingyi</P></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        PRC limited liability company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on October 10, 2018</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of $144,459 (RMB 1 million) with registered capital of $107,622 to be funded</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Engaged
        in technology development, transfer, service and consulting in the fields of medical technology and computer technology,
        market information consulting and investigating.</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">51% owned by Zhongchao Shanghai</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shanghai Huijing</P></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        PRC limited liability company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on September 28, 2016</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of $149,948 (RMB 1 million) with registered capital of $74,974 to be funded</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Engaged
        in technology development, transfer, service and consulting in the fields of computer technology, graphic designing, website
        page designing, planning cultural and artistic exchanges.</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">100% owned by Shanghai Maidemu</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 96; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>VIE
Arrangements</U>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Due to the restrictions
imposed by PRC laws and regulations on foreign ownership of companies engaged in value-added telecommunication services and certain
other businesses, we operate our businesses in which foreign investment is restricted or prohibited in the PRC through certain
PRC domestic companies. As such, Zhongchao Shanghai is controlled through VIE Arrangements in lieu of direct equity ownership
by us or any of our subsidiaries. Such VIE Arrangements consist of a series of six agreements&nbsp;(collectively,&nbsp;the &ldquo;VIE
Arrangements&rdquo;), which were signed on August 14, 2019. For more details and risks related to our variable interest entity
structure, please see &ldquo;Our Corporate History and Structure&mdash;VIE Arrangements&rdquo; and &ldquo;Risk Factors&mdash;Risks
Related to Our Corporate Structure&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">The significant terms
of the VIE Arrangements by and among our wholly-owned subsidiary, Zhongchao WFOE, our consolidated variable interest entity, Zhongchao
Shanghai, and the shareholders of Zhongchao Shanghai are as follows:</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Agreements that Provide Us Effective
Control over Zhongchao Shanghai</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our PRC Wholly Foreign
Owned Entity, Zhongchao WFOE, has entered into the following agreements with Zhongchao Shanghai and its shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Equity Interest
Pledge Agreement.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the equity
interest pledge agreement dated August 14, 2019, each shareholder of Zhongchao Shanghai has pledged all of its equity interest
in Zhongchao Shanghai to guarantee the shareholder&rsquo;s and Zhongchao Shanghai&rsquo;s performance of their obligations under
the master exclusive service agreement, business cooperation agreement, exclusive option agreement and proxy agreement and power
of attorney. If Zhongchao Shanghai or any of its shareholders breaches their contractual obligations under these agreements, Zhongchao
WFOE, as pledgee, will be entitled to dispose the pledged equity interest entirely or partially. Each of the shareholders of Zhongchao
Shanghai agrees that, during the term of the equity interest pledge agreement, it will not dispose of the pledged equity interests
or create or allow any encumbrance on the pledged equity interests without the prior written consent of Zhongchao WFOE. In addition,
Zhongchao WFOE has the right to collect dividends generated by the pledged equity interest during the term of the pledge. The
term of the initial equity interest pledge agreement is 20 years. After the expiration of the term of initial pledge registration,
Zhongchao WFOE may at its sole discretion require the Shareholders to extend the term of the equity interest registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Proxy Agreement
and Power of Attorney.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the proxy
agreement and power of attorney dated August 14, 2019, each shareholder of Zhongchao Shanghai has irrevocably appointed Zhongchao
WFOE to act as such shareholder&rsquo;s exclusive attorney-in-fact to exercise all shareholder rights, including, but not limited
to, voting on all matters of Zhongchao Shanghai requiring shareholder approval, disposing of all or part of the shareholder&rsquo;s
equity interest in Zhongchao Shanghai, oversee and review Zhongchao Shanghai&rsquo;s operation and financial information. Zhongchao
WFOE is entitled to designate any person to act as such shareholder&rsquo;s exclusive attorney-in-fact without notifying or the
approval of such shareholder, and if required by PRC law, Zhongchao WFOE shall designate a PRC citizen to exercise such right.
Each proxy agreement power of attorney will remain in force for so long as the Zhongchao Shanghai exists. The shareholders of
Zhongchao Shanghai do not have the right to terminate this agreement or revoke the appointment of the Attorney-in-Fact without
the prior written consent of Zhongchao WFOE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 97; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; margin-left: 0.5in"><I>Spouse
Consent&nbsp;Letters.&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Pursuant to the&nbsp;Spouse
Consent&nbsp;Letters dated August 14, 2019, the spouse of each married shareholder of Zhongchao Shanghai, unconditionally and
irrevocably agreed not to assert any rights over the equity interest in Zhongchao Shanghai held by and registered in the name
of their spouse. In addition, each of them agreed to be bound by the VIE Arrangements described here if the spouse obtains any
equity interest in Zhongchao Shanghai for any reason.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Agreement that allows us to Receive
Economic Benefits from Zhongchao Shanghai</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Master Exclusive
Service Agreement.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the master exclusive
service agreement between Zhongchao WFOE and Zhongchao Shanghai dated August 14, 2019, Zhongchao WFOE has the exclusive right
to provide Zhongchao Shanghai with technical support, consulting services and other services. Zhongchao WFOE has the right to
designate and appoint, at its sole discretion, any entities affiliated with the Zhongchao WFOE to provide any and all services.
The service fees are calculated and paid on a yearly basis and at the amount that equals to 100% of the consolidated net profits
of Zhongchao Shanghai. Zhongchao WFOE may adjust the service fee at its discretion after taking into account multiple factors,
such as the difficulty of the services provided, the time consumed, the content and commercial value of services provided and
the market price of comparable services. Zhongchao WFOE owns the intellectual property rights arising out of the performance of
this agreements. Zhongchao Shanghai shall seek approval from Zhongchao WFOE prior to entering into any contracts obtaining the
same or similar services as provided under the Master Exclusive Service Agreement. This agreement will remain effective as long
as Zhongchao Shanghai exists, unless Zhongchao WFOE advance written notice to Zhongchao Shanghai and its shareholders or upon
the transfer of all the equity interest held by Zhongchao Shanghai&rsquo;s shareholders to Zhongchao WFOE and/or a third party
designated by Zhongchao WFOE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Business Cooperation
Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the business
cooperation agreement dated August 14, 2019, without Zhongchao WFOE&rsquo;s prior written consent, Zhongchao Shanghai agrees not
to engage in any transaction which may materially affect its asset, obligation, right or operation, including but not limited
to: any activities not within its normal business scope, merger and acquisition, offering any loan to any third party and incurring
any debt from any third party. Zhongchao Shanghai shall seek approval from Zhongchao WFOE prior to entering into any material
contract, except the contracts executed in the ordinary course of business. Zhongchao Shanghai shall cause the persons designated
by Zhongchao WFOE to be the directors and executive officers of Zhongchao Shanghai. This agreement will remain effective as long
as Zhongchao Shanghai exists, unless Zhongchao WFOE advance written notice to Zhongchao Shanghai and its shareholders or upon
the transfer of all the equity interest held by Zhongchao Shanghai&rsquo;s shareholders to Zhongchao WFOE and/or a third party
designated by Zhongchao WFOE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 98; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Agreements that Provide Us with
the Option to Purchase the Equity Interest in Zhongchao Shanghai</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Exclusive Option
Agreement.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the exclusive
option agreement dated August 14, 2019, each shareholder of Zhongchao Shanghai has irrevocably granted Zhongchao WFOE an exclusive
option to purchase, or have its designated person or persons to purchase, at its discretion, to the extent permitted under PRC
law, all or part of the shareholder&rsquo;s equity interests in Zhongchao Shanghai. The purchase price is equal to the lowest
price allowable under PRC laws and regulations at the time of the transfer. Zhongchao Shanghai has agreed that without Zhongchao
WFOE&rsquo;s prior written consent, Zhongchao Shanghai shall cause the persons designated by Zhongchao WFOE to be the directors
and executive officers of Zhongchao Shanghai, not amend its articles of association, increase or decrease the registered capital,
sell or otherwise dispose of its assets or beneficial interest, create or allow any encumbrance on its assets or other beneficial
interests, provide any loans to any third parties, enter into any material contract, except the contracts executed in the ordinary
course of business, merge with or acquire any other persons or make any investments, or distribute dividends to the shareholders.
The shareholders of Zhongchao Shanghai have agreed that, without Zhongchao WFOE&rsquo;s prior written consent, they will not dispose
of their equity interests in Zhongchao Shanghai or create or allow any encumbrance on their equity interests. Moreover, without
Zhongchao WFOE&rsquo;s prior written consent, no dividend will be distributed to Zhongchao Shanghai&rsquo;s shareholders, and
if any of the shareholders receives any profit, interest, dividend or proceeds of share transfer or liquidation, the shareholder
must give such profit, interest, dividend and proceeds to Zhongchao WFOE. These agreements will remain effective as long as Zhongchao
Shanghai exists unless Zhongchao WFOE advance written notice to Zhongchao Shanghai and the shareholders or upon the transfer of
all the equity interest held by the shareholders to Zhongchao WFOE and/or its designee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Controlled Company</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Upon the completion
of this offering, our outstanding shares will consist of Class A Ordinary Shares and Class B Ordinary Shares, and we will be a
&ldquo;controlled company&rdquo; as defined under the Nasdaq Stock Market Rules because Mr. Weiguang Yang, our founder, chairman
of the board of directors and chief executive officer, will beneficially own all of our then issued Class B ordinary shares and
will be able to exercise 84.48% of the total voting power of our issued and outstanding shares, assuming the full exercise of
the over-allotment option by the underwriters and the exercise of the HF Warrant. Each Class A Ordinary Share is entitled to one
vote, and each Class B Ordinary Share is entitled to fifteen votes and is convertible into one Class A Ordinary Share at any time
by the holders thereof. Class A Ordinary Shares are not convertible into Class B Ordinary Shares under any circumstances. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Upon the completion
of this offering, our directors, executive officers and principal shareholders will continue to have substantial control over
our company. Our affiliates will be able to exercise 86.34% of the total voting power of our issued and outstanding shares, assuming
the full exercise of the over-allotment option by the underwriters and the exercise of the HF Warrant. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As long as our officers
and directors, either individually or in the aggregate, own at least 50% of the voting power of our Company, we are a &ldquo;controlled
company&rdquo; as defined under NASDAQ Marketplace Rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For so long as we
are a controlled company under that definition, we are permitted to elect to rely, and may rely, on certain exemptions from corporate
governance rules, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">an
                                         exemption from the rule that a majority of our board of directors must be independent
                                         directors;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">an
                                         exemption from the rule that the compensation of our chief executive officer must be
                                         determined or recommended solely by independent directors; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 72pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">an
                                         exemption from the rule that our director nominees must be selected or recommended solely
                                         by independent directors.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result, you will
not have the same protection afforded to shareholders of companies that are subject to these corporate governance requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we do not
intend to rely on the &ldquo;controlled company&rdquo; exemption under the NASDAQ listing rules, we could elect to rely on this
exemption in the future. If we elect to rely on the &ldquo;controlled company&rdquo; exemption, a majority of the members of our
board of directors might not be independent directors and our nominating and corporate governance and compensation committees
might not consist entirely of independent directors. (See &ndash; Risk Factor &ldquo;As a &ldquo;controlled company&rdquo; under
the rules of the NASDAQ Capital Market, we may choose to exempt our company from certain corporate governance requirements that
could have an adverse effect on our public shareholders.&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 99; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Industry and Market Background</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>The Internet</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Internet has emerged
as a global medium for communications, news, information and commerce. China Internet Network Information Center (CNNIC) released
the 43rd &ldquo;Statistical Report on China&rsquo;s Internet Development Status&rdquo; report, indicating that as of December
2018, the number of Chinese netizens was 829 million, an increase of 3.8% from the end of 2017. In 2018, the average weekly online
time spent by Chinese netizens is 27.6 hours, which is 0.6 hours higher than the same period in 2017. A number of factors drive
the Internet&rsquo;s continued growth, including the large and growing installed base of personal computers, a rapidly expanding
and improving Internet delivery infrastructure and an explosion of content and commerce offerings on the Web.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Internet allows
content delivery in a manner not possible through traditional broadcast and print media. These traditional media can have large
audiences but generally are limited to a specific geographic area, can deliver only limited content and are not effective for
distributing detailed information quickly. The Internet is distinct from traditional media in that it offers immediate access
to dynamic and interactive content and enables instantaneous communication among users. As a result, the Internet has become an
important alternative to traditional media, enabling users to seek current information and to communicate with one another. These
characteristics, combined with the fast growth of the Internet, have created a powerful, rapidly expanding direct marketing and
sales channel. Advertisers can target very specific demographic groups, measure the effectiveness of advertising campaigns and
quickly revise them in response to the prompt feedback allowed by the Internet&rsquo;s technology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As users hardly don&rsquo;t
rely on the Internet for their information needs, they have sought more detailed content on a wide variety of specific subjects.
Utilizing subject-specific sites, users can find information on selected topics quickly, easily and cost effectively, making these
sites a very attractive resource for users. In addition to offering detailed and comprehensive content, many of these subject-specific
sites have developed online communities that allow users to communicate with each other and to engage in other interactive activities.
We believe these community features are attractive to users who want to express themselves and who seek to interact with other
users who have similar interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Relevant Dynamics In The Healthcare
Industry</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Healthcare is the
largest sector of the Chinese economy. The 2018 Statistical Bulletin on the Development of China&rsquo;s Health and Wellness Industry
shows that the total health expenditure of China in 2018 is expected to reach RMB5,799.83 billion, among which, the government
health expenditure was RMB1,639.07 billion, representing 28.3% of the total health expenditure; social health expenditure was
RMB2,494.47 billion representing 43.0%; personal health expenditure was RMB1,66.29 billion, representing 28.7%. The total health
expenditure per capita is RMB4148.1. The total health expenditure took up 6.4% of China&rsquo;s GDP in 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The need of healthcare
in China is still on the rise. According to 2018 Statistical Bulletin on the Development of China&rsquo;s Health and Wellness
Industry, by the end of 2018, there are 997,434 healthcare institutions in China, with an increase of 10,785 over the previous
year. In 2018, the total number of healthcare services is 8.3 billion with an increase of 130 million over 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The healthcare industry
is continuing to change. According to the China Big Health Industry Development Report 2018, there are three trends in the development
of China&rsquo;s healthcare industry: (1) the need for integrated services for the prevention and treatment of chronic diseases
and the need to maintain people&rsquo;s health in all aspects and full cycles; (2) the total amount of medical and health resources
is insufficient, the structure of the industry is unreasonable, the basic service capacity is still a prominent weak link, and
the technical level needs to be improved; (3) with the change of disease spectrum of Chinese residents, the number of patients
with chronic non-communicable diseases is increasing year by year, which has become the primary problem that threatens the health
of our residents. Healthcare services will shift from treatment-centered to health-promoting centered mode.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 100; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Government is guiding
an active and healthy lifestyle for the public. According to the Healthy China Action (2019-2030), by 2030, the health awareness
of the general public will be greatly improved, healthy lifestyles will be broadly adopted, the main factors having impact on
people&rsquo;s health will be effectively controlled, and the average healthy life expectancy will be greatly increased. Also,
the level of population&rsquo;s main health indicators will enter the ranks of high-income countries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The healthcare industry
in China will continue to develop. According to a report from Prospective Industry Research Institute, in 2019, the scale of China&rsquo;s
healthcare industry will reach RMB 8.78 trillion, and by 2020 the scale of China&rsquo;s healthcare industry will exceed RMB 10
trillion. The annual compound annual growth rate in the next five years (2019-2023) is about 12.55%, and the scale of china&rsquo;s
healthcare industry can be expected to reach RMB 14.09 trillion in 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Convergence Of The Internet And The
Healthcare Industry</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">China has the largest
group of healthcare professionals in the whole world, providing a solid foundation for the development of the healthcare education
market. According to the 2018 Statistical Bulletin on the Development of China&rsquo;s Health and Wellness Industry, China currently
has more than 12 million healthcare professionals, including more than 3.6 million doctors, reflecting a huge demand on knowledge
learning and professional training.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With long working
hours and heavy workloads, it is very difficult for healthcare professionals in China to spare time and energy to participate
in offline academic conferences or training sessions. Continuing changes in the healthcare industry, including the increasing
adoption of managed care plans and the need to keep informed about rapidly emerging medical and pharmaceutical therapies are also
placing increasing pressures on healthcare professionals&rsquo; time. Healthcare professionals must keep abreast of the latest
developments within their medical specialty to provide their patients with the best possible care and to meet continuing medical
education requirements. There is a vast flow of information from many sources, including traditional medical journals, medical
textbooks, academic conferences and other training literature. The sheer volume of medical information and the time constraints
that physicians face make it extremely difficult for them to stay current and to quickly and efficiently access the information
most relevant to their practice. We believe online healthcare professionals education services will allow them to easily find
and manage the information they are seeking.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Internet Plus training
model emerged with the growth of technologies, internet and the needs for convenient and reliable source of information. Specifically,
Internet plus will optimize the traditional mode of education and training for healthcare professionals with real-time services
anytime, anywhere, based on users&rsquo; demands. Through the Internet, the latest medical information and online training courses
can be obtained from the mobile terminal and healthcare professionals can make full use of their spare time to get the information
most related to them. Gradually, the Internet plus education model has been accepted by healthcare professionals. A Chinese Internet
Doctors Insights Report (DIR) released by United States Medical Scientific in November 2018 provides that more than 90% of doctors
in China obtained medical information through professional online platform, 46.7% of doctors in China obtained medical information
through offline meetings, and 58.5% of doctors in China obtained information of pharmaceutical enterprises and drugs through professional
websites.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2019, Internet
plus healthcare education has become the education model guided and supported by the Chinese government. The Opinion Concerning
the Promotion of the Development of Internet Plus Medical and Health promulgated and implemented on April 25, 2018 by the General
Office of the State Council (the &ldquo;Opinion&rdquo;), states its plan to enhance the Internet plus medical education model.
The Opinion encourages the establishment of healthcare education training cloud platform that provides a diverse range of medical
online courses and healthcare information. The Opinion also encourages the establishment of a networked, digital, personalized,
and lifelong medical education and training system for the healthcare professionals to carry out researches and discussions on
incurable diseases and major diseases, and eventually improve their healthcare quality. The Opinion further includes the implementation
plan of the &ldquo;Continuous Medical Education + Appropriate Technology Promotion&rdquo; policy, focusing on the needs of healthcare
and poverty reduction, targeting the grass-root levels and deprived areas of the country, to popularize practical and appropriate
healthcare technologies via distance education. The Opinions further indicates to establish an Internet-based science platform
to provide accurate and up-to-date information on healthcare science knowledge and healthy lifestyles. The Opinion aims to improve
residents&rsquo; health management ability and health literacy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 101; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Healthcare education
is a large sector of the Chinese market with outstanding development prospects. According to the report released on December 24,
2018 by TrendForce (&ldquo;TrendForce Report&rdquo;), a global provider of market intelligence on the technology industries, driven
by the large amount of new drugs joining the market and the continuous increase in the use of new drug products, the 2018 market
size of global pharmaceutical is approximately USD 1.2 trillion, with a 3.8% annual growth rate. TrendForce Report indicates that
the expected global drug market will reach USD1.55 trillion in 2023 with a compound annual growth rate of 5.1% from 2018 to 2023.
According to a 2018 report by The Economic Observer, sales expenses in Chinese pharmaceutical industry account for more than 40%
of the total revenue and the costs of market promotion is a key part of sales expenses. We believe the need for Internet-based
healthcare education will continue to grow, driven by the increasing demand for healthcare services by Chinese people, the implementation
of China&rsquo;s grading diagnosis and treatment policy, and the establishment of doctors&rsquo; multi-point practice system.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Competition</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We face competition
from providers of traditional healthcare education programs and training services as well as the increasing competition from existing
competitors and new market entrants in the&nbsp;online healthcare education&nbsp;market, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 48px"></TD><TD STYLE="width: 24px; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Chinese
                                         online education companies and institutions that also offer continuing healthcare education
                                         and other online courses and training programs. Examples of our competitors include 91huayi,
                                         a Chinese medical education website dedicated to improving medical service providers
                                         professional skills and public&rsquo;s healthcare knowledge; bbs.iivi.com, a Chinese
                                         medical bulletin board system allowing medical professionals in different specialties
                                         to share their views regarding their medical practice, career development and medical
                                         examinations; and www.ccmtv.cn, a Chinese website providing surgery education videos
                                         to medical professionals in different specialties.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -31.5pt; ">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 48px"></TD><TD STYLE="width: 24px; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Healthcare
                                         education companies or institutions organizing onsite healthcare workshop, academic conference,
                                         and other healthcare communication activities. This segment is the most significant competitor
                                         to our onsite education programs. Examples of&nbsp;our competition&nbsp;in this segment
                                         include Medcon, MEDLINK, and Beijing Medical Group 3 AD Ltd., all of which are Chinese
                                         company dedicated to promoting medical information and health knowledge via onsite activities.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -31.5pt; ">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 48px"></TD><TD STYLE="width: 24px; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">China-based
                                         digital service provider in the healthcare industry that also offer information sharing
                                         services and data accumulation and management in China. Examples of our competitors include
                                         DXY (&#19969;&#39321;&#22253;), a Chinese medical knowledge sharing website, which is
                                         built as an academic article retrieving database. DXY has developed more functions to
                                         enrich the services it provides to healthcare professionals and the public, including
                                         but not limited to establishing online forum for physicians, launching a series of mobile
                                         applications such as Drug Assistant and Dingxiang Doctor, and opening its wholly-owned
                                         offline Family Clinics.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -31.5pt; ">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 48px"></TD><TD STYLE="width: 24px; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Education
                                         companies that targets the public and patients. This segment is the most significant
                                         competitor to our Sunshine Healthcare Forum. Examples of our competitors include CN-Healthcare,
                                         an internet-based healthcare education platform targeting patients. CN- Healthcare organizes
                                         content-partners, including healthcare professionals and medical associations to generate
                                         health-related news and information. CN-Healthcare currently has 1773 individual content-partners,
                                         751 association partners, and 1.3 million subscribers.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -31.5pt; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -31.5pt"></P>

<!-- Field: Page; Sequence: 102; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our Growth Strategy</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our objective is to
operate the premier healthcare destination Websites where physicians, allied healthcare professionals and consumers can find reliable
and comprehensive information that enables them to make better and more informed medical and health decisions. We believe we are
positioned to become a preferred online advertising medium, academic communication platform, and e-commerce partner in the PRC
healthcare sector. We intend to achieve this objective by pursuing the following strategies:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 18pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 48px"></TD><TD STYLE="width: 24px">&#9679;</TD><TD STYLE="text-align: justify"><I>Strengthening Our Brands</I>.
                                         We intend to build up MDMOOC as the leading single brand for healthcare information,
                                         education, and training for professionals and Sunshine Health Forums as the leading brand
                                         for online healthcare information forums. We believe that strengthening our brand awareness
                                         is critical to attracting and retaining users, advertisers, sponsors and strategic partners.
                                         We plan to pursue a brand development strategy through online and offline advertising,
                                         promotions, media coverage and word-of-mouth support. We believe our brand visibility
                                         will significantly benefit from promotion on leading we-media and medical associations,
                                         such as China Association of Health Promotion and Education, Beijing Medical and Health
                                         Foundation, and China Primary Health Care Foundation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 18pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 48px"></TD><TD STYLE="width: 24px">&#9679;</TD><TD STYLE="text-align: justify"><I>Improving and Enhancing
                                         Our Products</I>. We intend to expand the content on both our healthcare programs for
                                         professionals and the public by adding new medical specialty areas, enlarging our editorial
                                         staff and utilizing our extensive relationships with leading medical experts. We intend
                                         to enhance the users&rsquo; experience by adding general health and wellness information,
                                         community features and interactive programs that take advantage of our credibility with
                                         medical professionals and our existing professional medical specialty content.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 18pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 48px"></TD><TD STYLE="width: 24px">&#9679;</TD><TD STYLE="text-align: justify"><I>Growing User Community</I>.
                                         Except for the online training programs, we also share the latest news and healthcare
                                         information in the medical industry on MDMOOC online platform. We intend to build our
                                         medical professional community via Practice Improvement (PI), a problem-based and case-based
                                         form of healthcare course, which integrates state-of-the-art treatment information and
                                         clinical cases for particular diseases into interactive practice modules, and Community
                                         of Practice Share (COPS), an online and live clinical experience sharing platform that
                                         creates the most effective discussion in a particular healthcare domain or medical area
                                         due to the common interests of the users, and increase the frequency and length of their
                                         visits to our site. By continuing to offer compelling content, providing interactive
                                         programs and services, and building relationships with relevant healthcare organizations
                                         to increase user loyalty, repeat usage and time spent on our site, we believe MDMOOC
                                         online platform will become an integral part of the medical professional&rsquo;s daily
                                         work flow.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Developing
    Multiple Revenue Sources</I>. We believe our attractive audience demographics and high-quality content offerings provide us
    with significant opportunities to develop multiple sources of revenue. In addition to advertising and sponsorships, we plan
    to generate e-commerce revenues by building Sunshine Health Forums as a full-service online healthcare platform with functions
    of book selling and drug selling. We also plan develop other research products that we expect will complement pharmaceutical
    enterprises&rsquo; product detailing efforts. In addition, we plan to introduce products and services that appeal directly
    to our international and allied healthcare users.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our Competitive Strengths</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">MDMOOC is a healthcare
destination site that provides medical professionals with comprehensive, authoritative and timely medical information, interactive
programs, and training courses. We believe MDMOOC is positioned to help users expand their healthcare knowledge, improve their
professional skills, and change the way people access information and communicate about healthcare.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-align: justify; text-indent: 18pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-align: justify; text-indent: 18pt"></P>

<!-- Field: Page; Sequence: 103; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-align: justify; text-indent: 18pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that the
principal competitive factors in our markets are industry expertise, breadth and depth of service offerings, quality of the services
offered, reputation and track record, marketing and selling skills, scalability of infrastructure and price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that there
are several key strengths that prevail us from our competitors and will continue to contribute to our growth and success. We believe
that the combination of our large user base and high quality education content position us to be a leading provider of Internet-based
solutions to meet the needs of healthcare organizations and professionals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-align: justify; text-indent: 18pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe the following
factors drive our success:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Acknowledged
    by leading pharmaceutical enterprises</I>: our customers include leading pharmaceutical enterprises who position our MDMOOC
    as preeminent branded sources of consumer-oriented health and wellness information on the Internet. Almost all leading pharmaceutical
    enterprises have their own vendor lists regarding different types of service they request. It is an industry norm that it
    usually takes three to four years for a service provider to be accepted by the leading pharmaceutical enterprises to be included
    in the vendor list. We are one of the prominent service providers in the category of course production services on the vendor
    lists of a few well-known pharmaceutical enterprises. Pursuant to the consultant agreements we entered into with the pharmaceutical
    enterprises regarding the course production services, we will create online training courses of specific medical topics and
    then post them on our MDMOOC platforms. The users need to obtain the passwords from the pharmaceutical enterprises or from
    us to get free access to the series of online courses. We also entered into framework agreements with certain pharmaceutical
    enterprises. The terms of the agreements are usually one (1) years. Pursuant to the framework agreements, when our customers
    have a need for medical course production, they will reach out to us by sending over formal purchase order.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Reliable
    Professional Content Production</I>. We use reliable, highly relevant, interactive and multi-media content to satisfy the
    requirements of our customers, including the NPO and pharmaceutical enterprises, and our end-users. We maintain good long-term
    working relationship with many well-known healthcare professionals. With our self-generated resource library of healthcare
    professionals, we can easily reach out to the healthcare experts in certain medical fields when we receive purchase orders
    from our customers to generate relevant medical courses. We also have one of the most comprehensive online content library
    in China for different type of diseases and medical information which makes it easier for us to customize the content under
    different needs of our customers for online medical education. We also have a large pool of experienced in-house editors who
    incubate original medical information and present them in visually appealing formats. They also collaborate with healthcare
    professionals throughout the content generating process. Our content is interactive and largely in the form of videos, articles,
    and photographs, covering a full spectrum of the latest medical information.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify; padding-right: 0"><I>High-Quality,
                                         Timely and Original Medical Information:</I> We provide high-quality, timely and original
                                         content on important healthcare trends and disease topics. Using the real-time publishing
                                         capabilities of the Internet, we can deliver this content to our audience faster and
                                         more cost effectively than traditional print media and on-site training session, which
                                         is limited by publication schedules and physical distribution. Many of our articles are
                                         written by industry-leading medical experts and are peer-reviewed by other physicians
                                         to insure they meet the high standards of medical integrity. Our experienced editorial
                                         staff has strong medical background, most of whom graduated from well-known medical universities
                                         and have more than ten-year work experience in relevant areas. Our medical specialty
                                         areas are carefully designed and their features are regularly updated by our editorial
                                         and quality control staff.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 104; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify; padding-right: 0"><I>Well
                                         Organized and Easy-To-Use Websites and Apps</I>: We design our websites and mobile Apps
                                         to meet the needs of our users in a personalized and easy-to-use manner. We organize
                                         our training products on MDMOOC online platform by healthcare specialty area. We also
                                         provide functions of Practice Improvement (PI), Community of Practice Share (COPS), and
                                         Continuing Professional Development (CPD) to satisfy different needs of the healthcare
                                         professionals. We create different Sunshine Health Forums for different categories of
                                         diseases and healthcare matters. Currently, we have more than 150 forums, covering healthcare
                                         topics such as the kidney disease, the liver disease, and diabetes. In addition to high-quality
                                         medical content, our consumer sites provide community features and interactive programs
                                         to encourage academic discussion and communication as well as information and experience
                                         sharing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cost-Effective
    Access to Our Audience</I>: Our users registration profiles give us the ability to segment our audience based on their medical
    specialty or healthcare interest. In addition, our proprietary users&rsquo; profile and traffic database enables us to provide
    advertising and sponsored content. MDMOOC online platform also offers online programs that complement many of the pharmaceutical
    enterprises&rsquo; offline promotional and educational efforts. For example, we expand the audience of sponsored medical conferences
    by making next-day summaries of the proceedings available to users who were unable to attend. In addition, we believe Sunshine
    Health Forums create an attractive e-commerce environment for health-related products, i.e., educational healthcare books,
    due to the size of the audience and the focus on relevant healthcare topics.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify; padding-right: 0"><I>High-Level
                                         and Small-Class Teaching Onsite Training Courses. </I>Along with online training courses
                                         and education programs, we also organize onsite education and training sessions. To ensure
                                         the quality and results of the onsite training programs, we usually limit the size of
                                         our training session to a relatively small one and build up certain criteria for the
                                         applicants. Also, the good long-term working relationship with well-known healthcare
                                         professionals enable us to generate outstanding training content and create high-quality
                                         education experience. For Example, in the EWMA-certified wound-management collaboration
                                         training programs, we work with healthcare experts and institutions to do the lecturing.
                                         Our lecturers include Dr. Yixin Zhang, professor and doctoral supervisor of Shanghai
                                         Jiaotong University and vice president of Asian Pacific Federation of Societies for Reconstructive
                                         Microsurgery, Guozhong Lv, Dr. Yan Liu, vice president of Burn Injury Department of Chinese
                                         Medical Association, and Dr. Chunmeng Shi, professor and doctoral supervisor of Army
                                         Medical University. We plan to hold an aggregate of six (6) training programs. Each one
                                         of them will accept no more than twenty (20) applicants who shall hold academic credential
                                         above undergraduate. We also require all applicants to have more than six-year working
                                         experience in the field of wound repair.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt"><B>Risks and Challenges</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our prospects should
be considered in light of the risks, uncertainties, expenses and difficulties frequently encountered by similar companies. Our
ability to realize our business objectives and execute our strategies is subject to risks and uncertainties, including, among
others, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt; text-indent: 36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">our
                                         inability to effectively manage our rapid growth, which could place significant strain
                                         on our management personnel, systems and resources;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">adverse
                                         changes in the economic environment either in China or globally;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">intense
                                         competition from onshore and offshore healthcare information, education, and training
                                         services companies;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    reliance on a relatively small number of major customers, including a customer accounted for 38% and 55% of our total revenue
    for fiscal years 2018 and 2017, respectively;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">our
                                         ability to anticipate and develop new services and enhance existing services to keep
                                         pace with rapid changes in technology;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify">our
                                         ability to attract new customers for our services and/or growing revenues from existing
                                         customers;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 105; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">risks
                                         associated with having a long selling and implementation cycle for our services that
                                         require us to make significant resource commitments prior to realizing revenues for those
                                         services;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">increases
                                         in wages for professionals in China;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the
                                         international nature of our business;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">risks
                                         related to unauthorized disclosure of sensitive and confidential information;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">risks
                                         related to intellectual property infringement claims;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">risks
                                         related to material weakness in our internal control over financial reporting such that
                                         if we fail to develop and maintain an effective system of internal control over financial
                                         reporting, we may be unable to accurately report our financial results or prevent fraud;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">business
                                         interruptions resulting from occurrence of natural disasters, health epidemics and other
                                         outbreaks or events;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">fluctuation
                                         in the value of the Renminbi and other currencies;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">disruptions
                                         in disruptive technologies or significant failure in our technology platform that could
                                         harm our service;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">vulnerabilities
                                         to security risks that could disrupt our services and adversely affect our operations;
                                         and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">possibilities
                                         to expose us to malpractice liability and other liability inherent in healthcare delivery.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 41.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we face
other risks and uncertainties that may materially affect our business prospect, financial condition, and operations. You should
consider the risks discussed in &ldquo;Risk Factors&rdquo; and elsewhere in this prospectus before investing in our Class A Ordinary
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0"><B>Our Business Model</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We provide healthcare
information, education, and training services to the healthcare professionals under our &ldquo;MDMOOC&rdquo; brand via MDMOOC
website, mobile Apps, and Wechat subscription account (together, the &ldquo;MDMOOC online platform&rdquo;), and onsite education
activities. We also offer healthcare educational content to the public via our online &ldquo;Sunshine Health Forums&rdquo;. Our
MDMOOC online platform serves as an interactive and reliable healthcare information, education, and training community and offers
online interactive function that enables our end-users to both discover reliable content and share their own healthcare study
insights by uploading their own courseware or study notes to our platform, which incentivizes more visits and views. Certain open
courses on MDMOOC online platform provide the quiz function for our end-users to see if they obtain correct understanding to the
key point of such courses. We also highlight the knowledge points that are important but would be ignored by our end-users. Thus,
the end-users could have a relatively complete learning process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business model
has unique value propositions for its constituents. With reliable content and the function of Community of Practice Share (COPS)
on our platform, users seeking medical precedents or information can obtain comprehensive medical information on the medical area
most related to them by interacting among one another through our community functions. Also, once they complete certain online
courses study, our platform will issue them MDMOOC certificates with verified continuing professional credits if they are taking
one of the courses provided by our Continuing Professional Development (CPD) function. In addition, after end-users complete their
online training, our online platform encourages them to share their study experience through our Course Uploading, rating, and
review systems. This further enriches our content and drives more interaction within our community.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 106; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Our pharmaceutical
enterprises customers and NFPs customers with demands of course production and training organization benefit from our business
model when more end-users are drawn to our MDMOOC online platform because of our reliable self-developed content offered in rich
media formats and our reputation among healthcare professionals who are seeking healthcare service improvements. The original
content in our platform, as well as the ratings and reviews on the content, can effectively and efficiently incentivize our content
production to offer high-quality training programs. Our in-house editorial staff and research and development team responsible
for content generation and management can further increase their ability to create better courses in the most suitable forms to
the healthcare professionals working in different fields. Our online Community of Practice Share (COPS) function, in return, provides
data insights on current user landscape and learning trends that allow our customers to get a better understanding to the healthcare
industry in the practical aspect.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As corporate and NFP
customers, end-users, and course production teams and providers are inexorably connected through our content, Community of Practice
Share (COPS), and online course uploading function, our business model forms an overall virtuous cycle that fuels its continued
growth and expansion. In essence, end-users are attracted to our platform by our content and services offered on our platform,
while corporate customers and NFP customers are attracted to our platform by the access to the largest online healthcare professionals&rsquo;
community and the high-quality online programs and courses. As the number of end-users grows, more corporate customers and NFP
customers will want to join and get access to our platform. More corporate customers and NFP customers will then lead to more
tailored content production, as well as more targeted content, and ultimately attract more end-users.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0"><B><I>MDMOOC-Healthcare Information, Education,
and Training for Professionals</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0"><B>Our MDMOOC Online Platform</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our MDMOOC online
platform is realized through various products, including MDMOOC mobile App, MOOC Medical Wechat subscription account, and MDMOOC
website, where users can access our rich media content and engaging Community of Practice Share (COPS).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2017 and 2018,
our monthly UVs of MDMOOC website reached 16,500 and 22,300. Our mobile MAUs reached 32,000 and 64,000 in 2017 and 2018, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-indent: 36pt"><B>MOOC Mobile App</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our MOOC Medical mobile
app serves as a one-stop destination where we offer users relevant healthcare knowledge and study insights, assist them along
their journey to obtain the knowledge and information they are searching for in a supportive community, and allow them to review
and test their understanding of courses by participating in the Practice Improvement (PI) system. We designed the interface of
our platform in simple white and sky blue, signaling health and learning respectively, and creating a soft and welcoming texture
to our platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">When users open our
MOOC Medical mobile app, they will immediately see our featured banners that display academic courses, open classes, case library,
and continuing professional development channel. As users scroll down, courses that are most popular among the healthcare professionals,
courses recommended by our medical editors, and the latest healthcare news appear. Users can also explore various medical courses
by medical specialty and subject areas if they click &ldquo;courses&rdquo; at the bottom of the interface.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 107; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-indent: 36pt">Below are screenshots of our
mobile app main entrance interface:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_04.jpg" ALT="" STYLE="width: 250px; height: 259px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Community of Practice
Share, or COPS, an online and live clinical experience sharing platform that creates the most effective discussion in a particular
healthcare domain or medical area due to the common interests of the users, is where users communicate with other peers and get
detailed information written by users who have taken or generated healthcare courses and featured informational articles by practicing
medical professionals on the platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The screenshots below
illustrate the content in COPS:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_05.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Opening Course is
a collection of video courses of various medical fields and topics. The courses are often presented by medical experts. Most of
the courses are free to users.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 108; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The screenshots below
illustrate the content in the Opening Course:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_06.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>MDMOOC Wechat Subscription
Account</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Wechat Subscription
Account provides a new means to propagate information for the media and individuals, building better communication with readers
with a better management. It also facilitates discovery and consumption of services and products. It is useful for discovery and
quick actions, and complements full-function native apps by increasing their traffic.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our MDMOOC Wechat
subscription account features similar interfaces and functions as our mobile app. It serves as additional access points to our
platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-align: justify; text-indent: 0.5in"><B>MDMOOC
Website</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Users can access online
healthcare information, education and training content and our services through our website MDMOOC.org. In 2018, MDMOOC website
recorded an aggregate of 2 million users&rsquo; visits. As more internet users shift to mobile ends, our website mainly serves
a comprehensive knowledge base targeting users who are in the process of researching for specific medical courses, articles, or
news.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 109; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Below are screenshots
of MDMOOC.org website:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_07.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We designed our professional
website to meet the needs of our users in a personalized and easy-to-use manner. We currently organize our professional information
by the following medical specialty and subject areas, including but not limited to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Internal
                                         Medicine Department: cardiology, respiratory medicine, nephrology, neurology, gastroenterology,
                                         hematology, endocrinology</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Surgery
                                         Department: general surgical, neurosurgery, breast surgery, urology, hepatobiliary surgery,
                                         cardiothoracic surgery, plastic surgery</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Oncology
                                         Department: general oncology, surgical radiotherapy, oncology</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Gynaecology
                                         Department: Gynecologic endocrine</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Pediatrics
                                         Department: respiratory medicine, nephrology, neurology, gastroenterology, hematology,
                                         endocrinology</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Oral
                                         Cavity Department: oral and maxillofacial surgery, Restorative Dentistry, orthodontics</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Skin
                                         Beauty Department: Pharmacology, aesthetic health care</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Mental
                                         Psychology Department: depression, sensory disturbance, schizophrenia</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We plan to expand
into new medical specialty areas that appeal to our current users base and attract new users. Our objective is to be the category
leader in each of our medical specialty areas by delivering the highest quality specialty-based content and selectively acquiring
other high-quality medical specialty Websites. As part of this strategy, we will (1) work with more medical associations to produce
programs and courses to meet the need of healthcare professionals; (2) expand our R&amp;D team and provide more support to our
self-developed courses; (3) cooperate with international continuing medical education providers to improve the quality and diversity
of our courses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 110; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0"><B>Our MDMOOC Onsite Activities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to our
online presence, we also hold onsite activities to provide healthcare information and education services from time to time under
our &ldquo;MDMOOC&rdquo; brand. Our onsite activities not only provide our healthcare professionals with medical knowledge and
clinical skills but also another career path which enhance their professional competitiveness. Also, many of our onsite activities
were accompanied with live steaming, which will be uploaded to our MDMOOC online platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For instance, in January
2019, we launched EWMA-certified (defined as below) wound-management collaboration training programs, covering the topics including
but not limited to basic concepts of acute and chronic wounds, management of different levels of surgical and non-surgical wounds,
the construction of different levels of wound centers, and medical staff collaboration in the process of wound management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cooperate with
Beijing Chronic Disease Prevention and Health Education Research Association and Professor Yixin Zhang from the Ninth People&rsquo;s
Hospital of Shanghai Jiao Tong University School of Medicine to create courses titled &ldquo;Essential Course for Wound Care Management&rdquo;
and &ldquo;Advanced Course for Surgical Wound Treatment&rdquo;. These courses have been certified and authorized by the European
Wound Management Association (EWMA), a European not-for-profit umbrella organization, linking national wound management organizations,
individuals and groups with interest in wound care. We plan to hold four (4) training programs for Essential Course for Wound
Care Management and two (2) training programs for Advanced Course for Surgical Wound Treatment. Each program will accept no more
than twenty (20) applicants who shall hold academic credential above undergraduate. We also require all applicants to have more
than six-year working experience in the field of wound repair. We will issue a certificate to each of the applicant upon completion
of the training as their proof of achievement and ability in the wound management and treatment. We believe that after attending
these programs, our participants would acquire the basic capacity to lead a would-management department in a hospital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Sunshine Health Forums-Healthcare
Information and Education for the Public</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We developed Sunshine
Health Forum, a Wechat subscription account, Sunshine Health Forum mobile app, and Sunshine Health Forum.org, the official website
providing links to download the mobile app for Android and IOS system and portals to leading we-media we have strategic relationships
to improve the efficiency and effectiveness of the information acquisition for our users. The official website and mobile app
are organized by different types of medical disease. We establish one school for each disease to make it easier for the public
to obtain information they would like to know. As of the date of this prospectus, we have opened nearly 150 forums, with more
than an aggregate of 4.95 million subscriptions and an aggregate of 1.25 billion click-through. We have established our partnership
with the following we-media platforms, including but not limited Toutiao.com, WeChat official accounts platforms, Yidianzixun.com,
Douyin.com, CN-Healthcare.com, iQiyi, Youku, and Huoshan.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Recent Development</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Commencing from the fourth
quarter of 2018, in addition to providing trainings and education through our platforms, we have been engaged by certain customers
on project basis to establish individual websites to provide training and knowledge of certain drug treatment, most of which are
cancer-related treatment, to healthcare professionals and patients. Such websites are established to facilitate qualified patients
to obtain free drug treatment from NFPs till the free drugs are completely delivered and distributed as planned. For each website,
we also plug in features to manage the project including reviewing patients&rsquo; applications, tracking their usage of drugs
and collecting related information. Those customers are existing customers of us. They provide those drugs sponsored by pharmaceutical
companies without charge to qualified patients and we charge those customers on our services in connection with the websites and
related training and management.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 72pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 111; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 72pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 0; text-align: justify"><B>Our Content</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We strive to provide
our users with the broad range of high-quality and engaging original content on different healthcare areas. We believe that reliable
and well-crafted content provides the necessary information that users seek on our platform and improve the medical professional
community. Our content is available in a variety of rich media formats on our online platform, generated by users of all levels
of experience and medical professionals, including short-form videos, and featured articles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><I>Short-form
                                         Videos</I> -- We believe we have established a proven approach to producing popular,
                                         original, short-form videos and have continually released popular original titles and
                                         series, covering different popular healthcare topics, such as Standardized Diagnosis
                                         and Treatment of Skin Infections in Primary Practice, Emergency Experience Anti-infection
                                         Treatment, and Knee Osteoarthritis Treatment. Our experienced and large pool of in-house
                                         editors incubate original ideas and present them in video format and collaborate closely
                                         with medical professionals in the content creation process.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 72pt; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><I>Featured
                                         Articles</I> -- Our in-house content team and resources of well-known healthcare professionals
                                         bring our assessment and analysis of the latest medical theories and information to our
                                         users through featured articles. We closely work with healthcare professionals to ensure
                                         our high-quality science content. With our self-generated resource library of healthcare
                                         professionals, we can easily reach out to the relevant experts when an online course
                                         focusing on certain medical area is required. We currently have 200 medical editors that
                                         are responsible for the quality of our daily post of articles for Sunshine Health Forum.
                                         In addition to healthcare content, our articles cover a wide spectrum of user interests,
                                         ranging from career development to continuing education. Users can conveniently access
                                         these informational articles via on our MOOC Medical mobile app. Also,</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 72pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><I>Integration
                                         with Major Social Media Networks in China</I> -- We distribute our content through all
                                         major social network and media platforms in China, encouraging followers and readers
                                         to share and repost our content we generate via Sunshine Health Forum, which amplifies
                                         our brand image and enables us to reach a larger audience. The average daily views of
                                         all our social media content on third-party platforms was over 2 million. Our comprehensive
                                         and rich content provides us with continuous monetization opportunities. Through advertisements
                                         embedded within the content on our platform and social network networks, we get $1with
                                         every view of our articles.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 18pt; text-align: justify; text-indent: 18pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 18pt; text-align: justify; text-indent: 18pt">MDMOOC
offers two distinct types of high-quality content to users:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify">Original,
                                         exclusive and proprietary content.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our original content
is written exclusively for MDMOOC by medical experts, many of whom are nationally renowned in their specialties. This content
includes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><I>Practice
                                         Improvement (PI)</I> &ndash; a problem-based and case-based form of healthcare course,
                                         which integrates state-of-the-art treatment information and clinical cases for particular
                                         diseases into interactive practice modules.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><I>Community
                                         of Practice Share (COPS)</I> -- an online and live clinical experience sharing platform
                                         that creates the most effective discussion in a particular healthcare domain or medical
                                         area due to the common interests of the users. Through the process of information and
                                         experiences sharing, users will learn from each other and have opportunities to their
                                         knowledge and awareness of certain healthcare area.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><I>Continuing
                                         Professional Development (CPD)</I> &ndash; discussions and articles focusing on the future
                                         development and the differences between Continuing Medical Education (CME) and Continuing
                                         Professional Development (CPD), also includes general information of physician competency
                                         framework and Meta-analysis.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 112; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><I>Opening
                                         Courses -- </I>an online healthcare video collection, including authoritative evaluations
                                         of significant new changes in therapies and highlights of selected presentations at major
                                         medical conferences; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.25pt 0pt 72pt; text-align: justify"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><I>Medical
                                         Journals Hypothesis -- </I>peer-reviewed, electronic medical journals and hypothesis
                                         covering, cardiology, oncology, psychiatry, orthopedics, diabetes mellitus, amyotrophy,
                                         hepatology, gastroenterology.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: justify">High-quality
                                         case library</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">MDMOOC provides its
users access to a clinical case-share library via Internet and mobile application. Our case library has more than 20,000 clinical
cases elaborating general patient data, the diagnosis after admission, and academic discussions. Our users can easily locate the
cases most related to them by searching the keywords and selecting the medical fields while they encounter similar medical phenomenon
in their practice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our User Services</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We offer a number
of services that complement our high-quality content offerings and make MDMOOC a preferred professional destination site.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Continuing Medical
Education. </I>Pursuant to the Provisions on Continuing Medical Education issued by PRC Health Department, physicians and selected
other medical professionals are required to certify annually that they have accumulated a minimum number of continuing medical
education hours to maintain licensure. MDMOOC offers our professional users what we believe is one of the largest online libraries
of continuing medical education programs. Our extensive continuing medical education programs are produced in association with
entities accredited by the PRC Health Department, such as Chinese Medical Doctor Association and Chinese Journal of Continuing
Medical Education. From the convenience of their home or office computer and mobile application, our professional users can obtain
continuing medical education credits by accessing a variety of accredited editorial resources and programs including online journal
articles, medical conferences, and open classes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Physician self-uploaded
courseware</I>. We offer our users registered as physicians, nurses, medical technologists, and medical students the opportunity
to create courseware for their medical practices and upload them to MDMOOC that can be accessed by other healthcare professionals.
We believe these courseware sharing function will keep MDMOOC&rsquo;s high-quality medical information at the center of the communication
between healthcare professionals, and keep the healthcare professionals at the center of the healthcare dialogue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Through our warm and
supportive social community, users are able to improve their healthcare skills through the communications with each other. Moreover,
filled with user experience and active healthcare experts interaction, our platform enables our users to gain personal psychological
support during the learning process, thereby further increasing the reliability of our platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Registered Users</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To utilize all of
the features of MDMOOC online platforms, users must register. This information enables us to deliver targeted medical content
based on our users&rsquo; registration profiles. MDMOOC website and mobile app share the same login information of one user. Our
Wechat subscription account does not require registration. As of June 30, 2019, we have over 390,000 registered medical professionals
worldwide, an increase of 53.8% from December 31, 2018 and 100% from December 31, 2017. In 2018, MDMOOC website recorded an aggregate
of 2 million users&rsquo; visits reached.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 113; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To encourage initial
use, our consumer sites will allow visitors to access selected features without registering as users. Visitors, however, will
have to register as users to have access to all the features of our consumer sites, including the interactive programs such as
health diaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Registration information
will also enable us to deliver targeted advertising messages to the specific audience profile our customers seek to reach either
through MDMOOC or our consumer sites, or both. For example, through MDMOOC, an oncologist in Beijing, China can be targeted with
different messages than a cardiologist in Shanghai, China. The same targeting capabilities will be offered on Sunshine Health
Forum.org, where a consumer interested in diabetes can be targeted with different messages than a consumer interested in cancer.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Editorial, Design
And Production</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our editorial staff
has strong medical background, most of whom graduated from well-known medical universities, such as Shanxi Medical University,
Beijing University of Chinese Medicine, Donghua University, and have more than ten-year work experience in relevant areas. As
of June 2019, our editorial, design and production staff consisted of 21 professionals who are all experienced medical editors,
writers and producers. We intend to significantly increase our number of editors as we add additional medical specialty areas.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have an easy-to-use
interface that incorporates original and proprietary content written by medical experts with an extensive library of licensed
content and medical databases. We seek to be the premier online information resource in each of our medical specialty areas. To
support this effort, we cover major medical conferences in many specialties and plan to attend over 50 different conferences in
China, with our editors and medical experts summarizing and reporting on the breaking medical research and news delivered at these
events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Also, we communicate
with our healthcare experts on a daily basis, which helps us timely receive their new ideas and thoughts from their clinical practice
and academic study.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our Customers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Our customers are enterprises,
non-for-profit organizations (&ldquo;NFP&rdquo;), and medical journals, primarily located in China. Our terminal customers and
end-users are healthcare professionals, nurses, doctors and other healthcare workers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Our enterprise customers
are pharmaceutical enterprises, healthcare enterprises engaged in researches and develops pharmaceuticals, vaccines, and consumer
healthcare products, pharmaceutical enterprises that engages in drug innovation, manufacturing, and marketing, and medical journals.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Our NFP customers,
most of whom are sponsored by pharmaceutical enterprises for the production of the training courses for specific healthcare topics,
are charity organizations, national public foundations, and nonprofit national association, which are governed by provincial and
regional government agencies and commissions. Government agencies include the National Health and Family Planning Commission (NHFPC)
and Ministry of Civil Affairs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">For the fiscal year
ended December 31, 2017, we generated revenue from a total of 70 customers, of which 14 customers are NFP and 56 customers are
pharmaceutical enterprises. For the fiscal year ended December 31, 2018, we generated revenue from a total of 71 customers, of
which 15 are NFP and 56 are pharmaceutical enterprises. For the six months ended June 30, 2019, we generated revenue from a total
of 50 customers, of which 16 customers were NFP and 34 customers were pharmaceutical enterprises.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">We generate our revenues
from a relatively small number of customers. For the fiscal years ended December 31, 2018 and 2017, our pharmaceutical enterprise
customers accounted for 60.1% and 80.7% of our total revenues, respectively. For the fiscal years ended December 31, 2018 and
2017, our NFP customers accounted for 39.9% and 19.3% of our total revenues, respectively. For the six months ended June 30, 2019
and 2018, our pharmaceutical enterprise customers accounted for 33.6% and 78.2% of our total revenues, respectively. For the six
months ended June 30, 2019 and 2018, our NFP customers accounted for 66.4% and 21.8% of our total revenues, respectively. The
sharp decrease of revenues generated by pharmaceutical enterprises customers as a percentage of total revenue was mainly because
the pharmaceutical enterprises placed more orders through NFP to attract more medical experts and professionals in the name of
NFP.</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We plan to expand
our market coverage to international markets to service customers in different countries. We also intend to provide our solutions
and services to corporate and government customers in the markets we intend to target.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 114; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><B>Branding and Marketing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">We believe that our
rich content and satisfactory user experience have contributed to the expansion of our user base and the increase in user engagement,
leading to a strong&nbsp;word-of-mouth&nbsp;effect that strengthens our brand awareness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">We promote our platform
and enhance brand awareness through a variety of online and offline marketing and brand promotion activities. We cooperate with
third-party apps, popular search engines and social media platforms for online and mobile marketing. These online apps and websites
promote MDMOOC and Sunshine Health Forum to those website users who are potentially interested in our contents. MDMOOC and Sunshine
Health Forum gain a substantial growth of exposures in public and amounts of public subscribers under such precise measure of
online audience delivery. We also conduct onsite marketing primarily in the form of donation activities with hospitals to improve
our brand awareness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Infrastructure, Operations and Technology</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">The success of our
business is supported by our strong technological capabilities that enable us to deliver superior user experience and increase
our operational efficiency. Our technology team, coupled with the large volume of data generated and collected on our platform
each day, have created opportunities for continued improvements in our technology capabilities, empowering reliability, scalability
and flexibility.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> As of February 6, 2020,
we had a technology team with approximately 16 engineers, including those focusing on technology development to support every
aspect of our business operation and those focusing on underlying data and technology maintenance. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; "><I>Big Data</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">We build proprietary
big data analysis framework on our platform to improve operating efficiencies and user satisfaction. We leverage big data analytics
and artificial intelligence technologies to enhance the accuracy of user behavior predictions and user profiling and optimize
our operation, targeted content and user experience.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">The seamless collaboration
among our technology and operational teams, together with our big data analytics capability, result in improved operational efficiency
for our company and our healthcare training service providers. Our data engineers are involved in all critical operational areas.
They have thorough understanding of the computational needs from different business segments, and are therefore capable of providing
technological support to address diversified needs in operating our platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt; text-align: justify; text-indent: 23.75pt; "><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt; text-align: justify; text-indent: 23.75pt; "><I>Security
and Data Privacy</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">We are committed
to protecting information of all participants on our platform. We collect basic personal information and data, such as name, phone
numbers, professional certificate code, and personal address, only with users&rsquo; prior consent. We do not provide sensitive
user data to our medical company customers, NFP customers or other third-parties. In accordance with ISO27001 requirements, we
establish, implement, maintain and continuously improve the information security management system.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 115; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">We have a security
team of engineers and technicians dedicated to protecting the security of our platform. Our&nbsp;back-end&nbsp;proprietary security
system is capable of handling malicious attacks each day to safeguard the security of our platform and to protect the privacy
of our users and healthcare training service providers. We back up our user and certain other critical forms of data on a daily
basis in separate and various secured data&nbsp;back-up&nbsp;systems to minimize the risk of data lost. We encrypt confidential
personal information we gather from our platform. To further ensure data security and avoid data leakage, we have established
internal protocols under which we grant classified access to confidential personal data to limited employees with strictly defined
and layered access authority. We strictly control and manage the use of data within our various teams.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt; text-align: justify; text-indent: 23.75pt; "><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt; text-align: justify; text-indent: 23.75pt; "><I>Cloud
Services</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">We have developed
a secure, efficient and cost-effective cloud-based core system to operate our business. Cloud-based technology allows us to process
large amount of complex data&nbsp;in-house,&nbsp;which significantly reduces cost and improves operation efficiency. We utilize
the system of a leading enterprise cloud service provider, Alibaba Cloud, in China so that we enjoy the instant scalability and
robustness of cloud-based services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><B>Risk Management and Internal Control</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">We have adopted and
implemented various policies and procedures to ensure rigorous risk management and internal control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">We are committed
to complying with relevant laws and regulations on online content. We have invested significant resources in developing advanced
content monitoring technologies, policies and procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">We maintain content
management and review procedures to monitor&nbsp;short-form videos, featured articles, chat messages and other content on our
platform to ensure that we are able to promptly identify content that may be deemed to be inappropriate, without scientific support
or proof, in violation of laws, regulations and government policies or infringing upon third-party rights. When any inappropriate
or illegal content is identified, we promptly remove the content. Further actions may also be taken to hold relevant content creators
accountable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt; ">We have an automated
monitoring mechanism that serves as the first layer of defense in our content review system. This system automatically flags and
screens out content that duplicates other content, or involve in appropriate or illegal audio, video, comments or texts. Once
the content is processed by the automated monitoring mechanism, our system then extracts the content and sends to our manual content
screening team, our second layer of defense, for further review. We have a dedicated team reviewing and handling content on our
platform for compliance with applicable laws and regulations, and ensuring the quality of our content.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Research and Development</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Research and Development
(&ldquo;R&amp;D&rdquo;) is an integral part of our continued growth. Our R&amp;D consists of product development and technology
support. Our product development team is focused on market research and product development. We develop and update our products
and services based on market conditions and government policies. Our product development team closely monitors the market to adjust
and upgrade our existing educational products, and designs new products based on customers&rsquo; requests, Our technology team
has experience in the development, design, operation and maintenance of platform products, servers and mobile apps, responsible
for monitoring the performance of our websites, mobile apps and technology infrastructure to enable us to respond quickly to potential
problems, updating and exploring new and advanced technologies and integrating them into our existing and new services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 116; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of
this prospectus, we have 25 researchers in our product development team and 13 developers in our technology support team. Most
of our R&amp;D members have no less than 5 years of working experience and 30% R&amp;D staff have master or doctor degree.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our product development
team is focused on market research and product development. We develop and update our products and services based on market conditions
and government policies. Our product development team closely monitors the market to adjust and upgrade our existing educational
products, and designs new products based on customers&rsquo; requests. We a analysis the information about concepts and forms
of medical education by searching medical articles from medical journals, and attending medical conferences such as Global Alliance
for Medical Education, or GAME annual meeting, and integrate the information into our programs. Also, we work with healthcare
professionals to develop our programs. When starting to create any programs, we make face to face or telephone surveys and get
the learning needs from healthcare professionals, such as medical knowledge, clinical skills, case sharing, and the desire to
communicate with peers. We incorporate such needs into our program design. When developing our course module, the healthcare professionals,
after review and test, may give us advice on the module to match the learning and thinking habits of physicians and allied healthcare
professionals. After we complete the course production, we invite these professionals to do final review on the content to assure
its correctness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our technology team
are experienced in the development, design, operation and maintenance of platform products, servers and mobile apps. They are
responsible for monitoring the performance of our online platform, updating and exploring new and advanced technologies and integrating
them into our existing and new services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During fiscal years
2018 and 2017, our R&amp;D expense were approximately $1,447,949 and $943,253, respectively, representing 11.3% and 9.6% of our
total revenues for fiscal years 2018 and 2017, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Intellectual Property Rights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The PRC has domestic
laws for the protection of rights in copyrights, trademarks and trade secrets. The PRC is also a signatory to all of the world&rsquo;s
major intellectual property conventions, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Convention establishing the World Intellectual Property Organization
    (June 3, 1980);</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Paris Convention for the Protection of Industrial Property (March
    19, 1985);</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Patent Cooperation Treaty (January 1, 1994); and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Agreement on Trade-Related Aspects of Intellectual Property
    Rights (November 11, 2001).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify; text-indent: -18pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The PRC Trademark
Law, adopted in 1982 and was most recently amended on April 23, 2019 and will become effective on November 1, 2019, with its implementation
rules adopted in 2014, protects registered trademarks. The Trademark Office of the State Administration of Industry and Commerce
of the PRC, handles trademark registrations and grants trademark registrations for a term of ten years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our intellectual property
rights are important to our business. We rely on a combination of trade secrets, confidentiality procedures and contractual provisions
to protect our intellectual property. We also rely on and protect unpatented proprietary expertise, recipes and formulations,
continuing innovation and other trade secrets to develop and maintain our competitive position. We enter into confidentiality
agreements with most of our employees and consultants, and control access to and distribution of our documentation and other licensed
information. Despite these precautions, it may be possible for a third party to copy or otherwise obtain and use our technology
without authorization, or to develop similar technology independently. Since the Chinese legal system in general, and the intellectual
property regime in particular, is relatively weak, it is often difficult to enforce intellectual property rights in China. Policing
unauthorized use of our technology is difficult and the steps we take may not prevent misappropriation or infringement of our
proprietary technology. In addition, litigation may be necessary in the future to enforce our intellectual property rights, to
protect our trade secrets or to determine the validity and scope of the proprietary rights of others, which could result in substantial
costs and diversion of our resources and could have a material adverse effect on our business, results of operations and financial
condition. We require our employees to enter into non-disclosure agreements to limit access to and distribution of our proprietary
and confidential information. These agreements generally provide that any confidential or proprietary information developed by
us or on our behalf must be kept confidential. These agreements also provide that any confidential or proprietary information
disclosed to third parties in the course of our business must be kept confidential by such third parties. In the event of trademark
infringement, the State Administration for Industry and Commerce has the authority to fine the infringer and to confiscate or
destroy the infringing products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 117; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our primary trademark
portfolio consists of 5 registered trademarks. Our trademarks are valuable assets that reinforce the brand and our consumers&rsquo;
favorable perception of our products. The current registrations of these trademarks are effective for varying periods of time
and may be renewed periodically, provided that we, as the registered owner, comply with all applicable renewal requirements including,
where necessary, the continued use of the trademarks in connection with similar goods. In addition to trademark protection, we
own 4 URL designations and domain names, including www.mdmooc.org, www.mdmooc.com, www.zhongxun.online, and ygjkclass.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">We have registered for the following trademarks:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">No.</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Current
    Owner</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">Mark</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Registration
    Number</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Status</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Class/Description</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Expiration
    Date</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">Country
    of Registration</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; width: 2%; text-align: center"><FONT STYLE="font-size: 10pt">1</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 10%"><FONT STYLE="font-size: 10pt">Zhongchao Medical Technology <FONT STYLE="font-family: Times New Roman, Times, Serif">(</FONT>Shanghai)
    Corp. Ltd</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom; width: 10%"><IMG SRC="image_09.jpg" ALT=""></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 10%; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">21587105</P></TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 10%; text-align: center"><FONT STYLE="font-size: 10pt">Approved</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 31%"><FONT STYLE="font-size: 10pt">Fifth category: Pharmaceutical preparations; Vaccines;
    Analgesics; Medical drugs; Medical tea; Medical ointments; Supplements; Medical nutrients; Glucose used as medical food additives;
    Medical nutritional food (cut-off)</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 9%; text-align: center"><FONT STYLE="font-size: 10pt">2027.11.27</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 9%; text-align: center"><FONT STYLE="font-size: 10pt">China</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">2</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Zhongchao Medical Technology <FONT STYLE="font-family: Times New Roman, Times, Serif">(</FONT>Shanghai)
    Corp. Ltd</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><IMG SRC="image_10.jpg" ALT=""></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">18418154</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Approved</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Category 9: Recorded computer programs (programs); computer
    software (recorded); recorded computer operating procedures; downloadable computer application software; electronic publications
    (downloadable software); computer programs (downloadable software); measuring devices; dosimeters; measuring instruments;
    inspection mirrors (cut-off)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">2026.12.27</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">China</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">3</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Zhongchao Medical Technology <FONT STYLE="font-family: Times New Roman, Times, Serif">(</FONT>Shanghai)
    Corp. Ltd</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><IMG SRC="image_11.jpg" ALT=""></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">19719148</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Approved</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Category 38:Teleconference Services; Providing Internet Chat
    Room; Digital File Transfer; Video Conference Services; Providing Online Forum; Data Stream Transfer; Information Transfer;
    Television Broadcasting; Computer Aided Information and Image Transfer (Deadline)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">2027.06.06</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">China</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">4</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Zhongchao Medical Technology <FONT STYLE="font-family: Times New Roman, Times, Serif">(</FONT>Shanghai)
    Corp. Ltd</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><IMG SRC="image_12.jpg" ALT=""></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">21587230</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Approved</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Category 44: health care; medical assistance; rental of medical
    equipment; treatment services; health counseling; dietary and nutritional guidance; dispensing; art therapy; massage; beauty
    services (deadline)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">2027.11.27</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">China</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">5</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Zhongchao Medical Technology (Shanghai) Corp. Ltd</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><IMG SRC="image_13.jpg" ALT=""></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">21587258</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Approved</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Category 5: Pharmaceutical preparations; Vaccines; Analgesics;
    Medical drugs; Medical tea; Medical ointments (cut-off)</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">2028.01.20</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">China</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.25in"></P>

<!-- Field: Page; Sequence: 118; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">The following is a list of our patent applications:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 2%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">No.</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 15%; border-bottom: black 1.5pt solid"><FONT STYLE="font-size: 10pt">Current Owner</FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 15%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Patent Name</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 15%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Application Number</FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 8%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Status</FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 18%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Number of Patent
    Application</FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 10%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Registration Date</FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 10%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Country of Registration</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">1</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Zhongchao Medical Technology (Shanghai) Corp. Ltd</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Search-result optimization method, installation, computer equipment
    and storage media</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">201910274403.8</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">Pending</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">200942</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">May 31, 2019</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">China</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">The following is a list of our copyrights
that have been approved:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 2%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">No.</FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 15%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Registration Number</FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 25%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Software Name and<BR>
    Version Number</FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 15%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Copyright Owner</FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 10%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Country of Registration</FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 15%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Publication&nbsp;<BR>
    Date</FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 12%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Registration Date</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">1</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">2015SR138679</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Clinical Thinking Training Platform Software of Zhongchao Medical
    Technology</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Zhongchao Medical Technology (Shanghai) Corp. Ltd</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">China</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">2015.04.30</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">2015.07.21</FONT></TD></TR>
<TR STYLE="">
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">2</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">2017SR020431</P></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Course Classification Query and Learning Application Software
    V1.0 of Zhongchao Medical Technology</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Zhongchao Medical Technology (Shanghai) Corp. Ltd</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">China</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">null</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">2017.01.20</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">3</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">2017SR018299</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">COPS Practice Community Sharing Course PC Platform Software
    of Zhongchao Medical Technology</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Zhongchao Medical Technology (Shanghai) Corp. Ltd</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">China</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">null</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">2017.01.19</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">4</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">2017SR023211</P></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Application Software for Tracking and Effectiveness Analysis
    of Course Learning Report of Zhongchao Medical Technology</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Zhongchao Medical Technology (Shanghai) Corp. Ltd</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">China</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">null</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">2017.01.23</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">5</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">2019SR0192049</P></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Multidisciplinary Continuing Medical Education Digital Software
    V2.1 of Zhongchao Medical Technology</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Zhongchao Medical Technology (Shanghai) Corp. Ltd</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">China</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">2018.8.12</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">2019.02.27</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 119; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Facilities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our headquarters and
executive offices are located in Shanghai, China and consist of approximately 223.7 square meter of office space under one lease
which will expire on January 4, 2020. In addition to our headquarters, we lease space in Beijing and Shanghai. Rent expenses amounted
to $195,326 and $171,788 for the years ended December 31, 2018 and 2017, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We lease all of our
facilities and do not own any real property. We intend to procure additional space as we add employees and expand geographically.
We believe our facilities are adequate and suitable for our current needs and that, should it be needed, suitable additional or
alternative space will be available to accommodate any such expansion of our operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; ">
    <TD STYLE="width: 15%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Facility</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 53%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Address</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 30%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Space (m<SUP>2</SUP>)</FONT></TD></TR>
<TR STYLE="">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Beijing Office</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Floor 8, Wangjing Building A, No. 9, &nbsp;Zhonghuan South Road,&nbsp;Chaoyang
    District, Beijing, China</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">712.6 square meters</FONT></TD></TR>
<TR STYLE="">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Shanghai Office</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Nanxi Creative Center, Suite 218, 841 Yan&rsquo;An Middle Road,
    Jing&rsquo;An District, Shanghai, China</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">223.7 square meters</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Employees</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of
this prospectus, we had a total of 90 full-time employees, of which 28 are in research and development, 16 are in sales and marketing,
33 are in technical and customer services, and 13 are in general and administration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have standard employment,
comprehensive confidentiality and non-compete agreements with our management and standard confidentiality and non-compete terms
with all other employees. As required by laws and regulations in China, we participate in various social security plans that are
organized by municipal and provincial governments, including pension insurance, medical insurance, unemployment insurance, maternity
insurance, job-related injury insurance and housing fund. We are required by PRC laws to make contributions to employee social
security plans at specified percentages of the salaries, bonuses and certain allowances of our employees, up to a maximum amount
specified by the local government from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that we
maintain a good working relationship with our employees, and we have not experienced any labor disputes. None of our employee
is represented by a labor union or covered by collective bargaining agreements. We have not experienced any work stoppages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Legal Proceedings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time
we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. We are not
currently a party to any legal proceedings that in the opinion of the management, if determined adversely to us, would have a
material adverse effect on our business, financial condition, operating results or cash flows. Regardless of the outcome, litigation
can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 120; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Government Regulation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Regulation Related to Online Services</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Regulation Related to Online Transmission of Audio-Visual
Programs</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Measures for the
Administration of Publication of Audio-Visual Programs through Internet or Other Information Network, or the Audio-Visual Measures,
promulgated by the SAPPRFT, on July 6, 2004 and put into effect on October 11, 2004, apply to the activities relating to the opening,
broadcasting, integration, transmission or download of audio-visual programs using internet or other information network. Under
the Audio-Visual Measures, to engage in the business of transmitting audio-visual programs, a license issued by the SAPPRFT is
required, and &ldquo;audio-visual programs (including audio-visual products of films and televisions)&rdquo; is defined under
the Audio-Visual Measures as the audio-visual programs consisting of movable pictures or sounds that can be listened to continuously,
which are shot and recorded using video cameras, recorders and other audio-visual equipment for producing programs. Foreign invested
enterprises are not allowed to carry out such business. On April 13, 2005, the State Council promulgated the Certain Decisions
on the Entry of the Non-state-owned Capital into the Cultural Industry. On July 6, 2005, five PRC governmental authorities, including
the SAPPRFT, jointly adopted the Several Opinions on Canvassing Foreign Investment into the Cultural Sector. According to these
regulations, non-state-owned capital and foreign investors are not allowed to engage in the business of transmitting audio-visual
programs through information networks. However, the Audio-Visual Measures was repealed according to the Administrative Provisions
on Audio-Visual Program Service through Special Network and Directed Transmission that was promulgated by the SAPPRFT on April
25, 2016, effective as of June 1, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To further regulate
the provision of audio-visual program services to the public via the internet, including through mobile networks, within the territory
of China, the SAPPRFT and the MIIT jointly promulgated the Administrative Provisions on Internet Audio-Visual Program Service,
or the Audio-Visual Program Provisions, on December 20, 2007, which came into effect on January 31, 2008 and was last amended
on August 28, 2015. Under the Audio-Visual Program Provisions, &ldquo;internet audio-visual program services&rdquo; is defined
as activities of producing, redacting and integrating audio-visual programs, providing them to the general public via internet,
and providing service for other people to upload and transmit audio-visual programs, and providers of internet audio-visual program
services are required to obtain a License for Online Transmission of Audio-Visual Programs issued by the SAPPRFT, or complete
certain registration procedures with the SAPPRFT. In general, providers of internet audio-visual program services must be either
state-owned or state-controlled entities, and the business to be carried out by such providers must satisfy the overall planning
and guidance catalog for internet audio-visual program service determined by the SAPPRFT. On May 21, 2008, SAPPRFT issued a Notice
on Relevant Issues Concerning Application and Approval of License for the Online Transmission of Audio-Visual Programs, as amended
on August 28, 2015, which sets out detailed provisions concerning the application and approval process regarding the License for
Online Transmission of Audio-Visual Programs. According to the above regulations, providers of internet audio-visual program services
that engaged in such services prior to the promulgation of the Audio-Visual Program Provisions are eligible to apply for the license
so long as those providers did not violate the relevant laws and regulations in the past or their violation of the laws and regulations
is minor in scope and can be rectified in a timely manner and they have no records of violation during the last three months prior
to the promulgation of the Audio-Visual Program Provisions. Further, on March 30, 2009, SAPPRFT promulgated the Notice on Strengthening
the Administration of the Content of Internet Audio-Visual Programs, which reiterates the pre-approval requirements for the audio-visual
programs transmitted via the internet, including through mobile networks, where applicable, and prohibits certain types of internet
audio-visual programs containing violence, pornography, gambling, terrorism, superstition or other similarly prohibited elements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 121; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 17, 2010,
the SAPPRFT promulgated Tentative Categories of Internet Audio-Visual Program Services, or the Categories, which clarified the
scope of internet audio-visual programs services, which was amended on March 10, 2017. According to the Categories, there are
four categories of internet audio-visual program services which are further divided into seventeen sub-categories. The third sub-category
to the second category covers the making and editing of certain specialized audio-visual programs concerning, among other things,
educational content, and broadcasting such content to the general public online. However, there are still significant uncertainties
relating to the interpretation and implementation of the Audio-Visual Program Provisions, in particular, the scope of &ldquo;internet
audio-visual programs.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 16, 2018,
the SAPPRFT promulgated the Notice on Further Regulating the Transmission Order of Internet Audio-Visual Program Services, providing
that the classic literary works, radio, film and television programs, internet original audio-visual programs shall not be re-edited,
re-dubbed, re-subtitled or partly captured and consolidated as a new program without authorizations and providers of internet
audio-visual program services shall strictly manage and supervise such re-edited programs uploaded by the internet users and shall
not provide any transmission channel for those internet audio-visual programs which have political orientation issues, copyright
issues or content issues.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Regulation Related to Internet Live Streaming Services</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 2, 2016,
the SAPPRFT promulgated the Notice on Strengthening the Administration of Live Streaming Services of Internet Audio-Visual Program,
which provided that any company without a License for Online Transmission of Audio-Visual Programs shall not operate audio-visual
live streaming business and the live streaming programs provided by the qualified company shall not contain any content forbidden
by laws and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On November 6, 2016, the
CAC promulgated the Provisions on the Administration of Internet Live Streaming Services, or the Internet Live Streaming Provisions,
effective December 1, 2016. &ldquo;Internet live streaming service&rdquo; is defined in the Internet Live Stream Provisions as
the activities of continuously releasing real-time information to the public based on the internet in such forms as videos, audios,
images and texts and the &ldquo;internet live streaming service provider&rdquo; is defined therein as an entity providing internet
live streaming platform services. The Internet Live Streaming Provisions provide that internet live streaming service providers
shall examine the true identity information of each internet live-streaming issuer, and complete the filing with local counterparts
of the CAC.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 12, 2017,
the CAC issued a Notice on Development of the Filing Work for Enterprises providing Internet Live Streaming Services, which provided
that all the companies providing internet live streaming services shall complete the filing procedure with its local authority
since July 15, 2017, otherwise the CAC or its local counterparts may impose administrative sanctions on such company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Regulation Related to Internet Culture
Activities</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 17, 2011,
Ministry of Culture (<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">currently known as the Ministry
of Culture and Tourism, MOCT)</FONT> MOCT promulgated the Interim Administrative Provisions on Internet Culture, or the Internet
Culture Provisions, which became effective on April 1, 2011 and was amended on December 15, 2017. The Internet Culture Provisions
require ICP services providers engaging in commercial &ldquo;internet culture activities&rdquo; to obtain an Internet Culture
Business Operating License from the MOCT. &ldquo;Internet cultural activity&rdquo; is defined in the Internet Culture Provisions
as an act of provision of internet cultural products and related services, which includes (i) the production, duplication, importation,
and broadcasting of the internet cultural products; (ii) the online dissemination whereby cultural products are posted on the
internet or transmitted via the internet to end-users, such as computers, fixed-line telephones, mobile phones, television sets
and games machines, for online users&rsquo; browsing, use or downloading; and (iii) the exhibition and comparison of the internet
cultural products. In addition, &ldquo;internet cultural products&rdquo; is defined in the Internet Culture Provisions as cultural
products produced, broadcast and disseminated via the internet, which mainly include internet cultural products specially produced
for the internet, such as online music entertainment, online games, online shows and plays (programs), online performances, online
works of art and online cartoons, and internet cultural products produced from cultural products such as music entertainment,
games, shows and plays (programs), performances, works of art, and cartoons through certain techniques and duplicating those to
internet for dissemination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 122; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Regulation Related to Online Publishing</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June 27, 2002,
the SAPPRFT and the MIIT jointly promulgated the Tentative Internet Publishing Administrative Measures, or the Internet Publishing
Measures, which took effect on August 1, 2002. The Internet Publishing Measures require entities that engage in internet publishing
to obtain an Internet Publishing License for engaging in internet publishing from the SAPPRFT. Pursuant to the Internet Publishing
Measures, the definition of &ldquo;internet publishing&rdquo; is broad and refers to the act by ICP services providers to select,
edit and process works created by themselves or others and subsequently post such works on the internet or transmit such works
to the users&rsquo; end through internet for the public to browse. The &ldquo;works&rdquo; as defined under the Internet Publishing
Measures include (i) contents from books, newspapers, periodicals, audio-visual products, electronic publications that have already
been formally published or works that have been made public in other media, and (ii) all other edited or processed works of literatures,
art, natural science, social science, engineering technology, etc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 4, 2016,
the SAPPRFT and the MIIT jointly issued the Administrative Provisions on Online Publishing Services, or the Online Publishing
Provisions. The Online Publishing Provisions, taking effect on March 10, 2016, superseded the Internet Publishing Measures. Compared
with the Internet Publishing Measures, the Online Publishing Provisions set out more detailed provisions for online publishing
activities, which mainly cover issues such as defining online publishing services, licensing and approvals, the administrative
and supervisory regime and legal liabilities. According to the Online Publishing Provisions, all online publishing services provided
within the territory of China are subject to the Online Publishing Provisions, and an online publishing services permit shall
be obtained to provide online publishing services. Pursuant to the Online Publishing Provisions, &ldquo;online publishing services&rdquo;
refer to providing online publications to the public through information networks; and &ldquo;online publications&rdquo; refer
to digital works with publishing features such as having been edited, produced or processed and are made available to the public
through information networks, including: (i) written works, pictures, maps, games, cartoons, audio/video reading materials and
other original digital works containing useful knowledge or ideas in the field of literature, art, science or other fields; (ii)
digital works of which the content is identical to that of any published book, newspaper, periodical, audio/video product, electronic
publication or the like; (iii) network literature databases or other digital works, derived from any of the aforesaid works by
selection, arrangement, collection or other means; and (iv) other types of digital works as may be determined by the SAPPRFT.
As the scope of online publication is broad, certain contents we post on our website, such as video-audio clips and course materials,
may be deemed as online publications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Regulations Related to Internet Information Security
and Privacy Protection</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">PRC government authorities
have enacted laws and regulations with respect to internet information security and protection of personal information from any
abuse or unauthorized disclosure. Internet information in China is regulated and restricted from a national security standpoint.
The Decisions on Maintaining Internet Security which was enacted by the Standing Committee of the PRC National People&rsquo;s
Congress (&ldquo;SCNPC&rdquo;) in December 2000 and amended in August 2009, may subject violators to criminal punishment in China
for any effort to: (i) gain improper entry into a computer or system of strategic importance; (ii) disseminate politically disruptive
information; (iii) leak state secrets; (iv) spread false commercial information; or (v) infringe intellectual property rights.
The Ministry of Public Security has promulgated measures that prohibit use of the internet in ways which, among other things,
result in a leakage of state secrets or a spread of socially destabilizing content. If an information service provider violates
these measures, the Ministry of Public Security and the local security bureaus may revoke its operating license and shut down
its websites.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Decision
on Strengthening the Protection of Online Information issued by the SCNPC in December 2012, any collection and use of user personal
information must be subject to the consent of the user, abide by the principles of legality, rationality and necessity and in
accordance with the specified purposes, methods and scopes. Any entity collecting personal information must also keep such information
strictly confidential, and is further prohibited from divulging, tampering or destroying any such information, or selling or providing
such information to other parties, and is required to take technical and other measures to prevent the collected personal information
from any unauthorized disclosure, damage or loss. Any violation of these laws and regulations may subject the entity collecting
personal information to warnings, fines, confiscation of illegal gains, revocation of licenses, cancellation of filings, closedown
of websites or even criminal liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 123; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Notice
of the Supreme People&rsquo;s Court, the Supreme People&rsquo;s Procuratorate and the Ministry of Public Security on Legally Punishing
Criminal Activities Infringing upon the Personal Information of Citizens, issued in 2013, and the Interpretation of the Supreme
People&rsquo;s Court and the Supreme People&rsquo;s Procuratorate on Several Issues regarding Legal Application in Criminal Cases
Infringing upon the Personal Information of Citizens, which was issued on May 8, 2017 and took effect on June 1, 2017, the following
activities may constitute the crime of infringing upon a citizen&rsquo;s personal information: (i) providing a citizen&rsquo;s
personal information to specified persons or releasing a citizen&rsquo;s personal information online or through other methods
in violation of relevant national provisions; (ii) providing legitimately collected information relating to a citizen to others
without such citizen&rsquo;s consent (unless the information is processed, not traceable to a specific person and not recoverable);
(iii) collecting a citizen&rsquo;s personal information in violation of applicable rules and regulations when performing a duty
or providing services; or (iv) collecting a citizen&rsquo;s personal information by purchasing, accepting or exchanging such information
in violation of applicable rules and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Order
for the Protection of Telecommunication and Internet User Personal Information issued by the MIIT on July 16, 2013, which became
effective from September 1, 2013, any collection and use of user personal information must be subject to the consent of the user,
abide by the principles of legality, rationality and necessity and be within the specified purposes, methods and scopes. &ldquo;Personal
information&rdquo; is defined as information that identifies a citizen, the time or location for his/her use of telecommunication
and internet services, or involves privacy of any citizen such as his/her birth date, ID card number, and address. An internet
information service provider must also keep information collected strictly confidential, and is further prohibited from divulging,
tampering or destroying of any such information, or selling or providing such information to other parties. Any violation of the
above decision or order may subject the internet information service provider to warnings, fines, confiscation of illegal gains,
revocation of licenses, cancellation of filings, closedown of websites or even criminal liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Ninth
Amendment to the Criminal Law issued by the SCNPC in August 2015, which became effective in November 2015, any person or entity
that fails to fulfill the obligations related to internet information security administration as required by applicable laws and
refuses to rectify upon orders is subject to criminal penalty for the result of (i) any dissemination of illegal information in
large scale; (ii) any severe effect due to the leakage of the client&rsquo;s information; (iii) any serious loss of criminal evidence;
or (iv) other severe situation, and any individual or entity that (i) sells or provides personal information to others in a way
violating the applicable law, or (ii) steals or illegally obtain any personal information is subject to criminal penalty in severe
situation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the PRC
Cyber Security Law issued by the SCNPC in November 2016, effective June 2017, personal information refers to all kinds of information
recorded by electronic or otherwise that can be used to independently identify or be combined with other information to identify
natural persons&rsquo; personal information including but not limited to: natural persons&rsquo; names, dates of birth, ID numbers,
biologically identified personal information, addresses and telephone numbers, etc. The Cyber Security Law also provides that:
(i) to collect and use personal information, network operators shall follow the principles of legitimacy, rightfulness and necessity,
disclose their rules of data collection and use, clearly express the purposes, means and scope of collecting and using the information,
and obtain the consent of the persons whose data is gathered; (ii) network operators shall neither gather personal information
unrelated to the services they provide, nor gather or use personal information in violation of the provisions of laws and administrative
regulations or the scopes of consent given by the persons whose data is gathered; and shall dispose of personal information they
have saved in accordance with the provisions of laws and administrative regulations and agreements reached with users; (iii) network
operators shall not divulge, tamper with or damage the personal information they have collected, and shall not provide the personal
information to others without the consent of the persons whose data is collected. However, if the information has been processed
and cannot be recovered and thus it is impossible to match such information with specific persons, such circumstance is an exception.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 124; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->116<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Regulation Related to Private Education</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The laws and regulations
governing foreign investments in private education institutions in China are complex and have been developing. Pursuant to the
Catalog, which is the principal regulation governing foreign investment activities in China, foreign investments in pre-school
education institutions, ordinary senior high schools and institutions of higher education fall within the foreign restricted category
(limited to the form of sino-foreign cooperative joint ventures), and foreign investments in compulsory education institutions
are prohibited. The Catalog does not provide specific restrictions on foreign investments in institutions like us that provide
healthcare learning products and services to the public. Besides, pursuant to the PRC Regulations on Sino-foreign Cooperative
Education (2013 Revision) and other education-related laws and regulations in China, foreign education institutions and other
foreign organizations or individuals may not by themselves alone establish schools or other education institutions within China
which mainly enroll Chinese citizens, and sino-foreign cooperative education institutions shall have corresponding qualifications
and relatively high education quality.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Education Law of China</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 18, 1995,
the PRC National People&rsquo;s Congress promulgated the PRC Education Law, or the Education Law. The Education Law stipulates
that the government formulates plans for the development of education, establishes and operates schools and other types of educational
institutions, and in principle, enterprises, institutions, social organizations and individuals are encouraged to operate schools
and other types of educational organizations. It is provided in the Education Law that no organization or individual may establish
or operate a school or any other educational institution for commercial purposes. On December 27, 2015, the SCNPC published the
Decision on Amendment of the Education Law, which took effect on June 1, 2016. The SCNPC narrowed the provision prohibiting the
establishment or operation of schools or other educational institutions for commercial purposes to only restricting a school or
other educational institution founded with governmental funds or donated assets in the amended Education Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>The Law for Promoting Private Education and its Implementing
Rules</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">On
December 28, 2002, the SCNPC promulgated the Law for Promoting Private Education, or the Private Education Law and was later amended
on November 7, 2016 and December 29<FONT STYLE="font-family: Times New Roman, Times, Serif">,</FONT>2018<FONT STYLE="font-family: Times New Roman, Times, Serif">,</FONT>the
amendment of which took effect on </FONT>December <FONT STYLE="font-size: 10pt">29,2018. On March 5, 2004, the PRC State Council
promulgated the Implementation Rules for the Law for Promoting Private Education, which became effective on April 1, 2004, or
the PE Implementation Rules. The Private Education Law and the Private Education Implementation Rules provide rules for social
organizations or individuals, other than state-owned entities, to establish schools or other educational organizations using non-government
funds in China, such schools or educational organizations established using non-government funds are referred to as &ldquo;private
schools.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">According to the amended
Private Education Law, establishment of private schools for academic education, pre-school education, self-taught examination
support and other cultural education shall be subject to approval by the authorities in charge of education, while establishment
of private schools for vocational qualification training and vocational skill training shall be subject to approvals from the
authorities in charge of labor and social welfare. A duly approved private school will be granted a private school operating permit,
and shall be registered with the Ministry of Civil Affairs (&ldquo;MCA&rdquo;), or its local counterparts as a private non-enterprise
institution. Entities and individuals may choose to establish non-profit private schools or for-profit private schools at their
own discretion. Nonetheless, for-profit private schools that are engaged in compulsory education are not allowed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December 30, 2016,
the Ministry of Education(&ldquo;MOE&rdquo;), the SAIC and the Ministry of Human Resources and Social Security (&ldquo;MOHRSS&rdquo;)
jointly issued the Implementation Rules on the Supervision and Administration of For-profit Private Schools. Pursuant such rules,
the establishment, division, merger and other material changes of a for-profit private school shall first be approved by the education
authorities or the authorities in charge of labor and social welfare, and then be registered with the competent branch of SAIC.
In addition, it also provides that for-profit private training institutes shall be analogically governed by these Implementation
Rules on the Supervision and Administration of For-profit Private Schools.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 125; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->117<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 31, 2017,
SAIC and MOE jointly promulgated the Notice of the State Administration for Industry and Commerce and the Ministry of Education
on the Work Concerning the Administration of the Name Registration for For-profit Private Schools, which came into effect on September
1, 2017. Such notice provides that the industry expression in the name of the private culture education institutions shall typically
include &ldquo;training school /center,&rdquo; such as &ldquo;curriculum training school/center,&rdquo; &ldquo;extra-class education
school/center,&rdquo; &ldquo;self-learning school/center,&rdquo; &ldquo;tutorship school/center,&rdquo; &ldquo;extra tutoring
for examinations school/center&rdquo; and &ldquo;extra tutoring school/center&rdquo; and such industry expression is allowed to
embody the disciplines and characteristics of such education institution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In August 2018, the
State Council issued the Opinion on the Regulation of the Development of Extracurricular Training Institutions, or the New Opinion,
which primarily regulates extracurricular training institutions targeting K-12 students. The New Opinion reiterates prior guidance
that extracurricular training institutions must obtain a private school operating permit, and further requires such institutions
to meet certain minimum requirements; for example, extracurricular training institutions are required to (i) have a fixed training
premise that conforms to specified safety criteria, with an average area per student of no less than 3 square meters during the
applicable training period; (ii) comply with relevant fire safety, environmental protection, hygiene, food operation and other
specified requirements; (iii) purchase personal safety insurance for students to reduce safety risks; and (iv) not hire any teachers
who are working concurrently in primary or secondary schools. Extracurricular training institutions are prohibited from carrying
out exam-oriented training, training that goes beyond the school syllabus, training in advance of the corresponding school schedule
and any training activities associated with student admission. The training content of extracurricular training institutions is
not to exceed the corresponding national curricular standards and training progress is not to be more accelerated than the corresponding
progress of local schools. According to the New Opinion, extracurricular training institutions are also required to disclose relevant
information regarding the institution, including their training content, schedule, targeted students and school timetable to the
relevant education authority, and their training classes may not end later than 20:30 each day. Tuition can only be collected
for courses in three months or a shorter installments. Additionally, the New Opinion requests that competent local authorities
formulate relevant local standards for extracurricular training institutions within their administrative area.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Regulation Related to Online and Distance Education</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Interim
Administrative Regulations on Educational Websites and Online and Distance Education Schools issued by the MOE, on July 5, 2000,
educational websites may provide educational services in relation to higher education, elementary education, pre-school education,
teaching education, occupational education, adult education, other education and public educational information services. &ldquo;Educational
websites&rdquo; refer to organizations providing education or education-related information services to website visitors by means
of a database or online education platform connected via the internet or an educational television station through an internet
service provider. Setting up education websites is subject to approval from relevant education authorities, depending on the specific
types of education. Any educational website shall, upon the receipt of approval, indicate on its website such approval information
as well as the approval date and file number.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June 29, 2004,
the State Council promulgated the Decision on Setting Down Administrative Licenses for the Administrative Examination and Approval
Items Really Necessary to Be Retained, pursuant to which the administrative license for &ldquo;educational websites&rdquo; was
not retained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 3, 2016,
the State Council promulgated the Decision on Cancelling the Second Batch of 152 Items Subject to Administrative Examination and
Approval by Local Governments Designated by the Central Government, further explicitly withdrew the approval requirements for
operating educational websites as provided by the Administrative Regulations on Educational Websites and Online Education Schools,
and reiterated the principle that administrative approval requirements may only be imposed in accordance with the PRC Administrative
Licensing Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 126; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->118<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December 2017,
Shanghai Municipal Government promulgated the Management Methods of Classified Registration of Private Schools, the Setting Standards
for Private Training Institutions of Shanghai, the Management Measures for the For-profit Private Training Institutions of Shanghai,
and the Management Methods for the Non-Profit Private Training Institutions of Shanghai (collectively, the &ldquo;Shanghai Implementation
Regulations&rdquo;). Pursuant to the Shanghai Implementation Regulations, any management measures and regulations applied to the
institutions that provide training services only through internet will be further promulgated separately. However no specific
administration measures regarding the institutions offering training service only through internet have been promulgated by Shanghai
government as of the date of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Legal Regulations on Intellectual Property in the PRC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"><I>Copyright</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Copyright
Law of the PRC, which was first promulgated by the Standing Committee of the National People&rsquo;s Congress on September 7,
1990 and became effective from June 1, 1993, and was last amended on February 26, 2010 and became effective as of April 1, 2010,
copyrights include personal rights such as the right of publication and that of attribution as well as property rights such as
the right of production and that of distribution. Reproducing, distributing, performing, projecting, broadcasting or compiling
a work or communicating the same to the public via an information network without permission from the owner of the copyright therein,
unless otherwise provided in the Copyright Law of the PRC, shall constitute infringements of copyrights. The infringer shall,
according to the circumstances of the case, undertake to cease the infringement, take remedial action, and offer an apology, pay
damages, etc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"><I>Trademark</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Trademark
Law of the PRC, which was promulgated by the Standing Committee of the National People&rsquo;s Congress on August 23, 1982 and
became effective from March 1, 1983, and was most recently amended on April 23, 2019 and will become effective on November 1,
2019, the right to exclusive use of a registered trademark shall be limited to trademarks which have been approved for registration
and to goods for which the use of such trademark has been approved. The period of validity of a registered trademark shall be
ten years, counted from the day the registration is approved. According to this law, using a trademark that is identical to or
similar to a registered trademark in connection with the same or similar goods without the authorization of the owner of the registered
trademark constitutes an infringement of the exclusive right to use a registered trademark. The infringer shall, in accordance
with the regulations, undertake to cease the infringement, take remedial action, and pay damages, etc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"><I>Patent</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Patent
Law of the PRC, which was promulgated by the Standing Committee of the National People&rsquo;s Congress on September 4, 1992 and
became effective from January 1, 1983, and was most recently amended on December 27, 2008, and was most recently amended on December
27, 2008 and became effective on October 1, 2009, after the grant of the patent right for an invention or utility model, except
where otherwise provided for in the Patent Law, no entity or individual may, without the authorization of the patent owner, exploit
the patent, that is, make, use, offer to sell, sell or import the patented product, or use the patented process, or use, offer
to sell, sell or import any product which is a direct result of the use of the patented process, for production or business purposes.
And after a patent right is granted for a design, no entity or individual shall, without the permission of the patent owner, exploit
the patent, that is, for production or business purposes, manufacture, offer to sell, sell, or import any product containing the
patented design. Where the infringement of patent is decided, the infringer shall, in accordance with the regulations, undertake
to cease the infringement, take remedial action, and pay damages, etc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"></P>

<!-- Field: Page; Sequence: 127; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->119<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><I>Domain Name</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Administrative
Measures for Internet Domain Names of China, which was recently amended by the Ministry of Industry and Information Technology
on August 24, 2017 and became effective on November 1, 2017, &ldquo;domain name&rdquo; shall refer to the character mark of hierarchical
structure, which identifies and locates a computer on the internet and corresponds to the internet protocol (IP) address of that
computer. And the principle of &ldquo;first come, first serve&rdquo; is followed for the domain name registration service. After
completing the domain name registration, the applicant becomes the holder of the domain name registered by him/it. Furthermore,
the holder shall pay operation fees for registered domain names on schedule. If the domain name holder fails to pay the corresponding
fees as required, the original domain name registrar shall write it off and notify the holder of the domain name in written form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt"><B>Regulations on Labor Protection
in the PRC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">According to the Labor
Law of the PRC, or the Labor Law, which was promulgated by the Standing Committee of the NPC on July 5, 1994, came into effect
on January 1, 1995, and was most recently amended on December 29, 2018, an employer shall develop and improve its rules and regulations
to safeguard the rights of its workers. An employer shall develop and improve its labor safety and health system, stringently
implement national protocols and standards on labor safety and health, conduct labor safety and health education for workers,
guard against labor accidents and reduce occupational hazards. Labor safety and health facilities must comply with relevant national
standards. An employer must provide workers with the necessary labor protection gear that complies with labor safety and health
conditions stipulated under national regulations, as well as provide regular health checks for workers that are engaged in operations
with occupational hazards. Laborers engaged in special operations shall have received specialized training and have obtained the
pertinent qualifications. An employer shall develop a vocational training system. Vocational training funds shall be set aside
and used in accordance with national regulations and vocational training for workers shall be carried out systematically based
on the actual conditions of the company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Labor Contract
Law of the PRC, which was promulgated by the SCNPC on June 29, 2007, came into effect on January 1, 2008, and was amended on December
28, 2012 and became effective as of July 1, 2013, and the Implementation Regulations on Labor Contract Law, which was promulgated
on September 18, 2008, and became effective since the same day, regulate both parties through a labor contract, namely the employer
and the employee, and contain specific provisions involving the terms of the labor contract. It is stipulated under the Labor
Contract Law and the Implementation Regulations on Labor Contract Law that a labor contract must be made in writing. An employer
and an employee may enter into a fixed-term labor contract, an un-fixed term labor contract, or a labor contract that concludes
upon the completion of certain work assignments, after reaching agreement upon due negotiations. An employer may legally terminate
a labor contract and dismiss its employees after reaching agreement upon due negotiations with the employee or by fulfilling the
statutory conditions. Labor contracts concluded prior to the enactment of the Labor Law and subsisting within the validity period
thereof shall continue to be honored. With respect to a circumstance where a labor relationship has already been established but
no formal written contract has been made, a written labor contract shall be entered into within one month from the commencement
date of the employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">According to the Interim
Regulations on the Collection and Payment of Social Insurance Premiums, the Regulations on Work Injury Insurance, the Regulations
on Unemployment Insurance and the Trial Measures on Employee Maternity Insurance of Enterprises, enterprises in the PRC shall
provide benefit plans for their employees, which include basic pension insurance, unemployment insurance, maternity insurance,
work injury insurance and basic medical insurance. An enterprise must provide social insurance by processing social insurance
registration with local social insurance agencies, and shall pay or withhold relevant social insurance premiums for or on behalf
of employees. The Law on Social Insurance of the PRC, which was promulgated by the Standing Committee of the National People&rsquo;s
Congress on October 28, 2010, and became effective on July 1, 2011, and was most recently updated on December 29, 2018, has consolidated
pertinent provisions for basic pension insurance, unemployment insurance, maternity insurance, work injury insurance and basic
medical insurance, and has elaborated in detail the legal obligations and liabilities of employers who do not comply with relevant
laws and regulations on social insurance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 128; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->120<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">According to the Interim
Measures for Participation in the Social Insurance System by Foreigners Working within the Territory of China, which was promulgated
by the Ministry of Human Resources and Social Security on September 6, 2011, and became effective on October 15, 2011, employers
who employ foreigners shall participate in the basic pension insurance, unemployment insurance, basic medical insurance, occupational
injury insurance, and maternity leave insurance in accordance with the relevant law, with the social insurance premiums to be
contributed respectively by the employers and foreigner employees as required. In accordance with such Interim Measures, the social
insurance administrative agencies shall exercise their right to supervise and examine the legal compliance of foreign employees
and employers and the employers who do not pay social insurance premiums in conformity with the laws shall be subject to the administrative
provisions provided in the Social Insurance Law and the relevant regulations and rules mentioned above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">According to the Reform
Plan of the State Tax and Local Tax Collection Administration System ( the &ldquo;Reform Plan&rdquo;), which was issued by the
General Office of the Communist Party of China and the General Office of the State Council of the PRC On July 20, 2018. Under
the Reform Plan, beginning from January 1, 2019, tax authorities will be responsible for the collection of social insurance contributions
in the PRC. Pursuant to the Urgent Notice of the General Office of MOHRSS on Effectively Implementing the Spirit of the Standing
Meeting of the State Council and Effectively Conducting the Collection of Social Insurance Premiums in a Stable Manner (the &ldquo;Urgent
Notice&rdquo;), which was issued by the General Office of the MOHRSS on September 21, 2018, before the reform of the social insurance
collection authorities being in place, the relevant levying policies, including the base and rate of the social insurance premiums,
shall remain unchanged. The Urgent Notice also clarified that it is strictly prohibited for the local authorities themselves to
organize and conduct centralized collection of enterprises historical social insurance arrears. On April 1, 2019, the General
Office of the State Council of the PRC issued the Comprehensive Program on Reduction of Social Insurance Premiums, which generally
reduced the social insurance contribution burden of enterprises, and re-emphasized that local authorities shall not conduct centralized
collection of enterprises historical social insurance arrears before a uniform policy is published.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">According to the Regulations
on the Administration of Housing Provident Fund, which was promulgated by the State Counsel and became effective on April 3, 1999,
and was amended on March 24, 2002, housing provident fund contributions by an individual employee and housing provident fund contributions
by his or her employer shall belong to the individual employee. Registration by PRC companies at the applicable housing provident
fund management center is compulsory and a special housing provident fund account for each of the employees shall be opened at
an entrusted bank.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The employer shall
timely pay up and deposit housing provident fund contributions in full amount and late or insufficient payments shall be prohibited.
The employer shall process housing provident fund payment and deposit registrations with the housing provident fund administration
center. With respect to companies who violate the above regulations and fail to process housing provident fund payment and deposit
registrations or open housing provident fund accounts for their employees, such companies shall be ordered by the housing provident
fund administration center to complete such procedures within a designated period. Those who fail to process their registrations
within the designated period shall be subject to a fine ranging from RMB 10,000 to RMB 50,000. When companies breach these regulations
and fail to pay up housing provident fund contributions in full amount as due, the housing provident fund administration center
shall order such companies to pay up within a designated period, and may further apply to the People&rsquo;s Court for mandatory
enforcement against those who still fail to comply after the expiry of such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt"></P>

<!-- Field: Page; Sequence: 129; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->121<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt"><B>Regulations
on Tax in the PRC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt"><I>Income
Tax</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In January 2008, the
PRC Enterprise Income Tax Law (&ldquo;EIT Law&rdquo;) took effect, which was last amended by the Standing Committee of the National
People&rsquo;s Congress on December 29, 2018. The PRC Enterprise Income Tax Law applies a uniform 25 percent enterprise income
tax rate to both FIEs and domestic enterprises, except where tax incentives are granted to special industries and projects. The
PRC Enterprise Income Tax Law defines &ldquo;resident enterprise&rdquo; as an enterprise established outside of the territory
of China but with its &ldquo;de facto management body&rdquo; within China, which will also be subject to the 25% enterprise income
tax rate. The implementation rules define the term &ldquo;de facto management body&rdquo; as the body that exercises full and
substantial control and overall management over the business, productions, personnel, accounts, and properties of an enterprise.
Enterprises qualified as &ldquo;High and New Technology Enterprises&rdquo; are entitled to a 15% enterprises income tax rate rather
than the 25% uniform statutory tax rate. The preferential tax treatment continues as long as an enterprise can retain its &ldquo;High
and New Technology Enterprise&rdquo; status. Under the PRC Enterprise Income Tax Law and its implementation regulations, dividends
generated from the business of a PRC subsidiary after January 1, 2008, and payable to its foreign investor may be subject to a
withholding tax rate of 10 percent if the PRC tax authorities determine that the foreign investor is a Non-resident Enterprise,
unless there is a tax treaty with China that provides for a preferential withholding tax rate. Distributions of earnings generated
before January 1, 2008, are exempt from PRC withholding tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The State Administration
of Taxation (&ldquo;SAT&rdquo;) has promulgated several rules and notices to tighten the scrutiny over acquisition transactions
in recent years, including the Interim Measures for the Administration of Remittance of Income Tax for Non-Resident Enterprise
Withheld at Source (the &ldquo;Interim Measures&rdquo;) which became effective on January 1, 2009, the Notice of the SAT on Strengthening
the Administration of Enterprise Income Tax on Gain Derived from Equity Transfer Made by Non-Resident Enterprise (the &ldquo;Notice&rdquo;)
which became effective on January 1, 2008, the Announcement of the SAT on Issues Concerning the Withholding of Non-resident Enterprise
Income Tax at Source (the &ldquo;SAT Circular 37&rdquo;) which was promulgated on October 17, 2017 and became effective on December
1, 2017 and the Public Notice of the SAT Regarding Certain Enterprise Income Tax Matters on Indirect Transfer of Properties by
Non-Resident Enterprises (the &ldquo;Public Notice 7&rdquo;) which became effective on February 3, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The SAT Circular 37
amended some provisions in Public Notice 7, repealed the Interim Measures and the Notice and simplifies procedures of withholding
and payment of income tax levied on non-resident enterprises. Pursuant to these rules and notices, where a non-resident enterprise
investor transfers equity interests or other taxable assets in a PRC resident enterprise indirectly by way of disposing of equity
interests in an overseas holding company, the non-resident enterprise investor, being the transferor, may be subject to PRC enterprise
income tax if the indirect transfer is considered to be an abusive use of company structure without reasonable commercial purposes.
In addition, Public Notice 7 provides clear criteria on how to assess reasonable commercial purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt"><I>Value-Added
Tax</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">According to the Temporary
Regulations on Value-added Tax, which was most recently amended on November 19, 2017, and the Detailed Implementing Rules of the
Temporary Regulations on Value-added Tax, which was amended on October 28, 2011, and became effective on November 1, 2011, all
taxpayers selling goods, providing processing, repair or replacement services or importing goods within the PRC shall pay Value-Added
Tax. The rate of VAT is 17%, 11% or 6% in certain limited circumstances depending on the product type.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 4, 2018,
the Ministry of Finance and the SAT jointly issued the Notice of Adjustment of Value-added Tax Rates which declared that the VAT
tax rate in regard to the sale of goods, provision of processing, repairs and replacement services and importation of goods into
China shall be reduced from the previous 17% and 11% to 16% and 10% respectively from May 1, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">According to the Announcement
of the MOF, the SAT and the General Administration of Customs on Relevant Policies for Deepening Value-added Tax Reform promulgated
on March 20, 2019 and became effective on April 1, 2019 (the &ldquo;Announcement&rdquo;), for the VAT taxable sales or imports
by a general taxpayer of VAT, the applicable tax rate shall be adjusted to 13% from the original 16% and to 9% from original 10%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 130; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->122<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, according
to the Trial Scheme for the Conversion of Business Tax to Value-added Tax, which was promulgated by the MOF and the SAT, the PRC
began to launch taxation reforms in a gradual manner in January 1, 2012, whereby the collection of value-added tax in lieu of
business tax items was implemented on a trial basis in regions showing significant radiating effects in economic development and
providing outstanding reform examples, beginning with production service industries such as transportation and certain modern
service industries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with
a SAT circular that took effect on May 1, 2016, upon approval of the State Council, the pilot program of the collection of value-added
tax in lieu of business tax shall be promoted nationwide in a comprehensive manner starting May 1, 2016, and all taxpayers of
business tax engaged in the building industry, the real estate industry, the financial industry and the life service industry
shall be included in the scope of the pilot program with regard to payment of value-added tax instead of business tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Regulation of Foreign Currency Exchange
and Dividend Distribution</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Foreign Currency
Exchange.</U> The principal regulations governing foreign currency exchange in China are the Foreign Exchange Administration Regulations
(1996), as amended on August 5, 2008, the Administration Rules of the Settlement, Sale and Payment of Foreign Exchange (1996)
and the Interim Measures on Administration on Foreign Debts (2003). Under these regulations, Renminbi are freely convertible for
current account items, including the distribution of dividends, interest payments, trade and service-related foreign exchange
transactions, but not for most capital account items, such as direct investment, loans, repatriation of investment and investment
in securities outside China, unless the prior approval of SAFE or its local counterparts is obtained. In addition, any loans to
an operating subsidiary in China that is a foreign invested enterprise, cannot, in the aggregate, exceed the difference between
its respective approved total investment amount and its respective approved registered capital amount. Furthermore, any foreign
loan must be registered with SAFE or its local counterparts for the loan to be effective. Any increase in the amount of the total
investment and registered capital must be approved by the PRC Ministry of Commerce or its local counterpart.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The dividends paid
by the subsidiary to its shareholder are deemed shareholder income and are taxable in China. Pursuant to the Administration Rules
of the Settlement, Sale and Payment of Foreign Exchange (1996), foreign-invested enterprises in China may purchase or remit foreign
exchange, subject to a cap approved by SAFE, for settlement of current account transactions without the approval of SAFE. Foreign
exchange transactions under the capital account are still subject to limitations and require approvals from, or registration with,
SAFE and other relevant PRC governmental authorities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Dividend Distribution.
</U>The principal regulations governing the distribution of dividends by foreign holding companies include the Company Law of
the PRC, which was promulgated by SCNPC on December 29, 1993 and became effective on July 1, 1994 and subsequently amended on
December 25,1999, August 28, 2004, October 27, 2005, December 28, 2013 and October 26, 2018, the Foreign Investment Enterprise
Law (1986) and its detailed rules, Foreign Investment Law, which was promulgated by SCNPC on March 15, 2019 and will become effective
on January 1, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under these regulations,
wholly foreign-owned investment enterprises in China may pay dividends only out of their retained profits, if any, determined
in accordance with PRC accounting standards and regulations. In addition, wholly foreign-owned investment enterprises in China
are required to allocate at least 10% of their respective retained profits each year, if any, to fund certain reserve funds unless
these reserves have reached 50% of the registered capital of the enterprises. These reserves are not distributable as cash dividends,
and a wholly foreign-owned enterprise is not permitted to distribute any profits until losses from prior fiscal years have been
offset.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Circular 37</U>.
On July 4, 2014, SAFE issued Circular 37, which became effective as of July 4, 2014. According to Circular 37, PRC residents shall
apply to SAFE and its branches for going through the procedures for foreign exchange registration of overseas investments before
contributing the domestic assets or interests to a SPV. An amendment to registration or filing with the local SAFE branch by such
PRC resident is also required if the registered overseas SPV&rsquo;s basic information such as domestic individual resident shareholder,
name, operating period, or major events such as domestic individual resident capital increase, capital reduction, share transfer
or exchange, merger or division has changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 131; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->123<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Moreover, Circular
37 applies retroactively. As a result, PRC residents who have contributed domestic assets or interests to a SPV, but failed to
complete foreign exchange registration of overseas investments as required prior to implementation of Circular 37, are required
to send a letter to SAFE and its branches for explanation. Under the relevant rules, failure to comply with the registration procedures
set forth in Circular 37 may result in receiving a warning from SAFE and its branches, and may result in a fine of up to RMB 300,000
for an organization or up to RMB 50,000 for an individual. In the event of failing to register, if capital outflow occurred, a
fine up to 30% of the illegal amount may be assessed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Notice
on Further Simplifying and Improving Policies for the Foreign Exchange Administration of Direct Investment (the &ldquo;SAFE Circular
13&rdquo;), which was promulgated by SAFE on February 13, 2015 and became effective on June 1, 2015, the power to accept foreign
exchange registration was delegated from local foreign exchange bureau to local commercial banks where the assets or interest
in the domestic entity was located.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Regulation Related to M&amp;A Regulations
and Overseas Listings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 8, 2006,
six PRC regulatory agencies, including the Ministry of Commerce, the State Assets Supervision and Administration Commission, the
State Administration for Taxation, the State Administration for Industry and Commerce, CSRC and SAFE, jointly issued the Regulations
on Mergers and Acquisitions of Domestic Enterprises by Foreign Investors, or the M&amp;A Rule, which became effective on September
8, 2006 and was amended on June 22, 2009. The M&amp;A Rules, among other things, require that (i)&nbsp;PRC entities or individuals
obtain MOFCOM approval before they establish or control an SPV overseas, provided that they intend to use the SPV to acquire their
equity interests in a PRC company at the consideration of newly issued share of the SPV, or Share Swap, and list their equity
interests in the PRC company overseas by listing the SPV in an overseas market; (ii)&nbsp;the SPV obtains MOFCOM&rsquo;s approval
before it acquires the equity interests held by the PRC entities or PRC individual in the PRC company by Share Swap; and (iii)&nbsp;the
SPV obtains CSRC approval before it lists overseas.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">The Anti-Monopoly Law
promulgated by the SCNPC on August&nbsp;30, 2007 and effective on August&nbsp;1, 2008 requires that transactions which are deemed
concentrations and involve parties with specified turnover thresholds must be cleared by MOFCOM before they can be completed.
In addition, on February 3, 2011, the General Office of the State Council promulgated a Notice on Establishing the Security Review
System for Mergers and Acquisitions of Domestic Enterprises by Foreign Investors, or Circular 6, which officially established
a security review system for mergers and acquisitions of domestic enterprises by foreign investors. Further, on August&nbsp;25,
2011, MOFCOM promulgated the Regulations on Implementation of Security Review System for the Merger and Acquisition of Domestic
Enterprises by Foreign Investors, or the MOFCOM Security Review Regulations, which became effective on September 1, 2011, to implement
Circular 6. Under Circular 6, a security review is required for mergers and acquisitions by foreign investors having &ldquo;national
defense and security&rdquo; concerns and mergers and acquisitions by which foreign investors may acquire the &ldquo;de facto control&rdquo;
of domestic enterprises with &ldquo;national security&rdquo; concerns. Under the MOFCOM Security Review Regulations, MOFCOM will
focus on the substance and actual impact of the transaction when deciding whether a specific merger or acquisition is subject
to security review. If MOFCOM decides that a specific merger or acquisition is subject to security review, it will submit it to
the Inter-Ministerial Panel, an authority established under the Circular 6 led by the NDRC, and MOFCOM under the leadership of
the State Council, to carry out the security review. The regulations prohibit foreign investors from bypassing the security review
by structuring transactions through trusts, indirect investments, leases, loans, control through VIE Arrangements or offshore
transactions.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 132; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->124<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Regulations on Offshore Parent Holding
Companies&rsquo; Direct Investment in and Loans to Their PRC Subsidiaries</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An offshore company
may invest equity in a PRC company, which will become the PRC subsidiary of the offshore holding company after investment. Such
equity investment is subject to a series of laws and regulations generally applicable to any foreign-invested enterprise in China,
which include the Wholly Foreign Owned Enterprise Law, the Sino-foreign Equity Joint Venture Enterprise Law, the Sino-foreign
Contractual Joint Venture Enterprise Law, Foreign Investment Law, all as amended from time to time, and their respective implementing
rules; the Administrative Provisions on Foreign Exchange in Domestic Direct Investment by Foreign Investors; and the Notice of
the State Administration on Foreign Exchange on Further Improving and Adjusting Foreign Exchange Administration Policies for Direct
Investment. Under the aforesaid laws and regulations, the increase of the registered capital of a foreign-invested enterprise
is subject to the prior approval by the original approval authority of its establishment. In addition, the increase of registered
capital and total investment amount shall both be registered with SAIC and SAFE. Shareholder loans made by offshore parent holding
companies to their PRC subsidiaries are regarded as foreign debts in China for regulatory purpose, which is subject to a number
of PRC laws and regulations, including the PRC Foreign Exchange Administration Regulations, the Interim Measures on Administration
on Foreign Debts, the Tentative Provisions on the Statistics Monitoring of Foreign Debts and its implementation rules, and the
Administration Rules on the Settlement, Sale and Payment of Foreign Exchange. Under these regulations, the shareholder loans made
by offshore parent holding companies to their PRC subsidiaries shall be registered with SAFE. Furthermore, the total amount of
foreign debts that can be borrowed by such PRC subsidiaries, including any shareholder loans, shall not exceed the difference
between the total investment amount and the registered capital amount of the PRC subsidiaries, both of which are subject to the
governmental approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Regulations Relating to Foreign Investment</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>The Guidance Catalogue and Negative
List</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any investments conducted
by the foreign investors and foreign enterprises in the PRC shall be subject to the Catalogue of Industries for Guiding Foreign
Investment (the &ldquo;Guidance Catalogue&rdquo;), the latest version of which was promulgated by the MOFCOM and the NDRC on June
28, 2017 and came into effect since July 28, 2017. The Guidance Catalogue divides industries for foreign investment into three
categories: encouraged, restricted and prohibited. Those industries not set out in the Catalogue shall be classified as industries
permitted for foreign investment. The Catalogue serves as the main basis for management and guidance for the MOFCOM to manage
and supervise foreign investments to PRC. In addition, in June 30, 2019, MOFCOM and NDRC promulgated the Special Management Measures
(Negative List) for the Access of Foreign Investment, or the Negative List, effective July 30, 2019. The Negative List expands
the scope of permitted industries by foreign investment by reducing the number of industries that fall within the Negative List
where restrictions on the shareholding percentage or requirements on the composition of board or senior management still exists.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a provider of health
information, healthcare education and training services to healthcare professionals and the public in China, we offer a wide range
of online and onsite health information services, healthcare education programs, and healthcare training products. As of the date
of the prospectus, we have the Internet Content Provider License under our consolidated VIE, and it falls within the restricted
foreign investment for value-added telecommunications services that foreign ownership may not be more than 50%. We also have the
Radio and the TV Program Production and Business License under our consolidated VIE and it falls within the prohibited foreign
investment for making and editing radio and TV programs. In addition, if the competent PRC government authorities determine that
our business operations of health information, healthcare education and training services are subject to the licensing requirements
for internet audio-visual programming, internet culture business operating and online publishing (See &rdquo; Risk Factor&mdash;Risks
Related to Doing Business in China&mdash;We may face risks and uncertainties with respect to the licensing requirement for internet
audio-visual programs&rdquo;, and &ldquo;Risk Factors&mdash;Risks Related to Doing Business in China&mdash;Our failure to obtain,
maintain or renew other licenses, approvals, permits, registrations or filings necessary to conduct our operations in China could
have a material adverse impact on our business, financial conditions and results of operations.&rdquo;), we may be required to
obtain the Online Transmission of Audio-Visual Programs License, Internet Culture Business Operating License and Online Publishing
License, which fall into the category of prohibited foreign investment. Our business activities other than the abovementioned
are not set out in the Negative List or any encouraged catalogue.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>The Foreign Investment Law</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 15, 2019,
the National People&rsquo;s Congress approved the Foreign Investment Law, which will take effect on January 1, 2020 and replace
three existing laws on foreign investments in China, namely, the PRC Equity Joint Venture Law, the PRC Cooperative Joint Venture
Law and the Wholly Foreign-owned Enterprise Law, together with their implementation rules and ancillary regulations. The Foreign
Investment Law embodies an expected PRC regulatory trend to rationalize its foreign investment regulatory regime in line with
prevailing international practice and the legislative efforts to unify the corporate legal requirements for both foreign and domestic
invested enterprises in China. The Foreign Investment Law establishes the basic framework for the access to, and the promotion,
protection and administration of foreign investments in view of investment protection and fair competition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 133; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->125<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">According to the Foreign
Investment Law, &ldquo;foreign investment&rdquo; refers to investment activities directly or indirectly conducted by one or more
natural persons, business entities, or otherwise organizations of a foreign country (collectively referred to as &ldquo;foreign
investor&rdquo;) within China, and the investment activities include the following situations: (i) a foreign investor, individually
or collectively with other investors, establishes a foreign-invested enterprise within China; (ii) a foreign investor acquires
stock shares, equity shares, shares in assets, or other like rights and interests of an enterprise within China; (iii) a foreign
investor, individually or collectively with other investors, invests in a new project within China; and (iv) investments in other
means as provided by laws, administrative regulations, or the State Council. Based on our understanding of the current PRC Laws,
the Foreign Investment Law does not explicitly classify VIE Arrangements as a form of foreign investment and our VIE Arrangements
are valid and binding, and do not result in any violation of PRC laws or regulations currently in effect. However, the Foreign
Investment Law contains a catch-all provision under the definition of &ldquo;foreign investment&rdquo;, which includes investments
made by foreign investors in China through means stipulated in laws or administrative regulations or other methods prescribed
by the State Council. Therefore, it still leaves leeway for future laws, administrative regulations or provisions promulgated
by the Stale Council to provide for VIE Arrangements as a form of foreign investment, at which time it will be uncertain whether
our VIE Arrangements will be deemed to be in violation of the market access requirements for foreign investment in the PRC and
if yes, how our VIE Arrangements should be dealt with. In addition, if future laws, administrative regulations or provisions prescribed
by the State Council mandate further actions to be taken by companies with respect to existing VIE Arrangements, we may face substantial
uncertainties as to whether we can complete such actions in a timely manner, or at all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">According to the Foreign
Investment Law, the State Council will publish or approve to publish the &ldquo;negative list&rdquo; for special administrative
measures concerning foreign investment. The Foreign Investment Law grants national treatment to foreign-invested entities (&ldquo;FIEs&rdquo;),
except for those FIEs that operate in industries deemed to be either &ldquo;restricted&rdquo; or &ldquo;prohibited&rdquo; in the
&ldquo;negative list&rdquo;. It is unclear whether the &ldquo;negative list&rdquo; to be published will differ from the current
Special Administrative Measures for Market Access of Foreign Investment (Negative List). The Foreign Investment Law provides that
foreign-invested entities operating in &ldquo;restricted&rdquo; or &ldquo;prohibited&rdquo; industries will require market entry
clearance and other approvals from relevant PRC government authorities. If our control over our consolidated VIE through VIE Arrangements
are deemed as foreign investment in the future, and any business of our consolidated VIE is &ldquo;restricted&rdquo; or &ldquo;prohibited&rdquo;
from foreign investment under the &ldquo;negative list&rdquo; effective at the time, we may be deemed to be in violation of the
Foreign Investment Law, the VIE Arrangements that allow us to have control over our consolidated VIE may be deemed as invalid
and illegal, and we may be required to unwind such VIE Arrangements and/or restructure our business operations, any of which may
have a material adverse effect on our business operation.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Besides, the PRC government
will establish a foreign investment information reporting system, according to which foreign investors or foreign-invested enterprises
shall submit investment information to the competent department for commerce concerned through the enterprise registration system
and the enterprise credit information publicity system, and a security review system under which the security review shall be
conducted for foreign investment affecting or likely affecting the state security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, the Foreign
Investment Law provides that foreign invested enterprises established according to the existing laws regulating foreign investment
may maintain their structure and corporate governance within five years after the implementing of the Foreign Investment Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the Foreign
Investment Law also provides several protective rules and principles for foreign investors and their investments in the PRC, including,
among others, that a foreign investor may freely transfer into or out of China, in Renminbi or a foreign currency, its contributions,
profits, capital gains, income from disposition of assets, royalties of intellectual property rights, indemnity or compensation
lawfully acquired, and income from liquidation, among others, within China; local governments shall abide by their commitments
to the foreign investors; governments at all levels and their departments shall enact local normative documents concerning foreign
investment in compliance with laws and regulations and shall not impair legitimate rights and interests, impose additional obligations
onto FIEs, set market access restrictions and exit conditions, or intervene with the normal production and operation activities
of FIEs; except for special circumstances, in which case statutory procedures shall be followed and fair and reasonable compensation
shall be made in a timely manner, expropriation or requisition of the investment of foreign investors is prohibited; and mandatory
technology transfer is prohibited.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 134; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->126<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="a_013"></A><B>MANAGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">The following table sets forth our executive
officers and directors, their ages and the positions held by them:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 28%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    </FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Age
    </FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 60%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Position
    </FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weiguang Yang</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President, Chief
    Executive Officer, and Chairman of the Board</FONT></TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pei Xu</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial
    Officer, Secretary, and Director</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Xuejun Chen</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Medical
    Officer</FONT></TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Baoqian Tian</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Sales Officer</FONT></TD></TR>
<TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shuang Wu</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Operating
    Officer</FONT></TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top"><P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">John C. General
                                    (1)(4)(5)</FONT></P>


</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    director </FONT></TD></TR>
<TR STYLE="background-color: #CCECFF">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kevin Dean Vassily
    (2)(5)</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    director </FONT></TD></TR>
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dan Li (3)(5)</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent
    director </FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Chair
                                         of the Audit Committee.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Chair
                                         of the Compensation Committee.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(3)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Chair
                                         of the Nominating Committee.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(4)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Audit
                                         Committee financial expert.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(5)</TD><TD STYLE="text-align: justify">Effective
                                         upon the effectiveness of this prospectus.</TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Weiguang Yang</I></B>&nbsp;is
a founder of Zhongchao Inc. and Zhongchao Shanghai. He has served as our general manager Zhongchao Shanghai since August 2012.
From June 2013 to June 2016, Mr. Yang served as the first Chinese board member on the Global Alliance for Medical Education (GAME),
a non-for-profit organization dedicated to the advancement of innovation in medical education throughout the world. From October
2015 to July 2012, Mr. Yang was the general manager at Medwork, a continuing medical education company. Mr. Yang obtained a bachelor
degree in Clinical Medicine Science (traumatic surgery) from Gannan Medical University in 2005. Mr. Yang attended the master course
of Social Medicine and Health Management as continuing education from 2006 to 2008 in Capital Medical University of China. From
2010 to 2012, Mr. Yang took part in the master course of Integrated Marketing Communication in Tsinghua University.&nbsp; We believe
he is qualified to serve on the Board because of his extensive experience in healthcare training and education and his dedication
to the Company.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Pei Xu</I></B>
is the CFO of Zhongchao Inc. and Zhongchao Shanghai. She has been serving&nbsp;as our CFO of Zhongchao Shanghai since January
2016. From September 2013 to January 2016, Ms. Xu served as the financial director of Zhongchao Shanghai. From September 2008
to August 2013, Ms. Xu worked for Otsuka (China) Investment Co., Ltd.&nbsp;as a financial director. Ms. Xu holds a bachelor degree
in finance from Jiangxi University of Finance and Economics. We believe she is qualified to serve on the Board because of the
perspective and experience she brings as our cofounder and CFO.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Xuejun Chen
</I></B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is the Chief Medical Officer of Zhongchao Inc.
and Deputy General Manager of Medicine of Zhongchao Shanghai. He has been serving&nbsp;as our deputy general manager of medicine
of Zhongchao Shanghai since March 2012, mainly responsible for designing PI and COPS courses on our MDMOOC online platform. Mr.
Chen also serves as medical Director at Medwork from January 2010 to February 2012. From September 2008 to December 2009, Mr.
Chen served D&amp;S, a Chinese public relation corporation, as medical director. Mr. Chen holds a bachelor degree in Clinical
Medicine Science from Shanxi Medical University and a master degree in pharmacology from Harbin University of Commerce.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt"><B><I>Baoqian Tian
</I></B>has been serving as our Chief Sales Officer of Zhongchao Inc. and Deputy General Manager of Sales of Zhongchao Shanghai.
He has been serving as our deputy general manager of sales of Zhongchao Shanghai since November 2017. Prior to joining us, he
served as the account director in Beijing Think Marketing Consulting Co., Ltd., a provider of advertising and consulting services
to pharmaceutical enterprises from July 2010 to July 2016. From July 2007 to July 2010, Mr. Tian worked as a project manager of
China International Exhibition Center Group Corporation. Mr. Tian holds a bachelor degree in Tourism Management (Event Management)
from Beijing International Studies University and a master degree in Business Administration from University of Chinese Academy
of Sciences.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Shuang Wu </I></B>is
the Chief Operating Officer of Zhongchao Inc. and Zhongchao Shanghai. She has been serving&nbsp;as our Chief Operating Officer
of Zhongchao Shanghai since March 2012. She is also the founder of Sunshine Health Forum. Ms. Wu holds a Bachelor of Management
in healthcare management from North China University of Science and Technology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>John C. General
</I></B><FONT STYLE="font-family: Times New Roman,serif; font-size: 10pt">is an independent director of the Company. Mr. General
serves as a Senior Manager of Global Revenue Assurance for Avaya, responsible for the appropriate recognition of revenue under
current accounting standards, and review of transactions for audit purposes from April 2013 to present. He served as a manager
of financial operations for Bed Bath &amp; Beyond, Value Services Inc., responsible for the controllership and compliance reporting
for the Company&rsquo;s gift card business for all retail concepts from July 2010 to April 2013. He served as a director in the
department of SOX Implementation for Virgin Mobile, responsible for ensuring SOX compliance from July 2004 to March 2009. From
September 1986 to December 2003, he served in various positions at AT&amp;T Corp., where he last served as a Financial Director
responsible for revenue assurance and billing operations. He holds a license as a Certified Public Accountant, a certificate in
Senior Executive Education from Columbia University, an MBA in Finance from Rutgers University, and bachelor&rsquo;s degrees in
both economics and accounting from Fairleigh Dickinson University.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 135; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->127<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Kevin Dean Vassily
</I></B>is an independent director of the Company. Mr. Vassily served as an advisor at Woodseer, responsible to provide strategic
and business development services for financial technology firm providing global dividend forecasts from March 2019 to present.
He serves as an advisor at Go Capture, responsible to provide strategic, business development, and product development advisory
work for emerging &ldquo;Data as a Service&rdquo; platform from July 2018 to present. He also serves as an advisor at Prometheus
Fund, responsible to provide strategic, due diligence, and opportunity sourcing for Shanghai based merchant bank/PE firm focused
on the &ldquo;green&rdquo; economy from July 2018 to present. Mr. Vassily served as an associate director of research at Keybanc
Capital Markets, responsible for the KeyBanc Data Insights initiative and co-managed the Technology Research vertical from January
2015 to June 2018. From December 2010 to December 2014, he served as the director of research at Pacific Epoch, responsible for
a complete overhaul of product and a complete business model restart post acquisition focusing on a &ldquo;data-first&rdquo; offering.
From May 2007 to December 2010, he served as Asia technology business development/senior analyst at Pacific Crest Securities,
responsible for establishing firm&rsquo;s presence and relevance covering Asia Technology. From June 2003 to September 2006, he
served as senior research analyst in the semiconductor technology group at Susquehanna International Group, responsible for research
in semiconductor and related technologies. From January 2001 to May 2003, he served as the vice president and senior research
analyst for semiconductor capital equipment at Thomas Weisel Partners, responsible for publishing research and maintaining financial
models on each of the companies under coverage. He holds a bachelor degree in liberal arts from Denison University and a master
degree in business administration from the Tuck School of Business at Dartmouth College.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Dan Li </I></B>is
an independent director of the Company. Ms. Li works as the research assistant in Beijing Friendship Hospital - China Capital
Medical University, responsible for conducting research in tropical diseases and development of detection kit of pathogenic microorganism
from June 2012 to present. She served as a manager of the medicine management department in EPS Corporation, responsible for managing
the importation of medicines from Japan to China from October 2009 to November 2011. Ms. Li holds a bachelor degree in clinical
medicine from the Medical School of North China University of Science and Technology, a master degree in hemorheology from the
Medical School of Peking University, and a Ph.D. in biochemistry from the Medical School of Keio University.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; text-align: justify">None of the events
listed in Item 401(f) of Regulation S-K has occurred during the past ten years that is material to the evaluation of the ability
or integrity of any of our directors, director nominees or executive officers.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Board of Directors and Board Committees</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Composition of Board; Risk Oversight</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board of Directors
consists of five (5) directors upon the effectiveness of this prospectus. Pursuant to our Amended and Restated Memorandum and
Articles of Association, our officers will be elected by and serve at the discretion of the board. Our directors are not subject
to a term of office and hold office until such time as they resign or are removed from office by resolution of our shareholders.
Immediately prior to the consummation of this Offering, the directors shall be divided into two classes, being the class I directors
(the &ldquo;Class I Directors&rdquo;) and the class II directors (the &ldquo;Class II Directors&rdquo;). The number of directors
in each class shall be as nearly equal as possible. The Class I Directors shall stand elected for a term expiring at the Company&rsquo;s
initial meeting after the adoption of the Amended and Restated Memorandum and Articles of Association and the Class II Directors
shall stand elected for a term expiring at the Company&rsquo;s third annual general meeting following the initial meeting. Directors
elected to succeed those Class I Directors whose terms expire shall be elected for a term of office to expire at the first annual
general meeting following their election and directors elected to succeed those Class II Directors whose terms expire shall be
elected for a term of office to expire at the third annual general meeting following their election. The initial members of Class
I Directors are John C. General, Kevin Dean Vassily, Dan Li. The initial members of Class II Directors are Weiguang Yang and Pei
Xu. A director will be removed from office automatically if, among other things, the director becomes bankrupt or makes any arrangement
or composition with his creditors, or becomes physically or mentally incapable of acting as director. Except as noted above, there
are no family relationships between any of our executive officers and directors. Officers are elected by, and serve at the discretion
of, the board of directors. Our board of directors shall hold meetings on at least a quarterly basis.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a smaller reporting
company under the NASDAQ rules we are only required to maintain a board of directors comprised of at least 50% independent directors,
and an audit committee of at least two members, comprised solely of independent directors who also meet the requirements of Rule
10A-3 under the Securities Exchange Act of 1934. There are no membership qualifications for directors. Further, there are no share
ownership qualifications for directors unless so fixed by us in a general meeting. There are no other arrangements or understandings
pursuant to which our directors are selected or nominated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There is no formal
requirement under the Company&rsquo;s Amended and Restated Memorandum and Articles of Association mandating that we hold an annual
meeting of our shareholders. However, notwithstanding the foregoing, we&nbsp;intend to hold such meetings on our annual meeting
to, among other things, elect our directors.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board plays a
significant role in our risk oversight. The board makes all relevant Company decisions. As such, it is important for us to have
our Chief Executive Officer serve on the board as he plays key roles in the risk oversight or the Company. As a smaller reporting
company with a small board of directors, we believe it is appropriate to have the involvement and input of all of our directors
in risk oversight matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Director Independence</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board has reviewed
the independence of our directors, applying the NASDAQ independence standards. Based on this review, the board determined that
each of John C. General, Kevin Dean Vassily, and Dan Li is &ldquo;independent&rdquo; within the meaning of the NASDAQ rules. In
making this determination, our board considered the relationships that each of these non-employee directors has with us and all
other facts and circumstances our board deemed relevant in determining their independence. As required under applicable NASDAQ
rules, we anticipate that our independent directors will meet on a regular basis as often as necessary to fulfill their responsibilities,
including at least annually in executive session without the presence of non-independent directors and management.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 136; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->128<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Duties of Directors</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under Cayman Islands
law, our directors have a duty of loyalty to act honestly in good faith with a view to our best interests. Our directors also
have a duty to exercise the skill they actually possess and such care and diligence that a reasonably prudent person would exercise
in comparable circumstances. In fulfilling their duty of care to us, our directors must ensure compliance with our Amended and
Restated Memorandum and Articles of Association. A shareholder may have the right to seek damages in our name if a duty owed by
our directors is breached.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Board Committees</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Currently, three committees
have been established under the board: the Audit Committee, the Compensation Committee and the Nominating Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee
is responsible for overseeing the accounting and financial reporting processes of our company and audits of the financial statements
of our company, including the appointment, compensation and oversight of the work of our independent auditors. The Compensation
Committee of the board of directors reviews and makes recommendations to the board regarding our compensation policies for our
officers and all forms of compensation, and also administers our incentive compensation plans and equity-based plans (but our
board retains the authority to interpret those plans). The Nominating Committee of the board is responsible for the assessment
of the performance of the board, considering and making recommendations to the board with respect to the nominations or elections
of directors and other governance issues. The nominating committee considers diversity of opinion and experience when nominating
directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Audit Committee</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee
will be responsible for, among other matters:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">appointing, compensating, retaining, evaluating, terminating,
    and overseeing our independent registered public accounting firm;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">discussing with our independent registered public accounting
    firm the independence of its members from its management;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">reviewing with our independent registered public accounting
    firm the scope and results of their audit;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">approving all audit and permissible non-audit services to be
    performed by our independent registered public accounting firm;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">overseeing the financial reporting process and discussing with
    management and our independent registered public accounting firm the interim and annual financial statements that we file
    with the SEC;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">reviewing and monitoring our accounting principles, accounting
    policies, financial and accounting controls, and compliance with legal and regulatory requirements;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">coordinating the oversight by our board of directors of our
    code of business conduct and our disclosure controls and procedures</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">establishing procedures for the confidential and or anonymous
    submission of concerns regarding accounting, internal controls or auditing matters; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">reviewing and approving related-party transactions.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Audit Committee
consists of John C. General, Kevin Dean Vassily, and Dan Li, with John C. General serving as chair of the Audit Committee. Our
board has affirmatively determined that each of the members of the Audit Committee meets the definition of &ldquo;independent
director&rdquo; for purposes of serving on an Audit Committee under Rule 10A-3 of the Exchange Act and NASDAQ rules. In addition,
our board has determined that John C. General qualifies as an &ldquo;audit committee financial expert&rdquo; as such term is currently
defined in Item 407(d)(5) of Regulation S-K and meets the financial sophistication requirements of the NASDAQ rules.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Compensation Committee</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation Committee
will be responsible for, among other matters:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">reviewing and approving, or recommending to the board of directors
    to approve the compensation of our CEO and other executive officers and directors;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">reviewing key employee compensation goals, policies, plans and
    programs;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">administering incentive and equity-based compensation;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">reviewing and approving employment agreements and other similar
    arrangements between us and our executive officers; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">appointing and overseeing any compensation consultants or advisors.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Compensation Committee
consists of John C. General, Kevin Dean Vassily, and Dan Li, with Kevin Dean Vassily serving as chair of the Compensation Committee.
Our board has affirmatively determined that each of the members of the Compensation Committee meets the definition of &ldquo;independent
director&rdquo; for purposes of serving on Compensation Committee under NASDAQ rules.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 137; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->129<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nominating Committee</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Nominating Committee
will be responsible for, among other matters:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">selecting
                                         or recommending for selection candidates for directorships;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">evaluating
                                         the independence of directors and director nominees;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -18pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">reviewing
                                         and making recommendations regarding the structure and composition of our board and the
                                         board committees;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">developing
                                         and recommending to the board corporate governance principles and practices;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">reviewing
                                         and monitoring the Company&rsquo;s Code of Business Conduct and Ethics; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">overseeing
                                         the evaluation of the Company&rsquo;s management</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Nominating Committee
consists of consists of John C. General, Kevin Dean Vassily, and Dan Li, with Dan Li serving as chair of the Nominating Committee.
Our board has affirmatively determined that each of the members of the Nominating Committee meets the definition of &ldquo;independent
director&rdquo; for purposes of serving on a Nominating Committee under NASDAQ rules.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Code of Business Conduct and Ethics</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board has adopted
a code of business conduct and ethics that applies to our directors, officers and employees. A copy of this code is available
on our website. We intend to disclose on our website any amendments to the Code of Business Conduct and Ethics and any waivers
of the Code of Business Conduct and Ethics that apply to our principal executive officer, principal financial officer, principal
accounting officer, controller, or persons performing similar functions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Duties of Directors</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under Cayman Islands
law, our directors have a duty to act honestly, in good faith and with a view to our best interests. Our directors also have a
duty to exercise the care, diligence and skills that a reasonably prudent person would exercise in comparable circumstances. See
&ldquo;Description of Share Capital&mdash;Differences in Corporate Law&rdquo; for additional information on our directors&rsquo;
fiduciary duties under Cayman Islands law. In fulfilling their duty of care to us, our directors must ensure compliance with our
Amended and Restated Memorandum and Articles of Association. We have the right to seek damages if a duty owed by our directors
is breached.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The functions and
powers of our board of directors include, among others:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">appointing
                                         officers and determining the term of office of the officers;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">authorizing
                                         the payment of donations to religious, charitable, public or other bodies, clubs, funds
                                         or associations as deemed advisable;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">exercising
                                         the borrowing powers of the company and mortgaging the property of the company;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">executing
                                         checks, promissory notes and other negotiable instruments on behalf of the company; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">maintaining
                                         or registering a register of mortgages, charges or other encumbrances of the company.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 138; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->130<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Interested Transactions</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A director may vote,
attend a board meeting or sign a document on our behalf with respect to any contract or transaction in which he or she is interested.
A director must promptly disclose the interest to all other directors after becoming aware of the fact that he or she is interested
in a transaction we have entered into or are to enter into. A general notice or disclosure to the board or otherwise contained
in the minutes of a meeting or a written resolution of the board or any committee of the board that a director is a shareholder,
director, officer or trustee of any specified firm or company and is to be regarded as interested in any transaction with such
firm or company will be sufficient disclosure, and, after such general notice, it will not be necessary to give special notice
relating to any particular transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Remuneration and Borrowing</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The directors may
receive such remuneration as our board of directors may determine from time to time. Each director is entitled to be repaid or
prepaid for all traveling, hotel and incidental expenses reasonably incurred or expected to be incurred in attending meetings
of our board of directors or committees of our board of directors or shareholder meetings or otherwise in connection with the
discharge of his or her duties as a director. The compensation committee will assist the directors in reviewing and approving
the compensation structure for the directors. Our board of directors may exercise all the powers of the company to borrow money
and to mortgage or charge our undertakings and property or any part thereof, to issue debentures, debenture stock and other securities
whenever money is borrowed or as security for any debt, liability or obligation of the company or of any third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Executive Compensation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Summary Compensation Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">The following table shows the annual compensation
paid by us for the years ended 2018 and 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-size: 10pt">Name/principal position</FONT> </TD>
    <TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-size: 10pt">Year</FONT> </TD>
    <TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-size: 10pt">Salary</FONT> </TD>
    <TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-size: 10pt">Equity<BR>
    Compensation</FONT> </TD>
    <TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-size: 10pt">All&nbsp;Other<BR>
    Compensation</FONT> </TD>
    <TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-size: 10pt">Total Paid</FONT> </TD>
    <TD STYLE="padding-bottom: 1.5pt"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="width: 41%"> <FONT STYLE="font-size: 10pt">Weiguang Yang/ CEO(1)</FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 10%; text-align: center"> <FONT STYLE="font-size: 10pt">2019</FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%"> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="width: 9%; text-align: right"> <FONT STYLE="font-size: 10pt">76,432</FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%"> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="width: 9%; text-align: right"> <FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%"> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="width: 9%; text-align: right"> <FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 1%"> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="width: 9%; text-align: right"> <FONT STYLE="font-size: 10pt">76,432</FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-size: 10pt">2018</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">54,592</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">54,592</FONT> </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-size: 10pt">2017</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">48,883</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">-</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">-</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">48,883</FONT> </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD> <FONT STYLE="font-size: 10pt">Pei Xu / CFO (2)</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-size: 10pt">2019</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">47,147</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">6,809</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">-</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">53,956</FONT> </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-size: 10pt">2018</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">49,148</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">-</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">-</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">49,148</FONT> </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-size: 10pt">2017</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">45,833</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">-</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">-</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">45,833</FONT> </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD> <FONT STYLE="font-size: 10pt">Xuejun Chen / Chief Medical Officer&nbsp;(3)</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-size: 10pt">2019</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">55,535</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">-</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">-</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">55,535</FONT> </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-size: 10pt">2018</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">59,301</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">-</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">-</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">59,301</FONT> </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-size: 10pt">2017</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">54,593</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">-</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">-</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">54,593</FONT> </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD> <FONT STYLE="font-size: 10pt">Baoqian Tian / Chief Sales Officer (4)</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-size: 10pt">2019</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">69,478</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">92,855</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">-</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">162,333</FONT> </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-size: 10pt">2018</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">72,950</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">52,119</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">-</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">125,069</FONT> </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-size: 10pt">2017</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">70,223</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">52,935</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">-</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">123,158</FONT> </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: right"> &nbsp; </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD> <FONT STYLE="font-size: 10pt">Shuang Wu / Chief Operating Officer (5)</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-size: 10pt">2019</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">46,207</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">32,312</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">-</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">78,519</FONT> </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-size: 10pt">2018</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">48,988</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">-</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">-</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">48,988</FONT> </TD>
    <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-size: 10pt">2017</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">44,435</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">-</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">-</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-size: 10pt">$</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-size: 10pt">44,435</FONT> </TD>
    <TD> &nbsp; </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Appointed Chairman and CEO effective as of August 2019. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Appointed CFO effective as of August 2019</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Appointed Chief Medical Officer effective as of August 2019.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">(4)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Appointed Chief Sales Officer effective as of August 2019.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">(5)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Appointed Chief Operating Officer effective as of August 2019.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under Chinese law,
we may only terminate employment agreements without cause and without penalty by providing notice of non-renewal one month prior
to the date on which the employment agreement is scheduled to expire. If we fail to provide this notice or if we wish to terminate
an employment agreement in the absence of cause, then we are obligated to pay the employee one month&rsquo;s salary for each year
we have employed the employee. We are, however, permitted to terminate an employee for cause without penalty to our company, where
the employee has committed a crime or the employee&rsquo;s actions or inactions have resulted in a material adverse effect to
us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 139; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->131<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Employment Agreements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Weiguang Yang Employment Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 7, 2019,
we entered into an employment agreement with Weiguang Yang pursuant to which he agreed to serve as our Chief Executive Officer.
The agreement provides for an annual base salary of USD$69,593 payable in accordance with the Company&rsquo;s ordinary payroll
practices. The term of the agreement shall expire on August 6, 2022, which term will automatically extend for additional 3-year
periods unless a party to the agreement terminates it upon 1-month&rsquo; notice or proposes to re-negotiate the terms of the
employment with the other party within 3 months prior to the expiration of the applicable term, or unless the employment is terminated
earlier pursuant to the terms of the agreement. If the executive&rsquo;s employment with the Company is terminated for any reason,
the Company will pay to such executive any unpaid portion of his salary through the date of his termination, and any unpaid bonus
through the date of termination, as well as any unpaid or unused portions of his benefits under the agreement. If his employment
is terminated at our election without cause or by him, the Company shall provide 1-month&rsquo; advanced notice or payment of
1-month&rsquo; salary in lieu of the notice. Weiguang Yang has agreed not to compete with us for 2 years after the termination
of his employment; he also executed certain non-solicitation, confidentiality and other covenants customary for agreements of
this nature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Pei Xu Employment Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 7, 2019,
we entered into an employment agreement with Pei Xu pursuant to which she agreed to serve as our Chief Financial Officer. The
agreement provides for an annual base salary of USD$34,796 payable in accordance with the Company&rsquo;s ordinary payroll practices.
The term of the agreement shall expire on August 6, 2022, which term will automatically extend for additional 3-year periods unless
a party to the agreement terminates it upon 1-month&rsquo; notice or proposes to re-negotiate the terms of the employment with
the other party within 3 months prior to the expiration of the applicable term, or unless the employment is terminated earlier
pursuant to the terms of the agreement. If the executive&rsquo;s employment with the Company is terminated for any reason, the
Company will pay to such executive any unpaid portion of her salary through the date of her termination, and any unpaid bonus
through the date of termination, as well as any unpaid or unused portions of her benefits under the agreement. If her employment
is terminated at our election without cause or by her, the Company shall provide 1-month&rsquo; advanced notice or payment of
1-month&rsquo; salary in lieu of the notice. Pei Xu has agreed not to compete with us for 2 years after the termination of her
employment; she also executed certain non-solicitation, confidentiality and other covenants customary for agreements of this nature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Xuejun Chen Employment Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 7, 2019,
we entered into an employment agreement with Xuejun Chen pursuant to which he agreed to serve as our Chief Medical Officer. The
agreement provides for an annual base salary of USD$40,016 payable in accordance with the Company&rsquo;s ordinary payroll practices.
The term of the agreement shall expire on August 6, 2022, which term will automatically extend for additional 3-year periods unless
a party to the agreement terminates it upon 1-month&rsquo; notice or proposes to re-negotiate the terms of the employment with
the other party within 3 months prior to the expiration of the applicable term, or unless the employment is terminated earlier
pursuant to the terms of the agreement. If the executive&rsquo;s employment with the Company is terminated for any reason, the
Company will pay to such executive any unpaid portion of his salary through the date of his termination, and any unpaid bonus
through the date of termination, as well as any unpaid or unused portions of his benefits under the agreement. If his employment
is terminated at our election without cause or by him, the Company shall provide 1-month&rsquo; advanced notice or payment of
1-month&rsquo; salary in lieu of the notice. Xuejun Chen has agreed not to compete with us for 2 years after the termination of
his employment; he also executed certain non-solicitation, confidentiality and other covenants customary for agreements of this
nature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"></P>

<!-- Field: Page; Sequence: 140; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->132<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Baoqian Tian Employment Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 7, 2019,
we entered into an employment agreement with Baoqian Tian pursuant to which he agreed to serve as our Chief Sales Officer. The
agreement provides for an annual base salary of USD$52,195 payable in accordance with the Company&rsquo;s ordinary payroll practices.
The term of the agreement shall expire on August 6, 2022, which term will automatically extend for additional 3-year periods unless
a party to the agreement terminates it upon 1-month&rsquo; notice or proposes to re-negotiate the terms of the employment with
the other party within 3 months prior to the expiration of the applicable term, or unless the employment is terminated earlier
pursuant to the terms of the agreement. If the executive&rsquo;s employment with the Company is terminated for any reason, the
Company will pay to such executive any unpaid portion of his salary through the date of his termination, and any unpaid bonus
through the date of termination, as well as any unpaid or unused portions of his benefits under the agreement. If his employment
is terminated at our election without cause or by him, the Company shall provide 1-month&rsquo; advanced notice or payment of
1-month&rsquo; salary in lieu of the notice. Baoqian Tian has agreed not to compete with us for 2 years after the termination
of his employment; he also executed certain non-solicitation, confidentiality and other covenants customary for agreements of
this nature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Shuang Wu Employment Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 7, 2019,
we entered into an employment agreement with Shuang Wu pursuant to which she agreed to serve as our Chief Operating Officer. The
agreement provides for an annual base salary of USD$33,056 payable in accordance with the Company&rsquo;s ordinary payroll practices.
The term of the agreement shall expire on August 6, 2022, which term will automatically extend for additional 3-year periods unless
a party to the agreement terminates it upon 1-month&rsquo; notice or proposes to re-negotiate the terms of the employment with
the other party within 3 months prior to the expiration of the applicable term, or unless the employment is terminated earlier
pursuant to the terms of the agreement. If the executive&rsquo;s employment with the Company is terminated for any reason, the
Company will pay to such executive any unpaid portion of her salary through the date of her termination, and any unpaid bonus
through the date of termination, as well as any unpaid or unused portions of her benefits under the agreement. If her employment
is terminated at our election without cause or by her, the Company shall provide 1-month&rsquo; advanced notice or payment of
1-month&rsquo; salary in lieu of the notice. Shuang Wu has agreed not to compete with us for 2 years after the termination of
her employment; she also executed certain non-solicitation, confidentiality and other covenants customary for agreements of this
nature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Director Compensation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The directors may
receive such remuneration as our board of directors may determine from time to time. Each director is entitled to be repaid or
prepaid for all traveling, hotel and incidental expenses reasonably incurred or expected to be incurred in attending meetings
of our board of directors or committees of our board of directors or general meetings or separate meetings of any class of shares
or of debenture of the Company or otherwise in connection with the discharge of his or her duties as a director. Employee directors
will not receive any additional remuneration for serving as directors of the Company other than their remuneration as employees
of the Company. Each of the non-employee directors is entitled to receive annual cash compensation in the amount of $24,000, payable
quarterly, and stock option to purchase certain amount of Class A Ordinary Shares under Company&rsquo;s 2019 Equity Incentive
Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 141; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->133<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Limitation on Liability and Other Indemnification
Matters</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Companies Law
does not limit the extent to which a company&rsquo;s memorandum and articles of association may provide for indemnification of
officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public
policy, such as to provide indemnification against civil fraud or the consequences of committing a crime. Our Amended and Restated
Memorandum and Articles of Association permit indemnification of officers and directors for losses, damages, costs and expenses
incurred in their capacities as such unless such losses or damages arise from dishonesty of such directors or officers willful
default of fraud.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling us under the
foregoing provisions, we have been informed that in the opinion of the SEC, such indemnification is against public policy as expressed
in the Securities Act and is therefore unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>2019 Equity Incentive Plan (the &ldquo;2019
Plan&rdquo;)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have adopted a
2019 Equity Incentive Plan (the &ldquo;Plan&rdquo;). The Plan provides for discretionary grants of Awards (as defined in the Plan)
to key employees, directors and consultants of the Company. The purpose of the Plan is to recognize contributions made to our
company and its subsidiaries by such individuals and to provide them with additional incentive to achieve the objectives of our
Company. No grants have been made under the plan as of the date hereof. The following is a summary of the Plan and is qualified
by the full text of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Administration</I>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Plan will be administered
by our board of directors, or, once constituted, the Compensation Committee of the board of directors (we refer to body administering
the Plan as the &ldquo;Committee&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Number of Class A Ordinary Shares.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> The number of Class
A Ordinary Shares that may be issued under the Plan is the maximum aggregate number of Class A Ordinary Shares reserved and available
pursuant to this Plan shall be the aggregate of (i) 980,121 Class A Ordinary Shares (or up to 1,006,371 Class A Ordinary Shares
if the underwriters fully exercise the over-allotment option) and (ii) on each January 1, starting with January 1, 2020 until
December 31, 2025, an additional number of shares equal to the lesser of (A) 2% of the outstanding number of Class A Ordinary
Shares (on a fully-diluted basis) on the immediately preceding December 31, and (B) such lower number of Class A Ordinary Shares
as may be determined by the Committee, subject in all cases to adjustment as provided in. If an Award (or any portion thereof)
terminates, expires or lapses or is cancelled for any reason, any Class A Ordinary Shares subject to the Award (or such portion
thereof) shall again be available for the grant of an Award pursuant to the Plan (unless the Plan has terminated). If any Award
(in whole or in part) is settled in cash or other property in lieu of Class A Ordinary Shares, then the number of Class A Ordinary
Shares subject to such Award (or such part) shall again be available for grant pursuant to the Plan. Class A Ordinary Shares that
have actually been issued under the Plan, pursuant to Awards under the Plan shall not be returned to the Plan and shall not cause
the number of Class A Ordinary Shares available to be subject to Awards under the Plan to be increased. Subject to any required
action by the shareholders of the Company, the number of Class A Ordinary Shares covered by each outstanding Award, the number
of Class A Ordinary Shares which have been authorized for issuance under the Plan but as to which no Awards have yet been granted
or which have been returned to the Plan upon cancellation or expiration of an Award, and the number of Class A Ordinary Shares
subject to grant as Incentive Stock Options, as well as the price per Class A Ordinary Shares covered by each such outstanding
Award and any other affected terms of such Awards, shall be proportionally and equitably adjusted for any increase or decrease
in the number of issued Class A Ordinary Shares resulting from a subdivision or consolidation, share dividend, amalgamation, spin-off,
arrangement or consolidation, combination or reclassification of Class A Ordinary Shares. Except as the board of director or the
Committee determines, no issuance by the Company of shares of any class, or securities convertible into shares of any class, shall
affect, and no adjustment by reason hereof shall be made with respect to, the number or price of Shares subject to an Award. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 142; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->134<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Types of Awards</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">The 2019 Plan permits the granting of any
or all of the following types of awards to all grantees:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">share options, including incentive share options, or ISOs;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">share appreciation rights, or SARs;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">restricted shares;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">restricted share units; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">share payments</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Awards granted under
the 2019 Plan may, in the discretion of the Committee, be granted alone or in addition to, in tandem with or in substitution for,
any other award under the 2019 Plan. The material terms of each Award will be set forth in a written award agreement between the
grantee and us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Share Options and SARs</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Committee is authorized
to grant SARs and share options (including ISOs except that an ISO may only be granted to an employee of ours or one of our subsidiary
corporations). A share option allows a grantee to purchase a specified number of our Class A Ordinary Shares at a predetermined
price per share (the &ldquo;exercise price&rdquo;) during a fixed period measured from the date of grant. An SAR entitles the
grantee to receive the excess of the fair market value of a specified number of Class A Ordinary Shares on the date of exercise
over a predetermined exercise price per share. The exercise price of an option or an SAR will be determined by the Committee and
set forth in the award agreement but the exercise price may not be less than the fair market value of a share on the grant date.
The term of each option or SAR is determined by the Committee and set forth in the award agreement, except that the term may not
exceed 10 years. Options may be exercised by payment of the purchase price through one or more of the following means: payment
in cash, payment in check, payment in promissory note, , with the approval of the Committee, by delivery of our Class A Ordinary
Shares acquired upon the exercise of such option; consideration received by the Company under a broker-assisted or similar cashless
exercise program implemented by the Company in connection with the Plan; payment by such other consideration as may be approved
by the Committee from time to time to the extent permitted by applicable laws; or any combination of the foregoing methods of
payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Restricted Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Committee may
award restricted shares consisting of our Class A Ordinary Shares which remain subject to a risk of forfeiture and may not be
disposed of by grantees until certain restrictions established by the Committee lapse. A grantee receiving restricted shares will
have all of the rights of a shareholder, including the right to vote the shares and the right to receive any dividends, except
as otherwise provided in the award agreement. If the price for the restricted shares was paid in services, then upon termination
as a service provider, the grantee shall no longer have any right in the unvested restricted shares and such restricted shares
shall be and thereupon either cancelled or surrendered to the Company without consideration. If a purchase price was paid by the
grantee for the restricted shares (other than in services), then upon the grantee&rsquo;s termination as a service provider, the
Company shall have the right to repurchase from the grantee the unvested restricted shares then subject to restrictions at a cash
price per share equal to the price paid by the grantee for such restricted shares or such other amount as may be specified in
the award agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Restricted Share Units</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Committee may
also grant restricted share unit awards. A restricted share unit award is the grant of a right to receive a specified number of
our Class A Ordinary Shares upon lapse of a specified forfeiture condition. If the condition is not satisfied during the restriction
period, the award will lapse without the issuance of the Class A Ordinary Shares underlying such award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 143; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->135<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Restricted share units
carry no voting or other rights associated with share ownership until the Class A Ordinary Shares underlying the award are delivered
in settlement of the award. The Company shall cause such Class A Ordinary Shares to be evidenced as issued by entry in the Company&rsquo;s
register of shareholders promptly after the restricted share unit vests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Share Payments</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Committee may
grant share payments to any service provider in the manner determined from time to time by the Committee;&nbsp;provided, that
unless otherwise determined by the Committee such share payments shall be made in lieu of base salary, bonus, or other cash compensation
otherwise payable to such grantee, including any such compensation that has been deferred at the election of the grantee;&nbsp;provided,&nbsp;further,
that not less than the par value of any Class A Ordinary Share shall be received by the Company in connection with its issue pursuant
to any such share payment. In accordance with applicable law, such par value may be paid through the provision of services. The
number of Class A Ordinary Shares issuable as a share payment shall be determined by the Committee and may be based upon satisfaction
of such specific criteria as determined appropriate by the Committee, including specified dates for electing to receive such share
payment at a later date and the date on which such share payment is to be made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Change in Control</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If there is a merger
or consolidation of us with or into another corporation or a sale of substantially all of our ordinary shares, or, collectively,
a Change in Control, the Company as determined in the sole discretion of the Committee and without the consent of the grantee
may take any of the following actions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) accelerate or
not accelerate the vesting, in whole or in part, of any award, or some or all awards, of any grantee, some grantees or all grantees;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) purchase any
award for an amount of cash or ordinary shares equal to the value that could have been attained upon the exercise of such award
or realization of the grantee&rsquo;s rights had such award been currently exercisable or payable or fully vested (and, for the
avoidance of doubt, if as of such date the Committee determines in good faith that no amount would have been attained upon the
exercise of such award or realization of the grantee&rsquo;s rights, then such award may be terminated by the Company without
payment); or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii) provide for
the assumption, conversion or replacement of any award by the successor or surviving company or a parent or subsidiary of the
successor or surviving company with other rights (including cash) or property selected by the Committee in its sole discretion
or the assumption or substitution of such award by the successor or surviving company, or a parent or subsidiary thereof, with
such appropriate adjustments as to the number and kind of ordinary shares and prices as the Committee deems, in its sole discretion,
reasonable, equitable and appropriate. In the event the successor or surviving company refuses to assume, convert or replace outstanding
awards, the awards shall fully vest and the grantee shall have the right to exercise or receive payment as to all of the Class
A Ordinary Shares subject to the award, including Class A Ordinary Shares as to which it would not otherwise be vested, exercisable
or otherwise issuable (including at the time of the Change in Control).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 144; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->136<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Amendment to and Termination of the 2019 Plan</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board of Directors
in its sole discretion may terminate this 2019 Plan at any time. The Board of Directors may amend this 2019 Plan at any time in
such respects as the Board of Directors may deem advisable; provided, that, if required to comply with applicable laws or stock
exchange rules or the rules of any automated quotation systems (other than any requirement which may be disapplied by the Company
following any available home country exemption), the Company shall obtain shareholder approval of any 2019 Plan amendment in such
a manner and to such a degree as required.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, subject
to the terms of the 2019 Plan, no amendment or termination of the 2019 Plan may materially and adversely affect the right of a
grantee under any award granted under the 2019 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Employees</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of
this prospectus, we had 90 employees, all of which were full-time employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">None of our employees
are represented by a labor union or covered by a collective bargaining agreement. We have never experienced any employment related
work stoppages, and we consider our relations with our employees to be good.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Indemnification</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; text-align: justify">We have entered into
indemnification agreements with each of our directors and executive officers. Under these agreements, we have agreed to indemnify
our directors and executive officers against certain liabilities and expenses incurred by such persons in connection with claims
made by reason of their being a director or officer of our company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>


<!-- Field: Page; Sequence: 145; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->137<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="a_014"></A>RELATED
PARTY TRANSACTIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a
description of transactions since January 1, 2017, in which the amount involved in the transaction exceeded or will exceed the
lesser of $120,000 or one percent of the average of our total assets as at the year-end for the last two completed fiscal years,
and to which any of our directors, executive officers or beneficial holders of more than 5% of our capital stock, or any immediate
family member of, or person sharing the household with, any of these individuals, had or will have a direct or indirect material
interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December 31,
2018 and 2017 and June 30, 2019, the Company had no balances due from or due to related parties.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">During the year ended
December 31, 2018, Mr. Weiguang Yang, the principal shareholder, the CEO and Chairman of the Board of the Company, and Ms. Zhihua
Zhen, the spouse of Mr. Yang, provided guarantee for the Company&rsquo;s short-term borrowings of $727,220.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 3, 2017, Mr.
Weiguang Yang transferred 4% of equity interest of Shanghai Xingzhong Investment Management LLP, which was equivalent to 85,920
shares of ordinary share of Zhongchao Shanghai owned by himself to Mr. Baoqian Tian, the sales director of the Company. The fair
value of the ordinary share aggregated $274,027 which is to compensate the services to be rendered over 5 years by the employee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January 3, 2019,
Mr. Weiguang Yang transferred 101,997 shares of restricted share units to three of its employees and 30,000 shares to one non-employee.
The restricted share units will vest after a five-year service period is fulfilled. On February 28, 2019, Mr. Weiguang Yang transferred
29,907 shares and 142,229 shares of restricted share units to Ms. Pei Xu, the Chief Financial Officer of the Company, and Ms.
Shuang Wu, the Chief Operation Officer of the Company, respectively. The restricted share units will vest after a ten-year service
period is fulfilled. The fair value of these ordinary share aggregated $827,413 which is to compensate the services to be rendered
by the employee.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>VIE Arrangements with our VIE and its Shareholders</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">See &ldquo;Corporate
History and Structure&mdash;VIE Arrangements.&rdquo;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Policies and Procedures for Related Party Transactions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors
has created an audit committee in connection with this offering which will be tasked with review and approval of all related party
transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 146; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->138<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_015"></A>PRINCIPAL SHAREHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following tables
set forth certain information with respect to the beneficial ownership of our Class A Ordinary Shares (including Class A Ordinary
Shares issuable upon the conversion of outstanding Class B Ordinary Shares) and as adjusted to reflect the sale of the Class A
Ordinary Shares offered by us in our initial public offering, for:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">each
                                         shareholder known by us to be the beneficial owner of more than 5% of our outstanding
                                         Class A Ordinary Shares or Class B Ordinary Shares;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">each
                                         of our directors;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">each
                                         of our named executive officers; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">all
                                         of our directors and executive officers as a group.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The beneficial ownership
of our Class A Ordinary Shares is determined in accordance with the rules of the SEC and generally includes any shares over which
a person exercises sole or shared voting or investment power, and includes the Class A Ordinary Shares issuable upon the conversion
of the outstanding Class B Ordinary Shares and the Class A Ordinary Shares issuable pursuant to share options that are exercisable
within 60 days of the date of this prospectus. Class A Ordinary Shares issuable pursuant to share options are deemed outstanding
for computing the percentage of the person holding such options but are not outstanding for computing the percentage of any other
person. As of the date of this prospectus, there were no Class A Ordinary Shares issuable pursuant to share options exercisable
within 60 days thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> The percentage
of beneficial ownership owned prior to the Offering is based on 16,102,420 Class A Ordinary Shares (including 1,350,068 Class
A Ordinary Shares to be issued upon exercise of the HF Warrant the Company issued to HF Capital. For more details of the HF Warrant,
see &ldquo;Prospectus Summary- Our Corporate History and Structure&rdquo; on page 11) and 5,497,715 Class B Ordinary Shares outstanding
as of the date of this prospectus. Except as otherwise set forth in the footnotes to the table below, the percentage of beneficial
ownership owned after the Offering is based on 20,127,420 Class A Ordinary Shares and 5,497,715 Class B Ordinary Shares outstanding
after we close on $18,112,500 offering amount, assuming the full exercise of the over-allotment option by the underwriters and
the exercise of the HF Warrant. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 147; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->139<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except where otherwise
indicated, we believe, based on information furnished to us by such owners, that the beneficial owners of the Class A Ordinary
Shares and Class B Ordinary Shares listed below have sole investment and voting power with respect to such shares. Unless otherwise
indicated, the address of each beneficial owner listed in the table below is c/o Zhongchao, Nanxi Creative Center, Suite 218,
841 Yan&rsquo;An Middle Road, Jing&rsquo;An District, Shanghai, China 200040.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Beneficial Ownership Prior
    to the Offering</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Beneficial Ownership After
    to the Offering</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Name and Address of Beneficial Owner</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class&nbsp;A<BR> Ordinary&nbsp;Shares</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class&nbsp;B&nbsp;<BR>
    Ordinary&nbsp;Shares</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class A <BR> Ordinary Shares</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class B<BR> Ordinary <BR>
    shares</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">%&nbsp;of <BR> Total&nbsp;Voting <BR> Power</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">%&nbsp;of <BR> Total&nbsp;Voting <BR> Power</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">% after the</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">%&nbsp;of <BR> Total&nbsp;Voting <BR> Power</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">*</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">*</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Offering</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">*</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-style: italic">Directors,&nbsp;Named&nbsp;<BR> Executive Officers, and 5% Beneficial Owner</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 20%; text-indent: -5pt; padding-left: 5pt">Weiguang Yang(1)(6)(7)(8)(9)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">4,203,385</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">4.26</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">5,497,715</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">83.66</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">4,203,385</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">4.10</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">5,497,715</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">80.38</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt">Pei Xu (2) (10)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">371,628</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.38</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">371,628</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.36</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt">Xuejun Chen (3) (10)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">689,310</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.70</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">689,310</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.67</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt">Baoqian Tian (4) (10)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">199,879</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.20</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">199,879</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.19</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt">Shuang Wu (5) (10)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">651,719</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.66</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">651,719</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.64</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt">More Healthy Holdings Limited (6)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,497,715</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">83.66</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,497,715</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">80.38</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt">Running Puma Holdings Limited (7)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,047,606</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.06</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,047,606</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.02</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt">Unique Value Holdings Limited (8)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,036,806</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.05</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,036,806</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.01</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt">Enchanted Butterfly Holdings Limited (9)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,118,973</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.15</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,118,973</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.07</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt">Worthy Health Limited Partnership (10)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,997,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.04</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,997,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.92</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -5pt; padding-left: 5pt">All directors and executive officers as a group (5 persons)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,115,921</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.20</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,497,715</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">83.66</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,115,921</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.96</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,497,715</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">80.38</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; font-family: Times New Roman, Times, Serif">
<TD STYLE="width: 0; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><P STYLE="margin: 0pt 0; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Represents
                                         the voting power with respect to all of our Class A Ordinary Shares and Class B Ordinary
                                         Shares, voting as a single class. According to our charter, each Class A Ordinary Shares
                                         entitles to 1 vote and each Class B Ordinary Share entitles to 15 votes. (See &ldquo;Description
                                         of Share Capital&rdquo; on page 142).</FONT></P>
</TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Unless
                                         otherwise indicated, the business address of each of the individuals is Zhongchao, Nanxi
                                         Creative Center, Suite 218, 841 Yan&rsquo;An Middle Road, Jing&rsquo;An District, Shanghai,
                                         China 200040.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Mr.&nbsp;Weiguang
                                         Yang is the Chairman, Chief Executive Officer, and President of Zhongchao. Mr. Yang holds
                                         the shares through his control of More Healthy Holdings Limited.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Ms.
                                         Pei Xu is the Chief Financial Officer of Zhongchao.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 148; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->140<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.3in; text-align: left"><FONT STYLE="font-size: 10pt">(3)</FONT></TD><TD STYLE="text-align: justify"><P STYLE="margin: 0pt 0">Mr.
                                         Xuejun Chen is the Chief Medical Officer of Zhongchao.</P>


</TD>
</TR></TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.3in; text-align: left"><FONT STYLE="font-size: 10pt">(4)</FONT></TD><TD STYLE="text-align: justify"><P STYLE="margin: 0pt 0">Mr.
                                         Baoqian Tian is the Chief Sales Officer of Zhongchao.</P>


</TD>
</TR></TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.3in; text-align: left"><FONT STYLE="font-size: 10pt">(5)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Ms.
                                         Shuang Wu is the Chief Operating Officer of Zhongchao.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.3in; text-align: left"><FONT STYLE="font-size: 10pt">(6)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">More
                                         Healthy Holdings Limited is a company&nbsp;limited by shares incorporated under the laws
                                         of British Virgin Islands (&ldquo;More Healthy&rdquo;). The address of its business office
                                         is Craigmuir Chambers, Road Town, Tortola, VG 1110, British Virgin Islands. The person
                                         having voting, dispositive or investment powers over&nbsp;More Healthy Holdings Limited
                                         is Mr. Weiguang Yang.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.3in; text-align: left"><FONT STYLE="font-size: 10pt">(7)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Running
                                         Puma Holdings Limited is a company&nbsp;limited by shares incorporated under the laws
                                         of British Virgin Islands and wholly owned by More Healthy. The address of its business
                                         office is Craigmuir Chambers, Road Town, Tortola, VG 1110, British Virgin Islands. The
                                         person having voting, dispositive or investment powers over&nbsp;More Healthy Holdings
                                         Limited is Mr. Weiguang Yang.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.3in; text-align: left"><FONT STYLE="font-size: 10pt">(8)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Unique
                                         Value Holdings Limited is a company&nbsp;limited by shares incorporated under the laws
                                         of British Virgin Islands and wholly owned by More Healthy. The address of its business
                                         office is Craigmuir Chambers, Road Town, Tortola, VG 1110, British Virgin Islands. The
                                         person having voting, dispositive or investment powers over&nbsp;More Healthy Holdings
                                         Limited is Mr. Weiguang Yang.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.3in; text-align: left"><FONT STYLE="font-size: 10pt">(9)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Enchanted
                                         Butterfly Holdings Limited is a company&nbsp;limited by shares incorporated under the
                                         laws of British Virgin Islands and wholly owned by More Healthy. The address of its business
                                         office is Craigmuir Chambers, Road Town, Tortola, VG 1110, British Virgin Islands. The
                                         person having voting, dispositive or investment powers over&nbsp;More Healthy Holdings
                                         Limited is Mr. Weiguang Yang.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.3in; text-align: left"><FONT STYLE="font-size: 10pt">(10)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Worthy
                                         Health Limited Partnership is a limited partnership&nbsp;incorporated under the laws
                                         of British Virgin Islands (&ldquo;Worthy Health&rdquo;), the general partner of which
                                         is More Successful Group Limited, a company limited by shares incorporated under the
                                         laws of the British Virgin Islands (&ldquo;More Successful&rdquo;), which is controlled
                                         by Pei Xu who acts as the sole director of More Successful. The general partner exercises
                                         the voting rights with respect to the shares held by Worthy Health. The general partner
                                         disclaims beneficial ownership of our shares except to the extent of its pecuniary interest
                                         in Worthy Health. As limited partners, Pei Xu, Xuejun Chen, Baoqian Tian, and Shuang
                                         Wu respectively own 11.4%, 23%, 6.67%, and 21.75% partnership interests of Worthy Health,
                                         beneficially representing 341,658 Class A Ordinary Shares, 689,310 Class A Ordinary Shares,
                                         199,879 Class A Ordinary Shares, and 651,719 Class A Ordinary Shares of the Company.
                                         The principal office address of Worthy Health is at Craigmuir Chambers, P.O. Box 71,
                                         Road Town, Tortola, VG 1110, British Virgin Islands.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> As of February 6, 2020,
there were 13 holders of record entered in our share register. The number of individual holders of record is based exclusively
upon our share register and does not address whether a share or shares may be held by the holder of record on behalf of more than
one person or institution who may be deemed to be the beneficial owner of a share or shares in our company. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To our knowledge,
no other shareholder beneficially owns more than 5% of our shares. Our company is not owned or controlled directly or indirectly
by any government or by any corporation or by any other natural or legal person severally or jointly. Our major shareholders do
not have any special voting rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 149; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->141<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_016"></A>DESCRIPTION OF SHARE
CAPITAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
are a Cayman Islands exempted company with limited liability and our affairs are governed by our Amended and Restated Memorandum
and Articles of Association (&ldquo;Memorandum and Articles&rdquo;), the Companies Law, the common law of the Cayman Islands,
our corporate governance documents and rules and regulations of the stock exchange on which are shares are traded.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> As
of the date of the prospectus, the authorized share capital of the Company is USD50,000.00, consisting of 450,000,000 Class A
Ordinary Shares, par value $0.0001 each and 50,000,000 Class B Ordinary Shares, par value $0.0001 each. As of the date of this
prospectus, 14,752,352 Class A Ordinary Shares and 5,497,715 Class B Ordinary Shares are issued and outstanding&nbsp;and 1,350,068
Class A Ordinary Shares are to be issued upon the exercise of the HF Warrant. All of our issued and outstanding Class A Ordinary
Shares and Class B Ordinary Shares are fully paid. Immediately upon the completion of the Offering assuming the full exercise
of the over-allotment option by the underwriters and the exercise of the HF Warrant, there will be 20,127,420 Class A Ordinary
Shares outstanding; if the Class B Ordinary Shares are converted, there will be 25,625,135 outstanding following Offering. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Ordinary Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
following are summaries of material provisions of our Memorandum and Articles, corporate governance policies and the Companies
Law insofar as they relate to the material terms of our Class A Ordinary Shares and Class B Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Objects of Our Company</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Under
our Memorandum and Articles, the objects of our Company are unrestricted and we have the full power and authority to carry out
any object not prohibited by the law of the Cayman Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Share Capital</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
authorized share capital is divided into Class A Ordinary Shares and Class B Ordinary Shares. Holders of our Class A Ordinary
Shares and Class B Ordinary Shares will have the same rights except for voting rights and conversion rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
holders of Class A Ordinary Shares are entitled to 1 vote for each such share held and shall be entitled to notice of any shareholders&rsquo;
meeting, and, subject to the terms of Memorandum and Articles, to vote thereat. The Class A Ordinary Shares are not redeemable
at the option of the holder and are not convertible into shares of any other class.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
holders of Class B Ordinary Shares shall have the right to 15 votes for each such share held, and shall be entitled to notice
of any shareholders&rsquo; meeting and, subject to the terms of the Memorandum and Articles, to vote thereat. The Class B Ordinary
Shares are not redeemable at the option of the holder but are convertible into Class A Ordinary Shares at any time after issue
at the option of the holder on a one to one basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Dividends</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
holders of our Class A Ordinary Shares and Class B Ordinary Shares are entitled to such dividends as may be declared by our Board
of Directors subject to the Companies Law and to our Memorandum and Articles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Voting Rights</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
respect of all matters subject to a shareholders&rsquo; vote, each Class B Ordinary Share is entitled to 15 votes, and each Class
A Ordinary Share is entitled to 1 vote, voting together as one class. At any general meeting a resolution put to the vote of the
meeting shall be decided on a poll which shall be taken at such time and in such manner as the Chairman of the meeting directs
and the result of the poll shall be deemed to be the resolution of the meeting</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 150; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->142<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">No
business shall be transacted at any general meeting unless a quorum of members is present at the time when the meeting proceeds
to business; one or more members holding Ordinary Shares which carry in aggregate (or representing by proxy) not less than one-third
of all votes attaching to all Ordinary Shares in issue and entitled to vote at such general meeting, present in person or by proxy
or, if a corporation or other non-natural person, by its duly authorised representative, shall be a quorum for all purposes provided
always that if the Company has one (1) member of record, the quorum shall be that one (1) member present in person or by proxy.
To avoid confusion for the purpose, when counting the quorum, each issued and outstanding Class A Ordinary Share has one (1) vote
and each issued and outstanding Class B Ordinary Share has fifteen (15) votes. An ordinary resolution to be passed at a general
meeting requires the affirmative vote of a simple majority of the votes cast, while a special resolution requires the affirmative
vote of at least two-thirds of votes cast at a general meeting. A special resolution will be required for important matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Conversion</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Class
A Ordinary Shares are not convertible. Each Class B Ordinary Share shall be convertible, at the option of the holder thereof,
into such number of fully paid and non-assessable Class A Ordinary Shares on the basis that one Class B Ordinary Share shall be
converted into one Class A Ordinary Share (being a 1:1 ratio and hereafter referred to as the &ldquo;<B>Conversion Rate</B>&rdquo;),
subject to adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Transfer of Ordinary Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Subject
to the restrictions set out below, any of our shareholders may transfer all or any of his, its or her Class A Ordinary Shares
or Class B Ordinary Shares by an instrument of transfer in the usual or common form or any other form approved by our Board of
Directors or in a form prescribed by the stock exchange on which our shares are then listed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
Board of Directors may, in its sole discretion, decline to register any transfer of any Class A Ordinary Shares or Class B Ordinary
Shares whether or not it is fully paid up to the total consideration paid for such shares. Our directors may also decline to register
any transfer of any Class A Ordinary Shares or Class B Ordinary Shares if (a) the instrument of transfer is not accompanied by
the certificate covering the shares to which it relates or any other evidence as our Board of Directors may reasonably require
to prove the title of the transferor to, or his/her right to transfer the shares; or (b) the instrument of transfer is in respect
of more than one class of shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If
our directors refuse to register a transfer, they shall, within two months after the date on which the instrument of transfer
was lodged, send to the transferee notice of such refusal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
registration of transfers may be suspended and the register closed at such times and for such periods as our Board of Directors
may from time to time determine, provided, however, that the registration of transfers shall not be suspended nor the register
closed for more than 30 days in any year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Winding-Up/Liquidation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
a return of capital on winding up or otherwise (other than on conversion, redemption or purchase of shares), a liquidator may
be appointed to determine how to distribute the assets among the holders of the Class A Ordinary Shares and Class B Ordinary Shares.
If our assets available for distribution are insufficient to repay all of the paid-up capital, the assets will be distributed
so that the losses are borne by our shareholders proportionately; a similar basis will be employed if the assets are more than
sufficient to repay the whole of the capital at the commencement of the winding up.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 151; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->143<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Calls on Ordinary Shares and Forfeiture
of Ordinary Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
Board of Directors may from time to time make calls upon shareholders for any amounts unpaid on their Class A Ordinary Shares
or Class B Ordinary Shares in a notice served to such shareholders at least 14 days prior to the specified time and place of payment.
The shares that have been called upon and remain unpaid on the specified time are subject to forfeiture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Redemption of Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
may issue shares on terms that are subject to redemption, at our option or at the option of the holders, on such terms and in
such manner as may be determined by our Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Variations of Rights of Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">All
or any of the special rights attached to any class of shares may, be varied with the resolution of at least two thirds of the
issued shares of that class or a resolution passed at a general meeting of the holders of the shares of that class present in
person or by proxy or with the consent in writing of the holders of at least two-thirds of the issued shares of that class.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Inspection
of Books and Records</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Directors
shall from time to time determine whether and to what extent and at what times and places and under what conditions or regulations
the accounts and books of the Company or any of them shall be open to the inspection of members not being Directors and no member
(not being a Director) shall have any right of inspecting any account or book or document of the Company except as conferred by
Companies Law or authorized by the Directors or by the Company in a general meeting. However, the Directors shall from time to
time cause to be prepared and to be laid before the Company in a general meeting, profit and loss accounts, balance sheets, group
accounts (if any) and such other reports and accounts as may be required by Companies Law. (See &ldquo;Where You Can Find More
Information&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Issuance of Additional Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
Memorandum and Articles authorize our Board of Directors to issue additional Class A Ordinary Shares or Class B Ordinary Shares
from time to time as our Board of Directors shall determine, to the extent there are available authorized but unissued shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
Memorandum and Articles also authorizes our Board of Directors to establish from time to time one or more series of preferred
shares and to determine, subject to compliance with the variation of rights of shares provision in the Memorandum and Articles,
with respect to any series of preferred shares, the terms and rights of that series, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">the designation of the series;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.25pt; text-indent: -0.25in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">the number of shares of the series;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.25pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the dividend rights, dividend rates, conversion rights, voting
    rights; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.25pt; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the rights and terms of redemption and liquidation preferences.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
Board of Directors may, issue preferred shares without action by our shareholders to the extent there are authorized but unissued
shares available. Issuance of additional shares may dilute the voting power of holders of Class A Ordinary Shares and Class B
Ordinary Shares. However, our Memorandum of Association provides for authorized share capital comprising Class A Ordinary Shares
and Class B Ordinary Shares and to the extent the rights attached to any class may be varied, the Company must comply with the
provisions in the Memorandum and Articles relating to variations to rights of shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 152; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->144<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Anti-Takeover Provisions</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Some
provisions of our Memorandum and Articles may discourage, delay or prevent a change of control of our Company or management that
shareholders may consider favorable, including provisions that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">authorize our Board of Directors to issue preferred shares in
    one or more series and to designate the price, rights, preferences, privileges and restrictions of such preferred shares without
    any further vote or action by our shareholders (subject to variation of rights of shares provisions in our Memorandum and
    Articles); and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">limit the ability of shareholders to requisition and convene
    general meetings of shareholders. Our Memorandum and Articles allow our shareholders holding shares representing in aggregate
    not less than ten percent of our paid up share capital (as to the total consideration paid for such shares) in issue to requisition
    an extraordinary general meeting of our shareholders, in which case our directors are obliged to call such meeting and to
    put the resolutions so requisitioned to a vote at such meeting.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">However,
under Cayman Islands law, our directors may only exercise the rights and powers granted to them under our Memorandum and Articles
for a proper purpose and for what they believe in good faith to be in the best interests of our Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>General Meetings of Shareholders and Shareholder Proposals</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
shareholders&rsquo; general meetings may be held in such place within or outside the Cayman Islands as our Board of Directors
considers appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">As
a Cayman Islands exempted company, we are not obliged by the Companies Law to call shareholders&rsquo; annual general meetings.
However, our Memorandum and Articles provide that we shall hold a general meeting in each year as our annual general meeting other
than the year in which the Memorandum and Articles were adopted at such time and place as determined by the directors. The directors
may, whenever they think fit, convene an extraordinary general meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Shareholders&rsquo;
annual general meetings and any other general meetings of our shareholders may be convened by a majority of our Board of Directors.
Our Board of Directors shall give not less than seven days&rsquo; written notice of a shareholders&rsquo; meeting to those persons
whose names appear as members in our register of members on the date the notice is given (or on any other date determined by our
directors to be the record date for such meeting) and who are entitled to vote at the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Cayman
Islands law provides shareholders with only limited rights to requisition a general meeting, and does not provide shareholders
with any right to put any proposal before a general meeting. However, these rights may be provided in a company&rsquo;s articles
of association. Our Memorandum and Articles allow our shareholders holding shares representing in aggregate not less than ten
percent of our paid up share capital (as to the total consideration paid for such shares) in issue to requisition an extraordinary
general meeting of our shareholders, in which case our directors are obliged to call such meeting and to put the resolutions so
requisitioned to a vote at such meeting; otherwise, our Memorandum and Articles do not provide our shareholders with any right
to put any proposals before annual general meetings or extraordinary general meetings not called by such shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 153; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->145<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Exempted Company</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
are an exempted company with limited liability under the Companies Law. The Companies Law distinguishes between ordinary resident
companies and exempted companies. A Cayman Islands exempted company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">is a company that conducts its business mainly outside of the
    Cayman Islands;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">is exempted from certain requirements of the Companies Law,
    including the filing an annual return of its shareholders with the Registrar of Companies or the Immigration Board;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">does not have to make its register of members open for inspection;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">does not have to hold an annual general meeting;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">may issue negotiable or bearer shares or shares with no par
    value (subject to the provisions of the Companies Law);</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">may obtain an undertaking against the imposition of any future
    taxation (such undertakings are usually given for 20 years in the first instance); and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">may register by way of continuation in another jurisdiction
    and be deregistered in the Cayman Islands.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&ldquo;Limited
liability&rdquo; means that the liability of each shareholder is limited to the amount unpaid by the shareholder on the shares
of the company (except in exceptional circumstances, such as involving fraud, the establishment of an agency relationship or an
illegal or improper purpose or other circumstances in which a court may be prepared to pierce or lift the corporate veil).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Register of Members</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Under
Cayman Islands law, we must keep a register of members and there should be entered therein:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the names and addresses of the members, a statement of the shares
    held by each member, and of the amount paid or agreed to be considered as paid, on the shares of each member;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the date on which the name of any person was entered on the
    register as a member; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the date on which any person ceased to be a member.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Under
Cayman Islands law, the register of members of our Company is prima facie evidence of the matters set out therein (i.e. the register
of members will raise a presumption of fact on the matters referred to above unless rebutted) and a member registered in the register
of members is deemed as a matter of Cayman Islands law to have legal title to the shares as set against its name in the register
of members. Once our register of members has been updated, the shareholders recorded in the register of members are deemed to
have legal title to the shares set against their name.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If
the name of any person is incorrectly entered in, or omitted from, our register of members, or if there is any default or unnecessary
delay in entering on the register the fact of any person having ceased to be a member of our Company, the person or member aggrieved
(or any member of our Company or our Company itself) may apply to the Cayman Islands Grand Court for an order that the register
be rectified, and the Court may either refuse such application or it may, if satisfied of the justice of the case, make an order
for the rectification of the register.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 154; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->146<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Indemnification of Directors and
Executive Officers and Limitation of Liability</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Cayman
Islands law does not limit the extent to which a company&rsquo;s memorandum and articles of association may provide for indemnification
of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to
public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime. Our Memorandum
and Articles require us to indemnify our officers and directors for actions, proceedings, claims, losses, damages, costs, liabilities
and expenses (&ldquo;Indemnified Losses&rdquo;) incurred in their capacities as such unless such Indemnified Losses arise from
dishonesty of such directors or officers. This standard of conduct is generally the same as permitted under the Delaware General
Corporation Law for a Delaware corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling
us under the foregoing provisions, we have been informed that in the opinion of the SEC, such indemnification is against public
policy as expressed in the Securities Act and is therefore unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <B><I>Underwriter&rsquo;s Warrants</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Please see &ldquo;Underwriting
&ndash; Underwriter&rsquo;s Warrants&rdquo; below for a full description of the warrants (and shares underlying such warrants)
that we are issuing to the lead underwriter in connection with this Offering. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Differences in Corporate Law</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Companies Law
is modeled after that of English law but does not follow many recent English law statutory enactments. In addition, the Companies
Law differs from laws applicable to United States corporations and their shareholders. Set forth below is a summary of some of
the significant differences between the provisions of the Companies Law applicable to us and the laws applicable to companies
incorporated in the State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.55pt"><B><I>Mergers and
Similar Arrangements.</I></B>&nbsp;The Companies Law permits mergers and consolidations between Cayman Islands companies and between
Cayman Islands companies and non-Cayman Islands companies. For these purposes, a &ldquo;merger&rdquo; means the merging of two
or more constituent companies and the vesting of their undertaking, property and liabilities in one of such companies as the surviving
company, and a &ldquo;consolidation&rdquo; means the combination of two or more constituent companies into a consolidated company
and the vesting of the undertaking, property and liabilities of such companies to the consolidated company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.4pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to effect
a merger or consolidation, the directors of each constituent company must approve a written plan of merger or consolidation, which
must then be authorized by a special resolution of the shareholders of each constituent company, and such other authorization,
if any, as may be specified in such constituent company&rsquo;s articles of association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The plan of merger
or consolidation must be filed with the Registrar of Companies of the Cayman Islands together with a declaration as to: the solvency
of the consolidated or surviving company, the merger or consolidation being bona fide and not intended to defraud creditors, no
petition or other proceeding, order or resolution to wind up the Company, no receiver, administrator or similar having been appointed
over assets or property and no scheme or other arrangement having been entered into with creditors; a list of the assets and liabilities
of each constituent company and an undertaking that a copy of the certificate of merger or consolidation will be given to the
members and creditors of each constituent company; and that notification of the merger and consolidation will be published in
the Cayman Islands Gazette. The non-surviving constituent company must have resigned from any fiduciary office held or will do
so and each constituent company having complied with any applicable regulatory laws. Dissenting shareholders have the right to
be paid the fair value of their shares if they follow the required procedures under the Companies Law subject to certain exceptions.
The fair value of the shares will be determined by the Cayman Islands court if it cannot be agreed among the parties. Court approval
is not required for a merger or consolidation effected in compliance with these statutory procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 155; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->147<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, there
are statutory provisions that facilitate the reconstruction and amalgamation of companies, provided that the arrangement is approved
by a majority in number of each class of shareholders and creditors with whom the arrangement is to be made, and who must in addition
represent three-fourths in value of each such class of shareholders or creditors, as the case may be, that are present and voting
either in person or by proxy at a meeting, or meetings, convened for that purpose. The convening of the meetings and subsequently
the arrangement must be sanctioned by the Grand Court of the Cayman Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While a dissenting
shareholder has the right to express to the court the view that the transaction ought not to be approved, the court can be expected
to approve the arrangement if it determines that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the statutory provisions as to the required majority vote have
    been met;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the shareholders have been fairly represented at the meeting
    in question;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the arrangement is such that an intelligent and honest man of
    that class acting in respect of his interest would reasonably approve; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the arrangement is not one that would more properly be sanctioned
    under some other provision of the Companies Law or that would amount to a &ldquo;fraud on the minority.&rdquo;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">When a take-over offer
is made and accepted by holders of not less than 90% of the shares within four months, the offer, or may, within a two-month period
commencing on the expiration of such four months period, require the holders of the remaining shares to transfer such shares on
the terms of the offer. An objection can be made to the Grand Court of the Cayman Islands but this is unlikely to succeed unless
there is evidence of fraud, bad faith or collusion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the arrangement
and reconstruction is thus approved, the dissenting shareholder would have no rights comparable to appraisal rights, which would
otherwise ordinarily be available to dissenting shareholders of United States corporations, providing rights to receive payment
in cash for the judicially determined value of the shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Shareholders&rsquo;
Suits.</I></B>&nbsp;In principle, we will normally be the proper plaintiff to sue for a wrong done to us as a company and as a
general rule a derivative action may not be brought by a minority shareholder. However, based on English authorities, which would
in all likelihood be of persuasive authority in the Cayman Islands, there are exceptions to the foregoing principle, including
when:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">a company acts or proposes to act illegally or ultra vires and
    is therefore incapable of ratification by the shareholders;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the act complained of, although not ultra vires, could only
    be duly effected if authorized by more than a simple majority vote that has not been obtained; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">those who control the company are perpetrating a &ldquo;fraud
    on the minority.&rdquo;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Indemnification
of Directors and Executive Officers and Limitation of Liability.</I></B>&nbsp;The Companies Law does not limit the extent to which
a company&rsquo;s memorandum and articles of association may provide for indemnification of officers and directors, except to
the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification
against civil fraud or the consequences of committing a crime. As stated above, our Memorandum and Articles permit indemnification
of officers and directors for actions, proceedings, claims, losses, damages, costs, liabilities and expenses (&ldquo;Indemnified
Losses&rdquo;) incurred in their capacities as such unless such losses or damages arise from dishonesty of such directors or officers.
This standard of conduct is generally the same as permitted under the Delaware General Corporation Law for a Delaware corporation.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or persons
controlling us under the foregoing provisions, we have been informed that in the opinion of the SEC, such indemnification is against
public policy as expressed in the Securities Act and is therefore unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 156; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->148<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Directors&rsquo;
Fiduciary Duties.</I></B>&nbsp;Under Delaware corporate law, a director of a Delaware corporation has a fiduciary duty to the
corporation and its shareholders. This duty has two components: the duty of care and the duty of loyalty. The duty of care requires
that a director act in good faith, with the care that an ordinarily prudent person would exercise under similar circumstances.
Under this duty, a director must inform himself of, and disclose to shareholders, all material information reasonably available
regarding a significant transaction. The duty of loyalty requires that a director acts in a manner he reasonably believes to be
in the best interests of the corporation. He must not use his corporate position for personal gain or advantage. This duty prohibits
self-dealing by a director and mandates that the best interest of the corporation and its shareholders take precedence over any
interest possessed by a director, officer or controlling shareholder and not shared by the shareholders generally. In general,
actions of a director are presumed to have been made on an informed basis, in good faith and in the honest belief that the action
taken was in the best interests of the corporation. However, this presumption may be rebutted by evidence of a breach of one of
the fiduciary duties. Should such evidence be presented concerning a transaction by a director, the director must prove the procedural
fairness of the transaction, and that the transaction was of fair value to the corporation. As a matter of Cayman Islands law,
a director of a Cayman Islands company is in the position of a fiduciary with respect to the company and therefore it is considered
that he or she owes the following duties to the company: a duty to act bona fide in the best interests of the company, a duty
not to make a profit based on his or her position as director (unless the company permits him or her to do so) and a duty not
to put himself or herself in a position where the interests of the company conflict with his or her personal interest or his or
her duty to a third-party. Our Memorandum and Articles do not disqualify a director from acting or from contacting with the Company
as a vendor, purchaser or otherwise provided that it does not adversely affect his or her performance of duties or responsibilities
and the nature of the interest is disclosed at the meeting at which the contract or arrangement is considered (if not previously
disclosed), and having disclosed such interest the director is not counted in the quorum and must refrain from voting on the contract
or arrangement. A director of a Cayman Islands company also owes to the company a duty to exercise the powers for the purpose
for which they were given and the duty to act with skill and care. It was previously considered that a director need not exhibit
in the performance of his or her duties a greater degree of skill than may reasonably be expected from a person of his or her
knowledge and experience. However, courts are moving towards an objective standard with regard to the required skill and care
and these authorities are likely to be followed in the Cayman Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Shareholder
Action by Written Consent.</I></B>&nbsp;Under the Delaware General Corporation Law, a corporation may eliminate the right of shareholders
to act by written consent by amendment to its certificate of incorporation. Cayman Islands law and our Memorandum and Articles
provide that shareholders may approve corporate matters by way of a unanimous written resolution signed by or on behalf of each
shareholder who would have been entitled to vote on such matter at a general meeting without a meeting being held.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Shareholder
Proposals.</I></B>&nbsp;Under the Delaware General Corporation Law, a shareholder has the right to put any proposal before the
annual meeting of shareholders, provided it complies with the notice provisions in the governing documents. A special meeting
may be called by the board of directors or any other person authorized to do so in the governing documents, but shareholders may
be precluded from calling special meetings. The Companies Law provides shareholders with only limited rights to requisition a
general meeting and does not provide shareholders with any right to put any proposal before a general meeting. However, these
rights may be provided in articles of association. Our Memorandum and Articles allow our shareholders holding not less than 1/10
of all voting power of our (paid up) share capital in issue to requisition a shareholder&rsquo;s meeting. Other than this right
to requisition a shareholders&rsquo; meeting, our Memorandum and Articles do not provide our shareholders other rights to put
proposal before a meeting. As an exempted Cayman Islands company, we are not obliged by law to call shareholders&rsquo; annual
general meetings although our Memorandum and Articles provide for same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Cumulative Voting.</I></B>&nbsp;Under
the Delaware General Corporation Law, cumulative voting for elections of directors is not permitted unless the corporation&rsquo;s
certificate of incorporation specifically provides for it. Cumulative voting potentially facilitates the representation of minority
shareholders on a board of directors since it permits the minority shareholder to cast all the votes to which the shareholder
is entitled on a single director, which increases the shareholder&rsquo;s voting power with respect to electing such director.
There are no prohibitions in relation to cumulative voting under the Companies Law but our Memorandum and Articles do not provide
for cumulative voting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 157; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->149<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Removal of Directors.</I></B>&nbsp;Under
the Delaware General Corporation Law, a director of a corporation with a may be removed with the approval of a majority of the
outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise. Under our Memorandum and Articles,
directors may be removed with or without cause, by the directors or by an ordinary resolution of our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Transactions
with Interested Shareholders.</I></B>&nbsp;The Delaware General Corporation Law contains a business combination statute applicable
to Delaware corporations whereby, unless the corporation has specifically elected not to be governed by such statute by amendment
to its certificate of incorporation, it is prohibited from engaging in certain business combinations with an &ldquo;interested
shareholder&rdquo; for three years following the date that such person becomes an interested shareholder. An interested shareholder
generally is a person or a group who or which owns or owned 15% or more of the target&rsquo;s outstanding voting share within
the past three years. This has the effect of limiting the ability of a potential acquirer to make a two-tiered bid for the target
in which all shareholders would not be treated equally. The statute does not apply if, among other things, prior to the date on
which such shareholder becomes an interested shareholder, the board of directors approves either the business combination or the
transaction which resulted in the person becoming an interested shareholder. This encourages any potential acquirer of a Delaware
corporation to negotiate the terms of any acquisition transaction with the target&rsquo;s board of directors. The Cayman Islands
has no comparable statute. As a result, we cannot avail ourselves of the types of protections afforded by the Delaware business
combination statute. However, although Cayman Islands law does not regulate transactions between a company and its significant
shareholders, it does provide that such transactions must be entered into bona fide in the best interests of the company and for
a proper corporate purpose and not with the effect of constituting a fraud on the minority shareholders. Our Memorandum and Articles,
as well as our Code of Business Conduct and Ethics that applies to our officers, directors and employees outlines how to handle
these types of transactions and other potential conflicts of interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Dissolution;
Winding up.</I></B>&nbsp;Under the Delaware General Corporation Law, unless the board of directors approves the proposal to dissolve,
dissolution must be approved by shareholders holding 100% of the total voting power of the corporation. Only if the dissolution
is initiated by the board of directors may it be approved by a simple majority of the corporation&rsquo;s outstanding shares.
Delaware law allows a Delaware corporation to include in its certificate of incorporation a supermajority voting requirement in
connection with dissolutions initiated by the board. Under the Companies Law, a company may be wound up by either an order of
the courts of the Cayman Islands or by a special resolution of its members or, if the company is unable to pay its debts as they
fall due, by an ordinary resolution of its members. The court has authority to order winding up in a number of specified circumstances
including where it is, in the opinion of the court, just and equitable to do so. Under the Companies Law a company may be dissolved,
liquidated or wound up by a special resolution of our shareholders; however, under our Memorandum and Articles, only our Directors
have power to present a winding up petition in the name of the Company and/or to apply for the appointment of provisional liquidators
in respect of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Variation of
Rights of Shares.</I></B>&nbsp;Under the Delaware General Corporation Law, a corporation may vary the rights of a class of shares
with the approval of a majority of the outstanding shares of such class, unless the certificate of incorporation provides otherwise.
Under the Companies Law and our Memorandum and Articles, if our share capital is divided into more than one class of shares, we
may vary the rights attached to any class with the written consent of the holders of two-thirds of the issued shares of that class
or with the sanction of a special resolution passed at a separate general meeting of the holders of the shares of that class.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Amendment of
Governing Documents.</I></B>&nbsp;Under the Delaware General Corporation Law, a corporation&rsquo;s governing documents may be
amended with the approval of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation provides
otherwise. As permitted by the Companies Law, each of our Memorandum of Association and Articles of Association may only be amended
with a special resolution of our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 158; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->150<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Rights of Non-resident
or Foreign Shareholders.</I></B>&nbsp;There are no limitations imposed by our Memorandum and Articles on the rights of non-resident
or foreign shareholders to hold or exercise voting rights on our shares. In addition, there are no provisions in our Memorandum
and Articles governing the ownership threshold above which shareholder ownership must be disclosed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Lock-up Agreements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> In connection with
this Offering, all of our directors and executive officers and substantially all of our existing shareholders, have signed lock-up
agreements which, subject to certain exceptions, prevent them from selling or otherwise disposing of any of our shares, or any
securities convertible into or exercisable or exchangeable for shares for a period of not less than 180 days from the effective
date of this prospectus (each, a &ldquo;Lock Up Period&rdquo;), without the prior written consent of the underwriters. The underwriters
may in their sole discretion and at any time without notice (except in the case of officers and directors) release some or all
of the shares subject to lock-up agreements prior to the expiration of the Lock Up Period. When determining whether or not to
release shares from the lock-up agreements, the underwriters may consider, among other factors, the shareholder&rsquo;s reasons
for requesting the release, the number of shares for which the release is being requested and market conditions at the time. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><B><I>Rule 144</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.25pt"><B><I>Shares Held
for Six Months</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.25pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In general, under
Rule 144 as currently in effect, and subject to the terms of any lock-up agreement, commencing 90 days after the closing of this
Offering, a person (or persons whose shares are aggregated), including an affiliate, who has beneficially owned our Class A Ordinary
Shares for six months or more, including the holding period of any prior owner other than one of our affiliates (i.e., commencing
when the shares were acquired from our Company or from an affiliate of our Company as restricted securities), is entitled to sell
our shares, subject to the availability of current public information about us. In the case of an affiliate shareholder, the right
to sell is also subject to the fulfillment of certain additional conditions, including manner of sale provisions and notice requirements,
and to a volume limitation that limits the number of shares to be sold thereby, within any three-month period, to the greater
of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">1% of the number of Class A Ordinary Shares then outstanding;
    or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify; text-indent: -9pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the average weekly trading volume of our Class A Ordinary Shares
    on the NASDAQ Capital Market during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the
    sale.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify; text-indent: -9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The six-month holding
period of Rule 144 does not apply to sales of unrestricted securities. Accordingly, persons who hold unrestricted securities may
sell them under the requirements of Rule 144 described above without regard to the six-month holding period, even if they were
considered our affiliates at the time of the sale or at any time during the 90 days preceding such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.25pt"><B><I>Shares Held
by Non-Affiliates for One Year</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.25pt"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under Rule 144 as
currently in effect, a person (or persons whose shares are aggregated) who is not considered to have been one of our affiliates
at any time during the 90 days preceding a sale and who has beneficially owned the shares proposed to be sold for at least one
year, including the holding period of any prior owner other than one of our affiliates, is entitled to sell his, her or its shares
under Rule 144 without complying with the provisions relating to the availability of current public information or with any other
conditions under Rule 144. Therefore, unless subject to a lock-up agreement or otherwise restricted, such shares may be sold immediately
upon the closing of this Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 159; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->151<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_017"></A>SHARES ELIGIBLE
FOR FUTURE SALE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">Prior to this Offering,
no public market existed for our Class A Ordinary Shares. We cannot assure you that a liquid trading market for our ordinary shares
will develop on NASDAQ or be sustained after this Offering. Once approved for listing on NASDAQ, sales of substantial amounts
of our Class A Ordinary Shares following this Offering, or the perception that these sales could occur, could adversely affect
prevailing market prices of our Class A Ordinary Shares and could impair our future ability to obtain capital, especially through
an offering of equity securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"> We will have an
aggregate of 20,127,420 Class A Ordinary Shares outstanding immediately upon the closing of this Offering (including 1,350,068
Class A Ordinary Shares to be issued upon exercise of the HF Warrant the Company issued to HF Capital. For more details of the
HF Warrant, see &ldquo;Prospectus Summary- Our Corporate History and Structure&rdquo; on page 11) assuming the full exercise of
the over-allotment option by the underwriters. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">Of these shares, the
4,025,000 Class A Ordinary Shares sold in this Offering by us will be freely tradable without restriction or further registration
under the Securities Act, unless purchased by &ldquo;affiliates&rdquo; as that term is defined under Rule 144 of the Securities
Act, who may sell only the volume of shares described below and whose sales would be subject to additional restrictions described
below. The remaining 16,102,420 Class A Ordinary Shares&nbsp;(assuming the exercise of the HF Warrant), representing approximately
80.00% of our outstanding Class A Ordinary Shares, will be held by our existing shareholders. These shares will be &ldquo;restricted
securities&rdquo; as that phrase is defined in Rule 144 under the Securities Act. Subject to certain contractual restrictions,
including the&nbsp;lock-up&nbsp;agreements described below&nbsp;for our officers, directors and greater than 5% shareholders,
holders of restricted shares will be entitled to sell those shares in the public market pursuant to an effective registration
statement under the Securities Act or if they qualify for an exemption from registration under Rule 144. Sales of these shares
in the public market after the restrictions under the lock-up agreements lapse, or the perception that those sales may occur,
could cause the prevailing market price to decrease or to be lower than it might be in the absence of those sales or perceptions.
As a result of&nbsp;lock-up agreements described below, and the provisions of Rules 144 under the Securities Act, the restricted
securities will be available for sale in the public market.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt"> We also agreed to
register up to 362,250 Class A Ordinary Shares underlying the Underwriter&rsquo;s Warrants. Once exercised, of which there can
be no guarantee, subject to the relative lock up period described elsewhere in this prospectus, those Class A Ordinary Shares
shall be freely tradable without restriction or further registration under the Securities Act. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon expiration of
the respective lock-up periods after the date of this prospectus, outstanding shares will become eligible for sale, subject in
most cases to the limitations of Rule 144.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="width: 28%; border-bottom: black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 10pt"><B>Days After Date
    of this Prospectus</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 23%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Shares Eligible</B><BR>
    <B>for Sale</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 47%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Comment</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-size: 10pt">Upon Effectiveness</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">4,025,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Freely tradable shares sold in the Offering.</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-size: 10pt">180 days</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">20,127,420*&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Shares saleable under Rule 144 and after expiration of the lock-up.</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-size: 10pt">Six months</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">20,489,670**</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Shares saleable under Rule 144 and after expiration of the lock-up.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">Up to an additional
                                         6,115,921 Class A Ordinary Shares is therefore subject to such lock-up period if so issued.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"> ** </TD><TD STYLE="text-align: justify"> Up to an additional
                                         362,250 Class A Ordinary Shares underlying the Underwriter&rsquo;s Warrants fit into
                                         this category, if and upon exercise of same. </TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 160; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->152<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Regulation S</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Regulation S under
the Securities Act provides an exemption from registration requirements in the United States for offers and sales of securities
that occur outside the United States. Rule 903 of Regulation S provides the conditions to the exemption for a sale by an issuer,
a distributor, their respective affiliates or anyone acting on their behalf, while Rule 904 of Regulation S provides the conditions
to the exemption for a resale by persons other than those covered by Rule 903. In each case, any sale must be completed in an
offshore transaction, as that term is defined in Regulation S, and no directed selling efforts, as that term is defined in Regulation
S, may be made in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a foreign issuer
as defined in Regulation S. As a foreign issuer, securities that we sell outside the United States pursuant to Regulation S are
not considered to be restricted securities under the Securities Act, and are freely tradable without registration or restrictions
under the Securities Act, unless the securities are held by our affiliates. Generally, subject to certain limitations, holders
of our restricted shares who are not our affiliates or who are our affiliates solely by virtue of their status as an officer or
director of us may, under Regulation S, resell their restricted shares in an &ldquo;offshore transaction&rdquo; if none of the
seller, its affiliate nor any person acting on their behalf engages in directed selling efforts in the United States and, in the
case of a sale of our restricted shares by an officer or director who is an affiliate of us solely by virtue of holding such position,
no selling commission, fee or other remuneration is paid in connection with the offer or sale other than the usual and customary
broker&rsquo;s commission that would be received by a person executing such transaction as agent. Additional restrictions are
applicable to a holder of our restricted shares who will be an affiliate of us other than by virtue of his or her status as an
officer or director of us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are not claiming
the potential exemption offered by Regulation S in connection with the offering of newly issued shares outside the United States
and will register all of the newly issued shares under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Rule 144</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In general, under
Rule 144, beginning ninety days after the date of this prospectus, a person who is not our affiliate and has not been our affiliate
at any time during the preceding three months will be entitled to sell any ordinary shares that such person has held for at least
six months, including the holding period of any prior owner other than one of our affiliates, without regard to volume limitations.&nbsp;Sales
of our ordinary shares by any such person would be subject to the availability of current public information about us if the shares
to be sold were held by such person for less than one year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, under
Rule 144, a person may sell our ordinary shares acquired from us immediately upon the completion of this Offering, without regard
to volume limitations or the availability of public information about us, if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the person is not our affiliate and has not been our affiliate
    at any time during the preceding three months; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the person has beneficially owned the shares to be sold for
    at least six months, including the holding period of any prior owner other than one of our affiliates.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 161; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->153<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Beginning ninety days
after the date of this prospectus, our affiliates who have beneficially owned our ordinary shares for at least six months, including
the holding period of any prior owner other than another of our affiliates, would be entitled to sell within any three-month period
those shares and any other shares they have acquired that are not restricted securities, provided that the aggregate number of
shares sold does not exceed the greater of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">1% of the number of our ordinary shares then outstanding, which
    will equal approximately ordinary shares immediately after this Offering; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the average weekly trading volume in our ordinary shares on
    the listing exchange during the four calendar weeks preceding the filing of a notice on Form 144 with respect to such sale.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Sales under Rule 144
by our affiliates are generally subject to the availability of current public information about us, as well as certain &ldquo;manner
of sale&rdquo; and notice requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Lock-up Agreements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">See &ldquo;Description
of Share Capital &ndash; Lock-up Agreements&rdquo; for a description of the lock up agreement imposed upon certain of our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Rule 701</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
general, under Rule 701 of the Securities Act as currently in effect, each of our employees, consultants or advisors who purchases
our ordinary shares from us in connection with a compensatory stock or option plan or other written agreement relating to compensation
is eligible to resell such ordinary shares 90 days after we became a reporting company under the Exchange Act in reliance on Rule
144, but without compliance with some of the restrictions, including the holding period, contained in Rule 144. However, these
shares would remain subject to lock-up arrangements and would only become eligible for sale when the lock-up period expires.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 162; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->154<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_018"></A>TAXATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>The following summary
of the material Cayman Islands, PRC and U.S. federal income tax consequences of an investment in our Class A Ordinary Shares is
based upon laws and relevant interpretations thereof in effect as of the date of this prospectus, all of which are subject to
change. This summary does not deal with all possible tax consequences relating to an investment in our Class A Ordinary Shares,
such as the tax consequences under state, local and other tax laws.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cayman Islands Taxation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Cayman Islands
currently levy no taxes on individuals or corporations based upon profits, income, gains or appreciation and there is no taxation
in the nature of inheritance tax or estate duty. There are no other taxes likely to be material to the Company levied by the Government
of the Cayman Islands except for stamp duties which may be applicable on instruments executed in, or brought within the jurisdiction
of the Cayman Islands. The Cayman Islands is not party to any double tax treaties that are applicable to any payments made to
or by the Company. There are no exchange control regulations or currency restrictions in the Cayman Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Payments of dividends
and capital in respect of our Class A Ordinary Shares will not be subject to taxation in the Cayman Islands and no withholding
will be required on the payment of a dividend or capital to any holder of our Class A Ordinary Shares, nor will gains derived
from the disposal of our Class A Ordinary Shares be subject to Cayman Islands income or corporation tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No stamp duty is payable
in respect of the issue of our Class A Ordinary Shares or on an instrument of transfer in respect of our Class A Ordinary Shares
except on instruments executed in, or brought within, the jurisdiction of the Cayman Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Material PRC Income Tax Considerations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the new EIT
Law and the Implementing Rules, an enterprise established outside of the PRC with &ldquo;de facto management bodies&rdquo; within
the PRC is considered as a resident enterprise and will be subject to a PRC income tax rate of 25% on its global income. According
to the Implementing Rules, &ldquo;de facto management bodies&rdquo; refer to &ldquo;establishments that carry out substantial
and overall management and control over the manufacturing and business operations, personnel, accounting, properties, etc. of
an enterprise.&rdquo; Accordingly, our holding company may be considered a resident enterprise and may therefore be subject to
a PRC income tax on our global income. The State Administration of Taxation issued the Notice Regarding the Determination of Chinese-Controlled
Offshore Incorporated Enterprises as PRC Tax Resident Enterprises on the Basis of De Facto Management Bodies, or Circular 82,
on April 22, 2009. Circular 82 provides certain specific criteria for determining whether the &ldquo;de facto management body&rdquo;
of a Chinese-controlled offshore incorporated enterprise is located in China. Although Circular 82 only applies to offshore enterprises
controlled by PRC enterprises and not those invested in by individuals or foreign enterprises, the determining criteria set forth
in Circular 82 may reflect the State Administration of Taxation&rsquo;s general position on how the &ldquo;de facto management
body&rdquo; test should be applied in determining the tax resident status of offshore enterprises, regardless of whether they
are controlled by PRC enterprises or controlled by or invested in by individuals or foreign enterprises. If we are considered
a resident enterprise and earn income other than dividends from our PRC subsidiary, such PRC income tax on our global income could
significantly increase our tax burden and materially and adversely affect our cash flow and profitability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We do not believe
that Zhongchao meets all of the conditions required for PRC resident enterprise. The Company is a company incorporated outside
the PRC. As a holding company, its key assets are its ownership interests in its subsidiaries, and its key assets are located,
and its records (including the resolutions of its board of directors and the resolutions of its shareholders) are maintained,
outside the PRC. For the same reasons, we believe our other entities outside of China are not PRC resident enterprises either.
However, the tax resident status of an enterprise is subject to determination by the PRC tax authorities and uncertainties remain
with respect to the interpretation of the term &ldquo;de facto management body.&rdquo; There can be no assurance that the PRC
government will ultimately take a view that is consistent with ours.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 163; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->155<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">However, if the PRC
tax authorities determine that Zhongchao is a PRC resident enterprise for enterprise income tax purposes, we may be required to
withhold a 10% withholding tax from dividends we pay to our shareholders that are non-resident enterprises. Such 10% tax rate
could be reduced by applicable tax treaties or similar arrangements between China and the jurisdiction of our shareholders. For
example, for shareholders eligible for the benefits of the tax treaty between China and Hong Kong, the tax rate is reduced to
5% for dividends if relevant conditions are met. In addition, non-resident enterprise shareholders may be subject to a 10% PRC
tax on gains realized on the sale or other disposition of Class A Ordinary Shares, if such income is treated as sourced from within
the PRC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is unclear whether
our non-PRC individual shareholders would be subject to any PRC tax on dividends or gains obtained by such non-PRC individual
shareholders in the event we are determined to be a PRC resident enterprise. If any PRC tax were to apply to such dividends or
gains, it would generally apply at a rate of 20% unless a reduced rate is available under an applicable tax treaty. However, it
is also unclear whether non-PRC shareholders of the Company would be able to claim the benefits of any tax treaties between their
country of tax residence and the PRC in the event that the Company is treated as a PRC resident enterprise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Provided that our
Cayman Islands holding company, Zhongchao, is not deemed to be a PRC resident enterprise, our shareholders who are not PRC residents
will not be subject to PRC income tax on dividends distributed by us or gains realized from the sale or other disposition of our
shares. However, under Circular 7, where a non-resident enterprise conducts an &ldquo;indirect transfer&rdquo; by transferring
taxable assets, including, in particular, equity interests in a PRC resident enterprise, indirectly by disposing of the equity
interests of an overseas holding company, the non-resident enterprise, being the transferor, or the transferee or the PRC entity
which directly owned such taxable assets may report to the relevant tax authority such indirect transfer. Using a &ldquo;substance
over form&rdquo; principle, the PRC tax authority may disregard the existence of the overseas holding company if it lacks a reasonable
commercial purpose and was established for the purpose of reducing, avoiding or deferring PRC tax. As a result, gains derived
from such indirect transfer may be subject to PRC enterprise income tax, and the transferee would be obligated to withhold the
applicable taxes, currently at a rate of 10% for the transfer of equity interests in a PRC resident enterprise. We and our non-PRC
resident investors may be at risk of being required to file a return and being taxed under Circular 7, and we may be required
to expend valuable resources to comply with Bulletin 37, or to establish that we should not be taxed under Circular 7 and Bulletin
37.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prospective investors
should consult with their own tax advisors regarding the applicability of any such taxes, the effects of any applicable income
tax treaties, and any available foreign tax credits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Material U.S. Tax Considerations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a
summary of the material U.S. federal income tax consequences of owning and disposing of our Class A Ordinary Shares. The discussion
below of the U.S. federal income tax consequences to &ldquo;U.S. Holders&rdquo; will apply to a beneficial owner of our shares
that is for U.S. federal income tax purposes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">an individual citizen or resident of the United States;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">a corporation (or other entity treated as a corporation) that
    is created or organized (or treated as created or organized) in or under the laws of the United States, any state thereof
    or the District of Columbia;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">an estate whose income is includible in gross income for U.S.
    federal income tax purposes regardless of its source; or</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">a trust if (i) a U.S. court can exercise primary supervision
    over the trust&rsquo;s administration and one or more U.S. persons are authorized to control all substantial decisions of
    the trust, or (ii) it has a valid election in effect under applicable U.S. Treasury regulations to be treated as a U.S. person.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 164; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->156<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a beneficial owner
of our shares is not described as a U.S. Holder in one of the four bullet points above and is not an entity treated as a partnership
or other pass-through entity for U.S. federal income tax purposes, such owner will be considered a &ldquo;Non-U.S. Holder.&rdquo;
The U.S. federal income tax consequences applicable to Non-U.S. Holders is described below under the heading &ldquo;Tax Consequences
to Non-U.S. Holders of Class A Ordinary Shares.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This summary is based
on the Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;), its legislative history, existing Treasury regulations
promulgated thereunder, published rulings and court decisions, all as currently in effect. These authorities are subject to change
or differing interpretations, possibly on a retroactive basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This discussion does
not address all aspects of U.S. federal income taxation that may be relevant to us or to any particular holder of our shares based
on such holder&rsquo;s individual circumstances. In particular, this discussion considers only holders that own our shares as
capital assets within the meaning of Section 1221 of the Code. This discussion also does not address the potential application
of the alternative minimum tax or the U.S. federal income tax consequences to holders that are subject to special rules, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">financial institutions or financial services entities;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">broker-dealers;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">taxpayers who have elected mark-to-market accounting;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">tax-exempt entities;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">governments or agencies or instrumentalities thereof;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">insurance companies;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">regulated investment companies;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">real estate investment trusts;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">certain expatriates or former long-term residents of the United States;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">persons that actually or constructively own 5% or more of our voting shares;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">persons that acquired our shares pursuant to the exercise of
    employee stock options, in connection with employee stock incentive plans or otherwise as compensation;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">persons that hold our shares as part of a straddle, constructive
    sale, hedging, conversion or other integrated transaction; or</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">persons whose functional currency is not the U.S. dollar.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This discussion does
not address any aspect of U.S. federal non-income tax laws, such as gift or estate tax laws, or state, local or non-U.S. tax laws.
Additionally, this discussion does not consider the tax treatment of partnerships or other pass-through entities or persons who
hold our securities through such entities. If a partnership (or other entity classified as a partnership for U.S. federal income
tax purposes) is the beneficial owner of our shares, the U.S. federal income tax treatment of a partner in the partnership will
generally depend on the status of the partner and the activities of the partnership. This discussion also assumes that any distribution
made (or deemed made) in respect of our shares and any consideration received (or deemed received) by a holder in connection with
the sale or other disposition of such shares will be in U.S. dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 165; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->157<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have not sought,
and will not seek, a ruling from the Internal Revenue Service (or &ldquo;IRS&rdquo;), or an opinion of counsel as to any U.S.
federal income tax consequence described herein. The IRS may disagree with one or more aspects of the discussion herein, and its
determination may be upheld by a court. Moreover, there can be no assurance that future legislation, regulations, administrative
rulings or court decisions will not adversely affect the accuracy of the statements in this discussion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">BECAUSE OF THE COMPLEXITY
OF THE TAX LAWS AND BECAUSE THE TAX CONSEQUENCES TO ANY PARTICULAR HOLDER OF OUR SECURITIES MAY BE AFFECTED BY MATTERS NOT DISCUSSED
HEREIN, EACH HOLDER OF OUR SECURITIES IS URGED TO CONSULT WITH ITS TAX ADVISOR WITH RESPECT TO THE SPECIFIC TAX CONSEQUENCES OF
THE OWNERSHIP AND DISPOSITION OF OUR SECURITIES, INCLUDING THE APPLICABILITY AND EFFECT OF STATE, LOCAL AND NON-U.S. TAX LAWS,
AS WELL AS U.S. FEDERAL TAX LAWS AND APPLICABLE TAX TREATIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Tax Consequences to U.S. Holders of Class
A Ordinary Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Taxation of Distributions
Paid on Class A Ordinary Shares</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the passive
foreign investment company (or &ldquo;PFIC&rdquo;), rules discussed below, a U.S. Holder generally will be required to include
in gross income as ordinary income the amount of any cash dividend paid on our Class A Ordinary Shares. A cash distribution on
such shares will be treated as a dividend for U.S. federal income tax purposes to the extent the distribution is paid out of our
current or accumulated earnings and profits (as determined for U.S. federal income tax purposes). Any distributions in excess
of such earnings and profits generally will be applied against and reduce the U.S. Holder&rsquo;s basis in its Class A Ordinary
Shares and, to the extent in excess of such basis, will be treated as gain from the sale or exchange of such Class A Ordinary
Shares. With respect to corporate U.S. Holders, dividends on our shares will not be eligible for the dividends-received deduction
generally allowed to domestic corporations in respect of dividends received from other domestic corporations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With respect to non-corporate
U.S. Holders, including individual U.S. Holders, dividends on our shares will be taxed at the lower long-term capital gains rate
applicable to qualified dividend income (see &ldquo;&mdash; Taxation on the Disposition of Class A Ordinary Shares&rdquo; below),
provided that (1) our Class A Ordinary Shares are readily tradable on an established securities market in the United States or,
in the event we are deemed to be a Chinese &ldquo;resident enterprise&rdquo; under the EIT Law, we are eligible for the benefits
of the Agreement between the Government of the United States of America and the Government of the People&rsquo;s Republic of China
for the Avoidance of Double Taxation and the Prevention of Tax Evasion with Respect to Taxes on Income, or the &ldquo;U.S.-PRC
Tax Treaty,&rdquo; (2) we are not a PFIC, as discussed below, for either the taxable year in which the dividend was paid or the
preceding taxable year, and (3) certain holding period requirements are met. Under published IRS authority, shares are considered
for purposes of clause (1) above to be readily tradable on an established securities market in the United States only if they
are listed on certain exchanges, which presently include the Nasdaq Stock Market. U.S. Holders should consult their own tax advisors
regarding the tax treatment of any dividends paid with respect to our Class A Ordinary Shares, including the effects of any change
in law after the date of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If PRC taxes apply
to dividends paid to a U.S. Holder on our Class A Ordinary Shares, such U.S. Holder may be entitled to a reduced rate of PRC tax
under the U.S-PRC Tax Treaty. In addition, such PRC taxes may be treated as foreign taxes eligible for credit against such holder&rsquo;s
U.S. federal income tax liability (subject to certain limitations). U.S. Holders should consult their own tax advisors regarding
the creditability of any such PRC tax and their eligibility for the benefits of the U.S.-PRC Tax Treaty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 166; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->158<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Taxation on the
Disposition of Class A Ordinary Shares</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon a sale or other
taxable disposition of our Class A Ordinary Shares, and subject to the PFIC rules discussed below, a U.S. Holder will recognize
capital gain or loss in an amount equal to the difference between the amount realized in U.S. dollars and the U.S. Holder&rsquo;s
adjusted tax basis in the Class A Ordinary Shares. Capital gains recognized by U.S. Holders generally are subject to U.S. federal
income tax at the same rate as ordinary income, except that long-term capital gains recognized by non-corporate U.S. Holders are
generally subject to U.S. federal income tax at a maximum rate of 20%. Capital gain or loss will constitute long-term capital
gain or loss if the U.S. Holder&rsquo;s holding period for the Class A Ordinary Shares exceeds one year. The deductibility of
capital losses is subject to various limitations. If PRC taxes would otherwise apply to any gain from the disposition of our Class
A Ordinary Shares by a U.S. Holder, such U.S. Holder may be entitled to a reduction in or elimination of such taxes under the
U.S.-PRC Tax Treaty. Any PRC taxes that are paid by a U.S. Holder with respect to such gain may be treated as foreign taxes eligible
for credit against such holder&rsquo;s U.S. federal income tax liability (subject to certain limitations that could reduce or
eliminate the available tax credit). U.S. Holders should consult their own tax advisors regarding the creditability of any such
PRC tax and their eligibility for the benefits of the U.S.-PRC Tax Treaty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Passive Foreign Investment Company Rules</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A foreign (i.e., non-U.S.)
corporation will be a PFIC if at least 75% of its gross income in a taxable year of the foreign corporation, including its pro
rata share of the gross income of any corporation in which it is considered to own at least 25% of the shares by value, is passive
income. Alternatively, a foreign corporation will be a PFIC if at least 50% of its assets in a taxable year of the foreign corporation,
ordinarily determined based on fair market value and averaged quarterly over the year, including its pro rata share of the assets
of any corporation in which it is considered to own at least 25% of the shares by value, are held for the production of, or produce,
passive income. Passive income generally includes dividends, interest, rents and royalties (other than certain rents or royalties
derived from the active conduct of a trade or business) and gains from the disposition of passive assets. Based on our current
composition and assets, we do not expect to be treated as a PFIC under the current PFIC rules. Our PFIC status, however, will
not be determinable until after the end of each taxable year. Accordingly, there can be no assurance with respect to our status
as a PFIC for our current taxable year or any future taxable year. If we are determined to be a PFIC and a U.S. Holder did not
make either a timely qualified electing fund (or &ldquo;QEF&rdquo;), election for our first taxable year as a PFIC in which the
U.S. Holder held (or was deemed to hold) Class A Ordinary Shares, or a mark-to-market election, as described below, such holder
generally will be subject to special rules with respect to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any gain recognized by the U.S. Holder on the sale or other
    disposition of its Class A Ordinary Shares; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any &ldquo;excess distribution&rdquo; made to the U.S. Holder
    (generally, any distributions to such U.S. Holder during a taxable year of the U.S. Holder that are greater than 125% of the
    average annual distributions received by such U.S. Holder in respect of the Class A Ordinary Shares during the three preceding
    taxable years of such U.S. Holder or, if shorter, such U.S. Holder&rsquo;s holding period for the Class A Ordinary Shares).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under these rules,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the U.S. Holder&rsquo;s gain or excess distribution will be
    allocated ratably over the U.S. Holder&rsquo;s holding period for the Class A Ordinary Shares;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the amount allocated to the U.S. Holder&rsquo;s taxable year
    in which the U.S. Holder recognized the gain or received the excess distribution, or to the period in the U.S. Holder&rsquo;s
    holding period before the first day of our first taxable year in which we are a PFIC, will be taxed as ordinary income;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the amount allocated to other taxable years (or portions thereof)
    of the U.S. Holder and included in its holding period will be taxed at the highest tax rate in effect for that year and applicable
    to the U.S. Holder; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the interest charge generally applicable to underpayments of
    tax will be imposed in respect of the tax attributable to each such year of the U.S. Holder.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 167; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->159<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In general, a U.S.
Holder may avoid the PFIC tax consequences described above in respect to our Class A Ordinary Shares by making a timely QEF election
to include in income its pro rata share of our net capital gains (as long-term capital gain) and other earnings and profits (as
ordinary income), on a current basis, in each case whether or not distributed, in the taxable year of the U.S. Holder in which
or with which our taxable year ends. There can be no assurance, however, that we will pay current dividends or make other distributions
sufficient for a U.S. Holder who makes a QEF election to satisfy the tax liability attributable to income inclusions under the
QEF rules, and the U.S. Holder may have to pay the resulting tax from its other assets. A U.S. Holder may make a separate election
to defer the payment of taxes on undistributed income inclusions under the QEF rules, but if deferred, any such taxes will be
subject to an interest charge.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The QEF election is
made on a shareholder-by-shareholder basis and, once made, can be revoked only with the consent of the IRS. A U.S. Holder generally
makes a QEF election by attaching a completed IRS Form 8621 (Information Return by a Shareholder of a Passive Foreign Investment
Company or Qualified Electing Fund), to a timely filed U.S. federal income tax return for the tax year to which the election relates.
Retroactive QEF elections generally may be made only by filing a protective statement with such return and if certain other conditions
are met or with the consent of the IRS. In order to comply with the requirements of a QEF election, a U.S. Holder must receive
certain information from us. Upon request from a U.S. Holder, we will endeavor to provide to the U.S. Holder no later than 90
days after the request such information as the IRS may require, including a PFIC annual information statement, in order to enable
the U.S. Holder to make and maintain a QEF election. However, there is no assurance that we will have timely knowledge of our
status as a PFIC in the future or of the required information to be provided.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a U.S. Holder has
made a QEF election with respect to our Class A Ordinary Shares, and the special tax and interest charge rules do not apply to
such shares (because of a timely QEF election for our first taxable year as a PFIC in which the U.S. Holder holds (or is deemed
to hold) such shares), any gain recognized on the appreciation of our Class A Ordinary Shares generally will be taxable as capital
gain and no interest charge will be imposed. As discussed above, U.S. Holders of a QEF are currently taxed on their pro rata shares
of a PFIC&rsquo;s earnings and profits, whether or not distributed. In such case, a subsequent distribution of such earnings and
profits that were previously included in income generally should not be taxable as a dividend to those U.S. Holders who made a
QEF election. The tax basis of a U.S. Holder&rsquo;s shares in a QEF will be increased by amounts that are included in income,
and decreased by amounts distributed but not taxed as dividends, under the above rules. Similar basis adjustments apply to property
if by reason of holding such property the U.S. Holder is treated under the applicable attribution rules as owning shares in a
QEF.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although a determination
as to our PFIC status will be made annually, an initial determination that our company is a PFIC will generally apply for subsequent
years to a U.S. Holder who held Class A Ordinary Shares while we were a PFIC, whether or not we meet the test for PFIC status
in those years. A U.S. Holder who makes the QEF election discussed above for our first taxable year as a PFIC in which the U.S.
Holder holds (or is deemed to hold) our Class A Ordinary Shares, however, will not be subject to the PFIC tax and interest charge
rules discussed above in respect to such shares. In addition, such U.S. Holder will not be subject to the QEF inclusion regime
with respect to such shares for any taxable year of ours that ends within or with a taxable year of the U.S. Holder and in which
we are not a PFIC. On the other hand, if the QEF election is not effective for each of our taxable years in which we are a PFIC
and the U.S. Holder holds (or is deemed to hold) our Class A Ordinary Shares, the PFIC rules discussed above will continue to
apply to such shares unless the holder makes a purging election, and pays the tax and interest charge with respect to the gain
inherent in such shares attributable to the pre-QEF election period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 168; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->160<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Alternatively, if
a U.S. Holder, at the close of its taxable year, owns shares in a PFIC that are treated as marketable stock, the U.S. Holder may
make a mark-to-market election with respect to such shares for such taxable year. If the U.S. Holder makes a valid mark-to-market
election for the first taxable year of the U.S. Holder in which the U.S. Holder holds (or is deemed to hold) shares in us and
for which we are determined to be a PFIC, such holder generally will not be subject to the PFIC rules described above in respect
to its Class A Ordinary Shares. Instead, in general, the U.S. Holder will include as ordinary income each year the excess, if
any, of the fair market value of its Class A Ordinary Shares at the end of its taxable year over the adjusted basis in its Class
A Ordinary Shares. The U.S. Holder also will be allowed to take an ordinary loss in respect of the excess, if any, of the adjusted
basis of its Class A Ordinary Shares over the fair market value of its Class A Ordinary Shares at the end of its taxable year
(but only to the extent of the net amount of previously included income as a result of the mark-to-market election). The U.S.
Holder&rsquo;s basis in its Class A Ordinary Shares will be adjusted to reflect any such income or loss amounts, and any further
gain recognized on a sale or other taxable disposition of the Class A Ordinary Shares will be treated as ordinary income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The mark-to-market
election is available only for stock that is regularly traded on a national securities exchange that is registered with the SEC,
or on a foreign exchange or market that the IRS determines has rules sufficient to ensure that the market price represents a legitimate
and sound fair market value. U.S. Holders should consult their own tax advisors regarding the availability and tax consequences
of a mark-to-market election in respect to our Class A Ordinary Shares under their particular circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we are a PFIC and,
at any time, have a foreign subsidiary that is classified as a PFIC, U.S. Holders generally would be deemed to own a portion of
the shares of such lower-tier PFIC, and generally could incur liability for the deferred tax and interest charge described above
if we receive a distribution from, or dispose of all or part of our interest in, the lower-tier PFIC. Upon request, we will endeavor
to cause any lower-tier PFIC to provide to a U.S. Holder no later than 90 days after the request the information that may be required
to make or maintain a QEF election with respect to the lower-tier PFIC. However, there is no assurance that we will have timely
knowledge of the status of any such lower-tier PFIC or will be able to cause the lower-tier PFIC to provide the required information.
U.S. Holders are urged to consult their own tax advisors regarding the tax issues raised by lower-tier PFICs. If a U.S. Holder
owns (or is deemed to own) shares during any year in a PFIC, such holder may have to file an IRS Form 8621 (whether or not a QEF
election or mark-to-market election is made). The rules dealing with PFICs and with the QEF and mark-to-market elections are very
complex and are affected by various factors in addition to those described above. Accordingly, U.S. Holders of our Class A Ordinary
Shares should consult their own tax advisors concerning the application of the PFIC rules to our Class A Ordinary Shares under
their particular circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Tax Consequences to Non-U.S. Holders of
Class A Ordinary Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Dividends paid to
a Non-U.S. Holder in respect to its Class A Ordinary Shares generally will not be subject to U.S. federal income tax, unless the
dividends are effectively connected with the Non-U.S. Holder&rsquo;s conduct of a trade or business within the United States (and,
if required by an applicable income tax treaty, are attributable to a permanent establishment or fixed base that such holder maintains
in the United States).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, a Non-U.S.
Holder generally will not be subject to U.S. federal income tax on any gain attributable to a sale or other disposition of our
Class A Ordinary Shares, unless such gain is effectively connected with its conduct of a trade or business in the United States
(and, if required by an applicable income tax treaty, is attributable to a permanent establishment or fixed base that such holder
maintains in the United States) or the Non-U.S. Holder is an individual who is present in the United States for 183 days or more
in the taxable year of sale or other disposition and certain other conditions are met (in which case, such gain from United States
sources generally is subject to tax at a 30% rate or a lower applicable tax treaty rate).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Dividends and gains
that are effectively connected with the Non-U.S. Holder&rsquo;s conduct of a trade or business in the United States (and, if required
by an applicable income tax treaty, are attributable to a permanent establishment or fixed base in the United States) generally
will be subject to tax in the same manner as for a U.S. Holder and, in the case of a Non-U.S. Holder that is a corporation for
U.S. federal income tax purposes, may also be subject to an additional branch profits tax at a 30% rate or a lower applicable
tax treaty rate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 169; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->161<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Backup Withholding and Information Reporting</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In general, information
reporting for U.S. federal income tax purposes should apply to distributions made on our Class A Ordinary Shares within the United
States to a non-corporate U.S. Holder and to the proceeds from sales and other dispositions of our Class A Ordinary Shares by
a non-corporate U.S. Holder to or through a U.S. office of a broker. Payments made (and sales and other dispositions effected
at an office) outside the United States will be subject to information reporting in limited circumstances. In addition, backup
withholding of United States federal income tax, currently at a rate of 28%, generally will apply to dividends paid on our Class
A Ordinary Shares to a non-corporate U.S. Holder and the proceeds from sales and other dispositions of shares by a non-corporate
U.S. Holder, in each case who (a) fails to provide an accurate taxpayer identification number; (b) is notified by the IRS that
backup withholding is required; or (c) in certain circumstances, fails to comply with applicable certification requirements. A
Non-U.S. Holder generally may eliminate the requirement for information reporting and backup withholding by providing certification
of its foreign status, under penalties of perjury, on a duly executed applicable IRS Form W-8 or by otherwise establishing an
exemption.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Backup withholding
is not an additional tax. Rather, the amount of any backup withholding will be allowed as a credit against a U.S. Holder&rsquo;s
or a Non-U.S. Holder&rsquo;s U.S. federal income tax liability and may entitle such holder to a refund, provided that certain
required information is timely furnished to the IRS. Holders are urged to consult their own tax advisors regarding the application
of backup withholding and the availability of and procedure for obtaining an exemption from backup withholding in their particular
circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Individual U.S. Holders
may be required to report ownership of our Class A Ordinary Shares and certain related information on their individual federal
income tax returns in certain circumstances. Generally, this reporting requirement will apply if (1) the Class A Ordinary Shares
are held in an account of the individual U.S. Holder maintained with a &ldquo;foreign financial institution&rdquo; or (2) the
Class A Ordinary Shares are not held in an account maintained with a &ldquo;financial institution,&rdquo; as such terms are defined
in the Code. The reporting obligation will not apply to an individual, however, unless the total aggregate value of the individual&rsquo;s
foreign financial assets exceeds US$50,000 during a taxable year. For avoidance of doubt, this reporting requirement should not
apply to Class A Ordinary Shares held in an account with a U.S. brokerage firm. Failure to comply with this reporting requirement,
if it applies, will result in substantial penalties. In certain circumstances, additional tax and other reporting requirements
may apply, and U.S. Holders of our Class A Ordinary Shares are advised to consult with their own tax advisors concerning all such
reporting requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 170; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->162<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_019"></A>ENFORCEABILITY OF
CIVIL LIABILITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We incorporated in
the Cayman Islands in order to enjoy the following benefits: (1) political and economic stability; (2) an effective judicial system;
(3) a favorable tax system; (4) the absence of exchange control or currency restrictions; and (5) the availability of professional
and support services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">However, certain disadvantages
accompany incorporation in the Cayman Islands. These disadvantages include, but are not limited to, the following: (1) the Cayman
Islands has a less developed body of securities laws as compared to the United States and these securities laws provide significantly
less protection to investors; and (2) Cayman Islands companies may not have standing to sue before the federal courts of the United
States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our constitutional
documents do not contain provisions requiring that disputes, including those arising under the securities laws of the United States,
between us, our officers, directors and shareholders, be arbitrated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of our operations
are conducted outside the United States, and all of our assets are located outside the United States. All of our officers are
nationals or residents of jurisdictions other than the United States and a substantial portion of their assets are located outside
the United States. As a result, it may be difficult for a shareholder to effect service of process within the United States upon
these persons, or to enforce against us or them judgments obtained in United States courts, including judgments predicated upon
the civil liability provisions of the securities laws of the United States or any state in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have appointed
Hunter Taubman Fischer &amp; Li LLC, located at 1450 Broadway, 26th Floor, New York, NY 10018, as our agent upon whom process
may be served in any action brought against us under the securities laws of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Conyers Dill &amp;
Pearman, our counsel as to Cayman Islands law, and Zong Heng Law Firm, our counsel as to PRC law, have advised us, respectively,
that there is uncertainty as to whether the courts of the Cayman Islands and China, respectively, would:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">recognize or enforce judgments of United States courts obtained
    against us or our directors or officers predicated upon the civil liability provisions of the securities laws of the United
    States or any state in the United States; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">entertain original actions brought in each respective jurisdiction
    against us or our directors or officers predicated upon the securities laws of the United States or any state in the United
    States.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Conyers Dill &amp;
Pearman has advised us that it is uncertain whether the courts of the Cayman Islands will allow shareholders of our company to
originate actions in the Cayman Islands based upon securities laws of the United States. In addition, there is uncertainty with
regard to Cayman Islands law related to whether a judgment obtained from the U.S. courts under civil liability provisions of U.S.
securities laws will be determined by the courts of the Cayman Islands as penal or punitive in nature. If such determination is
made, the courts of the Cayman Islands will not recognize or enforce the judgment against a Cayman Islands company, such as our
company. As the courts of the Cayman Islands have yet to rule on making such a determination in relation to judgments obtained
from U.S. courts under civil liability provisions of U.S. securities laws, it is uncertain whether such judgments would be enforceable
in the Cayman Islands. Conyers Dill &amp; Pearman has further advised us that although there is no statutory enforcement in the
Cayman Islands of judgments obtained in the United States, a judgment obtained in such jurisdiction will be recognized and enforced
in the courts of the Cayman Islands at common law, without any re-examination of the merits of the underlying dispute, by an action
commenced on the foreign judgment debt in the Grand Court of the Cayman Islands, provided such judgment (a) is given by a foreign
court of competent jurisdiction, (b) imposes on the judgment debtor a liability to pay a liquidated sum for which the judgment
has been given, (c) is final, (d) is not in respect of taxes, a fine or a penalty and (e) was not obtained in a manner and is
not of a kind the enforcement of which is contrary to natural justice or the public policy of the Cayman Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Zong Heng Law Firm
has advised us that the recognition and enforcement of foreign judgments are provided for under PRC Civil Procedure Law. PRC courts
may recognize and enforce foreign judgments in accordance with the requirements of PRC Civil Procedure Law based either on treaties
between China and the country where the judgment is made or on reciprocity between jurisdictions. China does not have any treaties
or other form of reciprocity with the United States or the Cayman Islands that provide for the reciprocal recognition and enforcement
of foreign judgments. In addition, according to the PRC Civil Procedure Law, courts in the PRC will not enforce a foreign judgment
against us or our directors and officers if they decide that the judgment violates the basic principles of PRC law or national
sovereignty, security or public interest. As a result, it is uncertain whether and on what basis a PRC court would enforce a judgment
rendered by a court in the United States or in the Cayman Islands.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 171; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->163<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_020"></A>UNDERWRITING </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> In connection with
this offering, we will enter into an underwriting agreement with Network 1 Financial Securities, Inc., as the representative of
the underwriters (the &ldquo;Representative&rdquo;). Each underwriter has severally agreed to purchase, and we have agreed to
sell to them, severally, the numbers of Class A Ordinary Shares indicated in the following table.: </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; border-bottom: Black 1.5pt solid"> Name </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> Number
    of Shares </TD><TD STYLE="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Network 1 Financial Securities, Inc. </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> Tiger Brokers (NZ) Limited </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; font: bold 10pt Times New Roman, Times, Serif; text-align: justify"> Total </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD><TD STYLE="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right"> 3,500,000 </TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> &nbsp; </TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> The underwriting
agreement provides that the underwriters is obligated to purchase all shares in the offering if any are purchased, other than
those shares covered by the over-allotment option described below. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> We have agreed
to indemnify the underwriters and certain of their controlling persons against certain liabilities, including liabilities under
the Securities Act, and to contribute to payments that the underwriters may be required to make in respect of those liabilities. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> We have granted
to the underwriters a 45-day option to purchase up to 525,000 additional shares from us at the initial public offering price less
the underwriting discounts and commissions. The option may be exercised in whole or in part, and may be exercised more than once,
during the 45-day option period. The underwriters may exercise this option solely for the purpose of covering over-allotments,
if any, made in connection with the offering contemplated by this prospectus. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Tiger Brokers (NZ)
Limited, or TBNZ is not a broker-dealer registered with the SEC. To the extent that its conduct may involve the offer or sale
of ADSs to investors in the United States, those offers or sales will be made through US Tiger Securities, Inc., TBNZ's SEC-registered
broker-dealer affiliate in the United States. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Fees and Expenses</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"> The underwriters
have advised us that they propose to offer the shares to the public at the public offering price set forth on the cover page of
this prospectus and to certain dealers at that price less a concession not in excess of $0.315 per share. After this offering,
the public offering price and concession to dealers may be reduced by the underwriters. No such reduction shall change the amount
of proceeds to be received by us as set forth on the cover page of this prospectus. The securities are offered by the underwriters
as stated herein, subject to receipt and acceptance by them and subject to their right to reject any order in whole or in part.
The underwriters have informed us that it does not intend to confirm sales to any accounts over which it exercises discretionary
authority. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"> We have agreed to
pay the underwriters a cash fee equal to seven percent (7%) of the aggregate gross proceeds raised in this offering. The following
table shows the price per share and total public offering price, underwriting discounts and commissions, and proceeds before expenses
to us. These amounts are shown assuming both no exercise and full exercise of the underwriters&rsquo; over-allotment option. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; padding-bottom: 1.5pt; border-bottom: Black 1.5pt solid">Per&nbsp;Share</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: center; border-bottom: Black 1.5pt solid">Without<BR>
                                         Over-allotment</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: center; border-bottom: Black 1.5pt solid">With<BR>
                                         Over-allotment</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: center; border-bottom: Black 1.5pt solid">Without<BR>
                                         Over-allotment</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: center; border-bottom: Black 1.5pt solid">With<BR>
                                         Over-allotment</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left; text-indent: -12pt; padding-left: 12pt">Underwriting Discounts and Commissions paid
    by us</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">US$</TD><TD STYLE="width: 9%; text-align: right">0.315</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">US$</TD><TD STYLE="width: 9%; text-align: right">0.315</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">US$</TD><TD STYLE="width: 9%; text-align: right">1,102,500</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">US$</TD><TD STYLE="width: 9%; text-align: right">1,267,875</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -12pt; padding-left: 12pt">Proceeds, before expenses, to us</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">US$</TD><TD STYLE="text-align: right">4.185</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">US$</TD><TD STYLE="text-align: right">4.185</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">US$</TD><TD STYLE="text-align: right">14,647,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">US$</TD><TD STYLE="text-align: right">16,844,625</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"> We will also pay
to the underwriters by deduction from the net proceeds of the offering contemplated herein, a non-accountable expense allowance
equal to one and half percent (1.5%) of the gross proceeds received by us from the sale of the shares. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 172; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->164<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"> We have agreed to
reimburse the Representative 1 up to a maximum of $125,000 for out-of-pocket accountable expenses. We have paid expense deposits
of $50,000 to the Representative for its anticipated out-of-pocket expenses; any expense deposits will be returned to us to the
extent the Representative&rsquo;s out-of-pocket accountable expenses are not actually incurred in accordance with FINRA Rule 5110(f)(2)(C).
The following fees and expenses will be applied against the accountable expenses: the costs of any &ldquo;due diligence&rdquo;
meetings; the reasonable and documented fees and disbursements of the Representative&rsquo;s counsel (which maximum shall apply
solely to such fees and disbursements of counsel and not to other fees and expenses); background checks of the Company&rsquo;s
officers and directors; preparation of bound volumes and mementos in such quantities as the underwriters may reasonably request,
provided that the actual accountable expenses of the underwriters shall not exceed $125,000. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"> We have agreed to
pay expenses relating to the offering, including, without limitation: the Company&rsquo;s legal and accounting fees and disbursements;
the costs of preparing, printing, mailing and delivering the Registration Statement, the preliminary and final prospectus contained
therein and amendments thereto, post-effective amendments and supplements thereto, the underwriting agreement and related documents
(all in such quantities as the Underwriter may reasonably require); preparing and printing stock certificates and warrant certificates;
all road show expenses incurred by us; all filing fees (including SEC filing fees) and communication expenses relating to the
registration of the shares to be sold in the Offering, FINRA filing fees; transfer taxes, if any, payable upon the transfer of
securities from the Company to the underwriters; and the fees and expenses of the transfer agent, clearing firm and registrar
for the shares. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"> We estimate that
the total expenses of the offering payable by us, excluding the total underwriting discount and commissions will be approximately
$361,250, including (i) a maximum aggregate reimbursement of $125,000 of the Representative&rsquo;s accountable expenses, and
(ii) non-accountable expense allowance of 1.5% of the gross proceeds from this offering. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Underwriter&nbsp;Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt"> In addition, we have
agreed to grant the Representative non-redeemable warrants to purchase an amount equal to nine percent (9%) of the Class A Ordinary
Shares sold in the offering, which warrants will be exercisable six months after the closing of the offering, have a three (3)
year term after the effective date of the registration statement, of which this prospectus forms part, and a cashless exercise
feature. Such warrants are exercisable at a price of 125% of the public offering price of the Class A Ordinary Shares offered
pursuant to this offering. We will register the shares underlying the Underwriter Warrants and will file all necessary undertakings
in connection therewith. The Underwriter Warrants shall not be sold during the Offering, or sold, transferred, assigned, pledged,
or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective
economic disposition of the securities by any person for a period of 180 days immediately following the date of effectiveness,
except that they may be transferred to any member participating in the Offering and the officers or partners thereof, if all securities
so transferred remain subject to the lock-up restriction for the remainder of the time period. The Underwriter Warrants may be
exercised as to all or a lesser number of shares, will provide for cashless exercise and will contain provisions for one demand
registration of the sale of the underlying Class A Ordinary Shares at the Company&rsquo;s expense, an additional demand registration
at the warrant holders&rsquo; expense, and unlimited &ldquo;piggyback&rdquo; registration rights for a period of three years after
the effective date of the registration statement at the Company&rsquo;s expense. The Underwriter&rsquo;s Warrants shall further
provide for adjustment in the number and price of such warrants (and the Class A Ordinary Shares underlying such warrants) in
the event of recapitalization, merger or other structural transaction to prevent dilution. The Representative will have the option
to exercise their warrants at any time, provided that such shares are not transferred during the lock-up period; the 180-day lock
period will remain on these underlying shares. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 173; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->165<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Electronic Offer, Sale and Distribution
of Class A Ordinary Share&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> A prospectus in
electronic format may be made available on the websites maintained by the underwriters. In addition, the Class A Ordinary Share
may be sold by the underwriters to securities dealers who resell the Class A Ordinary Share to online brokerage account holders.
Other than the prospectus in electronic format, the information on the underwriters&rsquo; website and any information contained
in any other website maintained by the underwriters are not part of the prospectus or the registration statement of which this
prospectus forms a part, has not been approved and/or endorsed by us or the underwriters in their capacity as underwriters and
should not be relied upon by investors. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Lock-up Agreements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> We, each of our
directors and officers and holders of ten percent or more of our Class A Ordinary Share on a fully diluted basis immediately prior
to the consummation of this offering have agreed or are otherwise contractually restricted for a period of 180 days after the
date of this prospectus, without the prior written consent of the underwriters not to directly or indirectly: </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">issue
    (in the case of us), offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or
    contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of any shares of our
    Class A Ordinary Share or other capital stock or any securities convertible into or exercisable or exchangeable for our Class
    A Ordinary Share or other capital stock;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    the case of us, file or cause the filing of any registration statement under the Securities Act with respect to any shares
    of our Class A Ordinary Share or other capital stock or any securities convertible into or exercisable or exchangeable for
    our Class A Ordinary Share or other capital stock, other than registration statements on Form S-8 filed with the SEC after
    the closing date of this offering; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">enter
    into any swap or other agreement, arrangement, hedge or transaction that transfers to another, in whole or in part, directly
    or indirectly, any of the economic consequences of ownership of our Class A Ordinary Share or other capital stock or any securities
    convertible into or exercisable or exchangeable for our Class A Ordinary Share or other capital stock,</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">whether any transaction described in any
of the foregoing bullet points is to be settled by delivery of our Class A Ordinary Share or other capital stock, other securities,
in cash or otherwise, or publicly announce an intention to do any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> There are no existing
agreements between the underwriters and any person who will execute a lock-up agreement in connection with this offering providing
consent to the sale of shares prior to the expiration of the lock-up period. The lock up does not apply to the issuance of shares
upon the exercise of rights to acquire Class A Ordinary Shares pursuant to any existing stock option or the conversion of any
of our preferred convertible stock. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Procedures and Requirements for Subscription</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you decide to subscribe
for any shares in this offering, you must:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">execute
                                         and deliver a subscription agreement; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">deliver
                                         the subscription price to the Company by cashier&rsquo;s check or wire transfer of immediately
                                         available funds.</FONT></TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt"></P>

<!-- Field: Page; Sequence: 174; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->166<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The subscription agreement
requires you to disclose your name, address, social security number, telephone number, email address, number of shares you are
purchasing, and the price you are paying for your shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon the Company&rsquo;s
acceptance of a subscription and receipt of full payment, and subject to the timing qualification set forth above, the Company
shall countersign the subscription agreement and issue a stock certificate along with a copy of the subscription agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have the right
to accept or reject subscriptions in whole or in part, for any reason or for no reason. All monies from rejected subscriptions
will be returned immediately by us to the subscriber, without interest or deductions. Subscriptions for securities will be accepted
or rejected within three (3) business days after we receive them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Stabilization</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Upon the declaration of effectiveness
of the registration statement of which this prospectus is a part, we will enter into an underwriting agreement with the underwriters.
The terms of the underwriting agreement provide that the obligations of the underwriters are subject to certain conditions precedent,
including the absence of any material adverse change in our business and the receipt of certain certificates, opinions and letters
from us, our counsel and our auditors. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have applied to list our shares on
the NASDAQ Capital Market under the symbol &ldquo;ZCMD&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Prior to this offering, there has been
no public market for our shares. The initial public offering price was determined by negotiations among us and the underwriters
and will not necessarily reflect the market price of our Class A Ordinary Share following this offering. The principal factors
that were considered in determining the initial public offering price included: </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif">the
                                         information presented in this prospectus and otherwise available to the underwriters;</FONT> </TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
                                         history of, and prospects for, the industry in which we will compete;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
                                         ability of our management;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
                                         prospects for our future earnings;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
                                         present state of our development, results of operations and our current financial condition</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the
                                         general condition of the securities markets at the time of this offering; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    recent market prices of, and the demand for, publicly traded Class A Ordinary Share of generally comparable companies.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We cannot assure you that the initial
public offering price will correspond to the price at which our Class A Ordinary Share will trade in the public market subsequent
to this offering or that an active trading market for our Class A Ordinary Share will develop and continue after this offering.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> In connection with the offering the
underwriters may engage in stabilizing transactions, over-allotment transactions, syndicate covering transactions, penalty bids
and passive market making in accordance with Regulation M under the Securities Exchange Act of 1934 (the &ldquo;Exchange Act&rdquo;). </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stabilizing
                                         transactions permit bids to purchase the underlying security so long as the stabilizing
                                         bids do not exceed a specified maximum.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt"></P>

<!-- Field: Page; Sequence: 175; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->167<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-size: 10pt"> &nbsp; </TD>
    <TD STYLE="width: 24px; font-size: 10pt"> &#9679; </TD>
    <TD STYLE="text-align: justify; font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over-allotment
    involves sales by the Underwriter of the Class A Ordinary Share in excess of the number of shares the underwriters are obligated
    to purchase, which creates a syndicate short position. The short position may be either a covered short position or a naked
    short position. In a covered short position, the number of shares over-allotted by the underwriters is not greater than the
    number of shares that they may purchase in the over-allotment option. In a naked short position, the number of shares involved
    is greater than the number of shares in the over-allotment option. The underwriters may close out any covered short position
    by either exercising their over-allotment option and/or purchasing shares in the open market.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"> &nbsp; </TD>
    <TD STYLE="width: 24px"> &#9679; </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Syndicate covering
    transactions involve purchases of shares in the open market after the distribution has been completed in order to cover syndicate
    short positions. In determining the source of shares to close out the short position, the underwriters will consider, among
    other things, the price of our Class A Ordinary Share available for purchase in the open market as compared to the price at
    which they may purchase shares through the over-allotment option. If the underwriters sell more shares than could be covered
    by the over-allotment option, a naked short position, the position can only be closed out by buying shares in the open market.
    A naked short position is more likely to be created if the underwriters are concerned that there could be downward pressure
    on the price of the shares in the open market after pricing that could adversely affect investors who purchase in the offering.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px">&#9679;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Penalty bids permit the representatives to reclaim a selling concession from a syndicate member when the Class A Ordinary Share originally sold by the syndicate member is purchased in a stabilizing or syndicate covering transaction to cover syndicate short positions.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"> &nbsp; </TD>
    <TD STYLE="width: 24px"> &#9679; </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In passive market
    making, market makers in the shares who are the underwriters or prospective underwriter may, subject to limitations, make
    bids for or purchases of our Class A Ordinary Share until the time, if any, at which a stabilizing bid is made.</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These stabilizing transactions, syndicate
covering transactions and penalty bids may have the effect of raising or maintaining the market price of our Class A Ordinary
Share or preventing or retarding a decline in the market price of the shares. As a result the price of our Class A Ordinary Share
may be higher than the price that might otherwise exist in the open market. These transactions may be effected on NASDAQ Capital
Market or otherwise and, if commenced, may be discontinued at any time.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> A prospectus in electronic format may
be made available on the web sites maintained by one or more of the underwriters, or selling group members, if any, participating
in this offering and the underwriters may distribute prospectuses electronically. The underwriters may agree to allocate a number
of shares to selling group members for sale to their online brokerage account holders. Internet distributions will be allocated
by the underwriters and selling group members that will make internet distributions on the same basis as other allocations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> The underwriters and their respective
affiliates are full-service financial institutions engaged in various activities, which may include securities trading, commercial
and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing
and brokerage activities. The underwriters have, from time to time, performed, and may in the future perform, various financial
advisory and investment banking services for us, for which it received or will receive customary fees and expenses. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> In addition, in the ordinary course
of the business activities, the underwriters and their affiliates may make or hold a broad array of investments and actively trade
debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account
and for the accounts of their customers. These investments and securities activities may involve securities and/or instruments
of ours or our affiliates. The underwriters and their affiliates may also make investment recommendations and/or publish or express
independent research views in respect of such securities or financial instruments and may hold, or recommend to clients that they
acquire, long and/or short positions in such securities and instruments. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 176; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->168<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Selling Restrictions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No action has been
taken in any jurisdiction (except in the United States) that would permit a public offering of the Ordinary Shares, or the possession,
circulation or distribution of this prospectus or any other material relating to us or the Ordinary Shares, where action for that
purpose is required. Accordingly, the Ordinary Shares may not be offered or sold, directly or indirectly, and neither this prospectus
nor any other offering material or advertisements in connection with the Ordinary Shares may be distributed or published, in or
from any country or jurisdiction except in compliance with any applicable rules and regulations of any such country or jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Australia</I></B>.&nbsp;This
document has not been lodged with the Australian Securities&nbsp;&amp; Investments Commission and is only directed to certain
categories of exempt persons. Accordingly, if you receive this document in Australia:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) you confirm and
warrant that you are either:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) &ldquo;sophisticated
investor&rdquo; under section 708(8)(a) or (b) of the Corporations Act 2001 (Cth) of Australia, or the Corporations Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(ii) &ldquo;sophisticated investor&rdquo;
under section&nbsp;708(8)(c) or (d)&nbsp;of the Corporations Act and that you have provided an accountant&rsquo;s certificate
to the company which complies with the requirements of section&nbsp;708(8)(c)(i) or (ii)&nbsp;of the Corporations Act and related
regulations before the offer has been made;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(iii) person associated with
the company under section&nbsp;708(12) of the Corporations Act; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(iv) &ldquo;professional investor&rdquo;
within the meaning of section&nbsp;708(11)(a) or (b)&nbsp;of the Corporations Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">and to the extent that you are
unable to confirm or warrant that you are an exempt sophisticated investor, associated person or professional investor under the
Corporations Act, any offer made to you under this document is void and incapable of acceptance;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 177; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->169<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) you warrant and
agree that you will not offer any of the ordinary shares issued to you pursuant to this document for resale in Australia within
12&nbsp;months of those ordinary shares being issued unless any such resale offer is exempt from the requirement to issue a disclosure
document under section&nbsp;708 of the Corporations Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Canada.&nbsp;</I></B>&nbsp;The
ordinary shares may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors,
as defined in National Instrument&nbsp;45-106&nbsp;<I>Prospectus Exemptions</I>&nbsp;or subsection&nbsp;73.3(1) of the&nbsp;<I>Securities
Act</I>&nbsp;(Ontario), and are permitted customers, as defined in National Instrument&nbsp;31-103&nbsp;<I>Registration Requirements,
Exemptions and Ongoing Registrant Obligations</I>. Any resale of the ordinary shares must be made in accordance with an exemption
from, or in a transaction not subject to, the prospectus requirements of applicable securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Securities legislation
in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus
(including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised
by the purchaser within the time limit prescribed by the securities legislation of the purchaser&rsquo;s province or territory.
The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&rsquo;s province or territory
for particulars of these rights or consult with a legal&nbsp;advisor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Pursuant to section&nbsp;3A.3
(or, in the case of securities issued or guaranteed by the government of a non-Canadian jurisdiction, section&nbsp;3A.4) of National
Instrument&nbsp;33-105&nbsp;<I>Underwriting Conflicts</I>&nbsp;(&ldquo;NI&nbsp;33-105&rdquo;), the Underwriter is not required
to comply with the disclosure requirements of NI&nbsp;33-105 regarding underwriters conflicts of interest in connection with this&nbsp;offering. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> <B><I>Cayman Islands
</I></B>This prospectus does not constitute an invitation or offer to the public in the Cayman Islands of the Ordinary Shares,
whether by way of sale or subscription. The underwriters have not offered or sold, and will not offer or sell, directly or indirectly,
any Ordinary Shares in the Cayman Islands.&nbsp; </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>European Economic
Area.</I></B>&nbsp;In relation to each Member State of the European Economic Area which has implemented the Prospectus Directive
(each, a &ldquo;Relevant Member State&rdquo;) an offer to the public of any shares which are the subject of the offering contemplated
by this prospectus may not be made in that Relevant Member State unless the prospectus has been approved by the competent authority
in such Relevant Member State or, where appropriate, approved in another Relevant Member State and notified to the competent authority
in that Relevant Member State, all in accordance with the Prospectus Directive, except that an offer to the public in that Relevant
Member State of any shares may be made at any time under the following exemptions under the Prospectus Directive, if they have
been implemented in that Relevant Member State:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    legal entities which are authorized or regulated to operate in the financial markets or, if not so authorized or regulated,
    whose corporate purpose is solely to invest in securities;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    any legal entity which has two or more of (i) an average of at least 250 employees during the last financial year; (ii) a
    total balance sheet of more than &euro;43,000,000 and (iii) an annual net turnover of more than &euro;50,000,000, as shown
    in its last annual or consolidated accounts;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px"> &nbsp; </TD>
    <TD STYLE="width: 24px; font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
    the underwriters to fewer than 100 or, if the Relevant Member State has implemented the relevant provision of the 2010 PD
    Amending Directive, 150, natural or legal persons (other than &ldquo;qualified investors&rdquo; as defined in the Prospectus
    Directive) subject to obtaining the prior consent of the representatives for any such offer; or</FONT> </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    any other circumstances falling within Article 3(2) of the Prospectus Directive; provided that no such offer of shares shall
    result in a requirement for the publication by us or any representative of a prospectus pursuant to Article 3 of the Prospectus
    Directive or supplement a prospectus pursuant to Article 16 of the Prospectus Directive.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 178; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->170<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Any person making
or intending to make any offer of shares within the EEA should only do so in circumstances in which no obligation arises for us
or the underwriters to produce a prospectus for such offer. Neither we nor the underwriters have authorized, nor do they authorize,
the making of any offer of shares through any financial intermediary, other than offers made by the underwriters which constitute
the final offering of shares contemplated in this prospectus. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the purposes of
this provision, and your representation below, the expression an &ldquo;offer to the public&rdquo; in relation to any shares in
any Relevant Member State means the communication in any form and by any means of sufficient information on the terms of the offer
and any shares to be offered so as to enable an investor to decide to purchase any shares, as the same may be varied in that Relevant
Member State by any measure implementing the Prospectus Directive in that Relevant Member State and the expression &ldquo;Prospectus
Directive&rdquo; means Directive 2003/71/EC (including the 2010 PD Amending Directive, to the extent implemented in the Relevant
Member State) and includes any relevant implementing measure in each Relevant Member State and the expression &ldquo;2010 PD Amending
Directive&rdquo; means Directive 2010/73/EU.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Each person in
a Relevant Member State who receives any communication in respect of, or who acquires any shares under, the offer of shares contemplated
by this prospectus will be deemed to have represented, warranted and agreed to and with us and the underwriters that: </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">it
                                         is a &ldquo;qualified investor&rdquo; within the meaning of the law in that Relevant
                                         Member State implementing Article 2(1)(e) of the Prospectus Directive; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">in
                                         the case of any shares acquired by it as a financial intermediary, as that term is used
                                         in Article 3(2) of the Prospectus Directive, (i) the shares acquired by it in the offering
                                         have not been acquired on behalf of, nor have they been acquired with a view to their
                                         offer or resale to, persons in any Relevant Member State other than &ldquo;qualified
                                         investors&rdquo; (as defined in the Prospectus Directive), or in circumstances in which
                                         the prior consent of the representatives has been given to the offer or resale; or (ii)
                                         where shares have been acquired by it on behalf of persons in any Relevant Member State
                                         other than qualified investors, the offer of those shares to it is not treated under
                                         the Prospectus Directive as having been made to such persons.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, in the
United Kingdom, this document is being distributed only to, and is directed only at, and any offer subsequently made may only
be directed at persons who are &ldquo;qualified investors&rdquo; (as defined in the Prospectus Directive) (i)&nbsp;who have professional
experience in matters relating to investments falling within Article&nbsp;19 (5)&nbsp;of the Financial Services and Markets Act
2000 (Financial Promotion) Order 2005, as amended, or the Order, and/or (ii)&nbsp;who are high net worth companies (or persons
to whom it may otherwise be lawfully communicated) falling within Article&nbsp;49(2)(a) to (d)&nbsp;of the Order (all such persons
together being referred to as &ldquo;relevant persons&rdquo;). This document must not be acted on or relied on in the United Kingdom
by persons who are not relevant persons. In the United Kingdom, any investment or investment activity to which this document relates
is only available to, and will be engaged in with, relevant persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Hong Kong</I></B>.
The ordinary shares may not be offered or sold in Hong Kong by means of any document other than (i) in circumstances which do
not constitute an offer to the public within the meaning of the Companies (Winding Up and Miscellaneous Provisions) Ordinance
(Cap.32, Laws of Hong Kong), or (ii) to &ldquo;professional investors&rdquo; within the meaning of the Securities and Futures
Ordinance (Cap.571, Laws of Hong Kong) and any rules made thereunder, or (iii) in other circumstances which do not result in the
document being a &ldquo;prospectus&rdquo; within the meaning of the Companies (Winding Up and Miscellaneous Provisions) Ordinance
(Cap.32, Laws of Hong Kong), and no advertisement, invitation or document relating to the ordinary shares may be issued or may
be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed
at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under
the laws of Hong Kong) other than with respect to ordinary shares which are or are intended to be disposed of only to persons
outside Hong Kong or only to &ldquo;professional investors&rdquo; within the meaning of the Securities and Futures Ordinance (Cap.571,
Laws of Hong Kong) and any rules made thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 179; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->171<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Malaysia</I></B>.
The shares have not been and may not be approved by the securities commission Malaysia, or SC, and this document has not been
and will not be registered as a prospectus with the SC under the Malaysian capital markets and services act of 2007, or CMSA.
Accordingly, no securities or offer for subscription or purchase of securities or invitation to subscribe for or purchase securities
are being made to any person in or from within Malaysia under this document except to persons falling within any of paragraphs
2(g)(i) to (xi) of schedule 5 of the CMSA and distributed only by a holder of a capital markets services license who carries on
the business of dealing in securities and subject to the issuer having lodged this prospectus with the SC within seven days from
the date of the distribution of this prospectus in Malaysia. The distribution in Malaysia of this document is subject to Malaysian
laws. Save as aforementioned, no action has been taken in Malaysia under its securities laws in respect of this document. This
document does not constitute and may not be used for the purpose of a public offering or an issue, offer for subscription or purchase,
invitation to subscribe for or purchase any securities requiring the approval of the SC or the registration of a prospectus with
the SC under the CMSA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Japan</I></B>.
The ordinary shares have not been and will not be registered under the Financial Instruments and Exchange Law of Japan, and ordinary
shares will not be offered or sold, directly or indirectly, in Japan or to, or for the benefit of, any resident of Japan (which
term as used herein means any person resident in Japan, including any corporation or other entity organized under the laws of
Japan), or to others for re-offering or resale, directly or indirectly, in Japan or to a resident of Japan, except pursuant to
any exemption from the registration requirements of, and otherwise in compliance with, the Financial Instruments and Exchange
Law and any other applicable laws, regulations and ministerial guidelines of Japan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B><I>People&rsquo;s
Republic of China</I></B>. This prospectus has not been and will not be circulated or distributed in the PRC, and ordinary shares
may not be offered or sold, and will not be offered or sold to any person for re-offering or resale, directly or indirectly, to
any resident of the PRC except pursuant to applicable laws and regulations of the PRC.</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Singapore</I></B>.
This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus
and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of our ordinary
shares may not be circulated or distributed, nor may our ordinary shares be offered or sold, or be made the subject of an invitation
for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i) to an institutional investor
under Section 274 of the Securities and Futures Act, Chapter 289 of Singapore, or SFA, (ii) to a relevant person or any person
pursuant to Section 275(1A), and in accordance with the conditions specified in Section 275 of the SFA, and in accordance with
the conditions specified in Section 275 of the SFA or (iii) otherwise pursuant to, and in accordance with the conditions of, any
other applicable provision of the SFA, in each case subject to compliance with conditions set forth in the SFA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Where our ordinary
shares are subscribed or purchased under Section 275 by a relevant person which is: (a) a corporation (which is not an accredited
investor as defined in Section 4A of the SFA) the sole business of which is to hold investments and the entire share capital of
which is owned by one or more individuals, each of whom is an accredited investor; or (b) a trust (where the trustee is not an
accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited
investor; shares, debentures and units of shares and debentures of that corporation or the beneficiaries&rsquo; rights and interest
(howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired
the ordinary shares under Section 275 of the SFA, except: (1) to an institutional investor (for corporations under Section 274
of the SFA) or to a relevant person defined in Section 275(2) of the SFA, or to any person pursuant to an offer that is made on
terms that such shares, debentures and units of shares and debentures of that corporation or such rights and interest in that
trust are acquired at a consideration of not less than S$200,000 (or its equivalent in a foreign currency) for each transaction,
whether such amount is to be paid for in cash or by exchange of securities or other assets, and further for corporations, in accordance
with the conditions, specified in Section 275 of the SFA; (2) where no consideration is or will be given for the transfer; or
(3) where the transfer is by operation of law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 180; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->172<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><B><I>Taiwan
</I></B>The Ordinary Shares have not been and will not be registered or filed with, or approved by, the Financial Supervisory
Commission of Taiwan pursuant to relevant securities laws and regulations and may not be offered or sold in Taiwan through a public
offering or in circumstances which constitute an offer within the meaning of the Securities and Exchange Act of Taiwan or relevant
laws and regulations that require a registration, filing or approval of the Financial Supervisory Commission of Taiwan. No person
or entity in Taiwan has been authorized to offer or sell the Ordinary Shares in Taiwan.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>United Kingdom</I></B><I>.</I>&nbsp;An
offer of the shares may not be made to the public in the United Kingdom within the meaning of Section 102B of the Financial Services
and Markets Act 2000, as amended, or the FSMA, except to legal entities that are authorized or regulated to operate in the financial
markets or, if not so authorized or regulated, whose corporate purpose is solely to invest in securities or otherwise in circumstances
that do not require the publication by the company of a prospectus pursuant to the Prospectus Rules of the Financial Services
Authority, or the FSA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An invitation or inducement
to engage in investment activity (within the meaning of Section 21 of FSMA) may only be communicated to persons who have professional
experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial
Promotion) Order 2005 or in circumstances in which Section 21 of FSMA does not apply to the company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> All applicable
provisions of the FSMA with respect to anything done by the underwriters in relation to the shares must be complied with in, from
or otherwise involving the United Kingdom. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 181; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->173<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPENSES OF THE OFFERING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The estimated expenses
payable by us in connection with the offering described in this Registration Statement (other than the placement discounts and
commissions) will be as follows. With the exception of the filing fees for the U.S. Securities Exchange Commission, FINRA and
NASDAQ, all amounts are estimates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left">U.S. Securities and Exchange Commission registration fee</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">2,615.5</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">FINRA filing fee</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,952.5</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">NASDAQ listing fee</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Legal fees and expenses for Chinese counsel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">76,336</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Legal fees and expenses for Cayman Islands counsel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">20,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Legal fees and expenses for U.S. counsel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">250,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accounting fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">366,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Printing fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">42,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">Miscellaneous</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><P STYLE="margin: 0">248,500</P>


</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,013,904</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_021"></A>LEGAL MATTERS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Certain matters
as to U.S. federal law in connection with this offering will be passed upon for us by Hunter Taubman Fischer &amp; Li LLC. The
validity of the shares and certain legal matters relating to the offering as to Cayman Islands law will be passed upon for us
by Conyers Dill &amp; Pearman. Certain legal matters relating to the offering as to Chinese law will be passed upon for us by
Zong Heng Law Firm. VCL Law LLP has acted as counsel for the underwriters with respect to this offering. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_022"></A>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Financial statements
as of December 31, 2018 and 2017, respectively, and for the years then ended appearing in this prospectus, have been included
herein and in the registration statement in reliance upon the report of Marcum Bernstein &amp; Pinchuk LLP an independent registered
public accounting firm, appearing elsewhere herein, and upon the authority of that firm as experts in accounting and auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_023"></A>WHERE YOU CAN FIND
MORE INFORMATION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have filed with
the SEC a Registration Statement under the Securities Act relating to this Offering of our Class A Ordinary Shares. This prospectus
does not contain all of the information contained in the Registration Statement. The rules and regulations of the SEC allow us
to omit certain information from this prospectus that is included in the Registration Statement. Statements made in this prospectus
concerning the contents of any contract, agreement or other document are summaries of all material information about the documents
summarized, but are not complete descriptions of all terms of these documents. If we filed any of these documents as an exhibit
to the Registration Statement, you may read the document itself for a complete description of its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may read and copy
the Registration Statement, including the related exhibits and schedules, and any document we file with the SEC without charge
at the SEC&rsquo;s public reference room at 100 F Street, N.E., Room 1580, Washington, D.C. 20549. You may also obtain copies
of the documents at prescribed rates by writing to the Public Reference Section of the SEC at 100 F Street, N.E., Room 1580, Washington,
D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the public reference room. The SEC also maintains
an Internet website that contains reports and other information regarding issuers that file electronically with the SEC. Our filings
with the SEC are also available to the public through the SEC&rsquo;s website at http://www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon completion of
this Offering, we will be subject to the information reporting requirements of the Exchange Act that are applicable to foreign
private issuers, and under those requirements will file reports with the SEC. Those other reports or other information may be
inspected without charge at the locations described above. As a foreign private issuer, we will be exempt from the rules under
the Exchange Act related to the furnishing and content of proxy statements, and our officers, directors and principal shareholders
will be exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act. In addition,
we will not be required under the Exchange Act to file annual, quarterly and current reports and financial statements with the
SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act. However, we will file
with the SEC, within 120 days after the end of each fiscal year, or such applicable time as required by the SEC, an annual report
on Form 20-F containing financial statements audited by an independent registered public accounting firm, and will submit to the
SEC, on Form 6-K, unaudited quarterly financial information for the first three quarters of each fiscal year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We maintain a corporate
website www.mdmooc.orgInformation contained on, or that can be accessed through, our website does not constitute a part of this
prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 182; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->174<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 7pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%"><FONT STYLE="font-size: 10pt">Item 6.</FONT></TD>
    <TD STYLE="width: 92%"><FONT STYLE="font-size: 10pt">Indemnification of Directors and Officers</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Companies Law
does not limit the extent to which a company&rsquo;s Amended and Restated Memorandum and Articles of Association may provide for
indemnification of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to
be contrary to public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime.
Our Amended and Restated Memorandum and Articles of Association permit indemnification of officers and directors for losses, damages,
costs and expenses incurred in their capacities as such unless such losses or damages arise from dishonesty of such directors
or officers willful default of fraud.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling us under the
foregoing provisions, we have been informed that in the opinion of the SEC, such indemnification is against public policy as expressed
in the Securities Act and is therefore unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%; text-align: justify"><FONT STYLE="font-size: 10pt">Item 7.</FONT></TD>
    <TD STYLE="width: 92%; text-align: justify"><FONT STYLE="font-size: 10pt">Recent Sales of Unregistered Securities</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">As further discussed
below, in August 2019, we issued 14,752,352 Class A Ordinary Shares to 12 shareholders and 5,497,715 Class B Ordinary Shares to
1 shareholder as inducements for them to enter into VIE Arrangements pursuant to which the Company shall obtain absolute control
rights and the rights to the assets, property and revenue of Zhongchao Shanghai and issued HF Capital a warrant to purchase 1,350,068
Class A Ordinary Shares. The issuance was conducted in private transactions under Cayman Islands laws. All such share issuances
were deemed to be exempt under the Securities Act by virtue of Section 4(2) thereof as transactions not involving any public offering.
In addition, certain share issuances were deemed not to fall within Section 5 under the Securities Act and to be further exempt
under Rule 901 and 903 of Regulation S promulgated thereunder by virtue of being issuances of securities by non-U.S. companies
to non-U.S. citizens or residents, conducted outside the United States and not using any element of interstate commerce.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%"><FONT STYLE="font-size: 10pt">Item 8.</FONT></TD>
    <TD STYLE="width: 92%"><FONT STYLE="font-size: 10pt">Exhibits and Financial Statement Schedules</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 7pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>(a) Exhibits</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 7pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following exhibits are filed herewith or incorporated by
reference in this prospectus:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 7pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%; border-bottom: black 1.5pt solid; padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">Exhibit</FONT></TD>
    <TD STYLE="width: 1%; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 91%; border-bottom: black 1.5pt solid; padding: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-size: 10pt">Exhibit title</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"> <FONT STYLE="font-size: 10pt">1.1***</FONT> </TD>
    <TD STYLE="padding: 0; text-indent: 0"> &nbsp; </TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390020000736/ff12019a3ex1-1_zhongchao.htm"> <FONT STYLE="font-size: 10pt">Form of Underwriting Agreement</FONT> </A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">3.1**</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019024295/ff12019ex3-1_zhong.htm"><FONT STYLE="font-size: 10pt">Amended and Restated Memorandum and Articles of Association</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">4.1**</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019025969/ff12019a1ex4-1_zhongchao.htm"><FONT STYLE="font-size: 10pt">Specimen Class A Ordinary Share Certificate</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"> <FONT STYLE="font-size: 10pt">4.2***</FONT> </TD>
    <TD STYLE="padding: 0; text-indent: 0"> &nbsp; </TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390020000736/ff12019a3ex4-2_zhongchao.htm"> <FONT STYLE="font-size: 10pt">Form of Underwriter Warrant</FONT> </A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"> <FONT STYLE="font-size: 10pt">5.1***</FONT> </TD>
    <TD STYLE="padding: 0; text-indent: 0"> &nbsp; </TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"> <FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390020000736/ff12019a3ex5-1_zhongchao.htm">Opinion of Conyers Dill &amp; Pearman</A></FONT> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"> <FONT STYLE="font-size: 10pt">5.2***</FONT> </TD>
    <TD STYLE="padding: 0; text-indent: 0"> &nbsp; </TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"> <FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390020000736/ff12019a3ex5-2_zhongchao.htm">Opinion of Hunter Taubman Fischer &amp; Li LLC</A></FONT> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">10.1**</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019024295/ff12019ex10-1_zhong.htm"><FONT STYLE="font-size: 10pt">Employment Agreement between Zhongchao Inc. and Weiguang Yang dated as of August 7, 2019</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">10.2**</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019024295/ff12019ex10-2_zhong.htm"><FONT STYLE="font-size: 10pt">Employment Agreement between Zhongchao Inc. and Pei Xu dated as of August 7, 2019</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">10.3**</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019024295/ff12019ex10-3_zhong.htm"><FONT STYLE="font-size: 10pt">Employment Agreement between Zhongchao Inc. and Xuejun Chen dated as of August 7, 2019</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">10.4**</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019024295/ff12019ex10-4_zhong.htm"><FONT STYLE="font-size: 10pt">Employment Agreement between Zhongchao Inc. and Baoqian Tian dated as of August 7, 2019</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">10.5**</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019024295/ff12019ex10-5_zhong.htm"><FONT STYLE="font-size: 10pt">Employment Agreement between Zhongchao Inc. and Shuang Wu dated as of August 7, 2019</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">10.6**</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019024295/ff12019ex10-6_zhong.htm"><FONT STYLE="font-size: 10pt">Equity Interest Pledge Agreement among Beijing Zhongchao Zhongxing Technology Limited and Zhongchao Medical Technology (Shanghai) Corp. and its shareholders dated as of August 14, 2019</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">10.7**</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019024295/ff12019ex10-7_zhong.htm"><FONT STYLE="font-size: 10pt">Proxy Agreement and Power of Attorney among Beijing Zhongchao Zhongxing Technology Limited and Zhongchao Medical Technology (Shanghai) Corp. and its shareholders dated as of August 14, 2019</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">10.8**</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019024295/ff12019ex10-8_zhong.htm"><FONT STYLE="font-size: 10pt">Spouse Consent Letters of the spouse of each married shareholder of Zhongchao Medical Technology (Shanghai) Corp. dated as of August 14, 2019</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">10.9**</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019024295/ff12019ex10-9_zhong.htm"><FONT STYLE="font-size: 10pt">Master Exclusive Service Agreement among Beijing Zhongchao Zhongxing Technology Limited and Zhongchao Medical Technology (Shanghai) Corp. and its shareholders dated as of August 14, 2019</FONT></A></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 183; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0; width: 8%"><FONT STYLE="font-size: 10pt">10.10**</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; width: 91%"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019024295/ff12019ex10-10_zhong.htm"><FONT STYLE="font-size: 10pt">Business Cooperation Agreement among Beijing Zhongchao Zhongxing Technology Limited and Zhongchao Medical Technology (Shanghai) Corp. and its shareholders dated as of August 14, 2019</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD></TR>

<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0; width: 8%"><FONT STYLE="font-size: 10pt">10.11**</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0; width: 91%"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019024295/ff12019ex10-11_zhong.htm"><FONT STYLE="font-size: 10pt">Exclusive Option Agreement among Beijing Zhongchao Zhongxing Technology Limited and Zhongchao Medical Technology (Shanghai) Corp. and its shareholders dated as of August 14, 2019</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">10.12**</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019024295/ff12019ex10-12_zhong.htm"><FONT STYLE="font-size: 10pt">Director Offer Letter between Zhongchao Inc. and Weiguang Yang dated as of November 17, 2019</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">10.13**</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019024295/ff12019ex10-13_zhong.htm"><FONT STYLE="font-size: 10pt">Director Offer Letter between Zhongchao Inc. and Pei Xu dated as of November 17, 2019</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">10.14**</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019024295/ff12019ex10-14_zhong.htm"><FONT STYLE="font-size: 10pt">Independent Director Offer Letter between Zhongchao Inc. and John C. General dated as of November 17, 2019</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">10.15**</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019024295/ff12019ex10-5_zhong.htm"><FONT STYLE="font-size: 10pt">Independent Director Offer Letter between Zhongchao Inc. and Kevin Dean Vassily dated as of November 17, 2019</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">10.16**</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019024295/ff12019ex10-16_zhong.htm"><FONT STYLE="font-size: 10pt">Independent Director Offer Letter between Zhongchao Inc. and Dan Li dated as of November 17, 2019</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">10.17**</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019025969/ff12019a1ex10-17_zhongchao.htm"><FONT STYLE="font-size: 10pt">Warrant to Purchase Ordinary Shares between Zhongchao Inc. and HF Capital Management Delta, Inc. dated as of August 1, 2019</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">10.18**</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019025969/ff12019a1ex10-18_zhongchao.htm"><FONT STYLE="font-size: 10pt">English translated copy of Framework Agreement among Zhongchao Medical Technology (Shanghai) Corp., Mr. Weiguang Yang, and Yantai Hanfujingfei Investment Center (LP) dated as of August 1, 2019</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">14.1**</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019024295/ff12019ex14-1_zhong.htm"><FONT STYLE="font-size: 10pt">Code of Conduct and Ethics</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">21.1**</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019024295/ff12019ex21-1_zhong.htm"><FONT STYLE="font-size: 10pt">List of Subsidiaries of the Registrant</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">23.1*</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt"><A HREF="ff12019a4ex23-1_zhongchao.htm">Consent of Marcum Bernstein &amp; Pinchuk LLP</A></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"> <FONT STYLE="font-size: 10pt">23.2***</FONT> </TD>
    <TD STYLE="padding: 0; text-indent: 0"> &nbsp; </TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390020000736/ff12019a3ex5-1_zhongchao.htm"> <FONT STYLE="font-size: 10pt">Consent of Conyers Dill &amp; Pearman (included in Exhibit 5.1)</FONT> </A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"> <FONT STYLE="font-size: 10pt">23.3***</FONT> </TD>
    <TD STYLE="padding: 0; text-indent: 0"> &nbsp; </TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390020000736/ff12019a3ex5-2_zhongchao.htm"> <FONT STYLE="font-size: 10pt">Consent of Hunter Taubman Fischer &amp; Li LLC (included in Exhibit 5.2)</FONT> </A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"> <FONT STYLE="font-size: 10pt">24.1*</FONT> </TD>
    <TD STYLE="padding: 0; text-indent: 0"> &nbsp; </TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"> <FONT STYLE="font-size: 10pt"><A HREF="#power_001">Power of
    Attorney (included on signature page)</A></FONT> </TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">99.1**</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019024295/ff12019ex99-1_zhong.htm"><FONT STYLE="font-size: 10pt">Charter of the Audit Committee</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">99.2**</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019024295/ff12019ex99-2_zhong.htm"><FONT STYLE="font-size: 10pt">Charter of the Compensation Committee</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">99.3**</FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390019024295/ff12019ex99-3_zhong.htm"><FONT STYLE="font-size: 10pt">Charter of the Nominating and Corporate Governance Committee</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0; text-indent: 0"> <FONT STYLE="font-size: 10pt">99.4***</FONT> </TD>
    <TD STYLE="padding: 0; text-indent: 0"> &nbsp; </TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"> <FONT STYLE="font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/1785566/000121390020000736/ff12019a3ex99-4_zhongchao.htm">Registrant&rsquo;s Representation Pursuant To Requirements Of Form 20-F, Item 8.A.</A></FONT> </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Filed herewith.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">**</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Previously filed; incorporated
by reference to the identically named exhibit filed with the Registration Statement on Form F-1 (File No. 333- 333-234807) filed
with the Securities and Exchange Commission on December 27, 2019</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 7pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"> <FONT STYLE="font-size: 10pt">***</FONT> </TD><TD STYLE="text-align: justify"> <FONT STYLE="font-size: 10pt">Previously
                                         filed; incorporated by reference to the identically named exhibit filed with the Registration
                                         Statement on Form F-1 (File No. 333- 333-234807) filed with the Securities and Exchange
                                         Commission on January 10, 2020.</FONT> </TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 7pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>(b) Financial Statement Schedules</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 7pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%"><FONT STYLE="font-size: 10pt">Item 9.</FONT></TD>
    <TD STYLE="width: 92%"><FONT STYLE="font-size: 10pt">Undertakings</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> The undersigned
registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreement certificates
in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant
under the provisions described in Item 6, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification
is against public policy as expressed in the Securities Act and is therefore unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling
person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or
controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel
the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication
of such issue.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 184; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The undersigned registrant hereby undertakes:</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(1) For purposes of
determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this
registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant under Rule 424(b)(1)
or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared
effective.</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: justify; text-indent: 20.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(2) For the purpose
of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall
be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at
that time shall be deemed to be the initial bona fide offering thereof.</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0 0 0 2pt; text-align: justify; text-indent: 20.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(3) To file, during
any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) To include any
prospectus required by section 10(a)(3) of the Securities Act of 1933;</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) To reflect in
the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the
Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total
dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the
estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b)
(&sect;230.424(b) of this chapter) if, in the aggregate, the changes in volume and price represent no more than 20% change in
the maximum aggregate Offering Price set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in the effective Registration
Statement.</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii) To include any
material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material
change to such information in the Registration Statement;</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> To provide to the
underwriters at the closing specified in the underwriting agreements certificates in such denominations and registered in such
names as required by the underwriters to permit prompt delivery to each purchaser. </P>



<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">That, for the purpose
of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new
Registration Statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed
to be the initial bona fide offering thereof.</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">That, for purposes
of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part
of this Registration Statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant
to Rule 424(b) (1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this Registration Statement as of the
time it was declared effective.</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To remove from registration
by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To file a post-effective
amendment to the Registration Statement to include any financial statements required by Item 8.A. of Form 20-F at the start of
any delayed offering or throughout a continuous offering, unless the registrant includes in the prospectus, by means of a post-effective
amendment, financial statements required pursuant to this paragraph and other information necessary to ensure that all other information
in the prospectus is at least as current as the date of those financial statements.</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">That, for the purpose
of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the
securities: The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant
to this Registration Statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities
are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller
to the purchaser and will be considered to offer or sell such securities to such purchaser:</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) Any preliminary
prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424 (&sect;230.424
of this chapter);</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) Any free writing
prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned
registrant;</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii) The portion
of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
or its securities provided by or on behalf of the undersigned registrant; and</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iv) Any other communication
that is an offer in the offering made by the undersigned registrant to the purchaser.</P>

<P STYLE="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">That, insofar as indemnification
for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the
registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC
such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim
for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director,
officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the
opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final
adjudication of such issue.&nbsp;</P>


<!-- Field: Page; Sequence: 185; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="power_001"></A>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Pursuant to the
requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that
it meets all of the requirements for filing on Form F-1 and has duly caused this Registration Statement to be signed on its behalf
by the undersigned, thereunto duly authorized, in the People&rsquo;s Republic of China, on February 6, 2020. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt"><B>Zhongchao Inc. </B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="width: 6%; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="width: 34%; font-family: Times New Roman,serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt">/s/ Weiguang
    Yang</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt">Weiguang Yang</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt">Chief Executive Officer<BR>
    (Principal Executive Officer)</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">KNOW ALL PERSONS BY
THESE PRESENTS, that each person whose signature appears below constitutes and appoints each of Weiguang Yang and Pei Xu as an
attorney-in-fact with full power of substitution, for him or her in any and all capacities, to do any and all acts and all things
and to execute any and all instruments which said attorney and agent may deem necessary or desirable to enable the registrant
to comply with the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), and any rules, regulations and requirements
of the Securities and Exchange Commission thereunder, in connection with the registration under the Securities Act of Class A
Ordinary Shares of the registrant (the &ldquo;Shares&rdquo;), including, without limitation, the power and authority to sign the
name of each of the undersigned in the capacities indicated below to the Registration Statement on Form F-1 (the &ldquo;Registration
Statement&rdquo;) to be filed with the Securities and Exchange Commission with respect to such Shares, to any and all amendments
or supplements to such Registration Statement, whether such amendments or supplements are filed before or after the effective
date of such Registration Statement, to any related Registration Statement filed pursuant to Rule 462(b) under the Securities
Act, and to any and all instruments or documents filed as part of or in connection with such Registration Statement or any and
all amendments thereto, whether such amendments are filed before or after the effective date of such Registration Statement; and
each of the undersigned hereby ratifies and confirms all that such attorney and agent shall do or cause to be done by virtue hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities
and on the dates indicated:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%; border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 43%; border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 20%; border-bottom: black 1.5pt solid; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Weiguang Yang</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and </FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> February 6, 2020 </TD></TR>
<TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weiguang Yang</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> Chairman of the Board&nbsp;of Directors </P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> (Principal Executive Officer) </P></TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Pei Xu</FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial
    Officer and Director</FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> February 6, 2020 </TD></TR>
<TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pei Xu</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Accounting and Financial Officer)</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Xuejun Chen</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Medical Officer</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> February 6, 2020 </TD></TR>
<TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Xuejun Chen&nbsp;</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Baoqian Tian</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Sales Officer</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> February 6, 2020 </TD></TR>
<TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Baoqian Tian</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Shuang Wu</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Operation Officer</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> February 6, 2020 </TD></TR>
<TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shuang Wu</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/&nbsp;John
    C. General</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent Director</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> February 6, 2020 </TD></TR>
<TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John C. General</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Kevin Dean Vassily</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent Director</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> February 6, 2020 </TD></TR>
<TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kevin Dean Vassily</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/&nbsp;Dan
    Li</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent Director</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> February 6, 2020 </TD></TR>
<TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dan Li</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 186; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE OF AUTHORIZED REPRESENTATIVE
IN THE UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Pursuant to the
Securities Act of 1933, the undersigned, the duly authorized representative in the United States of the Company has signed this
Registration Statement or amendment thereto in New York on February 6, 2020. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt">Authorized U.S. Representative</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman,serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="width: 6%; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 34%; border-bottom: black 1.5pt solid; font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt">&nbsp;/s/
    Arila Zhou</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt">Arila Zhou</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font-family: Times New Roman,serif"><FONT STYLE="font-size: 10pt">Authorized Representative in the United States</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 187; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_024"></A>ZHONGCHAO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSOLIDATED FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; width: 93%; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
    Financial Statements for the Years Ended December 31, 2018 and 2017</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 7%; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt"><A HREF="#finnew_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Report
    of Independent Registered Public Accounting Firm</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt"><A HREF="#finnew_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
    Balance Sheets as of December 31, 2018 and 2017</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt"><A HREF="#finnew_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Consolidated
    Statements of Income and Comprehensive Income for the Years Ended December 31, 2018 and 2017</U></FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom">F-4</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt"><A HREF="#finnew_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
    Statements of Changes in Shareholders&rsquo; Equity for the Years Ended December 31, 2018 and 2017</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">F-5</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#finnew_005">Consolidated
    Statements of Cash Flows for the Years Ended December 31, 2018 and 2017</A></FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><A HREF="#finnew_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
    to Consolidated Financial Statements</FONT></A></TD>
    <TD STYLE="text-align: center; vertical-align: bottom">F-7</TD></TR>

<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unaudited Condensed
    Consolidated Financial Statements for the Six Months ended June 30, 2019 and 2018</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#c_001">Unaudited
    Condensed Consolidated Balance Sheet as of June 30, 2019</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">F-37</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#c_002">Unaudited
    Condensed Consolidated Statements of Income and Comprehensive Income for the Six Months Ended June 30, 2019 and 2018</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">F-38</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#c_003">Unaudited
    Condensed Consolidated Statements of Changes in Shareholders&rsquo; Equity for the Six Months Ended June 30, 2019 and 2018</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">F-39</TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#c_004">Unaudited
    Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2019 and 2018</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">F-40</TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#c_005">Notes to <FONT STYLE="font-size: 10pt">Unaudited
    Condensed </FONT>Consolidated Financial Statements</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">F-41</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 188; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_08.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="finnew_001"></A>REPORT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the Shareholders and Board of Directors
of Zhongchao Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Opinion on the Financial Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have audited the accompanying consolidated
balance sheets of Zhongchao Inc. (the &ldquo;Company&rdquo;) as of December 31, 2018 and 2017, the related consolidated statements
of income and comprehensive income<B>,</B> changes in shareholders&rsquo; equity and cash flows for each of the two years in the
period ended December 31, 2018, and the related notes (collectively referred to as the &ldquo;financial statements&rdquo;). In
our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December
31, 2018 and 2017, and the results of its operations and its cash flows for each of the two years in the period ended December
31, 2018, in conformity with accounting principles generally accepted in the United States of America.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Basis for Opinion</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These financial statements are the responsibility
of the Company&rsquo;s management. Our responsibility is to express an opinion on the Company&rsquo;s financial statements based on our audits.
We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&ldquo;PCAOB&rdquo;)
and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable
rules and regulations of the Securities and Exchange Commission and the PCAOB.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conducted our audits in accordance
with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about
whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required
to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are
required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company&rsquo;s internal control over financial reporting. Accordingly, we express no such opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our audits included performing procedures
to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures
that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures
in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made
by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide
a reasonable basis for our opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Marcum Bernstein &amp; Pinchuk <FONT STYLE="font-variant: small-caps">llp</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have served as the Company&rsquo;s auditor since 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">August 19, 2019</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 189; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="finnew_002"></A>ZHONGCHAO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSOLIDATED BALANCE SHEETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of December 31, 2018 and 2017</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Expressed in U.S. dollar, except for
the number of shares)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; white-space: nowrap">December
    31,<BR>
    2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; white-space: nowrap">December
    31,<BR>
    2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-indent: -0.125in; padding-left: 0.125in">ASSETS</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-indent: -0.125in; padding-left: 0.125in">Current Assets</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Cash and cash equivalents</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">7,918,675</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">2,978,515</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Short-term investments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,163,552</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,821,312</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,993,237</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,301,810</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">Prepayments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">562,575</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,673</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Other current assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">923,318</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">306,162</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Total Current Assets</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">12,561,357</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">6,409,472</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Property and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">669,905</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53,336</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Land use rights, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">392,761</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Intangible assets, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,054</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">51,758</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Deferred tax assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">378,047</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">461,437</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">Total Assets</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">14,046,124</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">6,976,003</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">LIABILITIES AND EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Current Liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Short-term borrowings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">727,220</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,625</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">582,130</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Advances from customers</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">553,409</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">712,671</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Deferred income, current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">407,243</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Income tax payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">288,111</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,869</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Accrued expenses and other
    liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">333,901</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">265,537</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Total Current Liabilities</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">2,333,509</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right"><P STYLE="margin: 0pt 0">1,563,207</P>


</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Deferred income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">327,249</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><P STYLE="margin: 0pt 0">215,176</P>


</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Total
    Liabilities</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,660,758</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,778,383</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Commitments and Contingencies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Shareholders&rsquo; Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Class A Ordinary Share (par value $0.0001 per share,
    450,000,000 shares authorized; 16,102,420 and 14,752,420 shares issued and outstanding at December 31, 2018 and 2017, respectively)*</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,610</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,475</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Class B Ordinary Share (par value $0.0001 per share,
    50,000,000 shares authorized; 5,497,715 and 5,497,715 shares issued and outstanding at December 31, 2018 and 2017, respectively)*</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">550</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">550</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,945,979</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,380,337</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Statutory reserve</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,539</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Accumulated deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(384,309</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,383,093</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Accumulated other comprehensive
    (loss) income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(171,167</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">208,353</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Total Zhongchao Inc.&rsquo;s
    Shareholders&rsquo; Equity</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">11,413,202</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">5,207,622</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Noncontrolling interests</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(27,836</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(10,002</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Total
    Shareholders&rsquo; Equity</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">11,385,366</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">5,197,620</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">Total Liabilities
    and Shareholders&rsquo; Equity</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">14,046,124</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">6,976,003</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         number of shares are presented on a retroactive basis to reflect the reorganization and
                                         the stock dividend announced on November 21, 2017 (Note 16).</FONT></TD>
</TR></TABLE>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">The</FONT>&nbsp;
<FONT STYLE="font-family: Times New Roman, Times, Serif">accompanying notes are an integral part of the consolidated financial
statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 190; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="finnew_003"></A>ZHONGCHAO
INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CONSOLIDATED STATEMENTS
OF INCOME AND COMPREHENSIVE INCOME</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>For the Years
Ended December 31, 2018 and 2017</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Expressed in
U.S. dollar, except for the number of shares)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Years Ended<BR>
    December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%">Revenues</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">12,865,870</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">9,816,312</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">Cost of revenues</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(4,456,353</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,970,068</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Gross Profit</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">8,409,517</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">5,846,244</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Operating Expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Selling and marketing expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,261,258</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,715,201</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">General and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,425,663</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,139,165</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Research and development expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,447,949</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(943,253</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Operating Expenses</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(5,134,870</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(4,797,619</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Income from Operations</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">3,274,647</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">1,048,625</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Interest income, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">191,609</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,331</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other income, net</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">37,364</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">275,019</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Income Before Income Taxes</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">3,503,620</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">1,340,975</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Income tax (expenses) benefits</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(502,131</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">153,953</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Net Income</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">3,001,489</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">1,494,928</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net loss attributable to noncontrolling interests</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">17,834</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">34,352</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt">Net Income Attributable to Zhongchao Inc.&rsquo;s shareholders</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3,019,323</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,529,280</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Other Comprehensive (Loss) Income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Foreign currency translation adjustment</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(379,520</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">228,786</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Comprehensive Income</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">2,621,969</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">1,723,714</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total comprehensive loss attributable to noncontrolling interests</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">17,834</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">34,352</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt">Total comprehensive income attributable to Zhongchao
    Inc.&rsquo;s shareholders</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,639,803</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,758,066</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">Weighted average number of ordinary share outstanding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Basic and Diluted*</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">20,764,245</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">19,562,121</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">Earnings per share</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in">Basic and Diluted*</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.15</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.08</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         number of shares are presented on a retroactive basis to reflect the reorganization and
                                         the stock dividend announced on November 21, 2017 (Note 16).</FONT></TD>
</TR></TABLE>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">The accompanying
notes are an integral part of the consolidated financial statements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 191; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="finnew_004"></A>ZHONGCHAO
INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CONSOLIDATED STATEMENTS
OF CHANGES IN SHAREHOLDERS&rsquo; EQUITY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>For the Years
Ended December 31, 2018 and 2017</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Expressed in
U.S. dollar, except for the number of shares)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; text-indent: -0.125in; padding-left: 0.125in"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="30" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 8pt">Attributable
    to Zhongchao Inc.&rsquo;s Shareholders</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; text-indent: -0.125in; padding-left: 0.125in"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="14" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 8pt">Ordinary
    share</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">Additional</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">Accumulated
    other comprehensive</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">Non-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; text-indent: -0.125in; padding-left: 0.125in"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 8pt">Class
    A</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 8pt">Class
    B</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">paid-in</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">Statutory</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">Accumulated</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">(loss)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">controlling</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">Total</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; text-indent: -0.125in; padding-left: 0.125in"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 8pt">Shares*</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 8pt">Amount</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 8pt">Shares*</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 8pt">Amount</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 8pt">capital</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 8pt">reserve</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 8pt">deficit</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 8pt">income</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 8pt">interest</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 8pt">equity</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 30%; font-weight: bold; text-indent: -0.125in; padding-left: 0.125in"><FONT STYLE="font-size: 8pt">Balance
    as of January 1, 2017</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">13,402,285</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 4%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">1,340</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">5,497,715</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 4%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">550</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 4%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">5,537,451</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 4%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 4%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">(4,912,373</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 4%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">(20,433</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 4%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">24,350</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 4%; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">630,885</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><FONT STYLE="font-size: 8pt">Capital contributions
    from shareholders</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,350,135</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">135</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">2,731,946</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">2,732,081</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><FONT STYLE="font-size: 8pt">Share-based compensation
    expenses</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">110,940</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">110,940</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><FONT STYLE="font-size: 8pt">Net income (loss)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,529,280</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(34,352</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,494,928</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><FONT STYLE="font-size: 8pt">Foreign
    currency translation adjustments</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 8pt">228,786</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 8pt">228,786</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-indent: -0.125in; padding-left: 0.125in"><FONT STYLE="font-size: 8pt">Balance as of December
    31, 2017</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">14,752,420</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">1,475</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">5,497,715</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">550</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">8,380,337</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">(3,383,093</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">208,353</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">(10,002</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">5,197,620</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><FONT STYLE="font-size: 8pt">Capital contributions
    from shareholders</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,350,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">135</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">3,580,125</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">3,580,260</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><FONT STYLE="font-size: 8pt">Reversal of share-based
    compensation expenses</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(14,483</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(14,483</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><FONT STYLE="font-size: 8pt">Net income (loss)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">3,019,323</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(17,834</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">3,001,489</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><FONT STYLE="font-size: 8pt">Appropriation of statutory
    reserve</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">20,539</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">(20,539</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><FONT STYLE="font-size: 8pt">Foreign
    currency translation adjustments</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 8pt">(379,520</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 8pt">(379,520</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in"><FONT STYLE="font-size: 8pt">Balance
    as of December 31, 2018</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 4pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">16,102,420</FONT></TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 4pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">1,610</FONT></TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 4pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">5,497,715</FONT></TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 4pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">550</FONT></TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 4pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">11,945,979</FONT></TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 4pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">20,539</FONT></TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 4pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">(384,309</FONT></TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 4pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">(171,167</FONT></TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 4pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">(27,836</FONT></TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 4pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><FONT STYLE="font-size: 8pt">11,385,366</FONT></TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         number of shares are presented on a retroactive basis to reflect the reorganization and
                                         the stock dividend announced on November 21, 2017 (Note 16).</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral
part of the consolidated financial statements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 192; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="finnew_005"></A>ZHONGCHAO
INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CONSOLIDATED STATEMENTS
OF CASH FLOWS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>For the Years
Ended December 31, 2018 and 2017</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Expressed in
U.S. dollar, except for the number of shares)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Years Ended<BR>
    December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-indent: -0.125in; padding-left: 0.125in">Cash Flows from Operating Activities:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 86%; font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Net income</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 4%; font-weight: bold; text-align: right">3,001,489</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 4%; font-weight: bold; text-align: right">1,494,928</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Adjustments to reconcile net income to net cash
    provided by (used in) operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Depreciation and amortization expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,699</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,270</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in; text-indent: -0.125in">(Reversal of) share-based compensation expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(14,483</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">110,940</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Deferred tax expenses (benefits)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,975</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(153,953</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Changes in operating assets and liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(792,031</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(777,425</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-indent: -0.125in">Prepayments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(583,613</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,352</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Other current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(659,145</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(237,676</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(548,507</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(737,353</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Advances from customers</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(125,872</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">146,875</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Income tax payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">296,904</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(14,999</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in; text-indent: -0.125in">Accrued expenses and other liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">85,954</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(598,809</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25in; padding-bottom: 1.5pt; text-indent: -0.125in">Deferred income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">552,277</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">207,196</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Net Cash
    Provided by (Used in) Operating Activities</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,312,647</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(537,654</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Cash Flows from Investing Activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Purchases of property and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(668,067</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(32,219</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Payment for land use rights</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(418,520</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Purchases of intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(49,477</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Investments in short-term investments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,920,260</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,753,763</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Release from short-term
    investments</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">3,502,799</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Net Cash
    Used in Investing Activities</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(504,048</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,835,459</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Cash Flows from Financing Activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Capital contribution from shareholders</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,580,260</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,732,081</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Proceeds from bank borrowings</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">756,544</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Net Cash
    Provided by Financing Activities</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,336,804</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,732,081</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Effect of exchange rate
    changes on cash and cash equivalents</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(205,243</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">195,860</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Net increase in cash and cash equivalents</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,940,160</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">554,828</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Cash and cash equivalents
    at beginning of year</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,978,515</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,423,687</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">Cash and cash equivalents
    at end of year</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">7,918,675</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">2,978,515</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Supplemental Cash Flow Information</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Cash paid for interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,840</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">-</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Cash paid for income tax</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">144,252</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">14,999</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">The accompanying
notes are an integral part of the consolidated financial statements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 193; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>1.</B></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><A NAME="finnew_006"></A>ORGANIZATION
                                         AND PRINCIPAL ACTIVITIES</B></FONT>&nbsp;&nbsp;</TD></TR></TABLE>

<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Zhongchao Inc. (&ldquo;Zhongchao Cayman&rdquo;,
or the &ldquo;Company&rdquo;) is a holding company incorporated on April 16, 2019, under the laws of the Cayman Islands. The Company
commenced operations in August 17, 2012, through its variable interest entity (&ldquo;VIE&rdquo;), Zhongchao Medical Technology
(Shanghai) Limited (&ldquo;Zhongchao Shanghai&rdquo;), a limited liability company established under the laws of the PRC. The
Company provides customized medical courses and customized medical training services to medical associations, pharmaceutical enterprises,
medical institutions, medical journals, medical foundations, hospitals and etc. in the PRC.</P>

<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying consolidated financial
statements reflect the activities of Zhongchao Shanghai and each of the following entities:</P>

<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 6pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; width: 19%; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 54%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Background</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 25%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ownership</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zhongchao Group Inc. (&ldquo;Zhongchao BVI&rdquo;)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        BVI company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on April 23, 2019</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        holding company</P></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% owned by Zhongchao Cayman </FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zhongchao Group Limited (&ldquo;Zhongchao HK&rdquo;)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        Hong Kong company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on May 14, 2019</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        holding company</P></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% owned by Zhongchao BVI</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beijing Zhongchao Zhongxing Technology Limited
    (&ldquo;Zhongchao WFOE&rdquo;)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        PRC company and deemed a wholly foreign owned enterprise</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on May 29, 2019</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of $10 million</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        holding company</P></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% owned by Zhongchao HK</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zhongchao Medical Technology (Shanghai) Co.,
    Ltd. (&ldquo;Zhongchao Shanghai&rdquo;)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        PRC limited liability company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on August 17, 2012</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of RMB 20,250,067 (approximately $3,064,272) with registered capital fully paid-up</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Engaged
        in technology development, technology transfer, and technical services in the field of medical technology, technical consulting
        in the field of network technology, and medical information consulting</P></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIE of Zhongchao WFOE</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shanghai Maidemu Cultural Communication Corp.
    (&ldquo;Shanghai Maidemu&rdquo;)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        PRC limited liability company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on March 12, 2015</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of $1,597,087 (RMB 10 million) with registered capital fully paid-up</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Planning
        for cultural and artistic exchanges, designing, producing, acting for and publishing various kinds of advertisements,
        and medical consultation (no medical diagnosis and treatment activities allowed).</P></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% owned by Zhongchao Shanghai</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shanghai Zhongxun<BR>
    Medical Technology Co., Ltd. (&ldquo;Shanghai Zhongxun&rdquo;)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        PRC limited liability company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on May 27, 2017</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of $1,021,525 (RMB 7 million) with registered capital fully paid-up</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Engaged
        in technology development, transfer, service and consulting in the fields of medical technology and computer technology
        (no medical diagnosis and treatment activities allowed).</P></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% owned by Zhongchao Shanghai</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Horgos Zhongchao<BR>
        Medical Technology Co., Ltd. (&ldquo;Horgos Zhongchao&rdquo;).</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        PRC limited liability company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on September 12, 2017</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of $153,060 (RMB 1 million) with registered capital of $153,060 to be funded</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Engaged
        in technology development, transfer, service and consulting in the fields of medical technology and computer technology.</P></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% owned by Zhongchao Shanghai</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Horgos Zhongchao Zhongxing Medical Technology
    Co., Ltd. (&ldquo;Horgos Zhongchao Zhongxing&rdquo; </FONT></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        PRC limited liability company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on July 29, 2019</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of $145,081 (RMB 1 million) with registered capital of $145,081 to be funded</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Engaged
        in technology development, transfer, service and consulting in the fields of medical technology and computer technology.</P></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% owned by Zhongchao Shanghai</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shanghai Jingyi Medical Technology Co., Ltd., (&ldquo;Shanghai
        Jingyi&rdquo;)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        PRC limited liability company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on October 10, 2018</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of $144,459 (RMB 1 million) with registered capital of $107,622 to be funded</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Engaged
        in technology development, transfer, service and consulting in the fields of medical technology and computer technology,
        market information consulting and investigating.</P></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51% owned by Zhongchao Shanghai</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shanghai Huijing Information Technology Co., Ltd.,
        (&ldquo;Shanghai Huijing&rdquo;)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
        PRC limited liability company</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incorporated
        on September 28, 2016</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of $149,948 (RMB 1 million) with registered capital of $74,974 to be funded</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Engaged
        in technology development, transfer, service and consulting in the fields of computer technology, graphic designing, website
        page designing, planning cultural and artistic exchanges.</P></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% owned by Shanghai Maidemu</FONT></TD></TR>
</TABLE>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>


<!-- Field: Page; Sequence: 194; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>1.</B></TD><TD><B>ORGANIZATION AND PRINCIPAL ACTIVITIES (CONTINUED)</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 14, 2019, Zhongchao WFOE entered
into a series of agreements (the &ldquo;VIE Agreements&rdquo;) with Zhongchao Shanghai and the shareholders of Zhongchao Shanghai.
The VIE Agreements are designed to provide Zhongchao WFOE with the power, rights and obligations equivalent in all material respects
to those it would possess as the sole equity holder of Zhongchao Shanghai, including absolute control rights and the rights to
the management, operations, assets, property and revenue of Zhongchao Shanghai. The purpose of the VIE Agreements is solely to
give Zhongchao WFOE the exclusive control over Zhongchao Shanghai&rsquo;s management and operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 14, 2019, Zhongchao Cayman completed
a reorganization of entities under common control of Weiguang Yang, who owned a majority of the voting power of Zhongchao Cayman
prior to the reorganization. Zhongchao Cayman, Zhongchao Group Inc. (&ldquo;Zhongchao BVI&rdquo;), and Zhongchao Group Limited
(&ldquo;Zhongchao HK&rdquo;) were established as the holding companies of Zhongchao WFOE. Zhongchao WFOE is the primary beneficiary
of Zhongchao Shanghai and its subsidiaries, and all of these entities are under common control which results in the consolidation
of Zhongchao Shanghai and subsidiaries which have been accounted for as a reorganization of entities under common control at carrying
value. The consolidated financial statements are prepared on the basis as if the reorganization became effective as of the beginning
of the first period presented in the consolidated financial statements. Total assets and liabilities presented on the Company&rsquo;s
consolidated balance sheets and revenues, expenses, net incomes presented on consolidated statements of incomes as well as the
cash flows from operating, investing and financing activities presented on the consolidated statements of cash flows are substantially
the financial positions, operations and cash flows of Zhongchao Shanghai and its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 15, 2019, HF Capital Management
Delta, Inc. (&ldquo;HF Capital&rdquo;), a 6.25% shareholder of Zhongchao Shanghai, planned to withdraw its equity interest in
Zhongchao Shanghai (which is representative of 1,350,068 shares in Zhongchao Shanghai, among which 675,068 shares were issued
by Zhongchao Shanghai and the remaining 675,000 shares were purchased from two existing shareholders), and to contribute the same
amount of capital to Zhongchao Cayman directly. <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and HF Capital entered into a certain warrant agreement to purchase ordinary shares of the Company, pursuant to which
the Company granted a warrant to HF Capital, who expects to exercise the warrant and receive the ordinary shares of the Company
before the effective date and closing of the offering because these conditions are considered to be administrative procedures
and there is no uncertainties of going through them. The warrant entitled HF Capital to purchase 1,350,068 Class A Ordinary Shares,
or 6.25% economic beneficial interest, or 1.37% of the voting ownership interest of the Company, from the Company, if the following
conditions are met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
                                         PRC governmental consent and approval required for HF Capital to exercise the warrant
                                         and payment of the capital contribution have been obtained, including without limitation,
                                         any approval or filing with respect to HF Capital&rsquo;s investment into the Company,
                                         and payment by HF Capital of the capital contribution to the Company, and reasonable
                                         evidence thereof shall have been provided to the Company;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HF
                                         Capital has fully paid the capital contribution to Zhongchao Cayman; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Company released the paid-in capital of HF Capital from Zhongchao Shanghai</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The practice is solely a result of tax
planning from HF Capital. As the warrant does not cause the Company to transfer or receive any assets, or exchange any other financial
instruments on potentially favorable or unfavorable terms with shareholder. The warrant does not meet the definition of a financial
instrument as defined in Glossary in ASC 480-10-20. The management believed the agreement between the Company and HF Capital is
a commitment rather than a financial instrument. As such, the warrant is not subject to accounting treatment. In addition, the
management expected that there is no circumstance under which the 1,350,068 Class A Ordinary Shares would not be issued, thus
the 1,350,068 underlying Class A Ordinary Shares should be included in the ordinary shares outstanding as of December 31, 2018
and 2017 and in the calculation of the basic and diluted weighted average ordinary share issued and outstanding for calculating
basic and diluted earnings per share.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 195; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>1.</B></TD><TD><B>ORGANIZATION AND PRINCIPAL ACTIVITIES (CONTINUED)</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Class A Ordinary Shares issued and outstanding
presented on the financial statements is reconciled with the number of shares legally as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">December&nbsp;31,</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">2018</P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">December&nbsp;31,</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">2017</P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Number of Class A Ordinary Shares legally issued and outstanding</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">14,752,352</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">13,402,352</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Class A Ordinary Shares committed to be issued to the investor</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,350,068</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,350,068</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Number of Class A Ordinary Shares outstanding and issued presented on the
    financial statements</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">16,102,420</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">14,752,420</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>VIE Agreements with Zhongchao Shanghai</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Due to the restrictions imposed by PRC
laws and regulations on foreign ownership of companies engaged in value-added telecommunication services and certain other businesses,
we operate our businesses in which foreign investment is restricted or prohibited in the PRC through certain PRC domestic companies.
As such, Zhongchao Shanghai is controlled through VIE Arrangements in lieu of direct equity ownership by us or any of our subsidiaries.
Such VIE Arrangements consist of a series of six agreements&nbsp;(collectively,&nbsp;the &ldquo;VIE Arrangements&rdquo;), which
were signed on August 14, 2019. For more details and risks related to our variable interest entity structure, please see &ldquo;Our
Corporate History and Structure&mdash;VIE Arrangements&rdquo; and &ldquo;Risk Factors&mdash;Risks Related to Our Corporate Structure&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The significant terms of the VIE Arrangements
by and among our wholly-owned subsidiary, Zhongchao WFOE, our consolidated variable interest entity, Zhongchao Shanghai, and the
shareholders of Zhongchao Shanghai are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Agreements that Provide Us Effective
Control over Zhongchao Shanghai</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our PRC Wholly Foreign Owned Entity, Zhongchao
WFOE, has entered into the following agreements with Zhongchao Shanghai and its shareholders.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Equity Interest Pledge Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the equity interest pledge
agreement dated August 14, 2019, each shareholder of Zhongchao Shanghai (collectively &ldquo;Shareholder&rdquo;) has pledged all
of its equity interest in Zhongchao Shanghai to guarantee the shareholder&rsquo;s and Zhongchao Shanghai&rsquo;s performance of
their obligations under the master exclusive service agreement, business cooperation agreement, exclusive option agreement and
proxy agreement and power of attorney. If Zhongchao Shanghai or any of its shareholders breaches their contractual obligations
under these agreements, Zhongchao WFOE, as pledgee, will be entitled to dispose the pledged equity interest entirely or partially.
Each of the shareholders of Zhongchao Shanghai agrees that, during the term of the equity interest pledge agreement, it will not
dispose of the pledged equity interests or create or allow any encumbrance on the pledged equity interests without the prior written
consent of Zhongchao WFOE. In addition, Zhongchao WFOE has the right to collect dividends generated by the pledged equity interest
during the term of the pledge. The term of the initial equity interest pledge agreement is 20 years. After the expiration of the
term of initial pledge registration, Zhongchao WFOE may at its sole discretion require the Shareholders to extend the term of
the equity interest registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Proxy Agreement and Power of Attorney</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the proxy agreement and power
of attorney dated August 14, 2019, each shareholder of Zhongchao Shanghai has irrevocably appointed Zhongchao WFOE to act as such
shareholder&rsquo;s exclusive attorney-in-fact to exercise all shareholder rights, including, but not limited to, voting on all
matters of Zhongchao Shanghai requiring shareholder approval, disposing of all or part of the shareholder&rsquo;s equity interest
in Zhongchao Shanghai, oversee and review Zhongchao Shanghai&rsquo;s operation and financial information. Zhongchao WFOE is entitled
to designate any person to act as such shareholder&rsquo;s exclusive attorney-in-fact without notifying or the approval of such
shareholder, and if required by PRC law, Zhongchao WFOE shall designate a PRC citizen to exercise such right. Each proxy agreement
power of attorney will remain in force for so long as the Zhongchao Shanghai exists. The shareholders of Zhongchao Shanghai do
not have the right to terminate this agreement or revoke the appointment of the attorney-in-fact without the prior written consent
of Zhongchao WFOE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Spouse Consent&nbsp;Letters</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the&nbsp;Spouse Consent&nbsp;Letters
dated August 14, 2019, the spouse of each married shareholder of Zhongchao Shanghai, unconditionally and irrevocably agreed not
to assert any rights over the equity interest in Zhongchao Shanghai held by and registered in the name of their spouse. In addition,
each of them agreed to be bound by the VIE Arrangements described here if the spouse obtains any equity interest in Zhongchao
Shanghai for any reason.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 196; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;<B>&nbsp;</B></I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>1.</B></TD><TD><B>ORGANIZATION AND PRINCIPAL ACTIVITIES (CONTINUED)</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>VIE Agreements with Zhongchao Shanghai (continued)</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Master Exclusive Service Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the master exclusive service agreement
between Zhongchao WFOE and Zhongchao Shanghai dated August 14, 2019, Zhongchao WFOE has the exclusive right to provide Zhongchao
Shanghai with technical support, consulting services and other services. Zhongchao WFOE has the right to designate and appoint,
at its sole discretion, any entities affiliated with the Zhongchao WFOE to provide any and all services. The service fees are
calculated and paid on a yearly basis and at the amount that equals to 100% of the consolidated net profits of Zhongchao Shanghai.
Zhongchao WFOE may adjust the service fee at its discretion after taking into account multiple factors, such as the difficulty
of the services provided, the time consumed, the content and commercial value of services provided and the market price of comparable
services. Zhongchao WFOE owns the intellectual property rights arising out of the performance of this agreements. Zhongchao Shanghai
shall seek approval from Zhongchao WFOE prior to entering into any contracts obtaining the same or similar services as provided
under the Master Exclusive Service Agreement. This agreement will remain effective as long as Zhongchao Shanghai exists, unless
Zhongchao WFOE advance written notice to Zhongchao Shanghai and its shareholders or upon the transfer of all the equity interest
held by Zhongchao Shanghai&rsquo;s shareholders to Zhongchao WFOE and/or a third party designated by Zhongchao WFOE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Business Cooperation Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the business cooperation agreement
dated August 14, 2019, without Zhongchao WFOE&rsquo;s prior written consent, Zhongchao Shanghai agrees not to engage in any transaction
which may materially affect its asset, obligation, right or operation, including but not limited to: any activities not within
its normal business scope, merger and acquisition, offering any loan to any third party and incurring any debt from any third
party. Zhongchao Shanghai shall seek approval from Zhongchao WFOE prior to entering into any material contract, except the contracts
executed in the ordinary course of business. Zhongchao Shanghai shall cause the persons designated by Zhongchao WFOE to be the
directors and executive officers of Zhongchao Shanghai. This agreement will remain effective as long as Zhongchao Shanghai exists,
unless Zhongchao WFOE advance written notice to Zhongchao Shanghai and its shareholders or upon the transfer of all the equity
interest held by Zhongchao Shanghai&rsquo;s shareholders to Zhongchao WFOE and/or a third party designated by Zhongchao WFOE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 197; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>1.</B></TD><TD><B>ORGANIZATION AND PRINCIPAL ACTIVITIES (CONTINUED)</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>VIE Agreements with Zhongchao Shanghai (continued)</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Agreements that Provide Us with
the Option to Purchase the Equity Interest in Zhongchao Shanghai</I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Exclusive Option Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the exclusive option agreement
dated August 14, 2019, each shareholder of Zhongchao Shanghai has irrevocably granted Zhongchao WFOE an exclusive option to purchase,
or have its designated person or persons to purchase, at its discretion, to the extent permitted under PRC law, all or part of
the shareholder&rsquo;s equity interests in Zhongchao Shanghai. The purchase price is equal to the lowest price allowable under
PRC laws and regulations at the time of the transfer. Zhongchao Shanghai has agreed that without Zhongchao WFOE&rsquo;s prior
written consent, Zhongchao Shanghai shall cause the persons designated by Zhongchao WFOE to be the directors and executive officers
of Zhongchao Shanghai, not amend its articles of association, increase or decrease the registered capital, sell or otherwise dispose
of its assets or beneficial interest, create or allow any encumbrance on its assets or other beneficial interests, provide any
loans to any third parties, enter into any material contract, merge with or acquire any other persons or make any investments,
or distribute dividends to the shareholders. The shareholders of Zhongchao Shanghai have agreed that, without Zhongchao WFOE&rsquo;s
prior written consent, they will not dispose of their equity interests in Zhongchao Shanghai or create or allow any encumbrance
on their equity interests. Moreover, without Zhongchao WFOE&rsquo;s prior written consent, no dividend will be distributed to
Zhongchao Shanghai&rsquo;s shareholders, and if any of the shareholders receives any profit, interest, dividend or proceeds of
share transfer or liquidation, the shareholder must give such profit, interest, dividend and proceeds to Zhongchao WFOE. These
agreements will remain effective as long as Zhongchao Shanghai exists unless Zhongchao WFOE advance written notice to Zhongchao
Shanghai and the shareholders or upon the transfer of all the equity interest held by the shareholders to Zhongchao WFOE and/or
its designee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has concluded that the Company
is the primary beneficiary of Zhongchao Shanghai and its subsidiaries, and should consolidate their financial statements. The
Company is the primary beneficiary based on the Proxy Agreement and Power of Attorney entered into as part of the VIE Agreements
that each equity holder of Zhongchao Shanghai assigned their rights as a shareholder of Zhongchao Shanghai to Zhongchao WOFE.
These rights include, but are not limited to, voting on all matters of Zhongchao Shanghai requiring shareholder approval, disposing
of all or part of the shareholder&rsquo;s equity interest in Zhongchao Shanghai, oversee and review Zhongchao Shanghai&rsquo;s
operation and financial information. As such, the Company, through Zhongchao WOFE, is deemed to hold all of the voting equity
interest in Zhongchao Shanghai and its subsidiaries. For the periods presented, the Company has not provided any financial or
other support to either Zhongchao Shanghai or its subsidiaries. However, pursuant to the Master Exclusive Services Agreement,
the Company may provide complete technical support, consulting services and other services during the term of the VIE agreements.
Though not explicit in the VIE agreements, the Company may provide financial support to Zhongchao Shanghai and its subsidiaries
to meet its working capital requirements and capitalization purposes. The terms of the VIE Agreements and the Company&rsquo;s
plan of financial support to the VIEs were considered in determining that the Company is the primary beneficiary of the VIEs.
Accordingly, the financial statements of the VIEs are consolidated in the Company&rsquo;s consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on the foregoing VIE Agreements,
Zhongchao WFOE has effective control of Zhongchao Shanghai and its subsidiaries, which enables Zhongchao WFOE to receive all of
their expected residual returns and absorb the expected losses of the VIE and its subsidiaries. Accordingly, the Company consolidates
the accounts of Zhongchao Shanghai and its subsidiaries for the periods presented herein, in accordance with Accounting Standards
Codification, or ASC, 810-10, Consolidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 198; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>2.</B></TD><TD STYLE="text-align: justify"><B>SUMMARY OF SIGNIFICANT
                                         ACCOUNTING POLICIES</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B><I>(a)</I></B></TD><TD STYLE="text-align: justify"><B><I>Basis of
                                         presentation</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying audited consolidated
financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America
(&ldquo;U.S. GAAP&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B><I>(b)</I></B></TD><TD STYLE="text-align: justify"><B><I>Principal
                                         of consolidation</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements
include the accounts of the Company, its wholly and majority owned subsidiaries, and consolidated VIE and its subsidiaries for
which the Company is the primary beneficiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All transactions and balances among the
Company, its subsidiaries and&nbsp;consolidated VIE have been eliminated upon consolidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B><I>(c)</I></B></TD><TD STYLE="text-align: justify"><B><I>Non-controlling
                                         interest</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-controlling interests represent the
equity interests in the subsidiaries of the VIE that are not attributable, either directly or indirectly, to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B><I>(d)</I></B></TD><TD STYLE="text-align: justify"><B><I>Foreign
                                         currency translation </I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Transactions denominated in currencies
other than the functional currency are translated into the functional currency at the exchange rates prevailing on the dates of
the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into
the functional currency using the applicable exchange rates on the date of the balance sheet. The resulting exchange differences
are recorded in the statement of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The reporting currency of the Company
and its subsidiaries is U.S. dollars (&ldquo;US$&rdquo;) and the accompanying consolidated financial statements have been expressed
in US$, because that is the primary and functional currency where all entities operate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In general, for consolidation purposes,
assets and liabilities of the Company and its subsidiaries whose functional currency is not the US$, are translated into US$,
using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the
period. The gains and losses resulting from translation of financial statements of the Company and its subsidiaries are recorded
as a separate component of accumulated other comprehensive income within the statement of shareholders&rsquo; equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Translation of amounts from RMB into US$
has been made at the following exchange rates for the respective periods:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Balance sheet items, except for equity accounts</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">6.8755</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">6.5063</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Years Ended<BR>
    December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; text-indent: -13.5pt; padding-left: 13.5pt">Items in the statements of income and
    comprehensive income, and statements of cash flows</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">6.6090</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">6.7569</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No representation is made that the RMB
amounts could have been, or could be, converted into U.S. dollars at the rates used in translation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 199; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>2.</B></TD><TD STYLE="text-align: justify"><B>SUMMARY OF SIGNIFICANT
                                         ACCOUNTING POLICIES (CONTINUED)</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B><I>(e)</I></B></TD><TD STYLE="text-align: justify"><B><I>Use of
                                         estimates</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements
in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets
and liabilities, disclosures of contingent assets and liabilities on the date of the financial statements, and the reported amounts
of revenue and expenses during the reporting period. Actual results could differ from those estimates. On an ongoing basis, management
reviews these estimates and assumptions using the currently available information. Changes in facts and circumstances may cause
the Company to revise its estimates. The Company bases its estimates on past experience and on various other assumptions that
are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and
liabilities. Estimates are used when accounting for items and matters including, but not limited to, equity value of the Company,
determinations of the useful lives and valuation of long-lived assets, estimates of allowances for doubtful accounts, valuation
of deferred tax assets, and other provisions and contingencies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B><I>(f)</I></B></TD><TD STYLE="text-align: justify"><B><I>Fair value
                                         of financial instruments</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s financial instruments
are accounted for at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset
or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The three levels
of the fair value hierarchy are described below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 1 &ndash; inputs to the valuation
methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 2 &ndash; inputs to the valuation
methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the
assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 3 &ndash; inputs to the valuation
methodology are unobservable and significant to the fair value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2018 and 2017, financial
instruments of the Company comprised primarily current assets and current liabilities including cash and cash equivalents, short-term
investments, accounts receivable, other receivables, short-term borrowings and other payables, which approximate their fair values
because of the short-term nature of these instruments. Short-term investments are held to their maturities and are carried at
amortized cost, which approximates fair value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B><I>(g)</I></B></TD><TD STYLE="text-align: justify"><B><I>Cash and
                                         cash equivalents</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash and cash equivalents primarily consist
of bank deposits, as well as highly liquid investments, with original maturities of three months or less, which are unrestricted
as to withdrawal and use.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B><I>(h)</I></B></TD><TD STYLE="text-align: justify"><B><I>Short-term
                                         investments</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Short-term investments consist primarily
of investments in financial products with variable return rates and maturities between three months and one year. Short-term investments
are held to their maturities and are carried at amortized cost, which approximates fair value because of the short-term nature
of these investments. The Company reviews its investments for other-than-temporary impairment (&ldquo;OTTI&rdquo;) based on the
specific identification method. The Company considers available quantitative and qualitative evidence in evaluating potential
impairment of its investments. If the cost of an investment exceeds the investment&rsquo;s fair value, the Company considers,
among other factors, general market conditions, expected future performance of the investees, the duration and the extent to which
the fair value of the investment is less than the cost, and the Company&rsquo;s intent and ability to hold the investment. OTTI
is recognized as a loss in the statement of income. For the years ended December 31, 2018 and 2017, the Company did not provide
OTTI on the short-term investments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 200; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>2.</B></TD><TD STYLE="text-align: justify"><B>SUMMARY OF SIGNIFICANT
                                         ACCOUNTING POLICIES (CONTINUED)</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B><I>(i)</I></B></TD><TD STYLE="text-align: justify"><B><I>Accounts
                                         receivable</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts receivable are recorded at the
gross amount less an allowance for any uncollectible accounts and do not bear interest, depending on credit assessment of customers.
Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends
and aging of receivables. Management also periodically evaluates individual customer&rsquo;s financial condition, credit history
and the current economic conditions to make adjustments in the allowance when necessary. Account balances are charged off against
the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. As of December
31, 2018 and 2017, the Company determined no allowances for doubtful accounts were necessary for accounts receivable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B><I>(j)</I></B></TD><TD STYLE="text-align: justify"><B><I>Prepayments</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prepayments represent amounts advanced
to suppliers for providing services to the Company. The suppliers usually require advance payments when the Company orders service
and the prepayments will be utilized to offset the Company&rsquo;s future payments. These amounts are unsecured, non-interest
bearing and generally short-term in nature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B><I>(k)</I></B></TD><TD STYLE="text-align: justify"><B><I>Property
                                         and equipment</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment primarily consist
of office equipment, which is stated at cost less accumulated depreciation less any provision required for impairment in value.
Depreciation is computed using the straight-line method with residual value rate of 5% based on the estimated useful life. The
useful life of office equipment is 3 years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Costs of repairs and maintenance are expensed
as incurred and asset improvements are capitalized. The cost and related accumulated depreciation of assets disposed of or retired
are removed from the accounts, and any resulting gain or loss is reflected in the consolidated statement of income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company constructs certain of its
property. In addition to cost under the construction contracts, interest cost and external costs directly related to the construction
of such facilities, including equipment installation and shipping costs, are capitalized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 201; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>2.</B></TD><TD STYLE="text-align: justify"><B>SUMMARY OF SIGNIFICANT
                                         ACCOUNTING POLICIES (CONTINUED)</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B><I>(l)</I></B></TD><TD STYLE="text-align: justify"><B><I>Land use
                                         rights, net</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Land use rights, net represent prepayments
to the current lessee for sub-lease of two land use rights. Land use rights are carried at cost less accumulated amortization
and any impairment loss. Amortization is provided to write off the cost of lease prepayments on a straight-line basis over the
period of the rights which are 16 years and 32&nbsp;years, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B><I>(m)</I></B></TD><TD STYLE="text-align: justify"><B><I>Intangible
                                         assets, net</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Purchased intangible assets are recognized
and measured at fair value upon acquisition. Separately identifiable intangible assets that have determinable lives continue to
be amortized over their estimated useful lives using the straight-line method based on their estimated useful lives as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left">Trademarks</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: right">10 years</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">License</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">10 years</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Software</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">10 years</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B><I>(n)</I></B></TD><TD STYLE="text-align: justify"><B><I>Impairment
                                         of long-lived assets</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reviews long-lived assets
for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.
Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted
net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment recognized
is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. No impairment of long-lived
assets was recognized for the years ended December 31, 2018 and 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 202; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>2.</B></TD><TD STYLE="text-align: justify"><B>SUMMARY OF SIGNIFICANT
                                         ACCOUNTING POLICIES (CONTINUED)</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B><I>(o)</I></B></TD><TD STYLE="text-align: justify"><B><I>Revenue
                                         recognition</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company early adopted ASC 606, Revenue
from Contracts with Customers (&ldquo;ASC 606&rdquo;) on January 1, 2017, using the modified retrospective approach. ASC 606 establishes
principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash flows arising from the
entity&rsquo;s contracts to provide goods or services to customers. The core principle requires an entity to recognize revenue
to depict the transfer of goods or services to customers in an amount that reflects the consideration that it expects to be entitled
to receive in exchange for those goods or services recognized as performance obligations are satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has assessed the impact of
the guidance by reviewing its existing customer contracts and current accounting policies and practices to identify differences
that will result from applying the new requirements, including the evaluation of its performance obligations, transaction price,
customer payments, transfer of control and principal versus agent considerations. Based on the assessment, the Company concluded
that there was no change to the timing and pattern of revenue recognition for its current revenue streams in scope of ASC 605
and therefore there was no material changes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In according with ASC 606, revenues are
recognized when control of the promised services is transferred to customers, in an amount that reflects the consideration the
Company expects to be entitled to in exchange for those services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company identified each distinct service,
or each series of distinct services that are substantially the same and that have the same pattern of transfer to the customer,
as a performance obligation. Transaction price is allocated among different performance obligations identified in one contract,
by using expected cost plus margin approach, if the standalone selling price of each performance obligation is not observable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Timing of revenue recognition may differ
from the timing of invoicing to customers. Accounts receivable represents amounts invoiced and revenue recognized prior to invoicing
when the Company has satisfied its performance obligation and has the unconditional right to payment. The balance of accounts
receivable was $1,993,237 and $1,301,810 as of December&nbsp;31, 2018 and 2017, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advances from customers consists of payments
received related to unsatisfied performance obligations at the end of the period. As of December&nbsp;31, 2017, the Company&rsquo;s
total advance from customers was $712,671, all of which was recognized as revenue for the year ended December&nbsp;31, 2018. The
Company&rsquo;s total advance from customers was $553,409 as of December&nbsp;31, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company applied a practical expedient
to expense costs as incurred for costs to obtain a contract with a customer when the amortization period would have been one year
or less. The Company has no material incremental costs of obtaining contracts with customers that the Company expects the benefit
of those costs to be longer than one year which need to be recognized as assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Medical training and education services</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company designs and provides both
online and offline medical training and education courses to physicians and allied healthcare professionals (the &ldquo;training
and education services&rdquo;). The Company identifies a single performance obligation from contracts for both offline and online
medical training and education services. The Company recognizes revenue at the point of provision of services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Offline medical training and education
services courses &ndash; though customers can benefit from each service commitment, including design, production and presentation
of medical courses, together with other readily available resources. The promises in the contracts with customers is integration
of all of these service commitments. &nbsp;&nbsp;The Company concludes that these service commitments are highly dependent with
each other, in the context of the contract term. Thus, these service commitments are not distinct from each other, and the Company
combines all service commitments performed as a single performance obligation. In cases where the Company engages third party
experts to provide presentation in medical courses, as the Company determines the contents and the participants, it has the ability
to direct these experts to provide medical training services for the Company. Therefore the Company is primarily responsible for
fulfilling the promise to provide the medial courses and has the discretion in establishing the transaction price. The Company
is a principal in the provision of services and recognizes revenues on a gross basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Online medical training and education
services courses &ndash; the promises in the contracts with customers consist of provision of online courses and presentation
of the courses online for users to access for a period of time. The performance obligation of presentation of the courses online
for users for a period of time is immaterial in the context of the contract because presentation of each course incurred no significant
additional cost, nor will it occupy any significant resources of the Company, except for little digital space on the Company&rsquo;s
server, which is inconsequential. Therefore, the Company combines all service commitments performed as a single performance obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fees are collected either in advance
to provision of services or after the services. In cases where fees are collected in advance, the fees are recorded as &ldquo;advance
from customers&rdquo; in the consolidated balance sheets. Advance from customers is recognized as revenue when the Company delivers
the courses to its customers. The fees are non-refundable. In cases where fees are collected after the sales, revenue and accounts
receivable are recognized upon delivery of medical training and education courses to the Company. The fees are fixed and determinable
at the inception of the services.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 203; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>2.</B></TD><TD STYLE="text-align: justify"><B>SUMMARY OF SIGNIFICANT
                                         ACCOUNTING POLICIES (CONTINUED)</B></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Other consulting services</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also provides consulting services
to its customers, including drafting research papers and other academic supports. The consulting services are accounted for as
a single performance obligation and was recognized as revenue when the Company delivers services to the customers. Fees are generally
collected after provision of services. For the years ended December 31, 2018 and 2017, the Company generated minimal amount from
other consulting services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(p)</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cost
                                         of revenues</I></B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of revenues was comprised of direct
related costs incurred by both online and offline seminars, including expenses of travelling and accommodation, seminar site-rental,
video production and backdrop production, professional service fees charged by experts who provide offline seminars, and salary
and welfare expenses incurred by the key members of the editorial, design and production team. The travelling and accommodation
expenses, including but not limited to the air-ticket expenses and hotel accommodation expenses, represented the costs arising
from lecturers&rsquo; attendance and participation of the offline seminars. Other travelling expenses were incurred by the Company&rsquo;s
medical department for videos production, live streaming of the offline seminars, and materials collection to create online courses.
These travelling and accommodation expenses are well budgeted before any agreements entered into by the Company and the customers.
Therefore, such expenses are well covered by the customers under those agreements. The Company is not reimbursed by the customers
separately.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(q)</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Employee
                                         benefits</I></B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The full-time employees of the Company
are entitled to staff welfare benefits including medical care, housing fund, pension benefits, unemployment insurance and other
welfare, which are government mandated defined contribution plans. The Company is required to accrue for these benefits based
on certain percentages of the employees&rsquo; respective salaries, subject to certain ceilings, in accordance with the relevant
PRC regulations, and make cash contributions to the state-sponsored plans out of the amounts accrued. Total expenses for the plans
were $476,765 and $313,777 for the years ended December 31, 2018 and 2017, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(r)</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Research
                                         and development costs</I></B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and development costs are mainly
comprised of labor cost of research and development department, amortization expenses of software which were used for the purpose
of research and development during the process of platform development. For the years ended December 31, 2018 and 2017, research
and development expenses of $1,447,949 and $943,253 were recorded in general administrative expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(s)</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Advertising
                                         expenses</I></B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 406.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advertising expenses primarily include
advertisement for the Company&rsquo;s platform for online medical courses. Advertising costs are expensed as incurred and the
total amounts charged to &ldquo;selling and marketing expenses&rdquo; in the consolidated statements of income were $1,989,895
and $2,436,734 for the fiscal years ended December 31, 2018 and 2017, respectively.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 204; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>2.</B></TD><TD STYLE="text-align: justify"><B>SUMMARY OF SIGNIFICANT
                                         ACCOUNTING POLICIES (CONTINUED)</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(t)</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Government
                                         grants</I></B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Government
grants include cash subsidies as well as other subsidies received from various government agencies by the VIE and its subsidiaries
of the Company. Government grants are recognized as income in other income. Such amounts are recognized in the consolidated statement
of income when all conditions attached to the grants are&nbsp;fulfilled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2017,
the Company received government grants of $221,995 as a reward for its IPO listing on NEEQ. The government grants were recognized
as other income upon receipt as the listing was successful in 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the years ended December 31, 2018
and 2017, the Company received government grants of $552,277 and $207,196, respectively, in connection with the Company&rsquo;s
development of medical database and online medical lectures sharing application and cloud. However the condition to attached to
the grants would not be fulfilled until quality check by local government. These grants are recognized as deferred income and
will be charged as a reduction of specific costs and expenses upon the Company passing the quality check, or recorded as an income
if the specific costs and expenses incurred in prior periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(u)</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Share-based
                                         compensation</I></B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Share-based awards granted to the Company&rsquo;s
employees and one non-employee are measured at fair value on grant date and measurement date, respectively, and share-based compensation
expense is recognized (i) immediately at the grant date if no vesting conditions are required, or (ii) using the accelerated attribution
method, net of estimated forfeitures, over the requisite service period. The fair value of restricted shares is determined with
reference to the fair value of the underlying shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At each date of measurement, the Company
reviews internal and external sources of information to assist in the estimation of various attributes to determine the fair value
of the share-based awards granted by the Company, including but not limited to the fair value of the equity value of the Company
(Note 15), expected life, expected volatility and expected forfeiture rates. The Company is required to consider many factors
and make certain assumptions during this assessment. If any of the assumptions used to determine the fair value of the share-based
awards changes significantly, share-based compensation expense may differ materially in the future from that recorded in the current
reporting period. Moreover, the estimates of fair value of the awards are not intended to predict actual future events or the
value that ultimately will be realized by grantees who receive share-based awards, and subsequent events are not indicative of
the reasonableness of the original estimates of fair value made by the Company for accounting purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(v)</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Value
                                         added tax</I></B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is subject to value added
tax (&ldquo;VAT&rdquo;) and related surcharges on the revenues earned for services provided in the PRC. The applicable rate of
value added tax is 6%. The related surcharges for revenues derived from provision medical courses are deducted from gross receipts
to arrive at net revenues.</P>








<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 205; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>2.</B></TD><TD STYLE="text-align: justify"><B>SUMMARY OF SIGNIFICANT
                                         ACCOUNTING POLICIES (CONTINUED)</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(w)</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Income
                                         taxes</I></B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for income taxes
in accordance with the U.S. GAAP for income taxes. Under the asset and liability method as required by this accounting standard,
the recognition of deferred income tax liabilities and assets for the expected future tax consequences of temporary differences
between the income tax basis and financial reporting basis of assets and liabilities. Provision for income taxes consists of taxes
currently due plus deferred taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The charge for taxation is based on the
results for the year as adjusted for items which are non-assessable or disallowed. It is calculated using tax rates that have
been enacted or substantively enacted by the balance sheet date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred tax is accounted for using the
balance sheet liability method in respect of temporary differences arising from differences between the carrying amount of assets
and liabilities in the financial statements and the corresponding tax basis. Deferred tax assets are recognized to the extent
that it is probable that taxable income to be utilized with prior net operating loss carried forwards. Deferred tax is calculated
using tax rates that are expected to apply to the period when the asset is realized or the liability is settled. Deferred tax
is charged or credited in the income statement, except when it is related to items credited or charged directly to equity. Deferred
tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion
or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the
relevant taxing authorities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An uncertain tax position is recognized
as a benefit only if it is &ldquo;more likely than not&rdquo; that the tax position would be sustained in a tax examination, with
a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50%
likely of being realized on examination. Penalties and interest incurred related to underpayment of income tax are classified
as income tax expense in the period incurred. As of December 31, 2018, income tax returns for the tax years ended December 31,
2013 through December 31, 2017 remain open for statutory examination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(x)</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Earnings
                                         per share</I></B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic earnings per ordinary share is computed
by dividing net earnings attributable to ordinary shareholders by the weighted-average number of ordinary shares outstanding during
the period. Diluted earnings per share is computed by dividing net income attributable to ordinary shareholders by the sum of
the weighted average number of ordinary share outstanding and &nbsp;of potential ordinary share (e.g., convertible securities,
options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential
ordinary share that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded
from the calculation of diluted earnings per share. For the years ended December 31, 2018 and 2017, the Company had no dilutive
stocks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(y)</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Comprehensive
                                         income</I></B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A Comprehensive income includes net income
and other comprehensive income (loss) arising from foreign currency adjustments. Comprehensive income is reported in the consolidated
statements of income and comprehensive income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(z)</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Commitments
                                         and contingencies</I></B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the normal course of business, the
Company is subject to loss contingencies, such as legal proceedings and claims arising out of its business, that cover a wide
range of matters, including, among others, government investigations and tax matters. In accordance with ASC No. 450 Sub topic
20, &ldquo;Loss Contingencies&rdquo;, the Company records accruals for such loss contingencies when it is probable that a liability
has been incurred and the amount of loss can be reasonably estimated.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 206; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>2.</B></TD><TD STYLE="text-align: justify"><B>SUMMARY OF SIGNIFICANT
                                         ACCOUNTING POLICIES (CONTINUED)</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(aa)</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Segment
                                         reporting</I></B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operating segments are reported in a manner
consistent with the internal reporting provided to the chief operating decision maker (the&nbsp;&ldquo;CODM&rdquo;), which is
comprised of certain members of the Company&rsquo;s management team. Consequently, the Company has determined that it has only
one reportable operating segment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(bb)</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Recently
                                         issued accounting pronouncements</I></B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In March 2019, the FASB issued ASU 2019-01:
&ldquo;Leases (Topic 842)-Codification Improvements&rdquo;. The amendments in this ASU (1) reinstate the exception in Topic 842
for lessors that are not manufacturers or dealers, specifically, those lessors will use their cost, reflecting any volume or trade
discounts that may apply, as the fair value of the underlying asset. However, if significant time lapses between the acquisition
of the underlying asset and lease commencement, those lessors will be required to apply the definition of fair value (exit price)
in Topic 820; (2) address the concerns of lessors within the scope of Topic 942 about where &ldquo;principal payments received
under leases&rdquo; should be presented, specifically, lessors that are depository and lending institutions within the scope of
Topic 942 will present all &ldquo;principal payments received under leases&rdquo; within investing activities; and (3) clarify
the Board&rsquo;s original intent by explicitly providing an exception to the paragraph 250-10-50-3 interim disclosure requirements
in the Topic 842 transition disclosure requirements. The effective date of the amendments in this ASU is for fiscal years beginning
after December 15, 2019, and interim periods within those fiscal years for any of the following: 1. A public business entity;
2. A not-for-profit entity that has issued, or is a conduit bond obligor for, securities that are traded, listed, or quoted on
an exchange or an over-the-counter market; and 3. An employee benefit plan that files financial statements with the U.S. Securities
and Exchange Commission (SEC). For all other entities, the effective date is for fiscal years beginning after December 15, 2019,
and interim periods within fiscal years beginning after December 15, 2020. Early application is permitted. An entity should early
apply the amendments as of the date that it first applied Topic 842, using the same transition methodology in accordance with
paragraph 842-10-65-1(c). The Company is evaluating the effect this new guidance will have on its consolidated financial statements
and related disclosures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2018, the Financial Accounting
Standards Board (&ldquo;FASB&rdquo;) issued Accounting Standards Update (&ldquo;ASU&rdquo;) 2018-20, Leases (Topic 842): Narrow-Scope
Improvements for Lessors. The amendments clarify or simplify certain narrow aspects of ASC 842 for lessors. Specifically: 1) The
amendments provide an accounting policy election whereby lessors may choose not to evaluate whether certain sales taxes and other
similar taxes are lessor costs or lessee costs. Instead, lessors making the election will account for those costs as if they are
lessee costs, i.e., through the balance sheet instead of the income statement. 2) Lessors will exclude from variable payments,
and therefore revenue, lessor costs paid by lessees directly to third parties. Conversely, lessors will include in variable payments,
and therefore revenue, such costs that are paid by the lessor and reimbursed by the lessee, and 3) Regarding contracts with lease
and nonlease components, lessors will allocate certain variable payments to the lease and nonlease components when the changes
in facts and circumstances on which the variable payment is based occur. The amount of variable payments allocated to the lease
components will be recognized in profit or loss, while the amount of variable payments allocated to nonlease components will be
recognized in accordance with other GAAP. If an entity has not yet adopted the new leases standard, it must adopt ASU 2018-20
concurrently with the leases standard. If an entity has previously adopted the new leases standard, specific transition requirements
apply. The Company is currently assessing the timing and impact of adopting the updated provisions to its consolidated financial
statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2016, the FASB issued ASU
2016-02, Amendments to the ASC 842 Leases. This update requires the lessee to recognize the assets and liability (the lease liability)
arising from operating leases on the balance sheet for the lease term. When measuring assets and liabilities arising from a lease,
a lessee (and a lessor) should include payments to be made in optional periods only if the lessee is reasonably certain to exercise
an option to extend the lease or not to exercise an option to terminate the lease. Within twelve months or less lease term, a
lessee is permitted to make an accounting policy election not to recognize lease assets and liabilities. If a lessee makes this
election, it should recognize lease expense on a straight-line basis over the lease term. In transition, this update will be effective
for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently
assessing the timing and impact of adopting the updated provisions to its consolidated financial statements.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 207; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>2.</B></TD><TD STYLE="text-align: justify"><B>SUMMARY OF SIGNIFICANT
                                         ACCOUNTING POLICIES (CONTINUED)</B></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(bb)</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Recently
                                         issued accounting pronouncements (continued)</I></B></FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As an &ldquo;emerging growth company,&rdquo;
or EGC, the Company has elected to take advantage of the extended transition period provided in the Securities Act Section 7(a)(2)(B)
for complying with new or revised accounting standards applicable to private companies. The amendments in this ASU are effective
for annual reporting periods beginning after December 15, 2019, including Interim periods beginning after December 15, 2020. The
Company is in the process of evaluating the impact of adoption of this guidance on its consolidated financial statement utilizing
the modified retrospective transition approach.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2018, the FASB issued ASU 2018-13,
Fair Value Measurement - Disclosure Framework (Topic 820). The updated guidance improves the disclosure requirements on fair value
measurements. The updated guidance if effective for fiscal years, and interim periods within those fiscal years, beginning after
December 15, 2019. Early adoption is permitted for any removed or modified disclosures. The Company is currently assessing the
timing and impact of adopting the updated provisions to its consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2018, the FASB issued ASU 2018-07,
which simplifies several aspects of the accounting for nonemployee share-based payment transactions resulting from expanding the
scope of Topic 718, Compensation-Stock Compensation, to include share-based payment transactions for acquiring goods and services
from non-employees. Some of the areas for simplification apply only to nonpublic entities. The amendments specify that Topic 718
applies to all share-based payment transactions in which a grantor acquires goods or services to be used or consumed in a grantor&rsquo;s
own operations by issuing share-based payment awards. The amendments also clarify that Topic 718 does not apply to share-based
payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services
to customers as part of a contract accounted for under Topic 606, Revenue from Contracts with Customers. The amendments in this
Update are effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods
within that fiscal year. Early adoption is permitted. We do not plan to early adopt this ASU. The Company is currently evaluating
the potential impacts of this updated guidance, and do not expect the adoption of this guidance to have a material impact on its
consolidated financial statements and related disclosures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In March 2018, the Financial Accounting
Standards Board issued Accounting Standards Update No. 2018-05: &ldquo;Income Taxes (Topic 805)&rdquo; to provide accounting and
disclosure guidance on accounting for income taxes under generally accepted accounting principles (&ldquo;U.S. GAAP&rdquo;). This
guidance addresses the recognition of taxes payable or refundable for the current year and the recognition of deferred tax liabilities
and deferred tax assets for the future tax consequences of events that have been recognized in an entity&rsquo;s financial statements
or tax returns. ASC Topic 740 also addresses the accounting for income taxes upon a change in tax laws or tax rates. The income
tax accounting effect of a change in tax laws or tax rates includes, for example, adjusting (or re-measuring) deferred tax liabilities
and deferred tax assets, as well as evaluating whether a valuation allowance is needed for deferred tax assets. The Company has
accounted for the changes related to the Tax Cuts and Jobs act passed by Congress in 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2018, the FASB issued ASU
No. 2018-02, &ldquo;Income Statement&mdash;Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects
from Accumulated Other Comprehensive Income&rdquo; (&ldquo;ASU 2018-02&rdquo;), which provides financial statement preparers with
an option to reclassify stranded tax effects within accumulated other comprehensive income to retained earnings in each period
in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act (or portion thereof)
is recorded. The amendments in this ASU are effective for all entities for fiscal years beginning after December 15, 2018, and
interim periods within those fiscal years. Early adoption of ASU 2018-02 is permitted, including adoption in any interim period
for the public business entities for reporting periods for which financial statements have not yet been issued. The amendments
in this ASU should be applied either in the period of adoption or retrospectively to each period (or periods) in which the effect
of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act is recognized. As the Company has no
U.S. operations or entities and thus the Tax Cuts and Jobs Act would not apply, the Company does not expect that the adoption
of this guidance will have a material impact on its consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 208; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>2.</B></TD><TD STYLE="text-align: justify"><B>SUMMARY OF SIGNIFICANT
                                         ACCOUNTING POLICIES (CONTINUED)</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(bb)</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Recently
                                         issued accounting pronouncements (continued)</I></B></FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2016, the FASB issued new accounting
guidance ASU 2016-13 for recognition of credit losses on financial instruments, which is effective January 1, 2020, with early
adoption permitted on January 1, 2019. The guidance introduces a new credit reserving model known as the Current Expected Credit
Loss (CECL) model, which is based on expected losses, and differs significantly from the incurred loss approach used today. The
CECL model requires measurement of expected credit losses not only based on historical experience and current conditions, but
also by including reasonable and supportable forecasts incorporating forward-looking information and will likely result in earlier
recognition of credit reserves. The Company does not intend to adopt the new standard early and is currently evaluating the impact
the new guidance will have on its financial position, results of operations and cash flows; however, it is expected that the new
CECL model will alter the assumptions used in calculating credit losses on loans, among other financial instruments, and may result
in material changes to the Company&rsquo;s credit reserves.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January&nbsp;2016, the FASB issued
ASU 2016-01, &ldquo;Financial Instruments&nbsp;&mdash;&nbsp;Overall (Subtopic 825-10): Recognition and Measurement of Financial
Assets and Financial Liabilities&rdquo; and issued certain technical corrections and improvements to the initial guidance within
ASU 2018-03&nbsp;in February&nbsp;2018. ASU 2016-01&nbsp;amends various aspects of the recognition, measurement, presentation,
and disclosure for financial instruments. The new guidance also simplifies the impairment assessment and enhances the disclosure
requirements of equity investments. The Company applied the new guidance beginning on January 1, 2017. The Company does not expect
that the adoption of this guidance will have a material impact on its consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not believe other recently
issued but not yet effective accounting standards, if currently adopted, would have a material effect would have a material effect
on the consolidated financial position, statements of operations and cash flows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 209; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>2.</B></TD><TD STYLE="text-align: justify"><B>SUMMARY OF SIGNIFICANT
                                         ACCOUNTING POLICIES (CONTINUED)</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(cc)</I></B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Significant
                                         risks and uncertainties</I></B></FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">1)</TD><TD STYLE="text-align: justify">Credit risk</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assets that potentially subject the Company
to significant concentration of credit risk primarily consist of cash and cash equivalents. The maximum exposure of such assets
to credit risk is their carrying amount as at the balance sheet dates. As of December 31, 2018 and 2017, the Company held cash
and cash equivalents of $7,918,675 and $2,978,515, respectively, which were primarily deposited in financial institutions located
in Mainland China, and each bank accounts is insured by the government authority with the maximum limit of RMB 500,000 (equivalent
to approximately $72,722). To limit exposure to credit risk relating to deposits, the Company primarily place cash and cash equivalent
deposits with large financial institutions in China which management believes are of high credit quality and also continually
monitors their worthiness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s operations are carried
out in China. Accordingly, the Company&rsquo;s business, financial condition and results of operations may be influenced by the
political, economic and legal environments in the PRC as well as by the general state of the PRC&rsquo;s economy. In addition,
the Company&rsquo;s business may be influenced by changes in governmental policies with respect to laws and regulations, anti-inflationary
measures, currency conversion and remittance abroad, rates and methods of taxation among other factors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">2)</TD><TD STYLE="text-align: justify">Liquidity
                                         risk</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is also exposed to liquidity
risk which is risk that it is unable to provide sufficient capital resources and liquidity to meet its commitments and business
needs. Liquidity risk is controlled by the application of financial position analysis and monitoring procedures. When necessary,
the Company will turn to other financial institutions and the shareholders to obtain short-term funding to meet the liquidity
shortage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">3)</TD><TD STYLE="text-align: justify">Foreign currency risk</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Substantially all of the Company&rsquo;s
operating activities and the Company&rsquo;s assets and liabilities are denominated in RMB, which is not freely convertible into
foreign currencies. All foreign exchange transactions take place either through the Peoples&rsquo; Bank of China (&ldquo;PBOC&rdquo;)
or other authorized financial institutions at exchange rates quoted by PBOC. Approval of foreign currency payments by the PBOC
or other regulatory institutions requires submitting a payment application form together with suppliers&rsquo; invoices and signed
contracts. The value of RMB is subject to changes in central government policies and to international economic and political developments
affecting supply and demand in the China Foreign Exchange Trading System market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 210; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>3.</B></TD><TD STYLE="text-align: justify"><B>VARIABLE INTEREST
                                         ENTITIES AND OTHER CONSOLIDATION MATTERS</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 14, 2019, Zhongchao WFOE entered
into VIE Agreements with Zhongchao Shanghai and its shareholders. The key terms of these VIE Agreements are summarized in &ldquo;Note
1 - Organization and Principal Acti<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vities</FONT>&rdquo;
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">VIE is an entity that has either a total
equity investment that is insufficient to permit the entity to finance its activities without additional subordinated financial
support, or whose equity investors lack the characteristics of a controlling financial interest, such as through voting rights,
right to receive the expected residual returns of the entity or obligation to absorb the expected losses of the entity. The variable
interest holder, if any, that has a controlling financial interest in a VIE is deemed to be the primary beneficiary and must consolidate
the VIE. Zhongchao WFOE is deemed to have a controlling financial interest and be the primary beneficiary of Zhongchao Shanghai,
because it has both of the following characteristics:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">power to direct
    activities of Zhongchao Shanghai that most significantly impact the its economic performance, and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">obligation to absorb
    losses of the entity that could potentially be significant to Zhongchao Shanghai or right to receive benefits from the entity
    that could potentially be significant to Zhongchao Shanghai.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, as all of these VIE agreements
are governed by PRC law and provide for the resolution of disputes through arbitration in the PRC, they would be interpreted in
accordance with PRC law and any disputes would be resolved in accordance with PRC legal procedures. The legal environment in the
PRC is not as developed as in other jurisdictions, such as the United States. As a result, uncertainties in the PRC legal system
could further limit the Company&rsquo;s ability to enforce these VIE agreements. Furthermore, these contracts may not be enforceable
in China if PRC government authorities or courts take a view that such contracts contravene PRC laws and regulations or are otherwise
not enforceable for public policy reasons. In the event the Company is unable to enforce these VIE Agreements, it may not be able
to exert effective control over Zhongchao Shanghai and its ability to conduct its business may be materially and adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All of the Company&rsquo;s main current
operations are conducted through Zhongchao Shanghai and its subsidiaries. Current regulations in China permit Zhongchao Shanghai
to pay dividends to the Company only out of its accumulated distributable profits, if any, determined in accordance with their
articles of association and PRC accounting standards and regulations. The ability of Zhongchao Shanghai to make dividends and
other payments to the Company may be restricted by factors including changes in applicable foreign exchange and other laws and
regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.05pt"><I><U>Risks
of variable interest entity structure</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.05pt">In the
opinion of management, (i) the corporate structure of the Company is in compliance with existing PRC laws and regulations; (ii)
the VIE Arrangements are valid and binding, and do not result in any violation of PRC laws or regulations currently in effect;
and (iii) the business operations of WFOE and the VIE are in compliance with existing PRC laws and regulations in all material
respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.05pt">However,
there are substantial uncertainties regarding the interpretation and application of current and future PRC laws and regulations.
Accordingly, the Company cannot be assured that PRC regulatory authorities will not ultimately take a contrary view to the foregoing
opinion of its management. If the current corporate structure of the Company or the VIE Arrangements is found to be in violation
of any existing or future PRC laws and regulations, the Company may be required to restructure its corporate structure and operations
in the PRC to comply with changing and new PRC laws and regulations. In the opinion of management, the likelihood of loss in respect
of the Company&rsquo;s current corporate structure or the VIE Arrangements is remote based on current facts and circumstances.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As Zhongchao Cayman, Zhongchao BVI, Zhongchao
HK, and Zhongchao WFOE were setup after December 31, 2018, the assets and liabilities presented in accompanying consolidated financial
statements reflected those accounts of Zhongchao Shanghai as of December 31, 2018 and 2017, and the revenues, cost of revenues,
expenses and income presented in the statements of income for the years ended December 31, 2018 and 2017 reflected those accounts
of Zhongchao Shanghai.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 211; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>4.</B></TD><TD><B>SHORT-TERM INVESTMENTS</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2018 and 2017, the
balance of short-term investments was comprised of investments of various financial products from Chinese banks and wealth management
companies, with variable return rate and with maturities between three months and one year. The Company classified these financial
assets as held-to-maturity financial assets and recorded the assets at amortized cost, which approximates fair value. As of December
31, 2018 and 2017, the Company did not provide OTTI on short-term investments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2018
and 2017, the Company earned interest income of $103,687 and $nil from the short-term investments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>5.</B></TD><TD><B>OTHER CURRENT ASSETS</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Other current assets consist of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&nbsp;31,<BR>
    2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&nbsp;31,<BR>
    2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; text-indent: -13.5pt; padding-left: 13.5pt">Prepaid advertising expense</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">738,331</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">161,382</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 13.5pt">Deferred contract cost</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">45,661</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 13.5pt">Prepaid rental fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,514</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,011</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 13.5pt">Office rental deposit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,114</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33,936</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 13.5pt">Prepaid consulting service fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">29,380</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,739</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 13.5pt">Prepaid travelling expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,907</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-indent: -13.5pt; padding-left: 13.5pt">Others</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">45,318</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">29,187</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">923,318</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">306,162</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>6.</B></TD><TD><B>PROPERTY AND EQUIPMENT, NET</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Property and equipment, net consist of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&nbsp;31, 2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&nbsp;31, 2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; text-indent: -13.5pt; padding-left: 13.5pt">Office equipment</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">213,563</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">78,029</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -13.5pt; padding-left: 13.5pt">Less: accumulated depreciation</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(46,106</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(24,693</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -13.5pt; padding-left: 13.5pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">167,457</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53,336</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 13.5pt; padding-bottom: 1.5pt">Construction in progress</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">502,448</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">669,905</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">53,336</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2018, the construction
in progress represented the construction in progress of an office campus and facilities in Beijing on newly leased land use rights
(Note 7). The construction is expected to complete in October 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Depreciation expenses totaled $23,655 and $13,077 for the years
ended December 31, 2018 and 2017, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>7.</B></TD><TD><B>LAND USE RIGHTS, NET</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Land use rights, net consist of the followings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; white-space: nowrap">December
    31,<BR>
    2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; white-space: nowrap">December&nbsp;31,
    <BR>
    2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; text-indent: -13.5pt; padding-left: 13.5pt">Land use rights</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">402,298</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 13.5pt; padding-bottom: 1.5pt">Less: accumulated amortization</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(9,537</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">392,761</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2018,
the Company acquired two pieces of land use rights for $418,520. Amortization expenses totaled $9,921 and $nil for the years ended
December 31, 2018 and 2017, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 212; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>8.</B></TD><TD><B>INTANGIBLE ASSETS, NET</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intangible
assets, net consist of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,<BR>
    2018</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,<BR>
    2017</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; text-indent: -13.5pt; padding-left: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Trademark
    and license</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,168</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,802</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -13.5pt; padding-left: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Software</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">41,597</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">43,958</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 13.5pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Less:
    accumulated amortization</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(8,711</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,002</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">44,054</FONT></TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">51,758</FONT></TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
the years ended December 31, 2018 and 2017, amortization expense totaled $5,123 and $3,193, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>9.</B></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SHORT
                                         TERM BORROWINGS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Short-term
borrowings consists of the follow</FONT>ing:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="font-weight: bold; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; white-space: nowrap">December&nbsp;31,</TD><TD STYLE="font-weight: bold; white-space: nowrap">&nbsp;</TD><TD STYLE="font-weight: bold; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; white-space: nowrap">December&nbsp;31,</TD><TD STYLE="font-weight: bold; white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Lender Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Interest rate</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Term</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 30%; text-align: left; text-indent: -10pt; padding-left: 10pt; vertical-align: top">Shanghai Pudong Development
    Bank</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 20%; text-align: left; vertical-align: top">Fixed annual rate of 5.09%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 24%">From August 30, 2018 to August&nbsp;29, 2019</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">290,888</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt; vertical-align: top">Shanghai
    Pudong Development Bank</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; vertical-align: top">Fixed annual rate of 5.09%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">From December 21, 2018 to December 20, 2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">436,332</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt; text-indent: -10pt; padding-left: 10pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">727,220</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Both bank borrowings were guaranteed by
Mr. Weiguang Yang, the principal shareholder, the CEO and Chairman of the Board of the Company, and Ms. Zhihua Zhen, the spouse
of Mr. Yang.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2018,
the interest expenses charged for the short term bank borrowings for the years ended 2018 and 2017 was $5,840 and $nil, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>10.</B></TD><TD><B>ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accrued expenses and other current liabilities consist of the
following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; white-space: nowrap">December
    31,<BR>
    2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; white-space: nowrap">December
    31,<BR>
    2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; text-indent: -13.5pt; padding-left: 13.5pt">Other tax payable</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">182,178</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">94,913</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 13.5pt">Accrued payroll</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">121,798</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">116,014</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 13.5pt; padding-bottom: 1.5pt">Other current liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">29,925</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">54,610</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">333,901</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">265,537</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Other tax payable</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other tax payables consist of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; white-space: nowrap">December
    31,<BR>
    2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; white-space: nowrap">December
    31,<BR>
    2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; text-indent: -13.5pt; padding-left: 13.5pt">Value added tax payable</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">168,439</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">69,682</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -13.5pt; padding-left: 13.5pt; padding-bottom: 1.5pt">Local tax payable</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">13,739</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">25,231</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt; padding-left: 0in">Total other tax payable</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">182,178</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">94,913</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 213; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>11.</B></TD><TD><B>INCOME TAXES</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Cayman Islands</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the current tax laws of the Cayman
Islands, the Company is not subject to tax on income or capital gain. Additionally, upon payments of dividends to the shareholders,
no Cayman Islands withholding tax will be imposed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>British Virgin Islands</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the current tax laws of BVI, the
Company&rsquo;s subsidiary incorporated in the BVI is not subject to tax on income or capital gains.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Hong Kong</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Zhongchao HK is incorporated in Hong Kong
and is subject to Hong Kong Profits Tax on the taxable income as reported in its statutory financial statements adjusted in accordance
with relevant Hong Kong tax laws. The applicable tax rate for the first HKD$2 million of assessable profits is 8.25% and assessable
profits above HKD$2 million will continue to be subject to the rate of 16.5% for corporations in Hong Kong, effective from the
year of assessment 2018/2019. Before that, the applicable tax rate was 16.5% for corporations in Hong Kong. The Company did not
make any provisions for Hong Kong profit tax as there were no assessable profits derived from or earned in Hong Kong since inception.
Under Hong Kong tax laws, Zhongchao HK is exempted from income tax on its foreign-derived income and there are no withholding
taxed in Hong Kong on remittance of dividends.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>PRC</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Zhongchao WFOE, Zhongchao Shanghai and
Shanghai Maidemu are subject to PRC Enterprise Income Tax (&ldquo;EIT&rdquo;) on the taxable income in accordance with the relevant
PRC income tax laws. The EIT rate for companies operating in the PRC is 25%. Shanghai Zhongxun, Shanghai Jingyi and Shanghai Huijing
qualify as Small and Low Profit Enterprises, and are subject to a preferential EIT of 10%. Horgos Zhongchao and Horgos Zhongchao
Zhongxing qualify as Enterprises in Underdeveloped Areas, and is subject to 0% EIT for a period of five years since it generated
revenues.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Entities qualifying as Software Development
Enterprises enjoy a preferential tax treatment of income tax exemption for the first two years, and 50% reduction of rate (i.e.
12.5%) for the next three years. Entities qualifying as High and New Technology Enterprises enjoy a preferential tax rate of 15%.
Qualified as a Software Development Enterprise and a High and New Technology Enterprise, Zhongchao Shanghai received the preferential
tax treatments from the year ended December 31, 2016, and was exempted from income taxes for the years ended December 31, 2016
and 2017, applied a preferential income tax rate of 12.5% for the years ended December 2018 through 2020, and a preferential income
tax rate of 15% from the year ended December 31, 2021 and thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In September 2018, the State Taxation
Administration of the PRC announced a preferential tax treatment for research and development expenses. Qualified entities is
entitled to deduct 175% research and development expenses against income to reach a net operating income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Income tax (expenses) benefits consist of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Years Ended<BR>
    December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Current income tax expenses</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(441,156</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Deferred income tax (expenses) benefits</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(60,975</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">153,953</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Income tax (expenses) benefits</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(502,131</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">153,953</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 214; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>11. INCOME TAXES (CONTINUED)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Below is a reconciliation of the statutory tax rate to the
effective tax rate:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; white-space: nowrap">For the
    Years Ended<BR>
    December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">PRC statutory income tax rate</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">25</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">25</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Effect of preferential tax benefits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7.30</TD><TD STYLE="text-align: left">)%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(27.60</TD><TD STYLE="text-align: left">)%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Effect of non-deductible expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.22</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.02</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Effect of research and development credits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3.28</TD><TD STYLE="text-align: left">)%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5.83</TD><TD STYLE="text-align: left">)%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Effect of intangible assets amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2.26</TD><TD STYLE="text-align: left">)%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Effect of share-based compensation</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(0.31</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(0.81</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Effective tax rate</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">14.33</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">%</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(11.48</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">)%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Deferred tax assets as of December 31, 2018 and 2017 consist
of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; white-space: nowrap">December&nbsp;31,<BR>
    2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; white-space: nowrap">December&nbsp;31,<BR>
    2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Excess advertising expense</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">323,720</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">318,910</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Deferred Intangible assets amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27,099</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,418</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Net operating loss carrying forward</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,731</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">91,541</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Share-based compensation</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">12,497</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">19,568</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">378,047</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">461,437</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2018 and 2017, the
Company had net operating loss carryforwards of $150,747 and $605,708, respectively. The net operating loss carryforwards begin
to expire in the tax year ending December 31, 2021. The Company reviews deferred tax assets for a valuation allowance based upon
whether it is more likely than not that the deferred tax asset will be fully realized. As of December 31, 2018 and 2017, the Company
did not accrue valuation allowance against the deferred tax assets based upon management&rsquo;s assessment as to their realization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company evaluates its valuation allowance
requirements at end of each reporting period by reviewing all available evidence, both positive and negative, and considering
whether, based on the weight of that evidence, a valuation allowance is needed. When circumstances cause a change in management&rsquo;s
judgement about the realizability of deferred tax assets, the impact of the change on the valuation allowance is generally reflected
in income from operations. The future realization of the tax benefit of an existing deductible temporary difference ultimately
depends on the existence of sufficient taxable income of the appropriate character within the carryforward period available under
applicable tax law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Uncertain tax positions</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company evaluates each uncertain tax
position (including the potential application of interest and penalties) based on the technical merits, and measure the unrecognized
benefits associated with the tax positions. As of December 31, 2018 and 2017, the Company did not have any significant unrecognized
uncertain tax positions or any unrecognized liabilities, interest or penalties associated with unrecognized tax benefit. The Company
does not believe that its uncertain tax benefits position will materially change over the next twelve months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 215; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>12.</B></TD><TD><B>EARNINGS PER SHARE</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth the computation
of basic and diluted loss per ordinary share for the years ended December 31, 2018 and 2017, respectively:</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Years Ended<BR>
    December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -7.05pt; padding-left: 7.05pt">Net
    Income Attributable to Shareholders</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right">3,019,323</TD><TD STYLE="width: 1%; padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,529,280</TD><TD STYLE="width: 1%; padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -7pt; padding-left: 7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-indent: -10.05pt; padding-left: 10.05pt">Weighted average number of ordinary share outstanding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt; text-indent: 0.125in">Basic and Diluted*</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">20,764,245</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">19,562,121</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 5.4pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">Earnings per share</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt; padding-left: 0.125in">Basic and Diluted*</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">0.15</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">0.08</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 14, 2019, Zhongchao Cayman completed
a reorganization of entities under common control of its then existing shareholders, who collectively owned a majority of the
equity interests of Zhongchao Cayman prior to the reorganization. All references to numbers of ordinary shares and per-share data
in the accompanying consolidated financial statements have been adjusted to reflect such issuance of shares on a retrospective
basis. In addition, the contingently issuable ordinary shares of 1,350,068 shares of Class A ordinary share underlying the warrant
(Note 1) issued to one existing shareholder of Zhongchao Shanghai is included in calculation of basic and diluted weighted average
number of ordinary share outstanding, as the Company does not expect any circumstances under which those shares would not be issued.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Potential ordinary share that have an
anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation
of diluted earnings per share. For the years ended December 31, 2018 and 2017, the Company had no dilutive stocks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>13.</B></TD><TD><B>RELATED PARTY TRANSACTIONS AND BALANES</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2018 and 2017, the
Company had no balances with related parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2018,
Mr. Weiguang Yang, the principal shareholder, the CEO and Chairman of the Board of the Company, and Ms. Zhihua Zhen, the spouse
of Mr. Yang, provided guarantee for the Company&rsquo;s short-term borrowings of $727,220 (Note 9).</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 3, 2017, Mr. Weiguang Yang transferred
4% of equity interest of Shanghai Xingzhong Investment Management LLP, which was equivalent to 85,920 shares of ordinary share
of Zhongchao Shanghai owned by himself to Mr. Baoqian Tian, the sales director of the Company. The fair value of the ordinary
share aggregated $274,027 (Note 16) which is to compensate the services to be rendered by the employee. According to the Q&amp;A
in Staff Accounting Bulletin No. 107, Topic 5, T. The value of the shares transferred by the principal shareholder of the Company
should be reflected as an expense in the Company&rsquo;s financial statements with a corresponding credit to contributed (paid-in)
capital. Thus, the fair value of the ordinary shares totaling $274,027 transferred will be charged to expenses over the 5 years
request service period in the Company&rsquo;s consolidated statements of income with a corresponding credit to additional paid-in
capital.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>14.</B></TD><TD><B>EQUITY</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Capital contribution from shareholders</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2017,
three new shareholders made additional cash paid-in capital aggregating $2,732,081 to Zhongchao Shanghai, and in return obtained
equity interest of 6.67% in Zhongchao Shanghai in aggregate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2018,
a new shareholders made additional cash paid-in capital of $3,580,260 to Zhongchao Shanghai, and in return obtained equity interest
of 6.25% economic beneficial interests in Zhongchao Shanghai in aggregate.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Ordinary share</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company&rsquo;s authorized share capital is 500,000,000 ordinary shares consisting of 450,000,000 Class A Ordinary Shares and
50,000,000 Class B ordinary shares, par value $0.0001 per share (each, a &ldquo;Class B Ordinary Share&rdquo;; collectively, &ldquo;Class
B Ordinary Shares&rdquo;). On April 16, 2019, the Company issued 10,000 Class B Ordinary Shares. On August 14, 2019, we issued
14,752,352</FONT> &nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">Class A Ordinary Shares and 5,487,815 Class B
Ordinary Shares. Holders of Class A Ordinary Shares and Class B Class A Ordinary Shares have the same rights except for voting
and conversion rights. In respect of matters requiring a shareholder vote, each Class A Ordinary Share will be entitled to 1 vote
and each Class B Ordinary Share will be entitled to 15 votes. The Class A Ordinary Shares are not convertible into shares of any
other class. The Class B Ordinary Shares are convertible into Class A Ordinary Shares at any time after issuance at the option
of the holder on a one to one basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 216; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the Company was committed
to issue 1,350,068 Class A Ordinary Shares to a 6.25 % shareholder of Zhongchao Shanghai, who is now in the progress of changing
from a shareholder of Zhongchao Shanghai to a direct investor of Zhongchao Cayman (Note 1). The 1,350,068 Class A Ordinary Shares,
or 6.25% economic beneficial interests, or 1.37% of the voting ownership interest in the Company, will be issued to the shareholder
upon its capital contribution in Zhongchao Cayman and the Company released its paid-in capital in Zhongchao Shanghai. The shareholder
expects to exercise the warrant and receive the ordinary shares of the Company before the effective date and closing of the offering
because these conditions are considered to be administrative procedures and there is no uncertainties of going through them. Such
ordinary shares are included in the shares issued and outstanding as of December 31, 2017 and 2018 and in the calculation of earnings
per share as such commitment to issue the shares is considered to be part the reorganization, and the shares are considered to
be in existence from the time this shareholder made the investment or January 1, 2017, whichever is earlier.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
connection with reorganization, all references to numbers of ordinary shares and per-share data in the consolidated financial
statements have been adjusted to reflect such reorganization have been retroactively stated as if it occurred on January 1, 2017,
other than the number of ordinary share issued to the shareholders who made capital contribution for the period from January 1,
2017 to December 31, 2018 as introduced in the note &ldquo;Capital contribution from shareholders<FONT STYLE="text-decoration: none">&rdquo;.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2018, there are 16,102,420
Class A Ordinary Shares and 5,497,815 Class B Ordinary Shares, issued and outstanding, respectively.&nbsp;As of December 31, 2017,
there are 14,752,420 Class A Ordinary Shares and 5,497,815 Class B Ordinary Shares, issued and outstanding, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Restricted net assets</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s ability to pay dividends
is primarily dependent on the Company receiving distributions of funds from its subsidiary or VIE. Relevant PRC statutory laws
and regulations permit payments of dividends by Zhongchao WFOE, Zhongchao Shanghai and its subsidiaries including, Shanghai Maidemu,
Shanghai Zhongxun, Horgos Zhongchao, Shanghai Jingyi and Shanghai Huijing only out of its retained earnings, if any, as determined
in accordance with PRC accounting standards and regulations and after it has met the PRC requirements for appropriation to statutory
reserves. Paid in capital of the PRC subsidiary and VIE and VIE&rsquo;s subsidiaries included in the Company&rsquo;s consolidated
net assets are also non-distributable for dividend purposes. The results of operations reflected in the accompanying consolidated
financial statements prepared in accordance with U.S. GAAP differ from those reflected in the statutory financial statements of
Zhongchao WFOE, Zhongchao Shanghai and its subsidiaries. The Company is required to set aside at least 10% of their after-tax
profits each year, if any, to fund certain statutory reserve funds until such reserve funds reach 50% of its registered capital.
In addition, the Company may allocate a portion of its after-tax profits based on PRC accounting standards to enterprise expansion
fund and staff bonus and welfare fund at its discretion. The statutory reserve funds and the discretionary funds are not distributable
as cash dividends.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2017, each of the Company&rsquo;s
PRC WFOE and VIE and its subsidiaries had accumulated deficits and did not have any statutory reserve funds or discretionary funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2018,
Shanghai Maidemu generated profit and had retained earnings as of December&nbsp;31, 2018. The Company accrued statutory reserve
funds of $20,539, which is 10% of the retained earnings of Shanghai Maidemu as of December 31, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December&nbsp;31, 2018 and 2017,
the Company had statutory reserve of $20,539 and $nil, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2018 and 2017, the
Company had net assets restricted in the aggregate, which include paid-in capital and statutory reserve of the Company&rsquo;s
PRC subsidiary and VIE and VIE&rsquo;s subsidiaries that are included in the Company&rsquo;s consolidated net assets, were approximately
$11,968,678 and $8,382,362, respectively.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The current PRC Enterprise Income Tax
(&ldquo;EIT&rdquo;) Law also imposed a 10% withholding income tax for dividends distributed by a foreign invested enterprise to
its immediate holding company outside China. A lower withholding tax rate will be applied if there is a tax treaty arrangement
between mainland China and the jurisdiction of the foreign holding company. Holding companies in Hong Kong, for example, will
be subject to a 5% withholding tax rate, subject to approval from the related PRC tax authorities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The ability of the Company&rsquo;s PRC
subsidiary and VIE and VIE&rsquo;s subsidiaries to make dividends and other payments to the Company may also be restricted by
changes in applicable foreign exchange and other laws and regulations. Foreign currency exchange regulation in China is primarily
governed by the following rules:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&Yuml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Foreign
                                         Exchange Administration Rules (1996), as amended in August 2008, or the Exchange Rules;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&Yuml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Administration
                                         Rules of the Settlement, Sale and Payment of Foreign Exchange (1996), or the Administration
                                         Rules.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Currently, under the Administration Rules,
Renminbi is freely convertible for current account items, including the distribution of dividends, interest payments, trade and
service related foreign exchange transactions, but not for capital account items, such as direct investments, loans, repatriation
of investments and investments in securities outside of China, unless the prior approval of the State Administration of Foreign
Exchange (the &ldquo;SAFE&rdquo;) is obtained and prior registration with the SAFE is made. Foreign-invested enterprises like
Rise King WFOE that need foreign exchange for the distribution of profits to its shareholders may effect payment from their foreign
exchange accounts or purchase and pay foreign exchange rates at the designated foreign exchange banks to their foreign shareholders
by producing board resolutions for such profit distribution. Based on their needs, foreign-invested enterprises are permitted
to open foreign exchange settlement accounts for current account receipts and payments of foreign exchange along with specialized
accounts for capital account receipts and payments of foreign exchange at certain designated foreign exchange banks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 217; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although the current Exchange Rules allow
the convertibility of Chinese Renminbi into foreign currency for current account items, conversion of Chinese Renminbi into foreign
exchange for capital items, such as foreign direct investment, loans or securities, requires the approval of SAFE, which is under
the authority of the People&rsquo;s Bank of China. These approvals, however, do not guarantee the availability of foreign currency
conversion. The Company cannot be sure that it will be able to obtain all required conversion approvals for its operations or
the Chinese regulatory authorities will not impose greater restrictions on the convertibility of Chinese Renminbi in the future.
Currently, most of the Company&rsquo;s retained earnings are generated in Renminbi. Any future restrictions on currency exchanges
may limit the Company&rsquo;s ability to use its retained earnings generated in Renminbi to make dividends or other payments in
U.S. dollars or fund possible business activities outside China.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2018 and 2017, there
was $nil retained earnings in the aggregate, respectively, which was generated by the Company&rsquo;s VIE and its subsidiaries
in Renminbi included in the Company&rsquo; consolidated net assets, aside from $20,539 and $nil statutory reserve funds as of
December 31, 2018 and 2017, that may be affected by increased restrictions on currency exchanges in the future and accordingly
may further limit the Company&rsquo;s PRC subsidiary and VIE and VIE&rsquo;s subsidiaries&rsquo; ability to make dividends or
other payments in U.S. dollars to the Company, in addition to $11,968,678 and $8,382,362 restricted net assets as of December
31, 2018 and 2017, respectively, as discussed above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>15.</B></TD><TD><B>CONCENTRATION RISK</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Customer concentration</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2018
and 2017, two and one customer contributed revenues which were over 10% of total revenues for the relevant period. Customers accounting
for 10% or more of the Company&rsquo;s revenue were as follows:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Years Ended<BR>
    December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Customer A</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">38</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">55</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Customer B</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">11</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">49</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">55</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2018 and 2017, accounts
receivable due from several customers as a percentage of consolidated accounts receivable were over 10%. The details are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Customer A</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Customer B</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Customer C</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Customer D</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Customer E</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">19</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">57</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">67</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Vendor concentration </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2018
and 2017, two and one vendor charged service expenses which were over 10% of total cost of revenues for the relevant period. Service
providers accounting for 10% or more of the Company&rsquo;s cost of revenues were as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Years Ended<BR>
    December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Vendor A</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">45</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">46</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Vendor B</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">15</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">70</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">48</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2018 and 2017, accounts
payable due to several vendors as a percentage of consolidated accounts payable were over 10%. The details are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Vendor A</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">39</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Vendor B</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">21</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">0</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">60</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 218; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>16.</B></TD><TD><B>STOCK BASED COMPENSATION</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 2, 2015, Zhongchao Shanghai
granted 552,000 shares of restricted share units to 13 personnel, among which 12 personnel were employees and 1 personnel was
non-employee. Among the 552,000 shares, 502,200 shares granted to 7 employees and 1 non-employee vested immediately upon grant;
while 49,800 shares granted to 5 employees vested after a three-year service period is fulfilled. For restricted share units that
fully vested on grant date, the cost of award is expensed on the grant date. For restricted share units that vest after fulfilment
of requisite service period, the Company recognizes the compensation cost over the requisite service period. The grant-date value
of a restricted share was $4.01, which was determined by backsolve method by referring to Zhongchao Shanghai&rsquo;s equity value
reached in its recent equity transactions with unrelated parties on October 26 and 29, 2015, respectively. The backsolve method
is relevant at any stage of development if transactions occur close to the measurement date and at arm&rsquo;s length. The Company
used equity allocation model to allocate the equity value of the Company to different classes of shares, comprised of ordinary
shares, the Series A-1 preferred shares issued on October 26, 2015 and the Series A-2 preferred shares issued on October 29, 2015.
The Company allocated equity under three basis, namely, liquidation scenario, redemption scenario and conversion scenario, given
probability of 25%, 25% and 50%, respectively. Later in 2016, both Series A-1 preferred shares and Series A-2 preferred shares
were converted into ordinary shares so as to facilitate Zhongchao Shanghai become listed in NEEQ.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company applied black-scholes model
to allocate equity value under both liquidation scenario and redemption scenario. The Company applied an as-if-fully-converted
basis to allocate equity value under conversion scenario. The significant estimation and assumption are as follows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">Current equity
                                         value: $14.0 million (RMB 90,886,000)</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">Life to expiration:
                                         3.17 years</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">Risk free rates:
                                         2.74%</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">Volatility:
                                         36.95%</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">Probability
                                         of each scenario: liquidation scenario 25%; redemption scenario 25%; conversion scenario
                                         50%</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 15, 2016, Zhongchao Shanghai
made a stock split, resulting in an increase to the restricted share units granted to 12 employees and 1 non-employee to 1,976,160
shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In September 2016, one of the employees
resigned and forfeited the unvested 21,480 shares of restricted share units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 3, 2017, Zhongchao Shanghai granted
85,920 shares of restricted share units to one employee. The restricted share units will vest after a five-year service period
is fulfilled. The grant-date value of a restricted share was $3.12 The fair value of the equity value was assessed using discounted
cash flow method under income approach, with a discount for lack of marketability given that the equity interests underlying the
awards were not publicly traded at the time of grant. This assessment required complex and subjective judgments regarding the
Zhongchao Shanghai&rsquo;s projected financial and operating results, its unique business risks, the liquidity of the equity interests
and its operating history and prospects at the time the equity interests were given. The fair value of these awards was determined
using management&rsquo;s estimates and assumptions. Significant estimates and assumptions used included revenue growth rate ranging
from 10.9% to 30.0%, terminal growth rate of 3%, and discount rate of 16%.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 19, 2017, Zhongchao Shanghai
announced an acceleration of vesting shares for employees whose restricted share units are subject to fulfilment of a requisite
service period. These employees were entitled to vest 7% of restricted shares units. Meantime, the 12 employees and 1 non-employee
exercised and sold 142,500 shares of ordinary shares to an external investor at a consideration of $478,800, in proportionate
to their granted number of ordinary shares. The Company recorded related expenses of the 7% restricted shares units upon the announcement,
as if the acceleration was separate grant of restricted share units which was granted and vested simultaneously.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 21, 2017, Zhongchao Shanghai
declared a stock dividend by delivering 5 new shares of ordinary share to each 10 existing shares. As the number of additional
shares issued as stock dividend is so significant that it has the effect of materially reducing the share value, the shareholders
do not anticipate the amount in the retained earnings is subject to further distributions either in stock or in cash. The substance
of the transaction is that of a stock split. Accordingly, the Company accounted for the stock dividend as stock split. No capitalization
of retained earnings is necessary and no additional accounting treatment is posted and the shares and per share data are presented
on a retroactive basis.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2017, 12 employees
and 1 non-employee had an aggregation of 2,847,150 shares of ordinary share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November and December 2018, two employees
resigned from the Company and forfeited the unvested 154,346 shares of ordinary share. Accordingly, the Company reversed the expenses
which was previously charged to the statement of income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2018, 10 employees
and 1 non-employee had an aggregation of 2,692,805 shares of restricted share units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2018
and 2017, the Company had a reversal of stock-based compensation of $14,483 and stock-based compensation expenses of $110,940,
respectively. As of December 31, 2018, the Company expected to incur stock based compensation expenses of $167,179 over a weighted
average period of 3.34 years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 219; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>16.</B></TD><TD><B>STOCK BASED COMPENSATION (CONTINUED)</B></TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes our unvested
restricted share units:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<BR>
    shares</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Weighted-<BR>
                                         Average</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Grant-Date<BR>
                                         Fair Value</B></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font-weight: bold">Unvested at December 31, 2016</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">156,804</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">4.01</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">85,920</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3.12</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Cancelled</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(16,950</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(3.36</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Increase of restricted share units pursuant to stock split</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">112,888</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">(1.31</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">Unvested at December 31, 2017</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">338,662</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">2.46</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Vested</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(64,436</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(2.67</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">Forfeited</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(154,346</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">(2.67</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 4pt">Unvested at December 31, 2018</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">119,880</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">$</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: right">2.08</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>17.</B></TD><TD><B>COMMITMENTS AND CONTINGENCIES</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0px">&nbsp;</TD>
    <TD STYLE="width: 0px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Contingencies</U></I></FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.05pt">From
time to time, the Company may be subject to certain legal proceedings, claims and disputes that arise in the ordinary course of
business. Although the outcomes of these legal proceedings cannot be predicted, the Company does not believe these actions, in
the aggregate, will have a material adverse impact on its financial position, results of operations or liquidity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.05pt"><I><U>Lease
commitment</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2017,
the Company entered into two office lease agreements with two lessors. The lease term of the two lease agreements expire in January
and May 2019, respectively. In January 2019, the Company extended one of the lease agreements for another one year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Future minimum lease payment under non-cancelable
operating leases are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Twelve months ending December 31,</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Minimum<BR>
    lease<BR>
    payments</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left">2019</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">160,367</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">17,622</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">Total</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">177,989</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Rental expense for the years ended December 31, 2018 and 2017
was $195,326 and $171,788, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.05pt"><I><U>Contractual
commitment for construction of the Company&rsquo;s office campus </U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.05pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2018,
the Company obtained two pieces of land use rights (Note 7), on which it commenced construction of the office campus and facilities
(Note 6). The construction is expected to complete in October 2019. Future minimum capital commitment under construction contract
as of December 31, 2018 are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Twelve months ending December 31,</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Minimum<BR>
    capital<BR>
    commitment</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left; padding-bottom: 1.5pt">2019</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="width: 9%; text-align: right; border-bottom: Black 1.5pt solid">61,013</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">Total</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">61,013</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.05pt"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 220; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>18.</B></TD><TD><B>SUBSEQUENT EVENTS</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 21.3pt"><B><I>1)</I></B></TD><TD STYLE="text-align: justify"><B><I>Formation
                                         of a new subsidiary</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company formed a wholly owned subsidiary,
Horgos Zhongchao Zhongxing Medical Technology Co., Ltd. (&ldquo;Horgos Zhongchao Zhongxing&rdquo;), with a registered capital
of RMB 1 million (equivalent of $145,081) in Horgos in July 2019. Horgos Zhongchao Zhongxing obtained its business licenses of
development medical technology on July 29, 2019, and has not commenced operations as of the date of this report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 21.3pt"><B><I>2)</I></B></TD><TD STYLE="text-align: justify"><B><I>Transfer
                                         of shares in Zhongchao Shanghai among shareholders</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 21, 2019, one existing shareholder
sold 1.5% equity interest in Zhongchao Shanghai to Mr. Weiguang Yang, the principal shareholder, the CEO and Chairman of the Board
of the Company. Upon the closing of the transaction, Mr. Weiguang Yang owns 44.91% equity interest in Zhongchao Shanghai, and
the existing shareholder has 1% equity interest in Zhongchao Shanghai.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 21, 2019, four existing shareholders
sold collectively 5.63% equity interest in Zhongchao Shanghai to two new shareholders. Upon the closing of the transactions, the
two new shareholders own 2.5% and 3.13% equity interest in Zhongchao Shanghai, respectively, while the four selling shareholders
are no longer shareholders of Zhongchao Shanghai.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 21.3pt"><B><I>3)</I></B></TD><TD STYLE="text-align: justify"><B><I>Entry into
                                         material construction agreements</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the period from January 1, 2019
through the date of this financial statements, the Company entered into several agreements for the construction of its office
campus and facilities in Beijing on newly leased land use rights. Pursuant to the agreements, the Company would incur capital
expenditure of approximately $0.78 million (equivalent of RMB 5.34 million) during the year ending December 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 21.3pt"><B><I>4)</I></B></TD><TD STYLE="text-align: justify"><B><I>Issuance
                                         of restricted share units</I></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> On January 3, 2019, Zhongchao Shanghai
granted 101,997 shares of restricted share units to three of its employees and 30,000 shares to one non-employee. The restricted
share units will vest after a five-year service period is fulfilled. The grant-date value of each restricted share units was $2.72,
and the total fair value of these restricted share units aggregated $359,390. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 28, 2019, Zhongchao Shanghai
granted 29,907 shares and 142,229 shares of restricted share units to Ms. Pei Xu, the Chief Financial Officer of the Company,
and Ms. Shuang Wu, the Chief Operation Officer of the Company, respectively. The restricted share units will vest after a 10-year
service period is fulfilled. The grant-date value of each restricted share units was $2.72, and the total fair value of these
restricted share units aggregated $468,380.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the restricted share
units was assessed using discounted cash flow method under income approach, with a discount for lack of marketability given that
the equity interests underlying the awards were not publicly traded at the time given to these customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>


<!-- Field: Page; Sequence: 221; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>19.</B></TD><TD><B>CONDENSED FINANCIAL INFORMATION OF THE PARENT
                                         COMPANY</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company performed a test on the restricted
net assets of consolidated subsidiary in accordance with Securities and Exchange Commission Regulation S-X Rule 4-08 (e) (3),
&ldquo;General Notes to Financial Statements&rdquo; and concluded that it was applicable for the Company to disclose the financial
statements for the parent company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The subsidiary did not pay any dividend
to the Company for the periods presented. For the purpose of presenting parent only financial information, the Company records
its investment in its subsidiary under the equity method of accounting. Such investment is presented on the separate condensed
balance sheets of the Company as &ldquo;Investment in subsidiary&rdquo; and the loss of the subsidiary is presented as &ldquo;share
of income (loss) of subsidiary&rdquo;. Certain information and footnote disclosures generally included in financial statements
prepared in accordance with U.S. GAAP have been condensed and omitted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company did not have significant capital
and other commitments, long-term obligations, or guarantees as of December 31, 2018 and 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PARENT COMPANY BALANCE SHEETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&nbsp;31,<BR> 2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&nbsp;31,<BR> 2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">ASSETS</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; padding-bottom: 1.5pt">Investment in subsidiaries</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">11,413,202</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">5,207,622</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt">Total Assets</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">11,413,202</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">5,207,622</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">LIABILITIES AND EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Commitments and Contingencies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Shareholders&rsquo; Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Class A Ordinary Share (par value $0.0001 per share,
    450,000,000 shares authorized; 16,102,420 and 14,752,420 shares issued and outstanding at December 31, 2018 and 2017, respectively)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,610</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,475</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Class B Ordinary Share (par value $0.0001 per share,
    50,000,000 shares authorized; 5,497,715 and 5,497,715 shares issued and outstanding at December 31, 2018 and 2017, respectively)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">550</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">550</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,945,979</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,380,337</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Statutory reserve</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,539</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accumulated deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(384,309</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,383,093</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Accumulated other comprehensive (loss) income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(171,167</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">208,353</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Shareholders&rsquo; Equity</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">11,413,202</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">5,207,622</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt">Total Liabilities and Equity</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">11,413,202</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">5,207,622</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 222; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>19. CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY
(CONTINUED)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PARENT COMPANY STATEMENTS OF INCOME
AND COMPREHENSIVE INCOME</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Years Ended<BR>
    December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; padding-bottom: 1.5pt">Share of Income of subsidiaries</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="width: 9%; text-align: right; border-bottom: Black 1.5pt solid">3,001,489</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="width: 9%; text-align: right; border-bottom: Black 1.5pt solid">1,494,928</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Net Income</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">3,001,489</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">1,494,928</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Other Comprehensive (Loss) Income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Foreign currency translation adjustment</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(379,520</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">228,786</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt">Comprehensive Income</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,621,969</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,723,714</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PARENT COMPANY STATEMENTS OF CASH FLOWS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Years Ended<BR>
    December 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Cash Flows from Operating Activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font-weight: bold; text-align: left">Net income</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">3,001,489</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1,494,928</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Adjustments to reconcile net income to net cash provided by&nbsp;operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Equity income of subsidiaries</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(3,001,489</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(1,494,928</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net Cash Provided by Operating Activities</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Net increase in cash and cash equivalents</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Cash and cash equivalents at beginning of year</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Cash and cash equivalents at end of year</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 223; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="c_001"></A>ZHONGCHAO
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONDENSED
CONSOLIDATED BALANCE SHEETS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>As
of June 30, 2019 and December 31, 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Expressed
in U.S. dollar, except for the number of shares)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30,<BR> 2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,<BR> 2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; padding-left: 10pt; text-indent: -10pt">ASSETS</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; padding-left: 10pt; text-indent: -10pt">Current Assets</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; padding-left: 10pt; text-indent: -10pt">Cash and cash equivalents</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">6,558,332</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">7,918,675</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt; text-indent: -10pt">Short-term investments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">436,999</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,163,552</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt; text-indent: -10pt">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,128,237</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,993,237</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">Prepayments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">425,804</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">562,575</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt">Other current assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">817,990</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">923,318</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 10pt; text-indent: -10pt">Total Current Assets</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">13,367,362</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">12,561,357</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt; text-indent: -10pt">Property and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,463,757</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">669,905</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt; text-indent: -10pt">Land use rights, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">382,469</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">392,761</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt; text-indent: -10pt">Intangible assets, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">41,556</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,054</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt">Deferred tax assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">420,414</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">378,047</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt">Total Assets</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">15,675,558</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">14,046,124</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 10pt; text-indent: -10pt">LIABILITIES AND EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 10pt; text-indent: -10pt">Current Liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt; text-indent: -10pt">Short-term borrowings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">728,332</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">727,220</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt; text-indent: -10pt">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">269,812</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,625</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt; text-indent: -10pt">Advances from customers</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">203,235</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">553,409</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt; text-indent: -10pt">Deferred income, current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">327,749</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">407,243</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt; text-indent: -10pt">Income tax payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">508,285</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">288,111</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt">Accrued expenses and other liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">503,927</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">333,901</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 10pt; text-indent: -10pt">Total Current Liabilities</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">2,541,340</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">2,333,509</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt">Deferred income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">327,249</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt">Total Liabilities</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,541,340</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,660,758</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 10pt; text-indent: -10pt">Commitments and Contingencies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 10pt; text-indent: -10pt">Shareholders&rsquo; Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">Class A Ordinary Share (par value $0.0001 per share, 450,000,000 shares
    authorized; 16,102,420 and 16,102,420 shares issued and outstanding at June 30, 2019 and December 31, 2018, respectively)*</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,610</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,610</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">Class B Ordinary Share (par value $0.0001 per share, 50,000,000 shares
    authorized; 5,497,715 and 5,497,715 shares issued and outstanding at June 30, 2019 and December 31, 2018, respectively)*</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">550</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">550</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt; text-indent: -10pt">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,961,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,945,979</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt; text-indent: -10pt">Statutory reserve</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,539</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,539</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt; text-indent: -10pt">Retained earnings (Accumulated deficit)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,346,220</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(384,309</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt">Accumulated other comprehensive
    loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(174,114</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(171,167</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 10pt; text-indent: -10pt">Total Zhongchao Inc.&rsquo;s Shareholders&rsquo;
    Equity</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">13,156,305</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">11,413,202</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt">Noncontrolling interests</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(22,087</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(27,836</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt">Total Shareholders&rsquo;
    Equity</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">13,134,218</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">11,385,366</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt">Total Liabilities
    and Shareholders&rsquo; Equity</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">15,675,558</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">14,046,124</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares are presented on a retroactive basis to reflect the reorganization (Note 1) and the stock dividend announced
    on November 21, 2017 (Note 13).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The&nbsp;accompanying
notes are an integral part of the unaudited condensed consolidated financial statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 224; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="c_002"></A>ZHONGCHAO
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNAUDITED
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Six Months Ended June 30, 2019 and 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Expressed
in U.S. dollar, except for the number of shares)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Six Months Ended<BR>
    June 30,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; padding-left: 10pt; text-indent: -10pt">Revenues</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">6,987,623</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">5,232,210</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt">Cost of revenues</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,237,277</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,736,783</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt">Gross Profit</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,750,346</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,495,427</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 10pt; text-indent: -10pt">Operating Expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt; text-indent: -10pt">Selling and marketing expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,303,740</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,456,105</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt; text-indent: -10pt">General and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,633,056</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(886,932</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt">Research and development expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(553,282</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(624,343</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt">Total Operating
    Expenses</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(3,490,078</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(2,967,380</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 10pt; text-indent: -10pt">Income from Operations</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">1,260,268</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">528,047</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt; text-indent: -10pt">Interest income, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">118,943</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">81,380</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt">Other income, net</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">535,587</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">25,966</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 10pt; text-indent: -10pt">Income Before Income Taxes</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">1,914,798</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">635,393</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt">Income tax expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(205,910</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(84,188</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 10pt; text-indent: -10pt">Net Income</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">1,708,888</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">551,205</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt">Net loss (income) attributable
    to noncontrolling interests</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">21,641</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(7,681</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt">Net Income Attributable
    to Zhongchao Inc.&rsquo;s shareholders</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,730,529</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">543,524</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 10pt; text-indent: -10pt">Other Comprehensive Loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt">Foreign currency translation adjustment</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,947</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(110,037</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 10pt; text-indent: -10pt">Comprehensive Income</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">1,705,941</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">441,168</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt">Total comprehensive loss (income)
    attributable to noncontrolling interests</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">21,641</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(7,681</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt">Total comprehensive
    income attributable to Zhongchao Inc.&rsquo;s shareholders</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,727,582</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">433,487</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-left: 10pt; text-indent: -10pt">Weighted average number of ordinary share outstanding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt; padding-left: 0.25in; text-indent: -10pt">Basic and Diluted*</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">21,600,135</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">20,250,135</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-left: 10pt; text-indent: -10pt">Earnings per share</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt; padding-left: 0.25in; text-indent: -10pt">Basic and Diluted*</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">0.08</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">0.03</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares are presented on a retroactive basis to reflect the reorganization (Note 1) and the stock dividend announced
    on November 21, 2017 (Note 13).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the unaudited condensed consolidated financial statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 225; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="c_003"></A>ZHONGCHAO
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNAUDITED
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&rsquo; EQUITY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Six Months Ended June 30, 2019 and 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Expressed
in U.S. dollar, except for the number of shares)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-left: 5pt; text-indent: -5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="30" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Attributable to Zhongchao
    Inc.&rsquo;s Shareholders</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-left: 5pt; text-indent: -5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Ordinary share</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Additional</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Accumulated other</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Non-</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-left: 5pt; text-indent: -5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class A</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Class B</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">paid-in</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Statutory</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Accumulated</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">comprehensive</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">controlling</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-left: 5pt; text-indent: -5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares*</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares*</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">capital</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">reserve</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">deficit</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">income (loss)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">interest</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">equity</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-left: 5pt; text-indent: -5pt">Balance as of December 31, 2017</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; font-weight: bold; text-align: right">14,752,420</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 7%; font-weight: bold; text-align: right">1,475</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; font-weight: bold; text-align: right">5,497,715</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 7%; font-weight: bold; text-align: right">550</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 7%; font-weight: bold; text-align: right">8,380,337</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 7%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 7%; font-weight: bold; text-align: right">(3,383,093</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">)</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 7%; font-weight: bold; text-align: right">208,353</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 7%; font-weight: bold; text-align: right">(10,002</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">)</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 7%; font-weight: bold; text-align: right">5,197,620</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5pt; text-indent: -5pt">Share-based compensation expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53,853</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53,853</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5pt; text-indent: -5pt">Net income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">543,524</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,681</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">551,205</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 5pt; text-indent: -5pt">Foreign&nbsp;currency translation&nbsp;adjustments</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(110,037</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(110,037</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 4pt; padding-left: 5pt; text-indent: -5pt">Balance as of June 30, 2018</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">14,752,420</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,475</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">5,497,715</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">550</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">8,434,190</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(2,839,569</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">98,316</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(2,321</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">5,692,641</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 5pt; text-indent: -5pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-left: 5pt; text-indent: -5pt">Balance as of December 31, 2018</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">16,102,420</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">1,610</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">5,497,715</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">550</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">11,945,979</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">20,539</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">(384,309</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">(171,167</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">(27,836</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">11,385,366</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5pt; text-indent: -5pt">Share-based compensation expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">76,629</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">76,629</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5pt; text-indent: -5pt">Acquisition of a noncontrolling interests</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(61,108</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27,390</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(33,718</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 5pt; text-indent: -5pt">Net income (loss)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,730,529</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(21,641</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,708,888</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 5pt; text-indent: -5pt">Foreign currency translation adjustments</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,947</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,947</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 4pt; padding-left: 5pt; text-indent: -5pt">Balance as of June 30, 2019</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">16,102,420</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,610</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">5,497,715</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">550</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">11,961,500</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">20,539</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,346,220</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(174,114</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(22,087</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">13,134,218</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares are presented on a retroactive basis to reflect the reorganization (Note 1) and the stock dividend announced
    on November 21, 2017 (Note 13).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the unaudited condensed consolidated financial statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 226; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="c_004"></A>ZHONGCHAO
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNAUDITED
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Six Months Ended June 30, 2019 and 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Expressed
in U.S. dollar, except for the number of shares)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Six Months Ended<BR>
    June 30,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net Cash (Used in) Provided by Operating
    Activities</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,290,429</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,821,810</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Cash Flows from Investing Activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Purchases of property and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(835,430</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,310</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Payment for land use rights</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(298,484</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Investments in short-term investments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(442,243</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,413,872</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Release from short-term investments</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,179,315</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,861,598</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net Cash (Used in) Provided by Investing Activities</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(98,358</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">145,932</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Cash Flows from Financing Activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net Cash Provided by Financing Activities</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Effect of exchange rate changes on cash and cash equivalents</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">28,444</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(124,691</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Net (decrease) increase in cash and cash equivalents</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,360,343</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,843,051</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Cash and cash equivalents at beginning of period</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">7,918,675</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,978,515</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Cash and cash equivalents at end of period</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">6,558,332</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">4,821,566</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Supplemental Cash Flow Information</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Cash paid for interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">18,967</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Cash paid for income tax</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">25,830</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Noncash investing activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Acquisition of noncontrolling interests in a subsidiary</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">33,168</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the unaudited condensed consolidated financial statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 227; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="c_005"></A>ZHONGCHAO
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Six Months Ended June 30, 2019 and 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Expressed
in U.S. dollar, except for the number of shares)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ORGANIZATION
    AND PRINCIPAL ACTIVITIES</B>&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying condensed consolidated financial statements include the financial statements of Zhongchao Inc. (&ldquo;Zhongchao
Cayman&rdquo;, or the &ldquo;Company&rdquo;), its subsidiaries and variable interest entity (&ldquo;VIE&rdquo;) and VIE&rsquo;s
subsidiaries for which the Company or its subsidiaries are the primary beneficiaries. The Company provides customized medical
courses and customized medical training services to medical associations, pharmaceutical enterprises, medical institutions, medical
journals, medical foundations, hospitals and etc. in the PRC.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 14, 2019, Beijing Zhongchao Zhongxing Technology Limited (&ldquo;Zhongchao WFOE&rdquo;), Zhongchao Cayman completed a reorganization
of entities under common control of Weiguang Yang, who owned a majority of the voting power of Zhongchao Cayman prior to the reorganization.
Zhongchao Cayman, Zhongchao Group Inc. (&ldquo;Zhongchao BVI&rdquo;), and Zhongchao Group Limited (&ldquo;Zhongchao HK&rdquo;)
were established as the holding companies of Beijing Zhongchao Zhongxing Technology Limited (&ldquo;Zhongchao WFOE&rdquo;). Zhongchao
WFOE is the primary beneficiary of Zhongchao Medical Technology (Shanghai) Limited (&ldquo;Zhongchao Shanghai&rdquo;) and its
subsidiaries, and all of these entities are under common control which results in the consolidation of Zhongchao Shanghai and
subsidiaries which have been accounted for as a reorganization of entities under common control at carrying value. The unaudited
condensed consolidated financial statements are prepared on the basis as if the reorganization became effective as of the beginning
of the first period presented in the unaudited condensed consolidated financial statements.&nbsp; Total assets and liabilities
presented on the Company&rsquo;s unaudited condensed consolidated balance sheets and revenues, expenses, net incomes presented
on unaudited condensed consolidated statements of incomes as well as the cash flows from operating, investing and financing activities
presented on the unaudited condensed consolidated statements of cash flows are substantially the financial positions, operations
and cash flows of Zhongchao Shanghai and its subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUMMARY
    OF SIGNIFICANT ACCOUNTING POLICIES</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(a)</I></B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Basis
    of presentation</I></B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Security
and Exchange Commission and accounting principles generally accepted in the United States of America (&ldquo;U.S. GAAP&rdquo;)
for interim financial reporting. Certain information and footnote disclosures normally included in financial statements prepared
in conformity with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these statements
should be read in conjunction with the Company&rsquo;s audited consolidated financial statements for the years ended December&nbsp;31,
2018 and 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
the opinion of the management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring
adjustments, which are necessary for a fair presentation of financial results for the interim periods presented. The Company believes
that the disclosures are adequate to make the information presented not misleading. The accompanying unaudited condensed consolidated
financial statements have been prepared using the same accounting policies as used in the preparation of the Company&rsquo;s consolidated
financial statements for the years ended December&nbsp;31, 2018 and 2017. The results of operations for the six months ended June
30, 2019 and 2018 are not necessarily indicative of the results for the full years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(b)</I></B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Accounts
    receivable</I></B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable are recorded at the gross amount less an allowance for any uncollectible accounts and do not bear interest, depending
on credit assessment of customers. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis,
using historical collection trends and aging of receivables. Management also periodically evaluates individual customer&rsquo;s
financial condition, credit history and the current economic conditions to make adjustments in the allowance when necessary. Account
balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery
is considered remote. As of June 30, 2019 and December 31, 2018, the Company determined no allowances for doubtful accounts were
necessary for accounts receivable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 228; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>ZHONGCHAO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Six Months Ended June 30, 2019 and 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Expressed
in U.S. dollar, except for the number of shares)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUMMARY
    OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(c)</I></B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Revenue
    recognition</I></B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company early adopted ASC 606, Revenue from Contracts with Customers (&ldquo;ASC 606&rdquo;) on January 1, 2017, using the modified
retrospective approach. ASC 606 establishes principles for reporting information about the nature, amount, timing and uncertainty
of revenue and cash flows arising from the entity&rsquo;s contracts to provide goods or services to customers. The core principle
requires an entity to recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the
consideration that it expects to be entitled to receive in exchange for those goods or services recognized as performance obligations
are satisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has assessed the impact of the guidance by reviewing its existing customer contracts and current accounting policies and
practices to identify differences that will result from applying the new requirements, including the evaluation of its performance
obligations, transaction price, customer payments, transfer of control and principal versus agent considerations. Based on the
assessment, the Company concluded that there was no change to the timing and pattern of revenue recognition for its current revenue
streams in scope of ASC 606 and therefore there was no material changes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
according with ASC 606, revenues are recognized when control of the promised services is transferred to customers, in an amount
that reflects the consideration the Company expects to be entitled to in exchange for those services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company identified each distinct service, or each series of distinct services that are substantially the same and that have the
same pattern of transfer to the customer, as a performance obligation. Transaction price is allocated among different performance
obligations identified in one contract, by using expected cost plus margin approach, if the standalone selling price of each performance
obligation is not observable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Timing
of revenue recognition may differ from the timing of invoicing to customers. Accounts receivable represents amounts invoiced and
revenue recognized prior to invoicing when the Company has satisfied its performance obligation and has the unconditional right
to payment. The balance of accounts receivable was $5,128,237 and $1,993,237 as of June 30, 2019 and December&nbsp;31, 2018, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advances
from customers consists of payments received related to unsatisfied performance obligations at the end of the period. As of December&nbsp;31,
2018, the Company&rsquo;s total advance from customers of $553,409 was recognized as revenue for the six months ended June 30,
2019. As of June 30, 2019, the balance of advance from customers was $203,235.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company applied a practical expedient to expense costs as incurred for costs to obtain a contract with a customer when the amortization
period would have been one year or less. The Company has no material incremental costs of obtaining contracts with customers that
the Company expects the benefit of those costs to be longer than one year which need to be recognized as assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 229; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;<BR STYLE="clear: both"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ZHONGCHAO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Six Months Ended June 30, 2019 and 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Expressed
in U.S. dollar, except for the number of shares)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUMMARY
    OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(c)</I></B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Revenue
    recognition</I></B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Medical
training and education services</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company designs and provides both online and offline medical training and education courses to physicians and allied healthcare
professionals (the &ldquo;training and education services&rdquo;). The Company identifies a single performance obligation from
contracts for both offline and online medical training and education services. The Company recognizes revenue at the point of
provision of services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offline
medical training and education services courses &ndash; though customers can benefit from each service commitment, including design,
production and presentation of medical courses, together with other readily available resources. The promises in the contracts
with customers is integration of all of these service commitments. &nbsp;&nbsp;The Company concludes that these service commitments
are highly dependent with each other, in the context of the contract term. Thus, these service commitments are not distinct from
each other, and the Company combines all service commitments performed as a single performance obligation. In cases where the
Company engages third party experts to provide presentation in medical courses, as the Company determines the contents and the
participants, it has the ability to direct these experts to provide medical training services for the Company. Therefore the Company
is primarily responsible for fulfilling the promise to provide the medial courses and has the discretion in establishing the transaction
price. The Company is a principal in the provision of services and recognizes revenues on a gross basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Online
medical training and education services courses &ndash; the promises in the contracts with customers consist of provision of online
courses and presentation of the courses online for users to access for a period of time. The performance obligation of presentation
of the courses online for users for a period of time is immaterial in the context of the contract because presentation of each
course incurred no significant additional cost, nor will it occupy any significant resources of the Company, except for little
digital space on the Company&rsquo;s server, which is inconsequential. Therefore, the Company combines all service commitments
performed as a single performance obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fees are collected either in advance to provision of services or after the services are provided. In cases where fees are collected
in advance, the fees are recorded as &ldquo;advance from customers&rdquo; in the consolidated balance sheets. Advance from customers
is recognized as revenue when the Company delivers the courses to its customers. The fees are non-refundable. In cases where fees
are collected after the sales, revenue and accounts receivable are recognized upon delivery of medical training and education
courses to the Company. The fees are fixed and determinable at the inception of the services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Assistance in operation of patient-aid
projects</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is engaged by not-for-profit organizations
(&ldquo;NFP&rdquo;) to assist in operation of patient aid projects with a purpose to facilitate qualified patients to obtain free
drug treatment from NFPs. The Company is responsible to provide doctors with access to training courses or training materials
in connection with the drug treatment, review the completeness of application documents from patients, and other ad-hoc works.
The arrangements are structured as fixed price contracts. The price is determined as stated in contracts and does not include
any variable consideration. The Company identifies a single performance obligation from contracts and recognizes revenue over
a period of time during which the Company provides the assistance to the NFPs till the free drugs are completely delivered. The
Company uses an input-based method to measure the progress, by reference to the cost incurred in performing the obligation.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fees are fixed at the inception of the
services and are collected either in advance to provision of services or after the services are provided.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
consulting services</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also provides consulting services to its customers, including drafting research papers and other academic supports. The
consulting services are accounted for as a single performance obligation and was recognized as revenue when the Company delivers
services to the customers. Fees are generally collected after provision of services. For the six months ended June 30, 2019 and
2018, the Company generated minimal amount from other consulting services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(d)</I></B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cost
    of revenues</I></B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of revenues was comprised of direct related costs incurred by both online and offline seminars, including expenses of travelling
and accommodation, seminar site-rental, video production and backdrop production, professional service fees charged by experts
who provide offline seminars, and salary and welfare expenses incurred by the key members of the editorial, design and production
team. The travelling and accommodation expenses, including but not limited to the air-ticket expenses and hotel accommodation
expenses, represented the costs arising from lecturers&rsquo; attendance and participation of the offline seminars. Other travelling
expenses were incurred by the Company&rsquo;s medical department for videos production, live streaming of the offline seminars,
and materials collection to create online courses. These travelling and accommodation expenses are well budgeted before any agreements
entered into by the Company and the customers. Therefore, such expenses are well covered by the customers under those agreements.
The Company is not reimbursed by the customers separately.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<BR STYLE="clear: both"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 230; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>ZHONGCHAO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Six Months Ended June 30, 2019 and 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Expressed
in U.S. dollar, except for the number of shares)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUMMARY
    OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(e)</I></B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Government
    grants</I></B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
grants include cash subsidies as well as other subsidies received from various government agencies by the VIE and its subsidiaries
of the Company. Government grants are recognized as income in other income, net. Such amounts are recognized in the consolidated
statement of income when all conditions attached to the grants are&nbsp;fulfilled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the six months ended June 30, 2019 and 2018, the Company received government grants of $nil and $552,277, respectively, in connection
with the Company&rsquo;s development of medical database and online medical lectures sharing application and cloud system. However
the condition to attached to the grants would not be fulfilled until quality check by local government. These grants are recognized
as deferred income when received and will be charged as a reduction of specific costs and expenses upon the Company passing the
quality check, or recorded as an income if the specific costs and expenses incurred in prior periods. For the six months ended
June 30, 2019 and 2018, in connection with the Company&rsquo;s development of medical database and online medical lectures sharing
application and cloud system, the Company recognized government grant income of $515,950 and $nil, respectively, included in the
&ldquo;other income, net&rdquo; in the unaudited condensed consolidated statement of income. Other immaterial government grants
are recognized as current period income when received.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(f)</I></B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Share-based
    compensation</I></B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted ASU 2018-07,&nbsp;Compensation-Stock Compensation (Topic 718), Improvements to Nonemployee Share-Based Payment
Accounting&nbsp;(&ldquo;ASU 2018-07&rdquo;) on January 1, 2019. The adoption of this ASU did not have a material impact on the Company&rsquo;s
unaudited condensed consolidated financial statements. which simplifies the accounting for share-based payments granted to non-employees
for goods and services. The guidance aligns the accounting for non-employee equity based awards with the accounting for employee
equity-based awards, and requires equity-classified share-based payment awards issued to non-employees to be measured based on
the grant date price, rather than remeasure the awards through the performance completion date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based
awards granted to the Company&rsquo;s employees and one non-employee are measured at fair value on grant date, and share-based
compensation expense is recognized (i) immediately at the grant date if no vesting conditions are required, or (ii) using the
accelerated attribution method, net of estimated forfeitures, over the requisite service period. The fair value of restricted
shares is determined with reference to the fair value of the underlying shares.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
each date of measurement, the Company reviews internal and external sources of information to assist in the estimation of various
attributes to determine the fair value of the share-based awards granted by the Company, including but not limited to the fair
value of the equity value of the Company (Note 13), expected life, expected volatility and expected forfeiture rates. The Company
is required to consider many factors and make certain assumptions during this assessment. If any of the assumptions used to determine
the fair value of the share-based awards changes significantly, share-based compensation expense may differ materially in the
future from that recorded in the current reporting period. Moreover, the estimates of fair value of the awards are not intended
to predict actual future events or the value that ultimately will be realized by grantees who receive share-based awards, and
subsequent events are not indicative of the reasonableness of the original estimates of fair value made by the Company for accounting
purposes.<BR STYLE="clear: both"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 231; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>ZHONGCHAO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Six Months Ended June 30, 2019 and 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Expressed
in U.S. dollar, except for the number of shares)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUMMARY
    OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(g)</I></B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Significant
    risks and uncertainties</I></B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit
    risk</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets
that potentially subject the Company to significant concentration of credit risk primarily consist of cash and cash equivalents.
The maximum exposure of such assets to credit risk is their carrying amount as at the balance sheet dates. As of June 30, 2019,
and December 31, 2018, the Company held cash and cash equivalents of $6,558,332 and $7,918,675, respectively, which were primarily
deposited in financial institutions located in Mainland China, and each bank accounts is insured by the government authority with
the maximum limit of RMB 500,000 (equivalent to approximately $72,800). To limit exposure to credit risk relating to deposits,
the Company primarily place cash and cash equivalent deposits with large financial institutions in China which management believes
are of high credit quality and also continually monitors their worthiness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s operations are carried out in China. Accordingly, the Company&rsquo;s business, financial condition and results
of operations may be influenced by the political, economic and legal environments in the PRC as well as by the general state of
the PRC&rsquo;s economy. In addition, the Company&rsquo;s business may be influenced by changes in governmental policies with
respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, rates and methods of taxation
among other factors.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SHORT-TERM
    INVESTMENTS</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2019 and December 31, 2018, the balance of short-term investments was comprised of investments of various financial
products from banks of China and wealth management companies, with variable return rate and with maturities between three months
and one year. The Company classified these financial assets as held-to-maturity financial assets and recorded the assets at amortized
cost, which approximates fair value. As of June 30, 2019 and December 31, 2018, the Company provided no other than temporary impairment
on the short-term investments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the six months ended June 30, 2019 and 2018, the Company earned income of $123,834 and $73,901 from the short-term investments
included &ldquo;interest income, net&rdquo; in the unaudited condensed consolidated statements of income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"></P>

<!-- Field: Page; Sequence: 232; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>ZHONGCHAO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Six Months Ended June 30, 2019 and 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Expressed
in U.S. dollar, except for the number of shares)</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OTHER
    CURRENT ASSETS</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
current assets consist of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30,<BR> 2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&nbsp;31,<BR> 2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Prepaid advertising expense</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">341,040</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">738,331</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Deferred offering costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">116,342</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Government grants receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">101,966</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Office rental deposit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">46,957</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,114</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Prepaid rental fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36,383</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,514</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Prepaid consulting service fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,092</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">29,380</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Deferred contract cost</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,103</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">45,661</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Staff advance</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">56,357</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,907</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">Others</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">72,750</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">42,411</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">817,990</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">923,318</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROPERTY
    AND EQUIPMENT, NET</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment, net consist of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30,<BR> 2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&nbsp;31,<BR> 2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Office equipment</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">224,461</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">213,563</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Less: accumulated depreciation</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(78,873</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(46,106</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">145,588</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">167,457</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Construction in progress</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,318,169</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">502,448</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,463,757</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">669,905</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2019 and December 31, 2018, the construction in progress represented the construction in progress of an office campus
and facilities in Beijing on newly leased land use rights. The construction is expected to complete in December 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expenses totaled $33,089 and $11,434 for the six months ended June 30, 2019 and 2018, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 233; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<BR STYLE="clear: both"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>ZHONGCHAO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Six Months Ended June 30, 2019 and 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Expressed
in U.S. dollar, except for the number of shares)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SHORT
    TERM BORROWINGS</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term
borrowings consists of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">June 30,</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">December&nbsp;31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid; padding-left: 10pt; text-indent: -10pt">Lender Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Interest rate</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Term</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="5">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 25%; text-align: left; padding-left: 10pt; text-indent: -10pt">Shanghai Pudong Development Bank</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 24%; text-align: left; vertical-align: bottom">Fixed annual rate of 5.09%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 25%">From August 30, 2018 to August&nbsp;29, 2019</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">291,333</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">290,888</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; text-indent: -10pt">Shanghai Pudong Development Bank</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; vertical-align: bottom">Fixed annual rate of 5.09%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">From December 21, 2018 to December 20, 2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">436,999</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">436,332</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt; padding-left: 10pt; text-indent: -10pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">728,332</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">727,220</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
bank borrowings were guaranteed by Mr. Weiguang Yang, the principal shareholder, the CEO and Chairman of the Board of the Company,
and Ms. Zhihua Zhen, the spouse of Mr. Yang.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the six months ended June 30, 2019 and 2018, the interest expenses charged for the short term bank borrowings was $18,967 and
$nil, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACCRUED
    EXPENSES AND OTHER CURRENT LIABILITIES</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
expenses and other current liabilities consist of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30,<BR> 2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&nbsp;31,<BR> 2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Other tax payable</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">332,645</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">182,178</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accrued payroll</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">108,872</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">121,798</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other current liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">62,410</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">29,925</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">503,927</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">333,901</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
tax payable</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
tax payables consist of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30,<BR> 2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&nbsp;31,<BR> 2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Value added tax payable</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">299,902</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">168,439</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Local tax payable</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">32,743</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">13,739</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Total other tax payable</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">332,645</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">182,178</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 234; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>ZHONGCHAO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Six Months Ended June 30, 2019 and 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Expressed
in U.S. dollar, except for the number of shares)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;<B>&nbsp;&nbsp;</B>&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INCOME
    TAXES</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cayman
Islands</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the current tax laws of the Cayman Islands, the Company is not subject to tax on income or capital gain. Additionally, upon payments
of dividends to the shareholders, no Cayman Islands withholding tax will be imposed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>British
Virgin Islands</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the current tax laws of BVI, the Company&rsquo;s subsidiary incorporated in the BVI is not subject to tax on income or capital
gains.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Hong
Kong</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Hong Kong tax laws, Zhongchao HK is exempted from income tax on its foreign-derived income and there are no withholding taxed
in Hong Kong on remittance of dividends.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>PRC</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
tax expenses consist of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Six Months Ended<BR>
    June 30,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Current income tax expenses</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(248,200</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(162,943</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Deferred income tax benefits</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">42,290</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">78,755</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Income tax expenses</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(205,910</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(84,188</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PRC Corporate Income Tax (&ldquo;CIT&rdquo;) is calculated based on the taxable income determined under the applicable CIT Law
and its implementation rules, which became effective on January&nbsp;1, 2008. CIT Law imposes a unified income tax rate of 25%
for all resident enterprises in China, including both domestic and foreign invested enterprises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reconciliation
between total income tax expense and the amount computed by applying the weighted average statutory income tax rate to income
before income taxes is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
    the Six Months Ended<BR>
    June 30,</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2019</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2018</B></FONT><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="width: 76%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRC statutory income tax
    rate</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect of preferential tax benefits</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCECFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect of research and development credits</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)%</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective tax rate</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double">&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11</B></FONT></TD>
    <TD STYLE="padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>%</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double">&nbsp;</TD>
    <TD STYLE="border-bottom: black 4.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13</B></FONT></TD>
    <TD STYLE="padding-bottom: 3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>%</B></FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Uncertain
tax positions</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates each uncertain tax position (including the potential application of interest and penalties) based on the technical
merits, and measure the unrecognized benefits associated with the tax positions. As of June 30, 2019 and December 31, 2018, the
Company did not have any significant unrecognized uncertain tax positions or any unrecognized liabilities, interest or penalties
associated with unrecognized tax benefit. The Company does not believe that its uncertain tax benefits position will materially
change over the next twelve months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 235; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;<B>&nbsp;&nbsp;<BR STYLE="clear: both">
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>ZHONGCHAO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Six Months Ended June 30, 2019 and 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Expressed
in U.S. dollar, except for the number of shares)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EARNINGS
    PER SHARE</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the computation of basic and diluted earnings per ordinary share for the six months ended June 30,
2019 and 2018, respectively:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Six Months Ended<BR>
    June 30,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font-weight: bold; text-align: left; padding-bottom: 4pt">Net Income Attributable to Shareholders</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,730,529</TD><TD STYLE="width: 1%; padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right">543,524</TD><TD STYLE="width: 1%; padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">Weighted average number of ordinary share outstanding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt; padding-left: 0.125in">Basic and Diluted*</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">21,600,135</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">20,250,135</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">Earnings per share</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt; padding-left: 0.125in">Basic and Diluted*</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">0.08</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">0.03</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 14, 2019, Zhongchao Cayman completed a reorganization of entities under common control of its then existing shareholders,
who collectively owned a majority of the equity interests of Zhongchao Cayman prior to the reorganization. All references to numbers
of ordinary shares and per-share data in the accompanying unaudited condensed consolidated financial statements have been adjusted
to reflect such reorganization on a retrospective basis. In addition, the contingently issuable ordinary shares of 1,350,068 shares
of Class A Ordinary Share underlying the warrant (Note 1) issued to one existing shareholder of Zhongchao Shanghai is included
in calculation of basic and diluted weighted average number of ordinary share outstanding, as the Company does not expect any
circumstances under which those shares would not be issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Potential
ordinary share that have an anti-dilutive effect (i.e., those that increase earnings per share or decrease loss per share) are
excluded from the calculation of diluted earnings per share. For the six months ended June 30, 2019 and 2018, the Company had
no dilutive shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RELATED
    PARTY TRANSACTIONS AND BALANES</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2019 and December 31, 2018, the Company had no balances with related parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 3, 2019, Mr. Weiguang Yang transferred 101,997 shares of restricted share units to three of its employees and 30,000 shares
to one non-employee. The restricted share units will vest after a five-year service period is fulfilled. On February 28, 2019,
Mr. Weiguang Yang transferred 29,907 shares and 142,229 shares of restricted share units to Ms. Pei Xu, the Chief Financial Officer
of the Company, and Ms. Shuang Wu, the Chief Operation Officer of the Company, respectively. The restricted share units will vest
after a ten-year service period is fulfilled. The fair value of these ordinary share aggregated $827,413 (Note 13) which is to
compensate the services to be rendered by the employee. According to the Q&amp;A in Staff Accounting Bulletin No. 107, Topic 5,
T. The value of the shares transferred by the principal shareholder of the Company should be reflected as an expense in the Company&rsquo;s
financial statements with a corresponding credit to contributed (paid-in) capital. Thus, the fair value of the ordinary shares
totaling $827,413 transferred will be charged to expenses over the five or ten years request service period in the Company&rsquo;s
consolidated statements of income with a corresponding credit to additional paid-in capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 236; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>ZHONGCHAO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Six Months Ended June 30, 2019 and 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Expressed
in U.S. dollar, except for the number of shares)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EQUITY</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Restricted
net assets</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2019 and December 31, 2018, there was $1,346,220 and $nil retained earnings in the aggregate, respectively, which
was generated by the Company&rsquo;s PRC subsidiary, VIE and VIE&rsquo;s subsidiaries in Renminbi included in the Company&rsquo;
consolidated net assets, aside from $20,539 statutory reserve funds as of June 30, 2019 and December 31, 2018, that may be affected
by increased restrictions on currency exchanges in the future and accordingly may further limit the Company&rsquo;s PRC subsidiary,
VIE&rsquo;s and VIE&rsquo;s subsidiaries&rsquo; ability to make dividends or other payments in U.S. dollars to the Company, in
addition to the approximately $11,984,199 and $11,968,678 restricted net assets as of June 30, 2019 and December 31, 2018, respectively,
as discussed above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONCENTRATION
    RISK</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Customer
concentration</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the six months ended June 30, 2019 and 2018, three and one customer contributed revenues which were over 10% of total revenues
for the relevant periods, respectively. Customers accounting for 10% or more of the Company&rsquo;s revenue were as follows:&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Six Months Ended<BR>
    June 30,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Customer A</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">24</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">5</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Customer B</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Customer C</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">12</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">63</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">54</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">70</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2019 and December 31, 2018, accounts receivable due from several customers as a percentage of consolidated accounts
receivable were over 10%. The details are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30,<BR>
    2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Customer A</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">18</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">2</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Customer B</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Customer C</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Customer D</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Customer E</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">14</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">22</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">67</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">52</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 237; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>ZHONGCHAO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Six Months Ended June 30, 2019 and 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Expressed
in U.S. dollar, except for the number of shares)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONCENTRATION
    RISK (CONTINUED)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Vendor
concentration </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the six months ended June 30, 2019 and 2018, one and two vendors charged service expenses which were over 10% of total cost of
revenues for the relevant periods, respectively. Service providers accounting for 10% or more of the Company&rsquo;s cost of revenues
were as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Six Months Ended<BR>
    June 30,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Vendor A</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">20</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Vendor B</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Vendor C</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">28</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">26</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">67</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2019 and December 31, 2018, accounts payable due to one vendor as a percentage of consolidated accounts payable was
32% and 0%, respectively.<BR STYLE="clear: both"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.25in">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STOCK
    BASED COMPENSATION</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 2, 2015, Zhongchao Shanghai granted 552,000 shares of restricted share units to 13 personnel, among which 12 personnel
were employees and 1 personnel was non-employee. Among the 552,000 shares, 502,200 shares granted to 7 employees and 1 non-employee
vested immediately upon grant; while 49,800 shares granted to 5 employees vested after a three-year service period is fulfilled.
For restricted share units that fully vested on grant date, the cost of award is expensed on the grant date. For restricted share
units that vest after fulfilment of requisite service period, the Company recognizes the compensation cost over the requisite
service period. The grant-date value of a restricted share was $4.01, which was determined by backsolve method by referring to
Zhongchao Shanghai&rsquo;s equity value reached in its recent equity transactions with unrelated parties on October 26 and 29,
2015, respectively. The backsolve method is relevant at any stage of development if transactions occur close to the measurement
date and at arm&rsquo;s length. The Company used equity allocation model to allocate the equity value of the Company to different
classes of shares, comprised of ordinary shares, the Series A-1 preferred shares issued on October 26, 2015 and the Series A-2
preferred shares issued on October 29, 2015. The Company allocated equity under three basis, namely, liquidation scenario, redemption
scenario and conversion scenario, given probability of 25%, 25% and 50%, respectively. Later in 2016, both Series A-1 preferred
shares and Series A-2 preferred shares were converted into ordinary shares so as to facilitate Zhongchao Shanghai to become listed
in NEEQ.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company applied black-scholes model to allocate equity value under both liquidation scenario and redemption scenario. The Company
applied an as-if-fully-converted basis to allocate equity value under conversion scenario. The significant estimation and assumption
are as follows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    equity value: $14.0 million (RMB 90,886,000)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Life
    to expiration: 3.17 years</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    free rates: 2.74%</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility:
    36.95%</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Probability
    of each scenario: liquidation scenario 25%; redemption scenario 25%; conversion scenario 50%</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 15, 2016, Zhongchao Shanghai made a stock split, resulting in an increase to the restricted share units granted to 12
employees and 1 non-employee to 1,976,160 shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2016, one of the employees resigned and forfeited the unvested 21,480 shares of restricted share units.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 238; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>ZHONGCHAO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Six Months Ended June 30, 2019 and 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Expressed
in U.S. dollar, except for the number of shares)</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STOCK
    BASED COMPENSATION (CONTINUED)</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 3, 2017, Zhongchao Shanghai granted 85,920 shares of restricted share units to one employee. The restricted share units will
vest after a five-year service period is fulfilled. The grant-date value of a restricted share was $3.12 The fair value of the
equity value was assessed using discounted cash flow method under income approach, with a discount for lack of marketability given
that the equity interests underlying the awards were not publicly traded at the time of grant. This assessment required complex
and subjective judgments regarding the Zhongchao Shanghai&rsquo;s projected financial and operating results, its unique business
risks, the liquidity of the equity interests and its operating history and prospects at the time the equity interests were given.
The fair value of these awards was determined using management&rsquo;s estimates and assumptions. Significant estimates and assumptions
used included revenue growth rate ranging from 10.9% to 30.0%, terminal growth rate of 3%, and discount rate of 16%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 19, 2017, Zhongchao Shanghai announced an acceleration of vesting shares for employees whose restricted share units are
subject to fulfilment of a requisite service period. These employees were entitled to vest 7% of restricted shares units. Meantime,
the 12 employees and 1 non-employee exercised and sold 142,500 shares of ordinary shares to an external investor at a consideration
of $478,800, in proportionate to their granted number of ordinary shares. The Company recorded related expenses of the 7% restricted
shares units upon the announcement, as if the acceleration was separate grant of restricted share units which was granted and
vested simultaneously.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 21, 2017, Zhongchao Shanghai declared a stock dividend by delivering 5 new shares of ordinary share to each 10 existing
shares. As the number of additional shares issued as stock dividend is so significant that it has the effect of materially reducing
the share value, the shareholders do not anticipate the amount in the retained earnings is subject to further distributions either
in stock or in cash. The substance of the transaction is that of a stock split. Accordingly, no capitalization of retained earnings
nor additional accounting treatment is necessary. The share numbers and per share data are adjusted on a retroactive basis to
reflect such stock dividend.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November and December 2018, two employees resigned from the Company and forfeited the unvested 154,346 shares of ordinary share.
Accordingly, the Company reversed the expenses which was previously charged to the statement of income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2018, 10 employees and 1 non-employee had an aggregation of 2,692,805 shares of restricted share units.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 3, 2019, Zhongchao Shanghai granted 101,997 shares of restricted share units to three of its employees and 30,000 shares
to one non-employee. The restricted share units will vest after a five-year service period is fulfilled. The grant-date value
of each restricted share units was $2.72, and the total fair value of these restricted share units aggregated $359,032. On February
28, 2019, Zhongchao Shanghai granted 29,970 shares and 142,229 shares of restricted share units to Ms. Pei Xu, the Chief Financial
Officer of the Company, and Ms. Shuang Wu, the Chief Operation Officer of the Company, respectively. The restricted share units
will vest after a 10-year service period is fulfilled. The grant-date value of each restricted share units was $2.72, and the
total fair value of these restricted share units aggregated $468,381. The fair value of both restricted share units was assessed
using discounted cash flow method under income approach, with a discount for lack of marketability given that the equity interests
underlying the awards were not publicly traded at the time of grant. Significant estimates and assumptions used included revenue
growth rate ranging from 8.6% to 30.0%, terminal growth rate of 3%, and discount rate of 16%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the six months ended June 30, 2019 and 2018, the Company had stock-based compensation expenses of $76,629 and $53,853, respectively.
As of June 30, 2019, the Company expected to incur stock based compensation expenses of $921,231 over a weighted average period
of 6.8 years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes our unvested restricted share units:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<BR> shares</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Weighted-<BR>
                                         Average</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Grant-Date<BR>
                                         Fair Value</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; font-weight: bold">Unvested at December 31, 2017</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; font-weight: bold; text-align: right">338,662</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 9%; font-weight: bold; text-align: right">2.46</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">Unvested at June 30, 2018 (unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">338,662</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">2.46</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">Unvested at December 31, 2018</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">119,880</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">2.08</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">Granted</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">304,196</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">2.72</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 4pt">Unvested at June 30, 2019 (unaudited)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">424,076</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">$</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: right">2.54</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 239; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;<B>&nbsp;&nbsp;<BR STYLE="clear: both">
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ZHONGCHAO
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Six Months Ended June 30, 2019 and 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Expressed
in U.S. dollar, except for the number of shares)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 3%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14.</B></FONT></TD>
    <TD STYLE="width: 97%; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMITMENTS
    AND CONTINGENCIES</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Contingencies</U></I></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05pt; text-align: justify; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05pt; text-align: justify; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company may be subject to certain legal proceedings, claims and disputes that arise in the ordinary course of
business. Although the outcomes of these legal proceedings cannot be predicted, the Company does not believe these actions, in
the aggregate, will have a material adverse impact on its financial position, results of operations or liquidity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05pt; text-align: justify; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05pt; text-align: justify; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Lease
commitment</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2018, the Company had two office lease agreements with two lessors. The lease term of the two lease agreements
expire in January and May 2019, respectively. In January 2019, the Company extended one of the lease agreements for one year.
For the six months ended June 30, 2019, the Company entered into two new office lease agreements with one lessor. As of June 30,
2019, the Company had three office lease agreements with two lessors, and the lease term will expire in February 2020 through
March 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
minimum lease payment under non-cancelable operating leases are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Minimum lease payments</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%">Six months ending December 31, 2019</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">123,665</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Twelve months ending December 31, 2020</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">233,968</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">Twelve months ending December 31, 2021 and thereafter</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">37,690</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">Total</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 4pt double">$</TD><TD STYLE="font-weight: bold; text-align: right; border-bottom: Black 4pt double">395,323</TD><TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rental
expense for the six months ended June 30, 2019 and 2018 were $177,192 and $100,948, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05pt; text-align: justify; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Contractual
commitment for construction of the Company&rsquo;s office campus </U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.05pt; text-align: justify; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2018, the Company obtained two pieces of land use rights, on which it commenced construction of the
office campus and facilities (Note 5). The construction is expected to complete in December 2019. Future minimum capital commitment
under construction contract as of June 30, 2019 are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid; text-align: left">Six months ending December 31,</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Minimum<BR> capital<BR>
    commitment</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left; padding-bottom: 1.5pt">2019</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">474,865</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt; text-align: left">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">474,865</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUBSEQUENT
    EVENTS</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 24px; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>1)</I></B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Formation
    of a new subsidiary</I></B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company formed a wholly owned subsidiary, Horgos Zhongchao Zhongxing Medical Technology Co., Ltd. (&ldquo;Horgos Zhongchao Zhongxing&rdquo;),
with a registered capital of RMB 1 million (equivalent of $145,081) in Horgos in July 2019. Horgos Zhongchao Zhongxing obtained
its business licenses of development medical technology on July 29, 2019, and has not commenced operations as of the date of this
report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">F-53</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>ff12019a4ex23-1_zhongchao.htm
<DESCRIPTION>CONSENT OF MARCUM BERNSTEIN & PINCHUK LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 23.1</B></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex23-1_001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><U>Independent
Registered Public Accounting Firm&rsquo;s Consent</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the inclusion in this Registration
Statement of Zhongchao Inc. on Form F-1 Amendment #4, file No. 333-234807, of our report dated August 19, 2019, with respect to
our audits of the consolidated financial statements of Zhongchao Inc. as of December 31, 2018 and 2017 and for the years ended
December 31, 2018 and 2017, which report appears in the Prospectus, which is part of this Registration Statement. We also consent
to the reference to our Firm under the heading &ldquo;Experts&rdquo; in such Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Marcum Bernstein &amp; Pinchuk <FONT STYLE="font-variant: small-caps">llp</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">February 6, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex23-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">NEW YORK OFFICE &bull; 7 Penn Plaza &bull;
Suite 830 &bull; New York, New York &bull; 10001</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Phone 646.442.4845 &bull; Fax 646.349.5200
&bull; www.marcumbp.com</P>



<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "' ;L# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH *JWU[9Z;97FHZC=6]CI^GVMQ>WU[=S);VMG9VD3SW-U<SRLL4-O;P1O-
M--(RI'&C.[!5)%JORW_X*=_'P>"OA0GPL\.7[)K_ (\U&WL?$$MK*4>Q\/VT
M1U*?3VEC96CN-3D2R:YB!8'2O,MKR'[/J\);XSQ#XTP'A[P9Q#QAF,56I9+E
MU?$8?">T5.>88^25'+\OIRM*498O&UL-2G.,)NCA_K-?E?L4I<^*Q$<+AZV(
MDKJE3E/EVYI:*,;].:4HJ_1-OH?+_P"U#_P4Y\7ZMK&I>$/V?YAX9\-V4\MG
M-XWN+.*;Q#KC12!'GTN&]CEAT339U600_P"C?VV8VBN&N],N#+80?G/=_M'?
M'V]O9M0G^-'Q1-U/,\[NGCSQ1&H=V+'9&FJ!$4$X154"-<*FT  >+T5_C3QA
MXM^(O'&;U\XSWBW._:5:TZF'P&6YIF6593EM.4W*GALNR[+LPP-"A2HQ<:<:
ME18K%U>3VN)Q=:M.;7YWB,PQF)J.I4Q%75W4(3G"G!7T4(0E%)+9-\TG:[DV
MV?IK^S]_P4Q^+WP^U:STSXKWEQ\3?!4TR1W<E_Y \6:5$[1*]UIVM,(Y=0>)
M1+*UKKLMXEPVR"*\TN-FN8_Z"O!/C3PU\1/"FA^-?"&IP:QX<\16$>H:7?P9
M DB<LDD,T;8DM[RTG26TOK294GL[R">UG1)HG0?Q@5^T/_!*KX]KILOBOX)^
M)=19--N9K/Q#X1ENICY%EJ5TZZ;?Z<KR,1##JA33EMHP8K>._A5(TDNM5D8?
MU%]%KQ^XF7%>!\.^-<ZQ>=Y-GD*V'R',LXQ,\7F&3YO1HSKX?!2S'$SGB<3E
MN94Z-;#0I8W$8B>"QL<-.AB50Q-6A'W,CS2O*O'!XBI*K"HI*E.;<IPG&+DH
M<SNY0E&,DE)MQDE9V;2_<>BBBO\ 2<^P"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HKR+XU?&WP-\!_!ESXR\;WS1P[FMM(
MTBT\M]6U[4MA=+#3H)'120,/<W4SQVUI&5,LGFRV\,WXD_$W_@I'\=_%VH3#
MP5<:;\.M#69C:VFEV-GJ>HR0]$%_JNKVES+-,I^;S;"#28G! >TX(K^<O&KZ
M4OA/X%8BAE/%689AFW$^)P]/&4^%>&<)1S'-Z.$K<WL,7F=2OB\'EV3X?$J$
MWA?[0Q:Q6+A"5;#8">'C]9E^Q>&O@9Q]XI4JN/R'!X3 9)1K2P]3/L[Q%3!9
M=4Q%/E]KA\%&EA\3C,QK4>:*K_4\/*CAY2C3K8J%9^PC_0G5._U'3]*M)K_5
M+ZTTZRMU+SWE]<PVEM"H!):6>=XXD& >685_-3I_[=O[4%B</\2;O4(227AU
M"PT^3<#U47$%O!>1?[+17*%/X<  5W^A_M":[\79##XCUS56\00*TYL+_5+R
M_BD18Q'+/I%Q>32S)$$_X^+-61HU);;+'OD'Y?P5].[PJX_QM/),FROB#)^(
ML4W#+\NXJ_LW 8?'U;2<:.$S#+<7F.'Q&)DHN4,$WA,37491P[K5%[)^UXB?
M1P\1_#K*JV?8NAEO$&1X2*GC\QX>Q&(Q$\MIMQB\1C\NQF$PN/HX.,I153&T
M88O#4.:,L4\-3E[:/ZD_&#]K?1]&@N]#^'+#5-696A?Q!+%BQLB=Z.;"VG3=
M<W"$92YNXEM4)CEBMM1A<LGXM?M5-J_BC0+'Q3J%Q<7]W9>(7FU*XFDDED\O
M5X9(1-(\A=RHNQ&'D=B[2W&^5W>1F/N]9^K:58:YIE_H^IP+<Z?J5K+:7<)X
M+12C!9&ZI+&P66&0?-'*B.O*BN3Q,QF;^)629QE>98N-/ZY@JU'+Z%-2IX#
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M'D_ZQX#GY>3$<E[>T]G&V^_)[3GMUVO;IT/Z:**^7/V8/VK/ /[3GAF6_P!
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M20Q"2>=Y)IG$:*'EFD>61LO([.Q8_P YG_!;#]IWXN>"?B/\-?@WX!\4>-/
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M3_H[#3/_  \OQA_^9BOF_P#B'?!/_1Y.$?\ PUY]_P#*#W?]>.+?^C6\2_\
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MGGFO]&/H+9CFE7*O$/*:LJL\EP689!CL&IN3HX?,\PPN8T<PIT+WC!XG"8'
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M=.A1I3J346I2]V*:<DS[X_X?P_"#_HA7Q'_\'FB?_(E2P?\ !=[X/2SPQ/\
M OXE*DDL<;M'K.@R2*CNJL8XY(K>.20*2422>"-VPKS1*3(OZQ?\,K?LP_\
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ME>(I580QV$RW&1JUZ."E[>]+$X;"UXXJ&&4ITZM"C5]A&I.C"E"E^0!(49)
M'J2 /S-?H-^PW^RKJ'Q;\=6/C3QIILMI\//"TEOJSVM] T;^*KJ.4&QTZ.WE
M"O\ V3<S1N;N[=#%=VMM>VMJPF9;B'UG2/A/\-=#G2ZTSP3H$-U&P:.XFM#>
MRQL""&C^WR7*HP(R&50P[,*_4/\ 9QTJ*R\!-?+AI-4U*9RPQ\L-G##;) ,
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M6FB:+9R3"WADN[R0(KW%PRLMO;0)NGNKAU*6]O%+,XV1L:^Z/^"7_P 9[O\
M9\_;-\#V6O2RZ3HOCR[N?A+XPM;MI+?[.WB:YM[72#=1M^[B?3_&-IX?N+J2
M=0;>S@O5WQAG)_H+C_PGX)J<*\0TN&^'\LR_B++\K_MG"/!/$_7/98.K4JSI
MNG4Q^)3HXZCA,PPL6Z+YZU&,824XN_XIP7XD<60XCR2IGN=9AC<CQN8?V7B5
MBE0^J^TQ5.%.,U.&#H6JX2KB<%B))55RTJLI2BXR5O[3****_AH_KP_S_/VE
MO^3B?CQ_V67XH?\ J<Z]7;_L<_ ;PU^TC\=?#?PI\6^.XOAQHNM6'B*[N/%,
ML-G<)9OHWA_4]8MX3%?:GI%NQO)[&.T&Z^C(,^Y5D8"-OU^^+/\ P16^('CC
MXH_$7QJ/CQ\,M)C\9>./%?BV#3+ZVUI+RQMO$NOZAK5O;7*BV*^=#%>K&[(6
MC9D+1NRD$\ O_!##XAHP9/VB_A2K#."L.M@\\'D6U?Z 0\4N JG#U' X?C?"
M97F$LDPN$I8ZG@,QQ-3+\9'+<#06(A1JY1+#UYX:O2J-4YRE1J2@TY2@TW_%
MT_#OC*&=U<97X2Q&88)9MB,34PD\;@</#&X5X_%UG0E5IYG&O1AB*52"<X*-
M6$9)I*5TO5O^'+W[/W_1Y5A_X*?"W_SPZ_.G]OW]BGX>_LC0?#*7P-\:+?XM
M'QRWBQ=12"UTBU.A_P#"/?\ "._9F<:9XCUYV&H#6I]IG6U -D_E-.?-$/V+
M_P .-_B1_P!'(?"W_OWKO_R/7PC^VS^PKXD_8TA^'DWB#XE^$_B!_P )\WB9
M;5/#0OU?2_\ A&_["\YKP7L48VWG]N1BW,9/-K<!@,*3Y7!W$%+'<1Y=A8^,
M];BQU7B;9!+A?#9=''\F#Q$[/&4\LP\Z/U?E^M:5H<[H>S?,I\K]'BC)*F$R
M+'8B7A72X<5-8>^<QXAKXZ6#YL31A=86>85HU?;\WU=WI2Y/:\ZLX\R^!E&Y
ME4G + 9],G&:_>[X-?\ !)/X'_$KX2?#'XAZO^UA8^'-5\<^ O"?BW4?#YTW
MPU,VAWWB'0['5;K2&EE\=VLSOITUT]H[36MM-NB/FV\$FZ)/P14;F5>FX@9^
MIQ7[4_"G_@CEX_\ BA\,?AY\2;'X_?#;1[/Q]X*\,>,K72+U-9:\TNW\2:-9
MZO#IUV8H#$;JRCNUM[CRR4$T;A25 )^R\1,SAEF!RRI/CR? 2JXW$4UC(912
MSAYBXX2,_JCI5<)BU05!/ZTJBA!S<O9N32Y3Y;@?+Y9AB\PA'@Z'&3IX6C-X
M6>9U,K6!4L3*'UE5*>)PSK.M_N_LW*:CR\_*F[GKWQ$_X)!? KP;\/\ QUXO
MT_\ :YL=8OO"O@[Q/XDLM)&E^&4.J7>AZ)?:I;:<'B\>W$B&]FM4M@T<$[KY
MN4AD;"'^?J5!'+(@.X([H&_O!6(!XR.<9ZFOWD/_  0V^)!!!_:/^%I!!!!C
MUS!!X(/^C]ZA_P"'%WQ _P"CB?A1_P!^-;_^1J^5X:\1^%,HI8N&?>*U/BJI
M7JT9X:MB<AQ&6/!4X4IPJT80R_)E&LJU24:KG5]Z#@HQ]V3/H\^X%XCS*IAI
MY/X<RX=IT:=6%>EA\YHY@L7.=2,J=64L;FCE2=*"E34:?NR4W*7O)'8?\$"_
M^1U_:-_[%3X??^GGQ/7[L_M<?\FK_M'_ /9#?BI_ZA.M5\W?\$]?V#_#O[%_
MA?QA./&MO\0O'7CZ?2X?$6O:=:M8Z)I^FZ VH2:9HNDVSW=Y-(ZS:M=W.HZC
M.UM)>LUG$MA:I9![GZ1_:X_Y-7_:/_[(;\5/_4)UJOYGX\S_ "SB;Q96;Y/6
MEB<NJYQPOAZ&(E2JT%7>"KY+AJM6%.M"G65*56,U2=2G3G.$>?V<(S@G^^<'
M9-F&0>&_]F9I2C0QU/+.(*]:A&I3JNBL52S;$4Z<ZE*4Z3J1IRBZBISJ1A*7
M)SR<9-?P-3_Z^;_KK)_Z&U?M;_P0I_Y.F\??]D1\2?\ J9?#^OQ2G_U\W_76
M3_T-J_:W_@A3_P G3>/O^R(^)/\ U,OA_7]B>+/_ ";;C7_L25O_ %,RP_E[
MPV_Y+KA/_L:T?_47''V/^T#_ ,%./VS/A?\ &OXG_#[P5^SMX4\2>$_"'C7Q
M%X>\/:Y>>!_B5>76J:5I.J75A9WUQ=V'BRPL;J2ZAMUN#<6=G;VLHD#6R-"4
MD?\ &[]MS]M3XT?M;^(/"=I\7/#&@^!YOAO:ZO867A?P]IWB#288;W6[BSN-
M4OM2L_$&MZS='4+B+3M+MP=\*106,8CB5I9VD_M7^(?CC1/AGX#\9_$3Q),+
M?0/ _AC7/%6KR%U1OL&A:;<:E<1Q%N#/,EN8;=,%I9Y(XT5G=5/^?Y\4?'VN
M_%/XB^-OB-XFN&N==\:^)]:\2ZI(99)D6\UC4+B_GBMWD^<6L,D[16D>%6&V
M2**-$1%1?RGP+GP[Q#6Q&9X+@#)\BQ/#>#P."CG^'QF88K%XW,<7A/88IJEB
M9_5J$Z^$H5\7B)4X2E3EC%2I>SC+F?Z/XOQSO)*5#+\5QGFF<4,]Q6,Q;R:O
MAL%A\+A,#AL3[;#IU*$/;U8TL36HX:A&I**FL*ZD^>4>5<& 20 "23@ <DD]
M !W)K]//V8?^"A'QM_8;^'#?#WPQ\'? )L_%^K2>.GU[QUH7C)=:UY+^PL-.
MLI[>XL?%6AVD^CP6FG)]@%O9F(2SWDPED>XD-?'_ .R]\'+WX_?'[X5_"6S6
M7R_&/B[3+'59X2PELO#]O(=0\2:C&R@D/IGA^SU/44Z;C:;=RD@C^BW_ (+8
M?L]V6O?LZ> ?BIX8TJ&VE^"&L6OAN\ALXBD5IX!\4I9:/:QA8P<PZ3XAL?#M
ME8QOA+:'6;YPRAGW?HG'7$7#$N(>%/#_ (CRO#9MAN*JU2M6CB:]:G1P-7#R
MJ4LFJ5:-"MAW7>,S%5Z$(U*\(4K0K*%63BH_#\(9)Q!').(^-,BS"OEN(X=I
M0I4I4*-*=7%TZT85,UA3JU:594EA<"Z-:;ITIRJ7E2<J<4W+X>_X?P_M)?\
M1*O@?_X*/'O_ ,\.O3-"_P""P/[<.O)I5[IW[,?@G5]+U-[66VN-(\"_%.Z%
M_:SR* =/F@\9W:S/.A*V[Q0W.YRI2&8XC;^>NOZY/^"*_P =F^)/[,VI?"_5
MK]KGQ#\%/$4FG6\<TWFW)\&>+'O-9T"1BWSE+;6(?$^F01C=':Z?9:= I53&
MB_(^(W"7 ? _#DN(<%X:Y!G-.AC,-AL;0JXK-L']7P^+=2C3Q4:E#'5Y2C#%
M*C1J1<8*,:\)QFI*Q]-P+Q+QCQ=GL<DQ7'F<Y7.MA<17PE:EA\MQ7MJV&4*M
M3#N%;"48Q<L,ZM6G).3E*C*#CRML_6WPIJNI:[X6\-:WK.B7'AK6-8T#1M5U
M;PY>2+-=Z!J6H:=;7=]HEU,BHDMQI5U-+8SR*BJ\L#,JJ" /Q5^.G_!%#PK\
M7?BYX_\ BAI/QVUGPK#X_P#%.N>,+S0;[P0GB.33]5\1ZG=:SJT4&K#Q=HQG
ML3J-[=/91/81R6MJT5M))<O$US+^Y-?B7\=/^"T?@[X._%KQ]\+;+X#>*_%/
M_" ^)]9\)7NMWGBN/PP;_4] OY]*U.:UTI_"FM.FGF_M;@:?</>EKVS$%X8K
M?S_(3^:_#B7B'+-LUEX;TZT,;/!J>8TL/_9LZ5/+Y8YRP\)O.&Z<HT\3*-.C
M)-XA\C<FU*HW^\\=QX(66Y;'CNI2EA(XIQP-2M]?A4GC5A%&O."RM*:=3#Q<
MZL6E12DE%*T$O$?^'!6D_P#1R]Y_X:Q?_GAT?\."M)_Z.7O/_#6+_P#/#K5_
MX?V^&_\ HV77_P#PYD/_ ,[ZC_A_;X;_ .C9=?\ _#F0_P#SOJ_8;_2?_P"?
M>)_\ X._S/RZWT?/YZ'_ (,XI,K_ (<%:3_T<O>?^&L7_P">'1_PX*TG_HY>
M\_\ #6+_ //#K5_X?V^&_P#HV77_ /PYD/\ \[ZOF#]K'_@LYXU^-7PNU#X9
M_"?P!>_!V7Q,)['Q=XH?Q8==UV?P]-#Y<^B:&\/A_0?['_M4.\6IZD'N+MK
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M&H>(]'DUO3+_ %*VUQM+N;%+W2[8V,T317T=A=7&J(L@99+33;U@08P#N_\
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M;D^%H4Z48PBIU,35<74Q-6<_]M?"_A_+.&/#S@W*,HITH82GP[D^,G4IJ/\
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M=6EC,)B\'5Q4*:E7^IT.?$4J532HI4E2;J+Y,_X)]?%W]H[X]?!X?%[X\/\
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M=?:'TE=0%DUZ&B%X8C.+:W#^6L7Q?^%4OQ2?X5/'K::+_P *V^,7@WXJR![
MWW]L1>%+?68&T12+JV^Q/?'5@POS]H$'D$&UE\S*_33QF3U^*%B:]'"K)5.4
M94L+A8X2A*C'*:L8J%&G3ERU99A/2K.G-JLJ56I&=*DHOY^.%S2CP\Z%&KB'
MFS@FJF(Q,L35C5>94Y-RJU)KFIQP4-:<:D4Z?M*<)1J5&UYA\'OVDM)^,_QV
M^*O@SP1X@\/^)_AUX)^'/PNU_3M5TNSU"&_3Q1XLUKXB6>O6-]<WOD+-;PV'
MAO0YK.*&R3R6N+AGN9S+Y5O/^UW\7_$OP9\ >"]<\,^(O#'@^3Q/\7_A_P"
M=9\7^+]%G\0Z)X6\.^*;N]@U779M)M]7T-KN:QCMXWA1]2MXBS'S&VG(])T3
MX62Z1\<_B!\8VUM;B+QO\//AUX%3P^+$QOIK^!-9\=ZL^I-J/VIQ<KJ8\9K
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MTY/XZM6;7-5K59U*M6;<ZE23?NE%%%<)W!1110 4444 %%%% !1110 4444
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)** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  R .,# 2(  A$! Q$!_\0
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M-UOQ%\8+GQ;XWFCFUSQ2OQ$UTW^KC7"\,(L;R1918I#$D,01 *_R1/AUX_\
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M-(OGO/#EL= N2L^OC3[.2*XD->S$DG:U2Z:[/:.OSY?)NWH?Z-W[%G_!-O\
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MBCNM/\.P2QRWEOICR3K!=WEV\<BQR)%'_FJ? []C']HK]HWX^?#+]G;X0_\
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MC=QSP:?):AIT^33^T%\>@"?^%U?%HD<;1\1O%P)..Q.L8&2#U(4'N1FE\O\
MABE3;UC/9O6S3OUWU/\ 7$\!_L2>"/A_\2_AW\4['XV_M/>(-?\ AGX+/P]T
M33/&/QSU_P 2>&=6\(N('FTKQ;HE[;^3XG>XN[+2]1N-1U22;5)=0TG3[EKW
M='*LWO6I_!/X5:M\9O"W[05WX6TS_A<'@[P7XC^'6C>.(#]GU?\ X0CQ5?:9
MJFK>&=0EB91J6E'5-(LM2LK>\$HTZ]$\]D86N[KSO\T#X.?\$^_VL?C7^Q5X
MQ_;[T#_@I1\+- _9\^&-O.GQ7N_$_P 0?VJ[;Q9\.-?L8=#;5/">L^'-.^&.
MH3:MK-C>^(M*TN&?PS-K&D:S=W"OHFHWUJR3G8^%7_!,C_@H-^T5^R#XR_;+
M_9=_;,\.?M&>"O MMK4FN_#3P#\2_P!H71_C+_:7AB&QN_%'AZR\(^.O!OAB
MVNM:T2PO3>I!'JHAUR."2#P_/J=U+;03/Y>?]?UV)<(]:BT?*W9JS[=//_AC
M_0/\>_\ !.K]FWQ=\:]7_:.\)?\ "PO@-\<_%%F=/\<?$G]GKXBZW\*M9^(E
MEY44,4/Q T[1WF\-^+IK80I);:AK&AW&J0S[KA;WSCOJW\5?^"??P"^,'P3\
M6? /Q1J_Q5M/!7Q)U*75/B]J6@_$_7-/\;?&2>YL(].N[?XF^,IFO-:\1Z;<
M6\%N/[*6XLM.M%MXK;3[6SL@UJW^8+\)?#?Q;^*/P*^+?QRU/_@H-H_PL'P8
MN=,M?%?PL\?^,?VD7^)M_)XCO+C2_")\-6/A+P7XC\/:P?$NK65]IR0KKT4_
MA^2RN+CQ1%H]H!.W<_LW_LX_MW_M%?"7QM^T=<?M :M\!?V7?AW='3/%?[2'
MQ]^,_CGP=\-1X@+Q10^%_"L.G2:YXK\>^([B>:.V32_!?A_6IDO'2UE*3R1I
M1\OZ[CY+:NHERM*]GH]&DNKZ-6OTL?Z,OAW_ ()/?L\>$OAI\'?A#X9^*W[5
M.A_#WX ^-+;Q]\(?#FF_M">)[>S\&>(M/9Y-)DLU6#%_8:)<W.HW>CZ9K(U&
MQTZYU74)+>%1+$L/5_MB?\$P_P!FG]NGQ+\-?%/Q_P!<^,VI7_P@'VCX;P>$
M?BUKO@FS\):](]E)=^+=(&@+;7EKXKOWTS2FN]:CO%G+Z782P+!+;AS_ )L>
MH_!?]I[4/@1\9?VE_A)^V[H'QS^#GP!@\+/\4M5\%_&'XN^%/&OAZX\:>+?#
MO@KPS$?A3\4M)\$?$6XT_5];\1HEKXDC\/-X<>/2M4']J">.WBN/AP?M!?'D
MG_DM?Q:[?\U%\7^G3_D,#@_7/?)P21_\'_(:IMW:J;-WT:L^N]M>O]:_ZI7Q
M#_X))?LX_%+XZ>"/VE_&?Q3_ &IM1^.?PRTJ#0_AQ\1H_C_X@M=<\#:3#'?K
M+8^'A!9K96\%])JVKW&IBXM;IM0GU2\:Z:5&BCB^CO@E^QG\-?@C\6O%7QSM
M?B#\;_B?\4O%_@?3OAO?^*/C1\6=;^(<FG>#-,UA=>M]$\/:;?+:Z/H%O+JL
M<=[>-IEA;RWTZ"6Z>64L[?Y$_P#PT#\>3_S6SXM8&/\ FHOB\]>^/[8R<GH"
M.A["C_AH'X\_]%L^+7_AQ?%^,9XS_P 3C(_]"Z 9I#]D_P"?IV>W;_@'^TKY
MD?\ ST3_ +Z7_&BO\6P?M _'HC(^-?Q9Y_ZJ-XN_KJI_P],"BB_I]Z)]C_?B
M>08XY]1GKGU./0@=<]0 >.,F&XZXZ=3[<9^IP!T!SGN28/8<8 SP<@].O!.<
M<C&.V1@TO3C!SUQSP?;!YZGG/ QW&*#H_P"'MY'T]^Q5XR^,?PW_ &L?@)\1
MOV?M!LO%7QD^'OQ#TGQSX%\+ZE@V'B74_"BRZW<Z#=#<'>'5=-LKZT:.#%VX
ME M<W!B!_J[\-:?_ ,$G_P#@OGXHU'Q/\#F\7?\ !/[_ (*N7.BZIXVTU;!A
M9:=\0/&FA:0]SJ>L V4D?ACXA6X6&[&HZGIK>$_B;IVC1RZQK&G2PV\D$W\A
M/[/7QT\>?LR?&SX<_'[X7OI,'Q$^%7B&'Q5X.N-<T\:MI-KKEK!-#9WE[I;2
MPPZA':M/YXM)W:UGD1$NH9H#)%)]>Z#_ ,%,_B;X'\:^*_C3\+_@3^S/\)/V
MFO&>D>(M'U?]I7X=^"/$^B>/-.?QCI6H:+XQUWP7X,D\:W7P9^'OBGQ1IVIZ
MA!JGB/P5\-M$U-6O+F6RFM9)G)::LKO7M_E_7I:US*<92=U9-123NEKU4D[I
MQMT]59IG[X_\&^6AVG@G]AK_ (+9^%O&^G7>H6_@SPK?>%_%^E^&=9M=)O;Q
MO"_@+XLZ)KUGH/B"^T?7+.QDFFT^[BTS5;K0M4@A!ANI=,ND#6S_ (!_MQ^*
M/AAXZC^"UM^Q+X>\>>&_@Z/V$_  \6?#[5?$,'BSQ5HLOP]U#5?$WQ ;XEZO
MID%G9:N^A>--.C\57FJIIND64TL=CJEGI&GQ-%:Q^J?L:?\ !7_XP?L.?!/X
MK? KX5?L\_LS^*M!^/-I>V7QP\4_$ZP^,7B/QG\48K[3-6T>4ZY?:?\ %W1=
M*THII>N:E;(OAC2-$C,]P^I2))J;O=MX5;_MT:;X8^!_QI^!GPB_8X_91^#-
MC\>O#EGX0\<_$KPK9_&SQ7\7;?PM::CI>IS:!X8\9?%/XQ^/&T#2=4ETFTCU
MC3[2Q-OJ,1E\^-I6WAW5K?TOQ[Z,2A)3<K)ZW6JMJK-O=W6KBEK?335G]#__
M  <4Z5H6B_\ !-+_ ()!Z;\$5L(_V;[3PPB:.NAN)=&?7I?A'X4N/#$SR6S&
MTDOIK!O&\TS2DSM?R:DPQ+]IK^1?1?&OC#0?"/Q$\&:'JE[:>$_B-8^%8/B#
MI4$9ELM6M?!_B6W\3>$GORRNMJ=.\2PP7%G<@Q/+*S68D=)GA?[<^#__  4J
M^/GPU_9TO_V/_'7AWX7?M+_LKW&I+K6B_!']H+P_K/B+0_ FNPM=RVNL_#?Q
M/X6\0^$O'G@6\M+J]O+RU3PYXHL[6"ZNKMDMPE[=1S?/GQ)_:&OO&OA!OAMX
M,^%WPL^!?PRGU>T\0:OX*^%FF>(YI/%&MZ<LHTR^\8>.OB!XC\;?$CQ5!HTE
MQ=SZ'I.M>+KO1]$GN9I-,L+=F4JG;OT[7?\ 6N_9;=G!2BN6R?O-\UULW>]M
M[I]._6Q_2S_P66=9/^""'_!$=XV$B+!\/D9T(95DC_9S\2Q2(S#*JR2JT; X
MQ(K+@$$#^<WXASQI^Q3^RY:.6%Q/\:/VJ+V)"K 2VT ^#%K/*CXVL([B:*)P
M"2&<<=:]Y\&_\%0?C78_LE:1^P_\8OAM\%_VHOV<?"6MQ^(/ASX4^-^D^.$\
M1?"[4([FZND'@'Q]\-/'/P_\9:-9J]_J,4=E)K%U;V]G?WEC L=I,8J^3?$_
MQROO&GB_P+K/BKX?^ =2\ ?#B$Z=X4^!EC#XF\-_"W3] ENI;_4=$QX9\2:5
MXV+:[J3KJ'B'Q&OBY?%NMWD,$VHZ]/Y$:J:*_I;;O_PWX[:!%-632]V<G=-:
MW3LK;J[?7\S^Z_\ X*(?LE?LQ?ML:Y_P1+^ /[17Q_\ %?P,F\5_!^P;P-:Z
M1X+TC6M&^*.IV'P_^&=[=_#:;QE?^*M+G\"^)O$-M"T7AJ]'AKQ%:ZA-'<V2
M_9]1>PBN/P=_X+;?'G]I7XG?\%7O@S\)/V@OA/I'P9T/]FWQA\/? OP2\,Z#
MJFH>)=)\3_#;6?'FAZAI_P 2;;Q=J.FZ3-XB_P"$L@L+!"J:=9+X?DT^?0KJ
M%M0MKNXG^+/VT_\ @L3\<?VZ/ 'P@\$?$SX'_L[^ ]2_9Y_LW_A0_P 1OA!:
M_&'PKX^^%:Z9%HUM:IH5[J'Q:US1M06.UT#2X(?^$@T75C926XOK$VU^?M0Z
M?X^_\%KOC=^U<?V>M5_:;_9I_9*^-7CS]FNZT.\\$_%+Q%X9^+6B?$#7Y]#B
MMY6B\<:KX-^+GAZTUS2]9UJSLO$^M:'!86.C7.N6QGBL;>UNKVUN'=7]&O\
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M&A7&IWLMW:>-?"LK++H_C&UOKFQ0V5\0O;_\%I])T+1_^"#G_!)&T^!:VB?
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M_L]_]$)^#7'3_BV'@C_Y1T44!=]W][#_ (9T_9\_Z(3\&O\ PV'@G_Y1T?\
M#.?[/?\ T0CX-?\ AL/!'_RCHHH"X?\ #.?[/?\ T0CX-?\ AL/!'_RCH_X9
MT_9\_P"B$_!K_P -AX)_^4=%% 7?=_>P_P"&<_V>_P#HA'P:_P##8>"/_E'1
M_P ,Y_L]_P#1"/@U_P"&P\$?_*.BB@+ON_O8?\,Y_L]_]$)^#7_AL/!'T_Z
M?IQ1_P ,Y_L]_P#1"/@U_P"&P\$?_*.BB@+ON_O?^8?\,Y_L]_\ 1"?@U_X;
M#P1]/^@'Z<4?\,Y_L]_]$(^#7_AL/!'_ ,HZ** N^[#_ (9S_9[_ .B$_!K_
M ,-AX(_^4='_  SI^SY_T0GX-?\ AL/!/_RCHHH"[[L/^&<_V>_^B$?!K_PV
M'@C_ .4='_#.?[/?_1"?@USU_P"+8>"/_E'110%WW8?\,Y_L]]?^%$_!K/K_
M ,*P\$?_ "CH_P"&=/V?/^B$_!K_ ,-AX)_^4=%% [ON_O?^8?\ #.G[/G_1
M"?@U_P"&P\$__*.C_AG3]GS_ *(3\&O_  V'@G_Y1T44"N^[#_AG/]GO_HA'
MP:_\-AX(_P#E'1_PSG^SW_T0GX->O_),/!'7U_Y =%% 7?=A_P ,Y_L]_P#1
M"/@U_P"&P\$?_*.C_AG/]GO_ *(3\&O_  V'@C_Y1T44!=]V+_PSI^SY_P!$
6)^#?_AL/!/\ \HZ***++LON7^0'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_03.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 'D E4# 2(  A$! Q$!_\0
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M@^+_ -&25LT 8W_"7^&?^ABTC_P-C_\ BJ/^$O\ #/\ T,6D?^!L?_Q5;-%
M&-_PE_AG_H8M(_\  V/_ .*H_P"$O\,_]#%I'_@;'_\ %5LT4 8W_"7^&?\
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M([1J58!<LN22@&X')(()ZBIT/A33XKZSM$O'>=7BFCC:X'F;B%8JQ(49.%W
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,?6_\
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MAZ[N9+FYT'2YIY&W/))9QLSGU)(R30!KT5B?\(;X6_Z%O1__  !B_P#B:/\
MA#?"W_0MZ/\ ^ ,7_P 30!MT5B?\(;X7_P"A;T?_ , 8O_B:RX_"OAT^*;JV
M/A_2?(6RAD"?88L!B\@)^[Z ?E0!U]%8G_"&^%O^A;T?_P  8O\ XFC_ (0W
MPM_T+>C_ /@#%_\ $T ;=8EW_P CQI7_ &#;W_T9:T?\(;X6_P"A;T?_ , 8
MO_B:LV/A_1M+G:?3M(L+.9EV&2WMDC8KD$C*@<9 X]A0!I4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5)Y<LAVL<(K8R>N#G'7 !UN:*\_USQKJ$.J7*:)<:;<V2064L<J0-<%S-=-
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M<]O(EN951MD@"G(P1SD=#0!N_P#"&^%O^A;T?_P!B_\ B:/^$-\+?]"WH_\
MX Q?_$UR^C>*O%&J2Z58SPZ?97.HQS7,5U-:OM:%(X3@0^;G<7E/)?[J9QSQ
M7C^(VK-:6U_)I 6SN--,ZND3,//#X.'+!63:&8+P< '(S0!V'_"&^%O^A;T?
M_P  8O\ XFC_ (0WPM_T+>C_ /@#%_\ $UH:7J$.K:5::C;[O)NH5F3<,'##
M(R/6K= &)_PAOA;_ *%O1_\ P!B_^)H_X0WPM_T+>C_^ ,7_ ,36W10!B?\
M"&^%O^A;T?\ \ 8O_B:/^$-\+?\ 0MZ/_P" ,7_Q-;=% &)_PAOA;_H6]'_\
M 8O_ (FC_A#?"W_0MZ/_ . ,7_Q-;=% &)_PAOA?_H6]'_\  &+_ .)K)\1^
M$O#<.F0M%X>TE&-_9J2ME&#@W,0(^[T()'XUV-8WB?\ Y!,'_81L?_2J*@!O
M_"&^%_\ H6]'_P# &+_XFC_A#?"W_0MZ/_X Q?\ Q-;=% &)_P (;X6_Z%O1
M_P#P!B_^)H_X0WPM_P!"WH__ ( Q?_$UMT4 8G_"&^%O^A;T?_P!B_\ B:/^
M$-\+?]"WH_\ X Q?_$UMT4 8G_"&^%O^A;T?_P  8O\ XFC_ (0WPM_T+>C_
M /@#%_\ $UMT4 8G_"&^%O\ H6]'_P# &+_XFC_A#?"W_0MZ/_X Q?\ Q-;=
M% &)_P (;X7_ .A;T?\ \ 8O_B:O:?HVEZ2)!INFV=D),;_LT"Q[L=,[0,]3
M^=7:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_DB@"QH":C'I$0U5B;LEBP)!(&3@$CC./3Z9/4Z=8GV7Q1_T&-'_ /!5+_\
M)%'V7Q3_ -!C1_\ P52__)% &W6-K'_(8\/?]?S_ /I--3?LOBG_ *#&C_\
M@JE_^2*:FE:Q/J5C<ZCJ=A-%:2M*L=O8/$S,8V3EFF88PY/3L* -VBBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&-._OZC_ .#.Y_\ CE5)]-ATK6M$:TFO1YUT\4BR7LTJLOD2M@J[$=54].U
M'24444 %%%9^LZQ::#IDNH7I<6\14,5&<;B%'ZD4 :%%9K>(-)4.&U&T61,[
MXC.@=2!D@C/!'I20^(]#GM&NXM8L'MT4LTHN4VJ <$DYXP2!SWXH TZ*S%\1
MZ&[JBZSIS,[^6H%TA);CY1SUY''N*B/BSP]]G\]-:T^6/;OS%<H_R_WN#T&"
M2>@ )/ - &Q15*TU?3K^=X+6^MIIT7>T4<RLP7.-V <XSWJ[0 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &)X4_Y
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MFOB(2#*:1JC#U6%3_P"S4[^WW_Z NK?]^%_^*H FT"_N=3TB*[NX!#*Y;@
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M )'/(Y'YT]_#NE/.TS68\QF+EM[ DG\?QQV))').6GPSI!92;/)4  ^:_&
M._8# ],G'4Y -"TO+>^MUN+:5986+ .O0E25/Z@U/4%I:PV5NMO;ILB3.U<D
MXR<GK[DU/0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !112&@!:*YC2;:_U:VN+N77=0B/VZ[B6.(0A56.XD10,QD_
M=4=35_\ L2[_ .ABU;_R!_\ &J -BBL?^Q+O_H8M6_\ ('_QJD_L2[_Z&+5O
M_('_ ,:H V:*Y>,02ZJ^F)XMU(WJ#)A_<AL>W[KGH>GH:O\ ]B7?_0Q:M_Y
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8M)3G/\ =POS_P# <TY=4MWN(( MSOFB\U";60*%P3\S;<*>/ND@^U7,48H
MSEUNS>"&8)>;)I/+3-E,#GW!3*CW( ]Z<^KVJ"Z)6[Q:D"3%I*<Y.!MPOS_\
M!SBKQ'%8%K=:[J2SSVLNG0P+<S0(DL#NW[N1H\DAP.=N>G>@#4&J6YN(H MS
MODB\Y3]EDV[>>K;<!N/ND@^U1)K5H\-O*$O-MQ)Y:9LI@0<X^8%,J/=L#WK
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M /G\.Z7<LSS6N]V<N7,K[N23C=G.W))"]!G@51M/!6DVDER^;J47$IEVR7#
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M^EV,=G:(R019V*TC.1DD]6))Y)[UG^'/^/:__P"PA<_^C#6S6-X<_P"/:_\
M^PA<_P#HPT ;-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4_Y \_\ V$K_ /\ 2N:MN@ HHHH ,TF:I:G)<)!&+=S&7E5&E"[C&I[X/7G
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M110 5C:Q_P ACP]_U_/_ .DTU;-8VL?\ACP__P!?S_\ I--0!LT444 %%%%
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MW5O:)<7'VA7C=ED?]TL95CM( X)SSR0>W.[I-M-9Z1:6MPZR2P0I&SJ2=Q4
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M^_Z_XT ;-9^MR-%H&HR17B64B6LK+=.,B A3AR/1>OX56_X2SP]_T&K#_O\
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M/M$FWR\EMH7=CJ361!;:'$CV T:^@C9D5H_M1PN'\O:N).%Q+DA>&#D')R*
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M>(((Q'%J>DJHR<#3).I.2?\ 7]2>:LZ1IUS8M?2WEU%<3WEP)V:*$Q*N(TC
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M%R3A2"QY()Z9K5TO3M3L-182WAN+!DD(,\S/*KE\C!P!MP3VR % [Y ,?3]
MN6O;O3X]?U""WT^1# D-O9H!O3+<"#'.YNW>M2+PW>0M(R>*-7!<@M^ZM.P
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6=?ZLEE<+
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M=H_MRZ_Z%[5O_('_ ,=K9HH QO[<NO\ H7M6_P#('_QVC^W+K_H7M6_\@?\
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M77_0O:M_Y _^.U-INLB_O;FS>RN[2XMXHY62X"<JY<*059AUC;]*TZP[4_\
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M_P#0Q:3_ .!L?_Q5(WC#PRJECXCT@ #))O8^/_'JV<BLGQ5_R)^M_P#7A/\
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M5G_W_7_&C^V=+_Z"5G_W_7_&G?V7I_\ SX6O_?E?\*/[+T[_ )\+7_ORO^%
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M#"B/C<0S%L-M&3'PH.WU)]1CYMKP_8W]C8,FI7 N+IW#/('+;CL4$] !D@G
M '/ '2FZ%I$NE13K).7\V9Y F]G" L=H#-R?EP/_ -5:] %;4?\ D&7?_7%_
M_037.^&/^0P__8#TW_T*YKHM1_Y!EW_UQ?\ ]!-<[X8_Y##_ /8#TW_T*YH
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M+_\ D)V__7H?_2FVH [&N:\6Z9_:JVMLES;PRD3%1),$:0;""H!5LKR"V.0
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M=Q$(1/C86"'S6)P44X;&<8().!C'.<:'2-)FN98X=?NT=O,<0M$Z*P8\LJ$
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M!/7'>EX]?UK&3POX8DSLT+2&QUQ:1''&?3T(/XT[_A$_#?\ T+^E?^ 4?^%
M%[42/[,N^?\ EB__ *":Y[PR1_;#\_\ ,#TW_P!"N:T_^$3\-_\ 0OZ5_P"
M4?\ A5F\T/2-1='O=*L;ET78C3VZ.57T&1P/:@"]QZTA"L"#@@C!![UD_P#"
M)^&_^A?TK_P"C_PH_P"$3\-_]"_I7_@%'_A0!JJB(@1 %51@*. !3N/6LC_A
M$_#?_0OZ5_X!1_X4?\(GX;_Z%_2O_ */_"@#7X]:./6LC_A$_#?_ $+^E?\
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MXT?\(IH?_0/C_P"^F_QH U\>],B@B@5EAC6,,Q=@HQEB<D_4FLO_ (130_\
MH'Q_]]-_C1_PBFA_] ^/_OIO\: -?'O1CWK(_P"$4T/_ *!\?_?3?XT?\(IH
M?_0/C_[Z;_&@#8Q44-O#;1^7!&D:9+;4&!DG)/XDYK,_X130_P#H'Q_]]-_C
M1_PBFA_] ^/_ +Z;_&@#7"@$D 9/4^M&*R/^$4T/_H'Q_P#?3?XT?\(IH?\
MT#X_^^F_QH V*Q/&7_(C^(/^P;<_^BVI_P#PBFA_] ^/_OIO\::_A+0G4H^F
M0NC AE;)!'H03R* %\2_\@ZV_P"PA9_^E$=;.1ZU#=6EM?6S6UY;Q7$#XW13
M('5L'(R#P>0#6;_PB?AO_H7]*_\  */_  H U\CUHR/6LC_A$_#?_0OZ5_X!
M1_X4?\(GX;_Z%_2O_ */_"@!9]!MYKN2Z%U<I*\OFY5QA3M4# (Q@;%/.>:D
MN-%@NK\W4US<MED(B\P;%VYX QT.>?7 ]*B_X1/PW_T+^E?^ 4?^%'_")^&_
M^A?TK_P"C_PH DTW0[;2YS-%-/)(8$@+2L#E5)(S@#GYC^N,9.=/(]:R/^$3
M\-_]"_I7_@%'_A1_PB?AO_H7]*_\ H_\* -?(]:,CUK(_P"$3\-_]"_I7_@%
M'_A1_P (GX;_ .A?TK_P"C_PH 3PJ<^&K/Z/_P"AFMFHX((K:!(((DBAC4*D
M<:A54#H !T%24 %%%% !1110 4444 %%%% !1110 4444 %%%% !16#J[7MQ
MXAT[3;;4KBQBEM;FXD>W2)G9D>%5'[Q&&/WC=!GIS3_[#U'_ *&O6/\ OU:?
M_&* -NBN<BL9IYY8(?&NI231$B2-!9%D(QD$"#(ZC\Q4TFC7T4;22>+M61%&
M69H[, #U)\B@#=HK!?2+V/&_Q?JR9!(W1V8X'7_EA5>VMC>1O):^.;^>- K.
MT1LF"A@&4DB'@$$$>H.: .FHK!CTB]E!,?B_5G ."5CLSCC/_/#T(IBZ;<-=
MO:+XSU,W*()&A"V>]5)(#%?(R 2#S[&@#H:\_P#&_C(:%XQ\,:6VD7UU)<7)
MD@DAV[9&,<D13DC!!D4G/&#706^EW5W L]MXQU2:%L[9(TLV4X.#@B#UJ&[\
M*R3SVUW=>(]3>6S9I(97AL\Q$J5)!\CC@F@#H+R W5E/;JX1I8V0/MW;<C&<
M=ZY[_A#8'FWS71E1L!T,0 90=V,CD'?DYSG&%[9JR^D7D4+32>+]62)5+,[1
MV84*.22?(Z5#8V<FIVJW6G^-]0N[=B0LMN+*1"1UY$!% &GI.E?V5%+$MS)+
M$S[HU?\ Y9C ! ^IR>W7ZDZ-84>C7TL:R1^+M7=&&598[,@CU!\BDBTB]GC6
M2+Q?JTD;<ADCLR#]#Y% &]17.SV$UK)#'<>--2ADG;9$L@LE,C>B@P<GV%.N
M=,N;.VDN;KQEJD$$2EI)95LU5 .I),& * .@HK!.D7BF,-XOU4&0X0%+/YC@
MG _<<\ GZ"G_ -AZA_T->L?]^K3_ .,4 ;=%<X\6HZ5J^D*VN7U[%=W30217
M,< 4#R)9 08XU.<QCOC!/'IT= !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!B77_
M "/.E?\ 8-O?_1MK6W6)=?\ (\Z5_P!@V]_]&VM;= ',7_@JUO[J>X:_NXWE
M9VQ&L6$W+M; *'J.#GKWS6;/\/(_,LXXM1N9+=#^^,[(S8"%%*Y0\X/J,8'8
M$'N:* .<TGPA!I&HR7L.I7SLZA/+<H$ "[1PJCH ,9]/2J8\"6UM;JEG?W4)
MCPP6,11!W"*F6*QYYV G'7)['%=?10!Q6I>!7O-.<)J,ZWCPI%L,BF%0%4,%
MW(V <9Z') STXV+OPU'?7%O-+>W""%8@(HP@C)3=@X*G/WSU/&!CD9K0N[YK
M>9((K:6YF=2^R-E!"@@$_,0.K"L?_A,[&%Y5O[>[LS&'/S1&7(3KQ'N.<8('
M?/R[J *%QX7T;3@B3W=\VZ-52&.(-N"A5^ZB<G''(^Z2HPHP*$7AWPU<K;E-
M?N(UB'D*K&*(H^^,X(* ARP4@'G+9'6M+5M>\.7,JF62^DD970);03HS*C E
ME=5!&W)P5/.649/%01V?A/4+FZEL[>YN+F"&1R/.N8R> 2%+$#!\SJ..2/6@
M"]H6B:2NH+>V&K37A4,V=Z/&ZL6!Y5<'Y@=Q!R67+9-22^"K6:XCN);^]>9+
M=+?+E&5E5]X)0KL)R/[ON.1FJ.A:KHFFHJQ07UF9'$4$-VDY9MS%B077=DL6
M."<X7(&#DZ;^--%A1VFN)EV;=P2UF?EB%4<)U)(XZT 4T\ 64:LJZC?[3C"Y
MC*J,[B -F!D_-_O -U (KZAX#266 PS_ &B(3^;-#<[ K@*0%XC)QR1G@@8P
M<#:>GM;^26Y\BYM9+64IYB*[JVY1@-@J3T)'YBKW% &&GAM/L5O";R>-UC*S
M/$$'FEL$DY4X.X9!&#3X] ,>BRZ2M_,+5[8P*1&@9,YR5PNT#!P%Q@8XXXK9
MHH YV/PC"FN0:P^H74MY$2Q=XX?G)383PF1\N!\N,X7/05T0%%% &+K7_(6\
M.?\ 81?_ -);BMJL76O^0MX<_P"PB_\ Z2W%;5 !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110!B77_(\Z5_V#;W_T;:UMU@ZLM[;^(M.U*VTVXOHHK2Y@D2W>)65G
M>%E/[QU!'[MNASTI_P#;FH?]"KJ__?VT_P#C] &W16+_ &YJ'_0JZO\ ]_;3
M_P"/T?VYJ'_0JZO_ -_;3_X_0!%JGB(:3JRV\J>=$T:$)$H\P$LV6.6 V@+T
M ))(JK_PFUN<!=-O)"8_,PC1'CYB>2X!X4_4@@<J<7O[;U#_ *%75_\ O[:?
M_'Z;+JUY/"\,WA'59(I%*NCO:%6!X((,_(H S3XRL9"MU_9EZSPPM(&#Q_=V
M%S_'R"%&#R#P1P,C$O/$NAR6]T__  AR2.8C.&FA@,;E\<,02V3N[ @G@$D@
M5UXUJ_50H\*:N . !+:<?^1Z7^V]0_Z%76/^_MI_\?H PIT\,'Q+!;/X=7SX
M)?LZ2".,1+O &2F>>HZKG!!Z8-5+?7]'L#/%)X9@W3"2.66S@A6)DWA-KEF!
M.?E!X(Z X/RUT_\ ;>H?]"KK'_?VT_\ C],EU2[G"B;PAJD@5@ZAWLSA@<@C
M,_4'D&@#FCK6A3RSQ'PA-%.K^698UMXV!)P2'#AE(V+SP?E&,[<B"\U+P[>0
M&"^\+/*AESOMO+Y55WKN;<K%L8)7GUY7YJZ_^V]0_P"A5UC_ +^VG_Q^C^V]
M0_Z%76/^_MI_\?H S]1UU['6FV_8]VZVCF5W8R0HY8G/.W\O3HW%6-9\0R6-
MRB6LMG*KVXF 8L6P6 #<=5.<#W(/2K']MZA_T*NK_P#?VT_^/T?VWJ _YE75
M_P#O[:?_ !^@"&PU^XN]:BLC;IY;&XWRISM,<FT*1G/ ZGD9('&:Z&L3^V]0
M_P"A5U?_ +^VG_Q^E_MS4/\ H5=7_P"_MI_\?H VJ*Q?[<U#_H5=7_[^VG_Q
M^C^W-0_Z%75_^_MI_P#'Z #6O^0MX<_["+_^DMQ6U7.22ZAJNKZ0S:)>V45I
M=-/)+<R0%<>1+&  DC'.9!VQ@'FNCH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_04.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_04.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (! >4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q;[Q-:6.H
MR6)M=0N)XD5W%K:/*%#9QDJ#C.#^50_\);;_ /0)US_P62_X4:9_R.^O_P#7
MO9_^U:WG;8A;&<5FN:6M_P #NJ>PI6BX7T3OS-;J_8P?^$MM_P#H$ZY_X+)?
M\*/^$MM_^@3KG_@LE_PK5^VMG_5#'^]_]:@7A)_U?_CW_P!:GRS_ )OP,?;X
M;_GW_P"3/_(RO^$MM_\ H$ZY_P""R7_"C_A+;?\ Z!.N?^"R7_"M?[7_ +'Z
MTGVS_8_\>HY9_P WX!]8PW_/M_\ @3_R,G_A+;?_ *!.N?\ @LE_PH_X2VW_
M .@3KG_@LE_PK7^V?['ZTGVS_IG_ ./4<L_YOP#ZQAO^?;_\"?\ D9/_  EM
MO_T"=<_\%DO^%'_"6V__ $"=<_\ !9+_ (5K_:_]C]:/M?\ L?K1RS_F_ /K
M&&_Y]O\ \"?^1D?\);;_ /0)US_P62_X4?\ "6V__0)US_P62_X5K?;?^F?Z
MTX7+MTA/YT<L_P";\!^VPW_/O_R9_P"1C_\ "6V__0)US_P62_X4?\);;_\
M0)US_P %DO\ A6V)'/6,#_@5/W'THY9_S?@/VN'_ .??_DS_ ,C!_P"$MM_^
M@3KG_@LE_P */^$MM_\ H$ZY_P""R7_"M_/M1GVHY9_S?@'M</\ \^__ "9_
MY&!_PEMO_P! G7/_  62_P"%'_"6V_\ T"=<_P#!9+_A6_GVHS[4<L_YOP#V
MN'_Y]_\ DS_R,#_A+;?_ *!.N?\ @LE_PH_X2VW_ .@3KG_@LE_PK>W'/3CZ
MTN?:CEG_ #?@'M</_P ^_P#R9_Y&!_PEMO\ ] G7/_!9+_A1_P );;_] G7/
M_!9+_A6\&..1C\:7/M1RS_F_ /:X?_GW_P"3/_(P/^$MM_\ H$ZY_P""R7_"
MC_A+;?\ Z!.N?^"R7_"M_/M1GVHY9_S?@'M</_S[_P#)G_D8'_"6V_\ T"=<
M_P#!9+_A1_PEMO\ ] G7/_!9+_A6_GVHS[4<L_YOP#VN'_Y]_P#DS_R,#_A+
M;?\ Z!.N?^"R7_"C_A+;?_H$ZY_X+)?\*W69POR*"?0MBEW>U'+/^;\ ]KA_
M^??_ ),_\C!_X2VW_P"@3KG_ (+)?\*/^$MM_P#H$ZY_X+)?\*WMQ]*7<?2C
MEG_-^ >UP_\ S[_\F?\ D8'_  EMO_T"=<_\%DO^%'_"6V__ $"=<_\ !9+_
M (5O[CZ4FXYZ<?6CEG_-^ >UP_\ S[_\F?\ D8/_  EMO_T"=<_\%DO^%'_"
M6V__ $"=<_\ !9+_ (5O%CC@?K4'F7?_ #PA_P"_Q_\ B:.6?\WX![7#_P#/
MO_R9_P"1D?\ "6V__0)US_P62_X4?\);;_\ 0)US_P %DO\ A6RDER6&^&(+
MZK*2?RVBI=Q]/UHY9_S?@'M</_S[_P#)G_D8/_"6V_\ T"=<_P#!9+_A3K7Q
M98W.J6NG-;:A;7%UO\D75H\0?:NYL%@.@_F*WJY/7_\ DH7@_P#[??\ T4*F
M7/'6_;H:T5AZTG#D:TD_B;V3?;R.LHHHK4X HHHH **** "BBN3L_'^D32WQ
MO+JUM((+EK>$M*3)+L^^Q3:-J@D<@GWQTH ZRBL>;Q7H%O>16DNK6JS2[ HW
MY!+XV#=T&[(QD\Y&.M0Z+XMT[6[V\LXG\NXM[F: 1MG+B/ 9AQT^84 ;U%8_
M_"5Z%O1/[4MP6MQ=#+8 B*E@Y/9< G)]*0>*]"-@]\-3@\A)!$QR=P<C(7;U
MR1SC'3GI0!LT5F:#K,6O:7]O@51"9YHD*ON#K'*R!@<=]N?Q[UIT %%%% !1
M110 4444 %%%% !1110!S^F_\COK_P#U[6?_ +5K>==R%<XS6#IO_([Z_P#]
M>UG_ .U:Z"HI[/U?YG5C/CC_ (8_^DHJ&U/]_P#2HS 5(^85>JIG+9-6<?(A
MOE#UH\H?WJIS0K>7CQ2RNJ1J&5%; .<_,<<GI]*6PWQO/;,Q=(2 K$DGGG&3
MSQQ^=,KE1;\H?WJ/*'K5*ZGE1RBR;"3QGGM]/:HI;V6+9\V0\6X<9R<_AZB@
M.5&F(U]S3@$'\ JFDS&SD8NQ925! &2>,<=,]J<\S_86?(655.0!G!% 61;#
MXZ(*7SC_ '16/%=7,EV(R#@%L@X [X]_2G1W4QN2GFJ<';@@ ']/K^5 6-;S
MS_=%'GG^Z*S9[B1;CRUDVAN@,3$C'7'KFDGN98IF .%^7'&,9^M(#3\\_P!T
M4>>?[HK(CN9WLQ(\J@[3GY<'^7]*MVLDDH)D9?\ ='44 7///]T4>>?[HJ.B
M@"3SS_=%'GG^Z*CHH D\\_W11YY_NBHZ* )///\ =%'GG^Z*CHH D\\_W11Y
MY_NBHZ* )///]T4>>?[HJ.B@"7SS_=%)YY_NBHZ* )///]T4]90WL:@HS@YH
M MT4@Y -+0 4&B@T .KD]?\ ^2A>#_\ M]_]%"NLKD]?_P"2A>#_ /M]_P#1
M0K.K\/S7YH[,!_%?^&?_ *3(ZRBBBM#C"BBB@ HHHH *\ZU?P'K$VJ-JNG7<
M/VAI9U,#7MS;(8I'#AM\!5MP(^Z<@YZC&:]%KFI_&$=K=7K3:9>#3+3SA)J"
M@,@:)-[@J#N X(!/4C'<9 .6UKP%XGO?(L;34K(:5;BU,$;7%PGE^3LR@0%@
M02A(9RY&<8X#5H#PMXFL]>EU#3Y])V_;KB6+SS(28IPF_( X93&N #AAG)6K
MS>/5M[6XDO='O+66.VCO(HW=&\V%W" @J3A@6&5/3(Y-.U#QTEIK[:-!I<]S
M="\2T7;(JAF:#SMW/0 <&@"K9^"+Q/#=WID]U"DTVF6EHLT+-\LD*GG(VG;N
M(Q@@XST-5+#P9KMC'_:D9TW^W4N$E1);V[N(I%6.2/#R2LS#B5R-JC!XYZU>
ML_B/876@7FL/;K%;0>6!F\A)#.P0+)\W[I@2-V[  /7@TS_A9FGOI\5Q###-
M(]TUJ0E_#Y(<('XFW;"2&&!D'.1QB@#H/#&F7>D:+]FOW@>Y:YN)W:W!"?O)
MGDX!Y'#=/U/6MBHX)?.MXY=A3>H;:2"1D9QD$@_@2*DH **** "BHYX(KJWE
MMYT$D,J%'1NC*1@@_A6'_P (/X8_Z EG_P!\5,N;H:TU2?\ $;7HD_S:.@HK
MG_\ A!O#'_0$L_\ OBC_ (0;PQ_T!+/_ +XI7GV7W_\  ->7"_S2_P# 5_\
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M_P"1)L?K)_Z&U=76BV/9H3<Z<9/JD%%%%!J%!HH- #JY/7_^2A>#_P#M]_\
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MZUZ-=Z9;7VH6<M]:F6TBTU3E0^XMG[HVGTS^E93>$- <Y:P\0$^Z"IAX=TL
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M>O\ _)0O!_\ V^_^BA765R>O_P#)0O!__;[_ .BA6=7X?FOS1V8#^*_\,_\
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M'T[#Z"E5<=L_C63FWL>%B,WJ3TI*R_$[>QE:>QAE8 ,Z@G%<WK__ "4+P?\
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M>QG08_,T^/QCH+*2VIV2GWN4_P :/:T^Y+HU4[<DO_ 7_D;M%80\7:&>NK6
M_P"WE/\ &GCQ;H'?6+#_ ,"5_P :?M(=Q*G5?_+N7_@+_P C:HK&/B[P^.FK
MZ?\ ^!"_XTP^+]#[:QI__@0G^-'M(=Q.G66U.7_@+_R-RD+ =3BL!O%FBG_F
M,V/_ ($)_C49\4:(?^8Q8_\ @0G^-+VL>YE*.)6U*7_@+_R.@,R#OFHVN/0?
MG6 ?$^B'_F,6'_@0G^--_P"$ET3_ *#%A_X$)_C2]K'N82CC7M2E_P" O_(W
M6N6]<5&T[GJQK%/B31?^@O8?^!*?XUCZYXML8X%@LM0MGEEZR+,I"#OSGK2=
M6'<Y:E'&VO[*7_@+_P C2U76W\XVEJW(XDD'8^@K/A3'7.:QK74=-C09U"US
MU),R_P"-7TUC2P/^0E9_]_U_QK)U(OJ>35P6/JRNZ,__  %_Y&LG J4&LD:Y
MI?'_ !,K/_O^O^-2#7=*_P"@G9?^!"_XT<\>XEEN-7_+F7_@+_R/1--YTVW_
M -P5SNO_ /)0O!__ &^_^BA5S3O$^@)I\"OKFF*P0 @W<8(_6L?4M5T[4_B%
MX2^P7]K=^7]LW^1,LFW,0QG!XS@_E6E22<59]5^:/N,MHU8/WHM6A+H_Y'Y'
M<4445L<0445D>(M3N],TZ,Z=;PSWUQ.EO;I.Y2/<QZLP!(  )X';% &O17!W
MWC37HE6WM=$LFU"UL6OM2AFOMJ(@=DVQNH(+$HYYP  ,\\!]OX_>[@>>&TC\
MHZQ:Z?'N8@F.9(WW$?WAYAX]J .YHKS/_A8/B6.QTW4;G1=/M]/O%\TS/-,R
MK'P,,RQE48_,PWD+C'.<XUXO&>HW'C1M,ATEY-*2X-J]RD%PSJX7)<L(_*";
MN/OY[X[4 =K17(^&O%6HZMX@O],U*QM[(PAWACW2";:K[?F5T4$8*G<A9>1S
M20>*M5-SJ%S/IUE'H\7VI+:=KT+(SP,5;S%8#"L5;!&< <B@#KZ*\S3QIXDU
M"VEMX[;3X+Z"^L 70SK')#-*5P/,C5B<K@D#&"<'(JTWQ'NX=4U&6?1IFT2T
M^TK]HBM[@N# &W,S&,1;28V48<G)7/? !Z%17GK^./$5BH@U#1=/%]=);FQC
M@O"R,TS[%$C%1MVX). <]JLV_BWQ'+J]IHC:3IZZGY\L=XPNF,,:(L3[T.W)
MRLN-I .<=J .YHKRK3OB'J<4-G#9Z-=7]O"H:[(CNKF<[I&&$98V4D* ?G9<
M]!TS73Z-XJU&^\87NCW]C;VD">9]F#&59I C !L,@1@RY;Y&;'0^P!UU%1W$
M\5K;2W$[B.&)"[NW15 R2?PK"_X3OPO_ -!NU_[Z/^%2Y16[-:=&K4^"+?HF
MSH:*Y[_A.O"__0;M?^^C_A1_PG7A?_H-VO\ WT?\*7M(=T:?4\1_S[E]S_R.
MAHKGO^$Z\+_]!NU_[Z/^%'_"=>%_^@W:_P#?1_PH]I#N@^IXC_GW+[G_ )'0
MT5SW_"=>%_\ H-VO_?1_PH_X3KPO_P!!NU_[Z/\ A1[2'=!]3Q'_ #[E]S_R
M*MZVIZEXFOK*R@T?9:0PL9+RU:1VW[N,AAP-OZUGZYX:U_4-$N[3;H \V/;F
MWLG23_@)+D UH>'-3LM6\6Z_=6%PEQ!Y%HN]#QD>;FNK/2HC!35[]SJQ%>=!
MJDHI>['=:W:UZH^?3\(M?/\ RVE_[Z6JS?"[Q/#)B**Z<>N]!7T3BC;1["/=
MG![:IY?^ _\ VQ\^I\/_ !<HP;64CW://\Z9+X \6QKO323-CJ!*@;]3C]:^
MA<4G2CV$>[(YGNU'_P !_P#MCY\C\#>+" 3HC+_O,G_Q564\"^*?^@2@^I7_
M .*KW*2]M8FVR7,2MZ,X%3(Z2 ,C*P/<'(H^KQ[L4HO?E7_@/_VQX6? WBD+
MQI<?_CO_ ,52VG@7Q0ENBMI<8P.DFTG\?FKW;%&*/81[L+OEY;1_\!_^V/$A
MX)\3<_\ $KMA_P !'_Q52#P1XE!)%A:9_P!W_P"RKVG;1MI?5X]V3R^4?_ ?
M_MSQ@>"?$NWG3[/KW3_[*E'@CQ(>MA9<#ILZ_P#CU>S;:,4?5X]V.WE'_P !
M_P#MCQG_ (0?Q)@'[#99SS\G_P!E3'\!^(F!!L;,C_<Z_P#CU>SLRJ,L0![T
MU9(V^ZZGZ&I]G!.U_P 0Y7O9?^ __;'ATOPVU]SG[# /]W_]JH8_AYXHMGS!
M:E/]UQC\B<5[V!GI1MJ_81[L=Y+HO_ ?_MCQJU\/>,K:/:VE65P?[TL29_\
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M6!=2W)#9!//6GR^"/#LVJ+J3:<!<K+%.I2:14$D8 1]@;;N &,XSCCI7044
M8$_@O0;BWMH'LY1%;P?9T2.ZE0-%G.Q]K#S%]FR.OK4__"+Z1_;!U7[-(+HR
M"8@7$@B,@7:',6[86V\;MN?>MBB@#(TSPQI&CWKW=E;R),R,@WW$DBQJS;BJ
M*S$(I(!PH X%0-X,\/O>7ET^GAY+Q95F#2N4/F#$A5"=JE@!DJ 3W-;U% '/
MP>"=!MQ<[+>Y+W+0M-+)?3O(QB;=&=[.6!4],'VZ47/@_29)KNZ@@\N[G$K
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M -OO_HH5G5^'YK\T=F _BO\ PS_])D=91116AQA1110 4444 %%%% !1110
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M+-C?@KG<O_?)':NN33+&-PZ65NK#HPB4$?I3OL-K@C[/%@D,1L')'0_AQ^5
M'"ZQJFJ)<WR1%UB\PJDWFR KEV7@!MO&PX&.2,<]_0(26A4G()'0]:@;3[1R
M2UK 2R[23&,D9SCITR:L(JQJ%4 *. !T% #J*** "N3U_P#Y*%X/_P"WW_T4
M*ZRN3U__ )*%X/\ ^WW_ -%"LZOP_-?FCLP'\5_X9_\ I,CK****T.,****
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M)+^4N[/7.!FF!8HHHH *Y/7_ /DH7@__ +??_10KK*Y/7_\ DH7@_P#[??\
MT4*SJ_#\U^:.S ?Q7_AG_P"DR.LHHHK0XPHHHH **** "BBB@ HHHH ****
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M8]:UAAU+J_O?^9@\PJKI'_P"'^1TZZ%XN897QLI'MI<7^-._X1_QA_T.J_\
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M1?XTH\.^,O\ H<A_X+H_\:[3 HP*/9+N_O?^8?7JO:/_ (!'_(XO_A'?&/\
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MJ:VZ* "BBB@"&ZDFALYY+>#SYTC9HX=X3S& X7<>!D\9KF/^$@\7_P#0C_\
ME6A_PKK:*F2;V=C:E4A"_-!2];_HT<E_PD'B_P#Z$?\ \JT/^%'_  D'B_\
MZ$?_ ,JT/^%=;14\DOYG^'^1I]8I?\^E]\O\SDO^$@\7_P#0C_\ E6A_PH_X
M2#Q?_P!"/_Y5H?\ "NMHHY)?S/\ #_(/K%+_ )]+[Y?YG)?\)!XO_P"A'_\
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M_24,KB-4\ 2ZSJTVI7^L/+-MVVJ^0-EMSU5=W)]SWYKMLU6U'4+?2[":]NI
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MY%E:.18T$,1_AQ\V#E@<=<8Z<U9\.>(M0U?6[I]1UB^M=,M8A*PW1XQQC>X
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MFG#_ ,#19F?:I.1EN!4*8QN9@%]/6JTFD>,I'W'2K'Z?::0Z/XS)R=+LB?\
MKYK7VJ[/[CH^I2_GA_X$O\C1$F[N/8#M5V-QYL@)X+?D:Q%TKQDI!_LFQ/\
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MN6VH1W"AD8,/8TKB21<$:CHH'X4N*3.5R*X2+QQ?3W+PQV<1;SYH8U!)9O+
M/3(SG/04[D5*T*;2EU.\P/2F[%/51^5<5#XRU"=9RMM;_N6*,=V0&4 L"0<<
M9]:0^-[N"YEBN+,%4>)59.I$F[!()XZ#UZTFU:Y'UJEI=G;&)/[H_*N5\0:
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MG0K.N!NE^8,FX]-V<G?CWSZ@?**ZJHX88H(ECAB2.-1A510 /P%24 %!HH-
M#J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M10 4444 %%%% !WHH[T4 %%%% !1110 4&B@T .HHHH **** "BBB@ HHHH
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M!)_PI>U79_<'U&?\\?\ P.)V&:3-<A]L\>?] C3/_ D_X4?;/'G_ $"-,_\
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MCL'>U"R I@2;< L2,A0>P]6_ <].NK@?'.E:A>S2&SLI9RXB*M& <;1)G/\
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MB23_ /6]OIZ4 4]/U6:YF2.:%$+%AE6/5>"<$=,Y_*M>H(M/M8&0Q1!/+!5
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M,O\ \71>?9??_P  /9X/_GY+_P !7_R1UE%<G_PK/PA_T"/_ "9E_P#BZ/\
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M_"L_"'_0(_\ )F7_ .+H_P"%9^$/^@1_Y,R__%T7GV7W_P# #V>#_P"?DO\
MP%?_ "1UE%<G_P *S\(?] C_ ,F9?_BZ/^%9^$/^@1_Y,R__ !=%Y]E]_P#P
M ]G@_P#GY+_P%?\ R1UE<EX@_P"2A>#_ /M]_P#10H_X5GX0_P"@1_Y,R_\
MQ=7-,\#>'-&U&*_L-.\FZBSL?SY&QD$'@L1T)I24Y:673K_P#6E+"T6YQG)N
MTE\*6Z:_F?<Z&BBBM3S@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
&HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_05.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_05.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $< @0# 2(  A$! Q$!_\0
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M&XL<8W$D[5!_&M;PWJESJVG//=QI'(L@7"J5X**W0G_:HM+O^ >TH?\ /O\
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M-+DD;KUPP .VM%$C6+:BKL(Z#H17-Z9IU[*ACE1HX>@W'!_"NC6 16WDQ;@
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MCK0!Q%SXMU@6\SK:V5J%QM=W:0)M,.\L1@;<2G!!_AS].V4Y4'(.1U'2EHH
M**** .5U+Q/>Z?K=Y"+03V5G$))=D;!P/+9L[R=F<@*%Z_-GH*=<^,XK.21+
MBPF0(?+W&1,>< I*'G@ ./FZ=?;/126ULRS&6&(K*O[TLHPX _B]1CUK(O++
MP[JZL7>R:6\(C$\3H))"A!VAAR<%1QSTYH HR>-T@L9;N;3)XDBC1W5Y$#99
M-Y4#.20H)_R2)E\7AM1%O_9ER(3+Y8GWIC'F^5NQG/WR.,=#GM5BUM/#3V2Z
M>C6%U%&NXK)(DI.T8+'.<X!Q[ XZ5I0VVGSQI/!#;2(WS+(BJ0?FW9!'^T,_
M7F@"W15#4/[6W)_9OV+;@[_M._.>V-M4O^*I]=&_*6I<K=&;PH<ROS17J_\
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M  #=HK"V^*/71_\ R+1M\4>NC_\ D6CG\F'U;^_'[_\ @&[6-X3_ .13TO\
MZ]UJ/;XH]='_ /(M7M%L7TS1;.QE=7D@B",RC )'I23O*]BIQ5.BX\R;;6SO
MT?DB_1116AR!1110 4444 %%%% !1110 4444 0W=N+NRGMBQ431M&6 Z9&,
MUSDG@M#+;^3?O#!%-%,84B 5B@B Z$8_U7N/F/'0UU-% ')-X"L6LFMA.4#1
MK&72)5.%A,7;USG'X5T&DZ='I6G):1B,!2S$QH5!+$DG!)/4^IJ[10 4444
M%%%% !61'_R-]S_UX1?^C)*UZR(_^1ON?^O"+_T9)4RZ>IO0VG_A?YH^9_&P
M_P"*]U__ *_I?YUC)6UXV_Y'S7_^OZ7^=8JU[M/X4>#4^)DHK6TS2KF^1U2W
MNLNI^SR*I\LN#RI.,<\@'L<5DJ,5L%/-NM(A?<4DBA4@$C(+D5H]C,272[F.
M-42*>2=5WSHB,?)!Z*WOCDCMQ[U0&<X!//I75ZMH]EH/C6+3[*\6Y43KG!RT
M1W?<8]"1_P#KI/ -[':>(@)KMK6.5?F?S41,+\V'W Y!Z<8--2]WF6HK>]9Z
M'-W-K=6-R8;N&:WG !*2J58 ^QYI8+2XNI$C@MY9I)&VJJ(6+'VQ7IVN7FHW
MVDZI?BYG>S*NK&+4;=XUR,!<!,GZ9S1\/WO)/#,,#SRQVBW,GE^0[Q/DD9!8
M$ C/;K4>V:AS6'[-.5KL\PFMYK=W2>"6-E.UA(A7!'8YK0'AW72%QH^HD$9'
M^C/T]N*[3X@7-XOAA()+E9+>2[;;OD>20LFX$$L> ,?CFNKL+;9I\5I' _DS
MB#SQNE<L#'NZAODY[].W>B5>2BG9 J46VKL\7N+"_L9UAN;2ZMYG&51XV1F'
MJ!U-,2TN9+B.W6VF:>4XCCV'<Y]AWKL]=E32_'6AW*)+&@B@D94D=F&XD':2
M2>]=8U[J$?B:TL&U(RSV$EM',)XT+3K(7)8$C<"/E'RT2JM).W0E4HMM79XQ
M!I6H7US,EGI]S/+&?WB0PEF3G'( XY%32>&]=V-))HNH[5!8N]L^ !U))%=C
MX307GBWQ'/<1^:Z[Y,!V0;O.QGY2/6NR\1V_VBQU6XN87,XM[DK)NECP(P O
M&[!X/7&#4SJM2M8TC"+C?4\(Z?-FJDSASP.G?UJPYW@#&!4$B;1D&M&3#1E:
M7[C?2OK.7_D3]"_ZZ6'_ *,CKY-D'R-]*^LI?^1/T+_KI8?^C(Z\S,/@7]=C
MV,L_C+^NYT]%%%<984444 %%%% !7G,^DZI%<W2#3[AU:9V#1@$,#7HU>7:U
M\1=3TB.YF9(72.9HD58^3R<9.?:@"\+;55EBD72+C*9XP,'-7M'T6_GLM9CG
M@:V-W&(TWG;SSZ>F:Y+3/BMJ6I;@3;6S 9&^(E3^.:U7\7^)!TEL/^_7_P!E
M0!L)X/O-MQO>!2TL<RE&^\R,<9RO'&WUR137\$74NGVMF]U$@A>3,B==KA>G
M&<C![_X#$;QAXLQE39$>T!_^*JB_Q!\3[6:.73W53@E8LX/IPU '7/X5U%UL
MBLEHC6\(5PR!Q*<GY?N\#&.3GZ=Z>?"]Z->^W P/%]H$N&<@JO!('']:D\!:
M_J'B'2+FYU+R?-CN#&OE)M&W:I]3ZFI-0\3W5GXD734L5D@R 9-QSR 3VP.O
M3O0!GZ=X0O+6ZOI'2V59H9$@*.?W1;D= ._IVX]J=-X,NKBQFB:6!&DE#;%)
M 51NZ-C/5NF./7FI8_%]]-!=O%IQ=X4#*BJQ).Y03@=1@D_A6YHFJ2ZG8P33
M0>5(X?</3:V.!_G!H%H8$G@^Y>SC@+Q/L64#=(< N$'<9V\-P"/PSD2R^$)+
MJ/3_ #WAWVBA5 !*DA6&6'&X$D?+Q@$\YYK=FU-XIWC$*L%;&X/[9QT^]Z#W
MIL>K%GAC: J\DFP\\*,9'.,$].*T]E*U[$^TCM<PXO"MZGB";4FFC56N!(JQ
MR.#C*Y''8@-QZFH8?"5\+BYDE:(RW$#P-+YFX!6V@<%<G 4]3R:[6BLRSF/"
MGAZ]T*:Z:ZF259U0@AB2I&<CD#CFNGHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *R(_\ D;[G_KPB_P#1DE:]
M9$?_ "-]S_UX1?\ HR2IET]3>AM/_"_S1\R^-YHE\>Z^#(H(OI>,^]8HN8,_
MZU?SJ]XS1'^)^N)+Q&VIR!LG'&ZH(K+2#<2@R+Y84!,R8^;)[YY[5ZT*S45H
M>1.DFV-6ZMN\B_\ ?5:L6O62PP)-96D[P($25I9%; )(^ZP&1GKBL=;;3A:V
M;$@R,0)1O(R2#^7.*1X-,#7>UV.T;8?WG!/<GBM/;-[HCV*[G00^(M-@G6>+
M3+%9E;>K^=,2&]>6YY]:I6^I6EO/'+%)LEC8,CB3H1T/2LN"'3Y+.W=LB4R;
M9=TF./7'88J^MCI9N+E59"B8$9,V,GOWJHUVNB(=%/J=)X@\:P^(%MENXX5C
M@!Q';2&-"QZL5P1N]ZL:'X]BT.VAM[1(5B24R$%AO?)Y!?;G'L"*XRWM=.>2
M(%@RG&\F3 !VDD?GCO5"^CBBO9$AQY8QMPV>WK1[1<O+RJPG1][FYG<]!U3Q
MII&K6$EM=V"LKWDEVI2Y(*,_W@#C[IZXKH(_BWIZ1VZ_V5;$P;"C&8YRJ[03
MZ\$BO%J*B4HM6<5^/^8U!Q=U)_U\CT[4?'VGWGB"SUA;.*&XM(U2';-\B@9Q
MP0<XS^@JE%X\5-7TO49UCN[G3]XA>YDWG#$GYC@$X).#VKSQC32<57M%:W*A
M*CK?F?WG?Z+XWBT35M0OH+>UD:\#"1)F++R^[C&.]:E[\5IKNPO+3[%ID:W2
M2H[J'W?O/O$98\GC\J\J/KZTW-1*:D[N*-(P<5929JFXMNSK_P!]5%+<0E>)
M%_.LTTQNE-UV^@*BD]RW+/&4/[Q>AKZUEY\'Z%_UTL/_ $9'7QS+_JV^AK[%
M<$>#=!!&#YFG_P#HR.N#&S<HZGIY?!1K1M_6C.HHHHKG **** "BBB@ KQ.:
M%+Y]3MY2 K32<E<XPY[5[97@5]J:Z=/?,1N9[F55'_ C0!F'1YXY3F(O@C8%
M.$_3O]:W;2*2&T6.3YG4''/Y"L6#6+B8%PYW]?*P,_\ UZW8Y6-L)98RC;=Q
M0<D4*P.YSVH33W:3*\Q@8Y"A#C ]/K5#PQH.H0WTEU(3';HK;AG_ %A/0$?K
M^%= ^J 2@FW1H#]YLC/U]ZV+&>"\TN>6"56P^QE!&5('<=NM+EUN4IM*QN>#
MR4^'OB0J2K+YY!!P1^Y%;G_"/^&8W*/HX:3RQ(S;V^8@9]>3S6+X67;\/O$H
M]I__ $2*[;S+),>;#F00AV;;G( J'%.>JZ?J=,*M2G0]R37O=/\ "C-L_#7A
MRZ'F1Z6$*Y0$R-G [9#5&=!\-0,\0TMEV'D*[8^OWN^:W+:ZL]FZ%-@:7R_N
MXRU23"UAB>9X5(4G)"#.3P:?LX=B?KF(_P"?C^]G-#1/##2X72<Y4R;M[<X_
MX%UJU9>&_#MVCF/3-@5L$&5NOX-5XW>G>;"#;$/+A5^0>X'X<&K.GW5K<F7[
M-$4QC=E<9ZT>SAV%]<Q'_/Q_>RE_PB&A?\^ _P"_K_XT?\(AH7_/@/\ OZ_^
M-;=%'LX=A_7,1_S\?WLQ/^$0T+_GP'_?U_\ &C_A$-"_Y\!_W]?_ !K;HH]G
M#L'US$?\_'][,3_A$-"_Y\!_W]?_ !H_X1#0O^? ?]_7_P :VZ*/9P[!]<Q'
M_/Q_>S$_X1#0O^? ?]_7_P :?X4);PIIA9BQ^SKRQR>GK6Q7(^&_#]G<^&]/
MF>?4 SPJQ"7TR*/H V!^%3;EDN5&RJ.M0E[:;T:MUZ/S.NHK&_X1BQ_Y^-3_
M /!C/_\ %T?\(Q8_\_&I_P#@QG_^+JKR[?B8<E#^=_\ @/\ P39HK&_X1BQ_
MY^-3_P#!C/\ _%T?\(Q8_P#/QJ?_ (,9_P#XNB\NWXAR4/YW_P" _P#!(_$/
M]K^?8_V3C/[WS=^[9CRSC.WOG&/>L%-3\410")8Y@\=JH(EM';&(T._> =SE
MRR[<'&,D<<]S&@CC6-2Q"@ %B2>/4GK39YEM[>29_NQJ6."!P/KQ5G.<F[ZU
M=:-K0WWR7+O"ULCP;3$K)&3@KPV&WY /&#ZTQ]2\3QWB0>6S%"R!C9,4F4-(
M#(Q!^7 5"%'WMW&<\:$?C73) C^5="(@F278"D1W.N&()ZF-A\N1THC\27-Q
MI]]<0V!BDBNX;:**Y.TGS!%AFVYQ_K.V>E &$VO>([AS;10SM*MH#)";4@DL
MLN6+C&TY1-JX!.>F>ELZAX@M;I;=8[VYW:@ZL7M?D6$NH # =E8D'V.3QBMG
M1]?&I7LMF]E)'=P;EN'CPT2E791AC@G.TD<<=\5N4 4=$69=!T];D2"<6T8D
M\S.[=M&<Y[YHJ]10 4444 %%%% !1110 4444 %85Y+=6/B-[N/3+J[ADM$B
M#6Y3Y6#N2#N8=F%;M%3)7-:53V;=U=-6_JWH>9>(O!'A_P 3:J^IW_A+6UNY
M !(\$L2>9@8!($F,X[UE?\*I\*_]"OXC_P# J/\ ^.5YG\2O$.KWOQ UB.34
M;E8K6Y:"&..5E5$7C@ ]^I/O7*?VGJ/_ $$;S_P(?_&O0A@JKBG[3\#-XFA?
M^$OO9[Q_PJKPK_T*_B/_ ,"H_P#XY1_PJOPM_P!"QXC_ / J/_XY7@_]I:C_
M -!&\_\  A_\:7^TM1_Z"-Y_X$/_ (U?U&K_ ,_/P)^LX?\ Y]+[V>\?\*L\
M+?\ 0L>(_P#P*C_^.4?\*L\+?]"OXC_\"H__ (Y7@_\ :6H_]!&\_P# A_\
M&E&I:C_T$;S_ ,"'_P :/J-;_GY^ ?6</_SZ7WL]W_X5;X6_Z%?Q'_X%1_\
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M,L=XX'O3T=)$#HRLIZ,IR#0 ZBBDR#WH 6BBB@ HHHH **** "BBB@ HHHH
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MQ6%S;S6 A)$@<C;$&P-HX&2,# Q67;^/+>Q?P]);K$C6-K/!*+>W9$3S7S@
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MXTG_  HWP-_SX77_ (%R?XU\]6S7<4!DFOKOY^@,[_XU;M?&&JZ:A@BNI7B
M^7=(Q(_'-3SS;T9I*BH0YI'T!:_!3P-:W44XTR60QL&"2W+LA(]03R/:O00
M  !@"OBJ/7-9ANS?PZG>1SHWF(ZSM\I'/K7V5I=P]WI%E<RX\R:!)&QTR5!-
M*=^K,TM+ENBBBH **** "BBB@ KS#6?B/J.D1W$KQ0.D<S1(JQG+$$X[^U>G
MUXG/!'?OJ=O*5"M-)RRYP0Y[4 7=-^*^H:GN 6TMV'(\R,D'\0:U'\8^)%/'
M]G_]^S_\57G)TB>.4YB9@"-BIPGZ=_K6]9QRPVBI)\SJ#CD?@*$#.C;QGXK
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M6WC1W'FV,2O'=)"@5R=R,<;A@<XP>> ?6M3PQK,NN:2;N9(D?S&3$9R./QH
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M0"<X8' W<'.?SKC_ (4QB/0+Y0,?Z8?_ $!:T=1\+75[XD_M198E4.N%R<X
M'.<<$$< >OM3)-E=+T97ED%M:@LN)#QRIYY]N3^=6$L;%Y9+E((6>8JSR  [
MBIR#GV('Y5S,/@N<QW,-Q?9CGB WHOS(=RMC!ZCY:V]"TJ72]/MX)7!:,29
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MB:!HT8PFDV"C_9MD']*4YR::CHS6G&,'KJ>):3<^&/#]GY5M=6TURWWY3_\
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M&O:Z^==:>X>XO$MLG%W*7V]<;C0"+31:9)(P$F.<,H)VY_I6DD<:1[$ "8Z
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MS)T;;U_.KMA%<0QNMPQ9MV02Q;C\:MT4 %%%% !1110 4444 %%%% !1110
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M444 %%%% !1110 5Y1<?"K5Y;^YN(]9M5669Y IA;(!8G'7WKU<\TFWW/YT
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8% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_06.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_06.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $C F4# 2(  A$! Q$!_\0
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M3\:2T7=:R+C.991C./XVKDHO!MZEKJ$6ZU4W 582LC?NE#*Q7[O3AC]3TZT
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M^='+/O\ A_P1>UP__/M_^!/_ .1.;_X2Z#_GQUC_ ,%<O^%'_"70?\^.L?\
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M#DX ;;Q]/KS3(_#*QVGV<71V^5(A8)R78YW8SCCI[]S6C;ZA'=+N@D5UP#D
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M6SWEE-9"&ZC?)1')^=MQ).SJ,8 /'6JU_H%SJ"V<;3V=O##<F?\ =K(V<XR
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M_,Z*BN=_X1(_]##KW_@9_P#8T?\ ")'_ *&'7O\ P,_^QK3FG_+^*,O8X?\
MY^_^2R_S(-:_Y'SPS_V\?^BVKH;[_D'W/_7)OY&L*T\,06WB*VNY-1U.[EMH
MV:+[5<;PI;Y3QCT-;M]_R#[G_KDW\C3@G=M]2<1*FU"$'?E6]K=6^OJ6*@NT
M9XEVKNVN&*_W@#TJ>BK.8Y+Q6ZS6^EA3N/\ :ML"IZCYNX/-7FT^/)/V<?\
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M<P:Z2&,>9_$3@?PCC/\ *K$F@ZW8C-UIKLHY+Q'>/TI.<[$RQ%;E33_ [O\
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MG_74_P#H#58JO<?Z^T_ZZG_T!J +%%%% !1110 4444 %%%% !1110 4444
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M)'"_Q8.?K3!XYL%C*GPOIY_?F7/' *L-H^7IDY_"E/PD\?G_ )@$G_@1%_\
M%4T_"'Q\?^9?D_\  B+_ .*KT*=7#):O\7_F8V9J?!ZX6Z^+UK.L2Q+*+AQ&
MO1 48X'L*^I:^>_A1\./%F@^/K34]6TLVMI#%+N=ID;)9"H "DGJ:][6*87<
MKEQY;+@ 'I7F9G6C5K)Q=U9(T@K(LT5GO8SE %N,G<3\Q/K2K93!Y-TN5?'
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M>G.*M>1[]/:E$ !Z\>F* ),_+GVJMDLW)ZU:J(P@G@XH YY?$$C/.JVF?*)
MP^2WS!?ZYK4M+G[5!YNTK\[+CGL<5;^S+G/RY_W:7R/]K]* '0L2"#VILK'=
MMSQ4BJ$&!2/&']C0!C76JFV29A&CF,L HE^8E?48XJ ZZX17-J=I#DD,3C;C
MV]_TK<-JA))"DGKE1S0MJBC"A5'H% H 2-B&'/!HN/\ 7VG_ %U/_H#5(L04
MY)R:CN/]?:?]=3_Z U %BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@"M9?ZAO^NTO_H;59JK:?\>LF./WLO\ Z&U)]B)SF5N?0G_&
M@3+=%5TM%48,CGZM4GD1^A_,T!J245$;=#_>'XUGZKHB:C;;4FDBF3F-PY'X
M'':IDVE=*Y<$G)*3LNYJT5QFE)+%XD@%Q-)'<Y=7@W$@C:?_ *QSWK3O=1U%
M->CMX2%M0RJ[>63UQG)QQUX.>3Q44:OM$W:QK7H^RDE>]T=!17(:?J^L3378
ME,A5$S&/(QGYER1@9/#$8]JBDUG7?(A>(2.3+(K[8!TP"G;C@_SK4P.THK-M
MKR_-K"9;"5Y"@+-N1<G'H3Q5;6-1U&#2YI8+.6&5<;6RC]QVR>V: -NBN.;6
M-9_LRTE!D65U?S#Y /.?EXQZ \=:M-JNJ'4I45L6ZHVS]T>2%..<=2>V>G-
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MB_7..<U/110 4444 %%%% !1110!5_YB@_ZX_P#LU.OO^0?<_P#7)OY&F_\
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M?E2[%_NC\JA@NXKA-R$@%BHW#&34RL'4,I!!Z$4 (40]54_A1Y:?W%_*G44
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M0R*O_,4'_7'_ -FIU]_R#[G_ *Y-_(TW_F*#_KC_ .S4Z^_Y!]S_ -<F_D:
M+%%%% !1110 4444 %07-HET%#LZ[3D;3BIZ* *ZV<88-ER0 !D_3_ 5'_9T
M6V52\A$A!;D=?R]JN44 016D,4'E!=R=]QSFIP,# HHH **** "BBB@ HHHH
M KVO^LNO^NW_ +*M%O\ \?%W_P!=!_Z M%K_ *RZ_P"NW_LJT6__ !\7?_70
M?^@+0!8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J]Q_K[3_KJ
M?_0&JQ5>X_U]I_UU/_H#4 6**** "BBB@ HHHH **** "BBB@ HHHH ****
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M^M "?9W_ .>[?D*/L[_\]V_(4AO8U#9*C;][+CC]:#>1JQ4E0P&<%USCUZT
M+]G?_GNWY"C[._\ SW;\A2?;(_DY7Y_N_./F^G-.^U+D# R1D?.O/ZT )]G?
M_GNWY"C[._\ SW;\A2"\C8J 5);A?G'/ZU.C!U# $>QH A^SO_SW;\A1]G?_
M )[M^0JQ10!7^SO_ ,]V_(4T>9#,JL^Y6Z'O5JJ]Q_KH?J: "U_UEU_UV_\
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M 5+>,2V4L9. \DRG\7:N?_X1*\7;MU1<+PH,/ _6NBLR!;N2<#S9?_0VIO\
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M !UYQCC%1IKNFR1"5;GY#((@Q1AECT'3VKGO,TI]1N@TEQ]K G1V,:CY0,L
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M44 %%%% !1110 4444 %%%% !5>X_P!?:?\ 74_^@-5BJ]Q_K[3_ *ZG_P!
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M_P!:I?WG^S1^\_V: (O.G_YXC_OK_P"M1YT__/$?]]?_ %JE_>?[-'[S_9H
MB\Z?_GB/^^O_ *U'G3_\\1_WU_\ 6J7]Y_LT?O/]F@"+SI_^>(_[Z_\ K4>=
M/_SQ'_?7_P!:I?WG^S1^\_V: (O.G_YXC_OK_P"M1YT__/$?]]?_ %JE_>?[
M-'[S_9H B\Z?_GB/^^O_ *U'G3_\\1_WU_\ 6J7]Y_LT?O/]F@"+SI_^>(_[
MZ_\ K4>=/_SQ'_?7_P!:I?WG^S1^\_V: (O.G_YXC_OK_P"M2!999E=P%"]
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M ,<7_"C^W=2_Y^?_ !Q?\*** #^W=2_Y^?\ QQ?\*/[=U+_GY_\ '%_PHHH
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;G1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_07.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_07.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '7 BD# 2(  A$! Q$!_\0
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MYX=R7@=!0234!NX?[_Z4AO(/[_Z&CD?8/:P[HGS1FJ_VN#_GI^AI/MD']_\
M0T^1]A>UAW1<A/[P?Y[U=K+M[J%YE57R21CCWK4K&HFGJ=6'DI1=F%%%%9G0
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% '%^+/$$]EK4.EV>E37MR\'VA3%(%V@-CH1[?K7.WNLZI*3<CPK=
MQB3'S&53G]*W=5Y^*5J/^H4__H9J>0>9HT@[QL?T-10YI5+\UK.VR_4[\6Z%
M&A%.BI-P3=W):Z]FNQQ_]M:G_P!"[=?]_5_PH_MK4_\ H7;K_OZ/\*U]U&ZO
M9]A5_P"?C^Z/^1\W]?PO_0+'_P "J?\ R1D?VUJ?_0NW7_?U?\*/[:U/_H7;
MK_OZO^%:^ZC=1["K_P _']T?\@^OX7_H%C_X%4_^2,C^VM3_ .A=NO\ OZO^
M%']MZG_T+MU_W]'^%:^ZC=1["K_S\?W1_P @^OX7_H%C_P"!5/\ Y(QI-?U"
M&)Y9= N5CC4L[&5< #DGI7DEU%=>,?$9,=U]JN[N0B"!5)VCJ%7T  KT?XC:
MK]@\*R6Z-B6]<0C_ '>K?IQ^-4_@)H'VOQ#?:Y*F8[&+R8B?^>C]?R4?^/5P
M8N-12Y/:-_)?Y'J8#$89Q=3ZM%?]O3_S.9_X5)XJ_P"@5-_WP/\ &C_A4GBO
M_H%S?]\C_&OJJBN/DG_-^"/0^M8?_GPO_ I_YGRM_P *F\6#IID__?(_QI?^
M%4>+A_S#KG\A_P#%5]444<D_YG]R#ZUA_P#GPO\ P*?^9\K_ /"K/%X_Y<+O
M\!_]E1_PK#QB.EE?#Z _XU]444<D_P"=_@'UK#_\^(_^!3_S/E?_ (5OXS3I
M:ZD/H&_QH_X0/QJG2'5Q]%D_QKZHHI\D_P"=_@+ZUA_^?$?OG_F?(&HVNLZ/
M=?9=1U2^M)]H?RYGD5L'H<$^U=SX'UG6(](=#!<:O"')CEW\J.XR<D\YKC/B
M)K1U[Q]J]XC;XEF,$./[B?*,?4@G\:]3\'6']F^&[:$C#%>?KW_7-=.%I5)3
MTF_P./'8S"PI:X>+_P"WI_YD_P#;>J?]"Y=?]_5_PI?[<U3_ *%RZ_[^K_A6
MQNI0U>A["K_S\?W1_P CQO[0PO\ T"Q_\"J?_)&.-<U7_H6[O_OZO^%/&N:K
M_P!"U=_]_5_PK7!IZFDZ%7_GX_NC_D"S#"_] L?_  *I_P#)&0-=U;_H6;O_
M +^K_A3QKVK_ /0L7G_?Y?\ "MI33P:AT*O_ #\?W+_(M8_"_P#0-'_P*I_\
MD87]OZO_ -"Q>?\ ?Y?\*:=>U;_H6+O_ +^K_A6\6INZA4*O_/Q_<O\ (F68
M87_H%C_X%4_^2,/^WM6_Z%F[_P"_J_X4X:_J_P#T+%W_ -_E_P *V@:GC3/+
M' H=&HO^7C^Y?Y$+'85O3"Q_\"J?_)&"NO:P3@>%KP_]ME_PJ1=>U@'YO"EZ
M?^VR_P"%="IP,*,"G@@5FZ57_GX_N7^1:QF$7_,+'_P*I_\ )'/_ /"1ZST'
MA.\ ]IE_PH_X2/6/^A3O?^_Z_P"%=#NHS4^QJ?\ /Q_<O\B_[0PO_0-'_P "
MJ?\ R1SQ\1ZS_P!"I>?]_E_PII\1:S_T*EY_W^7_  KHS32:?L:G_/Q_<O\
M(3Q^%_Z!8_\ @53_ .2.<_X2'6/^A5O/^_R_X4G_  D&L?\ 0JWG_?Y?\*Z/
M-)3]C4_Y^/[E_D3]>PO_ $"Q_P# JG_R1SG_  D&L?\ 0JWG_?Y?\*3_ (2#
M6/\ H5KS_O\ +_A71&FDT_8U/^?C^Y?Y">.PO_0+'_P*I_\ )&+I_BB\CUO3
M[:\T*XM1=3K$DCR@C.?3%>E5YIK'_(?\,?\ 817^5>EUQ3<_:2C)WM;\O(]F
M$*+PM*M2IJ'/S72;:TE;[3;V"BBBD2%%%% !1110 4444 %%%% !1110 444
M4 %%%% %"'6;&XU2;3HI7>YA.) (7VJ<!L%\;<X8'&>]7MRG'S#GISUKD=1\
M)W=W!X@:*\ECGU"8-$@N&$10+$"&7& 3L89P>#WZ5ES>#=5\BPAM(K:&.*83
MGS)@\D+><KL%?RQA2H/RH%Y/)(H [VWN[>[C,EO/'*@9D+(P(#*2"/P((J4L
MHSE@,#/6N#G\)ZK!;3Q:=9Z<A=K^(8E,89+@AED.$ZK@*5YXZ'M3KKP3<R:=
M=A!!]KFO(9G(?!FA2-%\LL5.!N4G&",@9ZT =E>7]O811R7$FU9)$B7 )RSL
M%7I[D59KSX>"+V.[LBEO:R1PO:2)+<7#/+:B*3>\:'8,AL_[([8X%>@T %%%
M% !1110 4444 </J?_)5;7_L%/\ ^AFKL<7[J\A[&1L?B :HZIQ\5+0_]0I_
M_0S6P5Q([#^(@_I65)VYGY_Y';CU=4D_Y(_G(Y#=1NJ\='O);B3"!(]QPS'M
MGTJV/#ZE,>>Y?U &*]^6)I1M=GQ\<'7E>T?OT,;=1NI]Y9SV3XE7Y3]UQT-5
MM^:WBU)7CL<LU*#Y9*S)MU&ZH2V.O%175Y'96<]U*?W<,9D;Z 9IM65V)-MV
M1Y7\2M5^V>(Q:*V8K&/8?]\\M_0?A7OGPLT#_A'O &GQ2)MN+E?M4_KN?D#\
M%VC\*^=?"NDR^,/'EE:3 L+NY,UQ[(#N?]./QKZ[P%4*H  X ':O J3YYN7<
M^JI4U3@H+H+N%&X4F*SK_6(-/FCBD1V9U9_E(^4#N<GWI1BY.R*E)15V:6X>
MM)YBYZUCKXALVP-DH)_W?3/K5RSNXM0LH[N L8I1E=PP?2K=*45>2)51/1,M
M^:F2-PXZUC:W:7][(BVES L+1LC"21E\MCT<!?OX_NG K1V  @=Z8RTE%"<Y
M+8H2VM\&;9J81> @,G0 8&>.3W-9^MZA+X9\(ZSJT^HO<O!;$1#>" V,*>G4
ML15C4[D091(9)93Z(<#ZFO,_C!J4MAX+T_2I#MN=2N3/*O0B./H,?4K52I*,
M.:Y,*TISY;'D&A6C7^MVD!^8F3>_OCD_Y]Z^@($$,$<0Z(H%>2_#:P\[5Y;M
MAE8@%!_4_P!/SKUC=7=@:?N.7<\O-:OOJ'8GW4H:H U.#5W6/)YBP&J1344,
M$\T32QQET5@I([$U*898WV.F&QNQN'(SCC\:AVV*2E:]B933MU"VUQY@CV#<
M=W1P1QU[TUXY8XT=DPLAPN""2>G2L]'U*:DEL*6IH)8X%#12*3N7@9R5.<8.
M#^M221R0 ;HV4$$YQFG=$\LGJT/4!.O+?RJS;F-G(F( QD$^W/Z]*@%M<XXB
MYR!@L,\].,T)!/(%*IG=TYYZ9Y].E0[/J:+FB](F@&M03TP 'QGKG^'\./RI
M0+;)4LORG:&SUR.OX&L\94D$8(."*ECCDE^XN1G!)( !K-PMU*55R=N5%I3$
MKNV$*_P GWQ3\PG.T1[AD*">#S_A5,13%MNS!QGEASSBE$4I9%V<N-RY..,9
MI.*[EJ4OY2Y))"6<X1B=QR?7/%(WV?YL;=O.3GD>F*I,'2-9&3"L<#D'-(X=
M,[EZ9SCG&#@T*'F#JRZQ+Q$.3CR]W.P9X(XQGWZU'$(\G>8R21P6X"]_QJK(
MLD8!=" >AQFE$4K*" F""1^\'0?C1RZ;BYVW\);C$+-PJE54$D]SGO\ A5.3
M*R."NT@GCTI8DN#AHD?#';D?YZ>],P<G<2#W'>FE9[DSDW%:6,75_P#D/^&?
M^PBO\J],KS36 !KWAC /_(27K]*]+KRZO\>?R_(^KH+_ (3L/_V__P"EA111
M2)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#"O/%$-GJ[V+6-TT<3P1S
M7*[/+C,QVIG+;CS@' XR*IKXVCDL(;J/1[]_-A>Y$0\L.+=,9D/S8ZM@+G<?
M2KK^%K&?Q!-K%R9)9',)2+>RHICSM)4'#$$Y&1P>E/N/"ND7-I:VKVSK%;1&
M&,1S.A\LXRC$$%E.!D'(.* ,N3Q_IZW%VL5I<S0VT$D[2QE"2$"DC9NW G>N
M,@9YJQ=>,8+"\6UO;&>"5H))MGFQ.P*(9"I57)'RJ>>F>,U%!X)ACU*^EEOI
M)+&\,GF684JK!N@)!QA>V #ZD]]*X\+:1=7\MY-;,TTV[?B9PI+1^6S;0<9*
M?+G&<4 9]GXTBNKZ*UDTF_MM\J0F27R]J-(F^/.&)Y'IT/6NHK-&@::)A*+;
MYQ)'+G>WWHUVH>O8<5I4 8UWJ>M0W4D=MX?:XA4X647<:;AZX/(J#^V/$'_0
MK/\ ^!T5=!14<K_F_(Z57II6=)/YR_S.?_MCQ!_T*S_^!T5']L>(/^A6?_P.
MBKH**.1_S/\ #_(?UBG_ ,^H_?+_ .2.?_MCQ!_T*S_^!T5']L>(/^A6?_P.
MBKH**.1_S/\ #_(/K%/_ )]1^^7_ ,D>>&>]O/B;;-?:>;&0:8X"&99-PW]<
MKTKJ_*QTK!U%L?%:SSQ_Q*G'_CYKH@PS@]:BDK<WJ_T-LPDI.DTK>Y'3YR[D
M17%)BK! (J%EP:U//(WCCEC:.1%=3U!'6L2[@:RFV@#RVY4X_2MQN"#45W;B
MZMF0\'J#Z&LZL7*-DS2E)1G=HY_S6!PQR#ZU%>Z;9:E:R6UU;I)#(,.OW<C\
M*)"QS%CYQP?8U9A4L>>F*XH59K1-_>=U2E3>KBON1E>'O#>D>%M6EU'2;3R[
MB2(Q9=RX5203C/0\"NF'B>[B?;+!$_HPR*H[".HS5>6-G0@'#>]:<\TM&3&G
M!NS1>O\ 5+BY<2I(8BJXPC$ U534YFB+BX+]1AVS6G8>%8+BSBEGO)9 Z@XC
M 4?3/)J_'X3T9$"FU+@?WW8_UKHA*O;XOZ^XPFL,G\-W_7F<Y;:DL]U''(I;
M+9*I$K;@!R/QKI8]:MA)'!Y$Z$L$3]UA<^WM5JUT>QLB3:V\<+'C<BC/YU9\
MD_WS^5=4)MQM4=W]QQU(KFO25E]XTU7=)221*47N:LF!C_&*:;=\8R"*::1#
MBV1Q.9$^7=C.T$]3[U\V?&761JGQ"N+=&S#IT2VR_P"]]YOU./PKZ1NITTNP
MN;VX($%M$\K<]E!)KXYDEGUO67GE),]]<%W/N[9/\ZF3N]"X)I:GJ'P_LOLF
M@K*PP\WS?GS_ "Q76[JSM/B6VL(8E& %'%6@]>_0I<E-1/D\77]I6E+S+ :G
M!JKAJ>&K6QS<QJV-Y';PNDAW!W& (P=F"#NYZ] ,?C4WVFW\PJLTGE&,C=Y?
M.[S"P./;-9*FI0:Q=-7N;+$245'L:T-]"MU%*W""1]RB,#(;')^O>@7I:&U*
MNR/%(,D]E'3'8]36:O3<W3^=.:3N?P%0Z4;EK$3MK_7]6-&:YAEMPB2^4BES
MY8!)=BV02?3G..U'VY2KIYKE$B9$W%MTA((.1TQDYYZ8K+,A)IZ&G[)6,I8N
M5]#36:U:!(75R2%)=2<*1T]^YR1[5/!=1(ELNYP(P=_R9SGJ!S_.LU*G4UG*
MFBX8F=[Z%@[/WA#9;?\ *%&!MQ3X)(XF9G4M@@@ D$X_SS4 -+FI<;JPXU+2
MYD3QRP0M(R>8 \9 ')()/.:>+F(2VSEMQ3Y7Q'C(Z=^V/QJL%)^GO3A&/<U+
MBNIO&K.VB_J]QYNCY4(0LKQR?DN<C'8_E2RR))"45_+4,[; "2Y)R#GT]J9L
M(')"BF-)$GJQIJ*Z%.<K>\R<3C!7S7940A22<N2#GCTR>_I4D<R(L9.-RQ>7
MDIDKSU_#TK/:Y/\ " *B:5FZDFG[*Y/UGEV-*.:V2)!+(#(A)&U6'//I^%0O
M<)YKF, @L2#C''TJCOI0V>E4J26IC/$RDDK%+5I3)K_AG)_YB*_RKTVO+M15
MQK_ADLI _M%>OTKU&O&K*U>?R_(^OPS;R[#M_P!__P!+"BBBI **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .
M)U$!OBK:!O\ H$O_ .AFN@D&%]37->++>YM_%EKJMGK.C64RV9A\O4)=I8%B
M<@>E9YUG73U\4>#_ /OZ:YE54')-=?+R\SVZF!GB:=*<)+2*6O-NG+M!]^YV
MT;Y&*5QD5PXU?7 <CQ1X/_[_ !IW]LZZ?^9H\'?]_35?6(]G^'^9C_8];^:/
M_DW_ ,@=?(P QWI@R_?BN/.IZVW7Q1X/_P"_QI1JNMCIXH\'_P#?XTOK$>S_
M  _S'_8];^:/_DW_ ,@:=_$(M0DX/S_,,"G0LJ>OXUS>L)J.N6OV>\\4>% F
M0<Q73(V1TY!JA;:/?6@Q#XST'_@6HR-_,U@W&]TOR_S.E9=6:2E)?^3?_('<
M$@U7O% A)!^8=*PDDU5$VGQ3X3;W:X.:4S:H1@^)O")_[;FDY)]/R_S''+JB
M?Q+_ ,F_^0.RTOQ-H]II]M;7VJ6EM<*N/+FF5"1G@X-:T6MZ3-_JM4LGS_=N
M%/\ 6O%]<\(P^(;F*?4/$'A5Y(TV*4O'7C.>QK);X7:0V,ZYX8X]+^3_ !K>
M-=))-/\ #_,YYY15<FU*/_DW_P @?1*3PR_ZN5'_ -U@:DKYVB^&NG0G,7B/
MPZG^[J<H_K5V+P8T'^I\9Z/'C^[K$X_]FJOK$>S_  _S)_L>M_-'_P F_P#D
M#WRBO$8='U6W_P!5\0=-7_N,S'^9J]"/$,/W?B%HS?[^H,W\Z/K$>S_#_,/[
M'K?S1_\ )O\ Y W/C5K/]E_#RXMT;$VH2+;+SSM/+?H"/QKP+P;9?:]>1B/E
MA7=^)X']:]3\0:%<^*8[9-9\6^&[I;8L8@;UEP3U/&,]*J:7X.@T=G:S\0>%
ME+XR6O';^9]ZNGB::FG).WR_S,ZN38ETY*$HWMI\7_RLT@U6ECMC+$IN\(T>
MYW\L_(W]W'?MS[U7_LVY_P"AD\)_^!3?XT?V=<_]#)X3_P# IO\ &O8EG&'>
MW,ODO\SYR/"..6\H/YS_ /E9,?+%LL@DW3%B#%MZ#L<^]/MRDEL\DC&.4 %8
M\9W'/(SVQ5<6%T/^9D\)_P#@2W^-.%E=C_F9?"?_ ($M_C2>;T/[WW+_ #'_
M *HXZ_Q0^^?_ ,K+SB-2GER^8"H+';C![C_Z]/0 C)Z?SJ@+6\'_ #,OA+_P
M);_&G>3??]#+X2_\"&_QJ?[7H=G]R_S'_JCCKWYH??+_ .5E\OW/X"HRQ)JH
M8+X]?$OA+_P);_&@07P_YF7PE_X$M_C0LWP_9_A_\D3+A#'O[</OE_\ *RZH
MJ=!6:$OQ_P S+X1_\"&_QIP_M$?\S+X1_P# AJ3S>CV?X?YDK@W'?SP^^7_R
MLUUXJ0-6+NU+_H9O"/\ X$-2A]24Y'B;PC_W_:H>:T>S_#_,I<'X[^>'WR_^
M5F\H)Y/ J>.,GH/Q-<ZL^J*<_P#"3>$/QG-*UUJ[#!\4>$<>TYJ'F=)]'^'^
M9M#A+&1WE'[Y?_*SI"8T^\VX^@J-[D]% 45DV6F^)M21GL=7\-W**<,T+.X!
M]#BK/_"-^-/^?K0O^^9?\*:Q]-Z\LG\O^"1/A_$Q?*ZM-?\ ;S_^0)7D+=3F
MHB:3_A&O&?\ S]:%_P!\R_X4]?#WC1?NW.@C_@$G^%7_ &C36T)?=_P3+_5V
ML]Z]/_P)_P#R BQ2/T4_C4@M?[[@>PIO]@>-C_R]Z%_WQ+_A1_PC_C;_ )^]
M"_[XD_PI/,H_RO[O^":+AR2WK4__  )__($RPQK_  EOK4@(7IA1[54/A[QJ
M?^7O0_\ OF7_  J,^&/&;=;S1/RE_P *7U^#WC+[O^"5_8%1?#5I_P#@3_\
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MQUK3DAV7W''];Q'_ #\E_P"!/_,;_P (AX;_ .@%I_\ X#K_ (4?\(AX;_Z
M6G_^ Z_X4I\10",,T$P)4' P>3VZ^G-:=K<I=VRSQ_=;/7ZT>SAV7W!]<Q'_
M #\E_P"!/_,R_P#A$/#?_0"T_P#\!U_PH_X1#PW_ - +3_\ P'7_  K1OKQ+
M"T:X=&=5(&U>IR<?UK.3Q+;,ZJT,R;DW_,,'\J/9P[+[@^N8C_GY+_P)_P"8
M?\(AX;_Z 6G_ /@.O^%'_"(>&_\ H!:?_P" Z_X5-!KL$]RD CD1GP/F  !Y
MX^O%:E'LX=E]P?7,1_S\E_X$_P#,Q?\ A$/#?_0"T_\ \!U_PH_X1#PW_P!
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MU&.(IMO^\>T;7_OG\A1M?^^?R%<C_P (UXM_Z'9__!?'_C1_PC7BW_H=G_\
M!?'_ (UM[27\C_#_ #/.^IT/^?\ '[I__(G7;7_OG\A1M?\ OG\A7(_\(UXM
M_P"AV?\ \%\?^-'_  C7BW_H=G_\%\?^-'M)?R/\/\P^IT/^?\?NG_\ (G7;
M7_OG\A1M?^^?R%<C_P (UXM_Z'9__!?'_C1_PC7BW_H=G_\ !?'_ (T>TE_(
M_P /\P^IT/\ G_'[I_\ R)UVU_[Y_(4;7_OG\A7(_P#"->+?^AV?_P %\?\
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MU7NON_X)Q>TP'_/N?_@2_P#D3E/^%E>%/^@R?_ :3_XFC_A97A3_ *#)_P#
M:3_XFNK\B'_GDG_?(H\B'_GDG_?(HM5[K[O^"'M,!_S[G_X$O_D3E/\ A97A
M3_H,G_P&D_\ B:/^%E>%/^@R?_ :3_XFNK\B'_GDG_?(H\B'_GDG_?(HM5[K
M[O\ @A[3 ?\ /N?_ ($O_D3G+#Q]X:U"^AL[;5/-GF8)&GD.,D].2M=/7&^,
MHT36O"NQ%7_B9KT&.U=E13E)MJ706+I48PIU**:4D]&T]G;HD%%%%:G"%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7$K7FC>3I<'#WTLRA< 8^5!DG)P ._M71><K'"_C7)>-_#^M^)$AL[.XMHK
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M?_Q=;]%'++^;\$/VU#_GU_Y-(P/^$FF_Z%O6_P#OS'_\71_PDTW_ $+>M_\
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ME'B;_H2;G_P-3_"CVDN__DK%]2H_\^__ "M#_(/^%F>&?^?BY_\  5_\*/\
MA9GAG_GXN?\ P%?_  H_X2CQ-_T)-S_X&I_A1_PE'B;_ *$FY_\  U/\*/:2
M[_\ DK#ZE1_Y]_\ E:'^0?\ "S/#/_/Q<_\ @*_^%'_"S/#/_/Q<_P#@*_\
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M5R'_  E'B;_H2;G_ ,#4_P */^$H\3?]"3<_^!J?X5/MH^?W/_(?]FU_[O\
MX'#_ .2.OHKD/^$H\3?]"3<_^!J?X4?\)1XF_P"A)N?_  -3_"CVT?/[G_D'
M]FU_[O\ X'#_ .2.OHKD/^$H\3?]"3<_^!J?X4?\)1XF_P"A)N?_  -3_"CV
MT?/[G_D']FU_[O\ X'#_ .2.OHKD/^$H\3?]"3<_^!J?X4?\)1XF_P"A)N?_
M  -3_"CVT?/[G_D']FU_[O\ X'#_ .2.OHKD/^$H\3?]"3<_^!J?X4?\)1XF
M_P"A)N?_  -3_"CVT?/[G_D']FU_[O\ X'#_ .2.OHKD/^$H\3?]"3<_^!J?
MX4?\)1XF_P"A)N?_  -3_"CVT?/[G_D']FU_[O\ X'#_ .2.OHKD/^$H\3?]
M"3<_^!J?X4?\)1XF_P"A)N?_  -3_"CVT?/[G_D']FU_[O\ X'#_ .2.OHKD
M/^$H\3?]"3<_^!J?X4?\)1XF_P"A)N?_  -3_"CVT?/[G_D']FU_[O\ X'#_
M .2.OHKD/^$H\3?]"3<_^!J?X4?\)1XF_P"A)N?_  -3_"CVT?/[G_D']FU_
M[O\ X'#_ .2.OHKD/^$H\3?]"3<_^!J?X4?\)1XF_P"A)N?_  -3_"CVT?/[
MG_D']FU_[O\ X'#_ .2,32/%6E^'?$'B6'47F1YM19TV0LP(Z=A6W_PLSPS_
M ,_%S_X"O_A1_P )1XF_Z$FY_P# U/\ "C_A*/$W_0DW/_@:G^%81DXJR?\
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M>R:]"/\ L&(W$97PWJ*Q*CAP[ABS$_(>W0<8SSP?:M%=&MC]WPO?-R",S9!
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M@;50=^.E1,"QR:(R!\IJ3%5RCOS(BV>U+LJ4+S3@A/:GR!RE?91Y=78K9Y9
MB*23TJ2YLI;0*9$(W?=R,9HY$5[&?+S6T,=T^<XIGEFKP@8Y..V:3R_:G[,Y
M90?8Z;X6Q@^.=/5E!4W$0((R#\U?5_V*T_Y]8?\ OV*^6?AFNWQSIG_7S%_Z
M%7U;7R^.BEBYK_#^1VXAN.&H)/I+_P!*(/L5I_SZP_\ ?L4?8K3_ )]8?^_8
MJ>BN:R.'GEW?WD'V*T_Y]8?^_8H^Q6G_ #ZP_P#?L5/119!SR[O[R#[%:?\
M/K#_ -^Q4]%%.PG)O=F5XEU631/#UYJ,*Q-) H($S$)RP&6(Z#FL"S\5:I=W
MRVL::?.(7N#-/!N99DB$1Q$,_>/F[3DD KWZ5UE]8V^I6<EI=)OADQN7)&<$
M$=/<"GQ6T$"HL,,<:H"%"* %!Y.,=*!' CQ]?+:H[?V=(9T@E26W#R+ )-YV
M.H.68;.Q7.3P,<W5\5:M''*UZ-/M3!;6ID^1Y"9YOX0 V, \=><]0.:Z._\
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M- F[%ZBJ(FO2WW$Q^/\ A4P^TG^Z/K0',6**AVW']]/RI"+G^\AH"Y/15?\
MTK_9H'VG_9% 7+%%,C$@!\P@GMBOGWQ5\<?%.B>+M7TJUL]+:WL[J2&-I(G+
M%5.!DAAS0E<9]"T5\Q_\-"^+_P#GRT@_2&3_ .+IP_:#\7G_ )<=(_[\R?\
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M19KY'E&[<0RX)[?P_2K$5KXF64[[NW*;".!W['I6QYX?\(L/(>+[=(590HW
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M'_OR*K][Y?B8VP'>?W0_S+7_  D6A_\ 09T[_P "D_QH_P"$BT/_ *#.G?\
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M;!&E*/K2=!=OS$\?-=+?-?YG%Q>#Y70!5!_&NKT^*\T_31:K9%0J;<Q/@/\
M45OPW4$0_>0P1?5P*FDUW38D.9("P[*<U"IJ&J=C"IBZE71QO_7D><VGA+=*
M[W,3>5&I=E'5N>!GW)KLX=&T_2S%?21?-;H BJ21N/8#IC\/>I#K]FTI*@!0
M,OZ8J&'Q%'*)Y1@*O!+<K[#'K12E&.B8ZTJU7XE9&=+.+FX-PVTRLVXJ691G
M\>U2OH6I:E%+<$P%6).TC=GO@9Z"H+K6+8WS+\I=$S(<'A@.G7U-++XC>TAP
M\RK@[2-WYUZ%*HDM-S"=.;7NJQS-]$NGV\L7V6 3L2NX*0P'?V%<G=PQ"!T-
MLSW#D,LGFC 4=B/_ *_&*Z&^U:WE4W!EBWE\!2&X'7()XK)_MCR[6Z@6.!A,
MHX #$GZGI^%=BFK^X9\LE\2.3N(7R0751Z+5![= ?XF/UQ_*M:YN74G,07Z+
M6;+=9K>,^YC)/H=IX!\4:!X?N-/%]IY@N8)Y7DU!8@Y:-D("'C=U(_*JVG^*
M= A\4Z7>KIIL;>VM)X;F984S/(R$+(57W-<3).#W%5VE'M^=.-&#DWKKYG/)
M,]0/C?P^-)$+SR_:%TF:T<B A9YF7"MU/MR>E9_A7QAX=T3PY9V^L&ZOY=^U
M+6,!DL1WF4NO^LSR ,UP=KJ/V-9A]EMIO, &9H]Q3K]WTZ_I45QJ2S7,<PL;
M6+9CY(T(5L>H)K6.%C9QUMOO_P #^O0B[.E;Q6VE^/WU;3]2:YC=E1[UMWF/
M&3AB00"&V\8P?:M/Q/XNT*\T'6]&LKJ]G@-RDFF#!V8(!D:3=SG.[ KB/[7Y
M_P"/"Q/&"/)'O_C^@ITVN">57.EZ<@  *QPX!P",]>O.?KBNJ.'BY1E9W5NJ
MZ?(F[/4;3Q_X932TM9+UD:XBA$J267VA,Q@?Z]SAG/'RE,;>^:Y&W\;1:;K/
MB.:U,[6^K'82X$K;.?XB5YY]*YE=8"C']G6##MNASCK_ (_H*B&I +.OV*S(
MF+'F+F/..%],8X]*TI8&G&ZU=_-=[]A.3.MO-8\/2Z/IDGVN9]2CU)))HS%N
MC%N.<D$8+>V>:[*;XC>%(I[F*SB@-I/#"-AMW095#D$ 8/)Z'CBO(&U+='&A
MLK,;/XA%@MTZ_E3_ .U<R!S86)(4C'D\')ZXK2>6PJ)*3>E^J[W[ I6/1/!/
MBWPKINAR0ZNRI>?;6G#"T#,4Y(&X#U^F,U8UWQGX8N/&WAG5;"ZD,5M*XO96
MB8,%. &)&&9L$_D*\PCU QWYNQ:6IRI7RFB!C'&,[3W[_6K*:V57']F:<W[K
MRLM;C/\ O?[WO5O*X.HZEW=WZKJK=@YM+'JEQ\0= DM]3@759GC:"5;7S+<A
M6<C"EMIW-QQS^-9?ACQ[I.BZ3X9MVE7?;1SQ7^Z)B55Y5=2OJ<#\.E>;W&H^
M?=1W'V.UC*$'8D>$./4=ZMIKR*0S:-I;MYA<DP]?]G .,5"RFFJ?)J[Z[KM;
MM_3#G=SO)/'VG3_%2TUMYHDL+:,PQ3>2V53>QW%1R6PQ_3BG:WXV\/ZCX+UJ
MS@>/[7-<2?8X98"-L;,N7X7:LAP><]#SS7GPUL  ?V7II4*R@&#UQSGKD8J7
M_A($*@-HNE'"!0?((Z'.>O6K_LV"E&23]VW5=/ZU#F9Z';^/O#L&F>&M.$LA
MB@A3[?\ NG^5^-V2"-W?U%9EMXMT&U\4>,KJ*Y=+'4;)[>Q(A8G>0-IQ_"!@
M\^]<6-<"Y TK3=OF!\>1GIVR><'N*<NOJ)TE_L?2]RLS8\CY3GL1TP.U*.60
MCS6OKYKO?M_2#F.]\=>,?"^K^#(-/TIG>[CDB(C9"%@ !+!"1R,X!Z=,UJ/\
M0O##?$.TUD3?Z!'"JNWE,&R$(^YM]37C]W=BZ$0%M!#Y8(_=+C=SGFJU-912
MY%!R?7JNMO\ (.=EG4)DN=3NYXL^7+,[KD8X+$BJU%%>JE96("BBBF![%^SU
M_P C-K'_ %YK_P"ABOH6OGK]GK_D9=8_Z\U_]#%?0M?$YW_ODO1?D;T_A"BB
MBO)+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@#D/&'B P/+X?@TJ[OKB\LG<>0 =JG*\CK_^NO+E\/ZY&,1^
M&;S_ (%;D_UKU*Y_Y*S9?]@E_P#T9775G"=6\N65M>R/4J/#4(4[TN9N*;?-
M);M]%IT/ QI?BE/N:#<I]+(G_P!FJ3[%XS'W=,OT_P!VR _K7O%%-^V?VW]R
M%''8=;8>/_@4CP@6?C0_>L]8QZ+;X_K2_P!G>*&_UFFZT_UB/^->[45#IS>\
MV:QS6E':A%?-GABZ9KPZZ%JS'WA_^O3OL7B(#Y- U(?6W_\ KU[C12]B_P";
M\$7_ &Q'_GRO_ I'B2V>OFU$4FA:N6+EF*P  C& .OU_.K$T>N&-8X/#FJHL
M8R@,&<O_ 'FYY]A7LM%"HR7VOP1+S:#=W17_ (%(\*M-*U^!G:70]5D9R"3Y
M'ISZ^N#^%1:GHOB"_<;-$U2-%& #;Y_K]:]ZHIJG-*RE^"!YK!N[HK_P*1\Y
M/X2\1NN/[)U/'_7L?\:JR>!?$+G/]E:D#Z_9?_KU]+T5:51?;_!$O,Z;_P"7
M*_\  I'S,/ WBA?NV&IX]#:9_K0? GB)_P#6Z+>/[_8R#_Z%7TS16T:^)CM4
M_!&$L7AI;T%_X%(^8V^'6L./^0-JBG_9MS_C5:3X9:XWW=,U/\;3_P"O7U+1
M6GUO%?S_ /DJ(]OAO^?'_D\SY4/PM\0'_F&ZA_X"'_XJFGX5^(?^@?J/_@(?
M_BJ^K:*:QF*7V_\ R5!]8PO_ #X7_@4SY1_X55XA_P"?#4O_  $/_P 51_PJ
MKQ#_ ,^&H_\ @'_]E7U=15+,,8O^7G_DJ#V^%_Y\+_P*9\H_\*J\0_\ 0/U'
M_P  S_\ %4?\*J\0_P#0/U'_ ,!#_P#%5]7452S/'+_EY_Y+$7ML)_SX7_@4
MSY1_X55XA_Z!^H_^ A_QI?\ A5?B'_H'ZC_X"'_XJOJVBK6:X]?\O?\ R6(>
MVPG_ #X7_@4SY2_X57X@_P"@?J/_ ("?_7H_X57XA_Z!^H_^ G_UZ^K:*?\
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M&D);:QQPPP=H7U!'7\<\/_PO8;R@\.MN[9NP ?QVU&?CV5)4^&)0XZC[4/\
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M%/@$Q:;Q"S$DGR,D_P# Z]KKY;,7?$R^7Y'KX:_LE<SKC7=,M;N2UFNU6>,
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M]#O%?&2-HZ_G7=!41*CC(ZN_W>2\C8;QNS07<<EF&>XQ\[2?=PH'''3BHO\
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MK_)#W\9SFZED6R #ILVI,4./F[KC/WN?I34\9SV0M9I;5I);>,QJ6FXP=G0
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M_P J["N.\9,&UGPH1_T$U[>U=C6,/CE\OR/0Q/\ NU#TE_Z4%%%%:G %%%%
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1%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image_08.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_08.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  ^ ,0# 2(  A$! Q$!_\0
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M>?L9^-? EG:S,K26I\4&PU7P)=S1'/\ 9_BV\1UD1F0_U!_\&UW[:+_MC_\
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MEF9CXL 50.220 .2:'9):)W5];]WY@DY2G><E:5DDTE:R?5'\VG[)'_!P?\
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M$;P]-X_^*&M:9;^#=*NM2NO!GA&Y>]U/2-6^[_\ @LK_ ,$L/VH?VCOVX?\
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M\[26M[H2ZBJW]H\<*NK7ZK3[^OR5U\RG%\]K>ZVIM]+I;?-I/Y'Y[O=?:/\
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M/#FJ:G=M##';Q-=7]]IL]U<-%;PPP1F65RD,4<2X1%49?_"B?@A_T1OX5?\
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M  <^(?\ XFOWO_X43\$/^B-_"K_PWGA'_P"4]'_"B?@A_P!$;^%7_AO/"/\
M\IZ/];O"[_HV57_P^3_^7!_Q _Z8/_276&_\5[0_^8#\W/V&/^"D_C3]K7XS
M7_PPU_X7:%X-L+3P-KGBQ=6T[4=5N;B2YTG4] L([/R[T>28YDUB25B,2*8
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M++\N^I0I44G@(4L3!UN2]7ZS=R?)I_)'_P $;OC=\>/%W[17PUT:?XI?M/\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image_09.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_09.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  4 $<# 2(  A$! Q$!_\0
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MM_K6ZT>/5+/PKX:T[Q!XKN['Q%/=^"HM.T*\N_$>AZI;0^77R=^U/\4/A_\
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1T[76VSLKVM_G[/1113$?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_10.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  > $<# 2(  A$! Q$!_\0
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6Y[CJ*@1R% ;D\\C@<''3G^M% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_11.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  5 $<# 2(  A$! Q$!_\0
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M]S7BDVE%WCJ_=;;8<TGNWNWOU=KOIJ[+7?1:Z'E]O^QQ^R_9_#NV^$EG\$_
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*G4]CHHHJB3__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_12.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  3 $<# 2(  A$! Q$!_\0
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MBX^*O@KXO6?AJ[;6=(N?V?XM%UG4O%'B+2FAT7Q5:ZGX;TCPTTFO336\WO\
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:75M&^['=ZZO7?5Z]====4GK?8["BBBF(_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_13.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  9 $<# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^[KQY\4/
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M(OV -%\"_#KQ=\6O%?@?QIX3\-ZEH?QB\?ZCJ%U\9=5D\.>/]"\92V=SX/\
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MO)5MC?Z;=Q6ZPGS'7_V(/@GXEA_L;5++5YO"%S\/?&?@O6-#_M:__MC6=?\
M&?B_P;XVG^*]UX[^U?\ ":P?%;1=?\%:9J/A_P ;V6LV^NZ/?B&\TZ]M9--T
MQ;7[#HHY(Z:6MRV2T2Y5:/*E91LM%RJ.B6UE9MWO?6[N[I-MWO[S:;EJV_><
MEJ[IW9R'@#P=!\/O!?AKP3;>(/%WBN#PSI-MI$/B/Q]XBOO%WC/68[52B7WB
M3Q-J1;4-<U65<?:-1O&:XN" TK,V22NOHJKMZMW;U;>K;[M]6+TLET2222V2
*26B22226B1__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ex23-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !. /H# 2(  A$! Q$!_\0
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MQ;_)GT&0Y_G]/.:W#>:SC*JZ;G3J1C;[T>9)_P %W])5?^2>WW![:Q'W_P"
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M']#U":ZTB?3[3RTO[_S8["Q2;R1*HC'FOP_2W4'AJ!GG?_!D:?\ C)'XY_\
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M1G)/7[6WT'[Z6/C/1]1\0WVD6VI6,^JZ6D,M[91S*UQ9I-N\EI4!W('V/M+
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MYRKV_2@#\P/VO_V7?B9^S'X+\-_"CX=^$?$GQ"^!?B;XA^$]6T"VT^![R_\
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M1\.+?PG=7&O:1IT.H1W7VG04NQ9VN)HKQVF@@,2MY-ZJ+N$-?7GA_P#X*!_
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M/F\H0E)N*7-HF]M^FQ^8O_#W_P"-G_0:\/\ _@KC_P :/^'O_P ;/^@UX?\
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:@P.)P>7TL/C*GM*D4DY?S/N24445SGL'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ex23-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  Q &0# 2(  A$! Q$!_\0
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,#[U%% "T444 ?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
